Citrus Sinensis ID: 030527

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-----
Protein Sequence
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEEccEEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEEcccccccccccccccccccccccHHHHHcccccccccccHHHHHHHHHHHHcccccccccccccc
Secondary Structure Prediction (SSPRO)
ccEEEcHHHHHHHHHHHHHHHHcccccEEEEEEEEcccccEEEEEEEccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccEcccccEEEccccccEEccccccEccccccHHHccHHHHHHHHEccHHHHHHHHHHHHHHHHcccccccccHHHHc
Coil and Loop (DISEMBL)
MLKKLNKHLKSCLDCELNflssvnhpniiRLFDAFQAENCIFLVVEFCaggnlssyirlhgrvPEQTARKFLQQLGLEIlnshhiihrdlkpenillsgldddvMLKIADFglsctlypgnyaekvcgsplymapevlqfqrydekvdmWSVGAILFELlngyppfsvgeehqfm
Flexible Loop (DISEMBL)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM
Low Complexity Region (SEG)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM
Disordered region (IsUnstruct)
*******HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDL***************LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF*********
Disordered Region (DISOPRED)
************LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV***HQFM
Disordered Region (DISEMBL)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM
Disordered Region (DISPRO)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	175	2.2.26 [Sep-21-2011]
Q9QY01	1037	Serine/threonine-protein	yes	no	0.862	0.145	0.446	1e-36
Q8IYT8	1036	Serine/threonine-protein	yes	no	0.862	0.145	0.446	2e-36
Q5ZJH6	468	Serine/threonine-protein	no	no	0.937	0.350	0.467	4e-36
A7KAL2	960	Serine/threonine-protein	yes	no	0.942	0.171	0.376	1e-35
Q86CS2	668	Serine/threonine-protein	yes	no	0.937	0.245	0.431	1e-35
Q0CLX3	964	Serine/threonine-protein	N/A	no	0.942	0.171	0.381	3e-35
Q3U3Q1	472	Serine/threonine-protein	no	no	0.931	0.345	0.476	5e-35
D3ZHP7	472	Serine/threonine-protein	no	no	0.931	0.345	0.476	5e-35
Q2UGZ7	934	Serine/threonine-protein	yes	no	0.942	0.176	0.376	6e-35
Q1DN93	969	Serine/threonine-protein	N/A	no	0.96	0.173	0.371	9e-35

>sp|Q9QY01|ULK2_MOUSE Serine/threonine-protein kinase ULK2 OS=Mus musculus GN=Ulk2 PE=1 SV=1

 Score =  152 bits (383), Expect = 1e-36,   Method: Composition-based stats.
 Identities = 71/159 (44%), Positives = 102/159 (64%), Gaps = 8/159 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y++  G + E T R FL Q+
Sbjct: 56  EIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQI 115

Query: 76  G--LEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGNYAEKVC 127
              + IL+S  IIHRDLKP+NILLS  +        + +KIADFG +  L+    A  +C
Sbjct: 116 AAAMRILHSKGIIHRDLKPQNILLSYANRRKSNVSGIRIKIADFGFARYLHSNTMAATLC 175

Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           GSP+YMAPEV+  Q YD K D+WS+G ++++ L G PPF
Sbjct: 176 GSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPF 214

Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652, FRS2, FRS3 and RPTOR; however such data need additional evidences. Not involved in ammonia-induced autophagy or in autophagic response of cerebellar granule neurons (CGN) to low potassium concentration. Plays a role early in neuronal differentiation and is required for granule cell axon formation: may govern axon formation via Ras-like GTPase signaling and through regulation of the Rab5-mediated endocytic pathways within developing axons.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8IYT8|ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens GN=ULK2 PE=1 SV=3

 Score =  151 bits (382), Expect = 2e-36,   Method: Composition-based stats.
 Identities = 71/159 (44%), Positives = 102/159 (64%), Gaps = 8/159 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y++  G + E T R FL Q+
Sbjct: 56  EIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQI 115

Query: 76  G--LEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGNYAEKVC 127
              + IL+S  IIHRDLKP+NILLS  +        + +KIADFG +  L+    A  +C
Sbjct: 116 AAAMRILHSKGIIHRDLKPQNILLSYANRRKSSVSGIRIKIADFGFARYLHSNMMAATLC 175

Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           GSP+YMAPEV+  Q YD K D+WS+G ++++ L G PPF
Sbjct: 176 GSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPF 214

Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652, FRS2, FRS3 and RPTOR; however such data need additional evidences. Not involved in ammonia-induced autophagy or in autophagic response of cerebellar granule neurons (CGN) to low potassium concentration. Plays a role early in neuronal differentiation and is required for granule cell axon formation: may govern axon formation via Ras-like GTPase signaling and through regulation of the Rab5-mediated endocytic pathways within developing axons.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5ZJH6|ULK3_CHICK Serine/threonine-protein kinase ULK3 OS=Gallus gallus GN=ULK3 PE=2 SV=1

 Score =  150 bits (379), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 78/167 (46%), Positives = 112/167 (67%), Gaps = 3/167 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           + LN+     L  E+  L ++ HP+I+ L D     + I+L++EFCAGG+LS +IR+   
Sbjct: 49  RSLNRASVENLLTEIEILKTIRHPHIVELKDFQWDSDHIYLIMEFCAGGDLSRFIRMRRI 108

Query: 63  VPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE+ AR FLQQL   L+ L+ H+I H DLKP+NILLS   ++  LK+ADFG +  + P 
Sbjct: 109 LPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLS-TPENPQLKLADFGFAQYMSPW 167

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           +    + GSPLYMAPE++  Q+YD +VD+WSVG IL+E L G PPF+
Sbjct: 168 DEKHVLRGSPLYMAPEMVCRQQYDARVDLWSVGVILYEALFGRPPFA 214

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A7KAL2|ATG1_PENCW Serine/threonine-protein kinase ATG1 OS=Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) GN=atg1 PE=3 SV=1

 Score =  149 bits (375), Expect = 1e-35,   Method: Composition-based stats.
 Identities = 81/215 (37%), Positives = 119/215 (55%), Gaps = 50/215 (23%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L KLNK LK  L  E++ L  ++HP+I+ L D  ++ + I LV+E+CA G+LS +I+   
Sbjct: 55  LSKLNKKLKENLSSEIDILKGLHHPHIVALIDCHESTSHIHLVMEYCALGDLSLFIKRRD 114

Query: 61  --------------------GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILL- 97
                               G + E   R FL+QL   L+ L   ++IHRD+KP+N+LL 
Sbjct: 115 TLGSHKYTRDMIAKYPNPPGGSLNEVVTRHFLKQLSSALKFLRDRNLIHRDIKPQNLLLC 174

Query: 98  --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
                                     +GL+   MLKIADFG + +L   + AE +CGSPL
Sbjct: 175 PSPSSYRSGHAQVMPYKGSDDSYEPTTGLESLPMLKIADFGFARSLPATSLAETLCGSPL 234

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           YMAPE+L++++YD K D+WSVG +L+E++ G PPF
Sbjct: 235 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGRPPF 269

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) (taxid: 500485)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q86CS2|ATG1_DICDI Serine/threonine-protein kinase atg1 OS=Dictyostelium discoideum GN=atg1 PE=3 SV=1

 Score =  148 bits (374), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 73/169 (43%), Positives = 107/169 (63%), Gaps = 5/169 (2%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGR 62
           N  L   L+ E+  L  ++H NI+RL+D    E     I++++E C GG+ S YIR H +
Sbjct: 47  NSKLTENLNYEIRILKELSHTNIVRLYDVLNEETDPTFIYMIMECCEGGDFSKYIRTHKK 106

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           + E+ A  F++QL  GL+ L    I+HRDLKP+N+LLS   +  +LKI DFG +  + P 
Sbjct: 107 LTEEKALYFMKQLANGLKFLRQKQIVHRDLKPQNLLLSDDSEHPILKIGDFGFAKFIDPF 166

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
           + ++  CGSPLYMAPE+L  + Y  K D+WSVG IL+E+L G P ++ G
Sbjct: 167 SLSDTFCGSPLYMAPEILHRKNYTVKADLWSVGIILYEMLVGEPAYNSG 215

Serine/threonine protein kinase involved in autophagy. Involved in the control of autophagic vacuolar cell death.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0CLX3|ATG1_ASPTN Serine/threonine-protein kinase atg1 OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) GN=atg1 PE=3 SV=1

 Score =  147 bits (372), Expect = 3e-35,   Method: Composition-based stats.
 Identities = 82/215 (38%), Positives = 117/215 (54%), Gaps = 50/215 (23%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L +LNK LK  L  E++ L  + HP+I+ L D  +  + I LV+E+CA G+LS +IR   
Sbjct: 59  LSQLNKKLKENLFSEIHILKGLYHPHIVALIDCHETTSHIHLVMEYCALGDLSQFIRHRN 118

Query: 61  --------------------GRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILL- 97
                               G + E   R FL+QL   L+ L   ++IHRD+KP+N+LL 
Sbjct: 119 TLGEHRYTRDMIAKYPNPRGGALNEVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLC 178

Query: 98  --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
                                     +GLD   MLKIADFG + +L   + AE +CGSPL
Sbjct: 179 PSPTSYRAGVAQIVPFKGSEDSFSPATGLDSLPMLKIADFGFARSLPATSLAETLCGSPL 238

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           YMAPE+L++++YD K D+WSVG +L+E++ G PPF
Sbjct: 239 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGKPPF 273

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Aspergillus terreus (strain NIH 2624 / FGSC A1156) (taxid: 341663)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3U3Q1|ULK3_MOUSE Serine/threonine-protein kinase ULK3 OS=Mus musculus GN=Ulk3 PE=2 SV=1

 Score =  146 bits (369), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 80/168 (47%), Positives = 112/168 (66%), Gaps = 5/168 (2%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG 61
           K LNK     L  E+  L  + HP+I++L D FQ +N  I+L++EFCAGG+LS +I    
Sbjct: 49  KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
            +PE+ AR F+QQL   L+ L+  +I H DLKP+NILLS L+    LK+ADFG +  + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            +    + GSPLYMAPE++  ++YD +VD+WSVG IL+E L G PPF+
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFA 214

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|D3ZHP7|ULK3_RAT Serine/threonine-protein kinase ULK3 OS=Rattus norvegicus GN=Ulk3 PE=3 SV=1

 Score =  146 bits (369), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 80/168 (47%), Positives = 112/168 (66%), Gaps = 5/168 (2%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG 61
           K LNK     L  E+  L  + HP+I++L D FQ +N  I+L++EFCAGG+LS +I    
Sbjct: 49  KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
            +PE+ AR F+QQL   L+ L+  +I H DLKP+NILLS L+    LK+ADFG +  + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            +    + GSPLYMAPE++  ++YD +VD+WSVG IL+E L G PPF+
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFA 214

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2UGZ7|ATG1_ASPOR Serine/threonine-protein kinase atg1 OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) GN=atg1 PE=3 SV=1

 Score =  146 bits (369), Expect = 6e-35,   Method: Composition-based stats.
 Identities = 81/215 (37%), Positives = 117/215 (54%), Gaps = 50/215 (23%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L KLNK LK  L  E++ L  + HP+I+ L D  +  + I LV+E+CA G+LS +I+   
Sbjct: 55  LSKLNKKLKENLSSEIHILKGLYHPHIVALIDCHETTSHIHLVMEYCALGDLSLFIKRRD 114

Query: 61  --------------------GRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILL- 97
                               G + E   R FL+QL   L+ L   ++IHRD+KP+N+LL 
Sbjct: 115 TLGDHRYTQDMIAKYPNPRGGALNEVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLC 174

Query: 98  --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
                                     +GL+   MLKIADFG + +L   + AE +CGSPL
Sbjct: 175 PSPSSYRSGVAQVVPFKGCDESFSPATGLESLPMLKIADFGFARSLPSTSLAETLCGSPL 234

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           YMAPE+L++++YD K D+WSVG +L+E++ G PPF
Sbjct: 235 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGKPPF 269

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Aspergillus oryzae (strain ATCC 42149 / RIB 40) (taxid: 510516)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1DN93|ATG1_COCIM Serine/threonine-protein kinase ATG1 OS=Coccidioides immitis (strain RS) GN=ATG1 PE=3 SV=1

 Score =  145 bits (367), Expect = 9e-35,   Method: Composition-based stats.
 Identities = 81/218 (37%), Positives = 116/218 (53%), Gaps = 50/218 (22%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           +  LN  LK  L  E+  L  + HP+I+ L D  ++ +CI LV+E+CA G+LS +IR   
Sbjct: 63  ISSLNPKLKDNLKLEIEILKGLQHPHIVALIDCDESTSCIHLVMEYCALGDLSLFIRKRD 122

Query: 61  --------------------GRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLS 98
                               G + E   R FL+QL   L+ L +  +IHRDLKP+N+LL+
Sbjct: 123 TLSKHELTRDMIAKYPNPPAGGLNEVIVRHFLKQLASALQFLRTKDLIHRDLKPQNLLLN 182

Query: 99  ---------------------------GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
                                      G++   MLKIADFG + +L   + AE +CGSPL
Sbjct: 183 PPPSTYAKGLLRIVPYKTREDSFTPLVGVESLPMLKIADFGFARSLPATSLAETLCGSPL 242

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
           YMAPE+L++++YD K D+WSVG +LFE++ G  PF  G
Sbjct: 243 YMAPEILRYEKYDAKADLWSVGTVLFEMVVGKSPFRAG 280

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Coccidioides immitis (strain RS) (taxid: 246410)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	175
255581995	321	serine/threonine-protein kinase, putativ	0.942	0.514	0.808	5e-72
359476946	260	PREDICTED: serine/threonine-protein kina	0.942	0.634	0.754	7e-69
225431573	275	PREDICTED: serine/threonine-protein kina	0.942	0.6	0.754	8e-69
224116060	266	predicted protein [Populus trichocarpa]	0.942	0.620	0.733	3e-67
357464547	290	Serine/threonine protein kinase GE16371	0.948	0.572	0.708	6e-64
356518738	278	PREDICTED: serine/threonine-protein kina	0.954	0.600	0.682	5e-60
297852566	266	hypothetical protein ARALYDRAFT_314341 [	0.942	0.620	0.670	6e-60
7770326	392	F27J15.5 [Arabidopsis thaliana]	0.942	0.420	0.646	9e-59
334183174	376	protein kinase-like protein [Arabidopsis	0.942	0.438	0.646	1e-58
30694500	408	protein kinase-like protein [Arabidopsis	0.942	0.404	0.646	1e-58

>gi|255581995|ref|XP_002531795.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223528561|gb|EEF30583.1| serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  275 bits (703), Expect = 5e-72,   Method: Compositional matrix adjust.
 Identities = 135/167 (80%), Positives = 146/167 (87%), Gaps = 2/167 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLNKHLK+CLDCELNFLSSVNHPNIIRLF  FQAE+ IFLV+EFCAGG+LSSYIR HG
Sbjct: 53  LSKLNKHLKNCLDCELNFLSSVNHPNIIRLFHVFQAESSIFLVLEFCAGGSLSSYIRHHG 112

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E+ AR+ +QQLG  LEIL+SHHIIHRDLKPENILLSG   DV+LKIADFGLS  + P
Sbjct: 113 RVQEEIARRLMQQLGAGLEILHSHHIIHRDLKPENILLSGQFADVVLKIADFGLSRRVQP 172

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G YAE VCGSPLYMAPEVLQFQ YD+K DMWSVG ILFELLNGYPPF
Sbjct: 173 GKYAETVCGSPLYMAPEVLQFQSYDDKADMWSVGVILFELLNGYPPF 219

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359476946|ref|XP_003631917.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 2 [Vitis vinifera]

 Score =  265 bits (676), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 126/167 (75%), Positives = 148/167 (88%), Gaps = 2/167 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++LK+ LDCE+NFLSSV+HPNIIRL   FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43  LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E  AR+F+QQLG  LE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G +AE VCG+PLYMAPEVL+F++YDEKVDMWS+GAILFELLNGYPPF
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMWSLGAILFELLNGYPPF 209

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225431573|ref|XP_002282420.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 1 [Vitis vinifera] gi|296088603|emb|CBI37594.3| unnamed protein product [Vitis vinifera]

 Score =  265 bits (676), Expect = 8e-69,   Method: Compositional matrix adjust.
 Identities = 126/167 (75%), Positives = 148/167 (88%), Gaps = 2/167 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++LK+ LDCE+NFLSSV+HPNIIRL   FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43  LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E  AR+F+QQLG  LE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G +AE VCG+PLYMAPEVL+F++YDEKVDMWS+GAILFELLNGYPPF
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMWSLGAILFELLNGYPPF 209

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116060|ref|XP_002332038.1| predicted protein [Populus trichocarpa] gi|222875263|gb|EEF12394.1| predicted protein [Populus trichocarpa]

 Score =  259 bits (662), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 124/169 (73%), Positives = 143/169 (84%), Gaps = 4/169 (2%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLNK+L++CLDCELNFLSSVNH NIIRL D F+ + C+FLV+EFC+GGNL+SY++ HG
Sbjct: 38  LSKLNKNLRNCLDCELNFLSSVNHTNIIRLLDVFEDDCCMFLVLEFCSGGNLASYLQQHG 97

Query: 62  RVPEQTARKFLQQLG----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           RV E+ A++F QQ+G    L+IL SHHIIHRDLKPENILLSG + DV+LKIADFGLS  +
Sbjct: 98  RVQEKIAKRFTQQMGSGDGLKILQSHHIIHRDLKPENILLSGKESDVVLKIADFGLSRRV 157

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            P NY E VCGSP YMAPEVLQFQRYD KVDMWSVG ILFELLNGYPPF
Sbjct: 158 LPDNYVETVCGSPFYMAPEVLQFQRYDYKVDMWSVGVILFELLNGYPPF 206

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357464547|ref|XP_003602555.1| Serine/threonine protein kinase GE16371 [Medicago truncatula] gi|355491603|gb|AES72806.1| Serine/threonine protein kinase GE16371 [Medicago truncatula]

 Score =  248 bits (633), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 119/168 (70%), Positives = 138/168 (82%), Gaps = 2/168 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN HL++ LDCE+NFLSSVNHPNI+ L   FQ   C++LV+EFCAGGNL+SYIR H 
Sbjct: 58  LSKLNSHLRASLDCEINFLSSVNHPNIVHLLHFFQGNGCVYLVLEFCAGGNLASYIRCHE 117

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV + TA+KF+QQLG  L++L+SH IIHRDLKPENILLS    D +LKIADFGLS T+ P
Sbjct: 118 RVHQLTAKKFIQQLGSGLKVLHSHGIIHRDLKPENILLSSHGADAVLKIADFGLSRTVRP 177

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           G Y E VCG+P YMAPEVLQFQRYD K DMWSVGA+LFELLNGYPPF+
Sbjct: 178 GEYVETVCGTPSYMAPEVLQFQRYDHKADMWSVGAMLFELLNGYPPFN 225

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356518738|ref|XP_003528035.1| PREDICTED: serine/threonine-protein kinase ULK3-like [Glycine max]

 Score =  235 bits (600), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 116/170 (68%), Positives = 134/170 (78%), Gaps = 3/170 (1%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            L KLN  LK+CLDCE+NFLSSVNHPNIIRL   FQ + C++LV+EFCAGGNL+SYI+ H
Sbjct: 52  FLSKLNPRLKACLDCEINFLSSVNHPNIIRLLHFFQYDGCVYLVLEFCAGGNLASYIQNH 111

Query: 61  GRVPEQTARKFLQQLG---LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           GRV +Q ARKF+QQLG      L +   + RDLKPENILLS    D +LK+ADFGLS T+
Sbjct: 112 GRVHQQIARKFMQQLGNFYFFFLYTLTALFRDLKPENILLSSHGVDAVLKLADFGLSRTI 171

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            PG YA  VCGSPLYMAPE L+FQRYD+K DMWSVG ILFELLNGYPPF+
Sbjct: 172 CPGEYAGTVCGSPLYMAPEALKFQRYDDKADMWSVGTILFELLNGYPPFN 221

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297852566|ref|XP_002894164.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata] gi|297340006|gb|EFH70423.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata]

 Score =  235 bits (599), Expect = 6e-60,   Method: Compositional matrix adjust.
 Identities = 112/167 (67%), Positives = 136/167 (81%), Gaps = 2/167 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L++CL+ EL FLSSV+HPNIIRL   FQ E  + +V+E+C GG LSSYI+ HG
Sbjct: 39  LSKLNRNLRTCLNNELEFLSSVDHPNIIRLLHVFQDEEFLVMVMEYCDGGTLSSYIQRHG 98

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E  A++FL+Q+G  LEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L P
Sbjct: 99  RVEEDIAKRFLKQIGAGLEIIHDNHIIHRDLKPENILIVGSGDDLVLKIADFSLARKLLP 158

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 159 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 205

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7770326|gb|AAF69696.1|AC016041_1 F27J15.5 [Arabidopsis thaliana]

 Score =  231 bits (589), Expect = 9e-59,   Method: Compositional matrix adjust.
 Identities = 108/167 (64%), Positives = 136/167 (81%), Gaps = 2/167 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 38  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 97

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E  A++F++Q+G  LEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 98  RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 157

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 158 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 204

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|334183174|ref|NP_001185178.1| protein kinase-like protein [Arabidopsis thaliana] gi|332194280|gb|AEE32401.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  231 bits (588), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 108/167 (64%), Positives = 136/167 (81%), Gaps = 2/167 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E  A++F++Q+G  LEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 206

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30694500|ref|NP_175344.2| protein kinase-like protein [Arabidopsis thaliana] gi|332194279|gb|AEE32400.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  230 bits (587), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 108/167 (64%), Positives = 136/167 (81%), Gaps = 2/167 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E  A++F++Q+G  LEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 206

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	175
TAIR|locus:2028496	408	AT1G49180 [Arabidopsis thalian	0.942	0.404	0.646	5.3e-56
TAIR|locus:2084440	712	AT3G53930 [Arabidopsis thalian	0.994	0.244	0.534	2.8e-46
TAIR|locus:2065680	733	AT2G37840 [Arabidopsis thalian	0.994	0.237	0.522	5.2e-46
TAIR|locus:2079527	626	AT3G61960 [Arabidopsis thalian	0.965	0.269	0.505	2.4e-44
UNIPROTKB|Q5ZJH6	468	ULK3 "Serine/threonine-protein	0.931	0.348	0.476	1.7e-34
MGI|MGI:1918992	472	Ulk3 "unc-51-like kinase 3" [M	0.931	0.345	0.476	5.8e-34
RGD|1587417	472	Ulk3 "unc-51-like kinase 3 (C.	0.931	0.345	0.476	5.8e-34
UNIPROTKB|F1N332	472	ULK3 "Uncharacterized protein"	0.925	0.343	0.473	1.5e-33
UNIPROTKB|F1SJ29	479	ULK3 "Uncharacterized protein"	0.925	0.338	0.473	1.5e-33
DICTYBASE|DDB_G0292390	668	atg1 "ULK family protein kinas	0.937	0.245	0.431	2.3e-33

TAIR|locus:2028496 AT1G49180 [Arabidopsis thaliana (taxid:3702)]

 Score = 577 (208.2 bits), Expect = 5.3e-56, P = 5.3e-56
 Identities = 108/167 (64%), Positives = 136/167 (81%)

Query:     2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
             L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct:    40 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99

Query:    62 RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
             RV E  A++F++Q+G  LEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct:   100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159

Query:   120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
             G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct:   160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 206

GO:0003676 "nucleic acid binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2084440 AT3G53930 [Arabidopsis thaliana (taxid:3702)]

 Score = 487 (176.5 bits), Expect = 2.8e-46, P = 2.8e-46
 Identities = 94/176 (53%), Positives = 124/176 (70%)

Query:     2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
             + +LNK L+  L  E+  L  +NHPNIIR  D  +A   I LV+E+C GG+LS YI  HG
Sbjct:    53 MARLNKKLQESLMSEIIILRKINHPNIIRFIDMIEAPGKINLVLEYCKGGDLSMYIHKHG 112

Query:    62 RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
              VPE TA+ F+ QL  GL++L  ++IIHRDLKP+N+LLS  D+D  LKIADFG + +L P
Sbjct:   113 SVPEATAKHFMLQLAAGLQVLRDNNIIHRDLKPQNLLLSTDDNDAALKIADFGFARSLQP 172

Query:   120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
                AE +CGSPLYMAPE++Q Q+YD K D+WSVGAILF+L+ G  PF+   + Q +
Sbjct:   173 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLL 228

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2065680 AT2G37840 [Arabidopsis thaliana (taxid:3702)]

 Score = 486 (176.1 bits), Expect = 5.2e-46, P = 5.2e-46
 Identities = 92/176 (52%), Positives = 127/176 (72%)

Query:     2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
             + +LNK L+  L  E+  L  +NHPNIIRL D  ++   + LV+E+C GG+LS Y++ HG
Sbjct:    45 MDRLNKKLQESLMSEIFILRRINHPNIIRLIDMIKSPGKVHLVLEYCKGGDLSVYVQRHG 104

Query:    62 RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
              VPE TA+ F+QQL  GL++L  ++IIHRDLKP+N+LLS  ++D  LKIADFG + +L P
Sbjct:   105 IVPEATAKHFMQQLAAGLQVLRDNNIIHRDLKPQNLLLSTNENDADLKIADFGFARSLQP 164

Query:   120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
                AE +CGSPLYMAPE++Q Q+YD K D+WSVGAILF+L+ G  PF+   + Q +
Sbjct:   165 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLL 220

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2079527 AT3G61960 [Arabidopsis thaliana (taxid:3702)]

 Score = 467 (169.5 bits), Expect = 2.4e-44, P = 2.4e-44
 Identities = 87/172 (50%), Positives = 124/172 (72%)

Query:     3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
             K L+  ++  L  E++ LS+++HPNIIR ++A +  + IFLV+E+C+GG+L+ YI  HG+
Sbjct:    44 KLLSPKVRDNLLKEISILSTIDHPNIIRFYEAIETGDRIFLVLEYCSGGDLAGYINRHGK 103

Query:    63 VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             VPE  A+ F++QL  GL++L   H IHRDLKP+N+LLS  +   +LKI DFG + +L P 
Sbjct:   104 VPEAVAKHFMRQLALGLQVLQEKHFIHRDLKPQNLLLSSKEVTPLLKIGDFGFARSLTPE 163

Query:   121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
             + AE  CGSPLYMAPE+++ Q+YD K D+WS GAILF+L+ G PPF  G  H
Sbjct:   164 SMAETFCGSPLYMAPEIIRNQKYDAKADLWSAGAILFQLVTGKPPFD-GNNH 214

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q5ZJH6 ULK3 "Serine/threonine-protein kinase ULK3" [Gallus gallus (taxid:9031)]

 Score = 374 (136.7 bits), Expect = 1.7e-34, P = 1.7e-34
 Identities = 80/168 (47%), Positives = 115/168 (68%)

Query:     3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
             + LN+     L  E+  L ++ HP+I+ L D FQ ++  I+L++EFCAGG+LS +IR+  
Sbjct:    49 RSLNRASVENLLTEIEILKTIRHPHIVELKD-FQWDSDHIYLIMEFCAGGDLSRFIRMRR 107

Query:    62 RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
              +PE+ AR FLQQL   L+ L+ H+I H DLKP+NILLS   ++  LK+ADFG +  + P
Sbjct:   108 ILPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLS-TPENPQLKLADFGFAQYMSP 166

Query:   120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
              +    + GSPLYMAPE++  Q+YD +VD+WSVG IL+E L G PPF+
Sbjct:   167 WDEKHVLRGSPLYMAPEMVCRQQYDARVDLWSVGVILYEALFGRPPFA 214

GO:0005524 "ATP binding" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=ISS

GO:0045879 "negative regulation of smoothened signaling pathway" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=ISS

MGI|MGI:1918992 Ulk3 "unc-51-like kinase 3" [Mus musculus (taxid:10090)]

 Score = 369 (135.0 bits), Expect = 5.8e-34, P = 5.8e-34
 Identities = 80/168 (47%), Positives = 112/168 (66%)

Query:     3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
             K LNK     L  E+  L  + HP+I++L D FQ +N  I+L++EFCAGG+LS +I    
Sbjct:    49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107

Query:    62 RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
              +PE+ AR F+QQL   L+ L+  +I H DLKP+NILLS L+    LK+ADFG +  + P
Sbjct:   108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166

Query:   120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
              +    + GSPLYMAPE++  ++YD +VD+WSVG IL+E L G PPF+
Sbjct:   167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFA 214

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0045879 "negative regulation of smoothened signaling pathway" evidence=ISO

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=ISO

RGD|1587417 Ulk3 "unc-51-like kinase 3 (C. elegans)" [Rattus norvegicus (taxid:10116)]

 Score = 369 (135.0 bits), Expect = 5.8e-34, P = 5.8e-34
 Identities = 80/168 (47%), Positives = 112/168 (66%)

Query:     3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
             K LNK     L  E+  L  + HP+I++L D FQ +N  I+L++EFCAGG+LS +I    
Sbjct:    49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107

Query:    62 RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
              +PE+ AR F+QQL   L+ L+  +I H DLKP+NILLS L+    LK+ADFG +  + P
Sbjct:   108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166

Query:   120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
              +    + GSPLYMAPE++  ++YD +VD+WSVG IL+E L G PPF+
Sbjct:   167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFA 214

GO:0003674 "molecular_function" evidence=ND

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0005737 "cytoplasm" evidence=ISO;ISS

GO:0006914 "autophagy" evidence=IEA

GO:0008150 "biological_process" evidence=ND

GO:0045879 "negative regulation of smoothened signaling pathway" evidence=ISO;ISS

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=ISO;ISS

GO:0046777 "protein autophosphorylation" evidence=ISO;ISS

UNIPROTKB|F1N332 ULK3 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 365 (133.5 bits), Expect = 1.5e-33, P = 1.5e-33
 Identities = 80/169 (47%), Positives = 113/169 (66%)

Query:     3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH 60
             K LNK     L  E+  L  + HP+I++L D FQ  ++N I+L++EFCAGG+LS +I   
Sbjct:    49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDSDN-IYLIMEFCAGGDLSRFIHTR 106

Query:    61 GRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
               +PE+ AR F+QQL   L+ L+  +I H DLKP+NILLS L+    LK+ADFG +  + 
Sbjct:   107 RILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMS 165

Query:   119 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
             P +    + GSPLYMAPE++  ++YD +VD+WSVG IL+E L G PPF+
Sbjct:   166 PRDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSVGVILYEALFGQPPFA 214

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=IEA

GO:0045879 "negative regulation of smoothened signaling pathway" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1SJ29 ULK3 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 365 (133.5 bits), Expect = 1.5e-33, P = 1.5e-33
 Identities = 80/169 (47%), Positives = 113/169 (66%)

Query:     3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH 60
             K LNK     L  E+  L  + HP+I++L D FQ  ++N I+L++EFCAGG+LS +I   
Sbjct:    56 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDSDN-IYLIMEFCAGGDLSRFIHTR 113

Query:    61 GRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
               +PE+ AR F+QQL   L+ L+  +I H DLKP+NILLS L+    LK+ADFG +  + 
Sbjct:   114 RILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMS 172

Query:   119 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
             P +    + GSPLYMAPE++  ++YD +VD+WSVG IL+E L G PPF+
Sbjct:   173 PWDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSVGVILYEALFGQPPFA 221

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=IEA

GO:0045879 "negative regulation of smoothened signaling pathway" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

DICTYBASE|DDB_G0292390 atg1 "ULK family protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 370 (135.3 bits), Expect = 2.3e-33, P = 2.3e-33
 Identities = 73/169 (43%), Positives = 107/169 (63%)

Query:     6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGR 62
             N  L   L+ E+  L  ++H NI+RL+D    E     I++++E C GG+ S YIR H +
Sbjct:    47 NSKLTENLNYEIRILKELSHTNIVRLYDVLNEETDPTFIYMIMECCEGGDFSKYIRTHKK 106

Query:    63 VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             + E+ A  F++QL  GL+ L    I+HRDLKP+N+LLS   +  +LKI DFG +  + P 
Sbjct:   107 LTEEKALYFMKQLANGLKFLRQKQIVHRDLKPQNLLLSDDSEHPILKIGDFGFAKFIDPF 166

Query:   121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
             + ++  CGSPLYMAPE+L  + Y  K D+WSVG IL+E+L G P ++ G
Sbjct:   167 SLSDTFCGSPLYMAPEILHRKNYTVKADLWSVGIILYEMLVGEPAYNSG 215

GO:0070265 "necrotic cell death" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016236 "macroautophagy" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0031288 "sorocarp morphogenesis" evidence=IMP

GO:0030587 "sorocarp development" evidence=IMP

GO:0030435 "sporulation resulting in formation of a cellular spore" evidence=IMP

GO:0006995 "cellular response to nitrogen starvation" evidence=IMP

GO:0005737 "cytoplasm" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0048102 "autophagic cell death" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0015031 "protein transport" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0006810 "transport" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0034045 "pre-autophagosomal structure membrane" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	175
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-70
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-58
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-53
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-53
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-50
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-49
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-48
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-47
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-46
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-45
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-41
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-41
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-41
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-40
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-38
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-38
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-37
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-37
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-37
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-37
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-36
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-36
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-36
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-36
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-35
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-35
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-35
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-35
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-34
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-34
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-34
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-33
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-32
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-32
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-32
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-32
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-32
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-31
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-31
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-31
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-31
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-30
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-30
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-30
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-30
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-29
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-29
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-29
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-29
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-29
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-29
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-29
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-28
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-28
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-28
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-28
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-28
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-28
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-28
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-28
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-27
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-27
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-27
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-27
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-27
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-27
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-27
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-27
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-27
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-27
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-27
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-27
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-26
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-26
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-26
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-26
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-26
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-26
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-26
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-26
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-26
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-26
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-25
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-25
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-25
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-25
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-25
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-25
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-25
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-25
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-25
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-25
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-25
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-25
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-24
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-24
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-24
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-24
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-24
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-24
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-24
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-24
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-24
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-24
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-24
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-23
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-23
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-23
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-23
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-23
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-23
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-23
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-23
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-23
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-23
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-23
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-23
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-22
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-22
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-22
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-22
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-22
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-22
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-22
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-22
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-22
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-22
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-22
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-22
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-22
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-22
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-22
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-22
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-21
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-21
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-21
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-21
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-21
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-21
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-21
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-21
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-21
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-20
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-20
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-20
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-20
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-20
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-20
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-20
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-20
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-20
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-20
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-20
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-20
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-20
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-20
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-19
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-19
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-19
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-19
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-19
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-19
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-19
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-18
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-18
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-18
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-18
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-18
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-18
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-18
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-18
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-17
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-17
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-17
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-17
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-16
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-15
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-15
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-13
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-12
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-12
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-11
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-09
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	7e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	9e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-08
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	9e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	3e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.002
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.003
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  212 bits (541), Expect = 6e-70
 Identities = 78/180 (43%), Positives = 112/180 (62%), Gaps = 9/180 (5%)

Query: 2   LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K + K            E+  L  + HPNI+RL+D F+ E+ ++LV+E+C GG+L   +
Sbjct: 29  IKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL 88

Query: 58  RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
           +  GR+ E  AR +L+Q+   LE L+S  I+HRDLKPENILL   D+D  +K+ADFGL+ 
Sbjct: 89  KKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILL---DEDGHVKLADFGLAR 145

Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
            L PG       G+P YMAPEVL  + Y + VD+WS+G IL+ELL G PPF   ++   +
Sbjct: 146 QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLEL 205

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  182 bits (464), Expect = 3e-58
 Identities = 80/175 (45%), Positives = 110/175 (62%), Gaps = 12/175 (6%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           +K L K  +          E+  L  ++HPNI+RL DAF+ ++ ++LV+E+C GG+L  Y
Sbjct: 29  VKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDY 88

Query: 57  IRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           +   G + E  A+K   Q+  GLE L+S+ IIHRDLKPENIL   LD++ ++KIADFGL+
Sbjct: 89  LSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENIL---LDENGVVKIADFGLA 145

Query: 115 CTLY-PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFS 167
             L    +      G+P YMAPEVL     Y  KVD+WS+G IL+ELL G PPFS
Sbjct: 146 KKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFS 200

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  168 bits (428), Expect = 2e-53
 Identities = 73/167 (43%), Positives = 104/167 (62%), Gaps = 11/167 (6%)

Query: 2   LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K + K   S L      E+  L  +NHPNI++L+  F+ EN ++LV+E+C GG+L   +
Sbjct: 23  IKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL 82

Query: 58  -RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
               G++ E    + L Q+  GLE L+S+ IIHRDLKPENILL    D+  +K+ADFGLS
Sbjct: 83  KENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD--SDNGKVKLADFGLS 140

Query: 115 CTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFEL 159
             L    +  + + G+P YMAPEVL  +  Y EK D+WS+G IL+EL
Sbjct: 141 KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  169 bits (430), Expect = 3e-53
 Identities = 72/161 (44%), Positives = 99/161 (61%), Gaps = 6/161 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E N LS +NHP I++L  AFQ E  ++LV+E+  GG L S++   GR  E+ AR +  + 
Sbjct: 43  ERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI 102

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLY 132
            L LE L+S  II+RDLKPENILL   D D  +K+ DFGL+  L          CG+P Y
Sbjct: 103 VLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           +APEVL  + Y + VD WS+G +L+E+L G PPF   +  +
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE 200

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  161 bits (409), Expect = 6e-50
 Identities = 62/164 (37%), Positives = 101/164 (61%), Gaps = 10/164 (6%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
             L+ E+  LSS+ HPNI+R + + + E  N + + +E+ +GG+LSS ++  G++PE   
Sbjct: 44  EALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI 103

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYA 123
           RK+ +Q+  GL  L+S+ I+HRD+K  NIL+     D ++K+ADFG +  L     G   
Sbjct: 104 RKYTRQILEGLAYLHSNGIVHRDIKGANILVDS---DGVVKLADFGCAKRLGDIETGEGT 160

Query: 124 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
             V G+P +MAPEV++ + Y    D+WS+G  + E+  G PP+S
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS 204

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  159 bits (404), Expect = 3e-49
 Identities = 57/158 (36%), Positives = 96/158 (60%), Gaps = 10/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARKF 71
           E+  L  +NHPNII+ +++F+ +  + +V+E+  GG+LS  I+   +     PE+    +
Sbjct: 49  EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW 108

Query: 72  LQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCG 128
             Q  L L+ L+S  I+HRD+KP+NI L     + ++K+ DFG+S  L    + A+ V G
Sbjct: 109 FVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVG 165

Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +P Y++PE+ Q + Y+ K D+WS+G +L+EL     PF
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  157 bits (398), Expect = 3e-48
 Identities = 65/175 (37%), Positives = 102/175 (58%), Gaps = 14/175 (8%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
             + K+    +  E + LS    P +++L+ +FQ +  ++LV+E+  GG+L+S +   G 
Sbjct: 30  DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS 89

Query: 63  VPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS------ 114
           + E  AR ++ +  L LE L+S+ IIHRDLKP+NIL+   D +  LK+ DFGLS      
Sbjct: 90  LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVR 146

Query: 115 --CTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               L      + ++ G+P Y+APEV+  Q + + VD WS+G IL+E L G PPF
Sbjct: 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF 201

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  154 bits (392), Expect = 2e-47
 Identities = 58/155 (37%), Positives = 91/155 (58%), Gaps = 6/155 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L    HPNI++ + ++  ++ +++V+EFC+GG+L   ++   +   E       ++
Sbjct: 47  EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKE 106

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           L  GLE L+S+ IIHRD+K  NILL+    D  +K+ DFGLS  L        + G+P +
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKARNTMVGTPYW 163

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           MAPEV+  + YD K D+WS+G    EL  G PP+S
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS 198

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  151 bits (383), Expect = 5e-46
 Identities = 67/182 (36%), Positives = 101/182 (55%), Gaps = 11/182 (6%)

Query: 2   LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK + K        +  +  E   L   NHP I++L+  F+ +  I++++E+C GG L +
Sbjct: 23  LKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWT 82

Query: 56  YIRLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
            +R  G   E TAR ++    L  E L++  II+RDLKPEN+LL   D +  +K+ DFG 
Sbjct: 83  ILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGF 139

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           +  L  G      CG+P Y+APE++  + YD  VD WS+G +L+ELL G PPF   +E  
Sbjct: 140 AKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP 199

Query: 174 FM 175
             
Sbjct: 200 ME 201

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  151 bits (383), Expect = 1e-45
 Identities = 65/153 (42%), Positives = 99/153 (64%), Gaps = 7/153 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L S+ HP ++ L+ +FQ ++ ++LV+E+  GG L S++R  GR PE  AR +  Q 
Sbjct: 51  EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L LE L+S  I++RDLKPEN+L   LD D  +KI DFG +  +    Y   +CG+P Y+
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLL---LDSDGYIKITDFGFAKRVKGRTYT--LCGTPEYL 165

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y + VD W++G +++E+L GYPPF
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  139 bits (352), Expect = 3e-41
 Identities = 60/178 (33%), Positives = 95/178 (53%), Gaps = 17/178 (9%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI---- 57
            + +  K  L  E+N L  + HPNI+R +D    ++   +++V+E+C GG+L+  I    
Sbjct: 37  NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK 96

Query: 58  RLHGRVPEQTARKFLQQLGL-------EILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           +    + E+   + L QL L            + ++HRDLKP NI L   D +  +K+ D
Sbjct: 97  KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGD 153

Query: 111 FGLSCTLYPGNYAEKVC-GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           FGL+  L   +   K   G+P YM+PE L    YDEK D+WS+G +++EL    PPF+
Sbjct: 154 FGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  139 bits (352), Expect = 3e-41
 Identities = 60/174 (34%), Positives = 90/174 (51%), Gaps = 28/174 (16%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL- 75
           L  L+   HP II+L+  FQ E  ++ V+E+   G L  YIR +G + E+  R +  ++ 
Sbjct: 55  LTRLN--GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL 112

Query: 76  -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----------------- 117
             LE L+S  IIHRDLKPENIL   LD D+ +KI DFG +  L                 
Sbjct: 113 LALEYLHSKGIIHRDLKPENIL---LDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169

Query: 118 --YPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
                N        G+  Y++PE+L  +   +  D+W++G I++++L G PPF 
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 7e-41
 Identities = 59/166 (35%), Positives = 86/166 (51%), Gaps = 29/166 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E++ L  + HPNI++L D    E  ++LV E+C   +L  Y+      +     +  + Q
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           L  GL   +SH I+HRDLKP+NIL   ++ D +LK+ADFGL+          +  G PL 
Sbjct: 107 LLRGLAYCHSHRILHRDLKPQNIL---INRDGVLKLADFGLA----------RAFGIPLR 153

Query: 132 ----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 166
                     Y APE+L   + Y   VD+WSVG I  E++ G P F
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  135 bits (341), Expect = 9e-40
 Identities = 57/153 (37%), Positives = 86/153 (56%), Gaps = 5/153 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L  +NHP ++ L+ +FQ E  ++LVV+   GG+L  ++    +  E+  + ++ + 
Sbjct: 50  ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI 109

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L LE L+S  IIHRD+KP+NILL   D+   + I DF ++  + P        G+P YM
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYM 166

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APEVL  Q Y   VD WS+G   +E L G  P+
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 1e-38
 Identities = 61/153 (39%), Positives = 95/153 (62%), Gaps = 7/153 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L  V+HP IIRLF     +  +++++E+  GG L SY+R  GR    T   +  ++
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              LE L+S  I++RDLKPENILL   D +  +K+ DFG +  L    +   +CG+P Y+
Sbjct: 111 VCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDRTWT--LCGTPEYL 165

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APEV+Q + +++ VD W++G +++E+L GYPPF
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  132 bits (333), Expect = 1e-38
 Identities = 64/157 (40%), Positives = 89/157 (56%), Gaps = 10/157 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E+  L+SVNHPNII   +AF   N + +V+E+   G+LS  I         +PEQ   + 
Sbjct: 49  EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
             QL  GL+ L+   I+HRDLK  NILL   D    +KI D G+S  +   N A+   G+
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILLVANDL---VKIGDLGIS-KVLKKNMAKTQIGT 164

Query: 130 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           P YMAPEV + + Y  K D+WS+G +L+E+    PPF
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  130 bits (330), Expect = 2e-37
 Identities = 66/175 (37%), Positives = 101/175 (57%), Gaps = 15/175 (8%)

Query: 2   LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK++ K L   L+       E + L++     +++L  AFQ +  ++L +E+  GG+  +
Sbjct: 31  LKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRT 90

Query: 56  YIRLHGRVPEQTARKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFG 112
            +   G + E  AR ++ ++  E +++ H    IHRDLKPEN L+   D    +K+ DFG
Sbjct: 91  LLNNLGVLSEDHARFYMAEM-FEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFG 146

Query: 113 LSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           LS  +    YA  V GSP YMAPEVL+ + YD  VD WS+G +L+E L G+PPFS
Sbjct: 147 LSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  129 bits (327), Expect = 2e-37
 Identities = 60/159 (37%), Positives = 90/159 (56%), Gaps = 12/159 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L +  HP +++L D F   +   LV+E+     LS  +R   R +PE   + +++ 
Sbjct: 49  EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRM 107

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGS 129
           L  G+  ++++ I+HRDLKP N+L+S    D +LKIADFGL+          Y+ +V  +
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQV-AT 163

Query: 130 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFS 167
             Y APE+L   R YD  VD+W+VG I  ELLNG P F 
Sbjct: 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  128 bits (325), Expect = 2e-37
 Identities = 53/156 (33%), Positives = 89/156 (57%), Gaps = 7/156 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L   + P I++ + ++     +++V+E+C  G++S  +++  +   E+     L Q
Sbjct: 48  EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQ 107

Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 131
              GLE L+S+  IHRD+K  NILL   +++   K+ADFG+S  L         V G+P 
Sbjct: 108 TLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF 164

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           +MAPEV+Q   Y+ K D+WS+G    E+  G PP+S
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYS 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 4e-37
 Identities = 62/184 (33%), Positives = 97/184 (52%), Gaps = 35/184 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + L+  + P I++L+ +FQ E  ++LV+E+  GG+L + +      PE+TAR ++ +L
Sbjct: 51  ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAEL 110

Query: 76  GLEI--LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-----------------CT 116
            L +  ++    IHRD+KP+NIL   +D D  +K+ADFGL                    
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNIL---IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 117 LYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 163
           L+  N              A    G+P Y+APEVL+   Y  + D WS+G IL+E+L G+
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227

Query: 164 PPFS 167
           PPF 
Sbjct: 228 PPFY 231

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  129 bits (325), Expect = 9e-37
 Identities = 64/169 (37%), Positives = 96/169 (56%), Gaps = 10/169 (5%)

Query: 12  CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           C   E   L+    HP + +L   FQ ++ +F V+E+  GG+L  +I+  GR  E  AR 
Sbjct: 41  CTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF 100

Query: 71  FLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 126
           +  +  LGL+ L+   II+RDLK +N+LL   D +  +KIADFG+ C   +  G      
Sbjct: 101 YAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGM-CKEGILGGVTTSTF 156

Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF-SVGEEHQF 174
           CG+P Y+APE+L +Q Y   VD W++G +L+E+L G  PF    E+  F
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  126 bits (319), Expect = 2e-36
 Identities = 54/159 (33%), Positives = 92/159 (57%), Gaps = 11/159 (6%)

Query: 16  ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
           E   +  ++HPN+++L     + E  +++V+E+  GG+L SY+R +  ++       F  
Sbjct: 51  EARIMRKLDHPNVVKLLGVCTEEEP-LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFAL 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SP 130
           Q+  G+E L S + IHRDL   N L+    +++++KI+DFGLS  LY  +Y  K  G  P
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYRKRGGKLP 166

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 167
           + +MAPE L+  ++  K D+WS G +L+E+   G  P+ 
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP 205

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  126 bits (317), Expect = 3e-36
 Identities = 58/146 (39%), Positives = 92/146 (63%), Gaps = 8/146 (5%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGLEILNSH 83
           P + +L+ +FQ+++ ++LV+E+  GG+ +S I+  G +PE  A++++ +  LG+E L+  
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            IIHRD+KPEN+L+   D    LK+ DFGLS     G   +K  G+P Y+APE +     
Sbjct: 117 GIIHRDIKPENLLI---DQTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGD 170

Query: 144 DEKVDMWSVGAILFELLNGYPPFSVG 169
           D+  D WS+G ++FE L GYPPF   
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAE 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  125 bits (317), Expect = 3e-36
 Identities = 54/167 (32%), Positives = 92/167 (55%), Gaps = 7/167 (4%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           K   + LKS +  E++ L ++ HPNI++   + +  + +++++E+   G+L   I+  G 
Sbjct: 37  KIKEEALKSIMQ-EIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP 95

Query: 63  VPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 119
            PE     ++ Q   GL  L+   +IHRD+K  NIL +    D ++K+ADFG++  L   
Sbjct: 96  FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK---DGVVKLADFGVATKLNDV 152

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                 V G+P +MAPEV++        D+WS+G  + ELL G PP+
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  125 bits (317), Expect = 7e-36
 Identities = 58/147 (39%), Positives = 90/147 (61%), Gaps = 7/147 (4%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPE-QTARKFLQQL-GLEIL 80
            HPNI+  +D++   + +++V+E+  GG+L+  I  +  R+ E Q A    + L GLE L
Sbjct: 73  KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 81  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLYMAPEVLQ 139
           +S ++IHRD+K +NILLS  D  V  K+ADFG +  L         V G+P +MAPEV++
Sbjct: 133 HSQNVIHRDIKSDNILLS-KDGSV--KLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189

Query: 140 FQRYDEKVDMWSVGAILFELLNGYPPF 166
            + Y  KVD+WS+G +  E+  G PP+
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  125 bits (315), Expect = 8e-36
 Identities = 61/163 (37%), Positives = 94/163 (57%), Gaps = 14/163 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFL 72
           E+  +S  NHPN+++ + +F   + ++LV+ + +GG+L   ++     G + E      L
Sbjct: 49  EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKV--- 126
           +++  GLE L+S+  IHRD+K  NIL   L +D  +KIADFG+S +L   G+   KV   
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNIL---LGEDGSVKIADFGVSASLADGGDRTRKVRKT 165

Query: 127 -CGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFS 167
             G+P +MAPEV+ Q   YD K D+WS G    EL  G  P+S
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 1e-35
 Identities = 53/171 (30%), Positives = 96/171 (56%), Gaps = 10/171 (5%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
            +  K + + L+CE+  L ++ H  I++ +   + +  + + +E+  GG++   ++ +G 
Sbjct: 42  PETKKEVNA-LECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA 100

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 119
           + E   RK+ +Q+  G+E L+S+ I+HRD+K  NIL    D    +K+ DFG S  L   
Sbjct: 101 LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTI 157

Query: 120 ---GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
              G   + V G+P +M+PEV+  + Y  K D+WSVG  + E+L   PP++
Sbjct: 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  123 bits (310), Expect = 4e-35
 Identities = 53/160 (33%), Positives = 89/160 (55%), Gaps = 12/160 (7%)

Query: 16  ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           E   +  ++HPNI++L     + E  + +V+E+  GG+L  Y+R +    +       F 
Sbjct: 51  EARIMRKLDHPNIVKLLGVCTEEEP-LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA 109

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-S 129
            Q+  G+E L S + IHRDL   N L+    +++++KI+DFGLS  LY  +Y +   G  
Sbjct: 110 LQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYKVKGGKL 166

Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 167
           P+ +MAPE L+  ++  K D+WS G +L+E+   G  P+ 
Sbjct: 167 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP 206

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  122 bits (309), Expect = 5e-35
 Identities = 52/159 (32%), Positives = 89/159 (55%), Gaps = 10/159 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E + +  ++HPNI+RL         +++V E+  GG+L  ++R HG  +  +   +   Q
Sbjct: 51  EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ 110

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+E L S + +HRDL   N L+    +++++KI+DFGLS  +Y  +Y  K  G  L 
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167

Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 167
             +MAPE L+  ++  K D+WS G +L+E+   G  P+ 
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206

Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  122 bits (309), Expect = 6e-35
 Identities = 59/174 (33%), Positives = 94/174 (54%), Gaps = 20/174 (11%)

Query: 16  ELNFLSSVNHPNIIRLF--DAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFL 72
           E+  L  + HPN+++ +  +  + +  IF+  E+C+GG L   +  HGR+  E   R + 
Sbjct: 49  EMKVLELLKHPNLVKYYGVEVHREKVYIFM--EYCSGGTLEELLE-HGRILDEHVIRVYT 105

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-----TLYPGNYAEK 125
            QL  GL  L+SH I+HRD+KP NI    LD + ++K+ DFG +      T   G   + 
Sbjct: 106 LQLLEGLAYLHSHGIVHRDIKPANIF---LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162

Query: 126 VCGSPLYMAPEVLQFQRYDEK---VDMWSVGAILFELLNGYPPFS-VGEEHQFM 175
           + G+P YMAPEV+   +        D+WS+G ++ E+  G  P+S +  E Q M
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  125 bits (314), Expect = 7e-35
 Identities = 75/187 (40%), Positives = 102/187 (54%), Gaps = 24/187 (12%)

Query: 2   LKKLNKHLKSC------LDCELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           LK L K L+S          E+  L+S+NHP NI++L+D FQ E  ++LV+E+  GG+L 
Sbjct: 27  LKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLE 86

Query: 55  SYIRLHGR---VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
             ++  GR   + E  A   L Q+   LE L+S  IIHRD+KPENILL    D  ++K+ 
Sbjct: 87  DLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD--RDGRVVKLI 144

Query: 110 DFGLSCTLYPGNYAEKV-------CGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFEL 159
           DFGL+  L        +        G+P YMAPEVL            D+WS+G  L+EL
Sbjct: 145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL 204

Query: 160 LNGYPPF 166
           L G PPF
Sbjct: 205 LTGLPPF 211

Length = 384

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  123 bits (311), Expect = 1e-34
 Identities = 62/160 (38%), Positives = 97/160 (60%), Gaps = 21/160 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + L  ++HP I+ +  +FQ EN ++ ++EF  GG L +++R  GR P   A+ +  + 
Sbjct: 68  EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL 127

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------- 126
            L  E L+S  II+RDLKPEN+LL   D+   +K+ DFG         +A+KV       
Sbjct: 128 VLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFG---------FAKKVPDRTFTL 175

Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           CG+P Y+APEV+Q + + + VD W++G +L+E + GYPPF
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 1e-34
 Identities = 61/183 (33%), Positives = 92/183 (50%), Gaps = 32/183 (17%)

Query: 3   KKLNKHLKSCLDC----ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           KK+ K   S  +C    E+  L  +N HPNI++L + F+  + ++ V E+  G NL   +
Sbjct: 30  KKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLM 88

Query: 58  RLHGRVP--EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +     P  E   R  + Q+  GL  ++ H   HRDLKPEN+L+SG +   ++KIADFGL
Sbjct: 89  KDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGL 145

Query: 114 SCTLYPGNYAEKVCGSP---------LYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGY 163
                    A ++   P          Y APE+ L+   Y   VD+W++G I+ EL    
Sbjct: 146 ---------AREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Query: 164 PPF 166
           P F
Sbjct: 197 PLF 199

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  120 bits (304), Expect = 2e-34
 Identities = 56/166 (33%), Positives = 98/166 (59%), Gaps = 6/166 (3%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L+ E+  LS + HPNI++     + E+ +++ +E   GG+L+  ++ +G  PE   R + 
Sbjct: 49  LEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT 108

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
           +Q+  GLE L+  + +HRD+K  NIL   +D + ++K+ADFG++  +   ++A+   GSP
Sbjct: 109 RQILLGLEYLHDRNTVHRDIKGANIL---VDTNGVVKLADFGMAKQVVEFSFAKSFKGSP 165

Query: 131 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
            +MAPEV+ Q   Y    D+WS+G  + E+  G PP+S  E    +
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV 211

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 1e-33
 Identities = 64/157 (40%), Positives = 89/157 (56%), Gaps = 11/157 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L  +NHPNII+L D F+ +  ++LV EF    +L   I+   R +PE   + +L Q
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ 106

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 130
           L  GL   +SH I+HRDLKPEN+L++       LK+ADFGL+ +       Y   V  + 
Sbjct: 107 LLQGLAFCHSHGILHRDLKPENLLINTEGV---LKLADFGLARSFGSPVRPYTHYVV-TR 162

Query: 131 LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 166
            Y APE+L   + Y   VD+WSVG I  ELL+  P F
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  117 bits (295), Expect = 7e-33
 Identities = 61/169 (36%), Positives = 89/169 (52%), Gaps = 17/169 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT----ARKF 71
           EL  L S   P +++ + AF  E  I +V+E+  GG+L+  ++  G++PE      AR+ 
Sbjct: 49  ELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI 108

Query: 72  LQQLGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKV 126
           L+  GL+ L    HIIHRD+KP N+L++    +V  KIADFG    L  TL   N     
Sbjct: 109 LK--GLDYLHTKRHIIHRDIKPSNLLIN-SKGEV--KIADFGISKVLENTLDQCNTF--- 160

Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
            G+  YM+PE +Q + Y    D+WS+G  L E   G  PF    +  F 
Sbjct: 161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  117 bits (294), Expect = 1e-32
 Identities = 61/180 (33%), Positives = 96/180 (53%), Gaps = 10/180 (5%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
               K +   L  E+  L  ++H NI++       E  + + +E+  GG++ S +R +GR
Sbjct: 45  DSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR 104

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL---SCTL 117
             EQ  R F +Q+  GL  L+S  I+HRDLK +N+L   +D D + KI+DFG+   S  +
Sbjct: 105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLL---VDADGICKISDFGISKKSDDI 161

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           Y  +    + GS  +MAPEV+      Y  KVD+WS+G ++ E+  G  P+S  E    M
Sbjct: 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM 221

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  116 bits (292), Expect = 1e-32
 Identities = 54/176 (30%), Positives = 98/176 (55%), Gaps = 10/176 (5%)

Query: 2   LKKLNKHLKS-CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           L K+N+  +   +D E   L+ ++   IIR +++F  +  + +V+E+   G+L   +++ 
Sbjct: 35  LSKMNRREREEAID-EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ 93

Query: 61  G--RVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
               +PE    +F  Q  LGL  L+S  I+HRD+K  N+ L   D+   +KI D G++  
Sbjct: 94  RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN---VKIGDLGVAKL 150

Query: 117 LYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           L    N+A  + G+P Y++PE+ + + Y+EK D+W++G +L+E   G  PF    +
Sbjct: 151 LSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  116 bits (293), Expect = 4e-32
 Identities = 64/156 (41%), Positives = 94/156 (60%), Gaps = 8/156 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E N L +V HP I+ L  AFQ    ++L++E+ +GG L  ++   G   E TA  +L + 
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPL 131
            L LE L+   II+RDLKPENILL   D    +K+ DFGL C  +++ G      CG+  
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGL-CKESIHEGTVTHTFCGTIE 165

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           YMAPE+L    + + VD WS+GA+++++L G PPF+
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 4e-32
 Identities = 56/167 (33%), Positives = 84/167 (50%), Gaps = 18/167 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--Q 73
           E   +  + HPN++RL      E  ++LV+E+  GG+L  Y+R    V     +  L  +
Sbjct: 46  EARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLK 105

Query: 74  QL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            L         G+E L S   +HRDL   N L+   +D V+ KI+DFGLS  +Y  +Y  
Sbjct: 106 DLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG--EDLVV-KISDFGLSRDVYDDDYYR 162

Query: 125 KVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 167
           K  G  L   +MAPE L+   +  K D+WS G +L+E+   G  P+ 
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP 209

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  116 bits (291), Expect = 6e-32
 Identities = 62/152 (40%), Positives = 91/152 (59%), Gaps = 6/152 (3%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGLEILNS 82
           HP +  LF  FQ +  +F V+E+  GG+L  +I+  GR  E  AR +  +   GL+ L+ 
Sbjct: 55  HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114

Query: 83  HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKVCGSPLYMAPEVLQFQ 141
             II+RDLK +N+LL   D D  +KIADFG+    +     A   CG+P Y+APE+L+ Q
Sbjct: 115 KGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171

Query: 142 RYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           +Y+E VD WS G +L+E+L G  PF   +E +
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  114 bits (287), Expect = 8e-32
 Identities = 53/150 (35%), Positives = 89/150 (59%), Gaps = 6/150 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  ++HPNII  ++ F  +  + +V+E+  GG L+ YI+      + E T   F  
Sbjct: 49  ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108

Query: 74  Q--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           Q  L L  +++  I+HRDLK +NILL      +++KI DFG+S  L   + A  V G+P 
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPC 166

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           Y++PE+ + + Y++K D+W++G +L+EL +
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  115 bits (289), Expect = 1e-31
 Identities = 64/156 (41%), Positives = 96/156 (61%), Gaps = 10/156 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E + L+ VNHP I++L  AFQ E  ++L+++F  GG+L  + RL   V   E+  + +L 
Sbjct: 48  ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA 105

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 130
           +L   L+ L+S  II+RDLKPENILL   D++  +K+ DFGLS  ++     A   CG+ 
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162

Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            YMAPEV+  + + +  D WS G ++FE+L G  PF
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  114 bits (287), Expect = 3e-31
 Identities = 59/156 (37%), Positives = 89/156 (57%), Gaps = 11/156 (7%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ---LGL 77
           +S  HP ++ LF  FQ E+ +  V+E+ AGG+L  +I  H  V  +    F      LGL
Sbjct: 57  NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAACVVLGL 114

Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAP 135
           + L+ + I++RDLK +N+LL   D +  +KIADFGL C   +  G+     CG+P ++AP
Sbjct: 115 QYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGL-CKEGMGFGDRTSTFCGTPEFLAP 170

Query: 136 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           EVL    Y   VD W +G +++E+L G  PF   +E
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  113 bits (285), Expect = 5e-31
 Identities = 58/165 (35%), Positives = 90/165 (54%), Gaps = 9/165 (5%)

Query: 12  CLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           C   E   L+ +  HP +  L   FQ ++ +F V+E+  GG+L   I+   +  E  +R 
Sbjct: 41  CTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF 100

Query: 71  FLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 126
           +  +  L L  L+ H +I+RDLK +NILL   D +   K+ADFG+ C   +  G      
Sbjct: 101 YAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGM-CKEGILNGVTTTTF 156

Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           CG+P Y+APE+LQ   Y   VD W++G +++E++ G PPF    E
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 8e-31
 Identities = 59/163 (36%), Positives = 87/163 (53%), Gaps = 18/163 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPE-QTA---RK 70
           E++ L    HPNI+  F ++   + +++V+E+C GG+L   Y    G + E Q A   R+
Sbjct: 50  EISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE 109

Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VC 127
            L+  GL  L+    IHRD+K  NILL+   +D  +K+ADFG+S  L       K     
Sbjct: 110 TLK--GLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQL--TATIAKRKSFI 162

Query: 128 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
           G+P +MAPEV   +R   YD K D+W++G    EL    PP  
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  112 bits (281), Expect = 3e-30
 Identities = 56/154 (36%), Positives = 96/154 (62%), Gaps = 8/154 (5%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F ++ NHP ++ L   FQ E+ +F V+EF +GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 49  FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 134
           L  L+   II+RDLK +N+LL   D +  +K+ D+G+ C   + PG+     CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGM-CKEGIRPGDTTSTFCGTPNYIA 164

Query: 135 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           PE+L+ + Y   VD W++G ++FE++ G  PF +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 3e-30
 Identities = 62/157 (39%), Positives = 86/157 (54%), Gaps = 15/157 (9%)

Query: 20  LSSVNHPNIIRLFDAF---QAENC--IFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           L S  HPNI+RL D     + +    + LV E     +L++Y+    +  +P +T +  +
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLM 113

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
           +QL  G++ L+SH I+HRDLKP+NIL++    D  +KIADFGL+  +Y    A       
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLA-RIYSFEMALTSVVVT 169

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           L Y APEVL    Y   VDMWSVG I  EL    P F
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  111 bits (280), Expect = 3e-30
 Identities = 65/169 (38%), Positives = 97/169 (57%), Gaps = 13/169 (7%)

Query: 3   KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           KK  KH+ +    E N  L +V HP ++ L  +FQ  + ++ V+++  GG L  +++   
Sbjct: 36  KKEQKHIMA----ERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER 91

Query: 62  RVPEQTARKFLQQLGLEI--LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--L 117
             PE  AR +  ++   +  L+S +II+RDLKPENILL   D    + + DFGL C   +
Sbjct: 92  SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGL-CKEGI 147

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                    CG+P Y+APEVL+ Q YD  VD W +GA+L+E+L G PPF
Sbjct: 148 EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  111 bits (278), Expect = 4e-30
 Identities = 62/189 (32%), Positives = 109/189 (57%), Gaps = 27/189 (14%)

Query: 2   LKKLNKH---LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +KK+NK    L++ +     E + L+   +P ++ +F +F+ +  + +V+E+  GG+ ++
Sbjct: 31  MKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCAT 90

Query: 56  YIRLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
            ++  G +P   AR +  +  L LE L+++ I+HRDLKP+N+L++ +     +K+ DFGL
Sbjct: 91  LLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH---IKLTDFGL 147

Query: 114 S--------CTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 157
           S          LY G+          ++VCG+P Y+APEV+  Q Y + VD W++G IL+
Sbjct: 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILY 207

Query: 158 ELLNGYPPF 166
           E L G  PF
Sbjct: 208 EFLVGCVPF 216

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 1e-29
 Identities = 57/157 (36%), Positives = 90/157 (57%), Gaps = 11/157 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FLS    P I + + +F   + +++++E+C GG+    ++  G++ E      L+++
Sbjct: 49  EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREV 107

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 130
             GLE L+    IHRD+K  NILLS   ++  +K+ADFG+S  L   +   K     G+P
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQL--TSTMSKRNTFVGTP 162

Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            +MAPEV++   YDEK D+WS+G    EL  G PP S
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  109 bits (274), Expect = 3e-29
 Identities = 56/154 (36%), Positives = 94/154 (61%), Gaps = 8/154 (5%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 49  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 134
           L  L+   II+RDLK +N+LL   D +  +K+ D+G+ C   L PG+     CG+P Y+A
Sbjct: 109 LNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIA 164

Query: 135 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           PE+L+ + Y   VD W++G ++FE++ G  PF +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  107 bits (270), Expect = 3e-29
 Identities = 52/152 (34%), Positives = 85/152 (55%), Gaps = 12/152 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQ 73
           E+  LS + HPNII  ++ F  +N + + +E+  GG L   I  +      E+    +L 
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVCG 128
           Q+   +  ++   I+HRD+K  NI L+      ++K+ DFG+S  L   Y    AE V G
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYSM--AETVVG 163

Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           +P YM+PE+ Q  +Y+ K D+W++G +L+ELL
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  109 bits (274), Expect = 3e-29
 Identities = 60/185 (32%), Positives = 90/185 (48%), Gaps = 29/185 (15%)

Query: 3   KKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGN 52
           KK++      +D      E+  L  + H NII L D  +       N +++V E     +
Sbjct: 31  KKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METD 89

Query: 53  LSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           L   I+    + +   + FL Q+  GL+ L+S ++IHRDLKP NIL+   + +  LKI D
Sbjct: 90  LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICD 146

Query: 111 FGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
           FGL+  + P    ++     L        Y APE+ L   RY + +D+WSVG I  ELL 
Sbjct: 147 FGLARGVDP----DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202

Query: 162 GYPPF 166
             P F
Sbjct: 203 RKPLF 207

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 4e-29
 Identities = 59/168 (35%), Positives = 87/168 (51%), Gaps = 30/168 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E++ L  +NHPNI+RL D   +EN ++LV EF    +L  Y+             + +L 
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLY 106

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           QL  G+   +SH ++HRDLKP+N+L   +D +  LK+ADFGL+          +  G P+
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLL---IDREGALKLADFGLA----------RAFGVPV 153

Query: 132 -----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFS 167
                      Y APE+L   R Y   VD+WS+G I  E++N  P F 
Sbjct: 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 4e-29
 Identities = 66/165 (40%), Positives = 92/165 (55%), Gaps = 20/165 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ LS   HPNI+ L++A+  EN +++++EFC GG L S +    R   E   R   +Q
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-----VC 127
           +   L  L+SH +IHRDLK  NILL+ LD DV  K+ADFG+S      N +         
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLT-LDGDV--KLADFGVSAK----NKSTLQKRDTFI 164

Query: 128 GSPLYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           G+P +MAPEV+     +   YD K D+WS+G  L EL    PP  
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  108 bits (270), Expect = 9e-29
 Identities = 63/174 (36%), Positives = 97/174 (55%), Gaps = 9/174 (5%)

Query: 5   LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
           LN+  +  +  E N  L +V HP ++ L  +FQ    ++ V++F  GG L  +++     
Sbjct: 34  LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSF 93

Query: 64  PEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYP 119
           PE  AR +  ++   L  L+S +I++RDLKPENILL      V+    DFGL C   +  
Sbjct: 94  PEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVL---TDFGL-CKEGIAQ 149

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            +     CG+P Y+APEV++ Q YD  VD W +GA+L+E+L G PPF   +  +
Sbjct: 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  106 bits (267), Expect = 1e-28
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 24/168 (14%)

Query: 14  DC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGR-VPEQT 67
           DC  E++ L  ++HPN+I+   +F   N + +V+E    G+LS  I   +   R +PE+T
Sbjct: 48  DCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 107

Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--- 122
             K+  QL   LE ++S  I+HRD+KP N+ ++      ++K+ D GL      G +   
Sbjct: 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGL------GRFFSS 158

Query: 123 ----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               A  + G+P YM+PE +    Y+ K D+WS+G +L+E+     PF
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  107 bits (269), Expect = 1e-28
 Identities = 58/152 (38%), Positives = 88/152 (57%), Gaps = 8/152 (5%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLE 78
            L ++ HP ++ L  +FQ    ++ V+++  GG L  +++      E  AR +  ++   
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASA 108

Query: 79  I--LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 134
           I  L+S +II+RDLKPENILL   D    + + DFGL C   + P       CG+P Y+A
Sbjct: 109 IGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGL-CKEGVEPEETTSTFCGTPEYLA 164

Query: 135 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           PEVL+ + YD  VD W +GA+L+E+L G PPF
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  106 bits (265), Expect = 1e-28
 Identities = 59/165 (35%), Positives = 95/165 (57%), Gaps = 7/165 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV--PEQTARKFL 72
           E+  L+ + HPNI+  F +FQ    +F+V+E+C GG+L   I R  G +   +Q    F+
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108

Query: 73  Q-QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSP 130
           Q  LGL+ ++   I+HRD+K +NI LS   + ++ K+ DFG++  L         C G+P
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166

Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
            Y++PE+ Q + Y+ K D+WS+G +L+EL     PF     HQ +
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  106 bits (266), Expect = 1e-28
 Identities = 60/155 (38%), Positives = 87/155 (56%), Gaps = 7/155 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  V+   I+ L  AF+ ++ + LV+    GG+L  +I   G    PE  A  +  
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102

Query: 74  Q--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           Q   GLE L+   I++RDLKPEN+LL   DD   ++I+D GL+  L  G   +   G+P 
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           YMAPEVLQ + YD  VD +++G  L+E++ G  PF
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  106 bits (266), Expect = 4e-28
 Identities = 56/150 (37%), Positives = 91/150 (60%), Gaps = 9/150 (6%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH 83
           P + +L   FQ  + ++ V+E+  GG+L  +I+  G+  E  A  +  ++  GL  L+S 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 141
            II+RDLK +N++L   D +  +KIADFG+ C   ++ G      CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DAEGHIKIADFGM-CKENIFGGKTTRTFCGTPDYIAPEIIAYQ 176

Query: 142 RYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            Y + VD W+ G +L+E+L G PPF  GE+
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFD-GED 205

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  106 bits (265), Expect = 5e-28
 Identities = 54/154 (35%), Positives = 94/154 (61%), Gaps = 8/154 (5%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--G 76
           F  + ++P ++ L   FQ  + +FLV+E+  GG+L  +++   ++PE+ AR +  ++   
Sbjct: 49  FEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA 108

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 134
           L  L+   II+RDLK +N+LL   D D  +K+ D+G+ C   L PG+     CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGM-CKEGLGPGDTTSTFCGTPNYIA 164

Query: 135 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           PE+L+ + Y   VD W++G ++FE++ G  PF +
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  105 bits (262), Expect = 5e-28
 Identities = 62/159 (38%), Positives = 92/159 (57%), Gaps = 12/159 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L+S +HPNI++L DAF  EN +++++EFCAGG + + +    R   +   + + + 
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111

Query: 76  GLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 131
            LE LN  H   IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P 
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRTIQRRDSFIGTPY 168

Query: 132 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPP 165
           +MAPEV+  +      YD K D+WS+G  L E+    PP
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  105 bits (263), Expect = 8e-28
 Identities = 65/169 (38%), Positives = 95/169 (56%), Gaps = 13/169 (7%)

Query: 3   KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           KK  KH+ S    E N  L +V HP ++ L  +FQ  + ++ V+++  GG L  +++   
Sbjct: 36  KKEEKHIMS----ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER 91

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TL 117
              E  AR +  ++   L  L+S +I++RDLKPENILL   D    + + DFGL C   +
Sbjct: 92  CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGL-CKENI 147

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                    CG+P Y+APEVL  Q YD  VD W +GA+L+E+L G PPF
Sbjct: 148 EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  105 bits (264), Expect = 8e-28
 Identities = 57/157 (36%), Positives = 92/157 (58%), Gaps = 7/157 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L+ +NHP  + L+ +F+ E+ ++LV+EF  GG   +++R + R P      +  Q+
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 76  GL--EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L S +I++RDLKPEN+LL   D D  +K+ DFG +  +    Y   +CG+P Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYI 195

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 170
           APE+L    + +  D W++G  ++E+L G PPF   E
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232

Length = 340

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 1e-27
 Identities = 58/161 (36%), Positives = 90/161 (55%), Gaps = 16/161 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL 72
           E+  L  + HPNI+RL +    + +  I++V E+    +L+  +     +  E   + ++
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYM 106

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVC 127
           +QL  GL+ L+S+ I+HRD+K  NIL+   ++D +LK+ADFGL+         +Y  +V 
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Query: 128 GSPL-YMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 166
              L Y  PE+L    RY  +VDMWSVG IL EL  G P F
Sbjct: 164 --TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 1e-27
 Identities = 61/155 (39%), Positives = 89/155 (57%), Gaps = 8/155 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L+ VN P I+ L  +FQ+   ++LV+ F  GG L  +++  GR     AR +  +L
Sbjct: 43  ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 131
              LE L+  ++I+RDLKPENILL   D    + + DFGL C L   +       CG+P 
Sbjct: 103 LCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGL-CKLNMKDDDKTNTFCGTPE 158

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y+APE+L    Y + VD W++G +L+E+L G PPF
Sbjct: 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  104 bits (263), Expect = 1e-27
 Identities = 64/166 (38%), Positives = 93/166 (56%), Gaps = 23/166 (13%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           E+ FL  + +HPNI++L +  +AEN   I+LV E+    +L + IR    + +   R  +
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY-METDLHAVIR-ANILEDVHKRYIM 113

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            QL   L+ ++S ++IHRDLKP NILL   + D  +K+ADFGL+ +L           +P
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENP---ENP 167

Query: 131 L---------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +         Y APE+L    RY + VDMWSVG IL E+L G P F
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  104 bits (261), Expect = 2e-27
 Identities = 60/155 (38%), Positives = 91/155 (58%), Gaps = 8/155 (5%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
            +P +  L+  FQ +  +F V+EF  GG+L  +I+  GR     A  +  ++  GL+ L+
Sbjct: 54  ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQ 139
           S  II+RDLK +N++L   D D  +KIADFG+ C   ++  N A   CG+P Y+APE+LQ
Sbjct: 114 SKGIIYRDLKLDNVML---DRDGHIKIADFGM-CKENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 140 FQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
             +Y   VD WS G +L+E+L G  PF   +E + 
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  103 bits (258), Expect = 2e-27
 Identities = 54/158 (34%), Positives = 89/158 (56%), Gaps = 9/158 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  ++ +NHP+IIR+  A   ++   L VE+ AGG++S  +  +G   E     + +QL
Sbjct: 53  EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL 112

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-----GNYAEKVCG 128
             GL  L+ + IIHRD+K  N+L+        L+IADFG +  L       G +  ++ G
Sbjct: 113 LRGLSYLHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLG 170

Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +  +MAPEVL+ ++Y    D+WSVG ++ E+    PP+
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  103 bits (259), Expect = 2e-27
 Identities = 55/158 (34%), Positives = 84/158 (53%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E++ +  + H NI+RL D    EN + LV E+    +L  Y+  HG    +   T + F 
Sbjct: 48  EISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFT 106

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  G+   + + ++HRDLKP+N+L++       LK+ADFGL+     P N       +
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINK---RGELKLADFGLARAFGIPVNTFSNEVVT 163

Query: 130 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 166
             Y AP+VL   R Y   +D+WSVG I+ E++ G P F
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  103 bits (259), Expect = 4e-27
 Identities = 58/152 (38%), Positives = 88/152 (57%), Gaps = 8/152 (5%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           NHP + +L+  FQ  + +F V+EF  GG+L  +I+   R  E  AR +  ++   L  L+
Sbjct: 54  NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAPEVLQ 139
              II+RDLK +N+LL   D +   K+ADFG+ C   ++ G      CG+P Y+APE+LQ
Sbjct: 114 DKGIIYRDLKLDNVLL---DHEGHCKLADFGM-CKEGIFNGKTTSTFCGTPDYIAPEILQ 169

Query: 140 FQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
              Y   VD W++G +L+E+L G+ PF    E
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  103 bits (257), Expect = 4e-27
 Identities = 55/146 (37%), Positives = 88/146 (60%), Gaps = 9/146 (6%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFLQQLGLEILN 81
           HPNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ LQ   LE L+
Sbjct: 75  HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ--ALEFLH 132

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQF 140
           S+ +IHRD+K +NILL G+D  V  K+ DFG    + P  +    + G+P +MAPEV+  
Sbjct: 133 SNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189

Query: 141 QRYDEKVDMWSVGAILFELLNGYPPF 166
           + Y  KVD+WS+G +  E++ G PP+
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  103 bits (258), Expect = 4e-27
 Identities = 61/156 (39%), Positives = 83/156 (53%), Gaps = 13/156 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQ 73
           E+  L  + HPNII L D F  ++ I LV EF    +L   I+    +    A  + ++ 
Sbjct: 52  EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIK-DKSIVLTPADIKSYML 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPG-NYAEKVCGS 129
               GLE L+S+ I+HRDLKP N+L   +  D +LK+ADFGL+ +   P      +V  +
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLL---IASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165

Query: 130 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 164
             Y APE+L   R Y   VDMWSVG I  ELL   P
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  105 bits (264), Expect = 5e-27
 Identities = 65/196 (33%), Positives = 101/196 (51%), Gaps = 33/196 (16%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI--- 57
           + L +  KS L  E+N +  + H NI+R  D F  +A   +++++EFC  G+LS  I   
Sbjct: 49  RGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC 108

Query: 58  -RLHGRVPEQTARKFLQQLGLEIL----------NSHHIIHRDLKPENILLS-------- 98
            ++ G++ E       +QL L  L          N   ++HRDLKP+NI LS        
Sbjct: 109 YKMFGKIEEHAIVDITRQL-LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167

Query: 99  ------GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL--QFQRYDEKVDMW 150
                  L+   + KI DFGLS  +   + A    G+P Y +PE+L  + + YD+K DMW
Sbjct: 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMW 227

Query: 151 SVGAILFELLNGYPPF 166
           ++G I++EL +G  PF
Sbjct: 228 ALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 5e-27
 Identities = 56/152 (36%), Positives = 89/152 (58%), Gaps = 7/152 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH 83
           P I+ L  +FQ ++ ++LV ++ +GG L  +++  GR  E  A+ ++ +L   LE L+ +
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAPEVLQFQR 142
            I++RDLKPENIL   LD    + + DFGLS   L         CG+  Y+APEVL  ++
Sbjct: 116 DIVYRDLKPENIL---LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 143 -YDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            Y + VD WS+G ++FE+  G+ PF   +  Q
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ 204

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  102 bits (255), Expect = 7e-27
 Identities = 55/155 (35%), Positives = 86/155 (55%), Gaps = 10/155 (6%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGLEILNSH 83
           P ++ L  AFQ +  + L++++  GG L +++       E   R ++ +  L L+ L+  
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ 141
            II+RD+K ENILL   D +  + + DFGLS          A   CG+  YMAPEV++  
Sbjct: 125 GIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181

Query: 142 R--YDEKVDMWSVGAILFELLNGYPPFSV-GEEHQ 173
              +D+ VD WS+G + FELL G  PF+V GE++ 
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS 216

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 1e-26
 Identities = 55/158 (34%), Positives = 86/158 (54%), Gaps = 12/158 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E+  L  + H NI+ L +AF+ +  ++LV E+     L   +    G +P    R ++ Q
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQ 108

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGS 129
           L   +   +SH+IIHRD+KPENIL+S   +  +LK+ DFG +  L         + V  +
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPASPLTDYV-AT 164

Query: 130 PLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
             Y APE+L     Y + VD+W++G I+ ELL+G P F
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 2e-26
 Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 51/209 (24%)

Query: 1   MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           ML+K    H+++    E + L+  ++P +++L+ +FQ EN ++L++E+  GG++ + +  
Sbjct: 39  MLEKEQVAHVRA----ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK 94

Query: 60  HGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT- 116
                E+  R ++ +  L ++ ++    IHRD+KP+N+L   LD    +K++DFGL CT 
Sbjct: 95  KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLL---LDAKGHIKLSDFGL-CTG 150

Query: 117 --------LY-------PGNYAEKVC------------------------GSPLYMAPEV 137
                    Y       P N+ + +                         G+P Y+APEV
Sbjct: 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210

Query: 138 LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                Y+++ D WS+G I++E+L GYPPF
Sbjct: 211 FLQTGYNKECDWWSLGVIMYEMLVGYPPF 239

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  101 bits (253), Expect = 2e-26
 Identities = 56/162 (34%), Positives = 85/162 (52%), Gaps = 18/162 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR---K 70
           EL    S   P I++ + AF  ++ + I + +E+C GG+L S   ++ +V ++  R   K
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS---IYKKVKKRGGRIGEK 105

Query: 71  FLQQL------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            L ++      GL  L+S  IIHRD+KP NILL        +K+ DFG+S  L   + A 
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELV-NSLAG 161

Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
              G+  YMAPE +Q + Y    D+WS+G  L E+     PF
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  102 bits (256), Expect = 2e-26
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 55/206 (26%)

Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           H+K+    E + L+  ++  +++L+ +FQ ++ ++ V+++  GG++ S +   G   E  
Sbjct: 47  HVKA----ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL 102

Query: 68  ARKFLQQLGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY------- 118
           AR ++ +L   I + H +  IHRD+KP+NIL   +D D  +K+ DFGL CT +       
Sbjct: 103 ARFYIAELTCAIESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CTGFRWTHDSK 158

Query: 119 ---PGNY-----------------------------------AEKVCGSPLYMAPEVLQF 140
               G++                                   A  + G+P Y+APEVL  
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218

Query: 141 QRYDEKVDMWSVGAILFELLNGYPPF 166
             Y +  D WSVG IL+E+L G PPF
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  100 bits (250), Expect = 2e-26
 Identities = 56/159 (35%), Positives = 95/159 (59%), Gaps = 8/159 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV-PEQTARKFLQ 73
           E   L+ + HPNI+   ++F+A+  +++V+E+C GG+L   I+L  G++ PE T  ++  
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107

Query: 74  Q--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 130
           Q  LG++ ++   ++HRD+K +NI L+    +  +K+ DFG +  L  PG YA    G+P
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTP 164

Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
            Y+ PE+ +   Y+ K D+WS+G IL+EL     PF   
Sbjct: 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  103 bits (257), Expect = 3e-26
 Identities = 60/171 (35%), Positives = 99/171 (57%), Gaps = 16/171 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVP--EQTARKF 71
           EL+ L++ +H  I++ FD F++++ + L++E+ +GG+L+  I  RL   +P  E      
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174

Query: 72  LQQ--LGLEILNSHHIIHRDLKPENILL--SGLDDDVMLKIADFGLSCTLYPG---NYAE 124
             Q  L L+ ++S  ++HRDLK  NI L  +G+     +K+ DFG S         + A 
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-----IKLGDFGFSKQYSDSVSLDVAS 229

Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
             CG+P Y+APE+ + +RY +K DMWS+G IL+ELL  + PF    + + M
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM 280

Length = 478

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  100 bits (251), Expect = 3e-26
 Identities = 64/179 (35%), Positives = 96/179 (53%), Gaps = 24/179 (13%)

Query: 3   KKLNKHLKSCLDCELNF-----LSSVN-HPNIIRL----FDAFQAENCIFLVVEFCAGGN 52
           K + KH KS L+   N      L  ++ HPNI+RL    FD  +    + LV E     N
Sbjct: 30  KCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEVLFD--RKTGRLALVFEL-MDMN 85

Query: 53  LSSYIRLHGR-VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           L   I+   R +PE+  + ++ QL   L+ ++ + I HRD+KPENIL+     D +LK+A
Sbjct: 86  LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLA 141

Query: 110 DFGLSCTLYP-GNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           DFG    +Y    Y E +  +  Y APE +L    Y  K+D+W+VG + FE+L+ +P F
Sbjct: 142 DFGSCRGIYSKPPYTEYI-STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF 199

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 99.7 bits (249), Expect = 5e-26
 Identities = 56/154 (36%), Positives = 81/154 (52%), Gaps = 9/154 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
           EL+ L   N P I+  + AF     I + +E+  GG+L   ++   GR+PE+   K    
Sbjct: 49  ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108

Query: 75  L--GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           +  GL  L   H IIHRD+KP NIL++       +K+ DFG+S  L   + A+   G+  
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLV-NSLAKTFVGTSS 164

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFEL-LNGYP 164
           YMAPE +Q   Y  K D+WS+G  L EL    +P
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 99.5 bits (248), Expect = 5e-26
 Identities = 53/173 (30%), Positives = 91/173 (52%), Gaps = 12/173 (6%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           K   + +   L  E+  L  + H NI++   +    + + + +E+  GG++++ +  +G 
Sbjct: 43  KDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA 102

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 119
             E   R F++Q+  GL  L++  IIHRD+K  NIL+   D+   +KI+DFG+S  L   
Sbjct: 103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKLEAN 159

Query: 120 ------GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                       + GS  +MAPEV++   Y  K D+WS+G ++ E+L G  PF
Sbjct: 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 6e-26
 Identities = 53/181 (29%), Positives = 84/181 (46%), Gaps = 37/181 (20%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQ--L 75
           L++++HP +  L+ +FQ E  + LV+++C GG L   ++      + E+ AR +  +  L
Sbjct: 55  LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL 114

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----------- 124
            LE L+   I++RDLKPENILL      +ML  +DF LS                     
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHE-SGHIML--SDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 125 ---------KVC----------GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 165
                                 G+  Y+APEV+    +   VD W++G +L+E+L G  P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Query: 166 F 166
           F
Sbjct: 232 F 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 99.0 bits (246), Expect = 8e-26
 Identities = 53/165 (32%), Positives = 92/165 (55%), Gaps = 11/165 (6%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           S L+CE+  L ++ H  I++ +   +  AE  + + +E+  GG++   ++ +G + E   
Sbjct: 49  SALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT 108

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 122
           RK+ +Q+  G+  L+S+ I+HRD+K  NIL    D    +K+ DFG S  L      G  
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTICMSGTG 165

Query: 123 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
              V G+P +M+PEV+  + Y  K D+WS+G  + E+L   PP++
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  100 bits (249), Expect = 9e-26
 Identities = 55/153 (35%), Positives = 90/153 (58%), Gaps = 8/153 (5%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH 83
           P + +L   FQ  + ++ V+E+  GG+L   I+  GR  E  A  +  ++  GL  L+S 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 141
            II+RDLK +N++L   D +  +KIADFG+ C   ++ G   +  CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DSEGHIKIADFGM-CKENMWDGVTTKTFCGTPDYIAPEIIAYQ 176

Query: 142 RYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
            Y + VD W+ G +L+E+L G  PF   +E + 
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 1e-25
 Identities = 60/171 (35%), Positives = 88/171 (51%), Gaps = 22/171 (12%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENC------IFLVVEFCAGG---NLSSYIRLHG-RVP 64
           E N L    NHPNI   + AF  +N       ++LV+E C GG   +L   +R  G R+ 
Sbjct: 52  EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111

Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
           E+     L++   GL  L+ + +IHRD+K +NILL+    +  +K+ DFG+S  L     
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLG 168

Query: 123 AEKVC-GSPLYMAPEVL----QFQR-YDEKVDMWSVGAILFELLNGYPPFS 167
                 G+P +MAPEV+    Q    YD + D+WS+G    EL +G PP  
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 99.8 bits (249), Expect = 2e-25
 Identities = 59/164 (35%), Positives = 92/164 (56%), Gaps = 22/164 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARKF 71
           E + ++  N   I++L  AFQ +  +++V+E+  GG+L    S+Y      +PE+ AR +
Sbjct: 93  ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFY 147

Query: 72  LQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKV 126
             +  L L+ ++S   IHRD+KP+N+LL   D    LK+ADFG +C     N     +  
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFG-TCMKMDANGMVRCDTA 203

Query: 127 CGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLNGYPPF 166
            G+P Y++PEVL+ Q     Y  + D WSVG  L+E+L G  PF
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 98.5 bits (245), Expect = 3e-25
 Identities = 54/153 (35%), Positives = 89/153 (58%), Gaps = 8/153 (5%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH 83
           P + +L   FQ  + ++ V+E+  GG+L  +I+  G+  E  A  +  ++  GL  L+  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 141
            II+RDLK +N++L   D +  +KIADFG+ C   +  G      CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DSEGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176

Query: 142 RYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
            Y + VD W+ G +L+E+L G PPF   +E + 
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 97.8 bits (243), Expect = 4e-25
 Identities = 57/159 (35%), Positives = 91/159 (57%), Gaps = 12/159 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQ 74
           E+  L++ NHP I++L  AF  +  +++++EFC GG + +  + L   + E   +   +Q
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 131
           +   L+ L+S  IIHRDLK  N+LL+ LD D+  K+ADFG+S   +      +   G+P 
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLT-LDGDI--KLADFGVSAKNVKTLQRRDSFIGTPY 175

Query: 132 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPP 165
           +MAPEV+  +      YD K D+WS+G  L E+    PP
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 97.5 bits (243), Expect = 4e-25
 Identities = 53/159 (33%), Positives = 92/159 (57%), Gaps = 17/159 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E+  +    HPNI+ ++ ++   + +++V+EF  GG L+  I  H R+ E Q A   L  
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAV 124

Query: 75  LG-LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------C 127
           L  L  L++  +IHRD+K ++ILL+    D  +K++DFG  C       +++V       
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGF-C----AQVSKEVPRRKSLV 176

Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G+P +MAPEV+    Y  +VD+WS+G ++ E+++G PP+
Sbjct: 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 97.6 bits (243), Expect = 5e-25
 Identities = 54/159 (33%), Positives = 81/159 (50%), Gaps = 7/159 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  +     P I+  + AF  EN I + +EF   G+L    +  G +P +   K    +
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112

Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L N H I+HRD+KP NIL++       +K+ DFG+S  L   + A+   G+  Y
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVSGELI-NSIADTFVGTSTY 168

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           M+PE +Q  +Y  K D+WS+G  + EL  G  PF+    
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 97.0 bits (241), Expect = 5e-25
 Identities = 54/166 (32%), Positives = 93/166 (56%), Gaps = 12/166 (7%)

Query: 10  KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K+  DC  E++ L  +NHPN+I+  D+F  +N + +V+E    G+LS  I+   +    +
Sbjct: 44  KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI 103

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           PE+T  K+  QL   +E ++S  ++HRD+KP N+ ++      ++K+ D GL        
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160

Query: 122 YA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            A   + G+P YM+PE +    Y+ K D+WS+G +L+E+     PF
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 97.1 bits (242), Expect = 7e-25
 Identities = 54/165 (32%), Positives = 84/165 (50%), Gaps = 29/165 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E+  L  + H NI+RL+D   ++  + LV E+C   +L  Y    +G +  +  + F+ Q
Sbjct: 49  EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQ 107

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           L  GL   +SH+++HRDLKP+N+L++   +   LK+ADFGL+          +  G P+ 
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLA----------RAFGIPVR 154

Query: 132 ----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPP 165
                     Y  P+VL   + Y   +DMWS G I  EL N   P
Sbjct: 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 97.3 bits (242), Expect = 7e-25
 Identities = 58/154 (37%), Positives = 87/154 (56%), Gaps = 6/154 (3%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGLEILN 81
            HP +  L+  FQ +  +F V+E+  GG+L  +I+   +  +P  T        GL+ L+
Sbjct: 54  EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF 140
           S  I++RDLK +NILL   D D  +KIADFG+      G+      CG+P Y+APE+L  
Sbjct: 114 SKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
           Q+Y+  VD WS G +L+E+L G  PF   +E + 
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 96.6 bits (240), Expect = 8e-25
 Identities = 54/166 (32%), Positives = 93/166 (56%), Gaps = 12/166 (7%)

Query: 10  KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K+  DC  E++ L  +NHPN+I+ + +F  +N + +V+E    G+LS  I+   +    +
Sbjct: 44  KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 103

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           PE+T  K+  QL   LE ++S  ++HRD+KP N+ ++      ++K+ D GL        
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160

Query: 122 YA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            A   + G+P YM+PE +    Y+ K D+WS+G +L+E+     PF
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 96.4 bits (240), Expect = 8e-25
 Identities = 52/159 (32%), Positives = 81/159 (50%), Gaps = 11/159 (6%)

Query: 16  ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARK 70
           E+  +   + HPNI+R +  F   + +++V++   G  L    +S      R  E+    
Sbjct: 58  EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 71  FLQQLGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
              Q+ L +   H    I+HRDL P NI+L G DD V   I DFGL+    P +    V 
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIML-GEDDKVT--ITDFGLAKQKQPESKLTSVV 174

Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G+ LY  PE+++ + Y EK D+W+ G IL+++    PPF
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 97.2 bits (242), Expect = 9e-25
 Identities = 58/165 (35%), Positives = 85/165 (51%), Gaps = 29/165 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I     +  E+  +LV+E+C G + S  + +H        +K LQ++
Sbjct: 65  EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVH--------KKPLQEV 115

Query: 76  -----------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
                      GL  L+SH  IHRD+K  NILL+   +   +K+ADFG +  + P N   
Sbjct: 116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPAN--- 169

Query: 125 KVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPF 166
              G+P +MAPEV+      +YD KVD+WS+G    EL    PP 
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 97.2 bits (242), Expect = 1e-24
 Identities = 53/155 (34%), Positives = 83/155 (53%), Gaps = 8/155 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  ++
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 131
              L  L+S  +++RDLK EN++L   D D  +KI DFGL C   +  G   +  CG+P 
Sbjct: 105 VSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 96.3 bits (239), Expect = 1e-24
 Identities = 55/155 (35%), Positives = 91/155 (58%), Gaps = 9/155 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +  + +PNI+   D+F   + +F+V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL 125

Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPL 131
           Q   LE L+++ +IHRD+K +N+LL G+D  V  K+ DFG    + P       + G+P 
Sbjct: 126 Q--ALEFLHANQVIHRDIKSDNVLL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +MAPEV+  + Y  KVD+WS+G +  E++ G PP+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 95.8 bits (238), Expect = 1e-24
 Identities = 51/151 (33%), Positives = 81/151 (53%), Gaps = 11/151 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
           E   LS ++HP I++   +F   +   ++ E+C G +L   +         + E    ++
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG 128
             QL  G+  ++   I+HRDLK +NI L     + +LKI DFG+S  L    + A    G
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTG 167

Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           +P YM+PE L+ Q YD K D+WS+G IL+E+
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 96.3 bits (239), Expect = 2e-24
 Identities = 55/155 (35%), Positives = 91/155 (58%), Gaps = 9/155 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126

Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPL 131
           Q   LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P  +    + G+P 
Sbjct: 127 Q--ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPY 181

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +MAPEV+  + Y  KVD+WS+G +  E++ G PP+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 2e-24
 Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 22/174 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR-----VPEQTA 68
           E+  L  + H N++ L + F   A+  ++L+ ++ A  +L   I+ H +     +P    
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLS-------CTLY 118
           +  L Q+  G+  L+S+ ++HRDLKP NIL+ G   +  ++KI D GL+         L 
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 119 PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSVGEE 171
             +    V  +  Y APE+L   R Y + +D+W++G I  ELL   P F   E 
Sbjct: 171 DLD---PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.5 bits (237), Expect = 2e-24
 Identities = 51/163 (31%), Positives = 91/163 (55%), Gaps = 11/163 (6%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           L+CE+  L ++ H  I++ +   +   E  + + VE+  GG++   ++ +G + E   R+
Sbjct: 51  LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR 110

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLY-PGNYAE 124
           + +Q+  G+  L+S+ I+HRD+K  NIL    D    +K+ DFG S    T+   G   +
Sbjct: 111 YTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQTICMSGTGIK 167

Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            V G+P +M+PEV+  + Y  K D+WSV   + E+L   PP++
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 95.0 bits (236), Expect = 3e-24
 Identities = 50/161 (31%), Positives = 89/161 (55%), Gaps = 12/161 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L S+ H NI++       +N I + +EF  GG++SS +   G +PE    K+ +Q+
Sbjct: 52  EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI 111

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-------LSCTLYPGNYAEKV 126
             G+  L+++ ++HRD+K  N++L     + ++K+ DFG       +       N  + +
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168

Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            G+P +MAPEV+    Y  K D+WS+G  +FE+  G PP +
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA 209

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 95.3 bits (237), Expect = 4e-24
 Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 20/167 (11%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR-----VP 64
           E++ L  ++    I+RL D    E       ++LV E+    +L  ++  +GR     +P
Sbjct: 50  EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108

Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPG 120
            +T + F+ QL  G+   + H ++HRDLKP+N+L+       +LKIAD GL    ++   
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVK 166

Query: 121 NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 166
           +Y  ++  +  Y APEVL     Y   VD+WSVG I  E+    P F
Sbjct: 167 SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 95.9 bits (239), Expect = 4e-24
 Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 34/166 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           EL  L    H NII + D  +        +++V++     +L   I     + E+  R F
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYF 112

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
           L QL  GL+ ++S ++IHRDLKP N+L++    D  L+I DFG+         A  +  S
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNE---DCELRIGDFGM---------ARGLSSS 160

Query: 130 PL--------------YMAPEVL-QFQRYDEKVDMWSVGAILFELL 160
           P               Y APE+L     Y   +DMWSVG I  E+L
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 94.3 bits (234), Expect = 5e-24
 Identities = 51/165 (30%), Positives = 92/165 (55%), Gaps = 11/165 (6%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           + L+CE+  L ++ H  I++ +   +   E  + + +E   GG++   ++ +G + E   
Sbjct: 49  NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT 108

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 122
           RK+ +Q+  G+  L+S+ I+HRD+K  NIL   + +   +K+ DFG S  L      G  
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN---VKLGDFGASKRLQTICLSGTG 165

Query: 123 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            + V G+P +M+PEV+  + Y  K D+WSVG  + E+L   PP++
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 94.1 bits (234), Expect = 7e-24
 Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 7/155 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     E+ A  +  
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 74  Q--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           +   GLE L+   I++RDLKPENILL   DD   ++I+D GL+  +  G       G+  
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVG 166

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           YMAPEV++ +RY    D W +G +++E++ G  PF
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 95.1 bits (237), Expect = 8e-24
 Identities = 57/169 (33%), Positives = 92/169 (54%), Gaps = 23/169 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAF----QAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  ++H N+I L D F      E+   ++LV     G +L++ ++   ++ +   +
Sbjct: 64  ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADLNNIVK-CQKLSDDHIQ 121

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             + Q+  GL+ ++S  IIHRDLKP NI    +++D  LKI DFGL+         +++ 
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARHT-----DDEMT 173

Query: 128 G---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
           G   +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  G +H
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP-GSDH 221

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 94.4 bits (234), Expect = 1e-23
 Identities = 54/155 (34%), Positives = 90/155 (58%), Gaps = 9/155 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 66  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 125

Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPL 131
           Q   L+ L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P       + G+P 
Sbjct: 126 Q--ALDFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +MAPEV+  + Y  KVD+WS+G +  E++ G PP+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 95.1 bits (236), Expect = 1e-23
 Identities = 57/159 (35%), Positives = 93/159 (58%), Gaps = 12/159 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ A+ +  + 
Sbjct: 93  ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEV 151

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 131
            L L+ ++S  +IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNML---LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD 208

Query: 132 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 166
           Y++PEVL+ Q     Y  + D WSVG  LFE+L G  PF
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 94.5 bits (235), Expect = 1e-23
 Identities = 62/165 (37%), Positives = 89/165 (53%), Gaps = 14/165 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           EL  L  + H NII L D F      I+ V E   G +L   +     + +Q  + FL Q
Sbjct: 59  ELKLLKHLRHENIISLSDIFISPLEDIYFVTEL-LGTDLHRLLT-SRPLEKQFIQYFLYQ 116

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           +  GL+ ++S  ++HRDLKP NIL+   +++  LKI DFGL+    P         +  Y
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP--QMTGYVSTRYY 171

Query: 133 MAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH--QF 174
            APE+ L +Q+YD +VD+WS G I  E+L G P F  G++H  QF
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP-GKDHVNQF 215

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 95.1 bits (236), Expect = 1e-23
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 55/213 (25%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           LN++  + +  E + L+  ++  +++L+ +FQ ++ ++ V+++  GG++ S +      P
Sbjct: 40  LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP 99

Query: 65  EQTARKFLQQLGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCT------ 116
           E  AR ++ +L L I + H +  IHRD+KP+NIL   +D D  +K+ DFGL CT      
Sbjct: 100 EVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL---IDLDGHIKLTDFGL-CTGFRWTH 155

Query: 117 ---------------LYPGNY----------------------------AEKVCGSPLYM 133
                          + P +                             A  + G+P Y+
Sbjct: 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYI 215

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APEVL  + Y +  D WSVG ILFE+L G PPF
Sbjct: 216 APEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 92.6 bits (230), Expect = 2e-23
 Identities = 49/159 (30%), Positives = 91/159 (57%), Gaps = 8/159 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP---EQTARKFL 72
           E+  LS++ HPNI++  ++F+    +++V+++C GG+L   I     V    +Q    F+
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108

Query: 73  QQ-LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSP 130
           Q  L L+ ++   I+HRD+K +NI L+    D  +K+ DFG++  L       + C G+P
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVELARTCIGTP 165

Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
            Y++PE+ + + Y+ K D+W++G +L+E+      F  G
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 93.7 bits (233), Expect = 2e-23
 Identities = 59/169 (34%), Positives = 92/169 (54%), Gaps = 14/169 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E + LS  N P I +L  AFQ ++ ++LV+E+  GG+L S + R   +  E  A+ +L +
Sbjct: 51  ERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE 110

Query: 75  LGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 130
           L L I + H +  +HRD+KPEN+L   +D    +K+ADFG +  L       ++   G+P
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVL---IDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167

Query: 131 LYMAPEVLQFQR------YDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            Y+APEVL          Y  + D WS+G I +E++ G  PF  G   +
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.5 bits (230), Expect = 3e-23
 Identities = 48/169 (28%), Positives = 91/169 (53%), Gaps = 15/169 (8%)

Query: 16  ELNFLSSVNH---PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---- 68
           E+  LS +     PNI + + ++     +++++E+  GG++ + ++  G + E+      
Sbjct: 49  EVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVII 107

Query: 69  RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-C 127
           R+ L    L+ ++   +IHRD+K  NIL++    +V L   DFG++  L   +       
Sbjct: 108 REVLV--ALKYIHKVGVIHRDIKAANILVT-NTGNVKL--CDFGVAALLNQNSSKRSTFV 162

Query: 128 GSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           G+P +MAPEV+   + YD K D+WS+G  ++E+  G PP+S  +  + M
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 93.2 bits (231), Expect = 6e-23
 Identities = 57/159 (35%), Positives = 92/159 (57%), Gaps = 12/159 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  + 
Sbjct: 93  ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 151

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 131
            L L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208

Query: 132 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 166
           Y++PEVL+ Q     Y  + D WSVG  L+E+L G  PF
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 91.4 bits (227), Expect = 7e-23
 Identities = 59/158 (37%), Positives = 88/158 (55%), Gaps = 10/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AFQ +  + LV+    GG+L  +I      +   PE  A  +
Sbjct: 43  EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 128
             Q+  GLE L+   II+RDLKPEN+LL   D+D  ++I+D GL+  L  G    K   G
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAG 159

Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +P +MAPE+LQ + YD  VD +++G  L+E++    PF
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 91.6 bits (227), Expect = 7e-23
 Identities = 54/155 (34%), Positives = 86/155 (55%), Gaps = 7/155 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     E  A  +  
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           ++  GLE L+   I++RDLKPENILL   DD   ++I+D GL+  +  G   +   G+  
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 166

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           YMAPEV++ +RY    D W++G +L+E++ G  PF
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 92.4 bits (229), Expect = 8e-23
 Identities = 59/173 (34%), Positives = 99/173 (57%), Gaps = 15/173 (8%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + ++  I  L  AFQ EN ++LV+++  GG+L + + +   R+
Sbjct: 40  LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL 99

Query: 64  PEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYP 119
           PE  AR +L ++ + I + H  H +HRD+KP+NIL+   D +  +++ADFG SC   +  
Sbjct: 100 PEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFG-SCLKLMED 155

Query: 120 GNYAEKVC-GSPLYMAPEVLQFQ-----RYDEKVDMWSVGAILFELLNGYPPF 166
           G     V  G+P Y++PE+LQ       +Y  + D WS+G  ++E+L G  PF
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 91.6 bits (227), Expect = 9e-23
 Identities = 55/160 (34%), Positives = 86/160 (53%), Gaps = 7/160 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     E+ A  +  
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           ++  GLE L+  + ++RDLKPENILL   DD   ++I+D GL+  +  G       G+  
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVG 166

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           YMAPEVL  QRY    D W +G +++E++ G  PF   +E
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 91.7 bits (228), Expect = 1e-22
 Identities = 61/159 (38%), Positives = 86/159 (54%), Gaps = 13/159 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
           E+  L ++ HPNI+ L +    +  + IFLV+E+C   +L+S +  +     E   +  +
Sbjct: 56  EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLM 114

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCG 128
            QL  GL+ L+ + IIHRDLK  N+LL+   D   LKIADFGL+ T  L       KV  
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLARTYGLPAKPMTPKVV- 170

Query: 129 SPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +  Y APE+L     Y   +DMW+VG IL ELL   P  
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 92.2 bits (229), Expect = 1e-22
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 58/224 (25%)

Query: 1   MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           M KK    H+K+    E + L+  + P ++ L+ +FQ    ++L++EF  GG+L + +  
Sbjct: 39  MFKKDQLAHVKA----ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK 94

Query: 60  HGRVPEQTARKFLQQLGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           +    E   R ++ +  L I   H +  IHRD+KP+NIL   +D    +K++DFGLS   
Sbjct: 95  YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNIL---IDRGGHIKLSDFGLSTGF 151

Query: 118 YP---GNYAEKV---------------------------------------------CGS 129
           +      Y +K+                                              G+
Sbjct: 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGT 211

Query: 130 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           P Y+APE+   Q Y ++ D WS+GAI+FE L G+PPF     H+
Sbjct: 212 PDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE 255

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 90.9 bits (225), Expect = 1e-22
 Identities = 52/155 (33%), Positives = 84/155 (54%), Gaps = 7/155 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P I R + ++     +++++E+  GG+    ++  G + E      L+++
Sbjct: 52  EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREI 110

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 111 LKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           MAPEV++   YD K D+WS+G    EL  G PP S
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 91.2 bits (226), Expect = 2e-22
 Identities = 54/155 (34%), Positives = 85/155 (54%), Gaps = 8/155 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  ++
Sbjct: 45  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 131
              LE L+S  +++RD+K EN++L   D D  +KI DFGL C   +  G   +  CG+P 
Sbjct: 105 VSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 93.0 bits (231), Expect = 2e-22
 Identities = 54/169 (31%), Positives = 81/169 (47%), Gaps = 13/169 (7%)

Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVP-E 65
           H ++    E    + + HPNI+ L D+ +A    +F V E+  G  L   +   G +P  
Sbjct: 20  HQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79

Query: 66  QTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---- 120
           +T R  LQ L  L   ++  I+HRDLKP+NI++S        K+ DFG+  TL PG    
Sbjct: 80  ETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG-TLLPGVRDA 138

Query: 121 -----NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 164
                    +V G+P Y APE L+ +      D+++ G I  E L G  
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 90.3 bits (224), Expect = 2e-22
 Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 30/161 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++       +P    + +L 
Sbjct: 49  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLF 107

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+          +  G P+
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLA----------RAFGVPV 154

Query: 132 -----------YMAPEVLQFQR-YDEKVDMWSVGAILFELL 160
                      Y APE+L   + Y   VD+WS+G I  E++
Sbjct: 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 89.9 bits (224), Expect = 2e-22
 Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 23/159 (14%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           ++PN I+L+ +        L++++   G+L   ++  G++ E   +K ++QL   L  L+
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-------YMA 134
            H+IIH D+K EN+L     D +   + D+GL           K+ G+P        Y +
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRI--YLCDYGLC----------KIIGTPSCYDGTLDYFS 174

Query: 135 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF--SVGEE 171
           PE ++   YD   D W+VG + +ELL G  PF     EE
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213

Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 90.4 bits (224), Expect = 2e-22
 Identities = 60/166 (36%), Positives = 89/166 (53%), Gaps = 9/166 (5%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           N+ +K     EL  L ++   NI+ L +AF+    ++LV E+     L     +   VP 
Sbjct: 40  NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP 99

Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--- 120
           +  R ++ QL   +   + + I+HRD+KPEN+L+S  D   +LK+ DFG +  L  G   
Sbjct: 100 EKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNA 156

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           NY E V  +  Y +PE+L    Y + VDMWSVG IL EL +G P F
Sbjct: 157 NYTEYV-ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 90.8 bits (225), Expect = 3e-22
 Identities = 62/177 (35%), Positives = 99/177 (55%), Gaps = 18/177 (10%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
           MLK+      +C   E N L + +   I  L  AFQ EN ++LV+++  GG+L + + + 
Sbjct: 39  MLKRAET---ACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF 95

Query: 60  HGRVPEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSC-- 115
             R+PE  AR ++ ++ L I + H  H +HRD+KP+N+L   LD +  +++ADFG SC  
Sbjct: 96  EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL---LDMNGHIRLADFG-SCLK 151

Query: 116 TLYPGNYAEKVC-GSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPF 166
               G     V  G+P Y++PE+LQ       +Y  + D WS+G  ++E+L G  PF
Sbjct: 152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 89.7 bits (222), Expect = 3e-22
 Identities = 53/172 (30%), Positives = 99/172 (57%), Gaps = 18/172 (10%)

Query: 1   MLKKLN-----KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLS 54
           ++KKLN     +  +   + E   LS + HPNI+   ++++ E+  +++V+ FC GG+L 
Sbjct: 29  VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDL- 87

Query: 55  SYIRLHGR----VPE-QTARKFLQ-QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            Y +L  +    +PE Q    F+Q  + L+ L+  HI+HRDLK +N+ L+  +   ++K+
Sbjct: 88  -YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN---IIKV 143

Query: 109 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 159
            D G++  L      A  + G+P YM+PE+   + Y+ K D+W++G  ++E+
Sbjct: 144 GDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 90.5 bits (225), Expect = 4e-22
 Identities = 58/158 (36%), Positives = 80/158 (50%), Gaps = 20/158 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRL---HGRVPEQ 66
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   H R+   
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQMDLDHERM--- 120

Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
                L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T        
Sbjct: 121 --SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMT 175

Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
               +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 89.8 bits (223), Expect = 4e-22
 Identities = 53/168 (31%), Positives = 85/168 (50%), Gaps = 31/168 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKFL 72
           E++ L  + HPNI+ L D    E+ ++L+ EF +  +L  Y   +     +  +  + +L
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYL 107

Query: 73  QQLGLEIL--NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q+   IL  +S  ++HRDLKP+N+L   +D+  ++K+ADFGL+          +  G P
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLL---IDNKGVIKLADFGLA----------RAFGIP 154

Query: 131 L-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +           Y APEVL    RY   VD+WS+G I  E+    P F
Sbjct: 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 89.4 bits (222), Expect = 5e-22
 Identities = 63/191 (32%), Positives = 91/191 (47%), Gaps = 32/191 (16%)

Query: 1   MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           MLK  +   K   D   E+  +  +  H NII L      E  +++VVE+ A GNL  ++
Sbjct: 49  MLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL 107

Query: 58  RLHGRVPEQTARKFL-----QQL--------------GLEILNSHHIIHRDLKPENILLS 98
           R   R P + A         + L              G+E L S   IHRDL   N+L++
Sbjct: 108 RAR-RPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166

Query: 99  GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAI 155
             +D VM KIADFGL+  ++  +Y  K     L   +MAPE L  + Y  + D+WS G +
Sbjct: 167 --EDHVM-KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 223

Query: 156 LFEL--LNGYP 164
           L+E+  L G P
Sbjct: 224 LWEIFTLGGSP 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 89.3 bits (221), Expect = 7e-22
 Identities = 57/172 (33%), Positives = 93/172 (54%), Gaps = 21/172 (12%)

Query: 13  LDCELNFLSSV-NHPNIIRLFDAF-QAENCI----FLVVEFCAGGNLSSYI----RLHGR 62
           ++ E N L S+ NHPN+++ +  F +A+  +    +LV+E C GG+++  +        R
Sbjct: 65  IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124

Query: 63  VPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           + E      L    LGL+ L+++ IIHRD+K  NILL+    +  +K+ DFG+S  L   
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTST 181

Query: 121 NYAEKV-CGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 166
                   G+P +MAPEV+  ++     YD + D+WS+G    EL +G PP 
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 89.0 bits (221), Expect = 7e-22
 Identities = 58/165 (35%), Positives = 90/165 (54%), Gaps = 7/165 (4%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +K +K     E+  L  + H N++ L + F+ +  ++LV EF     L    +    + E
Sbjct: 40  DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDE 99

Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNY 122
              RK+L Q+  G+E  +SH+IIHRD+KPENIL+S      ++K+ DFG + TL  PG  
Sbjct: 100 SRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEV 156

Query: 123 AEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
                 +  Y APE+L    +Y   VD+W+VG ++ E+L G P F
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 89.5 bits (222), Expect = 9e-22
 Identities = 57/150 (38%), Positives = 88/150 (58%), Gaps = 15/150 (10%)

Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQLGLEILNSH--H 84
           I  L  AFQ EN ++LV+++  GG+L + + +   R+PE  AR +L ++ L I + H   
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 85  IIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVC-GSPLYMAPEVLQFQ 141
            +HRD+KP+N+LL   D +  +++ADFG SC   L  G     V  G+P Y++PE+LQ  
Sbjct: 123 YVHRDIKPDNVLL---DKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAM 178

Query: 142 -----RYDEKVDMWSVGAILFELLNGYPPF 166
                RY  + D WS+G  ++E+L G  PF
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 88.6 bits (219), Expect = 9e-22
 Identities = 52/155 (33%), Positives = 83/155 (53%), Gaps = 7/155 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++     +++++E+  GG+    +R  G   E      L+++
Sbjct: 52  EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI 110

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           MAPEV+Q   YD K D+WS+G    EL  G PP S
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 89.4 bits (222), Expect = 9e-22
 Identities = 55/164 (33%), Positives = 81/164 (49%), Gaps = 17/164 (10%)

Query: 16  ELNFLSSV-NHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           EL  L     H NI  L+D         N ++L  E     +L   IR    + +   + 
Sbjct: 51  ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQS 109

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYA 123
           F+ Q+  GL+ ++S +++HRDLKP N+L++    D  LKI DFGL+            + 
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPGENAGFM 166

Query: 124 EKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +   +  Y APE+ L FQ Y + +D+WSVG IL ELL   P F
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 88.9 bits (220), Expect = 1e-21
 Identities = 60/160 (37%), Positives = 84/160 (52%), Gaps = 15/160 (9%)

Query: 17  LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 55  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIK 113

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A    
Sbjct: 114 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLA-RIYSFQMALTSV 169

Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
              L Y APEVL    Y   VD+WSVG I  E+    P F
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 88.9 bits (220), Expect = 1e-21
 Identities = 54/154 (35%), Positives = 89/154 (57%), Gaps = 10/154 (6%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGLEILNSH 83
           P ++ L  AFQ +  + L++++  GG L +++    R  EQ  + +  +  L LE L+  
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ 141
            II+RD+K ENILL   D +  + + DFGLS   +      A   CG+  YMAP++++  
Sbjct: 125 GIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181

Query: 142 R--YDEKVDMWSVGAILFELLNGYPPFSV-GEEH 172
              +D+ VD WS+G +++ELL G  PF+V GE++
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 89.0 bits (220), Expect = 1e-21
 Identities = 55/157 (35%), Positives = 84/157 (53%), Gaps = 13/157 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E+ FL  + HPN I     +  E+  +LV+E+C G + S  + +H +  ++     +   
Sbjct: 75  EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHG 133

Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
              GL  L+SH++IHRD+K  NILL+   +   +K+ADFG +    P N      G+P +
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPAN---SFVGTPYW 187

Query: 133 MAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPF 166
           MAPEV+      +YD KVD+WS+G    EL    PP 
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 89.7 bits (222), Expect = 1e-21
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 59/217 (27%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+    H+K+    E + L+  ++  ++RL+ +FQ ++ ++ V+++  GG++ S +   
Sbjct: 40  LLRNQVAHVKA----ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM 95

Query: 61  GRVPEQTARKFLQQLGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           G  PE  AR ++ +L   + + H +  IHRD+KP+NIL   +D D  +K+ DFGL CT +
Sbjct: 96  GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CTGF 151

Query: 119 ----------------------------PGN---------------------YAEKVCGS 129
                                       P N                      A  + G+
Sbjct: 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGT 211

Query: 130 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           P Y+APEVL    Y +  D WSVG IL+E+L G PPF
Sbjct: 212 PNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 88.1 bits (218), Expect = 1e-21
 Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 7/155 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     EQ A  +  
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           +L  GLE L    I++RDLKPENILL   DD   ++I+D GL+  +  G       G+  
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVG 166

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           YMAPEV+  ++Y    D W +G +++E++ G  PF
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 88.2 bits (218), Expect = 2e-21
 Identities = 58/165 (35%), Positives = 86/165 (52%), Gaps = 29/165 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I     +  E+  +LV+E+C G + S  + +H        +K LQ++
Sbjct: 71  EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVH--------KKPLQEV 121

Query: 76  -----------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
                      GL  L+SH++IHRD+K  NILL+   +   +K+ADFG +    P N   
Sbjct: 122 EIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSPAN--- 175

Query: 125 KVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPF 166
              G+P +MAPEV+      +YD KVD+WS+G    EL    PP 
Sbjct: 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 87.8 bits (217), Expect = 3e-21
 Identities = 58/165 (35%), Positives = 88/165 (53%), Gaps = 29/165 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I+    +  E+  +LV+E+C G + S  + +H        +K LQ++
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVH--------KKPLQEV 115

Query: 76  -----------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
                      GL  L+SH++IHRD+K  NILLS   +  ++K+ DFG +  + P N   
Sbjct: 116 EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN--- 169

Query: 125 KVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPF 166
              G+P +MAPEV+      +YD KVD+WS+G    EL    PP 
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 86.9 bits (215), Expect = 4e-21
 Identities = 53/153 (34%), Positives = 87/153 (56%), Gaps = 7/153 (4%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-- 74
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  +  
Sbjct: 48  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107

Query: 75  LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
           LGLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163

Query: 135 PEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 166
           PEVLQ    YD   D +S+G +LF+LL G+ PF
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 87.5 bits (217), Expect = 4e-21
 Identities = 54/169 (31%), Positives = 80/169 (47%), Gaps = 22/169 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  ++ + H NI+ L D +   + I LV++  A  +L   +    R+ E   +  L Q+
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQI 128

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS----CTLYPGNYAEKVCGS 129
             GL +L+  + +HRDL P NI +   +   + KIADFGL+       Y    ++     
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 130 P-----------LYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 166
                        Y APE+L   ++Y   VDMWSVG I  ELL G P F
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234

Length = 335

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 87.9 bits (218), Expect = 4e-21
 Identities = 52/182 (28%), Positives = 96/182 (52%), Gaps = 27/182 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHG 61
           E+  +  ++H NI+++++                   N +++V E     +L++ +   G
Sbjct: 52  EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQE-YMETDLANVLE-QG 109

Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
            + E+ AR F+ QL  GL+ ++S +++HRDLKP N+ ++   +D++LKI DFGL+  + P
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDP 167

Query: 120 -----GNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
                G  +E +  +  Y +P  +L    Y + +DMW+ G I  E+L G P F+   E +
Sbjct: 168 HYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226

Query: 174 FM 175
            M
Sbjct: 227 QM 228

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 87.1 bits (216), Expect = 4e-21
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 16/157 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PE      L ++
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----NILGKI 104

Query: 76  GLEIL-------NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 128
            + +L         H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G
Sbjct: 105 SIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVG 160

Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG-YP 164
           +  YM+PE LQ   Y  + D+WS+G  L E+  G YP
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 86.3 bits (214), Expect = 5e-21
 Identities = 49/167 (29%), Positives = 87/167 (52%), Gaps = 18/167 (10%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            LK  +   ++ L  E + ++++ HPN+++L       N +++V E+ A G+L  Y+R  
Sbjct: 36  CLKDDSTAAQAFLA-EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR 94

Query: 61  GR--VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--- 113
           GR  +       F   +  G+E L   + +HRDL   N+L+S   +D++ K++DFGL   
Sbjct: 95  GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKE 151

Query: 114 -SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 159
            S     G    K      + APE L+ +++  K D+WS G +L+E+
Sbjct: 152 ASQGQDSGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 86.6 bits (214), Expect = 5e-21
 Identities = 53/153 (34%), Positives = 88/153 (57%), Gaps = 7/153 (4%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-- 74
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E+  R +  +  
Sbjct: 48  LSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107

Query: 75  LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
           LGLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163

Query: 135 PEVLQF-QRYDEKVDMWSVGAILFELLNGYPPF 166
           PEVLQ    YD   D +S+G +LF+LL G+ PF
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 85.8 bits (212), Expect = 7e-21
 Identities = 56/168 (33%), Positives = 89/168 (52%), Gaps = 14/168 (8%)

Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK+    E   L   +HPNI+RL      +  I++V+E   GG+  +++R  G  P    
Sbjct: 36  LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--PRLKV 93

Query: 69  RKFLQQL-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
           ++ +Q +     G+E L S H IHRDL   N L++   +  +LKI+DFG+S     G YA
Sbjct: 94  KELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYA 150

Query: 124 EK--VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 167
               +   P+ + APE L + RY  + D+WS G +L+E  + G  P++
Sbjct: 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 7e-21
 Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++ ++HP I+RL    + E  + LV+E    G L  Y++    +P    ++   Q 
Sbjct: 46  EASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV 104

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS-P 130
            +G+  L S H +HRDL   N+LL    +    KI+DFG+S  L  G+  Y     G  P
Sbjct: 105 AMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDYYRATTAGRWP 161

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           L + APE + + ++  K D+WS G  L+E  + G  P+
Sbjct: 162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 86.0 bits (213), Expect = 1e-20
 Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 43/174 (24%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFC---------AGGNLSSYIRLHGRVPEQ 66
           E++ L  + H NI+RL D   +E  ++LV E+          +  + +   RL       
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRL------- 103

Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + +L Q+  G+   +SH ++HRDLKP+N+L+    +   LK+ADFGL+          
Sbjct: 104 -IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLA---------- 150

Query: 125 KVCGSPL-----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 166
           +  G P+           Y APE+L   R Y   VD+WSVG I  E++N  P F
Sbjct: 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204

Length = 294

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 86.3 bits (213), Expect = 1e-20
 Identities = 53/162 (32%), Positives = 87/162 (53%), Gaps = 9/162 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  +FQ ++ +  V+E+  GG L  ++       E   R +  ++
Sbjct: 45  ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI 104

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 131
              L+ L+S  I++RDLK EN++L   D D  +KI DFGL C   +      +  CG+P 
Sbjct: 105 VSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGL-CKEGITDAATMKTFCGTPE 160

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           Y+APEVL+   Y   VD W +G +++E++ G  PF   ++H+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 85.1 bits (210), Expect = 1e-20
 Identities = 53/158 (33%), Positives = 84/158 (53%), Gaps = 13/158 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ----TARKF 71
           E+  +    H NI+  F ++   + +++ +EFC GG+L     + G + E      +R+ 
Sbjct: 56  EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRET 115

Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSP 130
           LQ  GL  L+S   +HRD+K  NILL+   D+  +K+ADFG+S  +       K   G+P
Sbjct: 116 LQ--GLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTP 170

Query: 131 LYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPP 165
            +MAPEV   +R   Y++  D+W+VG    EL    PP
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 85.1 bits (210), Expect = 2e-20
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 7/155 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 52  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 110

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           MAPEV++   YD K D+WS+G    EL  G PP S
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 85.9 bits (212), Expect = 2e-20
 Identities = 62/165 (37%), Positives = 82/165 (49%), Gaps = 15/165 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  VNH NII L + F  +        ++LV+E     NL   I  H  +  +   
Sbjct: 70  ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVI--HMELDHERMS 126

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTACTNFMMTPYV 183

Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            +  Y APEV+    Y E VD+WSVG I+ EL+ G   F  G +H
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ-GTDH 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 3e-20
 Identities = 55/164 (33%), Positives = 83/164 (50%), Gaps = 19/164 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L    H NII + D  +       N +++V E     +L   I+    +     + 
Sbjct: 53  EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQY 110

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYA 123
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL         + G   
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLT 167

Query: 124 EKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           E V  +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 168 EYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 84.7 bits (209), Expect = 3e-20
 Identities = 50/154 (32%), Positives = 91/154 (59%), Gaps = 7/154 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +   +H N++ +++++   + +++V+EF  GG L+  I  H R+  EQ A   L  
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSV 127

Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L  L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 128 LRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYW 184

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           MAPEV+    Y  +VD+WS+G ++ E+++G PP+
Sbjct: 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 84.7 bits (210), Expect = 4e-20
 Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 29/170 (17%)

Query: 16  ELNFLSSVNHPNIIRLFD-----AFQAENC---IFLVVEFC----AGGNLSSYIRLHGRV 63
           E+  L  + H N++ L +     A          +LV EFC    AG  L S   +   +
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVKFTL 118

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--- 118
            E   +K ++ L  GL  ++ + I+HRD+K  NIL++    D +LK+ADFGL+       
Sbjct: 119 SE--IKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSK 173

Query: 119 ---PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 164
              P  Y  +V  +  Y  PE+L  +R Y   +DMW  G I+ E+    P
Sbjct: 174 NSKPNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 84.3 bits (209), Expect = 4e-20
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 9/154 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + HPN++ L + F+ +  + LV E+C    L+   +    VPE   +K + Q 
Sbjct: 50  EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT 109

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPL 131
              +   + H+ IHRD+KPENIL++       +K+ DFG +  L     +Y + V  +  
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYV-ATRW 165

Query: 132 YMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 164
           Y APE+L    +Y   VD+W++G +  ELL G P
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 84.3 bits (208), Expect = 4e-20
 Identities = 51/173 (29%), Positives = 94/173 (54%), Gaps = 21/173 (12%)

Query: 13  LDCELNFLSSV-NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSS----YIRLHGR 62
           ++ E N L ++ +HPN+++ +  +  ++      ++LV+E C GG+++     +++   R
Sbjct: 61  IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120

Query: 63  VPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           + E      L +  +GL+ L+ +  IHRD+K  NILL+    +  +K+ DFG+S  L   
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVSAQLTST 177

Query: 121 NYAEKV-CGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFS 167
                   G+P +MAPEV+  ++     YD + D+WS+G    EL +G PP +
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 84.3 bits (208), Expect = 5e-20
 Identities = 49/154 (31%), Positives = 91/154 (59%), Gaps = 7/154 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +    H N++ +++++   + +++V+EF  GG L+  I  H R+  EQ A   L  
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAV 125

Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 182

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           MAPE++    Y  +VD+WS+G ++ E+++G PP+
Sbjct: 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 84.2 bits (209), Expect = 5e-20
 Identities = 59/170 (34%), Positives = 84/170 (49%), Gaps = 35/170 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL- 72
           E+N L  + HPNI+ + +     N   I++V+E+    +L S +    +   Q+  K L 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCG 128
            QL  G+  L+ + I+HRDLK  N+LL+  G+     LKI DFGL+          +  G
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-----LKICDFGLA----------REYG 157

Query: 129 SPL-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
           SPL           Y APE+L   + Y   +DMWSVG I  ELL   P F
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 83.0 bits (205), Expect = 6e-20
 Identities = 52/160 (32%), Positives = 80/160 (50%), Gaps = 9/160 (5%)

Query: 7   KHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           K L+   +     L+ + H  PN++ L     +E+ +FLV++   GG L S+I     +P
Sbjct: 24  KGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83

Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
           E+  +++  ++   L+ L+   I+ RDL P NILL   DD   +++  F     +     
Sbjct: 84  EECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDSCD 140

Query: 123 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
            E V    +Y APEV       E  D WS+GAILFELL G
Sbjct: 141 GEAV--ENMYCAPEVGGISEETEACDWWSLGAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 84.9 bits (210), Expect = 6e-20
 Identities = 57/165 (34%), Positives = 84/165 (50%), Gaps = 17/165 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  VNHPN+++  D F     I +++EF  GG+L        +     AR+ L   
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-- 179

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKVCGSPL 131
           G+  L+  HI+HRD+KP N+L   ++    +KIADFG    L+ T+ P N +    G+  
Sbjct: 180 GIAYLHRRHIVHRDIKPSNLL---INSAKNVKIADFGVSRILAQTMDPCNSS---VGTIA 233

Query: 132 YMAPEV----LQFQRYDEKV-DMWSVGAILFELLNGYPPFSVGEE 171
           YM+PE     L    YD    D+WS+G  + E   G  PF VG +
Sbjct: 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ 278

Length = 353

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 8e-20
 Identities = 54/157 (34%), Positives = 79/157 (50%), Gaps = 11/157 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E + L  + H NI+ L D    +  + LV E+    +L  Y+   G  +     R FL Q
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGN-YAEKVCGSP 130
           L  GL   +   ++HRDLKP+N+L+S   +   LK+ADFGL+     P   Y+ +V  + 
Sbjct: 112 LLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPSKTYSNEVV-TL 167

Query: 131 LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 166
            Y  P+VL     Y   +DMW VG I +E+  G P F
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 83.5 bits (206), Expect = 8e-20
 Identities = 52/155 (33%), Positives = 84/155 (54%), Gaps = 7/155 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   L  VN P I+ L  AF+++  + LV+    GG+L  +I   G    +  R   +  
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 74  QLGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           Q+   IL+ H   I++RD+KPEN+LL   DD    +++D GL+  L  G    +  G+  
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           YMAPE+L+ + Y   VD +++G  ++E++ G  PF
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 82.9 bits (205), Expect = 9e-20
 Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 17/164 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L   +HPNI++L      +  I++V+E   GG+L +++R   +    T +K LQ  
Sbjct: 42  EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLR--KKKNRLTVKKLLQMS 99

Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCG 128
                G+E L S + IHRDL   N L+    ++ +LKI+DFG+S     G Y   + +  
Sbjct: 100 LDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQ 156

Query: 129 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNG----YPPFS 167
            P+ + APE L + RY  + D+WS G +L+E  +     YP  S
Sbjct: 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 83.9 bits (207), Expect = 9e-20
 Identities = 53/156 (33%), Positives = 85/156 (54%), Gaps = 9/156 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  ++
Sbjct: 45  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104

Query: 76  --GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSP 130
              L+ L+S  ++++RDLK EN++L   D D  +KI DFGL C   +  G   +  CG+P
Sbjct: 105 VSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGL-CKEGIKDGATMKTFCGTP 160

Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 83.5 bits (206), Expect = 1e-19
 Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 7/153 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112

Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 165
           M+PE LQ   Y  + D+WS+G  L E+  G  P
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 83.8 bits (207), Expect = 1e-19
 Identities = 56/169 (33%), Positives = 83/169 (49%), Gaps = 22/169 (13%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
           E   L +VNHP++IR+ D     A  C+ L        +L +Y+ +    +P   A    
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS---DLYTYLTKRSRPLPIDQALIIE 163

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLY-PGNYAEKVCG 128
           +Q+  GL  L++  IIHRD+K ENI +   +D   + I D G +   +  P      + G
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLG--LAG 218

Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP------PFSVGEE 171
           +    APEVL   +Y+ K D+WS G +LFE+L  YP      P S  EE
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML-AYPSTIFEDPPSTPEE 266

Length = 357

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 83.5 bits (206), Expect = 2e-19
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 41/200 (20%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L K   + +  E + L   +   ++++F +FQ +  ++L++EF  GG++ + +     + 
Sbjct: 40  LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS 99

Query: 65  EQTARKFLQQLGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---- 118
           E+  + ++ +  L I   H +  IHRD+KP+N+L   LD    +K++DFGL   L     
Sbjct: 100 EEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL---LDAKGHVKLSDFGLCTGLKKAHR 156

Query: 119 -----------PGNY---------------------AEKVCGSPLYMAPEVLQFQRYDEK 146
                      P ++                     A    G+P Y+APEV     Y++ 
Sbjct: 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL 216

Query: 147 VDMWSVGAILFELLNGYPPF 166
            D WS+G I++E+L GYPPF
Sbjct: 217 CDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 83.5 bits (206), Expect = 2e-19
 Identities = 63/188 (33%), Positives = 98/188 (52%), Gaps = 28/188 (14%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +      +  +LV+ F  G
Sbjct: 45  IKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPF-MG 103

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L   ++ H ++ E   +  + Q+  GL+ +++  IIHRDLKP N+    +++D  LKI
Sbjct: 104 TDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNL---AVNEDCELKI 159

Query: 109 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 164
            DFGL+          ++ G   +  Y APEV L +  Y + VD+WSVG I+ E+L G P
Sbjct: 160 LDFGLA-----RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214

Query: 165 PFSVGEEH 172
            F  G +H
Sbjct: 215 LFK-GHDH 221

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 82.2 bits (203), Expect = 2e-19
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 22/156 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  ++H  +++L+     +  I++V E+ + G L +Y+R HG+  +        QL
Sbjct: 49  EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQ------PSQL 102

Query: 76  ---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
                    G+  L S   IHRDL   N L   +DD   +K++DFGLS  +    Y   V
Sbjct: 103 LEMCKDVCEGMAYLESKQFIHRDLAARNCL---VDDQGCVKVSDFGLSRYVLDDEYTSSV 159

Query: 127 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
            GS     +  PEVL + ++  K D+W+ G +++E+
Sbjct: 160 -GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 82.6 bits (204), Expect = 2e-19
 Identities = 52/165 (31%), Positives = 82/165 (49%), Gaps = 19/165 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           EL+ L     P I+  + AF  E  +++ +E+   G+L            +PE   R+  
Sbjct: 49  ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRIT 108

Query: 73  QQL--GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
             +  GL+ L   H+IIHRD+KP N+L++G   +  +K+ DFG+S  L   + A+   G 
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLV-ASLAKTNIGC 164

Query: 130 PLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNG---YPP 165
             YMAPE +      Q   Y  + D+WS+G  + E+  G   YPP
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 82.0 bits (203), Expect = 2e-19
 Identities = 56/177 (31%), Positives = 78/177 (44%), Gaps = 27/177 (15%)

Query: 9   LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRV 63
           L   +D    E   + S++H N+IRL+        + +V E    G+L   +R    G  
Sbjct: 36  LSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHF 94

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---- 117
              T   +  Q+  G+  L S   IHRDL   NILL+  DD V  KI DFGL   L    
Sbjct: 95  LISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS-DDKV--KIGDFGLMRALPQNE 151

Query: 118 --YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
             Y      KV   P  + APE L+ + +    D+W  G  L+E+      F+ GEE
Sbjct: 152 DHYVMEEHLKV---PFAWCAPESLRTRTFSHASDVWMFGVTLWEM------FTYGEE 199

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 83.2 bits (205), Expect = 3e-19
 Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 41/177 (23%)

Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHI-- 85
           ++++F +FQ +  ++L++EF  GG++ + +     + E+  + ++ +  L I + H +  
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--------------------- 124
           IHRD+KP+N+L   LD    +K++DFGL   L   +  E                     
Sbjct: 123 IHRDIKPDNLL---LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179

Query: 125 ---------------KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                             G+P Y+APEV     Y++  D WS+G I++E+L GYPPF
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 82.8 bits (204), Expect = 3e-19
 Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 8/153 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++   R+PE+   K    +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112

Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 113 LRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNG-YP 164
           M+PE LQ   Y  + D+WS+G  L EL  G YP
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 81.5 bits (201), Expect = 4e-19
 Identities = 53/153 (34%), Positives = 78/153 (50%), Gaps = 10/153 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   + P II  + AF  EN I +  EF  GG+L  Y     ++PE    +    +
Sbjct: 49  ELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAV 104

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             GL  L S  I+HRD+KP N+L++       +K+ DFG+S  L   + A+   G+  YM
Sbjct: 105 VKGLTYLWSLKILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLV-NSIAKTYVGTNAYM 160

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE +  ++Y    D+WS+G    EL  G  P+
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 81.2 bits (201), Expect = 5e-19
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 22/162 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +V+E  A G+L SY+R   R PE          
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLR--SRRPEAENNPGLGPP 116

Query: 67  TARKFLQ---QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           T +KF+Q   ++  G+  L +   +HRDL   N +++   +D+ +KI DFG++  +Y  +
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETD 173

Query: 122 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           Y  K     L   +MAPE L+   +  K D+WS G +L+E+ 
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 81.0 bits (200), Expect = 6e-19
 Identities = 50/173 (28%), Positives = 84/173 (48%), Gaps = 25/173 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK----- 70
           E   +S + HPNI+ L      E    ++ E+ A G+L  ++  +    +  A       
Sbjct: 58  EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117

Query: 71  --------FLQ---QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
                   FL    Q+  G+E L+SHH +HRDL   N L+    + + +KI+DFGLS  +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTVKISDFGLSRDI 174

Query: 118 YPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           Y  +Y      S L   +M PE + + ++  + D+WS G +L+E+ + G  P+
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 80.8 bits (199), Expect = 7e-19
 Identities = 59/160 (36%), Positives = 84/160 (52%), Gaps = 15/160 (9%)

Query: 17  LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L + +HPNI+RL D         E  + LV E     +L +Y+       +P +T +
Sbjct: 53  LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIK 111

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 126
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+  +Y    A   V
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG---QVKLADFGLA-RIYSCQMALTPV 167

Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
             +  Y APEVL    Y   VDMWSVG I  E+    P F
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 80.8 bits (199), Expect = 1e-18
 Identities = 49/156 (31%), Positives = 88/156 (56%), Gaps = 11/156 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLS---SYIRLHGRVPEQTARKFL 72
           E+  +    H N++ ++ ++     +++++EF  GG L+   S  RL+           L
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVL 127

Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSP 130
           Q   L  L+S  +IHRD+K ++ILL+ LD  V  K++DFG  C     +  ++  + G+P
Sbjct: 128 Q--ALCYLHSQGVIHRDIKSDSILLT-LDGRV--KLSDFGF-CAQISKDVPKRKSLVGTP 181

Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +MAPEV+    Y  +VD+WS+G ++ E+++G PP+
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.4 bits (198), Expect = 1e-18
 Identities = 55/182 (30%), Positives = 92/182 (50%), Gaps = 36/182 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------------ 63
           E N L  VNHP++I+L+ A   +  + L+VE+   G+L S++R   +V            
Sbjct: 53  EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112

Query: 64  ------PEQTAR------KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                 P++ A        F  Q+  G++ L    ++HRDL   N+L++   +   +KI+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKIS 169

Query: 110 DFGLSCTLYPGN-YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----NG 162
           DFGLS  +Y  + Y ++  G  P+ +MA E L    Y  + D+WS G +L+E++    N 
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229

Query: 163 YP 164
           YP
Sbjct: 230 YP 231

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 80.3 bits (198), Expect = 1e-18
 Identities = 57/172 (33%), Positives = 90/172 (52%), Gaps = 17/172 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
           E+   S + H NI++   +        + +E   GG+LS+ +R      +  EQT   + 
Sbjct: 55  EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114

Query: 73  QQL--GLEILNSHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKV 126
           +Q+  GL+ L+ + I+HRD+K +N+L+   SG+     +KI+DFG S  L   N   E  
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGV-----VKISDFGTSKRLAGINPCTETF 169

Query: 127 CGSPLYMAPEVL-QFQR-YDEKVDMWSVGAILFELLNGYPPF-SVGEEHQFM 175
            G+  YMAPEV+ +  R Y    D+WS+G  + E+  G PPF  +GE    M
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 80.8 bits (199), Expect = 1e-18
 Identities = 50/151 (33%), Positives = 83/151 (54%), Gaps = 8/151 (5%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGLEILNSH 83
           P ++ L  AFQ E  + L++++ +GG + +++       E   R +  +  L LE L+  
Sbjct: 65  PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL 124

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQ 141
            I++RD+K ENILL   D +  + + DFGLS              CG+  YMAPE+++ +
Sbjct: 125 GIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181

Query: 142 R-YDEKVDMWSVGAILFELLNGYPPFSVGEE 171
             + + VD WS+G ++FELL G  PF++  E
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGE 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 79.6 bits (196), Expect = 2e-18
 Identities = 51/164 (31%), Positives = 88/164 (53%), Gaps = 16/164 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   ++ ++H N++RL       N +++V+E  + GNL +++R  GR      +     L
Sbjct: 49  ETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL 107

Query: 76  ----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
               G+E L S  ++HRDL   NIL+S   +D + K++DFGL+     G    K+   P+
Sbjct: 108 DVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKL---PV 161

Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN----GYPPFSVGE 170
            + APE L+ +++  K D+WS G +L+E+ +     YP  S+ E
Sbjct: 162 KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.4 bits (198), Expect = 2e-18
 Identities = 55/171 (32%), Positives = 87/171 (50%), Gaps = 28/171 (16%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQT------ 67
           H NII L  A   +  ++++VE+ + GNL  Y+R              ++PE+       
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 68  -ARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
            +  +    G+E L S   IHRDL   N+L++  +D+VM KIADFGL+  ++  +Y +K 
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVT--EDNVM-KIADFGLARDVHNIDYYKKT 193

Query: 127 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGE 170
               L   +MAPE L  + Y  + D+WS G +L+E+     + YP   V E
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 80.5 bits (198), Expect = 2e-18
 Identities = 61/187 (32%), Positives = 96/187 (51%), Gaps = 26/187 (13%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 47  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 105

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 106 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 162

Query: 110 DFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPP 165
           DFGL+      +  +++ G   +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   
Sbjct: 163 DFGLA-----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 217

Query: 166 FSVGEEH 172
           F  G +H
Sbjct: 218 FP-GTDH 223

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 79.4 bits (196), Expect = 2e-18
 Identities = 54/171 (31%), Positives = 81/171 (47%), Gaps = 21/171 (12%)

Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PE 65
           E +FL      S  NH NI+RL          F+++E  AGG+L S++R   R     P 
Sbjct: 53  ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPS 111

Query: 66  QTARKFLQQLGLEI------LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
               K L     ++      L  +H IHRD+   N LL+      + KIADFG++  +Y 
Sbjct: 112 SLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171

Query: 120 GNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +Y  K   + L   +M PE      +  K D+WS G +L+E+ + GY P+
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 81.1 bits (200), Expect = 2e-18
 Identities = 40/112 (35%), Positives = 72/112 (64%), Gaps = 5/112 (4%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           +NK++   +  E + L+    P I+ L+ + Q+ N ++LV+E+  GG++ S + ++G   
Sbjct: 43  INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD 102

Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           E+ A K++ +  L L+ L+ H IIHRDLKP+N+L+S   ++  +K+ DFGLS
Sbjct: 103 EEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 80.0 bits (197), Expect = 2e-18
 Identities = 57/169 (33%), Positives = 84/169 (49%), Gaps = 38/169 (22%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPE-------- 65
           H NII L      E  ++++VE+ A GNL  ++R              +VPE        
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 66  -----QTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
                Q AR      G+E L S   IHRDL   N+L++  +D+VM KIADFGL+  ++  
Sbjct: 137 VSCAYQVAR------GMEYLESRRCIHRDLAARNVLVT--EDNVM-KIADFGLARGVHDI 187

Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 79.7 bits (196), Expect = 3e-18
 Identities = 58/173 (33%), Positives = 88/173 (50%), Gaps = 26/173 (15%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ------- 66
           H NII L  A   +  ++++VE+ + GNL  Y+R              +VPE+       
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 67  TARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
            +  +    G+E L S   IHRDL   N+L++  +D+VM KIADFGL+  ++  +Y +K 
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNVM-KIADFGLARDIHHIDYYKKT 199

Query: 127 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYPPFSVGEEHQF 174
               L   +MAPE L  + Y  + D+WS G +L+E+  L G P   V  E  F
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 79.2 bits (195), Expect = 3e-18
 Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 11/157 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + L  + H NI+ L D    +  +  V E+    +L+ Y+  H G +     R F+ Q
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQ 111

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--SCTLYPGNYAEKVCGSP 130
           L  GL  ++  HI+HRDLKP+N+L+S L +   LK+ADFGL  + ++    Y+ +V  + 
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVV-TL 167

Query: 131 LYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 166
            Y  P+VL     Y   +D+W  G I  E+L G P F
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 78.5 bits (193), Expect = 4e-18
 Identities = 46/151 (30%), Positives = 82/151 (54%), Gaps = 9/151 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  ++RL+     E  I+++ E+ A G+L  +++    G+V       F  
Sbjct: 51  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
           Q+  G+  +   + IHRDL+  N+L+S   + +M KIADFGL+  +    Y A +    P
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 167

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           + + APE + F  +  K D+WS G +L+E++
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 79.0 bits (195), Expect = 4e-18
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 18/152 (11%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNS--- 82
           P I++ +  F  ++ +F+ +E  +        R+ G +PE    K    + + I+ +   
Sbjct: 74  PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGK----MTVAIVKALHY 129

Query: 83  ----HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 138
               H +IHRD+KP NIL   LD    +K+ DFG+S  L       +  G   YMAPE +
Sbjct: 130 LKEKHGVIHRDVKPSNIL---LDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERI 186

Query: 139 ----QFQRYDEKVDMWSVGAILFELLNGYPPF 166
                  +YD + D+WS+G  L EL  G  P+
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPY 218

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 78.6 bits (193), Expect = 5e-18
 Identities = 55/170 (32%), Positives = 85/170 (50%), Gaps = 24/170 (14%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIR------LHGR 62
           E+N L   +H  NI   + AF  +N       ++LV+EFC  G+++  I+      L   
Sbjct: 52  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111

Query: 63  VPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
                 R+ L+  GL  L+ H +IHRD+K +N+LL+   ++  +K+ DFG+S  L     
Sbjct: 112 WIAYICREILR--GLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVG 166

Query: 122 YAEKVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 166
                 G+P +MAPEV+         YD K D+WS+G    E+  G PP 
Sbjct: 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 78.3 bits (193), Expect = 7e-18
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 24/164 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-------VPEQTA 68
           E   L++  H NI++ +      +   +V E+   G+L+ ++R HG              
Sbjct: 58  EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117

Query: 69  RKFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
              L QL         G+  L S H +HRDL   N L+     D+++KI DFG+S  +Y 
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMSRDVYT 174

Query: 120 GNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
            +Y  +V G  +    +M PE + ++++  + D+WS G +L+E+
Sbjct: 175 TDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 78.1 bits (192), Expect = 7e-18
 Identities = 52/170 (30%), Positives = 88/170 (51%), Gaps = 24/170 (14%)

Query: 16  ELNFLSSVNH-PNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQ- 66
           E+N L   +H  NI   + AF        ++ ++LV+EFC  G+++  ++   G   ++ 
Sbjct: 62  EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121

Query: 67  ----TARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
                 R+ L+  GL  L++H +IHRD+K +N+LL+   ++  +K+ DFG+S  L     
Sbjct: 122 WIAYICREILR--GLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVG 176

Query: 122 YAEKVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 166
                 G+P +MAPEV+         YD + D+WS+G    E+  G PP 
Sbjct: 177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 79.5 bits (196), Expect = 8e-18
 Identities = 60/184 (32%), Positives = 92/184 (50%), Gaps = 32/184 (17%)

Query: 13  LDCELN--FLSSVN-HPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           + C LN  F S V  H +  +  D    EN   I LV+++   G+L   I+   +    T
Sbjct: 82  VCCLLNCDFFSIVKCHEDFAKK-DPRNPENVLMIALVLDYANAGDLRQEIKSRAK----T 136

Query: 68  ARKFLQQ----------LGLEILNSHHIIHRDLKPENILL--SGLDDDVMLKIADFGLSC 115
            R F +           L +  ++S H+IHRD+K  NILL  +GL     +K+ DFG S 
Sbjct: 137 NRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL-----VKLGDFGFS- 190

Query: 116 TLYPGNYAEKV----CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            +Y    ++ V    CG+P Y+APE+ + + Y +K DM+S+G +L+ELL    PF     
Sbjct: 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250

Query: 172 HQFM 175
            + M
Sbjct: 251 EEVM 254

Length = 496

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 78.9 bits (194), Expect = 8e-18
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 14/155 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 129

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 186

Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 78.1 bits (192), Expect = 9e-18
 Identities = 58/171 (33%), Positives = 90/171 (52%), Gaps = 28/171 (16%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ--TARKF 71
           H NII L  A   +  ++++VE+ + GNL  Y+R              RVP++  T +  
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 72  LQ---QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
           +    Q+  G+E L S   IHRDL   N+L++  +++VM KIADFGL+  +   +Y +K 
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARDVNNIDYYKKT 196

Query: 127 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNG--YPPFSVGE 170
               L   +MAPE L  + Y  + D+WS G +++E+  L G  YP   V E
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 78.1 bits (192), Expect = 1e-17
 Identities = 57/165 (34%), Positives = 88/165 (53%), Gaps = 14/165 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E++ L ++ H NI+ L D    E C+ LV E+    +L  Y+   G +      + F+ Q
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 130
           L  GL   +   I+HRDLKP+N+L+   ++   LK+ADFGL+   ++    Y+ +V  + 
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVV-TL 167

Query: 131 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF---SVGEE 171
            Y  P+VL     Y   +DMW VG IL+E+  G P F   +V EE
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 77.4 bits (190), Expect = 1e-17
 Identities = 53/163 (32%), Positives = 87/163 (53%), Gaps = 13/163 (7%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTA- 68
           S +  E+  +    H NI+  F ++ +   +++ +E+C GG+L     + G + E Q A 
Sbjct: 51  SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY 110

Query: 69  --RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK- 125
             R+ LQ  GL  L+S   +HRD+K  NILL+   D+  +K+ADFG++  +       K 
Sbjct: 111 VCRETLQ--GLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKS 165

Query: 126 VCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPP 165
             G+P +MAPEV   ++   Y++  D+W+VG    EL    PP
Sbjct: 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 76.8 bits (189), Expect = 2e-17
 Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 9/150 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  V          
Sbjct: 52  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
           Q+   +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y A      P
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFP 168

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           + + APE L + ++  K D+W+ G +L+E+
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.9 bits (192), Expect = 2e-17
 Identities = 57/178 (32%), Positives = 84/178 (47%), Gaps = 23/178 (12%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           LKK+    ++ + C     EL  L    H N++   D  Q  +      I++V E     
Sbjct: 30  LKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS- 88

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L   I     +     + FL Q+  GL+ L+S  I+HRD+KP N+L   ++ + +LKI 
Sbjct: 89  DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL---VNSNCVLKIC 145

Query: 110 DFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNG 162
           DFGL+    P        E V  +  Y APE+L   + Y   VD+WSVG I  ELL  
Sbjct: 146 DFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 77.4 bits (190), Expect = 3e-17
 Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 27/182 (14%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 45  VKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL-MG 103

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L++ ++   ++ ++  +  + QL  GL+ ++S  IIHRDLKP N+    +++D  L+I
Sbjct: 104 ADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRI 159

Query: 109 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 164
            DFGL+         +++ G   +  Y APE+ L +  Y++ VD+WSVG I+ ELL G  
Sbjct: 160 LDFGLA-----RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214

Query: 165 PF 166
            F
Sbjct: 215 LF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 3e-17
 Identities = 48/165 (29%), Positives = 85/165 (51%), Gaps = 14/165 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HPN+++L+     +  IF+V E+ A G L +Y+R   G++  +        
Sbjct: 49  EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 130
           +   +E L S+  IHRDL   N L+    +D ++K++DFGL+  +    Y     G+  P
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSSQ-GTKFP 164

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLNG----YPPFSVGE 170
           + +  PEV  + R+  K D+WS G +++E+ +     Y  FS  E
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 76.0 bits (187), Expect = 4e-17
 Identities = 52/168 (30%), Positives = 91/168 (54%), Gaps = 21/168 (12%)

Query: 24  NHPNIIRLFD-AFQAENC-----IFLVVEFCAGGNLSSYI---RLHG---RVPEQTARKF 71
           +HPN+++L    F+A +        +++ F   G+L S++   RL G   ++P QT  KF
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118

Query: 72  LQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
           +    LG+E L++ + IHRDL   N +L    +D+ + +ADFGLS  +Y G+Y  +   +
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 130 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEHQ 173
            +   ++A E L  + Y  K D+W+ G  ++E+   G  P+   E H+
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 76.7 bits (188), Expect = 5e-17
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMS 122

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 179

Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 7e-17
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 10/147 (6%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G 76
           ++SV+HP+++RL     +   + L+ +    G L  Y+R H   +  Q    +  Q+  G
Sbjct: 63  MASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--PL-YM 133
           +  L    ++HRDL   N+L+        +KI DFGL+  L          G   P+ +M
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELL 160
           A E +  + Y  K D+WS G  ++EL+
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.4 bits (185), Expect = 8e-17
 Identities = 57/174 (32%), Positives = 86/174 (49%), Gaps = 32/174 (18%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
           EL  L  + +HPNII L  A +    +++ +E+   GNL  ++R              HG
Sbjct: 52  ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111

Query: 62  RVPEQTARKFLQ-----QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                T+++ LQ       G++ L+    IHRDL   N+L+    +++  KIADFGLS  
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS-- 166

Query: 117 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
              G   Y +K  G  P+ +MA E L +  Y  K D+WS G +L+E+  L G P
Sbjct: 167 --RGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 76.0 bits (187), Expect = 8e-17
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 17/154 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTA----R 69
           E++ L +++H  II L  A++ ++  C+ +    C   +L +Y+   G +P + A    R
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQR 192

Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
           + L+   L  L+   IIHRD+K ENI L   ++ V+    DFG +C L       +  G 
Sbjct: 193 RLLE--ALAYLHGRGIIHRDVKTENIFLDEPENAVL---GDFGAACKLDAHPDTPQCYGW 247

Query: 130 PLYM---APEVLQFQRYDEKVDMWSVGAILFELL 160
              +   +PE+L    Y  K D+WS G +LFE+ 
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 75.4 bits (186), Expect = 9e-17
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 30/174 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAF-------QAENCIFLVVEFCAGGNLSSYIRLHG---RVPE 65
           E+  L  + HPN++ L D         + +     +V      +LS    L     ++ E
Sbjct: 57  EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGL--LENPSVKLTE 114

Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
              + ++ QL  G+  L+ +HI+HRD+K  NIL+   D+  +LKIADFGL+         
Sbjct: 115 SQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPN 171

Query: 124 EKVCGSPL------------YMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYP 164
            K  G               Y  PE +L  +RY   VD+W +G +  E+    P
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 74.3 bits (182), Expect = 1e-16
 Identities = 51/162 (31%), Positives = 81/162 (50%), Gaps = 14/162 (8%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L + LK     E   L   +HPNI++L         I++V+E   GG+  S++R   +  
Sbjct: 31  LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLR---KKK 87

Query: 65  EQTARKFLQQL------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           ++   K L +       G+  L S + IHRDL   N L+    ++ +LKI+DFG+S    
Sbjct: 88  DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQED 144

Query: 119 PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE 158
            G Y+       P+ + APE L + RY  + D+WS G +L+E
Sbjct: 145 DGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 74.1 bits (182), Expect = 2e-16
 Identities = 54/166 (32%), Positives = 83/166 (50%), Gaps = 15/166 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S+ NHPNI++L          ++++E   GG+L SY+R             L++L
Sbjct: 49  EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108

Query: 76  ---------GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAE 124
                    G   L   H IHRDL   N L+S  G D D ++KI DFGL+  +Y  +Y  
Sbjct: 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168

Query: 125 KVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           K     L   +MAPE L   ++  + D+WS G +++E+L  G  P+
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 74.4 bits (183), Expect = 2e-16
 Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 12/154 (7%)

Query: 16  ELNFLSSVNHPNIIRL--FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
           E+  L +++H NI++            + L++E+   G+L  Y++ H  ++  +    F 
Sbjct: 56  EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS 115

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVC 127
            Q+  G++ L S   IHRDL   NIL   ++ + ++KI+DFGL+  L       Y ++  
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNIL---VESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172

Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            SP+ + APE L+  ++    D+WS G  L+EL 
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 73.9 bits (182), Expect = 2e-16
 Identities = 43/156 (27%), Positives = 82/156 (52%), Gaps = 15/156 (9%)

Query: 17  LNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTAR 69
           L+FL+        +HPNIIRL         + ++ E+   G+L  ++R + G+       
Sbjct: 50  LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV 109

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP--GNYAEK 125
             L+ +  G++ L+  + +HRDL   NIL++    +++ K++DFGLS  L      Y  K
Sbjct: 110 GMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLEDSEATYTTK 166

Query: 126 VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
               P+ + APE + ++++    D+WS G +++E++
Sbjct: 167 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 73.6 bits (181), Expect = 3e-16
 Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 12/181 (6%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           LK  +   +     E+  L  + H ++I LF        ++++ E    G+L +++R   
Sbjct: 38  LKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE 97

Query: 61  GRV-PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           G+V P  +      Q+  G+  L   + IHRDL   NIL+    +D++ K+ADFGL+  +
Sbjct: 98  GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLI 154

Query: 118 YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN----GYPPFSVGEEH 172
               Y       P  + APE      +  K D+WS G +L+E+       YP  +  E +
Sbjct: 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214

Query: 173 Q 173
            
Sbjct: 215 D 215

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 73.9 bits (181), Expect = 3e-16
 Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 14/169 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E++ L  + H NI+ L D    E  + LV E+    +L  Y+   G  +     + FL Q
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 130
           L  GL   +   ++HRDLKP+N+L+   ++   LK+ADFGL+   ++    Y+ +V  + 
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVV-TL 168

Query: 131 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF---SVGEEHQFM 175
            Y  P++L     Y  ++DMW VG I +E+  G P F   +V E+  F+
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 73.6 bits (180), Expect = 4e-16
 Identities = 53/156 (33%), Positives = 79/156 (50%), Gaps = 9/156 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + L  + H NI+ L D    +  + LV E+    +L  Y+  H G +  +  + FL Q
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQ 111

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPL 131
           L  GL  ++  +I+HRDLKP+N+L+S   D   LK+ADFGL+     P +       +  
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYSNEVVTLW 168

Query: 132 YMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y  P+V L    Y   +DMW VG I  E++ G   F
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 73.6 bits (181), Expect = 5e-16
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 13/160 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L  ++H N+I + D       +A N +++V E     +L   IR    + +   + 
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL-MDTDLHQIIRSSQTLSDDHCQY 112

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVC 127
           FL QL  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+  T   G++  +  
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARTTSEKGDFMTEYV 169

Query: 128 GSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +  Y APE+ L    Y   +D+WSVG I  ELL   P F
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF 209

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.9 bits (179), Expect = 7e-16
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 37/182 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT-------- 67
           E   ++  +HPNI++L         + L+ E+ A G+L+ ++R   R P           
Sbjct: 58  EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR--HRSPRAQCSLSHSTS 115

Query: 68  -ARKFLQ---------QL--------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            ARK            QL        G+  L+    +HRDL   N L+     ++++KIA
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGE---NMVVKIA 172

Query: 110 DFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYP 164
           DFGLS  +Y  +Y  K   +      +M PE + + RY  + D+W+ G +L+E+ + G  
Sbjct: 173 DFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231

Query: 165 PF 166
           P+
Sbjct: 232 PY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 72.4 bits (177), Expect = 1e-15
 Identities = 45/168 (26%), Positives = 86/168 (51%), Gaps = 25/168 (14%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV----PEQTARKFLQ 73
           S + HPNI+ L      E  + ++  +C+  +L  ++ +   H  V     ++T +  L+
Sbjct: 63  SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122

Query: 74  -----------QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
                        G+E L+SHH++H+DL   N+L+    D + +KI+D GL   +Y  +Y
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---DKLNVKISDLGLFREVYAADY 179

Query: 123 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            + +  S L   +M+PE + + ++    D+WS G +L+E+ + G  P+
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 72.3 bits (177), Expect = 1e-15
 Identities = 45/180 (25%), Positives = 84/180 (46%), Gaps = 25/180 (13%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R +        + +V E+   G+L+ ++R HG
Sbjct: 43  LKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 102

Query: 62  ---RVPEQTARKFLQQLGLE--------------ILNSHHIIHRDLKPENILLSGLDDDV 104
              ++          QL L                L S H +HRDL   N L+      +
Sbjct: 103 PDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QGL 159

Query: 105 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + D+WS G +L+E+ 
Sbjct: 160 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 72.4 bits (177), Expect = 1e-15
 Identities = 42/164 (25%), Positives = 85/164 (51%), Gaps = 23/164 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------R 62
           E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG              
Sbjct: 57  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           + +       QQ+  G+  L S H +HRDL   N L+    +++++KI DFG+S  +Y  
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYST 173

Query: 121 NYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           +Y  +V G  +    +M PE + ++++  + D+WS+G +L+E+ 
Sbjct: 174 DYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 72.0 bits (177), Expect = 1e-15
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 19/155 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + H  +++L+     E  I++V E+ + G+L  ++    +  E    +  Q +
Sbjct: 51  EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL----KSGEGKKLRLPQLV 106

Query: 76  --------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
                   G+  L S + IHRDL   NIL+    ++++ KIADFGL+  +    Y  +  
Sbjct: 107 DMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDEYTARE- 162

Query: 128 GSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           G+     + APE   + R+  K D+WS G +L E+
Sbjct: 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 71.9 bits (176), Expect = 1e-15
 Identities = 52/153 (33%), Positives = 82/153 (53%), Gaps = 12/153 (7%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E+N L ++ H NI++     + Q    + L++E+   G+L  Y+  H     Q    F Q
Sbjct: 56  EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-FAQ 114

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---G 128
           Q+  G+  L+S H IHRDL   N+L   LD+D ++KI DFGL+  +  G+   +V     
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171

Query: 129 SPLY-MAPEVLQFQRYDEKVDMWSVGAILFELL 160
           SP++  A E L+  ++    D+WS G  L+ELL
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 72.6 bits (178), Expect = 1e-15
 Identities = 55/159 (34%), Positives = 83/159 (52%), Gaps = 23/159 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  + H N+I L D F +          +LV+ +    +L   I  H    ++   
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQK-IMGHPLSEDKVQY 121

Query: 70  KFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVC 127
              Q L GL+ ++S  IIHRDLKP N+    +++D  LKI DFGL+       +A+ ++ 
Sbjct: 122 LVYQMLCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGLA------RHADAEMT 172

Query: 128 G---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 162
           G   +  Y APEV L +  Y++ VD+WSVG I+ E+L G
Sbjct: 173 GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 71.9 bits (176), Expect = 2e-15
 Identities = 51/157 (32%), Positives = 83/157 (52%), Gaps = 11/157 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E++ L  + H NI+ L D    +  + LV E+    +L  Y+   G +      + FL Q
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ 112

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 130
           +  GL   +   ++HRDLKP+N+L++   +   LK+ADFGL+   ++    Y+ +V  + 
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVV-TL 168

Query: 131 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
            Y  P+VL     Y  ++DMW VG I FE+ +G P F
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 72.8 bits (178), Expect = 2e-15
 Identities = 57/167 (34%), Positives = 86/167 (51%), Gaps = 18/167 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAF------QAENCIFL--VVEFCAGGNLSSYIRLHGR----V 63
           EL  + ++NH NII L D +      + E  IFL  V+EF     +  Y++ + R    +
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           P    + +  QL   L  ++S  I HRDLKP+N+L+    +   LK+ DFG +  L  G 
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQ 225

Query: 122 YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            +     S  Y APE+ L    Y   +D+WS+G I+ E++ GYP FS
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272

Length = 440

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 71.1 bits (174), Expect = 2e-15
 Identities = 50/168 (29%), Positives = 88/168 (52%), Gaps = 11/168 (6%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +  LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ +++ +  V E
Sbjct: 36  DPALKDELLREANVMQQLDNPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTE 94

Query: 66  QTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-- 121
           +   + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      
Sbjct: 95  KNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENY 151

Query: 122 YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           Y  K  G  P+ + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 71.1 bits (174), Expect = 2e-15
 Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+      + I LV EF   G LS Y+R   G+  ++T       
Sbjct: 49  EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L S ++IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQYTSST-GTKFP 164

Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             + +PEV  F +Y  K D+WS G +++E+ + G  P+
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 71.3 bits (174), Expect = 2e-15
 Identities = 54/174 (31%), Positives = 83/174 (47%), Gaps = 32/174 (18%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
           EL  L  + +HPNII L  A +    ++L +E+   GNL  ++R              + 
Sbjct: 45  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 104

Query: 62  RVPEQTARKFLQ-----QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                ++++ L        G++ L+    IHRDL   NIL+    ++ + KIADFGLS  
Sbjct: 105 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-- 159

Query: 117 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
              G   Y +K  G  P+ +MA E L +  Y    D+WS G +L+E+  L G P
Sbjct: 160 --RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 71.2 bits (175), Expect = 3e-15
 Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 21/172 (12%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + + +     E+  LS ++ PNI RL      +  + +++E+   G+L+ +++ H     
Sbjct: 59  SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118

Query: 66  QTARKFLQ-----------QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
             A                Q+  G+  L S + +HRDL   N L+        +KIADFG
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN---YTIKIADFG 175

Query: 113 LSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           +S  LY  +Y  +V G       +MA E +   ++  K D+W+ G  L+E+L
Sbjct: 176 MSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 70.8 bits (173), Expect = 3e-15
 Identities = 44/150 (29%), Positives = 82/150 (54%), Gaps = 12/150 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           E + ++ + H N+++L      E   +++V E+ A G+L  Y+R  GR  +      KF 
Sbjct: 49  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
             +   +E L +++ +HRDL   N+L+S   +D + K++DFGL+          K+   P
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 162

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           + + APE L+ +++  K D+WS G +L+E+
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 70.6 bits (173), Expect = 4e-15
 Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 25/164 (15%)

Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE---------QTAR 69
           +   +HPN++ L      +E    +V+ +   G+L ++IR     P          Q A+
Sbjct: 50  MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAK 109

Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVC 127
                 G+E L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       
Sbjct: 110 ------GMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHT 160

Query: 128 GSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 167
           G+ L   +MA E LQ Q++  K D+WS G +L+EL+  G PP+ 
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 70.8 bits (173), Expect = 4e-15
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 26/174 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV-----PEQT 67
           E + ++ ++HPNI+ L      E  + ++ E+   G+L  ++ +   H  V      + T
Sbjct: 57  EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116

Query: 68  ARKFLQQ-----------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
            +  L              G+E L+SH  +H+DL   NIL+    + + +KI+D GLS  
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLSRE 173

Query: 117 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  +Y      S L   +M PE + + ++    D+WS G +L+E+ + G  P+
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 70.8 bits (173), Expect = 5e-15
 Identities = 48/181 (26%), Positives = 90/181 (49%), Gaps = 32/181 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--------VPEQT 67
           E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG          P Q 
Sbjct: 57  EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116

Query: 68  ARKF-LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
             +  L Q+         G+  L S H +HRDL   N L+     ++++KI DFG+S  +
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMSRDV 173

Query: 118 YPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           Y  +Y  +V G  +    +M PE + ++++  + D+WS G IL+E+      F+ G++  
Sbjct: 174 YSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI------FTYGKQPW 226

Query: 174 F 174
           F
Sbjct: 227 F 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 70.5 bits (172), Expect = 6e-15
 Identities = 56/175 (32%), Positives = 87/175 (49%), Gaps = 20/175 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTA 68
           E+  L  + HPN+I L   F   A+  ++L+ ++ A  +L   I+ H      + P Q  
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106

Query: 69  RKFLQQLGLEILNSHH------IIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 117
           R  ++ L  +IL+  H      ++HRDLKP NIL+ G   +   +KIAD G +      L
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            P    + V  +  Y APE+L   R Y + +D+W++G I  ELL   P F   +E
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 6e-15
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 19/156 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HP +I+L+     E  I++V E    G+L  Y  L G      A K  Q +
Sbjct: 51  EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEY--LQGG--AGRALKLPQLI 106

Query: 76  --------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
                   G+  L + + IHRDL   N+L+    ++ + K+ADFGL+  +    Y  +  
Sbjct: 107 DMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDIYEARE- 162

Query: 128 GSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           G+     + APE   + R+  K D+WS G +L E++
Sbjct: 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 70.1 bits (172), Expect = 8e-15
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 17/166 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E+     + HPNI+    +F  ++ +++V    A G+    ++ H     PE      L+
Sbjct: 49  EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK 108

Query: 74  Q--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSP 130
                L+ ++S   IHR +K  +ILLSG D  V+L  +    S ++   G     V   P
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSG-DGKVVL--SGLRYSVSMIKHGKRQRVVHDFP 165

Query: 131 LY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFS 167
                    ++PEVLQ   Q Y+EK D++SVG    EL NG+ PF 
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 70.1 bits (171), Expect = 9e-15
 Identities = 55/175 (31%), Positives = 87/175 (49%), Gaps = 20/175 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTA 68
           E+  L  + HPN+I L   F   ++  ++L+ ++ A  +L   I+ H      + P Q  
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106

Query: 69  RKFLQQLGLEILNSHH------IIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 117
           R  ++ L  +IL+  H      ++HRDLKP NIL+ G   +   +KIAD G +      L
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            P    + V  +  Y APE+L   R Y + +D+W++G I  ELL   P F   +E
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.4 bits (170), Expect = 1e-14
 Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 21/180 (11%)

Query: 4   KLNKHLKSC-LDCEL----NFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGN 52
           K+   +K+C           FL         +HP+I++L      EN +++V+E    G 
Sbjct: 34  KIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGE 92

Query: 53  LSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           L SY++++   +   +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ 
Sbjct: 93  LRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLG 149

Query: 110 DFGLSCTL-YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           DFGLS  L     Y       P+ +MAPE + F+R+    D+W  G  ++E+L  G  PF
Sbjct: 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 69.1 bits (169), Expect = 1e-14
 Identities = 44/158 (27%), Positives = 79/158 (50%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  +++V EF   G L +Y+R   G++ +       Q 
Sbjct: 49  EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+E L  +  IHRDL   N L+S      ++K++DFG++  +    Y     G+   
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFP 164

Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +  PEV  F +Y  K D+WS G +++E+   G  PF
Sbjct: 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 69.1 bits (169), Expect = 2e-14
 Identities = 44/164 (26%), Positives = 85/164 (51%), Gaps = 19/164 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ EF   G L S++R + G+         L+ 
Sbjct: 55  EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG 114

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--------YPGNYAE 124
           +  G++ L+  + +HRDL   NIL   ++ +++ K++DFGLS  L        Y  +   
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171

Query: 125 KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           K+   P+ + APE + ++++    D+WS G +++E+++ G  P+
Sbjct: 172 KI---PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 69.1 bits (169), Expect = 2e-14
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 34/186 (18%)

Query: 1   MLK-KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           MLK   +   +  L  EL  +S + NH NI+ L  A      I ++ E+C  G+L +++R
Sbjct: 72  MLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR 131

Query: 59  LHGRVPEQTARKFLQ---------QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLK 107
                  +    FL          Q+  G+  L S + IHRDL   N+LL+      ++K
Sbjct: 132 -------RKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVK 181

Query: 108 IADFGLSC-TLYPGNYAEKVCGS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--- 159
           I DFGL+   +   NY  K  G+   P+ +MAPE +    Y  + D+WS G +L+E+   
Sbjct: 182 ICDFGLARDIMNDSNYVVK--GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239

Query: 160 -LNGYP 164
             N YP
Sbjct: 240 GSNPYP 245

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 68.9 bits (168), Expect = 2e-14
 Identities = 47/158 (29%), Positives = 82/158 (51%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F  
Sbjct: 51  EANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
           Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y A +    P
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKFP 166

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE + F  +  K D+WS G +L E++  G  P+
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.8 bits (168), Expect = 2e-14
 Identities = 43/160 (26%), Positives = 83/160 (51%), Gaps = 11/160 (6%)

Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNII L         + +V E+   G+L +++R H G+         L+
Sbjct: 54  SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCG 128
            +  G++ L+    +HRDL   NIL+   + +++ K++DFGLS  L       Y  +   
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170

Query: 129 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            P+ + APE + ++++    D+WS G +++E+++ G  P+
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 68.8 bits (168), Expect = 2e-14
 Identities = 47/155 (30%), Positives = 83/155 (53%), Gaps = 11/155 (7%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G 76
           + S++H  I+RL       + + LV +    G+L  ++R H   +  Q    +  Q+  G
Sbjct: 63  MGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL-YM 133
           +  L  H ++HR+L   NILL     D +++IADFG++  LYP +  Y      +P+ +M
Sbjct: 122 MYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 167
           A E + F RY  + D+WS G  ++E+++ G  P++
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 68.4 bits (167), Expect = 2e-14
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 16/161 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E   +  +++P I+R+    +AE  + LV+E  +GG L+ +  L G+   +      + +
Sbjct: 45  EAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKF--LSGKKDEITVSNVVELM 101

Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCG 128
            Q  +G++ L   + +HRDL   N+LL    +    KI+DFGLS  L   +  Y  +  G
Sbjct: 102 HQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYYKARSAG 158

Query: 129 S-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             PL + APE + F+++  + D+WS G  ++E  + G  P+
Sbjct: 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.4 bits (167), Expect = 2e-14
 Identities = 49/171 (28%), Positives = 87/171 (50%), Gaps = 23/171 (13%)

Query: 16  ELNFLSSVNHPNIIRLFD------AFQAENCIFLVVEFCAGGNLSSYIRLHGR------- 62
           E   +   +HPN+I+L        A        +++ F   G+L +++ L  R       
Sbjct: 51  EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFT 109

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +P QT  +F+  +  G+E L+S + IHRDL   N +L   ++++ + +ADFGLS  +Y G
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSG 166

Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 167
           +Y  + C S L   ++A E L    Y    D+W+ G  ++E++  G  P++
Sbjct: 167 DYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 68.5 bits (168), Expect = 2e-14
 Identities = 39/122 (31%), Positives = 59/122 (48%), Gaps = 17/122 (13%)

Query: 56  YIRLHGRVPEQTARKFLQQLGLEILNS-------HHIIHRDLKPENILLSGLDDDVMLKI 108
           Y  L   +PE+     L ++ +  + +         IIHRD+KP NIL   LD +  +K+
Sbjct: 97  YEVLKSVIPEE----ILGKIAVATVKALNYLKEELKIIHRDVKPSNIL---LDRNGNIKL 149

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPP 165
            DFG+S  L       +  G   YMAPE +       YD + D+WS+G  L+E+  G  P
Sbjct: 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Query: 166 FS 167
           + 
Sbjct: 210 YP 211

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 68.1 bits (166), Expect = 4e-14
 Identities = 58/165 (35%), Positives = 80/165 (48%), Gaps = 33/165 (20%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE---------QTARKF-LQQ 74
           HPNII L  A +    ++L +E+   GNL  ++R   RV E          TA     QQ
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQ 125

Query: 75  L---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YA 123
           L         G++ L+    IHRDL   NIL+    ++ + KIADFGLS     G   Y 
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS----RGQEVYV 178

Query: 124 EKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           +K  G  P+ +MA E L +  Y    D+WS G +L+E+  L G P
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 68.7 bits (168), Expect = 4e-14
 Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 25/168 (14%)

Query: 16  ELNFLSSVNHPNI-----IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L  + HP+I     I L  + +    I++V E     +L   I+ +  +  +  + 
Sbjct: 49  EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQF 107

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--------CTLYPG 120
           FL QL   L+ +++ ++ HRDLKP+NIL +    D  LKI DFGL+          ++  
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWT 164

Query: 121 NYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 166
           +Y      +  Y APE+    F +Y   +D+WS+G I  E+L G P F
Sbjct: 165 DYV----ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.4 bits (164), Expect = 7e-14
 Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 23/166 (13%)

Query: 20  LSSVNHPNIIRLFDA-FQ-AENCIF----LVVEFCAGGNLSSYIRLHGRV-------PEQ 66
           +   +HPN++RL     Q  E+  +    +++ F   G+L S++ L+ R+       P Q
Sbjct: 54  MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFL-LYSRLGDCPQYLPTQ 112

Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
              KF+  +  G+E L+S   IHRDL   N +   L++++ + +ADFGLS  +Y G+Y  
Sbjct: 113 MLVKFMTDIASGMEYLSSKSFIHRDLAARNCM---LNENMNVCVADFGLSKKIYNGDYYR 169

Query: 125 --KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             ++   P+ ++A E L  + Y  K D+WS G  ++E+   G  P+
Sbjct: 170 QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 66.0 bits (161), Expect = 1e-13
 Identities = 42/151 (27%), Positives = 78/151 (51%), Gaps = 10/151 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
           E N +  + HP ++RL+ A   +  I+++ E+   G+L  +++     ++          
Sbjct: 51  EANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
           Q+  G+  +   + IHRDL+  NIL+S   + +  KIADFGL+  +    Y A +    P
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAREGAKFP 166

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           + + APE + +  +  K D+WS G +L E++
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.6 bits (160), Expect = 3e-13
 Identities = 47/185 (25%), Positives = 87/185 (47%), Gaps = 21/185 (11%)

Query: 1   MLKKLNK----HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           ++K L K    +L+S    EL+    ++H N++RL    +     ++++E+   G+L  +
Sbjct: 39  LVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQF 98

Query: 57  IRLHGRVPEQTARKFLQQ-----------LGLEILNSHHIIHRDLKPENILLSGLDDDVM 105
           +R      E+     L             LG++ L++   +HRDL   N L+S       
Sbjct: 99  LRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS---QRE 155

Query: 106 LKIADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 162
           +K++   LS  +Y   Y + +    PL ++APE +Q   +  K D+WS G +++E+   G
Sbjct: 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215

Query: 163 YPPFS 167
             PF 
Sbjct: 216 ELPFY 220

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 65.3 bits (159), Expect = 4e-13
 Identities = 48/180 (26%), Positives = 84/180 (46%), Gaps = 29/180 (16%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----G 61
           NK+ ++    E+  LS +  PNIIRL      E+ + ++ E+   G+L+ ++  H     
Sbjct: 59  NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK 118

Query: 62  RVPEQTARKFLQQL-----------------GLEILNSHHIIHRDLKPENILLSGLDDDV 104
                 A      L                 G++ L+S + +HRDL   N L+     ++
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE---NL 175

Query: 105 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +KIADFG+S  LY G+Y  ++ G  +    +MA E +   ++    D+W+ G  L+E+L
Sbjct: 176 TIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.9 bits (158), Expect = 5e-13
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 21/163 (12%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-------L 75
           +NHPN+++            LV+EFC  G+L +Y+R +  +  Q A+K + Q        
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLY 132
           GL  L+    IH DL   N  L+    D+ +KI D+GL+   YP +Y    +       +
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168

Query: 133 MAPEVLQFQRYDEKV-------DMWSVGAILFELL-NGYPPFS 167
           +APE+++ +  D          ++WS+G  ++EL      P+ 
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 65.0 bits (158), Expect = 6e-13
 Identities = 46/178 (25%), Positives = 86/178 (48%), Gaps = 24/178 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------LHGRVPEQ 66
           E+  +S + +PNIIRL     +++ + ++ E+   G+L+ ++              +P  
Sbjct: 67  EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126

Query: 67  TARKFLQQL-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +    L        G++ L S + +HRDL   N L   + +   +KIADFG+S  LY G+
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL---VGNHYTIKIADFGMSRNLYSGD 183

Query: 122 YAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYPPFSVGEEHQ 173
           Y  ++ G  +    +MA E +   ++    D+W+ G  L+E+  L    P+S+  + Q
Sbjct: 184 YY-RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 64.3 bits (156), Expect = 6e-13
 Identities = 46/158 (29%), Positives = 81/158 (51%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  ++ L+ A  +E  I++V EF   G+L  +++     + ++P+      
Sbjct: 51  EAQIMKKLRHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109

Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + IHRDL+  NIL+    D+++ KIADFGL+  +    Y A +    P
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNEYTARQGAKFP 166

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL+  G  P+
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 64.0 bits (156), Expect = 1e-12
 Identities = 58/178 (32%), Positives = 83/178 (46%), Gaps = 32/178 (17%)

Query: 16  ELNFLSSVNHPNIIRL----------FDAFQAENCIFLVVEFCAG---GNLSSYIRLHGR 62
           E+  L  +NH NI+ L           D  + +   +LV E+      G L S     G 
Sbjct: 56  EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES-----GL 110

Query: 63  V--PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           V   E   + F++QL  GL   +  + +HRD+K  NILL   ++   +K+ADFGL+  LY
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLADFGLA-RLY 166

Query: 119 PGN----YAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
                  Y  KV  +  Y  PE+L   +RY   +D+WS G IL EL    P F   +E
Sbjct: 167 NSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 63.7 bits (155), Expect = 2e-12
 Identities = 44/115 (38%), Positives = 62/115 (53%), Gaps = 20/115 (17%)

Query: 66  QTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAE 124
           Q AR      G+E L S   IHRDL   NILLS   ++ ++KI DFGL+  +Y   +Y  
Sbjct: 181 QVAR------GMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVR 231

Query: 125 KVCGS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEE 171
           K  G    PL +MAPE +  + Y  + D+WS G +L+E+     + YP   + EE
Sbjct: 232 K--GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 62.8 bits (152), Expect = 3e-12
 Identities = 42/152 (27%), Positives = 81/152 (53%), Gaps = 14/152 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 51  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 107

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
             Q+  G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 108 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 164

Query: 129 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
            P+ + APE   + R+  K D+WS G +L EL
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 3e-12
 Identities = 46/115 (40%), Positives = 64/115 (55%), Gaps = 20/115 (17%)

Query: 66  QTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAE 124
           Q AR      G+E L S   IHRDL   NILLS  +++V +KI DFGL+  +Y   +Y  
Sbjct: 182 QVAR------GMEFLASRKCIHRDLAARNILLS--ENNV-VKICDFGLARDIYKDPDYVR 232

Query: 125 KVCGS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEE 171
           K  GS   PL +MAPE +  + Y  + D+WS G +L+E+     + YP   + EE
Sbjct: 233 K--GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 62.7 bits (152), Expect = 4e-12
 Identities = 59/171 (34%), Positives = 84/171 (49%), Gaps = 23/171 (13%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARK 70
           L  EL+     NHPNI+     F A+N +++V  F A G+    I  H    + E     
Sbjct: 46  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY 105

Query: 71  FLQQLGLEILNS-HHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-- 125
            LQ + L+ L+  HH+  +HR +K  +IL+S +D  V L     GL   L   N+ ++  
Sbjct: 106 ILQGV-LKALDYIHHMGYVHRSVKASHILIS-VDGKVYLS----GLRSNLSMINHGQRLR 159

Query: 126 -VCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 166
            V   P Y       ++PEVLQ   Q YD K D++SVG    EL NG+ PF
Sbjct: 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 62.3 bits (151), Expect = 4e-12
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 20/160 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQT 67
           E + +      +++RL           +V+E  A G+L SY+R          GR P  T
Sbjct: 59  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPT 117

Query: 68  ARKFLQQL-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
            ++ +Q       G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y  +Y
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDY 174

Query: 123 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
             K     L   +MAPE L+   +    DMWS G +L+E+
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 62.3 bits (151), Expect = 4e-12
 Identities = 47/170 (27%), Positives = 85/170 (50%), Gaps = 15/170 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +H NIIRL           ++ E+   G L  Y+R H    E ++ + +  L
Sbjct: 56  EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGML 113

Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YP-GNYAEKVC 127
                G++ L+  + +HRDL   NIL+   + ++  K++DFGLS  L   P G Y     
Sbjct: 114 RGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGG 170

Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEHQFM 175
             P+ + APE + ++++    D+WS G +++E+++ G  P+     H+ M
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM 220

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.6 bits (149), Expect = 6e-12
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGR---VPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++   GR   +P       
Sbjct: 51  EAQIMKKLRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA 109

Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + IHRDL+  NIL+    D ++ KIADFGL+  +    Y A +    P
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNEYTARQGAKFP 166

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL+  G  P+
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 61.9 bits (150), Expect = 9e-12
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 16/156 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----EQTARKF 71
           E + L ++NHP+II+L   F       L++      +L  Y+     +         R  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191

Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----GNYAEKVC 127
           L+   ++ L+ + IIHRD+K ENI ++   D   + + DFG +C  +P     N      
Sbjct: 192 LR--AIQYLHENRIIHRDIKAENIFINHPGD---VCLGDFGAAC--FPVDINANKYYGWA 244

Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 163
           G+    APE+L    Y   VD+WS G +LFE+   +
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.8 bits (150), Expect = 1e-11
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 30/159 (18%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTA-- 68
           E   L  ++HP ++ L D        C+ L        +L +Y+    R   + + TA  
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS---DLYTYLGARLRPLGLAQVTAVA 266

Query: 69  RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 128
           R+ L    ++ ++   IIHRD+K EN+L++G +D   + + DFG +C      +A     
Sbjct: 267 RQLLS--AIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAAC------FARGSWS 315

Query: 129 SPLYM---------APEVLQFQRYDEKVDMWSVGAILFE 158
           +P +          APEVL    Y   VD+WS G ++FE
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.2 bits (148), Expect = 2e-11
 Identities = 40/103 (38%), Positives = 58/103 (56%), Gaps = 10/103 (9%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-Y 132
           G+E L S   IHRDL   NILLS   ++ ++KI DFGL+  +Y   +Y  K     PL +
Sbjct: 191 GMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEE 171
           MAPE +  + Y  + D+WS G +L+E+     + YP   + EE
Sbjct: 248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.5 bits (147), Expect = 2e-11
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 18/156 (11%)

Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
           E+  L S+ H NI++     + A      + LV+E+   G+L  Y++ H  R+  +    
Sbjct: 55  EIEILKSLQHDNIVKYKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL 112

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEK 125
           +  Q+  G+E L S   +HRDL   NIL+   + +  +KI DFGL+  L P +   Y  +
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVL-PQDKEYYKVR 168

Query: 126 VCG-SPLY-MAPEVLQFQRYDEKVDMWSVGAILFEL 159
             G SP++  APE L   ++    D+WS G +L+EL
Sbjct: 169 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 60.8 bits (147), Expect = 2e-11
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 12/164 (7%)

Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
           K  LD E   ++SV++P++ RL       + + L+ +    G L  Y+R H   +  Q  
Sbjct: 54  KEILD-EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 111

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
             +  Q+  G+  L    ++HRDL   N+L+        +KI DFGL+  L         
Sbjct: 112 LNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHA 168

Query: 127 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            G  +   +MA E +  + Y  + D+WS G  ++EL+  G  P+
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 60.3 bits (146), Expect = 2e-11
 Identities = 46/174 (26%), Positives = 84/174 (48%), Gaps = 23/174 (13%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           NK+ ++    E+  +S +  PNIIRL       + + ++ E+   G+L+ ++  H    E
Sbjct: 59  NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQE 117

Query: 66  Q------------TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
                        T      Q+  G++ L+S + +HRDL   N L+     +  +KIADF
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADF 174

Query: 112 GLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           G+S  LY G+Y  ++ G  +    +M+ E +   ++    D+W+ G  L+E+L 
Sbjct: 175 GMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 60.3 bits (146), Expect = 2e-11
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 20/162 (12%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEI--- 79
           + HPNI++            LV E+C  G+L SY+         +    LQ++  EI   
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 80  ---LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYM 133
              ++ H+ +H DL   N  L+    D+ +K+ D+G+  + Y  +Y E     C    ++
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTS---DLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168

Query: 134 APE-VLQFQ------RYDEKVDMWSVGAILFELL-NGYPPFS 167
           APE V +F          +  ++W++G  L+EL  N   P+S
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 60.1 bits (146), Expect = 2e-11
 Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 23/166 (13%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           + L  E   L  ++H NI+ +     +     F++  +   GNL  +++          +
Sbjct: 53  TLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ 112

Query: 70  KFLQQ----LGLEI------LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
               Q    + ++I      L+   +IH+D+   N ++   D+++ +KI D  LS  L+P
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFP 169

Query: 120 GNYAEKVC-----GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
            +Y    C       P+ +MA E L  + Y    D+WS G +L+EL
Sbjct: 170 MDYH---CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL 212

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 59.7 bits (144), Expect = 4e-11
 Identities = 41/160 (25%), Positives = 76/160 (47%), Gaps = 20/160 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------T 67
           E + +   N  +++RL           +++E    G+L SY+R   R   +        +
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVQAPPS 117

Query: 68  ARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
            +K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y
Sbjct: 118 LKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY 174

Query: 123 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
             K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.2 bits (143), Expect = 6e-11
 Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 12/154 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
           E+  L ++ H NI++       +  N I L++EF   G+L  Y+ R   ++  +   K+ 
Sbjct: 56  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV---C 127
            Q+  G++ L S   +HRDL   N+L+   + +  +KI DFGL+  +        V    
Sbjct: 116 VQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172

Query: 128 GSPLY-MAPEVLQFQRYDEKVDMWSVGAILFELL 160
            SP++  APE L   ++    D+WS G  L+ELL
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 58.2 bits (141), Expect = 1e-10
 Identities = 36/96 (37%), Positives = 51/96 (53%), Gaps = 8/96 (8%)

Query: 76  GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
            LE L+S   +IHRD+KP N+L   ++ +  +K+ DFG+S  L          G   YMA
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVL---INRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMA 171

Query: 135 PE----VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           PE     L  + YD K D+WS+G  + EL  G  P+
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 57.2 bits (138), Expect = 2e-10
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 8/154 (5%)

Query: 12  CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
               E   L   +H NI+RL       N + +V E+ + G L S++R H G++       
Sbjct: 52  GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG 111

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-LSCTLYPGNYAEKVC 127
            L  L  G++ L+    +H+ L    +L++    D++ KI+ F  L        Y     
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQEDKSEAIYTTMSG 168

Query: 128 GSP-LYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            SP L+ APE +Q+  +    D+WS G +++E++
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 57.6 bits (139), Expect = 4e-10
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 10/167 (5%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-L 59
           ++K++N  + S    E+  +  + HPNI++L    ++E   +L+ E+  G NLS  +R L
Sbjct: 719 VVKEIND-VNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL 777

Query: 60  HGRVPEQTARKFLQQLG-LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
                 + A    + L  L    S  ++  +L PE I++ G  D+  L+++  GL CT  
Sbjct: 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG-KDEPHLRLSLPGLLCT-- 834

Query: 119 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 165
                 K   S  Y+APE  + +   EK D++  G IL ELL G  P
Sbjct: 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 55.8 bits (134), Expect = 1e-09
 Identities = 41/154 (26%), Positives = 75/154 (48%), Gaps = 11/154 (7%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G 76
           ++S++HP+++RL     +   I LV +    G L  Y+  H   +  Q    +  Q+  G
Sbjct: 63  MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG 121

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YM 133
           +  L    ++HRDL   N+L+   +    +KI DFGL+  L          G  +   +M
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWM 178

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           A E + ++++  + D+WS G  ++EL+  G  P+
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 52.0 bits (125), Expect = 7e-09
 Identities = 32/87 (36%), Positives = 46/87 (52%), Gaps = 11/87 (12%)

Query: 87  HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK 146
           HR  K  NILL+    D +LK+   G S        +      P +MAPEV+Q Q Y EK
Sbjct: 34  HRQAKSGNILLT---WDGLLKL--DG-SVAFKTPEQSR---PDPYFMAPEVIQGQSYTEK 84

Query: 147 VDMWSVGAILFELLNGYPPFSVGEEHQ 173
            D++S+G  L+E L+   P++  EE +
Sbjct: 85  ADIYSLGITLYEALDYELPYN--EERE 109

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 53.2 bits (128), Expect = 9e-09
 Identities = 35/112 (31%), Positives = 55/112 (49%), Gaps = 26/112 (23%)

Query: 76  GLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFGLSCTLY- 118
            +E ++S  ++HRDLKP+NILL                  L+++ +L I D       Y 
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI-DVDERNICYS 183

Query: 119 ----PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               PG    K+ G+P YMAPE L      E  D++++G IL+++L    P+
Sbjct: 184 SMTIPG----KIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.7 bits (126), Expect = 2e-08
 Identities = 36/96 (37%), Positives = 52/96 (54%), Gaps = 12/96 (12%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL--- 131
           G+E L S + +HRDL   N+LL+      ++KI DFGL+   ++  NY  K  GS     
Sbjct: 249 GMEFLASKNCVHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNYVSK--GSTFLPV 303

Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
            +MAPE +    Y    D+WS G +L+E+  L G P
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 52.3 bits (125), Expect = 2e-08
 Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 14/105 (13%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGS---PL 131
           G+E L S + +HRDL   N+L+    +  ++KI DFGL+   +   NY  K  GS   PL
Sbjct: 251 GMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISK--GSTFLPL 305

Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNG--YPPFSVGEE 171
            +MAPE +    Y    D+WS G +L+E+  L G  YP   + E+
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 51.9 bits (124), Expect = 2e-08
 Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 32/183 (17%)

Query: 9   LKSCLDCELNFLSS-------VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L++C +  L  L +         HPNI+  +  F   + ++++  F A G+ +S ++ + 
Sbjct: 35  LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY- 93

Query: 62  RVPEQTARKFLQQL------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 114
             PE  +   +  +      GL  L+ +  IHR++K  +IL+SG D  V L     GLS 
Sbjct: 94  -FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG-DGLVSLS----GLSH 147

Query: 115 --CTLYPGNYAEKVCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGY 163
               +  G  A+ V   P +       ++PE+L+     Y+ K D++SVG    EL  G 
Sbjct: 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Query: 164 PPF 166
            PF
Sbjct: 208 VPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.0 bits (124), Expect = 2e-08
 Identities = 43/167 (25%), Positives = 79/167 (47%), Gaps = 23/167 (13%)

Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVV---EFCAGGNLSSYI-----RLH 60
               L+ E+  L  +NH NI+++ +  ++E   +++    +F    +L S++        
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWK 261

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 117
            R   +  R  ++QL   +E ++   +IHRD+K ENI L+    D  + + DFG +    
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC---DGKIVLGDFGTAMPFE 318

Query: 118 ---YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
                 +Y     G+    +PE+L    Y E  D+WS G IL ++L+
Sbjct: 319 KEREAFDYGW--VGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.5 bits (123), Expect = 3e-08
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 23/164 (14%)

Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQQLGLEI 79
           S+ H N+++            LV+EFC  G+L  Y+R   R  E        LQ++  EI
Sbjct: 51  SLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSC-RKAELMTPDPTTLQRMACEI 109

Query: 80  ------LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 130
                 L+ ++ IH DL   N LL+    D+ +KI D+GLS   Y  +Y    +++    
Sbjct: 110 ALGLLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166

Query: 131 LYMAPEV-------LQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            ++APE+       L      ++ ++WS+G  ++EL   G  P+
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.0 bits (122), Expect = 5e-08
 Identities = 20/43 (46%), Positives = 29/43 (67%)

Query: 124 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           E++ G+P Y+APE+L  + +   VD W++G  LFE L G PPF
Sbjct: 538 ERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPF 580

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 50.3 bits (120), Expect = 9e-08
 Identities = 42/144 (29%), Positives = 62/144 (43%), Gaps = 18/144 (12%)

Query: 35  FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSH---HIIHRDLK 91
           FQ E     +V    G  L  +I  HG    +   + + Q G+ +   H   H++H DLK
Sbjct: 200 FQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259

Query: 92  PENILLSGLD-------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 138
           PENIL+   D             D   ++I D G  C       A  +  +  Y +PEV+
Sbjct: 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA--IVSTRHYRSPEVV 317

Query: 139 QFQRYDEKVDMWSVGAILFELLNG 162
               +    DMWS+G I++EL  G
Sbjct: 318 LGLGWMYSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 49.2 bits (117), Expect = 2e-07
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 12/164 (7%)

Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
           K  LD E   ++ V  P + RL       + + LV +    G L  Y+R +  R+  Q  
Sbjct: 54  KEILD-EAYVMAGVGSPYVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDL 111

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
             +  Q+  G+  L    ++HRDL   N+L+   +    +KI DFGL+  L         
Sbjct: 112 LNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH---VKITDFGLARLLDIDETEYHA 168

Query: 127 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            G  +   +MA E +  +R+  + D+WS G  ++EL+  G  P+
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.7 bits (116), Expect = 3e-07
 Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 14/102 (13%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGS---PL 131
           G++ L S + IHRD+   N+LL+   D  + KI DFGL+  +    NY  K  G+   P+
Sbjct: 224 GMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYVVK--GNARLPV 278

Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNGYPPFSV 168
            +MAPE +    Y  + D+WS G +L+E+     + YP   V
Sbjct: 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 47.2 bits (112), Expect = 1e-06
 Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 16/99 (16%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGS---PL 131
           G+  L S + IHRDL   NILL+      + KI DFGL+  +    NY  K  G+   P+
Sbjct: 226 GMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSNYVVK--GNARLPV 280

Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
            +MAPE +    Y  + D+WS G +L+E+      FS+G
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEI------FSLG 313

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 43.2 bits (102), Expect = 2e-05
 Identities = 27/73 (36%), Positives = 38/73 (52%), Gaps = 8/73 (10%)

Query: 69  RKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAE 124
           +  ++Q+ L  L+  H   I+HRD+KP+NI+ S  +     KI D G +  L  G NY  
Sbjct: 258 QTIMRQI-LFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIP 314

Query: 125 K-VCGSPLYMAPE 136
           K     P Y APE
Sbjct: 315 KEFLLDPRYAAPE 327

Length = 566

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.0 bits (98), Expect = 7e-05
 Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 7/93 (7%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG--SPLYM 133
           GL  L+   I+HRD+KPEN+L++    D  +KI DFG +  +  G     + G   P Y 
Sbjct: 321 GLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377

Query: 134 APEVLQFQRYDEKVDMWSVGAIL--FELLNGYP 164
            PE L   +   +    ++ A+L  F  L G P
Sbjct: 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRP 410

Length = 507

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.5 bits (93), Expect = 3e-04
 Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 11/92 (11%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNS 82
           VN P  +   D         +V+E+  G  L   I  +G    + +R+  + +G   L+S
Sbjct: 61  VNVP-AVYFVD----PENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVGK--LHS 113

Query: 83  HHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
             IIH DL   N++LSG    + L I DFGL+
Sbjct: 114 AGIIHGDLTTSNMILSG--GKIYL-I-DFGLA 141

Length = 211

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 37.1 bits (86), Expect = 0.002
 Identities = 38/175 (21%), Positives = 81/175 (46%), Gaps = 17/175 (9%)

Query: 1   MLKKLNKHLKSCLDCEL---NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +LK L+K  ++  +      + +S ++H +++  +      +   +V E+   G+L +Y+
Sbjct: 31  LLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL 90

Query: 58  RL-HGRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDV-----MLKIA 109
           +     +      +  +QL   L  L    + H ++  +N+LL   +D        +K++
Sbjct: 91  KKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150

Query: 110 DFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNG 162
           D G+S T+ P     E++   P ++ PE ++  Q      D WS G  L+E+ +G
Sbjct: 151 DPGISITVLPKEILLERI---P-WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 37.0 bits (86), Expect = 0.003
 Identities = 39/178 (21%), Positives = 76/178 (42%), Gaps = 19/178 (10%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNL 53
            KK +K  K  +D    E+  L  ++  NI++++  F  +       + L++E+C  G L
Sbjct: 51  FKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY-GFIIDIVDDLPRLSLILEYCTRGYL 109

Query: 54  SSYIRLHGRVPEQTARKFLQQLGLEILNSHHII---HRDLKPENILLSGLDDDVMLKIAD 110
              +     +  +T           + N +      +++L   + L+    ++  LKI  
Sbjct: 110 REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIIC 166

Query: 111 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 166
            GL   L    +  K     +Y + ++L   F  Y  K D++S+G +L+E+  G  PF
Sbjct: 167 HGLEKILSSPPF--KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222

Length = 283

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 36.7 bits (85), Expect = 0.003
 Identities = 37/159 (23%), Positives = 71/159 (44%), Gaps = 16/159 (10%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--LQQL-- 75
           +S ++H ++++L+     +  I +V E+   G L  ++            K    +QL  
Sbjct: 55  MSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNV-SLHWKLDVAKQLAS 112

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDV----MLKIADFGLSCTLYPGNYAEKVCGSPL 131
            L  L    ++H ++  +NIL++    +      +K++D G+  T+   +  E+V   P 
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV--LSREERVERIP- 169

Query: 132 YMAPEVLQ--FQRYDEKVDMWSVGAILFELL-NGYPPFS 167
           ++APE ++          D WS G  L E+  NG  P S
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	175
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.98
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.98
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.98
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.98
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.98
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.98
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.98
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.98
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.98
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.98
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.98
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.98
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.98
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.98
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.98
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.98
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.98
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.98
KOG0584	632	consensus Serine/threonine protein kinase [General	99.98
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.98
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.98
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.98
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.98
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.98
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.98
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.98
PTZ00283	496	serine/threonine protein kinase; Provisional	99.98
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.98
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.98
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.98
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.98
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.98
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.98
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.98
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.98
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.96
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.96
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.96
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.96
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.94
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.94
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.94
KOG3653	534	consensus Transforming growth factor beta/activin	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.93
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.92
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.92
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.9
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.9
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.88
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.88
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
PRK09188	365	serine/threonine protein kinase; Provisional	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.79
PRK10345	210	hypothetical protein; Provisional	99.75
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.74
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.72
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.72
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.71
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.7
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.67
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.67
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.66
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.65
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.63
PRK14879	211	serine/threonine protein kinase; Provisional	99.62
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.59
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.58
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
smart00090	237	RIO RIO-like kinase.	99.57
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.45
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.43
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.42
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.41
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.41
KOG1243	690	consensus Protein kinase [General function predict	99.4
KOG3087	229	consensus Serine/threonine protein kinase [General	99.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.32
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.24
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.22
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.18
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.15
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.12
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.02
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.96
COG4248	637	Uncharacterized protein with protein kinase and he	98.91
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.9
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.85
PRK09902	216	hypothetical protein; Provisional	98.75
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.75
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.59
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.57
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.51
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.48
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.44
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.3
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.15
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.88
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.87
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.81
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.75
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.68
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.41
PLN02876	822	acyl-CoA dehydrogenase	97.39
PF01636	239	APH: Phosphotransferase enzyme family This family	97.38
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.28
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.23
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.23
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.82
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.4
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.07
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.89
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.19
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.13
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.06
PRK05231	319	homoserine kinase; Provisional	94.81
KOG2270	520	consensus Serine/threonine protein kinase involved	94.76
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.44
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.74
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	93.67
PRK10593	297	hypothetical protein; Provisional	93.55
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	93.39
PTZ00384	383	choline kinase; Provisional	93.38
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	93.37
PHA03111	444	Ser/Thr kinase; Provisional	93.04
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	93.02
COG2334	331	Putative homoserine kinase type II (protein kinase	92.22
PRK10271	188	thiK thiamine kinase; Provisional	92.09
COG3231	266	Aph Aminoglycoside phosphotransferase [Translation	92.05
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	92.01
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.94
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	91.4
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	91.37
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	91.28
PLN02236	344	choline kinase	90.86
KOG1234	363	consensus ABC (ATP binding cassette) 1 protein [Ge	89.81
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	89.73
KOG4720	391	consensus Ethanolamine kinase [Lipid transport and	89.36
PRK11768	325	serine/threonine protein kinase; Provisional	88.89

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4e-45  Score=267.21  Aligned_cols=169  Identities=53%  Similarity=0.968  Sum_probs=156.7

Q ss_pred             cchhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      +.+..+..+..|+.+|+.++||||+.++++...++..++|||||.||+|.+|+++.+.+++..+...+.|+  |+++||+
T Consensus        48 l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~  127 (429)
T KOG0595|consen   48 LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE  127 (429)
T ss_pred             cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35556778889999999999999999999999999999999999999999999999999999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCC---ceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDD---VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      +++||||+||.||+++.....   ..+||.|||+|+...++....+..|++.|||||+++...|+-++|+||+|+++|+|
T Consensus       128 ~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~  207 (429)
T KOG0595|consen  128 NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQC  207 (429)
T ss_pred             CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHH
Confidence            999999999999999754232   67999999999999998888899999999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCccC
Q 030527          160 LNGYPPFSVGEEHQ  173 (175)
Q Consensus       160 ~~g~~pf~~~~~~~  173 (175)
                      ++|+.||+..+..+
T Consensus       208 l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  208 LTGKPPFDAETPKE  221 (429)
T ss_pred             HhCCCCccccCHHH
Confidence            99999999766544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7e-42  Score=247.62  Aligned_cols=161  Identities=41%  Similarity=0.720  Sum_probs=150.0

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+....|..++++++||+||++...|++.+.+|+|+||+.||.|..++++.+.++++.+..++++|  ||.|||++||+
T Consensus        68 e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIi  147 (357)
T KOG0598|consen   68 EVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGII  147 (357)
T ss_pred             hHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCee
Confidence            3456678999999999999999999999999999999999999999999999999999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |||+||+||++   +..+.++|+|||+++..... ..+.+..||+.|+|||++.+.+++.++|-||||+++|+|++|.+|
T Consensus       148 yRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pP  224 (357)
T KOG0598|consen  148 YRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPP  224 (357)
T ss_pred             eccCCHHHeee---cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCC
Confidence            99999999999   79999999999999866544 456678999999999999999999999999999999999999999


Q ss_pred             CCCCCcc
Q 030527          166 FSVGEEH  172 (175)
Q Consensus       166 f~~~~~~  172 (175)
                      |.+.+..
T Consensus       225 F~~~~~~  231 (357)
T KOG0598|consen  225 FYAEDVK  231 (357)
T ss_pred             CcCccHH
Confidence            9887643

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-42  Score=254.71  Aligned_cols=161  Identities=41%  Similarity=0.762  Sum_probs=148.4

Q ss_pred             hHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecC
Q 030527           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRD   89 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~d   89 (175)
                      .+.+|+++|++|+|||||++.++|......|+|+||+.||+|.+++-.++.+.+.....+++|+  |+.|||++|++|||
T Consensus       222 ~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRD  301 (475)
T KOG0615|consen  222 DVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRD  301 (475)
T ss_pred             hhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCccccc
Confidence            4579999999999999999999999999999999999999999999999999999999999998  99999999999999


Q ss_pred             CCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccC--C-CcchhHHHHHHHHHHHHhCCCCC
Q 030527           90 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR--Y-DEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        90 i~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~-~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |||+||++.+...+..+|++|||+|+..+......+..||+.|+|||.+.++.  + ..+.|+||+||++|-+++|++||
T Consensus       302 iKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPF  381 (475)
T KOG0615|consen  302 IKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPF  381 (475)
T ss_pred             CCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCc
Confidence            99999999765566779999999999999888899999999999999997664  3 34789999999999999999999


Q ss_pred             CCCCcc
Q 030527          167 SVGEEH  172 (175)
Q Consensus       167 ~~~~~~  172 (175)
                      ++...+
T Consensus       382 S~~~~~  387 (475)
T KOG0615|consen  382 SEEYTD  387 (475)
T ss_pred             ccccCC
Confidence            886554

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=246.26  Aligned_cols=160  Identities=34%  Similarity=0.606  Sum_probs=151.6

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC-eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ++..++++.+|+++++.++||+||.+++.|..++ ...++||||.||+|++.+++.+++++.....++.++  +|.|||+
T Consensus       117 ~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~  196 (364)
T KOG0581|consen  117 DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE  196 (364)
T ss_pred             CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            8889999999999999999999999999999999 499999999999999999988999999999999998  9999995


Q ss_pred             -cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           83 -HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        83 -~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                       .+++||||||+|+++   +..+.+||||||.+....+. ...+..||..|||||.+.+..|+.++||||||+.++|++.
T Consensus       197 ~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~  272 (364)
T KOG0581|consen  197 ERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI  272 (364)
T ss_pred             ccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhh
Confidence             999999999999999   68899999999999888666 6778899999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 030527          162 GYPPFSVG  169 (175)
Q Consensus       162 g~~pf~~~  169 (175)
                      |+.||...
T Consensus       273 GrfP~~~~  280 (364)
T KOG0581|consen  273 GRFPYPPP  280 (364)
T ss_pred             CCCCCCCc
Confidence            99999774

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-40  Score=252.01  Aligned_cols=162  Identities=36%  Similarity=0.701  Sum_probs=153.7

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ++.++..+.+|+++-++|+|||||+++++|++.+..|+|.|+|..++|..++++..+++|.++..++.||  ++.|||++
T Consensus        58 k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~  137 (592)
T KOG0575|consen   58 KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL  137 (592)
T ss_pred             CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence            6677889999999999999999999999999999999999999999999999999999999999999999  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      +|+|||+|..|+++   +.+-.+||+|||+|.....+ +...+..||+.|.|||++.....+..+||||+||++|.++.|
T Consensus       138 ~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G  214 (592)
T KOG0575|consen  138 GIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVG  214 (592)
T ss_pred             Cceecccchhheee---cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhC
Confidence            99999999999999   67778999999999999855 667789999999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      ++||...+
T Consensus       215 ~PPFetk~  222 (592)
T KOG0575|consen  215 RPPFETKT  222 (592)
T ss_pred             CCCcccch
Confidence            99998764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=232.77  Aligned_cols=159  Identities=38%  Similarity=0.761  Sum_probs=149.6

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .+..-..+|.++|+.+.||+++++++.+.+.+.+++||||.+||.|.+++++.+++++..+..+++|+  |++|||++++
T Consensus        86 KQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~i  165 (355)
T KOG0616|consen   86 KQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDI  165 (355)
T ss_pred             HHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCe
Confidence            33445678999999999999999999999999999999999999999999999999999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      ++||+||+|+++   +.++.++++|||+|.+....  +.+-.||+.|+|||.+.+++++.++|=||||+++|||+.|++|
T Consensus       166 iYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pP  240 (355)
T KOG0616|consen  166 IYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPP  240 (355)
T ss_pred             eeccCChHHeee---ccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCC
Confidence            999999999999   78999999999999998655  6678899999999999999999999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+..+
T Consensus       241 F~~~~~  246 (355)
T KOG0616|consen  241 FYDDNP  246 (355)
T ss_pred             CcCCCh
Confidence            987765

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7e-39  Score=239.70  Aligned_cols=159  Identities=38%  Similarity=0.605  Sum_probs=144.1

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCC-eEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .+.|.+|+.++.+++||||+++++++.+.. ..++||||+++|+|.+++.+  ...++...+..++.++  |+.|||+.+
T Consensus        83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~  162 (362)
T KOG0192|consen   83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG  162 (362)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            669999999999999999999999999887 79999999999999999987  5789999999999999  999999999


Q ss_pred             -CeecCCCCCcEEEeecCCCc-eEEEeeecceeeccCC-CccccccCCCCccCccccc--ccCCCcchhHHHHHHHHHHH
Q 030527           85 -IIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        85 -~~h~di~~~ni~~~~~~~~~-~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~--~~~~~~~~Di~slg~~~~~~  159 (175)
                       +||+|+|++|+++   +... .+||+|||+++..... .......||..|+|||.+.  ...++.++|+||||+++||+
T Consensus       163 ~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl  239 (362)
T KOG0192|consen  163 PIIHRDLKSDNILV---DLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWEL  239 (362)
T ss_pred             CeeecccChhhEEE---cCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHH
Confidence             9999999999999   5665 8999999999877654 2333367899999999999  66899999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030527          160 LNGYPPFSVGEE  171 (175)
Q Consensus       160 ~~g~~pf~~~~~  171 (175)
                      +||+.||.+-.+
T Consensus       240 ~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  240 LTGEIPFEDLAP  251 (362)
T ss_pred             HHCCCCCCCCCH
Confidence            999999987653

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=242.06  Aligned_cols=159  Identities=38%  Similarity=0.689  Sum_probs=146.0

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+..|...|.+| .||+|++++..|.+...+|+|+||.++|+|.+++++.|.|.+..+..+.++|  |++|||+.|||
T Consensus       117 vkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GII  196 (604)
T KOG0592|consen  117 VKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGII  196 (604)
T ss_pred             cchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCce
Confidence            45678899999999 9999999999999999999999999999999999999999999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--------------cccccCCCCccCcccccccCCCcchhHHHH
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  152 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--------------~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl  152 (175)
                      ||||||+||++   +.+.+++|+|||.|....+...              .....||..|++||++.....++.+|+|+|
T Consensus       197 HRDlKPENILL---d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAl  273 (604)
T KOG0592|consen  197 HRDLKPENILL---DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWAL  273 (604)
T ss_pred             eccCChhheeE---cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHH
Confidence            99999999999   7999999999999977643211              134789999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCc
Q 030527          153 GAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       153 g~~~~~~~~g~~pf~~~~~  171 (175)
                      ||++|.|+.|++||.+..+
T Consensus       274 GCilyQmlaG~PPFra~Ne  292 (604)
T KOG0592|consen  274 GCILYQMLAGQPPFRAANE  292 (604)
T ss_pred             HHHHHHHhcCCCCCccccH
Confidence            9999999999999987654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.9e-40  Score=232.44  Aligned_cols=163  Identities=31%  Similarity=0.587  Sum_probs=144.4

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      +..+.-..+|+++|++|+|||+|.++++|...+..++|+||| ..++.+.+.+.. .++...+..++.|+  |++|||+.
T Consensus        42 ~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~-dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~  120 (396)
T KOG0593|consen   42 PVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC-DHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN  120 (396)
T ss_pred             HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec-chHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc
Confidence            445566688999999999999999999999999999999999 557777777764 69999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeecc-CCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHh
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~  161 (175)
                      +++||||||+||++   ..++.++|||||+|+... ++..-.....|++|.|||.+.+ .+|+++.||||+||++.||++
T Consensus       121 n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~  197 (396)
T KOG0593|consen  121 NCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLT  197 (396)
T ss_pred             CeecccCChhheEE---ecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhc
Confidence            99999999999999   588899999999999887 4443344567999999999987 789999999999999999999


Q ss_pred             CCCCCCCCCccC
Q 030527          162 GYPPFSVGEEHQ  173 (175)
Q Consensus       162 g~~pf~~~~~~~  173 (175)
                      |++.|+++++-+
T Consensus       198 G~pL~PG~SDiD  209 (396)
T KOG0593|consen  198 GEPLWPGRSDID  209 (396)
T ss_pred             CCcCCCCcchHH
Confidence            999999987643

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-40  Score=232.26  Aligned_cols=162  Identities=34%  Similarity=0.651  Sum_probs=144.8

Q ss_pred             cchhhhhhHHHHHHHHhhCCCCCeeeEee-EEeeCCe-EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHH--H
Q 030527            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFD-AFQAENC-IFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--G   76 (175)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~-~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i--~   76 (175)
                      +++..++.+..|+.+|++|+||||+++++ .+.+++. +++|||+|.+|+|.+.++..    ..+++..++.++.|+  |
T Consensus        57 md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~A  136 (375)
T KOG0591|consen   57 MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRA  136 (375)
T ss_pred             ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHH
Confidence            36777899999999999999999999998 5555555 89999999999999988633    459999999999999  9


Q ss_pred             HHHHHH--cC--CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHH
Q 030527           77 LEILNS--HH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWS  151 (175)
Q Consensus        77 l~~lh~--~~--~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~s  151 (175)
                      |..+|+  ..  +.||||||.||++   +.++.+||+|||+++...+.. ...+..||+.||+||.+.+.+|+.++||||
T Consensus       137 L~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWs  213 (375)
T KOG0591|consen  137 LYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWS  213 (375)
T ss_pred             HHHHhccccccceeeccCcchheEE---cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHH
Confidence            999998  44  8999999999999   688899999999999886654 355788999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCC
Q 030527          152 VGAILFELLNGYPPFSVG  169 (175)
Q Consensus       152 lg~~~~~~~~g~~pf~~~  169 (175)
                      +||++|||+.-+.||.++
T Consensus       214 lGCllyEMcaL~~PF~g~  231 (375)
T KOG0591|consen  214 LGCLLYEMCALQSPFYGD  231 (375)
T ss_pred             HHHHHHHHHhcCCCcccc
Confidence            999999999999999876

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=237.45  Aligned_cols=159  Identities=45%  Similarity=0.800  Sum_probs=146.7

Q ss_pred             hhhhHHHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|+.++++++ ||||+++++++.....+++||||+.||+|.+++.+.+++.+..+..++.|+  |++|||++|+
T Consensus        62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi  141 (370)
T KOG0583|consen   62 LDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGI  141 (370)
T ss_pred             cchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCE
Confidence            4556678999999998 999999999999999999999999999999999998999999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCC-ceEEEeeecceeec-cCCCccccccCCCCccCcccccccC-CC-cchhHHHHHHHHHHHHh
Q 030527           86 IHRDLKPENILLSGLDDD-VMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YD-EKVDMWSVGAILFELLN  161 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~-~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~~pe~~~~~~-~~-~~~Di~slg~~~~~~~~  161 (175)
                      +||||||+|+++   +.+ ++++|+|||++... .......+..|++.|+|||++.+.. |+ .++|+||+|+++|.|++
T Consensus       142 ~HRDLK~ENill---d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~  218 (370)
T KOG0583|consen  142 VHRDLKPENILL---DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLC  218 (370)
T ss_pred             eeCCCCHHHEEe---cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHh
Confidence            999999999999   455 88999999999888 5666777889999999999999877 75 68999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |..||++.+
T Consensus       219 G~~PF~d~~  227 (370)
T KOG0583|consen  219 GRLPFDDSN  227 (370)
T ss_pred             CCCCCCCcc
Confidence            999999854

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=220.06  Aligned_cols=170  Identities=39%  Similarity=0.647  Sum_probs=157.3

Q ss_pred             cccchhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527            3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         3 k~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      |+...+..+.+.+|++|.+.|+||||+.+.+.+...+..|+|+|++.|++|..-+-++.-.++..+-.+..||  +|+|+
T Consensus        47 ~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yC  126 (355)
T KOG0033|consen   47 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYC  126 (355)
T ss_pred             hhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            4556677888999999999999999999999999999999999999999998777766778899999999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      |++||+|+|+||+|+++.+.+.+..+||+|||++...+.+.......|++.|++||.++..+++..+|+|+.|+++|-++
T Consensus       127 H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL  206 (355)
T KOG0033|consen  127 HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL  206 (355)
T ss_pred             HhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH
Confidence            99999999999999999877788889999999999999777778889999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCcc
Q 030527          161 NGYPPFSVGEEH  172 (175)
Q Consensus       161 ~g~~pf~~~~~~  172 (175)
                      .|.+||.+.+.+
T Consensus       207 ~G~~PF~~~~~~  218 (355)
T KOG0033|consen  207 VGYPPFWDEDQH  218 (355)
T ss_pred             hCCCCCCCccHH
Confidence            999999986654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-38  Score=245.03  Aligned_cols=163  Identities=39%  Similarity=0.771  Sum_probs=152.8

Q ss_pred             cchhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      +.+.+...+++|+-+|+.++|||++.+++++++..++|+|.||.+||.|.+++-+.|++++.++.+++.||  ++.|||.
T Consensus        51 ~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~  130 (786)
T KOG0588|consen   51 LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA  130 (786)
T ss_pred             cccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh
Confidence            35566788999999999999999999999999999999999999999999999999999999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHh
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLN  161 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~  161 (175)
                      .+++|+|+||+|+++   +..+++||.|||+|....++..-.+-.|++.|.+||++++.+| +.++||||+|+++|.+++
T Consensus       131 ~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt  207 (786)
T KOG0588|consen  131 FNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT  207 (786)
T ss_pred             hcceeccCCchhhhh---hcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh
Confidence            999999999999999   5666699999999998888888889999999999999999987 668999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |++||++..
T Consensus       208 G~LPFdDdN  216 (786)
T KOG0588|consen  208 GKLPFDDDN  216 (786)
T ss_pred             CCCCCCCcc
Confidence            999999654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.7e-39  Score=243.22  Aligned_cols=164  Identities=38%  Similarity=0.728  Sum_probs=148.7

Q ss_pred             cccchhhhhh-----HHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--
Q 030527            3 KKLNKHLKSC-----LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--   75 (175)
Q Consensus         3 k~~~~~~~~~-----~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--   75 (175)
                      |.++...+..     +.+|+++++.++||||+.++++|+...+.++|+||+.| +|..++...+.++++.+..+..++  
T Consensus        33 k~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVs  111 (808)
T KOG0597|consen   33 KFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVS  111 (808)
T ss_pred             EEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHH
Confidence            4444444444     89999999999999999999999999999999999977 999999999999999999999998  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  154 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~  154 (175)
                      ||.|||+.+++|+|+||.||++   ++++.+|+||||+|+..+.+.. .....||+.|+|||...+.+|+..+|+||+||
T Consensus       112 aL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGc  188 (808)
T KOG0597|consen  112 ALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGC  188 (808)
T ss_pred             HHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHH
Confidence            9999999999999999999999   6899999999999998876643 33567899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCC
Q 030527          155 ILFELLNGYPPFSVGE  170 (175)
Q Consensus       155 ~~~~~~~g~~pf~~~~  170 (175)
                      ++||++.|++||-.++
T Consensus       189 ilYE~~~G~PPF~a~s  204 (808)
T KOG0597|consen  189 ILYELYVGQPPFYARS  204 (808)
T ss_pred             HHHHHhcCCCCchHHH
Confidence            9999999999996543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=230.50  Aligned_cols=156  Identities=38%  Similarity=0.701  Sum_probs=137.2

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCC--eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .+.+.+|+++|++++|||||++++......  .+++.|||+++|+|.+++++.+ .+++..+..+..|+  +|+|||++|
T Consensus        58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g  137 (313)
T KOG0198|consen   58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG  137 (313)
T ss_pred             HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            556899999999999999999999855544  6899999999999999999877 79999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCC-CceEEEeeecceeeccC----CCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYP----GNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~-~~~~~l~df~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~  158 (175)
                      ++||||||+||++   +. ++.++|+|||++.....    ........||+.|+|||.+.. ....+++|+||+||++.|
T Consensus       138 ~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvE  214 (313)
T KOG0198|consen  138 IVHCDIKPANILL---DPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVE  214 (313)
T ss_pred             EeccCcccceEEE---eCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEe
Confidence            9999999999999   45 67899999999987763    122345778999999999985 334469999999999999


Q ss_pred             HHhCCCCCCC
Q 030527          159 LLNGYPPFSV  168 (175)
Q Consensus       159 ~~~g~~pf~~  168 (175)
                      |+||+.||..
T Consensus       215 M~Tg~~PW~~  224 (313)
T KOG0198|consen  215 MLTGKPPWSE  224 (313)
T ss_pred             ccCCCCcchh
Confidence            9999999986

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=232.09  Aligned_cols=161  Identities=29%  Similarity=0.567  Sum_probs=143.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...|.+|++++++|+|++|+++++++..++.+++||||++.|+|.+|++.  ++.+...+...+..||  +++||+++++
T Consensus       245 ~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~  324 (468)
T KOG0197|consen  245 PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNY  324 (468)
T ss_pred             hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCc
Confidence            46788999999999999999999999999999999999999999999997  3568999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcccc--ccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      ||||+.+.||++   +.+..+|++|||+|+...++.....  ..-...|.|||.+....++.++||||||++++|++| |
T Consensus       325 IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G  401 (468)
T KOG0197|consen  325 IHRDLAARNILV---DEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYG  401 (468)
T ss_pred             cchhhhhhheee---ccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccC
Confidence            999999999999   6888999999999996655544332  223566999999999999999999999999999999 8


Q ss_pred             CCCCCCCCccC
Q 030527          163 YPPFSVGEEHQ  173 (175)
Q Consensus       163 ~~pf~~~~~~~  173 (175)
                      +.|+.+-+..+
T Consensus       402 ~~py~~msn~e  412 (468)
T KOG0197|consen  402 RVPYPGMSNEE  412 (468)
T ss_pred             CCCCCCCCHHH
Confidence            99998876554

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.1e-37  Score=229.81  Aligned_cols=159  Identities=33%  Similarity=0.676  Sum_probs=142.3

Q ss_pred             hHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecC
Q 030527           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRD   89 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~d   89 (175)
                      -+..|=.+|....+|.||+++..|++...+||||||++||++..++.+.+.|++..+..+++++  |+..+|+.|+||+|
T Consensus       187 hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRD  266 (550)
T KOG0605|consen  187 HVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRD  266 (550)
T ss_pred             HHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCccccc
Confidence            3456888999999999999999999999999999999999999999999999999999999997  99999999999999


Q ss_pred             CCCCcEEEeecCCCceEEEeeecceeeccC----------------------C--Cc-----------------------
Q 030527           90 LKPENILLSGLDDDVMLKIADFGLSCTLYP----------------------G--NY-----------------------  122 (175)
Q Consensus        90 i~~~ni~~~~~~~~~~~~l~df~~~~~~~~----------------------~--~~-----------------------  122 (175)
                      |||+|+++   +..++++|+|||++.-...                      +  ..                       
T Consensus       267 IKPdNlLi---D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~  343 (550)
T KOG0605|consen  267 IKPDNLLI---DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQ  343 (550)
T ss_pred             CChhheee---cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhh
Confidence            99999999   7999999999999842210                      0  00                       


Q ss_pred             -cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccC
Q 030527          123 -AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ  173 (175)
Q Consensus       123 -~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~~~  173 (175)
                       .....||+.|+|||++.+.+|+..+|.|||||++|||+.|++||.+.++.+
T Consensus       344 ~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~  395 (550)
T KOG0605|consen  344 LAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQE  395 (550)
T ss_pred             hhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence             013668999999999999999999999999999999999999999887654

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.7e-36  Score=227.68  Aligned_cols=159  Identities=30%  Similarity=0.633  Sum_probs=141.2

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+..|.+++++++|++|+++++.+.+....++||||++|++|.+++.+.+.+++..+..++.|+  ||+|||+.|++|
T Consensus        45 ~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givH  124 (363)
T cd05628          45 VGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH  124 (363)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence            456788999999999999999999999999999999999999999999988899999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC------------------------------------ccccccCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCGSPL  131 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~------------------------------------~~~~~~~~~~  131 (175)
                      |||||+||++   +.++.++|+|||++.......                                    ......||+.
T Consensus       125 rDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~  201 (363)
T cd05628         125 RDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPD  201 (363)
T ss_pred             cCCCHHHeEE---CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCcc
Confidence            9999999999   567789999999986542210                                    0113468899


Q ss_pred             ccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       132 ~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      |+|||.+.+..++.++|+||+|+++|+|++|+.||.+.+.
T Consensus       202 Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~  241 (363)
T cd05628         202 YIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP  241 (363)
T ss_pred             ccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCH
Confidence            9999999988999999999999999999999999987553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-36  Score=221.70  Aligned_cols=161  Identities=38%  Similarity=0.738  Sum_probs=151.5

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      +.--.+.+|++|++.|+||+|.+++++|+....+.+||||..+|.|.+|+..++.|++.++..++.||  |+.|||..++
T Consensus        95 qDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrV  174 (668)
T KOG0611|consen   95 QDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRV  174 (668)
T ss_pred             HHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccc
Confidence            33446788999999999999999999999999999999999999999999999999999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+|+|.+||++   +.++++++.|||++..+.......+..|++.|.+||++-+.+| ++..|.||||+++|.+.-|..
T Consensus       175 vHRDLKLENILL---D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtM  251 (668)
T KOG0611|consen  175 VHRDLKLENILL---DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTM  251 (668)
T ss_pred             eecccchhheee---cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccc
Confidence            999999999999   6888999999999999988888889999999999999998887 678999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||++.+-
T Consensus       252 PFDG~Dh  258 (668)
T KOG0611|consen  252 PFDGRDH  258 (668)
T ss_pred             ccCCchH
Confidence            9998764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.6e-36  Score=224.48  Aligned_cols=159  Identities=33%  Similarity=0.560  Sum_probs=142.0

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++++++++||||+++.+++...+..++||||+.+++|.+++.+.+.+++..+..++.|+  ||+|||+.|++|
T Consensus        39 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH  118 (323)
T cd05571          39 VAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY  118 (323)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence            345678999999999999999999999999999999999999999999988889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||||+||++   +.++.++|+|||++..... ........|++.|+|||.+.+..++.++|+||+|+++++|++|..||
T Consensus       119 rDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf  195 (323)
T cd05571         119 RDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  195 (323)
T ss_pred             CCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCC
Confidence            9999999999   5777899999999875422 22233456899999999999889999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       196 ~~~~~  200 (323)
T cd05571         196 YNQDH  200 (323)
T ss_pred             CCCCH
Confidence            76543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.2e-36  Score=224.28  Aligned_cols=157  Identities=35%  Similarity=0.685  Sum_probs=142.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+++++.++||||+++++++.+.+..++||||+.+++|.+++.+...+++..+..++.|+  ||+|||+.|++|
T Consensus        75 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH  154 (340)
T PTZ00426         75 VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY  154 (340)
T ss_pred             HHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEc
Confidence            456778999999999999999999999999999999999999999999988889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      |||+|+||++   +.++.++|+|||++......  .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.
T Consensus       155 rDLkp~NILl---~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~  229 (340)
T PTZ00426        155 RDLKPENLLL---DKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY  229 (340)
T ss_pred             cCCCHHHEEE---CCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCC
Confidence            9999999999   57788999999999776432  234568899999999988889999999999999999999999998


Q ss_pred             CCCc
Q 030527          168 VGEE  171 (175)
Q Consensus       168 ~~~~  171 (175)
                      +.++
T Consensus       230 ~~~~  233 (340)
T PTZ00426        230 ANEP  233 (340)
T ss_pred             CCCH
Confidence            7654

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-36  Score=221.70  Aligned_cols=158  Identities=39%  Similarity=0.717  Sum_probs=142.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.+.+.+++..+..++.|+  ||++||+.|++
T Consensus        44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  123 (291)
T cd05612          44 QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIV  123 (291)
T ss_pred             HHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3456788999999999999999999999999999999999999999999988889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |+||+|+||++   +.++.++|+|||++......  .....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||
T Consensus       124 H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf  198 (291)
T cd05612         124 YRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF  198 (291)
T ss_pred             ecCCCHHHeEE---CCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999   56778999999998766433  22345788999999998888999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       199 ~~~~~  203 (291)
T cd05612         199 FDDNP  203 (291)
T ss_pred             CCCCH
Confidence            87653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-35  Score=221.98  Aligned_cols=159  Identities=33%  Similarity=0.563  Sum_probs=141.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+++++.++||||+++.+++...+..++||||+.+++|..++.+.+.+++..+..++.|+  ||+|||++|++|
T Consensus        39 ~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH  118 (323)
T cd05595          39 VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY  118 (323)
T ss_pred             HHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            345677999999999999999999999999999999999999999999888889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||||+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|++++|+.||
T Consensus       119 ~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf  195 (323)
T cd05595         119 RDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  195 (323)
T ss_pred             cCCCHHHEEE---cCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCC
Confidence            9999999999   57788999999998754322 2223456789999999998888999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      ...+.
T Consensus       196 ~~~~~  200 (323)
T cd05595         196 YNQDH  200 (323)
T ss_pred             CCCCH
Confidence            76653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-36  Score=227.09  Aligned_cols=165  Identities=35%  Similarity=0.668  Sum_probs=152.1

Q ss_pred             cchhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCe-EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHH
Q 030527            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~   79 (175)
                      ..+..++...+|+.++++++||||+.+.+.|.+++. .+++|+||.||++.+.+++..  .+++..+..|+.|+  |+.|
T Consensus        42 ~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~y  121 (426)
T KOG0589|consen   42 LTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNY  121 (426)
T ss_pred             cCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence            355667788999999999999999999999999998 999999999999999997653  59999999999998  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      ||+++++|+|+|+.|||+   ..++.++|.|||+|+...+.. ...+..||+.|++||.+.+.+|+.++|+|||||++||
T Consensus       122 lH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yE  198 (426)
T KOG0589|consen  122 LHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYE  198 (426)
T ss_pred             HHhhhhhcccchhhhhhc---cccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHH
Confidence            999999999999999999   577778999999999998876 6778999999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCcc
Q 030527          159 LLNGYPPFSVGEEH  172 (175)
Q Consensus       159 ~~~g~~pf~~~~~~  172 (175)
                      |++-+.+|.+.+..
T Consensus       199 m~~lk~aF~a~~m~  212 (426)
T KOG0589|consen  199 MCTLKPAFKASNMS  212 (426)
T ss_pred             HHhcccccCccchH
Confidence            99999999987643

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=229.67  Aligned_cols=157  Identities=32%  Similarity=0.656  Sum_probs=144.3

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      +.-+.+|+.+++..+|+|||++++.|...+.++.||||+.|++|.+.+... .+++.++..+..++  ||++||.+|++|
T Consensus       314 keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiH  392 (550)
T KOG0578|consen  314 KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIH  392 (550)
T ss_pred             hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceee
Confidence            445688999999999999999999999999999999999999999988854 48999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +|||.+||++   ..++.++|+|||++....... ...+..||+.|+|||....+.|+++.||||||++++||+.|++||
T Consensus       393 rDIKSDnILL---~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPY  469 (550)
T KOG0578|consen  393 RDIKSDNILL---TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPY  469 (550)
T ss_pred             eccccceeEe---ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCc
Confidence            9999999999   578889999999998886654 677889999999999999999999999999999999999999999


Q ss_pred             CCCC
Q 030527          167 SVGE  170 (175)
Q Consensus       167 ~~~~  170 (175)
                      -..+
T Consensus       470 lnE~  473 (550)
T KOG0578|consen  470 LNEN  473 (550)
T ss_pred             cCCC
Confidence            7644

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-36  Score=221.27  Aligned_cols=160  Identities=37%  Similarity=0.610  Sum_probs=142.3

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+..|++++++++||||+++.+++...+..++||||+++++|.+++.+.+.+++..+..++.|+  ||+|||+.|++
T Consensus        36 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  115 (312)
T cd05585          36 EVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI  115 (312)
T ss_pred             HHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            3456678999999999999999999999999999999999999999999988889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||++...... .......|++.|+|||.+.+..++.++|+||+|+++++|++|+.|
T Consensus       116 HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p  192 (312)
T cd05585         116 YRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP  192 (312)
T ss_pred             eCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCC
Confidence            99999999999   57788999999998754322 223345688999999999988899999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.+.
T Consensus       193 f~~~~~  198 (312)
T cd05585         193 FYDENV  198 (312)
T ss_pred             cCCCCH
Confidence            976543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-36  Score=223.62  Aligned_cols=158  Identities=38%  Similarity=0.697  Sum_probs=142.8

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+.+.+|++++++++||||+++++++...+..++||||++|++|.+++.+.+.+++..+..++.|+  +|++||+.|++
T Consensus        44 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv  123 (333)
T cd05600          44 EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYI  123 (333)
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3456788999999999999999999999999999999999999999999988889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |+||+|+||++   +.++.++|+|||++.....  ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus       124 H~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf  198 (333)
T cd05600         124 HRDLKPENFLI---DASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF  198 (333)
T ss_pred             ccCCCHHHEEE---CCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCC
Confidence            99999999999   5778899999999876543  233456789999999999889999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       199 ~~~~~  203 (333)
T cd05600         199 SGSTP  203 (333)
T ss_pred             CCCCH
Confidence            87654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-35  Score=222.10  Aligned_cols=157  Identities=38%  Similarity=0.718  Sum_probs=142.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      .+.+.+|++++++++||||+++++++.+.+..+++|||+.|++|.+++.+.+.+++..+..++.|+  ||+|||+.|++|
T Consensus        62 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH  141 (329)
T PTZ00263         62 VQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIY  141 (329)
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            456788999999999999999999999999999999999999999999988889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      +||+|+||++   +.++.++|+|||++.......  ....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.
T Consensus       142 ~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  216 (329)
T PTZ00263        142 RDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF  216 (329)
T ss_pred             cCCCHHHEEE---CCCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCC
Confidence            9999999999   577889999999998764432  24567899999999998889999999999999999999999997


Q ss_pred             CCCc
Q 030527          168 VGEE  171 (175)
Q Consensus       168 ~~~~  171 (175)
                      +.++
T Consensus       217 ~~~~  220 (329)
T PTZ00263        217 DDTP  220 (329)
T ss_pred             CCCH
Confidence            6543

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-36  Score=227.27  Aligned_cols=159  Identities=33%  Similarity=0.651  Sum_probs=139.8

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|.+++++++||||+++++++.+.+..++||||++|++|.+++.+.+.+++..+..++.|+  ||+|||+.|++|
T Consensus        45 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givH  124 (377)
T cd05629          45 LAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIH  124 (377)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            456788999999999999999999999999999999999999999999988889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC------------c---------------------------------
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------Y---------------------------------  122 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~------------~---------------------------------  122 (175)
                      +||||+||++   +.++.++|+|||++.......            .                                 
T Consensus       125 rDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (377)
T cd05629         125 RDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNR  201 (377)
T ss_pred             cCCCHHHEEE---CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc
Confidence            9999999999   577889999999986321100            0                                 


Q ss_pred             ---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          123 ---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       123 ---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                         .....|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.++
T Consensus       202 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~  253 (377)
T cd05629         202 RLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENS  253 (377)
T ss_pred             cccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCH
Confidence               0013578899999999888899999999999999999999999977554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=233.35  Aligned_cols=165  Identities=37%  Similarity=0.676  Sum_probs=150.8

Q ss_pred             chhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ..+.......|.+++... +||.+++++..|+...++++||||..||++..+ ++.+.+++..+..+++++  ||.|||+
T Consensus       408 ~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~  486 (694)
T KOG0694|consen  408 QRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHE  486 (694)
T ss_pred             ccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHh
Confidence            455566778899999988 699999999999999999999999999995544 446789999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeecc-CCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      +||||||+|.+||++   |..+.++|.|||+++... .+..+.+..||+.|+|||++.+..|+.+.|=||||+++|+|+.
T Consensus       487 ~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~  563 (694)
T KOG0694|consen  487 NGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLV  563 (694)
T ss_pred             cCceeeecchhheEE---cccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHc
Confidence            999999999999999   799999999999998876 5677889999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccCC
Q 030527          162 GYPPFSVGEEHQF  174 (175)
Q Consensus       162 g~~pf~~~~~~~~  174 (175)
                      |+.||.+.+++++
T Consensus       564 Gq~PF~gddEee~  576 (694)
T KOG0694|consen  564 GESPFPGDDEEEV  576 (694)
T ss_pred             CCCCCCCCCHHHH
Confidence            9999999887753

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-36  Score=224.34  Aligned_cols=166  Identities=30%  Similarity=0.446  Sum_probs=144.8

Q ss_pred             ccccchhh---hhhHHHHHHHHhhCCCCCeeeEeeEEeeCC-eEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH
Q 030527            2 LKKLNKHL---KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL   75 (175)
Q Consensus         2 lk~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i   75 (175)
                      ||+++...   .++|.+|+.++.+++|||+++++|||.+.+ ..++|+||+++|+|.+++....  .+++.+...|+.++
T Consensus       104 VK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~  183 (361)
T KOG1187|consen  104 VKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGA  183 (361)
T ss_pred             EEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            56565544   467999999999999999999999999998 5999999999999999997654  88999999999999


Q ss_pred             --HHHHHHHcC---CeecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccc-cCCCCccCcccccccCCCcchh
Q 030527           76 --GLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKV-CGSPLYMAPEVLQFQRYDEKVD  148 (175)
Q Consensus        76 --~l~~lh~~~---~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~-~~~~~~~~pe~~~~~~~~~~~D  148 (175)
                        ||+|||+..   ++|+|||++||++   |.+..+|++|||+|..... ....... .||.+|++||+...+..+.++|
T Consensus       184 A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsD  260 (361)
T KOG1187|consen  184 ARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSD  260 (361)
T ss_pred             HHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccc
Confidence              999999854   9999999999999   7889999999999965543 3322233 7899999999999889999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCC
Q 030527          149 MWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       149 i~slg~~~~~~~~g~~pf~~~~  170 (175)
                      |||||++++|+++|+.|.+...
T Consensus       261 VySFGVvllElitgr~~~d~~~  282 (361)
T KOG1187|consen  261 VYSFGVVLLELITGRKAVDQSR  282 (361)
T ss_pred             cccchHHHHHHHhCCcccCCCC
Confidence            9999999999999999887643

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=225.25  Aligned_cols=159  Identities=32%  Similarity=0.690  Sum_probs=140.9

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+++++.++||||+++++++.+.+..++||||++|++|.+++.+.+.+++..+..++.|+  ||+|||+.|++|
T Consensus        45 ~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH  124 (364)
T cd05599          45 VAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIH  124 (364)
T ss_pred             HHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            445778999999999999999999999999999999999999999999988889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC---------------------------------------ccccccC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------------------------------------YAEKVCG  128 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---------------------------------------~~~~~~~  128 (175)
                      +||||+||++   +.++.++|+|||++.......                                       ......|
T Consensus       125 ~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  201 (364)
T cd05599         125 RDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVG  201 (364)
T ss_pred             ccCCHHHeEE---CCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccccc
Confidence            9999999999   677889999999986543211                                       0012357


Q ss_pred             CCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       129 ~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      |+.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.
T Consensus       202 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~  244 (364)
T cd05599         202 TPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP  244 (364)
T ss_pred             CccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCH
Confidence            8999999999888899999999999999999999999986543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-35  Score=221.38  Aligned_cols=160  Identities=32%  Similarity=0.543  Sum_probs=142.0

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|+++++.++||||+++.+++...+..++||||+++++|.+++.+...+++.++..++.|+  ||+|||+.|++
T Consensus        38 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv  117 (328)
T cd05593          38 EVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIV  117 (328)
T ss_pred             HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            3456778999999999999999999999999999999999999999999888889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||||+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus       118 HrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~P  194 (328)
T cd05593         118 YRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  194 (328)
T ss_pred             ecccCHHHeEE---CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCC
Confidence            99999999999   57788999999998754322 223345688999999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.+.
T Consensus       195 f~~~~~  200 (328)
T cd05593         195 FYNQDH  200 (328)
T ss_pred             CCCCCH
Confidence            976543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-35  Score=225.97  Aligned_cols=160  Identities=35%  Similarity=0.659  Sum_probs=140.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|++++++++||||+++++.+.+.+..++||||+++++|.+++.+.+.+++..+..++.|+  |+++||++|++
T Consensus        44 ~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~iv  123 (382)
T cd05625          44 QVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI  123 (382)
T ss_pred             HHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3456788999999999999999999999999999999999999999999888889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCC----------------------------------------------
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----------------------------------------------  120 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~----------------------------------------------  120 (175)
                      |+||||+||++   +.++.++|+|||++......                                              
T Consensus       124 HrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (382)
T cd05625         124 HRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQH  200 (382)
T ss_pred             cCCCCHHHEEE---CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccc
Confidence            99999999999   57788999999987432100                                              


Q ss_pred             --CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          121 --NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       121 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                        .......|++.|+|||.+.+..++.++|+||+||++|+|++|+.||.+.++
T Consensus       201 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~  253 (382)
T cd05625         201 QRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP  253 (382)
T ss_pred             ccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCH
Confidence              001123578899999999988999999999999999999999999987653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-36  Score=223.16  Aligned_cols=158  Identities=36%  Similarity=0.574  Sum_probs=138.9

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .-..+|+.+|++|+||||+++.+...+.  +.+|+|+||| ..+|.-++...+ .+++.++..+++|+  +|+|||++|+
T Consensus       161 ~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gv  239 (560)
T KOG0600|consen  161 ITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGV  239 (560)
T ss_pred             HHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCe
Confidence            3447799999999999999999998776  7999999999 569998887643 79999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g  162 (175)
                      +|||||.+||++   +.++.++|.|||+|+.+.....  .....-|++|.|||++.+. .|+.+.|+||.||++.||+.|
T Consensus       240 lHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~g  316 (560)
T KOG0600|consen  240 LHRDIKGSNILI---DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLG  316 (560)
T ss_pred             eeccccccceEE---cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcC
Confidence            999999999999   7899999999999997755432  2234558999999999865 599999999999999999999


Q ss_pred             CCCCCCCCcc
Q 030527          163 YPPFSVGEEH  172 (175)
Q Consensus       163 ~~pf~~~~~~  172 (175)
                      ++.|.++++-
T Consensus       317 kPI~~G~tEv  326 (560)
T KOG0600|consen  317 KPILQGRTEV  326 (560)
T ss_pred             CCCcCCccHH
Confidence            9999998753

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-35  Score=219.25  Aligned_cols=157  Identities=39%  Similarity=0.661  Sum_probs=140.5

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      ..+..|++++++++||||+++++++..++..++||||+.+++|.+++.+.+.+++..+..++.|+  +|++||+.|++|+
T Consensus        45 ~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  124 (323)
T cd05584          45 AHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYR  124 (323)
T ss_pred             HHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            45678999999999999999999999999999999999999999999988889999999999998  9999999999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      ||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.
T Consensus       125 dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~  201 (323)
T cd05584         125 DLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT  201 (323)
T ss_pred             CCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCC
Confidence            999999999   57788999999998754322 22334567899999999988889999999999999999999999998


Q ss_pred             CCC
Q 030527          168 VGE  170 (175)
Q Consensus       168 ~~~  170 (175)
                      +.+
T Consensus       202 ~~~  204 (323)
T cd05584         202 AEN  204 (323)
T ss_pred             CCC
Confidence            754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.7e-36  Score=226.32  Aligned_cols=159  Identities=34%  Similarity=0.651  Sum_probs=139.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++++++++||||+++++.+.+.+..++||||+++++|.+++.+.+.+++..+..++.|+  ||++||+.|++|
T Consensus        45 ~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH  124 (376)
T cd05598          45 AAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIH  124 (376)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            456788999999999999999999999999999999999999999999988889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCC--------------------------------------------Ccc
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------------------------------------------NYA  123 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~--------------------------------------------~~~  123 (175)
                      |||||+||++   +.++.++|+|||++......                                            ...
T Consensus       125 rDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (376)
T cd05598         125 RDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLA  201 (376)
T ss_pred             CCCCHHHEEE---CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccc
Confidence            9999999999   57788999999987422100                                            000


Q ss_pred             ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          124 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       124 ~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ....|++.|+|||.+.+..++.++|+||+||++|+|++|+.||.+.++
T Consensus       202 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~  249 (376)
T cd05598         202 HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP  249 (376)
T ss_pred             cccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCH
Confidence            123578899999999988899999999999999999999999987654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1e-34  Score=213.10  Aligned_cols=158  Identities=34%  Similarity=0.553  Sum_probs=140.5

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+.+|++++++++|++++++.+++.+++..++++||+++++|.+++...  ..+++..+..++.|+  |+++||+.|++
T Consensus        45 ~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ii  124 (285)
T cd05631          45 AMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV  124 (285)
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            35678999999999999999999999999999999999999999887643  358999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|++++|+.||
T Consensus       125 H~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf  201 (285)
T cd05631         125 YRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF  201 (285)
T ss_pred             eCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCC
Confidence            99999999999   567789999999998765444444556889999999999889999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       202 ~~~~~  206 (285)
T cd05631         202 RKRKE  206 (285)
T ss_pred             CCCCc
Confidence            87543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-36  Score=219.77  Aligned_cols=160  Identities=36%  Similarity=0.589  Sum_probs=140.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCC-----eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLE   78 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l~   78 (175)
                      ++.-..|.++|+.++||||+++..+|....     ...+|+||++ .+|.+.++.    +.+++...+.-+..|+  |++
T Consensus        61 ~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~  139 (364)
T KOG0658|consen   61 KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLA  139 (364)
T ss_pred             CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHH
Confidence            345577999999999999999998886432     4579999995 588888874    4678889999999999  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccccc-CCCcchhHHHHHHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILF  157 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~  157 (175)
                      |||+.|++||||||.|++++  ...+.+||||||+|+....++.......++.|.|||.+.+. .|+.+.|+||.||++.
T Consensus       140 yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~a  217 (364)
T KOG0658|consen  140 YLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMA  217 (364)
T ss_pred             HHHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHH
Confidence            99999999999999999995  45688999999999999988888888889999999999765 5999999999999999


Q ss_pred             HHHhCCCCCCCCCcc
Q 030527          158 ELLNGYPPFSVGEEH  172 (175)
Q Consensus       158 ~~~~g~~pf~~~~~~  172 (175)
                      ||+-|++-|.+.+..
T Consensus       218 ELl~g~plFpG~s~~  232 (364)
T KOG0658|consen  218 ELLKGQPLFPGDSSV  232 (364)
T ss_pred             HHhcCCcccCCCCHH
Confidence            999999999997654

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.5e-35  Score=222.56  Aligned_cols=160  Identities=34%  Similarity=0.642  Sum_probs=140.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|.+++++++||||+++++++.+.+..++||||++|++|.+++.+.+.+++..+..++.|+  ||++||+.|++
T Consensus        44 ~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~giv  123 (381)
T cd05626          44 QVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI  123 (381)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3456788999999999999999999999999999999999999999999988889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---------------------------------------------
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------------------------------------------  121 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---------------------------------------------  121 (175)
                      |+||||+||++   +..+.++|+|||++.......                                             
T Consensus       124 HrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (381)
T cd05626         124 HRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQH  200 (381)
T ss_pred             ecCCcHHHEEE---CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccc
Confidence            99999999999   577889999999875321000                                             


Q ss_pred             ---ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          122 ---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       122 ---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                         ......|+..|+|||.+.+..++.++|+||+||++|+|++|+.||...++
T Consensus       201 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~  253 (381)
T cd05626         201 QRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTP  253 (381)
T ss_pred             cccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCH
Confidence               01123588999999999888899999999999999999999999987654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.4e-35  Score=217.65  Aligned_cols=156  Identities=35%  Similarity=0.719  Sum_probs=139.5

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      .+.+..|..+++++ +||||+++++++...+..++||||++|++|.+++.+.+.+++..+..++.|+  |+++||++|++
T Consensus        39 ~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv  118 (329)
T cd05588          39 IDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII  118 (329)
T ss_pred             HHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            44577899999998 7999999999999999999999999999999999888899999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeecc-CCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||++.... .........|+..|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus       119 H~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~P  195 (329)
T cd05588         119 YRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP  195 (329)
T ss_pred             ecCCCHHHeEE---CCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCC
Confidence            99999999999   567889999999986532 22333445688999999999988899999999999999999999999


Q ss_pred             CCC
Q 030527          166 FSV  168 (175)
Q Consensus       166 f~~  168 (175)
                      |..
T Consensus       196 f~~  198 (329)
T cd05588         196 FDI  198 (329)
T ss_pred             ccc
Confidence            963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.3e-35  Score=223.15  Aligned_cols=160  Identities=30%  Similarity=0.642  Sum_probs=141.4

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+..|..++.+++||+|+++++.+.+.+..++||||++|++|.+++.+.+.+++..+..++.|+  +|++||+.|++
T Consensus        44 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~giv  123 (360)
T cd05627          44 QVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFI  123 (360)
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            3456788999999999999999999999999999999999999999999988889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC------------------------------------ccccccCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCGSP  130 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~------------------------------------~~~~~~~~~  130 (175)
                      |+||||+||++   +.++.++|+|||++.......                                    ......|++
T Consensus       124 HrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  200 (360)
T cd05627         124 HRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTP  200 (360)
T ss_pred             ccCCCHHHEEE---CCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCc
Confidence            99999999999   577889999999986442110                                    011245789


Q ss_pred             CccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       131 ~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      .|+|||.+.+..++.++|+||+||++|+|++|+.||.+.++
T Consensus       201 ~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~  241 (360)
T cd05627         201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP  241 (360)
T ss_pred             cccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCH
Confidence            99999999988999999999999999999999999977654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=225.76  Aligned_cols=161  Identities=34%  Similarity=0.638  Sum_probs=141.1

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      .....+.+|+++++.++||||+++++++...+..++||||++|++|.+++.+    ..++++..+..++.|+  +|+++|
T Consensus       107 ~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH  186 (478)
T PTZ00267        107 RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH  186 (478)
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3345678899999999999999999999999999999999999999988754    3468999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      +.|++||||||+||++   +..+.++|+|||++.......   ......|++.|+|||.+.+..++.++|+||+|+++++
T Consensus       187 ~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  263 (478)
T PTZ00267        187 SRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYE  263 (478)
T ss_pred             hCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHH
Confidence            9999999999999999   577889999999998764432   1234558899999999988889999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030527          159 LLNGYPPFSVGEE  171 (175)
Q Consensus       159 ~~~g~~pf~~~~~  171 (175)
                      |++|+.||.+.+.
T Consensus       264 l~tg~~Pf~~~~~  276 (478)
T PTZ00267        264 LLTLHRPFKGPSQ  276 (478)
T ss_pred             HHhCCCCCCCCCH
Confidence            9999999987653

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=218.07  Aligned_cols=162  Identities=40%  Similarity=0.734  Sum_probs=149.7

Q ss_pred             hhhHHHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|+++++++. ||||+.+.+++++....++|||++.|+.|.+.+.+. .+++..+..++.|+  +++|||+.|++
T Consensus        79 ~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvv  157 (382)
T KOG0032|consen   79 REDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVV  157 (382)
T ss_pred             HHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence            458899999999997 999999999999999999999999999999999877 59999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCC-CceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+|+||+|+++.+.+. .+.++++|||++.....+.......||+.|+|||.+...+++...|+||+|+++|.|++|..|
T Consensus       158 HrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~P  237 (382)
T KOG0032|consen  158 HRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPP  237 (382)
T ss_pred             eccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCC
Confidence            9999999999975544 358999999999999886677788999999999999999999999999999999999999999


Q ss_pred             CCCCCcc
Q 030527          166 FSVGEEH  172 (175)
Q Consensus       166 f~~~~~~  172 (175)
                      |.+.++.
T Consensus       238 F~~~~~~  244 (382)
T KOG0032|consen  238 FWGETEF  244 (382)
T ss_pred             CcCCChh
Confidence            9987754

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.8e-35  Score=219.88  Aligned_cols=159  Identities=33%  Similarity=0.567  Sum_probs=141.0

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH-cCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-HHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~-~~~~   86 (175)
                      ...+..|.++++.++||||+++.+++...+..++||||+++++|.+++.+...+++..+..++.|+  ||+|||+ .|++
T Consensus        39 ~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~iv  118 (325)
T cd05594          39 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV  118 (325)
T ss_pred             HHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEE
Confidence            345677999999999999999999999999999999999999999999888889999999999998  9999997 7999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||||+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus       119 HrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~P  195 (325)
T cd05594         119 YRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  195 (325)
T ss_pred             ecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCC
Confidence            99999999999   5778899999999875432 2223345688999999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.+.
T Consensus       196 f~~~~~  201 (325)
T cd05594         196 FYNQDH  201 (325)
T ss_pred             CCCCCH
Confidence            977654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.9e-35  Score=217.06  Aligned_cols=160  Identities=38%  Similarity=0.651  Sum_probs=140.9

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+..|.++++.+ +||||+++++++...+..++||||+++++|.+++.+.+.+++..+..++.|+  ||++||+.|++
T Consensus        39 ~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~iv  118 (320)
T cd05590          39 VECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGII  118 (320)
T ss_pred             HHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            44566788888876 7999999999999999999999999999999999988899999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||++..... ........|++.|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus       119 H~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~P  195 (320)
T cd05590         119 YRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP  195 (320)
T ss_pred             eCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCC
Confidence            99999999999   5778899999999875432 2223345688999999999888899999999999999999999999


Q ss_pred             CCCCCcc
Q 030527          166 FSVGEEH  172 (175)
Q Consensus       166 f~~~~~~  172 (175)
                      |.+.+..
T Consensus       196 f~~~~~~  202 (320)
T cd05590         196 FEAENED  202 (320)
T ss_pred             CCCCCHH
Confidence            9876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=219.44  Aligned_cols=155  Identities=36%  Similarity=0.581  Sum_probs=139.9

Q ss_pred             HHHHHHHhhCC-CCCeeeEeeEEeeCC-eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           14 DCELNFLSSVN-HPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        14 ~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      .+|+..|++++ ||||+++.+++.+.. .+++|||+| ..+|.++++.++ .+++..+..|+.||  +|+++|..|+.||
T Consensus        56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHR  134 (538)
T KOG0661|consen   56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHR  134 (538)
T ss_pred             HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence            46999999997 999999999999887 999999999 679999998764 69999999999999  9999999999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccc-cccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      |+||+||++   .....+||.|||+|+.......-.....|++|.|||++ ++..|+.+.|+||+||+++|+.+-++.|.
T Consensus       135 DlKPENiLi---~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP  211 (538)
T KOG0661|consen  135 DLKPENILI---SGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP  211 (538)
T ss_pred             cCChhheEe---cccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC
Confidence            999999999   35778999999999998776655566779999999987 56679999999999999999999999999


Q ss_pred             CCCcc
Q 030527          168 VGEEH  172 (175)
Q Consensus       168 ~~~~~  172 (175)
                      +.++-
T Consensus       212 G~sE~  216 (538)
T KOG0661|consen  212 GASEI  216 (538)
T ss_pred             CCcHH
Confidence            87653

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.5e-34  Score=214.93  Aligned_cols=158  Identities=33%  Similarity=0.671  Sum_probs=140.4

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ..+.+..|..++.++ +||+|+++.+++...+..++||||+++++|.+++.+.+.+++..+..++.|+  |+++||++|+
T Consensus        38 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~i  117 (327)
T cd05617          38 DIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGI  117 (327)
T ss_pred             HHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345577899999888 7999999999999999999999999999999999888889999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeecc-CCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+||+|+||++   +.++.++|+|||++.... .........|+..|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus       118 vHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~  194 (327)
T cd05617         118 IYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRS  194 (327)
T ss_pred             eccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCC
Confidence            999999999999   577789999999987532 2233344568899999999998899999999999999999999999


Q ss_pred             CCCCC
Q 030527          165 PFSVG  169 (175)
Q Consensus       165 pf~~~  169 (175)
                      ||...
T Consensus       195 pf~~~  199 (327)
T cd05617         195 PFDII  199 (327)
T ss_pred             CCCcc
Confidence            99653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=221.91  Aligned_cols=160  Identities=38%  Similarity=0.702  Sum_probs=143.7

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+..|.+++..++||||+++++++.+.+..++||||+++++|.+++.+.+.+++..+..++.|+  ||++||+.|++
T Consensus        44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~gii  123 (350)
T cd05573          44 QIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFI  123 (350)
T ss_pred             HHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3456788999999999999999999999999999999999999999999988889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC------------------------------ccccccCCCCccCcc
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------YAEKVCGSPLYMAPE  136 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~------------------------------~~~~~~~~~~~~~pe  136 (175)
                      |+||+|+||++   +.++.++|+|||++.......                              ......++..|+|||
T Consensus       124 H~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  200 (350)
T cd05573         124 HRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE  200 (350)
T ss_pred             ccCCCHHHeEE---CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence            99999999999   577889999999987664433                              223456789999999


Q ss_pred             cccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          137 VLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       137 ~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      .+.+..++.++|+|||||++|+|++|+.||...+.
T Consensus       201 ~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         201 VLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             HHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence            99988999999999999999999999999987653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=208.81  Aligned_cols=166  Identities=37%  Similarity=0.662  Sum_probs=145.8

Q ss_pred             ccccchhhhhhHHHHHHHHhhC-CCCCeeeEeeEEe----eCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHH
Q 030527            2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQ   74 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~   74 (175)
                      ||.+.++.+  .++|++.-... .|||||.++++++    ...++.+|||.+.||.|.+.++.++.  +++.++..|..|
T Consensus        92 LKvL~Ds~K--ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~q  169 (400)
T KOG0604|consen   92 LKVLLDSPK--ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQ  169 (400)
T ss_pred             HHHHhcCHH--HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHH
Confidence            444444433  35677766666 7999999999975    45688999999999999999998764  999999999999


Q ss_pred             H--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHH
Q 030527           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  152 (175)
Q Consensus        75 i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl  152 (175)
                      |  |++|||+.+|.|||+||+|+++++...+..+||+|||+|+....+....+...|+.|+|||.+....|+...|+||+
T Consensus       170 I~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSl  249 (400)
T KOG0604|consen  170 IGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSL  249 (400)
T ss_pred             HHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccch
Confidence            9  99999999999999999999998777788899999999999887766778889999999999988889999999999


Q ss_pred             HHHHHHHHhCCCCCCCC
Q 030527          153 GAILFELLNGYPPFSVG  169 (175)
Q Consensus       153 g~~~~~~~~g~~pf~~~  169 (175)
                      |+++|-+++|++||..+
T Consensus       250 gVimYIlLCGyPPFYS~  266 (400)
T KOG0604|consen  250 GVIMYILLCGYPPFYSN  266 (400)
T ss_pred             hHHHHHhhcCCCccccc
Confidence            99999999999999754

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-35  Score=220.25  Aligned_cols=159  Identities=38%  Similarity=0.640  Sum_probs=142.2

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+..|++++++++||||+++++++...+..++||||+.+++|.+++.+...+++..+..++.|+  ||+|||+.|++|
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H  121 (318)
T cd05582          42 RVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY  121 (318)
T ss_pred             HHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence            345677999999999999999999999999999999999999999999888889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||
T Consensus       122 ~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~  198 (318)
T cd05582         122 RDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF  198 (318)
T ss_pred             CCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCC
Confidence            9999999999   56778999999998765444 2233456788999999998888999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       199 ~~~~~  203 (318)
T cd05582         199 QGKDR  203 (318)
T ss_pred             CCCCH
Confidence            87653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-34  Score=219.46  Aligned_cols=157  Identities=36%  Similarity=0.658  Sum_probs=138.0

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|..+++.++||||+++++++.+++..++||||++|++|.+++.. ..+++..+..++.|+  ||++||+.|++|
T Consensus        87 ~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvH  165 (370)
T cd05621          87 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIH  165 (370)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            44577899999999999999999999999999999999999999999874 468999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccC----CCcchhHHHHHHHHHHHHh
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slg~~~~~~~~  161 (175)
                      |||||+||++   +..+.++|+|||++........  .....|++.|+|||.+.+..    ++.++|+||+|+++|+|++
T Consensus       166 rDLKp~NILl---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~  242 (370)
T cd05621         166 RDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV  242 (370)
T ss_pred             cCCCHHHEEE---CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh
Confidence            9999999999   5778899999999987643322  23456899999999986543    7889999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |..||.+.+
T Consensus       243 G~~Pf~~~~  251 (370)
T cd05621         243 GDTPFYADS  251 (370)
T ss_pred             CCCCCCCCC
Confidence            999998654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.5e-34  Score=214.45  Aligned_cols=160  Identities=33%  Similarity=0.558  Sum_probs=142.7

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc-
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH-   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~-   83 (175)
                      +.....+.+|++++++++||||+++++++..++..++||||+++++|.+++.+...+++..+..++.|+  +++|||+. 
T Consensus        44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  123 (331)
T cd06649          44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH  123 (331)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence            345677899999999999999999999999999999999999999999999988889999999999998  99999986 


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +++|+||+|+||++   +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|+++|++++|+
T Consensus       124 ~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~  199 (331)
T cd06649         124 QIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR  199 (331)
T ss_pred             CEEcCCCChhhEEE---cCCCcEEEccCcccccccccc-cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence            59999999999999   567789999999987664332 23456788999999999888999999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||...+
T Consensus       200 ~p~~~~~  206 (331)
T cd06649         200 YPIPPPD  206 (331)
T ss_pred             CCCCCCC
Confidence            9997644

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-34  Score=216.49  Aligned_cols=159  Identities=35%  Similarity=0.635  Sum_probs=140.6

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+..|.+++..+ +||+|+++.+++...+..++||||+++++|.+++.+.+.+++..+..++.|+  ||++||+.|++
T Consensus        39 ~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  118 (321)
T cd05591          39 VDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI  118 (321)
T ss_pred             HHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            44567788888876 8999999999999999999999999999999999888889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus       119 HrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P  195 (321)
T cd05591         119 YRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP  195 (321)
T ss_pred             ccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCC
Confidence            99999999999   57788999999998764322 223345578999999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.++
T Consensus       196 f~~~~~  201 (321)
T cd05591         196 FEADNE  201 (321)
T ss_pred             CCCCCH
Confidence            987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.5e-34  Score=215.29  Aligned_cols=159  Identities=40%  Similarity=0.663  Sum_probs=139.1

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+..|.+++... +||+|+++++++.+.+..++||||+.+++|.+++.+.+.+++.++..++.|+  |+++||+.|++
T Consensus        39 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  118 (316)
T cd05620          39 VECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGII  118 (316)
T ss_pred             HHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            34556677887765 9999999999999999999999999999999999888889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++++|++|+.|
T Consensus       119 HrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~P  195 (316)
T cd05620         119 YRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP  195 (316)
T ss_pred             ecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence            99999999999   57778999999988653222 223345678999999999988999999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.+.
T Consensus       196 f~~~~~  201 (316)
T cd05620         196 FHGDDE  201 (316)
T ss_pred             CCCCCH
Confidence            987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-34  Score=216.18  Aligned_cols=157  Identities=36%  Similarity=0.639  Sum_probs=136.6

Q ss_pred             hHHHHH-HHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           12 CLDCEL-NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        12 ~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      .+..|. .+++.++||||+++.+++.+.+..++||||+++++|..++.+...+++..+..++.|+  +|++||+.|++|+
T Consensus        41 ~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~  120 (321)
T cd05603          41 HIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR  120 (321)
T ss_pred             HHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            344444 4678889999999999999999999999999999999999888889999999999998  9999999999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      ||||+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.
T Consensus       121 Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  197 (321)
T cd05603         121 DLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFY  197 (321)
T ss_pred             cCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCC
Confidence            999999999   5778899999999875422 222334567889999999988889999999999999999999999998


Q ss_pred             CCCc
Q 030527          168 VGEE  171 (175)
Q Consensus       168 ~~~~  171 (175)
                      ..+.
T Consensus       198 ~~~~  201 (321)
T cd05603         198 SRDV  201 (321)
T ss_pred             CCCH
Confidence            7653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.1e-34  Score=214.60  Aligned_cols=160  Identities=38%  Similarity=0.698  Sum_probs=141.0

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+..|.++++.+ +||||+++++++...+..++||||++|++|.+++.+.+.+++..+..++.|+  ||++||+.|+
T Consensus        38 ~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i  117 (318)
T cd05570          38 DVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGI  117 (318)
T ss_pred             HHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            345667788899888 7999999999999999999999999999999999988899999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|++++++++|+.
T Consensus       118 vH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~  194 (318)
T cd05570         118 IYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS  194 (318)
T ss_pred             EccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCC
Confidence            999999999999   5778899999998865322 222334457889999999998899999999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.+.
T Consensus       195 pf~~~~~  201 (318)
T cd05570         195 PFEGDDE  201 (318)
T ss_pred             CCCCCCH
Confidence            9987654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.1e-35  Score=207.54  Aligned_cols=155  Identities=41%  Similarity=0.835  Sum_probs=144.5

Q ss_pred             HHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecC
Q 030527           13 LDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRD   89 (175)
Q Consensus        13 ~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~d   89 (175)
                      -.+|+.||+++ .||+|.++.++++.+.-.++|+|+++.|.|.|++...-.+++.....++.|+  ++.|+|.++++|+|
T Consensus        69 T~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRD  148 (411)
T KOG0599|consen   69 TRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRD  148 (411)
T ss_pred             HHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence            35699999999 8999999999999999999999999999999999988889999999999999  99999999999999


Q ss_pred             CCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc------cCCCcchhHHHHHHHHHHHHhCC
Q 030527           90 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        90 i~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +||+||++   +.+-+++|+|||++....++.......||++|+|||.+..      .+|+...|.||+|+++|.++.|.
T Consensus       149 LKpENILl---ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc  225 (411)
T KOG0599|consen  149 LKPENILL---DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC  225 (411)
T ss_pred             cChhheee---ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence            99999999   6777899999999999999998888999999999999853      35889999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      +||..+.
T Consensus       226 pPFwHRk  232 (411)
T KOG0599|consen  226 PPFWHRK  232 (411)
T ss_pred             CchhHHH
Confidence            9997654

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.4e-34  Score=215.99  Aligned_cols=156  Identities=38%  Similarity=0.687  Sum_probs=136.2

Q ss_pred             HHHHH-HHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecC
Q 030527           13 LDCEL-NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRD   89 (175)
Q Consensus        13 ~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~d   89 (175)
                      +..|. .+++.++||||+++++.+...+..++||||+.+++|..++.+.+.+++..+..++.|+  ||+|||++|++|+|
T Consensus        42 ~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~d  121 (323)
T cd05575          42 IMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD  121 (323)
T ss_pred             HHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence            33443 4567889999999999999999999999999999999999988889999999999998  99999999999999


Q ss_pred             CCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030527           90 LKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV  168 (175)
Q Consensus        90 i~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~  168 (175)
                      |+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus       122 ikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  198 (323)
T cd05575         122 LKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             CCHHHeEE---CCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence            99999999   57788999999998654322 223345678899999999988899999999999999999999999987


Q ss_pred             CCc
Q 030527          169 GEE  171 (175)
Q Consensus       169 ~~~  171 (175)
                      .+.
T Consensus       199 ~~~  201 (323)
T cd05575         199 RDT  201 (323)
T ss_pred             CCH
Confidence            653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.3e-34  Score=214.18  Aligned_cols=158  Identities=42%  Similarity=0.735  Sum_probs=138.3

Q ss_pred             hhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ..+..|.+++..+ +||||+++++++...+..++||||++|++|.+++...+.+++..+..++.|+  ||+|||+.|++|
T Consensus        40 ~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH  119 (316)
T cd05592          40 ECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY  119 (316)
T ss_pred             HHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence            3445566777654 8999999999999999999999999999999999888889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||+|+||++   +.++.++|+|||++...... .......|+..|+|||.+.+..++.++|+||+|+++++|++|+.||
T Consensus       120 ~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf  196 (316)
T cd05592         120 RDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF  196 (316)
T ss_pred             CCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCC
Confidence            9999999999   57788999999998765332 2233456789999999998888999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       197 ~~~~~  201 (316)
T cd05592         197 HGEDE  201 (316)
T ss_pred             CCCCH
Confidence            87654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.4e-34  Score=216.11  Aligned_cols=153  Identities=37%  Similarity=0.663  Sum_probs=135.0

Q ss_pred             HHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCC
Q 030527           16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPE   93 (175)
Q Consensus        16 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~   93 (175)
                      +..+++.++||||+++++++...+..++||||+.+++|.+++.+.+.+++..+..++.|+  ||++||+.|++|+||||+
T Consensus        46 ~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~  125 (325)
T cd05602          46 RNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPE  125 (325)
T ss_pred             HHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH
Confidence            334567889999999999999999999999999999999999988889999999999998  999999999999999999


Q ss_pred             cEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527           94 NILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus        94 ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.
T Consensus       126 Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  201 (325)
T cd05602         126 NILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT  201 (325)
T ss_pred             HeEE---CCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence            9999   5677899999999875432 2223345688999999999988899999999999999999999999987553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.2e-34  Score=214.10  Aligned_cols=160  Identities=36%  Similarity=0.660  Sum_probs=139.5

Q ss_pred             hhhhHHHHHHHHhhCCC-CCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+..|.+++..++| ++|+++.+++...+..++||||+++++|.+++.+.+.+++..+..++.|+  ||+|||+.|+
T Consensus        43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i  122 (324)
T cd05587          43 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI  122 (324)
T ss_pred             HHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567789999999965 46888999999999999999999999999999888889999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+||||+||++   +.++.++|+|||++..... ........|+..|+|||.+.+..++.++|+||+|+++|+|++|+.
T Consensus       123 vH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~  199 (324)
T cd05587         123 IYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP  199 (324)
T ss_pred             EecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCC
Confidence            999999999999   5677899999999865422 222334568899999999998889999999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.+.
T Consensus       200 pf~~~~~  206 (324)
T cd05587         200 PFDGEDE  206 (324)
T ss_pred             CCCCCCH
Confidence            9987654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.6e-35  Score=225.06  Aligned_cols=163  Identities=38%  Similarity=0.560  Sum_probs=143.9

Q ss_pred             chhhhhhHHHHHHHHhhCC-CC-----CeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--
Q 030527            6 NKHLKSCLDCELNFLSSVN-HP-----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--   75 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--   75 (175)
                      +....++-..|+.+|..|+ |.     |+++++++|...++.|+|+|++ +.+|.++++.+.  .++...+..+..|+  
T Consensus       222 ~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~  300 (586)
T KOG0667|consen  222 KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILT  300 (586)
T ss_pred             ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHH
Confidence            4455667778999999996 33     9999999999999999999988 789999999773  68999999999998  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  155 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~  155 (175)
                      +|..||+.|+||||+||+||++.+.+ ...+|++|||++........  +...++.|.|||++.+.+|+.+.|+|||||+
T Consensus       301 ~L~~L~~l~IIHcDLKPENILL~~~~-r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCI  377 (586)
T KOG0667|consen  301 ALLFLHELGIIHCDLKPENILLKDPK-RSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCI  377 (586)
T ss_pred             HHHHHHhCCeeeccCChhheeeccCC-cCceeEEecccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhh
Confidence            99999999999999999999996433 34799999999988865543  6677899999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCcc
Q 030527          156 LFELLNGYPPFSVGEEH  172 (175)
Q Consensus       156 ~~~~~~g~~pf~~~~~~  172 (175)
                      ++||++|.+.|.+.++.
T Consensus       378 lAEL~tG~PLfpG~ne~  394 (586)
T KOG0667|consen  378 LAELFTGEPLFPGDNEY  394 (586)
T ss_pred             HHhHhcCccccCCCCHH
Confidence            99999999999988754

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.2e-34  Score=213.43  Aligned_cols=158  Identities=39%  Similarity=0.658  Sum_probs=138.5

Q ss_pred             hhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ..+..|.++++.. +||||+++++++.+.+..++||||+++++|.+++.+...+++.++..++.|+  |++|||+.|++|
T Consensus        40 ~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH  119 (316)
T cd05619          40 ECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVY  119 (316)
T ss_pred             HHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence            4456677788764 9999999999999999999999999999999999988889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|++++|+.||
T Consensus       120 rdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf  196 (316)
T cd05619         120 RDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF  196 (316)
T ss_pred             CCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence            9999999999   57778999999998754322 2233456789999999998888999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       197 ~~~~~  201 (316)
T cd05619         197 HGHDE  201 (316)
T ss_pred             CCCCH
Confidence            87654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=212.02  Aligned_cols=161  Identities=35%  Similarity=0.613  Sum_probs=142.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      -..+..|++.++.++||||++++..|..+..+++||.++.+|++.+.++..  ..+.+..+..+++++  ||.|||.+|.
T Consensus        68 ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~  147 (516)
T KOG0582|consen   68 LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGH  147 (516)
T ss_pred             HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCc
Confidence            567889999999999999999999999999999999999999999999876  349999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc-----ccccCCCCccCccccc--ccCCCcchhHHHHHHHHHH
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~pe~~~--~~~~~~~~Di~slg~~~~~  158 (175)
                      ||||||+.||++   +.++.++|+|||.+.....+...     .+..+++.|+|||.++  ..+|+.++||||||+++.|
T Consensus       148 IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~E  224 (516)
T KOG0582|consen  148 IHRDVKAGNILI---DSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACE  224 (516)
T ss_pred             eecccccccEEE---cCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHH
Confidence            999999999999   68999999999988766544321     3457899999999964  4579999999999999999


Q ss_pred             HHhCCCCCCCCCccC
Q 030527          159 LLNGYPPFSVGEEHQ  173 (175)
Q Consensus       159 ~~~g~~pf~~~~~~~  173 (175)
                      +++|..||..-.+.+
T Consensus       225 LA~G~aPf~k~pPmk  239 (516)
T KOG0582|consen  225 LAHGHAPFSKYPPMK  239 (516)
T ss_pred             HhcCCCCcccCChHH
Confidence            999999997654443

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.5e-34  Score=216.83  Aligned_cols=157  Identities=36%  Similarity=0.658  Sum_probs=137.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|..+++.++||||+++++.+.+.+..++||||++|++|.+++.. ..+++..+..++.|+  ||++||+.|++|
T Consensus        87 ~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH  165 (371)
T cd05622          87 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIH  165 (371)
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence            44577899999999999999999999999999999999999999999875 468899999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccC----CCcchhHHHHHHHHHHHHh
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slg~~~~~~~~  161 (175)
                      +||||+||++   +.++.++|+|||++........  .....|++.|+|||.+.+..    ++.++|+||+|+++|+|++
T Consensus       166 rDLkp~NIll---~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~  242 (371)
T cd05622         166 RDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV  242 (371)
T ss_pred             CCCCHHHEEE---CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh
Confidence            9999999999   5778899999999987644322  23456899999999986543    7889999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |..||.+.+
T Consensus       243 G~~Pf~~~~  251 (371)
T cd05622         243 GDTPFYADS  251 (371)
T ss_pred             CCCCCCCCC
Confidence            999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.9e-34  Score=213.54  Aligned_cols=155  Identities=34%  Similarity=0.688  Sum_probs=138.3

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+..|..++.++ +||||+++++++...+..++||||+++++|.+++.+.+.+++..+..++.|+  |++|||++|++
T Consensus        39 ~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iv  118 (329)
T cd05618          39 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII  118 (329)
T ss_pred             HHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34567888888877 8999999999999999999999999999999999888889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||||+||++   +.++.++|+|||++..... ........|+..|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus       119 H~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~P  195 (329)
T cd05618         119 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP  195 (329)
T ss_pred             eCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCC
Confidence            99999999999   5778899999999875422 2223345678999999999988999999999999999999999999


Q ss_pred             CC
Q 030527          166 FS  167 (175)
Q Consensus       166 f~  167 (175)
                      |.
T Consensus       196 f~  197 (329)
T cd05618         196 FD  197 (329)
T ss_pred             Cc
Confidence            95

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.9e-34  Score=213.52  Aligned_cols=159  Identities=35%  Similarity=0.647  Sum_probs=139.6

Q ss_pred             hhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ..+..|.+++..+ .|++++++.+++...+..++||||+++++|.+++.+.+.+++..+..++.|+  ||++||+.|++|
T Consensus        45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH  124 (323)
T cd05616          45 ECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY  124 (323)
T ss_pred             HHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence            3456678888877 6899999999999999999999999999999999888889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||||+||++   +.++.++|+|||++...... .......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||
T Consensus       125 rDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf  201 (323)
T cd05616         125 RDLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF  201 (323)
T ss_pred             cCCCHHHeEE---CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCC
Confidence            9999999999   57788999999998754322 2233456789999999999889999999999999999999999999


Q ss_pred             CCCCcc
Q 030527          167 SVGEEH  172 (175)
Q Consensus       167 ~~~~~~  172 (175)
                      .+.+..
T Consensus       202 ~~~~~~  207 (323)
T cd05616         202 EGEDED  207 (323)
T ss_pred             CCCCHH
Confidence            876543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-34  Score=215.48  Aligned_cols=157  Identities=38%  Similarity=0.696  Sum_probs=137.0

Q ss_pred             hHHHHHH-HHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           12 CLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        12 ~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      .+..|.. +++.++||||+++++++...+..++||||+.+++|..++.+.+.+++..+..++.|+  ||+|||+.|++|+
T Consensus        41 ~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~  120 (325)
T cd05604          41 HIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR  120 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            4444444 567789999999999999999999999999999999999888899999999999998  9999999999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      ||||+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.
T Consensus       121 Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~  197 (325)
T cd05604         121 DLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY  197 (325)
T ss_pred             CCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCC
Confidence            999999999   5777899999999875422 222334567899999999998889999999999999999999999998


Q ss_pred             CCCc
Q 030527          168 VGEE  171 (175)
Q Consensus       168 ~~~~  171 (175)
                      ..+.
T Consensus       198 ~~~~  201 (325)
T cd05604         198 CRDV  201 (325)
T ss_pred             CCCH
Confidence            7653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-33  Score=207.07  Aligned_cols=157  Identities=37%  Similarity=0.562  Sum_probs=137.6

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ..+..|+++++.++|++|+++.+++...+..++||||+++++|.+++..    ...+++..+..++.|+  |++|||+.|
T Consensus        38 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  117 (280)
T cd05608          38 EGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR  117 (280)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4567799999999999999999999999999999999999999988743    3468999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      ++|+||+|+||++   +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|++++|+
T Consensus       118 i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~  194 (280)
T cd05608         118 IIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR  194 (280)
T ss_pred             cccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence            9999999999999   5677899999999876644322 22346788999999999889999999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||...+
T Consensus       195 ~pf~~~~  201 (280)
T cd05608         195 GPFRARG  201 (280)
T ss_pred             CCCCCCC
Confidence            9997653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.4e-34  Score=216.85  Aligned_cols=158  Identities=34%  Similarity=0.620  Sum_probs=137.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|.++++.++||||+++.+++.+.+..++||||++|++|.+++.. ..+++..+..++.|+  ||+|||+.|++|
T Consensus        87 ~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH  165 (370)
T cd05596          87 SAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIH  165 (370)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            34567899999999999999999999999999999999999999998874 468899999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC--ccccccCCCCccCccccccc----CCCcchhHHHHHHHHHHHHh
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~----~~~~~~Di~slg~~~~~~~~  161 (175)
                      +||+|+||++   +.++.++|+|||.+.......  ......|++.|+|||.+.+.    .++.++|+||+|+++|+|++
T Consensus       166 rDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt  242 (370)
T cd05596         166 RDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV  242 (370)
T ss_pred             cCCCHHHEEE---cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh
Confidence            9999999999   578889999999997764332  12345689999999998643    37889999999999999999


Q ss_pred             CCCCCCCCCc
Q 030527          162 GYPPFSVGEE  171 (175)
Q Consensus       162 g~~pf~~~~~  171 (175)
                      |..||.+.+.
T Consensus       243 G~~Pf~~~~~  252 (370)
T cd05596         243 GDTPFYADSL  252 (370)
T ss_pred             CCCCcCCCCH
Confidence            9999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.1e-33  Score=205.40  Aligned_cols=156  Identities=33%  Similarity=0.531  Sum_probs=138.1

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+..|++++++++||||+++.+++..+...++||||++|++|.+++...+  .+++..+..++.|+  |+++||+.|++
T Consensus        38 ~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv  117 (277)
T cd05607          38 KMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV  117 (277)
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            345669999999999999999999999999999999999999998886543  58889889999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|++++|+.||
T Consensus       118 H~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~  194 (277)
T cd05607         118 YRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF  194 (277)
T ss_pred             EccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCC
Confidence            99999999999   567789999999998775544444456788999999998888999999999999999999999999


Q ss_pred             CCC
Q 030527          167 SVG  169 (175)
Q Consensus       167 ~~~  169 (175)
                      ...
T Consensus       195 ~~~  197 (277)
T cd05607         195 KDH  197 (277)
T ss_pred             CCC
Confidence            764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.5e-34  Score=208.85  Aligned_cols=158  Identities=33%  Similarity=0.578  Sum_probs=135.9

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|++++++++||||+++++++...+..++|+|++.+ +|.+++...+ .+++..+..++.|+  ||++||+.|++
T Consensus        47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  125 (288)
T cd07871          47 PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL  125 (288)
T ss_pred             chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            34667899999999999999999999999999999999965 8999887654 47899999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      |+||||+||++   +.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|++++++++|+.
T Consensus       126 H~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~  202 (288)
T cd07871         126 HRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP  202 (288)
T ss_pred             cCCCCHHHEEE---CCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999   567789999999987654332 2234456888999998865 458999999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.+.
T Consensus       203 pf~~~~~  209 (288)
T cd07871         203 MFPGSTV  209 (288)
T ss_pred             CCCCCCH
Confidence            9987553

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4e-34  Score=209.93  Aligned_cols=159  Identities=33%  Similarity=0.575  Sum_probs=138.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|++++++++||||+++.+++..++..++||||++++.+..+......+++..+..++.|+  ||++||+.|++
T Consensus        43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~  122 (287)
T cd07848          43 VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV  122 (287)
T ss_pred             chhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4556788999999999999999999999999999999999887666655545679999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      |+||+|+||++   +.++.++|+|||++........  .....++..|+|||.+.+..++.++|+||+|+++|++++|+.
T Consensus       123 H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~  199 (287)
T cd07848         123 HRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP  199 (287)
T ss_pred             cCCCCHHHEEE---cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCC
Confidence            99999999999   5777899999999977643321  223457889999999988889999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||.+.+
T Consensus       200 pf~~~~  205 (287)
T cd07848         200 LFPGES  205 (287)
T ss_pred             CCCCCC
Confidence            998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=206.67  Aligned_cols=158  Identities=34%  Similarity=0.550  Sum_probs=140.1

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+.+|+++++.++||||+++.+.+..++..++||||+.+++|.+++.+.  ..+++..+..++.|+  |+++||+.|++
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  124 (285)
T cd05605          45 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV  124 (285)
T ss_pred             HHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence            45678999999999999999999999999999999999999999888654  358999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |+||+|+||++   +..+.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|++++|+.||
T Consensus       125 H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf  201 (285)
T cd05605         125 YRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF  201 (285)
T ss_pred             ecCCCHHHEEE---CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCC
Confidence            99999999999   567789999999988765444334456788999999998888999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       202 ~~~~~  206 (285)
T cd05605         202 RQRKE  206 (285)
T ss_pred             CCCch
Confidence            87543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.4e-33  Score=211.42  Aligned_cols=160  Identities=34%  Similarity=0.573  Sum_probs=141.4

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc-
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH-   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~-   83 (175)
                      ......+.+|++++++++||||+++++++.+++..++||||+++++|.+++.+.+.+++..+..++.++  +++|||+. 
T Consensus        44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  123 (333)
T cd06650          44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH  123 (333)
T ss_pred             HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence            345567899999999999999999999999999999999999999999999988889999999999998  99999985 


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +++|+||+|+||++   +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|+++|++++|+
T Consensus       124 ~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~  199 (333)
T cd06650         124 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR  199 (333)
T ss_pred             CEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhhc-cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            79999999999999   567789999999987653322 23345788999999998888999999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||...+
T Consensus       200 ~p~~~~~  206 (333)
T cd06650         200 YPIPPPD  206 (333)
T ss_pred             CCCCCcc
Confidence            9997654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.4e-34  Score=212.85  Aligned_cols=158  Identities=37%  Similarity=0.684  Sum_probs=136.0

Q ss_pred             hhhHHHHHHHH---hhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527           10 KSCLDCELNFL---SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus        10 ~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ...+..|.+++   +.++||||+++++++...+..++||||+.|++|..++. .+.+++..+..++.|+  |+++||+.|
T Consensus        43 ~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~  121 (324)
T cd05589          43 VESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENK  121 (324)
T ss_pred             HHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34566676665   45689999999999999999999999999999998876 3579999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      ++|+||+|+||++   +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|+
T Consensus       122 ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~  198 (324)
T cd05589         122 IVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE  198 (324)
T ss_pred             eEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCC
Confidence            9999999999999   5778899999998865432 22233456789999999998888999999999999999999999


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||.+.+.
T Consensus       199 ~pf~~~~~  206 (324)
T cd05589         199 SPFPGDDE  206 (324)
T ss_pred             CCCCCCCH
Confidence            99987653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-33  Score=211.71  Aligned_cols=157  Identities=30%  Similarity=0.563  Sum_probs=134.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ..++.+|+++++.++||||+++.+++...     ...++||||+ +++|.+++.+...+++..+..++.|+  ||+|||+
T Consensus        43 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  121 (338)
T cd07859          43 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT  121 (338)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH
Confidence            44678899999999999999999887543     3579999999 56999999888889999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC----ccccccCCCCccCcccccc--cCCCcchhHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAIL  156 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slg~~~  156 (175)
                      .|++|+||||+||++   +.++.++|+|||++.......    ......++..|+|||.+.+  ..++.++|+||+|+++
T Consensus       122 ~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl  198 (338)
T cd07859         122 ANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF  198 (338)
T ss_pred             CCeecCCCCHHHeEE---CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHH
Confidence            999999999999999   677889999999987543221    1123467889999999865  5789999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030527          157 FELLNGYPPFSVGE  170 (175)
Q Consensus       157 ~~~~~g~~pf~~~~  170 (175)
                      ++|++|+.||.+.+
T Consensus       199 ~el~tg~~pf~~~~  212 (338)
T cd07859         199 AEVLTGKPLFPGKN  212 (338)
T ss_pred             HHHHcCCCCCCCCC
Confidence            99999999997654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-33  Score=211.51  Aligned_cols=157  Identities=33%  Similarity=0.577  Sum_probs=138.0

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+..|.++++.+ .||+|+++.+++...+..++||||+.+++|.+++.+...+++..+..++.|+  ||++||+.|++
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  127 (332)
T cd05614          48 VEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIV  127 (332)
T ss_pred             HHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence            34567899999999 5999999999999999999999999999999999888889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC--ccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      ||||||+||++   +.++.++|+|||++.......  ......|+..|+|||.+.+. .++.++|+||+|+++++|++|+
T Consensus       128 HrDlkp~Nili---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~  204 (332)
T cd05614         128 YRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA  204 (332)
T ss_pred             ecCCCHHHeEE---CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence            99999999999   567789999999987653332  22245688999999998765 4788999999999999999999


Q ss_pred             CCCCCC
Q 030527          164 PPFSVG  169 (175)
Q Consensus       164 ~pf~~~  169 (175)
                      .||...
T Consensus       205 ~pf~~~  210 (332)
T cd05614         205 SPFTLE  210 (332)
T ss_pred             CCCCCC
Confidence            999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=220.74  Aligned_cols=165  Identities=34%  Similarity=0.643  Sum_probs=155.1

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      +..+..-+..|-+++.+++.|.||+++-.|.+++..|++||-|.||.++..+.+++.+++.++..+...+  |++|||++
T Consensus       460 dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k  539 (732)
T KOG0614|consen  460 DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK  539 (732)
T ss_pred             chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc
Confidence            4444555677999999999999999999999999999999999999999999999999999999998887  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      |+|++|+||+|+++   +.++.+||.|||+|++..++..+.+..||+.|+|||++..+....++|.||||++++|+++|.
T Consensus       540 ~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~  616 (732)
T KOG0614|consen  540 GIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGS  616 (732)
T ss_pred             CceeccCChhheee---ccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCC
Confidence            99999999999999   789999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCccC
Q 030527          164 PPFSVGEEHQ  173 (175)
Q Consensus       164 ~pf~~~~~~~  173 (175)
                      +||++.++..
T Consensus       617 pPFs~~dpmk  626 (732)
T KOG0614|consen  617 PPFSGVDPMK  626 (732)
T ss_pred             CCCCCCchHH
Confidence            9999988753

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-34  Score=213.81  Aligned_cols=168  Identities=36%  Similarity=0.691  Sum_probs=152.6

Q ss_pred             cchhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHH
Q 030527            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ++.-....+.+|++-++.++|||||.++++...+..+|+|.|+-.+|+|.+|+-+. ..+.++.+..++.||  |+.|||
T Consensus        56 lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH  135 (864)
T KOG4717|consen   56 LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH  135 (864)
T ss_pred             cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh
Confidence            34555667888999999999999999999999999999999999999999999776 469999999999999  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCC-cchhHHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELL  160 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slg~~~~~~~  160 (175)
                      +..+||+|+||+|+.|.  .+-+-++|.|||++..+.++....+..|+..|.|||++.+..|. ++.||||||+++|-+.
T Consensus       136 qLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLV  213 (864)
T KOG4717|consen  136 QLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLV  213 (864)
T ss_pred             hhhhhcccCCcceeEEe--eecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHH
Confidence            99999999999999886  67788999999999999999988899999999999999988875 6899999999999999


Q ss_pred             hCCCCCCCCCccCC
Q 030527          161 NGYPPFSVGEEHQF  174 (175)
Q Consensus       161 ~g~~pf~~~~~~~~  174 (175)
                      +|++||....+.+.
T Consensus       214 CGq~PFqeANDSET  227 (864)
T KOG4717|consen  214 CGQPPFQEANDSET  227 (864)
T ss_pred             hCCCccccccchhh
Confidence            99999987655543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-33  Score=209.90  Aligned_cols=159  Identities=33%  Similarity=0.570  Sum_probs=133.5

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeC-CeEEEEEeccCCCChHHHHHhc--------------------------
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH--------------------------   60 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--------------------------   60 (175)
                      ....+.+|+++++.+ +||||+++++++... +..+++|||+++++|.+++...                          
T Consensus        53 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  132 (338)
T cd05102          53 EHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR  132 (338)
T ss_pred             HHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhc
Confidence            345688899999999 899999999987754 4689999999999999998753                          


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCC
Q 030527           61 ------------------------------------GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDD  102 (175)
Q Consensus        61 ------------------------------------~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~  102 (175)
                                                          ..++...+..++.|+  ||+|||+.|++|+||||+||++   +.
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~  209 (338)
T cd05102         133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SE  209 (338)
T ss_pred             cccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cC
Confidence                                                136777888899998  9999999999999999999999   56


Q ss_pred             CceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 030527          103 DVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGE  170 (175)
Q Consensus       103 ~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g~~pf~~~~  170 (175)
                      ++.++|+|||++........   .....++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+..
T Consensus       210 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~  281 (338)
T cd05102         210 NNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  281 (338)
T ss_pred             CCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence            77899999999976533221   122334577999999988889999999999999999997 999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.6e-33  Score=206.73  Aligned_cols=157  Identities=22%  Similarity=0.322  Sum_probs=137.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEee----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH-
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-   82 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~-   82 (175)
                      ...+.+|++++++++||||+++++++.+    ....+++|||+++++|.+++.+...++......++.++  +++++|+ 
T Consensus        62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~  141 (283)
T PHA02988         62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY  141 (283)
T ss_pred             HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc
Confidence            4667899999999999999999999876    45789999999999999999988889999999999998  9999998 


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc--cCCCcchhHHHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slg~~~~~~~  160 (175)
                      .+++|+||+|+|+++   +.++.++++|||++.......  ....++..|+|||.+.+  ..++.++|+||||+++|+++
T Consensus       142 ~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~  216 (283)
T PHA02988        142 TNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF  216 (283)
T ss_pred             CCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH
Confidence            599999999999999   577889999999987654332  23456788999999875  67899999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030527          161 NGYPPFSVGEE  171 (175)
Q Consensus       161 ~g~~pf~~~~~  171 (175)
                      +|+.||.+.+.
T Consensus       217 ~g~~Pf~~~~~  227 (283)
T PHA02988        217 TGKIPFENLTT  227 (283)
T ss_pred             HCCCCCCCCCH
Confidence            99999987654

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.4e-33  Score=210.59  Aligned_cols=158  Identities=35%  Similarity=0.666  Sum_probs=138.5

Q ss_pred             hhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ..+..|.+++..+ .|++++++.+++...+..++||||++|++|.+++.+.+.+++.++..++.|+  |+++||+.|++|
T Consensus        45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH  124 (323)
T cd05615          45 ECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIY  124 (323)
T ss_pred             HHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            4566788888888 4678889999999999999999999999999999988889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||
T Consensus       125 rDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf  201 (323)
T cd05615         125 RDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF  201 (323)
T ss_pred             cCCCHHHeEE---CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCC
Confidence            9999999999   577789999999987543322 233455789999999998888999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.++
T Consensus       202 ~~~~~  206 (323)
T cd05615         202 DGEDE  206 (323)
T ss_pred             CCCCH
Confidence            87654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.9e-34  Score=214.75  Aligned_cols=159  Identities=35%  Similarity=0.604  Sum_probs=140.0

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|..+++.++||+|+++.+++.+.+..++||||+++++|.+++.+. ..+++..+..++.|+  ||++||+.|+
T Consensus        44 ~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i  123 (330)
T cd05601          44 TVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY  123 (330)
T ss_pred             HHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4456788999999999999999999999999999999999999999999876 679999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCccccc------ccCCCcchhHHHHHHHHH
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~------~~~~~~~~Di~slg~~~~  157 (175)
                      +|+||+|+||++   +..+.++|+|||++........  .....++..|+|||.+.      ...++.++|+||+|+++|
T Consensus       124 ~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~  200 (330)
T cd05601         124 VHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY  200 (330)
T ss_pred             EcccCchHheEE---CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceee
Confidence            999999999999   5778899999999987654332  22346788999999986      455788999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 030527          158 ELLNGYPPFSVGE  170 (175)
Q Consensus       158 ~~~~g~~pf~~~~  170 (175)
                      +|++|+.||...+
T Consensus       201 el~~g~~Pf~~~~  213 (330)
T cd05601         201 EMIYGRSPFHEGT  213 (330)
T ss_pred             eeccCCCCCCCCC
Confidence            9999999997654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=219.69  Aligned_cols=156  Identities=33%  Similarity=0.612  Sum_probs=144.1

Q ss_pred             HHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCC
Q 030527           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLK   91 (175)
Q Consensus        14 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~   91 (175)
                      +.++.=|+.|+||||..+.++|.....+|+|||||..|-|...++....++......|.++|  ++.|||...|||+|+|
T Consensus       160 ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLK  239 (904)
T KOG4721|consen  160 ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLK  239 (904)
T ss_pred             hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccC
Confidence            45788899999999999999999999999999999999999999998899999999999999  9999999999999999


Q ss_pred             CCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527           92 PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus        92 ~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      .-||++   ..+..+||+|||-++....-.+.-...||..|||||+++..+-+.+.||||||+++|||+||..||.+-+.
T Consensus       240 SPNiLI---s~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds  316 (904)
T KOG4721|consen  240 SPNILI---SYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS  316 (904)
T ss_pred             CCceEe---eccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence            999999   46778999999988877666666678899999999999999999999999999999999999999987654


Q ss_pred             c
Q 030527          172 H  172 (175)
Q Consensus       172 ~  172 (175)
                      .
T Consensus       317 s  317 (904)
T KOG4721|consen  317 S  317 (904)
T ss_pred             h
Confidence            3

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=209.99  Aligned_cols=159  Identities=33%  Similarity=0.653  Sum_probs=138.4

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ..+.+.+|..+++.++|++|+++.+++.+.+..++||||+.|++|.+++.+. ..+++..+..++.|+  +|++||++|+
T Consensus        44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  123 (331)
T cd05597          44 ETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY  123 (331)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3455788999999999999999999999999999999999999999999864 579999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccc-----cCCCcchhHHHHHHHHHH
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slg~~~~~  158 (175)
                      +|+||+|+||++   +.++.++|+|||++........  .....+++.|+|||.+..     ..++.++|+||+|+++|+
T Consensus       124 vH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~e  200 (331)
T cd05597         124 VHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE  200 (331)
T ss_pred             EECCCCHHHEEE---CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHH
Confidence            999999999999   5778899999999876644322  223457899999999863     346889999999999999


Q ss_pred             HHhCCCCCCCCC
Q 030527          159 LLNGYPPFSVGE  170 (175)
Q Consensus       159 ~~~g~~pf~~~~  170 (175)
                      |++|+.||.+.+
T Consensus       201 l~~g~~Pf~~~~  212 (331)
T cd05597         201 MLYGETPFYAES  212 (331)
T ss_pred             HhhCCCCCCCCC
Confidence            999999997654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-33  Score=213.09  Aligned_cols=155  Identities=26%  Similarity=0.418  Sum_probs=136.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      +..+.+|++++++++||||+++.+++...+..+++++++ +++|..++.....++...+..++.|+  ||+|||+.|++|
T Consensus       127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvH  205 (391)
T PHA03212        127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIH  205 (391)
T ss_pred             hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            456788999999999999999999999999999999998 57899998887889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCC--CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +||||+||++   +..+.++|+|||++......  .......|++.|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus       206 rDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  282 (391)
T PHA03212        206 RDIKAENIFI---NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS  282 (391)
T ss_pred             CCCChHhEEE---cCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            9999999999   56778999999998654322  122234689999999999888899999999999999999999988


Q ss_pred             CCC
Q 030527          166 FSV  168 (175)
Q Consensus       166 f~~  168 (175)
                      |-.
T Consensus       283 ~~~  285 (391)
T PHA03212        283 LFE  285 (391)
T ss_pred             cCC
Confidence            754

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.3e-33  Score=207.56  Aligned_cols=155  Identities=33%  Similarity=0.544  Sum_probs=133.4

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ..+.+|+++++.++||||+++.+++.+....++||||+. ++|.+++.+. +.+++..+..++.|+  ||++||+.|++|
T Consensus        48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH  126 (303)
T cd07869          48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILH  126 (303)
T ss_pred             hhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            356789999999999999999999999999999999994 6888877654 568999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +||||+||++   +..+.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.|
T Consensus       127 ~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  203 (303)
T cd07869         127 RDLKPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA  203 (303)
T ss_pred             CCCCHHHEEE---CCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999   56778999999998755332 22234557888999998865 4578899999999999999999999


Q ss_pred             CCCC
Q 030527          166 FSVG  169 (175)
Q Consensus       166 f~~~  169 (175)
                      |.+.
T Consensus       204 f~~~  207 (303)
T cd07869         204 FPGM  207 (303)
T ss_pred             CCCC
Confidence            9764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.8e-33  Score=210.67  Aligned_cols=158  Identities=34%  Similarity=0.663  Sum_probs=137.8

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|..++..++|++|+++.+.+.+.+..++||||+++++|.+++.+. ..+++..+..++.|+  ++++||+.|++
T Consensus        45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ii  124 (332)
T cd05623          45 TACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV  124 (332)
T ss_pred             HHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            345788999999999999999999999999999999999999999999874 678999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCccccc-----ccCCCcchhHHHHHHHHHHH
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~~~  159 (175)
                      |+||||+||++   +.++.++|+|||++........  .....|++.|+|||.+.     ...++.++|+||+|+++|+|
T Consensus       125 HrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~el  201 (332)
T cd05623         125 HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM  201 (332)
T ss_pred             ecCCCHHHEEE---CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHH
Confidence            99999999999   5778899999999876543322  22356899999999885     34578899999999999999


Q ss_pred             HhCCCCCCCCC
Q 030527          160 LNGYPPFSVGE  170 (175)
Q Consensus       160 ~~g~~pf~~~~  170 (175)
                      ++|+.||.+.+
T Consensus       202 l~g~~Pf~~~~  212 (332)
T cd05623         202 LYGETPFYAES  212 (332)
T ss_pred             hcCCCCCCCCC
Confidence            99999998654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-33  Score=211.37  Aligned_cols=158  Identities=33%  Similarity=0.657  Sum_probs=138.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|..+++.++|++|+++.+++.+.+..++||||++|++|.+++.+. ..+++..+..++.|+  +|++||+.|++
T Consensus        45 ~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~ii  124 (331)
T cd05624          45 TACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV  124 (331)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            445778999999999999999999999999999999999999999999874 678999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccc-----cCCCcchhHHHHHHHHHHH
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slg~~~~~~  159 (175)
                      |+||||+||++   +.++.++|+|||++........  .....|+..|+|||.+.+     ..++.++|+||+|+++|+|
T Consensus       125 HrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~el  201 (331)
T cd05624         125 HRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM  201 (331)
T ss_pred             eccCchHHEEE---cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhh
Confidence            99999999999   5777899999999877654332  223468899999998865     4578899999999999999


Q ss_pred             HhCCCCCCCCC
Q 030527          160 LNGYPPFSVGE  170 (175)
Q Consensus       160 ~~g~~pf~~~~  170 (175)
                      ++|+.||.+.+
T Consensus       202 l~g~~Pf~~~~  212 (331)
T cd05624         202 LYGETPFYAES  212 (331)
T ss_pred             hhCCCCccCCC
Confidence            99999997654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-34  Score=205.87  Aligned_cols=159  Identities=38%  Similarity=0.600  Sum_probs=138.9

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEee-----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      .-++-.+|+.+++.++|+||+.+.+.+..     -+..|+|+|++ +.+|.+.++.+..+++..+...+.|+  +|+|+|
T Consensus        64 ~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH  142 (359)
T KOG0660|consen   64 DAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH  142 (359)
T ss_pred             HHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh
Confidence            34456789999999999999999998865     35789999999 78999999988789999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC---CccccccCCCCccCccccc-ccCCCcchhHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~~~  157 (175)
                      +.|++|||+||+|+++   +.+..+|+||||+|+...+.   ........|++|.|||+.. ...|+.+.|+||.||+++
T Consensus       143 SAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~A  219 (359)
T KOG0660|consen  143 SANVIHRDLKPSNLLL---NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILA  219 (359)
T ss_pred             cccccccccchhheee---ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHH
Confidence            9999999999999999   67788999999999988642   2223456789999999875 567999999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030527          158 ELLNGYPPFSVGEE  171 (175)
Q Consensus       158 ~~~~g~~pf~~~~~  171 (175)
                      ||++|++.|.+.+.
T Consensus       220 EmL~gkplFpG~d~  233 (359)
T KOG0660|consen  220 EMLTGKPLFPGKDY  233 (359)
T ss_pred             HHHcCCCCCCCCch
Confidence            99999999998764

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-34  Score=203.52  Aligned_cols=164  Identities=35%  Similarity=0.581  Sum_probs=143.1

Q ss_pred             chhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ..+.+.++-+|++++.++ .|+||+++++||+++..+|+|||-+.||+|.+++++...+.+.++..+.+++  ||.+||.
T Consensus       115 ~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~  194 (463)
T KOG0607|consen  115 PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHT  194 (463)
T ss_pred             CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh
Confidence            556788999999999999 7999999999999999999999999999999999999999999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC--------ccccccCCCCccCccccc-----ccCCCcchhH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDM  149 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di  149 (175)
                      +||.|+|+||+||+....+.-..+|||||.+.....-..        ..-++.|+..|||||+..     ...|+.+.|.
T Consensus       195 kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDl  274 (463)
T KOG0607|consen  195 KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDL  274 (463)
T ss_pred             cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccH
Confidence            999999999999999766666679999998775432111        112567888899999863     3358999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCC
Q 030527          150 WSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus       150 ~slg~~~~~~~~g~~pf~~~  169 (175)
                      ||||+++|-|++|++||.+.
T Consensus       275 wSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  275 WSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             HHHHHHHHHHHhCCCCccCc
Confidence            99999999999999999765

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.4e-33  Score=197.03  Aligned_cols=161  Identities=35%  Similarity=0.525  Sum_probs=142.3

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      +-......+|+..|+.++|+||+.++++|...+...+|+||+ ..+|...++.. ..++...+..++.++  +++|||++
T Consensus        42 dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~  120 (318)
T KOG0659|consen   42 DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK  120 (318)
T ss_pred             cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh
Confidence            334556788999999999999999999999999999999999 56999998865 468999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc-cccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHh
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~  161 (175)
                      .++|||+||.|+++   +.++.+|+.|||+|+...+..... ...-|++|.|||.+.|. .|+...|+||.||++.|++-
T Consensus       121 ~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELll  197 (318)
T KOG0659|consen  121 WILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLL  197 (318)
T ss_pred             hhhcccCCccceEE---cCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHc
Confidence            99999999999999   688999999999999887654332 23568999999999765 59999999999999999999


Q ss_pred             CCCCCCCCCc
Q 030527          162 GYPPFSVGEE  171 (175)
Q Consensus       162 g~~pf~~~~~  171 (175)
                      +.+-|.+.++
T Consensus       198 r~P~fpG~sD  207 (318)
T KOG0659|consen  198 RVPFFPGDSD  207 (318)
T ss_pred             cCCCCCCCch
Confidence            9999988765

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-33  Score=205.00  Aligned_cols=161  Identities=33%  Similarity=0.571  Sum_probs=141.1

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      .+.+.|.+||+.+.||.++.++..++.+...|++||||+||+|..+++++.  .+++..+..+++++  ||+|||..|||
T Consensus       122 ~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGiv  201 (459)
T KOG0610|consen  122 KRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIV  201 (459)
T ss_pred             HHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhcee
Confidence            456779999999999999999999999999999999999999999998773  59999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCC--------------------------------C-c-----------
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------------------------------N-Y-----------  122 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~--------------------------------~-~-----------  122 (175)
                      +||+||+||++   ..++.+.|+||.++.+....                                . .           
T Consensus       202 YRDLKPENILv---redGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~  278 (459)
T KOG0610|consen  202 YRDLKPENILV---REDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASR  278 (459)
T ss_pred             eccCCcceeEE---ecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccc
Confidence            99999999999   68999999999987433110                                0 0           


Q ss_pred             -------------cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCC
Q 030527          123 -------------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF  174 (175)
Q Consensus       123 -------------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~~~~  174 (175)
                                   .....||-.|+|||++.+...+.+.|=|+||+++|||+.|.-||.+...++.
T Consensus       279 ~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T  343 (459)
T KOG0610|consen  279 SLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET  343 (459)
T ss_pred             cchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh
Confidence                         0123466779999999999999999999999999999999999999877654

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-34  Score=211.66  Aligned_cols=156  Identities=34%  Similarity=0.640  Sum_probs=132.0

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      .++.+|+.++++|.|||||+++++..+  .+.+|+|+|||..|.+...-..+..+++.+++.++.++  +|.|||.+|++
T Consensus       153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qgii  232 (576)
T KOG0585|consen  153 EKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGII  232 (576)
T ss_pred             HHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCee
Confidence            477889999999999999999999876  45899999999888876533322338999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC------ccccccCCCCccCcccccccC----CCcchhHHHHHHHH
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAIL  156 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slg~~~  156 (175)
                      ||||||+|+++   +.++++||+|||.+.....+.      .-....||+.|+|||...+..    -+.+.|+||+|+++
T Consensus       233 HRDIKPsNLLl---~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTL  309 (576)
T KOG0585|consen  233 HRDIKPSNLLL---SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTL  309 (576)
T ss_pred             ccccchhheEE---cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhH
Confidence            99999999999   577999999999998763321      223477999999999987532    36689999999999


Q ss_pred             HHHHhCCCCCCCC
Q 030527          157 FELLNGYPPFSVG  169 (175)
Q Consensus       157 ~~~~~g~~pf~~~  169 (175)
                      |.++.|+.||-+.
T Consensus       310 YCllfG~~PF~~~  322 (576)
T KOG0585|consen  310 YCLLFGQLPFFDD  322 (576)
T ss_pred             HHhhhccCCcccc
Confidence            9999999999764

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.1e-33  Score=212.50  Aligned_cols=156  Identities=29%  Similarity=0.467  Sum_probs=138.4

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      ....+|++++++++||||+++++++...+..+++|+++ +++|.+++...+.+++..+..++.|+  ||++||++|++|+
T Consensus       131 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHr  209 (392)
T PHA03207        131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHR  209 (392)
T ss_pred             ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            34578999999999999999999999999999999998 56899999777889999999999998  9999999999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      ||||+||++   +..+.++|+|||++........   .....++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus       210 Dlkp~Nill---~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~p  286 (392)
T PHA03207        210 DVKTENIFL---DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT  286 (392)
T ss_pred             CCCHHHEEE---cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            999999999   5778899999999876654322   2234678999999999988899999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |.+..
T Consensus       287 f~~~~  291 (392)
T PHA03207        287 LFGKQ  291 (392)
T ss_pred             CCCCC
Confidence            97654

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=199.28  Aligned_cols=157  Identities=33%  Similarity=0.659  Sum_probs=139.4

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      ..+.+|++++++++||||+++++++.+....++++|++++++|.+++.+.+.+++..+..++.|+  ++++||+.|++|+
T Consensus        49 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~  128 (263)
T cd06625          49 NALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR  128 (263)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            46788999999999999999999999999999999999999999999988889999999999998  9999999999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeeccCCCcc----ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      ||+|+||++   +.++.++|+|||.+.........    ....++..|+|||.+.+..++.++|+||+|+++|++++|+.
T Consensus       129 dl~p~nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  205 (263)
T cd06625         129 DIKGANILR---DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP  205 (263)
T ss_pred             CCCHHHEEE---cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCC
Confidence            999999999   56778999999998765432211    22346778999999998889999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||...+
T Consensus       206 p~~~~~  211 (263)
T cd06625         206 PWAEFE  211 (263)
T ss_pred             Cccccc
Confidence            997643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.4e-33  Score=201.39  Aligned_cols=154  Identities=35%  Similarity=0.527  Sum_probs=136.8

Q ss_pred             HHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           14 DCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        14 ~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      .+|+.+|.+++|||||.+.++....  +.+|+||||+ ..+|...+...+ ++...++..+..|+  +++|||+..++||
T Consensus       123 LREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHR  201 (419)
T KOG0663|consen  123 LREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHR  201 (419)
T ss_pred             HHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEec
Confidence            6799999999999999999887654  4799999999 679999998775 79999999999998  9999999999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeeccCCCcc-ccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |+|++|+++   ...+.++++|||+|+.++.+... ....-|.+|.|||.+.+. .|+.+.|+||+||++.|++++++.|
T Consensus       202 DLK~SNLLm---~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf  278 (419)
T KOG0663|consen  202 DLKTSNLLL---SHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF  278 (419)
T ss_pred             ccchhheee---ccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC
Confidence            999999999   57888999999999999877432 234458999999998765 4999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.++
T Consensus       279 ~G~sE  283 (419)
T KOG0663|consen  279 PGKSE  283 (419)
T ss_pred             CCCch
Confidence            98765

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-34  Score=216.86  Aligned_cols=164  Identities=30%  Similarity=0.518  Sum_probs=143.1

Q ss_pred             cchhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHH
Q 030527            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      +......++.+|++++++++||||++++|+......+++|||+|.||+|.+++++.+ .++..+...++.+.  +++|||
T Consensus       200 ~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh  279 (474)
T KOG0194|consen  200 LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH  279 (474)
T ss_pred             ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH
Confidence            346678889999999999999999999999999999999999999999999999987 49999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc-cccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      +++++||||-++|+++   +.+..++++|||+++....-.... ...-...|+|||.+...-++.++||||+|+++||++
T Consensus       280 ~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif  356 (474)
T KOG0194|consen  280 SKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF  356 (474)
T ss_pred             HCCCcchhHhHHHhee---cCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeee
Confidence            9999999999999999   466678999999986654221111 223457899999999889999999999999999999


Q ss_pred             h-CCCCCCCCCc
Q 030527          161 N-GYPPFSVGEE  171 (175)
Q Consensus       161 ~-g~~pf~~~~~  171 (175)
                      + |..||.+-..
T Consensus       357 ~~g~~Py~g~~~  368 (474)
T KOG0194|consen  357 ENGAEPYPGMKN  368 (474)
T ss_pred             ccCCCCCCCCCH
Confidence            9 7889987653

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6e-33  Score=200.66  Aligned_cols=156  Identities=37%  Similarity=0.614  Sum_probs=138.3

Q ss_pred             hHHHHHHHHhhCCCCC-eeeEeeEEeeCC------eEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHH--HHH
Q 030527           12 CLDCELNFLSSVNHPN-IIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQL--GLE   78 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i--~l~   78 (175)
                      ...+|+.+++.|+|+| |+.+.+++...+      ..++|+|+. ..+|.+++....    .++...+..++.|+  |++
T Consensus        56 taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~  134 (323)
T KOG0594|consen   56 TAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLA  134 (323)
T ss_pred             hhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHH
Confidence            4478999999999999 999999998877      889999998 679999998765    47888999999998  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCccccccc-CCCcchhHHHHHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAIL  156 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~  156 (175)
                      |||+.+++|||+||.|+++   ++.+.+||+|||+|+...-+ ..-.....|.+|.|||.+.+. .|+...|+||+||++
T Consensus       135 ~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIf  211 (323)
T KOG0594|consen  135 FLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIF  211 (323)
T ss_pred             HHHhCCeecccCCcceEEE---CCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHH
Confidence            9999999999999999999   57889999999999877633 334456678999999999876 699999999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030527          157 FELLNGYPPFSVGEE  171 (175)
Q Consensus       157 ~~~~~g~~pf~~~~~  171 (175)
                      +||++++..|++.++
T Consensus       212 aEm~~~~~LFpG~se  226 (323)
T KOG0594|consen  212 AEMFTRRPLFPGDSE  226 (323)
T ss_pred             HHHHhCCCCCCCCcH
Confidence            999999999998765

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-34  Score=198.76  Aligned_cols=161  Identities=36%  Similarity=0.650  Sum_probs=147.6

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--LHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ....+++.+|+++-+.|+||||.+++++|-+....|+++||.++|++...++  +..++++.....++.|+  |+.|+|.
T Consensus        63 ~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~  142 (281)
T KOG0580|consen   63 TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL  142 (281)
T ss_pred             hcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc
Confidence            3446688889999999999999999999999999999999999999999998  55679999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      .+++||||+|+|+++   +..+.+++.|||++.... .....+..||..|++||...+...+...|+|++|++.||++.|
T Consensus       143 k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg  218 (281)
T KOG0580|consen  143 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVG  218 (281)
T ss_pred             CCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhc
Confidence            999999999999999   578889999999987665 5567788999999999999999999999999999999999999


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      .+||...+.
T Consensus       219 ~ppFes~~~  227 (281)
T KOG0580|consen  219 LPPFESQSH  227 (281)
T ss_pred             CCchhhhhh
Confidence            999987653

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-33  Score=221.56  Aligned_cols=164  Identities=28%  Similarity=0.601  Sum_probs=146.9

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------GRVPEQTARKFLQ   73 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~l~~~~~~~~~~   73 (175)
                      +.+.+|++|++++..|+|||||+++|++.+++.+++|+||+..|+|.+++...              .+|+..+...|+.
T Consensus       531 ~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~  610 (774)
T KOG1026|consen  531 QARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIAT  610 (774)
T ss_pred             HHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHH
Confidence            37889999999999999999999999999999999999999999999999532              1288899999999


Q ss_pred             HH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc---cccCCCCccCcccccccCCCcchh
Q 030527           74 QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVD  148 (175)
Q Consensus        74 ~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~D  148 (175)
                      ||  ++.||-+..+||+|+.++|+++   +.+-.|||+|||+++.....+...   ...-..+|||||.+..+.+|.++|
T Consensus       611 QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSD  687 (774)
T KOG1026|consen  611 QIAAGMEYLSSHHFVHRDLATRNCLV---GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESD  687 (774)
T ss_pred             HHHHHHHHHHhCcccccchhhhhcee---ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhh
Confidence            99  8999999999999999999999   588889999999999887665432   334567899999999999999999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCccCC
Q 030527          149 MWSVGAILFELLN-GYPPFSVGEEHQF  174 (175)
Q Consensus       149 i~slg~~~~~~~~-g~~pf~~~~~~~~  174 (175)
                      |||+|+++||+++ |+.||.+-++++.
T Consensus       688 VWs~GVvLWEIFsyG~QPy~glSn~EV  714 (774)
T KOG1026|consen  688 VWSFGVVLWEIFSYGKQPYYGLSNQEV  714 (774)
T ss_pred             hhhhhhhhhhhhccccCcccccchHHH
Confidence            9999999999999 9999988777653

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.2e-32  Score=200.87  Aligned_cols=157  Identities=35%  Similarity=0.572  Sum_probs=139.0

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+.+|++++++++|++++++.+.+...+..+++|||++|++|.+++...+  .+++.++..++.|+  |+++||+.|++
T Consensus        45 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ii  124 (285)
T cd05630          45 SMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV  124 (285)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            456789999999999999999999999999999999999999999886543  58999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |+||+|+||++   +..+.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++++|++|+.||
T Consensus       125 H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf  201 (285)
T cd05630         125 YRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF  201 (285)
T ss_pred             eCCCCHHHEEE---CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence            99999999999   567789999999987665443333456789999999998888999999999999999999999999


Q ss_pred             CCCC
Q 030527          167 SVGE  170 (175)
Q Consensus       167 ~~~~  170 (175)
                      ....
T Consensus       202 ~~~~  205 (285)
T cd05630         202 QQRK  205 (285)
T ss_pred             CCCC
Confidence            8643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.4e-32  Score=200.94  Aligned_cols=157  Identities=40%  Similarity=0.760  Sum_probs=142.0

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|++++++++||||+++++++.+.+..++++||+++++|.+++.+.+.+++..+..++.|+  +|++||+.|++
T Consensus        44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~  123 (290)
T cd05580          44 QVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIV  123 (290)
T ss_pred             HHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            4556788999999999999999999999999999999999999999999988899999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |+||+|+||++   +.++.++|+|||++......  .....++..|+|||...+...+.++|+||+|++++++++|+.||
T Consensus       124 H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  198 (290)
T cd05580         124 YRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF  198 (290)
T ss_pred             cCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            99999999999   56778999999998776544  33445788899999998888899999999999999999999999


Q ss_pred             CCCC
Q 030527          167 SVGE  170 (175)
Q Consensus       167 ~~~~  170 (175)
                      ...+
T Consensus       199 ~~~~  202 (290)
T cd05580         199 FDDN  202 (290)
T ss_pred             CCCC
Confidence            7655

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.9e-32  Score=200.65  Aligned_cols=161  Identities=29%  Similarity=0.574  Sum_probs=139.2

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF   71 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~   71 (175)
                      .....+.+|++.+++++||||+++++++...+..++++||+.+++|.+++.+.                ..++...+..+
T Consensus        50 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  129 (283)
T cd05048          50 KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI  129 (283)
T ss_pred             HHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHH
Confidence            44567899999999999999999999999999999999999999999999765                34788889999


Q ss_pred             HHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcc
Q 030527           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK  146 (175)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~  146 (175)
                      +.|+  |+++||+.|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||.+.+..++.+
T Consensus       130 ~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (283)
T cd05048         130 AIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE  206 (283)
T ss_pred             HHHHHHHHHHHHhCCeeccccccceEEE---cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh
Confidence            9998  9999999999999999999999   5677899999999876543321   223345678999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          147 VDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       147 ~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      +|+||||++++++++ |..||.+.+.
T Consensus       207 sDv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05048         207 SDIWSFGVVLWEIFSYGLQPYYGFSN  232 (283)
T ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999998 9999976544

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8.3e-33  Score=203.22  Aligned_cols=157  Identities=37%  Similarity=0.593  Sum_probs=133.5

Q ss_pred             hhHHHHHHHHhhC---CCCCeeeEeeEEe-----eCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHH
Q 030527           11 SCLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLE   78 (175)
Q Consensus        11 ~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~   78 (175)
                      ..+.+|..+++.+   +||||+++++++.     .....++++|++. ++|.+++.+.  ..+++..+..++.|+  ||+
T Consensus        46 ~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~  124 (290)
T cd07862          46 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD  124 (290)
T ss_pred             HHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH
Confidence            3456677777765   6999999999875     3456899999995 6999998764  358999999999998  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      +||+.|++|+||||+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|+
T Consensus       125 ~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~e  201 (290)
T cd07862         125 FLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE  201 (290)
T ss_pred             HHHHCCeeeCCCCHHHEEE---cCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHH
Confidence            9999999999999999999   5677899999999987655544445567899999999988889999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030527          159 LLNGYPPFSVGEE  171 (175)
Q Consensus       159 ~~~g~~pf~~~~~  171 (175)
                      +++|..||.+.++
T Consensus       202 l~~g~~~f~~~~~  214 (290)
T cd07862         202 MFRRKPLFRGSSD  214 (290)
T ss_pred             HHcCCCCcCCCCH
Confidence            9999999987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.9e-32  Score=199.46  Aligned_cols=158  Identities=35%  Similarity=0.551  Sum_probs=139.5

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+.+|+++++.++|++++++.+.+..++..++++||+.+++|.+++...  ..+++..+..++.|+  ++.+||+.|++
T Consensus        45 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~ii  124 (285)
T cd05632          45 SMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV  124 (285)
T ss_pred             HHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            45678999999999999999999999999999999999999999888654  369999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |+||+|+|+++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|++++++++|..||
T Consensus       125 H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~  201 (285)
T cd05632         125 YRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF  201 (285)
T ss_pred             ecCCCHHHEEE---CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCC
Confidence            99999999999   566789999999987664443333456789999999998888999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+..+
T Consensus       202 ~~~~~  206 (285)
T cd05632         202 RGRKE  206 (285)
T ss_pred             CCCCH
Confidence            87543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-32  Score=207.77  Aligned_cols=159  Identities=30%  Similarity=0.513  Sum_probs=135.7

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc---------------------------
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------------------------   60 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------------------   60 (175)
                      ....+.+|+++++.+ +|+||+++++++...+..++||||+++++|.+++.+.                           
T Consensus        84 ~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (374)
T cd05106          84 EREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLE  163 (374)
T ss_pred             HHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchh
Confidence            345678899999999 8999999999999999999999999999999998643                           


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcE
Q 030527           61 -------------------------------------------GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENI   95 (175)
Q Consensus        61 -------------------------------------------~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni   95 (175)
                                                                 .+++...+..++.|+  ||+|||++|++|+||||+||
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Ni  243 (374)
T cd05106         164 KKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNV  243 (374)
T ss_pred             cccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheE
Confidence                                                       136778889999998  99999999999999999999


Q ss_pred             EEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 030527           96 LLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGE  170 (175)
Q Consensus        96 ~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g~~pf~~~~  170 (175)
                      ++   +.+..++|+|||++........   .....++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||....
T Consensus       244 l~---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~  319 (374)
T cd05106         244 LL---TDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL  319 (374)
T ss_pred             EE---eCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence            99   4677899999999876543321   112234567999999988889999999999999999997 999997654

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.5e-32  Score=196.27  Aligned_cols=163  Identities=30%  Similarity=0.605  Sum_probs=142.7

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      .......+.+|+++++.++|||++++++++.+.+..++++||+++++|.+++...  ..++...+..++.++  ++.+||
T Consensus        39 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH  118 (256)
T cd08529          39 NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH  118 (256)
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3455677889999999999999999999999999999999999999999999764  468899999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      +.|++|+|++|+||++   +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||+++++++
T Consensus       119 ~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  195 (256)
T cd08529         119 SKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECC  195 (256)
T ss_pred             HCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence            9999999999999999   5677899999999876644322 22345678899999998888999999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030527          161 NGYPPFSVGEE  171 (175)
Q Consensus       161 ~g~~pf~~~~~  171 (175)
                      +|+.||...++
T Consensus       196 ~g~~p~~~~~~  206 (256)
T cd08529         196 TGKHPFDANNQ  206 (256)
T ss_pred             hCCCCCCCCCH
Confidence            99999976653

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.4e-32  Score=212.69  Aligned_cols=157  Identities=33%  Similarity=0.552  Sum_probs=130.1

Q ss_pred             hHHHHHHHHhhCCCCCeeeEeeEEeeC--------CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HH
Q 030527           12 CLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GL   77 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l   77 (175)
                      ...+|+.++++++||||+++.+++...        ..+++||||++ +++.+++..    ...+++..+..++.|+  ||
T Consensus       105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL  183 (440)
T PTZ00036        105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL  183 (440)
T ss_pred             hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence            456799999999999999998876432        24679999996 477776642    3569999999999998  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccccc-CCCcchhHHHHHHHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAIL  156 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~  156 (175)
                      +|||+.|++||||||+||++.  ..+..++|+|||+++............+++.|+|||.+.+. .++.++|+||+||++
T Consensus       184 ~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil  261 (440)
T PTZ00036        184 AYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCII  261 (440)
T ss_pred             HHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHH
Confidence            999999999999999999994  23456999999999877555444455678999999988654 689999999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030527          157 FELLNGYPPFSVGEE  171 (175)
Q Consensus       157 ~~~~~g~~pf~~~~~  171 (175)
                      |+|++|++||.+.+.
T Consensus       262 ~elltG~~pf~~~~~  276 (440)
T PTZ00036        262 AEMILGYPIFSGQSS  276 (440)
T ss_pred             HHHHhCCCCCCCCCh
Confidence            999999999987643

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.8e-32  Score=206.23  Aligned_cols=157  Identities=38%  Similarity=0.548  Sum_probs=133.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      .....+.+|+.+++.++||||+++++++...+      ..++||||+. +++.+.+.  ..+++..+..++.|+  ||++
T Consensus        62 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~  138 (359)
T cd07876          62 THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH--MELDHERMSYLLYQMLCGIKH  138 (359)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHh--ccCCHHHHHHHHHHHHHHHHH
Confidence            34556778999999999999999999986543      5799999995 46766654  357888999999998  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      ||+.|++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus       139 LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el  215 (359)
T cd07876         139 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL  215 (359)
T ss_pred             HHhCCcccCCCCHHHEEE---CCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHH
Confidence            999999999999999999   57788999999999765444434445678899999999988999999999999999999


Q ss_pred             HhCCCCCCCCC
Q 030527          160 LNGYPPFSVGE  170 (175)
Q Consensus       160 ~~g~~pf~~~~  170 (175)
                      ++|+.||.+.+
T Consensus       216 ~tg~~pf~~~~  226 (359)
T cd07876         216 VKGSVIFQGTD  226 (359)
T ss_pred             HhCCCCCCCCC
Confidence            99999998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-33  Score=215.46  Aligned_cols=159  Identities=33%  Similarity=0.591  Sum_probs=138.8

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCC------eEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHH--HHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQL--GLE   78 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i--~l~   78 (175)
                      +.+--.|++++++|+|||||++++.=++..      ...++||||.||+|+..+++-   ..|++.+.+.++.++  |++
T Consensus        55 ~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~  134 (732)
T KOG4250|consen   55 RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALR  134 (732)
T ss_pred             HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHH
Confidence            445567999999999999999998855443      458999999999999999743   459999999999999  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecC-CCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL  156 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~  156 (175)
                      +||+.||+||||||.||+..... .....||+|||.|+...++.......||..|++||.... +.++...|.||||+++
T Consensus       135 ~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gvtl  214 (732)
T KOG4250|consen  135 HLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTL  214 (732)
T ss_pred             HHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHH
Confidence            99999999999999999985323 333479999999999999888888999999999999984 7789999999999999


Q ss_pred             HHHHhCCCCCCC
Q 030527          157 FELLNGYPPFSV  168 (175)
Q Consensus       157 ~~~~~g~~pf~~  168 (175)
                      |+++||+.||-.
T Consensus       215 Y~caTG~lPF~p  226 (732)
T KOG4250|consen  215 YECATGELPFIP  226 (732)
T ss_pred             HHHhccCCCCCc
Confidence            999999999953

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=210.18  Aligned_cols=156  Identities=37%  Similarity=0.640  Sum_probs=134.5

Q ss_pred             HHHHHHHHhhC---CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           13 LDCELNFLSSV---NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        13 ~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...|..++..+   +||+|+++.+++...+..++||||+.+++|.+++.+.+.+++..+..++.|+  |++|||+.|++|
T Consensus        40 ~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivH  119 (330)
T cd05586          40 TIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVY  119 (330)
T ss_pred             HHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            34456666654   7999999999999999999999999999999999988899999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +||||+||++   +.++.++|+|||++...... .......|+..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       120 rDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~P  196 (330)
T cd05586         120 RDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP  196 (330)
T ss_pred             ccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCC
Confidence            9999999999   56778999999998754332 223345688999999998654 478999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.+.
T Consensus       197 f~~~~~  202 (330)
T cd05586         197 FYAEDT  202 (330)
T ss_pred             CCCCCH
Confidence            987653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.8e-32  Score=201.78  Aligned_cols=160  Identities=28%  Similarity=0.539  Sum_probs=135.5

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-------------------CCCHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------------RVPEQTA   68 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~l~~~~~   68 (175)
                      ..+..+.+|++++++++||||+++++++.+.+..++++||+.+++|.+++....                   .++...+
T Consensus        61 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (304)
T cd05096          61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSL  140 (304)
T ss_pred             HHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHH
Confidence            345678899999999999999999999999999999999999999999986432                   3567788


Q ss_pred             HHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCC
Q 030527           69 RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY  143 (175)
Q Consensus        69 ~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~  143 (175)
                      ..++.|+  |+++||+.|++|+||||+||++   +.++.++|+|||++........   .....++..|+|||.+.+..+
T Consensus       141 ~~i~~~i~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  217 (304)
T cd05096         141 LHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF  217 (304)
T ss_pred             HHHHHHHHHHHHHHHHCCccccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC
Confidence            8999998  9999999999999999999999   5678899999999876644321   223334678999999988889


Q ss_pred             CcchhHHHHHHHHHHHHh--CCCCCCCCC
Q 030527          144 DEKVDMWSVGAILFELLN--GYPPFSVGE  170 (175)
Q Consensus       144 ~~~~Di~slg~~~~~~~~--g~~pf~~~~  170 (175)
                      +.++|+||||++++++++  +..||...+
T Consensus       218 ~~~~Dv~slG~~l~el~~~~~~~p~~~~~  246 (304)
T cd05096         218 TTASDVWAFGVTLWEILMLCKEQPYGELT  246 (304)
T ss_pred             CchhhhHHHHHHHHHHHHccCCCCCCcCC
Confidence            999999999999999986  567886543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-33  Score=212.50  Aligned_cols=164  Identities=41%  Similarity=0.766  Sum_probs=150.9

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      +...++.+.+|+++++.|+||||++++.+......+|+||||..++.+.+++.+.+.+.+..+..++.|+  |++|||++
T Consensus        95 n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k  174 (596)
T KOG0586|consen   95 NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK  174 (596)
T ss_pred             ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc
Confidence            3444566788999999999999999999999999999999999999999999999999999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHhC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~g  162 (175)
                      +++|+|+|++|+++   +.+-.++|+|||++..+..+....+..|++.|.|||+..+.++ ++..|+||+|+++|.+..|
T Consensus       175 ~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~G  251 (596)
T KOG0586|consen  175 NIVHRDLKAENILL---DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEG  251 (596)
T ss_pred             ceeccccchhhccc---ccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeec
Confidence            99999999999999   5677799999999999988888888999999999999988776 6789999999999999999


Q ss_pred             CCCCCCCCcc
Q 030527          163 YPPFSVGEEH  172 (175)
Q Consensus       163 ~~pf~~~~~~  172 (175)
                      .+||++.+-.
T Consensus       252 sLPFDG~~lk  261 (596)
T KOG0586|consen  252 SLPFDGQNLK  261 (596)
T ss_pred             ccccCCcccc
Confidence            9999987543

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.5e-32  Score=201.21  Aligned_cols=160  Identities=34%  Similarity=0.582  Sum_probs=141.2

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH-c
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-H   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~-~   83 (175)
                      .....++.+|++++++++||||+++++.+..++..++++||+++++|.+++.+.+.+++..+..++.|+  +++|||+ .
T Consensus        40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  119 (308)
T cd06615          40 PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH  119 (308)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence            344567888999999999999999999999999999999999999999999988889999999999998  9999997 5


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +++|+||+|+||++   +.++.++|+|||.+....... .....++..|+|||...+..++.++|+||+|++++++++|.
T Consensus       120 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~  195 (308)
T cd06615         120 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR  195 (308)
T ss_pred             CEEECCCChHHEEE---ecCCcEEEccCCCcccccccc-cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCC
Confidence            89999999999999   467789999999886653332 23445788999999998888999999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||...+
T Consensus       196 ~p~~~~~  202 (308)
T cd06615         196 YPIPPPD  202 (308)
T ss_pred             CCCCCcc
Confidence            9997544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.7e-32  Score=199.45  Aligned_cols=161  Identities=24%  Similarity=0.444  Sum_probs=137.7

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+.+|+..+++++||||+++.+++..++..++||||+++++|.+++.+. ..+++..+..++.|+  |+++||+.|
T Consensus        48 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~  127 (266)
T cd05064          48 KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG  127 (266)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34457888999999999999999999999999999999999999999999875 578999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  161 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-  161 (175)
                      ++|+||+|+|+++   +.++.++++|||.+.........  ....++..|+|||.+.+..++.++|+||+|++++++++ 
T Consensus       128 iiH~dikp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~  204 (266)
T cd05064         128 YVHKGLAAHKVLV---NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSY  204 (266)
T ss_pred             EeeccccHhhEEE---cCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcC
Confidence            9999999999999   56778999999977654332211  12233567999999988889999999999999999775 


Q ss_pred             CCCCCCCCCc
Q 030527          162 GYPPFSVGEE  171 (175)
Q Consensus       162 g~~pf~~~~~  171 (175)
                      |..||.+.+.
T Consensus       205 g~~p~~~~~~  214 (266)
T cd05064         205 GERPYWDMSG  214 (266)
T ss_pred             CCCCcCcCCH
Confidence            9999976543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.9e-32  Score=200.37  Aligned_cols=161  Identities=26%  Similarity=0.609  Sum_probs=138.7

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------RVPEQTARKFLQQ   74 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~~~~~   74 (175)
                      .....+.+|++++++++|||++++++++...+..++++||+++++|.+++...+             .+++.++..++.|
T Consensus        49 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  128 (288)
T cd05093          49 NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ  128 (288)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHH
Confidence            345678899999999999999999999999999999999999999999987543             3899999999999


Q ss_pred             H--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhH
Q 030527           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM  149 (175)
Q Consensus        75 i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di  149 (175)
                      +  |+++||+.|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||.+.+..++.++|+
T Consensus       129 l~~aL~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi  205 (288)
T cd05093         129 IAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV  205 (288)
T ss_pred             HHHHHHHHHhCCeeecccCcceEEE---ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhH
Confidence            8  9999999999999999999999   5677899999999876543321   122334567999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCc
Q 030527          150 WSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       150 ~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      ||||+++++|++ |..||...+.
T Consensus       206 wslG~il~~l~t~g~~p~~~~~~  228 (288)
T cd05093         206 WSLGVVLWEIFTYGKQPWYQLSN  228 (288)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.6e-32  Score=197.07  Aligned_cols=160  Identities=39%  Similarity=0.740  Sum_probs=143.7

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .....+.+|++++++++||||+++++.+.+.+..++++||.++++|.+++.+...+++..+..++.|+  ++++||+.|+
T Consensus        35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~  114 (262)
T cd05572          35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGI  114 (262)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence            34567889999999999999999999999999999999999999999999988889999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +|+||+|+||++   +.++.++|+|||.+.............++..|++||.+.+..++.++|+||+|+++|++++|..|
T Consensus       115 ~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p  191 (262)
T cd05572         115 IYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP  191 (262)
T ss_pred             ccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCC
Confidence            999999999999   56778999999999877554333345578889999999888899999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |...+
T Consensus       192 ~~~~~  196 (262)
T cd05572         192 FGEDD  196 (262)
T ss_pred             cCCCC
Confidence            98765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.1e-32  Score=195.21  Aligned_cols=163  Identities=32%  Similarity=0.549  Sum_probs=142.9

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ++...+.+.+|++++++++|+||+++++++.+.+..++++||+++++|.+++.+.  ..+++..+..++.|+  ++++||
T Consensus        39 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh  118 (256)
T cd08221          39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH  118 (256)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3455677889999999999999999999999999999999999999999999865  468999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      +.|++|+|++|+||++   +.++.++++|||.+....... ......++..|.|||...+..++.++|+||+|+++++++
T Consensus       119 ~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~  195 (256)
T cd08221         119 KAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL  195 (256)
T ss_pred             hCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHH
Confidence            9999999999999999   467789999999987664433 233455788999999998888899999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030527          161 NGYPPFSVGEE  171 (175)
Q Consensus       161 ~g~~pf~~~~~  171 (175)
                      +|..||...+.
T Consensus       196 ~g~~~~~~~~~  206 (256)
T cd08221         196 TLKRTFDATNP  206 (256)
T ss_pred             HCCCCCCCCCH
Confidence            99999976543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.2e-32  Score=220.73  Aligned_cols=161  Identities=25%  Similarity=0.401  Sum_probs=136.9

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHH-
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQTARKFLQQL-   75 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~~i-   75 (175)
                      ..++++.+|++++++++||||+++++++.+++..+++|||++|++|.+++...           ..++...+..++.|+ 
T Consensus        44 ~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa  123 (932)
T PRK13184         44 LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC  123 (932)
T ss_pred             HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHH
Confidence            34567889999999999999999999999999999999999999999988642           124556778888898 


Q ss_pred             -HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-------------------ccccccCCCCccCc
Q 030527           76 -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-------------------YAEKVCGSPLYMAP  135 (175)
Q Consensus        76 -~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-------------------~~~~~~~~~~~~~p  135 (175)
                       ||++||+.|++||||||+||++   +..+.++++|||++.......                   ......|++.|+||
T Consensus       124 ~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP  200 (932)
T PRK13184        124 ATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP  200 (932)
T ss_pred             HHHHHHHHCCccccCCchheEEE---cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence             9999999999999999999999   577789999999997652110                   01124588999999


Q ss_pred             ccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          136 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       136 e~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      |...+..++.++|+||+|+++++|++|..||...+.
T Consensus       201 E~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        201 ERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             HHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            999988999999999999999999999999976543

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.3e-32  Score=197.10  Aligned_cols=158  Identities=33%  Similarity=0.613  Sum_probs=139.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+.++++++||||+++.+++.+.+..++++||+++++|.+++.+.+.+++..+..++.|+  ++++||+.|++|
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH  129 (267)
T cd06628          50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIH  129 (267)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCccc
Confidence            356788999999999999999999999999999999999999999999988889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-------cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      +||+|+||++   +.++.++|+|||.+........       .....++..|+|||.+.+..++.++|+||+|+++++++
T Consensus       130 ~di~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~  206 (267)
T cd06628         130 RDIKGANILV---DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML  206 (267)
T ss_pred             ccCCHHHEEE---cCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHh
Confidence            9999999999   5777899999999876642211       11234677899999998888999999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|+.||...+
T Consensus       207 ~g~~p~~~~~  216 (267)
T cd06628         207 TGKHPFPDCT  216 (267)
T ss_pred             hCCCCCCCcc
Confidence            9999997643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-32  Score=196.20  Aligned_cols=159  Identities=33%  Similarity=0.583  Sum_probs=140.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|++++++++|||++++++++...+..+++|||+++++|.+++.+. ..+++..+..++.|+  ++++||+.|+
T Consensus        43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i  122 (262)
T cd06613          43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK  122 (262)
T ss_pred             hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4567889999999999999999999999999999999999999999999876 789999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccccc---CCCcchhHHHHHHHHHHHHh
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~---~~~~~~Di~slg~~~~~~~~  161 (175)
                      +|+|++|+||++   +.++.++|+|||.+....... ......++..|+|||...+.   .++.++|+||+|+++++|++
T Consensus       123 ~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~t  199 (262)
T cd06613         123 IHRDIKGANILL---TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE  199 (262)
T ss_pred             eecCCChhhEEE---CCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHh
Confidence            999999999999   577789999999987654432 22334567789999998766   78899999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |+.||...+
T Consensus       200 g~~p~~~~~  208 (262)
T cd06613         200 LQPPMFDLH  208 (262)
T ss_pred             CCCCCCCCC
Confidence            999997654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.9e-32  Score=199.95  Aligned_cols=159  Identities=26%  Similarity=0.590  Sum_probs=137.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARKFLQ   73 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~~~   73 (175)
                      ...+.+|++.+++++|+||+++.+++...+..++||||+++++|.+++...+                .+++..+..++.
T Consensus        51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  130 (291)
T cd05094          51 RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS  130 (291)
T ss_pred             HHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHH
Confidence            4578899999999999999999999999999999999999999999997542                378899999999


Q ss_pred             HH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchh
Q 030527           74 QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVD  148 (175)
Q Consensus        74 ~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~D  148 (175)
                      |+  ++++||++|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||.+.+..++.++|
T Consensus       131 ~i~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  207 (291)
T cd05094         131 QIASGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD  207 (291)
T ss_pred             HHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhh
Confidence            98  9999999999999999999999   5677899999999876543321   12333467799999998888999999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          149 MWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       149 i~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      +||+|++++++++ |..||...+.
T Consensus       208 i~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         208 VWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999 9999966543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=211.42  Aligned_cols=161  Identities=32%  Similarity=0.599  Sum_probs=146.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+++|+.++.+++++||.++++.+..+..++++||||.||++.+.++.+..+.+..+..++.++  |+.|+|+++.+|
T Consensus        55 Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiH  134 (467)
T KOG0201|consen   55 IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIH  134 (467)
T ss_pred             hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceec
Confidence            446788999999999999999999999999999999999999999999987777888888888887  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +|||+.||++.   ..+.++|+|||.+........ ..+..||+.|||||++....|+.++||||||++++||++|.+||
T Consensus       135 rDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~  211 (467)
T KOG0201|consen  135 RDIKAANILLS---ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPH  211 (467)
T ss_pred             ccccccceeEe---ccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCC
Confidence            99999999994   668899999999988766543 47888999999999999889999999999999999999999999


Q ss_pred             CCCCccC
Q 030527          167 SVGEEHQ  173 (175)
Q Consensus       167 ~~~~~~~  173 (175)
                      ..-.+..
T Consensus       212 s~~hPmr  218 (467)
T KOG0201|consen  212 SKLHPMR  218 (467)
T ss_pred             cccCcce
Confidence            8876654

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.2e-32  Score=207.03  Aligned_cols=158  Identities=31%  Similarity=0.509  Sum_probs=134.6

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--------------------------
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------------------------   61 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------   61 (175)
                      ....+.+|+++++.+ +||||+++++++...+..++||||+++++|.+++.+..                          
T Consensus        81 ~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (375)
T cd05104          81 EREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREM  160 (375)
T ss_pred             HHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcc
Confidence            345678899999999 89999999999999999999999999999999986432                          


Q ss_pred             -------------------------------------------------CCCHHHHHHHHHHH--HHHHHHHcCCeecCC
Q 030527           62 -------------------------------------------------RVPEQTARKFLQQL--GLEILNSHHIIHRDL   90 (175)
Q Consensus        62 -------------------------------------------------~l~~~~~~~~~~~i--~l~~lh~~~~~h~di   90 (175)
                                                                       .+++..+..++.|+  +++|||+.|++|+||
T Consensus       161 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  240 (375)
T cd05104         161 SCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDL  240 (375)
T ss_pred             cchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence                                                             36778888999998  999999999999999


Q ss_pred             CCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-CCCCC
Q 030527           91 KPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF  166 (175)
Q Consensus        91 ~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g~~pf  166 (175)
                      ||+||++   +.+..++|+|||++........   .....++..|+|||.+.+..++.++|+||||++++++++ |..||
T Consensus       241 kp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~  317 (375)
T cd05104         241 AARNILL---THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY  317 (375)
T ss_pred             chhhEEE---ECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence            9999999   4567799999999976643321   112233557999999998899999999999999999998 89999


Q ss_pred             CCC
Q 030527          167 SVG  169 (175)
Q Consensus       167 ~~~  169 (175)
                      ...
T Consensus       318 ~~~  320 (375)
T cd05104         318 PGM  320 (375)
T ss_pred             CCC
Confidence            764

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.3e-32  Score=202.30  Aligned_cols=160  Identities=31%  Similarity=0.509  Sum_probs=135.8

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHH
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~   70 (175)
                      .....+.+|++++.++ +||||+++.+++..++..++++||+++++|.+++.+.+                .+++.++..
T Consensus        49 ~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  128 (303)
T cd05088          49 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH  128 (303)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHH
Confidence            3456788899999999 89999999999999999999999999999999997543                478889999


Q ss_pred             HHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchh
Q 030527           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVD  148 (175)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D  148 (175)
                      ++.|+  |+++||+.|++|+||+|+||++   +.++.++|+|||++..............+..|+|||...+..++.++|
T Consensus       129 ~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  205 (303)
T cd05088         129 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD  205 (303)
T ss_pred             HHHHHHHHHHHHHhCCccccccchheEEe---cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCccccc
Confidence            99998  9999999999999999999999   577789999999886432221112222356799999988888899999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCC
Q 030527          149 MWSVGAILFELLN-GYPPFSVGE  170 (175)
Q Consensus       149 i~slg~~~~~~~~-g~~pf~~~~  170 (175)
                      +||+|++++++++ |..||...+
T Consensus       206 i~slG~il~ellt~g~~p~~~~~  228 (303)
T cd05088         206 VWSYGVLLWEIVSLGGTPYCGMT  228 (303)
T ss_pred             chhhhhHHHHHHhcCCCCcccCC
Confidence            9999999999998 999997544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.8e-32  Score=205.81  Aligned_cols=157  Identities=36%  Similarity=0.545  Sum_probs=134.5

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      .....+.+|+.+++.++||||+++++++...      ...++||||+. +++.+++..  .++...+..++.|+  ||++
T Consensus        65 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~  141 (364)
T cd07875          65 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKH  141 (364)
T ss_pred             hhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHH
Confidence            3345677899999999999999999887543      35799999995 578777753  47888899999998  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      ||+.|++|+||||+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus       142 LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el  218 (364)
T cd07875         142 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM  218 (364)
T ss_pred             HhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHH
Confidence            999999999999999999   56788999999999876554444455678999999999988999999999999999999


Q ss_pred             HhCCCCCCCCC
Q 030527          160 LNGYPPFSVGE  170 (175)
Q Consensus       160 ~~g~~pf~~~~  170 (175)
                      ++|+.||.+.+
T Consensus       219 l~g~~pf~~~~  229 (364)
T cd07875         219 IKGGVLFPGTD  229 (364)
T ss_pred             HhCCCCCCCCC
Confidence            99999998765

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.1e-32  Score=201.46  Aligned_cols=160  Identities=30%  Similarity=0.552  Sum_probs=131.8

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHH--H
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQL--G   76 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---------~~l~~~~~~~~~~~i--~   76 (175)
                      ...+.+|++++++++||||+++.+++..  +...++++|++ +++|.+++...         ..+++..+..++.|+  |
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  120 (317)
T cd07868          42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG  120 (317)
T ss_pred             cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence            3457789999999999999999998854  45689999998 56888887532         248899999999998  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeec-CCCceEEEeeecceeeccCCCc----cccccCCCCccCccccccc-CCCcchhHH
Q 030527           77 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMW  150 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~-~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~-~~~~~~Di~  150 (175)
                      |+|||+.|++|+||||+||++... +..+.++|+|||++........    .....+++.|+|||.+.+. .++.++|+|
T Consensus       121 l~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  200 (317)
T cd07868         121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  200 (317)
T ss_pred             HHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHH
Confidence            999999999999999999999532 2456799999999977643321    2234578899999998764 589999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCC
Q 030527          151 SVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       151 slg~~~~~~~~g~~pf~~~~  170 (175)
                      |+|+++++|++|+.||....
T Consensus       201 slG~il~el~~g~~~f~~~~  220 (317)
T cd07868         201 AIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             HHHHHHHHHHhCCCCccCCc
Confidence            99999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-32  Score=196.65  Aligned_cols=159  Identities=26%  Similarity=0.483  Sum_probs=137.9

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .+.+.+|++++++++|||++++.+++...+..++++|++++++|.+++.+..  .++...+..++.++  ++++||+.|+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  124 (261)
T cd05068          45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY  124 (261)
T ss_pred             HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4568889999999999999999999999999999999999999999997654  68999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcccc--ccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      +|+||+|+||++   +.++.++|+|||++...........  ...+..|+|||...+..++.++|+||||++++++++ |
T Consensus       125 ~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g  201 (261)
T cd05068         125 IHRDLAARNVLV---GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYG  201 (261)
T ss_pred             eeccCCcceEEE---cCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcC
Confidence            999999999999   5677899999999987754322111  112346999999988889999999999999999999 9


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      +.||.+.++
T Consensus       202 ~~p~~~~~~  210 (261)
T cd05068         202 RMPYPGMTN  210 (261)
T ss_pred             CCCCCCCCH
Confidence            999976543

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1e-31  Score=193.88  Aligned_cols=158  Identities=34%  Similarity=0.623  Sum_probs=140.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|++++++++|||++++.+++......++++|++.+++|.+++... ..+++..+..++.++  ++++||+.|++
T Consensus        42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~  121 (256)
T cd06612          42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI  121 (256)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            568899999999999999999999999999999999999999999999764 568999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+|++|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++|+.|
T Consensus       122 H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p  198 (256)
T cd06612         122 HRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP  198 (256)
T ss_pred             cCCCCcceEEE---CCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999   567789999999987765443 23344567889999999888899999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |...+
T Consensus       199 ~~~~~  203 (256)
T cd06612         199 YSDIH  203 (256)
T ss_pred             CCCcc
Confidence            97654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-31  Score=195.06  Aligned_cols=158  Identities=32%  Similarity=0.619  Sum_probs=139.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++++++++|+||+++.+++.+.+..++++||+++++|.+++.+.+++++..+..++.|+  ++++||+.|++|
T Consensus        46 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  125 (265)
T cd06631          46 YEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH  125 (265)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            456888999999999999999999999999999999999999999999888889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC-------ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      +||+|+||++   +.++.++|+|||.+.......       ......++..|+|||...+..++.++|+||+|+++++++
T Consensus       126 ~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  202 (265)
T cd06631         126 RDIKGNNVML---MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMA  202 (265)
T ss_pred             CCcCHHhEEE---CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHH
Confidence            9999999999   577889999999887543211       112344678899999998888999999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|+.||...+
T Consensus       203 ~g~~p~~~~~  212 (265)
T cd06631         203 TGKPPLASMD  212 (265)
T ss_pred             hCCCccccCC
Confidence            9999997643

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.9e-32  Score=204.51  Aligned_cols=156  Identities=33%  Similarity=0.570  Sum_probs=131.7

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ......+.+|+++++.++|+||+++++++...+..++|+||+.+++|.+.    ...++..+..++.|+  ||+|||+.|
T Consensus       113 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~  188 (353)
T PLN00034        113 DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH  188 (353)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34566788999999999999999999999999999999999999998653    345677888899998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccc-----cCCCcchhHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slg~~~~~  158 (175)
                      ++|+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+..     ...+.++|+||||+++|+
T Consensus       189 ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~e  265 (353)
T PLN00034        189 IVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE  265 (353)
T ss_pred             EeecCCCHHHEEE---cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHH
Confidence            9999999999999   577889999999987664332 2234567899999998742     234568999999999999


Q ss_pred             HHhCCCCCCCC
Q 030527          159 LLNGYPPFSVG  169 (175)
Q Consensus       159 ~~~g~~pf~~~  169 (175)
                      |++|+.||...
T Consensus       266 l~~g~~pf~~~  276 (353)
T PLN00034        266 FYLGRFPFGVG  276 (353)
T ss_pred             HHhCCCCCCCC
Confidence            99999999743

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-31  Score=193.73  Aligned_cols=162  Identities=33%  Similarity=0.640  Sum_probs=142.6

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ......+.+|++++++++|||++++++.+...+..++|+|++++++|.+++.+.  ..+++..+..++.++  ++++||+
T Consensus        40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~  119 (256)
T cd08220          40 KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT  119 (256)
T ss_pred             cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            345678899999999999999999999999999999999999999999999864  348999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      +|++|+|++|+||++.  +.+..++++|||.+.............++..|+|||...+..++.++|+||+|++++++++|
T Consensus       120 ~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~  197 (256)
T cd08220         120 KLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL  197 (256)
T ss_pred             CCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC
Confidence            9999999999999994  34556899999999877655444445678889999999888889999999999999999999


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      +.||...+
T Consensus       198 ~~~~~~~~  205 (256)
T cd08220         198 KRAFEAAN  205 (256)
T ss_pred             CCCcccCc
Confidence            99997654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.3e-32  Score=206.09  Aligned_cols=159  Identities=33%  Similarity=0.513  Sum_probs=136.6

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC-----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ..+++.+|+++++.++||||+++++++...+     ..++|+||+. ++|.+++.....+++..+..++.|+  ||+|||
T Consensus        42 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH  120 (372)
T cd07853          42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH  120 (372)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3456788999999999999999999998776     7899999985 6898888877889999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCccccccc-CCCcchhHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE  158 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~  158 (175)
                      +.|++|+||+|+||++   +.++.++|+|||++........  .....++..|+|||.+.+. .++.++|+||+|+++++
T Consensus       121 ~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e  197 (372)
T cd07853         121 SAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAE  197 (372)
T ss_pred             hCCeeCCCCChHHEEE---CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHH
Confidence            9999999999999999   5778899999999976543321  2234567889999998764 47899999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030527          159 LLNGYPPFSVGEE  171 (175)
Q Consensus       159 ~~~g~~pf~~~~~  171 (175)
                      |++|+.||.+.++
T Consensus       198 l~~g~~pf~~~~~  210 (372)
T cd07853         198 LLGRRILFQAQSP  210 (372)
T ss_pred             HHcCCCCCCCCCH
Confidence            9999999987653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.2e-32  Score=204.96  Aligned_cols=156  Identities=36%  Similarity=0.535  Sum_probs=134.0

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ....+.+|+.+++.++||||+++++++...      ...+++|||+. +++.+.+..  .++...+..++.|+  ||++|
T Consensus        59 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~L  135 (355)
T cd07874          59 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHL  135 (355)
T ss_pred             HHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHH
Confidence            345677899999999999999999988643      35799999995 477776653  57888999999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      |+.|++|+||||+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++++|+
T Consensus       136 H~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~  212 (355)
T cd07874         136 HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV  212 (355)
T ss_pred             HhCCcccCCCChHHEEE---CCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence            99999999999999999   567789999999998765554444566789999999999888999999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|+.||.+.+
T Consensus       213 ~g~~pf~~~~  222 (355)
T cd07874         213 RHKILFPGRD  222 (355)
T ss_pred             hCCCCCCCCC
Confidence            9999998754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-31  Score=195.08  Aligned_cols=157  Identities=31%  Similarity=0.550  Sum_probs=137.8

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+.+++.++|||++++++++...+..++++||+++++|.+++...+.+++.++..++.|+  ++++||+.|++|
T Consensus        50 ~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  129 (267)
T cd06645          50 FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMH  129 (267)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            345778999999999999999999999999999999999999999999888899999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccc---ccCCCcchhHHHHHHHHHHHHhCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +||+|+||++   +..+.++|+|||.+....... ......++..|+|||.+.   ...++.++|+||+|++++++++|.
T Consensus       130 ~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~  206 (267)
T cd06645         130 RDIKGANILL---TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQ  206 (267)
T ss_pred             CCCCHHHEEE---CCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCC
Confidence            9999999999   567789999999987654332 123446788999999874   455888999999999999999999


Q ss_pred             CCCCCC
Q 030527          164 PPFSVG  169 (175)
Q Consensus       164 ~pf~~~  169 (175)
                      .||...
T Consensus       207 ~p~~~~  212 (267)
T cd06645         207 PPMFDL  212 (267)
T ss_pred             CCcccc
Confidence            998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.3e-32  Score=196.57  Aligned_cols=160  Identities=27%  Similarity=0.574  Sum_probs=138.3

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------------RVPEQTARKFLQQ   74 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~~~~~   74 (175)
                      ....+.+|+++++.++|+|++++++++...+..+++|||+++++|.+++...+              .+++..+..++.|
T Consensus        51 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  130 (280)
T cd05049          51 ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ  130 (280)
T ss_pred             HHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHH
Confidence            45688999999999999999999999999999999999999999999997542              3788889999999


Q ss_pred             H--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhH
Q 030527           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM  149 (175)
Q Consensus        75 i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di  149 (175)
                      +  +++++|+.|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||.+.+..++.++|+
T Consensus       131 i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  207 (280)
T cd05049         131 IASGMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV  207 (280)
T ss_pred             HHHHHHHHhhCCeeccccccceEEE---cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhH
Confidence            8  9999999999999999999999   5778899999999876533221   122334567999999998899999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCc
Q 030527          150 WSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       150 ~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      ||+|+++++|++ |..||...+.
T Consensus       208 ~slG~il~e~~~~g~~p~~~~~~  230 (280)
T cd05049         208 WSFGVVLWEIFTYGKQPWYGLSN  230 (280)
T ss_pred             HHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.5e-32  Score=193.88  Aligned_cols=161  Identities=34%  Similarity=0.597  Sum_probs=137.3

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      .+....+.+|++++++++||||+++++++...+..++|+||+++++|.+++.+.+ .+++..+..++.|+  +|+|||+.
T Consensus        34 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~  113 (252)
T cd05084          34 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK  113 (252)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4456778999999999999999999999999999999999999999999997654 58999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc---cccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      |++|+||+|+||++   +.++.++|+|||.+....+.....   ....+..|+|||.+.+..++.++|+||+|+++++++
T Consensus       114 ~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~  190 (252)
T cd05084         114 HCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAF  190 (252)
T ss_pred             CccccccchheEEE---cCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence            99999999999999   567789999999987654322111   112234699999998888999999999999999999


Q ss_pred             h-CCCCCCCCC
Q 030527          161 N-GYPPFSVGE  170 (175)
Q Consensus       161 ~-g~~pf~~~~  170 (175)
                      + |..||...+
T Consensus       191 ~~~~~p~~~~~  201 (252)
T cd05084         191 SLGAVPYANLS  201 (252)
T ss_pred             hCCCCCccccC
Confidence            8 899996544

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.6e-32  Score=195.18  Aligned_cols=159  Identities=26%  Similarity=0.568  Sum_probs=137.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|++++++++||||+++++++...+..+++|||+++++|.+++... +.+++..+..++.++  |+++||+.|++
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  122 (256)
T cd05114          43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI  122 (256)
T ss_pred             HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            457888999999999999999999999999999999999999999998754 568999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc--cccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-CC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  163 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g~  163 (175)
                      |+|++|+|+++   +.++.++++|||.+..........  ...++..|+|||...+..++.++|+||+|++++++++ |+
T Consensus       123 H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~  199 (256)
T cd05114         123 HRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK  199 (256)
T ss_pred             ccccCcceEEE---cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCC
Confidence            99999999999   567789999999887654332211  1223457999999988889999999999999999999 89


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||...+.
T Consensus       200 ~p~~~~~~  207 (256)
T cd05114         200 MPFEKKSN  207 (256)
T ss_pred             CCCCCCCH
Confidence            99987654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-32  Score=196.10  Aligned_cols=160  Identities=31%  Similarity=0.509  Sum_probs=135.2

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHH
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~   70 (175)
                      ...+.+.+|+++++++ +||||+++++++...+..+++|||+++++|.+++.+..                .++..++..
T Consensus        37 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  116 (270)
T cd05047          37 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH  116 (270)
T ss_pred             HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHH
Confidence            4456788899999999 89999999999999999999999999999999987543                378889999


Q ss_pred             HHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchh
Q 030527           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVD  148 (175)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D  148 (175)
                      ++.|+  |+++||+.|++|+||+|+|+++   +.++.++++|||++..............+..|+|||...+..++.++|
T Consensus       117 ~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D  193 (270)
T cd05047         117 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD  193 (270)
T ss_pred             HHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhh
Confidence            99998  9999999999999999999999   577889999999885432211111222345699999998888999999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCC
Q 030527          149 MWSVGAILFELLN-GYPPFSVGE  170 (175)
Q Consensus       149 i~slg~~~~~~~~-g~~pf~~~~  170 (175)
                      +||||++++++++ |..||.+.+
T Consensus       194 i~slG~il~el~~~g~~pf~~~~  216 (270)
T cd05047         194 VWSYGVLLWEIVSLGGTPYCGMT  216 (270)
T ss_pred             HHHHHHHHHHHHcCCCCCccccC
Confidence            9999999999997 999996543

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.4e-31  Score=195.69  Aligned_cols=158  Identities=38%  Similarity=0.579  Sum_probs=139.3

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+..|++++++++||+++++.+.+...+..++|+||+++++|.+++.+..  .+++..+..++.|+  ++.+||+.|+
T Consensus        37 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i  116 (277)
T cd05577          37 EQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI  116 (277)
T ss_pred             hHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4456789999999999999999999999999999999999999999997765  68999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +|+||+|+||++   +.++.++|+|||.+.............++..|+|||...+..++.++|+||+|++++++++|+.|
T Consensus       117 ~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p  193 (277)
T cd05577         117 VYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP  193 (277)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCC
Confidence            999999999999   56778999999988766443333344567789999999888899999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |...+
T Consensus       194 ~~~~~  198 (277)
T cd05577         194 FRQRK  198 (277)
T ss_pred             CCCCc
Confidence            97654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.8e-32  Score=199.92  Aligned_cols=157  Identities=31%  Similarity=0.552  Sum_probs=134.4

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ..+.+|++++++++||||+++++++..++..++||||+. ++|.+++...+ .++...+..++.|+  ||++||+.|++|
T Consensus        49 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH  127 (309)
T cd07872          49 CTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH  127 (309)
T ss_pred             hhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            356789999999999999999999999999999999996 48888887654 48899999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.|
T Consensus       128 ~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~p  204 (309)
T cd07872         128 RDLKPQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPL  204 (309)
T ss_pred             CCCCHHHEEE---CCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999   567789999999987654332 2223456788999998864 4578999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.+.
T Consensus       205 f~~~~~  210 (309)
T cd07872         205 FPGSTV  210 (309)
T ss_pred             CCCCCh
Confidence            987653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-31  Score=194.19  Aligned_cols=159  Identities=28%  Similarity=0.554  Sum_probs=136.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|++++++++||||+++++++...+..++++|++++++|.+++.+. ..+++..+..++.|+  ++++||+.|++
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  122 (256)
T cd05059          43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            346788999999999999999999999999999999999999999999764 468999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc--cccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-CC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  163 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g~  163 (175)
                      |+|++|+||++   +.++.++++|||.+....+.....  ...++..|+|||...+..++.++|+||+|+++|++++ |.
T Consensus       123 H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~  199 (256)
T cd05059         123 HRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK  199 (256)
T ss_pred             cccccHhhEEE---CCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCC
Confidence            99999999999   567789999999887664332211  1123356999999988889999999999999999999 89


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||...++
T Consensus       200 ~p~~~~~~  207 (256)
T cd05059         200 MPYERFSN  207 (256)
T ss_pred             CCCCCCCH
Confidence            99976543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.9e-32  Score=196.69  Aligned_cols=163  Identities=29%  Similarity=0.502  Sum_probs=137.3

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHH--HHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~~i--~l~~   79 (175)
                      ....+..|+.+++.++|+||+++++++.+.+..++++||+.|++|.+++.+.+       .+++..+..++.|+  ++++
T Consensus        52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  131 (277)
T cd05036          52 DESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY  131 (277)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence            34568889999999999999999999999889999999999999999997653       48889999999998  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~  156 (175)
                      ||+.+++|+||+|+||++........++|+|||++........   ......+..|+|||.+.+..++.++|+||||+++
T Consensus       132 LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il  211 (277)
T cd05036         132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL  211 (277)
T ss_pred             HHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHH
Confidence            9999999999999999996433345699999999876633221   1122234579999999888899999999999999


Q ss_pred             HHHHh-CCCCCCCCCc
Q 030527          157 FELLN-GYPPFSVGEE  171 (175)
Q Consensus       157 ~~~~~-g~~pf~~~~~  171 (175)
                      +++++ |..||.+.+.
T Consensus       212 ~el~~~g~~pf~~~~~  227 (277)
T cd05036         212 WEIFSLGYMPYPGRTN  227 (277)
T ss_pred             HHHHcCCCCCCCCCCH
Confidence            99997 9999987553

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9e-32  Score=198.57  Aligned_cols=160  Identities=30%  Similarity=0.498  Sum_probs=135.1

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHH
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARKF   71 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~   71 (175)
                      ..+.+.+|++++.++ +||||+++.+++...+..++++||+++++|.+++.+..                .+++..+..+
T Consensus        45 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i  124 (297)
T cd05089          45 DHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF  124 (297)
T ss_pred             HHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHH
Confidence            345788899999999 79999999999999999999999999999999997542                4788899999


Q ss_pred             HHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhH
Q 030527           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDM  149 (175)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di  149 (175)
                      +.|+  |+++||+.|++|+||+|+||++   +.+..++|+|||++..............+..|+|||...+..++.++|+
T Consensus       125 ~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  201 (297)
T cd05089         125 ASDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDV  201 (297)
T ss_pred             HHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhH
Confidence            9998  9999999999999999999999   5677899999998864322211112223456999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCc
Q 030527          150 WSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       150 ~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      ||||+++++|++ |..||...+.
T Consensus       202 wSlG~il~el~t~g~~pf~~~~~  224 (297)
T cd05089         202 WSFGVLLWEIVSLGGTPYCGMTC  224 (297)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999997 9999976543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-32  Score=215.28  Aligned_cols=161  Identities=27%  Similarity=0.502  Sum_probs=136.9

Q ss_pred             chhhhhhHHHHHHHHhhC-CCCCeeeEeeE-Eee---C---CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDA-FQA---E---NCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL   75 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~---~---~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i   75 (175)
                      ++..-+.+.+|++++++| .|+|||.+++. ...   +   -...++||||.|+.|-|++.++  ..|++.+++.|+.++
T Consensus        74 de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv  153 (738)
T KOG1989|consen   74 DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDV  153 (738)
T ss_pred             CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHH
Confidence            677778889999999999 59999999993 221   1   2468999999999999999855  469999999999999


Q ss_pred             --HHHHHHHcC--CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc----------ccccCCCCccCcccc---
Q 030527           76 --GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----------EKVCGSPLYMAPEVL---  138 (175)
Q Consensus        76 --~l~~lh~~~--~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~pe~~---  138 (175)
                        |+++||.+.  +||||||.+|||+   +.++..||||||.+.........          ....-|+-|++||++   
T Consensus       154 ~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly  230 (738)
T KOG1989|consen  154 CEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY  230 (738)
T ss_pred             HHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh
Confidence              999999998  9999999999999   57788999999999766443311          124457889999987   


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030527          139 QFQRYDEKVDMWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus       139 ~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~  169 (175)
                      .+.+.+.++|||||||++|.++-...||...
T Consensus       231 sg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  231 SGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             cCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            5778899999999999999999999999876

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.4e-31  Score=193.58  Aligned_cols=159  Identities=28%  Similarity=0.514  Sum_probs=136.0

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .....+.+|+.+++.++||||+++++++.. ...++++||+++++|.+++.+...+++..+..++.|+  ++++||+.|+
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i  116 (257)
T cd05116          38 ALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF  116 (257)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            345678899999999999999999998764 4568999999999999999887889999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc----ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      +|+||+|.||++   +.+..++|+|||.+.........    ....++..|+|||.+....++.++|+||||++++++++
T Consensus       117 ~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t  193 (257)
T cd05116         117 VHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS  193 (257)
T ss_pred             eecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHh
Confidence            999999999999   56778999999998766443211    12223467999999887788999999999999999998


Q ss_pred             -CCCCCCCCC
Q 030527          162 -GYPPFSVGE  170 (175)
Q Consensus       162 -g~~pf~~~~  170 (175)
                       |+.||....
T Consensus       194 ~g~~p~~~~~  203 (257)
T cd05116         194 YGQKPYKGMK  203 (257)
T ss_pred             CCCCCCCCCC
Confidence             999997654

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-31  Score=193.80  Aligned_cols=158  Identities=30%  Similarity=0.533  Sum_probs=137.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+.++++++|||++++++++...+..++|+||+++++|.+++.+.+.+++..+..++.|+  ++++||+.|++|
T Consensus        50 ~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  129 (267)
T cd06646          50 FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH  129 (267)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            345778999999999999999999999999999999999999999999888889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCccccc---ccCCCcchhHHHHHHHHHHHHhCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +|++|+||++   +..+.++|+|||++........ .....++..|+|||.+.   ...++.++|+||+|++++++++|+
T Consensus       130 ~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~  206 (267)
T cd06646         130 RDIKGANILL---TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQ  206 (267)
T ss_pred             cCCCHHHEEE---CCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCC
Confidence            9999999999   5677799999999987643322 23345778899999874   344788999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||...+
T Consensus       207 ~p~~~~~  213 (267)
T cd06646         207 PPMFDLH  213 (267)
T ss_pred             CCccccc
Confidence            9996543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-31  Score=196.85  Aligned_cols=158  Identities=27%  Similarity=0.571  Sum_probs=135.3

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------------GRVPEQTARKFL   72 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----------------~~l~~~~~~~~~   72 (175)
                      ...+.+|++++++++||||+++++++......+++|||+++++|.+++...                 ..+++.++..++
T Consensus        51 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  130 (283)
T cd05090          51 WGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA  130 (283)
T ss_pred             HHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHH
Confidence            457888999999999999999999999999999999999999999998532                 237788888999


Q ss_pred             HHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcch
Q 030527           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  147 (175)
Q Consensus        73 ~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~  147 (175)
                      .|+  ++++||++|++|+||+|+||++   +.+..++|+|||++........   .....++..|+|||...+..++.++
T Consensus       131 ~~i~~al~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  207 (283)
T cd05090         131 IQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDS  207 (283)
T ss_pred             HHHHHHHHHHHhcCeehhccccceEEE---cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchh
Confidence            998  9999999999999999999999   5677899999999977643321   2223345679999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCC
Q 030527          148 DMWSVGAILFELLN-GYPPFSVGE  170 (175)
Q Consensus       148 Di~slg~~~~~~~~-g~~pf~~~~  170 (175)
                      |+||||++++++++ |..||.+.+
T Consensus       208 Dv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05090         208 DIWSFGVVLWEIFSFGLQPYYGFS  231 (283)
T ss_pred             hhHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999999999998 999997654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-33  Score=211.01  Aligned_cols=163  Identities=35%  Similarity=0.625  Sum_probs=147.6

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....++++|+.||+++.||+||.+...++..+..+.|||-+.|+-|.-.+.. .+++++.....++.||  ||+|||-++
T Consensus       605 kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn  684 (888)
T KOG4236|consen  605 KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN  684 (888)
T ss_pred             chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc
Confidence            3457889999999999999999999999999999999999966555555543 4789999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      |+|||+||+|+++.+.+.-..+||||||+|+..+.........||+.|+|||.++++.|.++-|+||.|+++|--++|-.
T Consensus       685 IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTF  764 (888)
T KOG4236|consen  685 IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTF  764 (888)
T ss_pred             eeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccc
Confidence            99999999999998766777899999999999988888888999999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||...+
T Consensus       765 PFNEdE  770 (888)
T KOG4236|consen  765 PFNEDE  770 (888)
T ss_pred             cCCCcc
Confidence            996543

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-31  Score=194.65  Aligned_cols=160  Identities=34%  Similarity=0.617  Sum_probs=140.3

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|++.++.++|+|++++++++.+.+..++++||+.+++|.+++.+.+++++..+..++.|+  |+++||++|++
T Consensus        46 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~  125 (268)
T cd06630          46 VVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII  125 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            4567889999999999999999999999999999999999999999999888889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      |+||+|+||++.  ..+..++|+|||.+........     .....++..|+|||.+.+..++.++|+||+|++++++++
T Consensus       126 H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~  203 (268)
T cd06630         126 HRDVKGANLLID--STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT  203 (268)
T ss_pred             cCCCCHHHEEEc--CCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh
Confidence            999999999994  2334699999999877654321     123456778999999988889999999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |..||...+
T Consensus       204 g~~p~~~~~  212 (268)
T cd06630         204 AKPPWNAEK  212 (268)
T ss_pred             CCCCCCCCC
Confidence            999997543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.98  E-value=9.7e-32  Score=194.51  Aligned_cols=158  Identities=27%  Similarity=0.529  Sum_probs=137.1

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|++++++++||||+++++++......+++|||+.+++|.+++.+. ..+++.++..++.|+  ++++||+.|++
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  122 (256)
T cd05113          43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI  122 (256)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            356888999999999999999999999988999999999999999999865 468999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc--cccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-CC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  163 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g~  163 (175)
                      |+||+|+||++   +.++.++|+|||.+.....+....  ...++..|++||...+..++.++|+||||++++++++ |.
T Consensus       123 H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~  199 (256)
T cd05113         123 HRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK  199 (256)
T ss_pred             ccccCcceEEE---cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCC
Confidence            99999999999   567789999999987664433211  1224467999999988889999999999999999998 99


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||....
T Consensus       200 ~p~~~~~  206 (256)
T cd05113         200 MPYERFN  206 (256)
T ss_pred             CCcCcCC
Confidence            9997544

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.98  E-value=1.6e-31  Score=199.70  Aligned_cols=158  Identities=29%  Similarity=0.433  Sum_probs=132.7

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+.+|+++++.++||||+++++++..++..++|+||+++++|.+++.+.  ..+++..+..++.|+  ||+|||+.|
T Consensus        42 ~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  121 (327)
T cd08227          42 MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG  121 (327)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456788999999999999999999999999999999999999999999753  458999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC--------ccccccCCCCccCcccccc--cCCCcchhHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGA  154 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slg~  154 (175)
                      ++|+||+|+||++   +.++.++++||+.........        ......++..|+|||.+.+  ..++.++|+||+|+
T Consensus       122 iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~  198 (327)
T cd08227         122 YVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI  198 (327)
T ss_pred             EecCCCChhhEEE---ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHH
Confidence            9999999999999   466789999997654332111        0112234567999999875  35889999999999


Q ss_pred             HHHHHHhCCCCCCCC
Q 030527          155 ILFELLNGYPPFSVG  169 (175)
Q Consensus       155 ~~~~~~~g~~pf~~~  169 (175)
                      +++++++|+.||...
T Consensus       199 il~el~~g~~pf~~~  213 (327)
T cd08227         199 TACELANGHVPFKDM  213 (327)
T ss_pred             HHHHHHHCCCCCCCc
Confidence            999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.98  E-value=1.1e-31  Score=193.79  Aligned_cols=159  Identities=31%  Similarity=0.576  Sum_probs=141.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHH--HHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQL--GLE   78 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------~~l~~~~~~~~~~~i--~l~   78 (175)
                      ...+.+|++.++.++|++++++++++...+..++++||+++++|.++++..         ..+++..+..++.|+  |++
T Consensus        40 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~  119 (262)
T cd00192          40 RKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME  119 (262)
T ss_pred             HHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHH
Confidence            568889999999999999999999999999999999999999999999875         679999999999998  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCCCcchhHHHHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  155 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~  155 (175)
                      +||+.|++|+||+|+||++   +.++.++|+|||.+.......   ......++..|+|||......++.++|+||+|++
T Consensus       120 ~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  196 (262)
T cd00192         120 YLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVL  196 (262)
T ss_pred             HHHcCCcccCccCcceEEE---CCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHH
Confidence            9999999999999999999   567889999999998775432   1233445778999999988889999999999999


Q ss_pred             HHHHHh-CCCCCCCCCc
Q 030527          156 LFELLN-GYPPFSVGEE  171 (175)
Q Consensus       156 ~~~~~~-g~~pf~~~~~  171 (175)
                      ++++++ |..||...+.
T Consensus       197 l~~l~~~g~~p~~~~~~  213 (262)
T cd00192         197 LWEIFTLGATPYPGLSN  213 (262)
T ss_pred             HHHHHhcCCCCCCCCCH
Confidence            999999 6999987643

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.98  E-value=1.6e-31  Score=218.39  Aligned_cols=165  Identities=36%  Similarity=0.672  Sum_probs=137.6

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHH--HH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GL   77 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i--~l   77 (175)
                      .......+..|+.++++++||||+++++++..  ...+++||||+.+++|.+++.+.    +.+++..+..|+.||  ||
T Consensus        52 ~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~AL  131 (1021)
T PTZ00266         52 KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL  131 (1021)
T ss_pred             CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHH
Confidence            34456678899999999999999999998854  45789999999999999998753    569999999999998  99


Q ss_pred             HHHHHc-------CCeecCCCCCcEEEeec--------------CCCceEEEeeecceeeccCCCccccccCCCCccCcc
Q 030527           78 EILNSH-------HIIHRDLKPENILLSGL--------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE  136 (175)
Q Consensus        78 ~~lh~~-------~~~h~di~~~ni~~~~~--------------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe  136 (175)
                      +|||+.       +++|+||+|+||++...              +....++|+|||++.............+++.|+|||
T Consensus       132 aYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPE  211 (1021)
T PTZ00266        132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPE  211 (1021)
T ss_pred             HHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHH
Confidence            999985       49999999999999521              123458999999998765544444556899999999


Q ss_pred             cccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030527          137 VLQF--QRYDEKVDMWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       137 ~~~~--~~~~~~~Di~slg~~~~~~~~g~~pf~~~~  170 (175)
                      .+.+  ..++.++|||||||++|+|++|..||...+
T Consensus       212 vL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        212 LLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             HHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence            9854  347899999999999999999999997543

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.98  E-value=2e-31  Score=195.16  Aligned_cols=161  Identities=26%  Similarity=0.577  Sum_probs=137.6

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC---------------CCCHHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------------RVPEQTARKF   71 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~   71 (175)
                      ......+.+|+++++.++|+||+++++++.+.+..++++||+++++|.+++...+               .+++.++..+
T Consensus        48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  127 (280)
T cd05092          48 ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI  127 (280)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHH
Confidence            3445678999999999999999999999999999999999999999999987543               3788999999


Q ss_pred             HHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcc
Q 030527           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK  146 (175)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~  146 (175)
                      +.|+  |+++||+.|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||...+..++.+
T Consensus       128 ~~qi~~al~~LH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (280)
T cd05092         128 ASQIASGMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE  204 (280)
T ss_pred             HHHHHHHHHHHHHCCeecccccHhhEEE---cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch
Confidence            9998  9999999999999999999999   4677899999999876543321   112233567999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCC
Q 030527          147 VDMWSVGAILFELLN-GYPPFSVGE  170 (175)
Q Consensus       147 ~Di~slg~~~~~~~~-g~~pf~~~~  170 (175)
                      +|+||||++++++++ |..||....
T Consensus       205 ~Di~slG~il~el~~~g~~p~~~~~  229 (280)
T cd05092         205 SDIWSFGVVLWEIFTYGKQPWYQLS  229 (280)
T ss_pred             hhHHHHHHHHHHHHcCCCCCCccCC
Confidence            999999999999998 999996543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.98  E-value=2.1e-31  Score=195.14  Aligned_cols=160  Identities=31%  Similarity=0.556  Sum_probs=138.7

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+.+.+|++++++++|||++++++++...+..++++||++++.+..+..+...+++..+..++.|+  ++++||+.|++
T Consensus        43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~  122 (286)
T cd07847          43 IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI  122 (286)
T ss_pred             ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            3456788999999999999999999999999999999999988888877766789999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      |+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|++++++++|..
T Consensus       123 H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~  199 (286)
T cd07847         123 HRDVKPENILI---TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP  199 (286)
T ss_pred             ecCCChhhEEE---cCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCC
Confidence            99999999999   567789999999998765443 2223446778999999865 457889999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.++
T Consensus       200 p~~~~~~  206 (286)
T cd07847         200 LWPGKSD  206 (286)
T ss_pred             CCCCCCh
Confidence            9986543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.98  E-value=1.6e-31  Score=198.62  Aligned_cols=161  Identities=30%  Similarity=0.559  Sum_probs=131.3

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEe--eCCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHH--H
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQL--G   76 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~---------~~l~~~~~~~~~~~i--~   76 (175)
                      ...+.+|++++++++||||+++.+++.  .+...++++||+. ++|.+++...         ..+++..+..++.|+  |
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  120 (317)
T cd07867          42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG  120 (317)
T ss_pred             cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence            346788999999999999999999885  3567899999984 5888877521         248889999999998  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeec-CCCceEEEeeecceeeccCCCc----cccccCCCCccCccccccc-CCCcchhHH
Q 030527           77 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMW  150 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~-~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~-~~~~~~Di~  150 (175)
                      |++||+.|++|+||||+||++... +..+.++|+|||++........    .....++..|+|||.+.+. .++.++|+|
T Consensus       121 L~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  200 (317)
T cd07867         121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  200 (317)
T ss_pred             HHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHH
Confidence            999999999999999999999532 2456799999999987644321    1234568889999998764 578999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCc
Q 030527          151 SVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       151 slg~~~~~~~~g~~pf~~~~~  171 (175)
                      |+|+++++|++|+.||....+
T Consensus       201 SlG~il~el~tg~~~f~~~~~  221 (317)
T cd07867         201 AIGCIFAELLTSEPIFHCRQE  221 (317)
T ss_pred             hHHHHHHHHHhCCCCcccccc
Confidence            999999999999999976543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.98  E-value=6e-32  Score=195.52  Aligned_cols=160  Identities=35%  Similarity=0.607  Sum_probs=144.7

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+.+|++.+++++||||+++++.+.+.+..++++||+.|++|.+++.+...+++..+..++.|+  ++++||+.|+
T Consensus        42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i  121 (258)
T cd05578          42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI  121 (258)
T ss_pred             hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567888999999999999999999999999999999999999999999887789999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +|+|++|+||++   +.++.++|+|||.+.............++..|+|||...+..++.++|+||+|++++++++|..|
T Consensus       122 ~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p  198 (258)
T cd05578         122 IHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP  198 (258)
T ss_pred             eccCCCHHHeEE---cCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCC
Confidence            999999999999   57788999999998877655444455678889999999888899999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |...+
T Consensus       199 ~~~~~  203 (258)
T cd05578         199 YRGHS  203 (258)
T ss_pred             CCCCC
Confidence            98765

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.98  E-value=1.8e-32  Score=198.70  Aligned_cols=162  Identities=35%  Similarity=0.589  Sum_probs=136.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      +....+.+|++.+++++||||+++++++...+..++|+||+++++|.+++...  ..++..+...|+.|+  |++|||+.
T Consensus        43 ~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~  122 (259)
T PF07714_consen   43 EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN  122 (259)
T ss_dssp             HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            34678899999999999999999999999888899999999999999999987  679999999999999  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      +++|++|+++||++   +.++.++|+|||++........   .........|+|||.+....++.++||||||++++|++
T Consensus       123 ~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~  199 (259)
T PF07714_consen  123 NIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEIL  199 (259)
T ss_dssp             TEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999   4677999999999987733221   22334567799999998888999999999999999999


Q ss_pred             h-CCCCCCCCCcc
Q 030527          161 N-GYPPFSVGEEH  172 (175)
Q Consensus       161 ~-g~~pf~~~~~~  172 (175)
                      + |+.||...+..
T Consensus       200 ~~~~~p~~~~~~~  212 (259)
T PF07714_consen  200 TLGKFPFSDYDNE  212 (259)
T ss_dssp             TTSSGTTTTSCHH
T ss_pred             ccccccccccccc
Confidence            9 78999776443

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.2e-31  Score=194.25  Aligned_cols=157  Identities=34%  Similarity=0.634  Sum_probs=140.0

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+++++.++|+|++++.+++.++...++|+|++++++|.+++... .+++..+..++.|+  ++.+||+.+++|
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h  121 (274)
T cd06609          43 IEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIH  121 (274)
T ss_pred             HHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            456788999999999999999999999999999999999999999998865 88999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +|++|+|+++   +.++.++++|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|++++|+.||
T Consensus       122 ~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~  198 (274)
T cd06609         122 RDIKAANILL---SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL  198 (274)
T ss_pred             CCCCHHHEEE---CCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            9999999999   567889999999998775442 223445677899999998888999999999999999999999999


Q ss_pred             CCCC
Q 030527          167 SVGE  170 (175)
Q Consensus       167 ~~~~  170 (175)
                      ...+
T Consensus       199 ~~~~  202 (274)
T cd06609         199 SDLH  202 (274)
T ss_pred             ccCc
Confidence            7644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.98  E-value=2e-31  Score=197.40  Aligned_cols=159  Identities=33%  Similarity=0.625  Sum_probs=137.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+++++.++||||+++++.+..++..++++|+++|++|.+++...+.+++..+..++.++  ++++||+.|++|
T Consensus        45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  124 (305)
T cd05609          45 IQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVH  124 (305)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            456778999999999999999999999999999999999999999999888889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC----------------ccccccCCCCccCcccccccCCCcchhHHH
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWS  151 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~----------------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~s  151 (175)
                      +|++|+||++   +..+.++++|||.+.......                ......++..|+|||.+.+..++.++|+||
T Consensus       125 ~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  201 (305)
T cd05609         125 RDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWA  201 (305)
T ss_pred             cCCchHHEEE---CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHH
Confidence            9999999999   567789999999875321110                001234567899999998888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCc
Q 030527          152 VGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       152 lg~~~~~~~~g~~pf~~~~~  171 (175)
                      +|++++++++|..||.+.+.
T Consensus       202 lG~vl~el~~g~~pf~~~~~  221 (305)
T cd05609         202 MGIILYEFLVGCVPFFGDTP  221 (305)
T ss_pred             HHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999986554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.7e-32  Score=221.38  Aligned_cols=167  Identities=29%  Similarity=0.550  Sum_probs=147.5

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHH--H
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------GRVPEQTARKFLQQL--G   76 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~i--~   76 (175)
                      +.+....|.+|+.+++.++||||++++|++.+.+..++++|||.||+|..++++.       ..++......+..++  +
T Consensus       735 ~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G  814 (1025)
T KOG1095|consen  735 SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKG  814 (1025)
T ss_pred             CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhh
Confidence            5667789999999999999999999999999999999999999999999999876       248889999999999  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc---cccCCCCccCcccccccCCCcchhHHHHH
Q 030527           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      ..||+++++|||||.++|+++   +....+|+.|||+|+...+.....   .......|||||.+....++.++||||||
T Consensus       815 ~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFG  891 (1025)
T KOG1095|consen  815 MNYLESKHFVHRDLAARNCLL---DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFG  891 (1025)
T ss_pred             hHHHHhCCCcCcchhhhheee---cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhH
Confidence            999999999999999999999   577889999999999655443221   22335679999999999999999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCccCCC
Q 030527          154 AILFELLN-GYPPFSVGEEHQFM  175 (175)
Q Consensus       154 ~~~~~~~~-g~~pf~~~~~~~~l  175 (175)
                      +++||++| |..||++.++.++|
T Consensus       892 VllWEifslG~~PY~~~~n~~v~  914 (1025)
T KOG1095|consen  892 VLLWEIFSLGATPYPSRSNFEVL  914 (1025)
T ss_pred             HHHHHHHhCCCCCCCCcchHHHH
Confidence            99999999 99999998877653

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.98  E-value=2.3e-32  Score=208.77  Aligned_cols=165  Identities=30%  Similarity=0.537  Sum_probs=143.4

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      .++.-+.|++|+..+++-+|.||+-++|++...+. .+|+.+|.|-+|..++... -+|...+.+.|+.|+  ++.|||.
T Consensus       428 t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA  506 (678)
T KOG0193|consen  428 TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA  506 (678)
T ss_pred             CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh
Confidence            56678899999999999999999999999999887 9999999999999998754 468889999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeecc---CCCccccccCCCCccCccccc---ccCCCcchhHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~---~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~  156 (175)
                      ++|||+|+|..|||+   .+++.|+|+|||++....   .........+...|+|||+++   ..+|+..+||||||++.
T Consensus       507 K~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~  583 (678)
T KOG0193|consen  507 KNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVW  583 (678)
T ss_pred             hhhhhhhccccceEE---ccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHH
Confidence            999999999999999   567899999999996442   222334556778899999996   34689999999999999


Q ss_pred             HHHHhCCCCCCCCCccCC
Q 030527          157 FELLNGYPPFSVGEEHQF  174 (175)
Q Consensus       157 ~~~~~g~~pf~~~~~~~~  174 (175)
                      |||++|..||.++..+++
T Consensus       584 YELltg~lPysi~~~dqI  601 (678)
T KOG0193|consen  584 YELLTGELPYSIQNRDQI  601 (678)
T ss_pred             HHHHhCcCCcCCCChhhe
Confidence            999999999997666554

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.98  E-value=1.4e-31  Score=194.22  Aligned_cols=159  Identities=28%  Similarity=0.508  Sum_probs=137.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|++++++++|||++++++++..++..++++||+++++|.+++....  .++...+..++.|+  ++++||+.|+
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i  125 (263)
T cd05052          46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF  125 (263)
T ss_pred             HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            3467889999999999999999999999999999999999999999997643  58899999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc--cccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      +|+||+|+||++   +.++.++|+|||.+..........  ....+..|+|||.+.+..++.++|+||||++++++++ |
T Consensus       126 ~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g  202 (263)
T cd05052         126 IHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG  202 (263)
T ss_pred             eecccCcceEEE---cCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCC
Confidence            999999999999   577889999999987765443221  1223457999999988889999999999999999998 9


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||.+.+.
T Consensus       203 ~~p~~~~~~  211 (263)
T cd05052         203 MSPYPGIDL  211 (263)
T ss_pred             CCCCCCCCH
Confidence            999976543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.98  E-value=1e-31  Score=194.17  Aligned_cols=153  Identities=42%  Similarity=0.781  Sum_probs=138.6

Q ss_pred             HHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCC
Q 030527           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLK   91 (175)
Q Consensus        14 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~   91 (175)
                      ..|+.++++++||||+++.+++...+..+++++++.+++|.+++.+...+++..+..++.|+  +|++||+.|++|+||+
T Consensus        46 ~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dik  125 (260)
T PF00069_consen   46 IREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIK  125 (260)
T ss_dssp             HHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBS
T ss_pred             hhhhhccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            45899999999999999999999999999999999888999999988899999999999999  9999999999999999


Q ss_pred             CCcEEEeecCCCceEEEeeecceeec-cCCCccccccCCCCccCccccc-ccCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030527           92 PENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus        92 ~~ni~~~~~~~~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~~~~~~~g~~pf~~~  169 (175)
                      |+||++   +.++.++|+|||.+... ..........++..|.|||... +...+.++|+||+|+++++|++|..||...
T Consensus       126 p~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  126 PENILL---DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             GGGEEE---STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999   67888999999998763 2233344566788999999998 788999999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.4e-32  Score=202.21  Aligned_cols=159  Identities=39%  Similarity=0.606  Sum_probs=147.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ..-..+|.+++++++.+.||.+-..|+....+|+|+..|.||+|.-++-+.+  .+++..+..++++|  +|.+||..++
T Consensus       229 e~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~i  308 (591)
T KOG0986|consen  229 ETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRI  308 (591)
T ss_pred             hHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcce
Confidence            3445779999999999999999999999999999999999999999988766  69999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+||+||++   |..++++|+|+|+|.....+.......||.+|||||++.+..|+.+.|-||+||++|+|+.|+.|
T Consensus       309 VYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sP  385 (591)
T KOG0986|consen  309 VYRDLKPENILL---DDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSP  385 (591)
T ss_pred             eeccCChhheee---ccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCc
Confidence            999999999999   78999999999999999888777777999999999999999999999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |....+
T Consensus       386 Fr~~Ke  391 (591)
T KOG0986|consen  386 FRQRKE  391 (591)
T ss_pred             hhhhhh
Confidence            976543

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.98  E-value=3.3e-31  Score=192.42  Aligned_cols=157  Identities=32%  Similarity=0.604  Sum_probs=136.1

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|++++++++||||+++.+++.+.  ...++++||+++++|.+++.+.+.+++..+..++.|+  ++++||+.|+
T Consensus        48 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i  127 (265)
T cd06652          48 VNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI  127 (265)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            45778899999999999999999988763  5678999999999999999887888999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC----ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      +|+||+|+||++   +.++.++|+|||.+.......    ......++..|+|||...+..++.++|+||||+++|++++
T Consensus       128 ~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~  204 (265)
T cd06652         128 VHRDIKGANILR---DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT  204 (265)
T ss_pred             ecCCCCHHHEEe---cCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhh
Confidence            999999999999   567789999999887653221    1123446788999999988889999999999999999999


Q ss_pred             CCCCCCCC
Q 030527          162 GYPPFSVG  169 (175)
Q Consensus       162 g~~pf~~~  169 (175)
                      |..||...
T Consensus       205 g~~p~~~~  212 (265)
T cd06652         205 EKPPWAEF  212 (265)
T ss_pred             CCCCCCcc
Confidence            99999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.98  E-value=2.2e-31  Score=192.80  Aligned_cols=158  Identities=25%  Similarity=0.530  Sum_probs=133.7

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|++++++++||||+++++++.. ...++|+||+++++|.+++... ..+++..+..++.|+  ++++||+.|+
T Consensus        38 ~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  116 (257)
T cd05115          38 VRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF  116 (257)
T ss_pred             HHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCe
Confidence            34568899999999999999999998754 4689999999999999998753 578999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc----ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      +|+||+|+||++   +.+..++|+|||.+.........    ....++..|+|||...+..++.++|+||||++++++++
T Consensus       117 ~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  193 (257)
T cd05115         117 VHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS  193 (257)
T ss_pred             eecccchheEEE---cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhc
Confidence            999999999999   56778999999998765433211    11222467999999888889999999999999999996


Q ss_pred             -CCCCCCCCC
Q 030527          162 -GYPPFSVGE  170 (175)
Q Consensus       162 -g~~pf~~~~  170 (175)
                       |+.||.+..
T Consensus       194 ~g~~p~~~~~  203 (257)
T cd05115         194 YGQKPYKKMK  203 (257)
T ss_pred             CCCCCcCcCC
Confidence             999997654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=4.7e-32  Score=207.63  Aligned_cols=158  Identities=34%  Similarity=0.602  Sum_probs=142.4

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC--eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      +....+|.+|+.+|+.|+||||+++++++.+..  .+.+|+|++..|+|+.|+++.+......+..|..||  +|.|||+
T Consensus        82 ~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs  161 (632)
T KOG0584|consen   82 PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHS  161 (632)
T ss_pred             hHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhc
Confidence            444588999999999999999999999997654  588999999999999999999999999999999999  9999999


Q ss_pred             cC--CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           83 HH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        83 ~~--~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      +.  |+|||||.+|||+.  +..+.+||+|+|+|+.....-.. ...||+.|||||... ..|....||||||.+++||+
T Consensus       162 ~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s~ak-svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMv  237 (632)
T KOG0584|consen  162 QDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKSHAK-SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMV  237 (632)
T ss_pred             CCCCccccccccceEEEc--CCcCceeecchhHHHHhhccccc-eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHH
Confidence            85  99999999999996  67888999999999877554333 478999999999997 78999999999999999999


Q ss_pred             hCCCCCCC
Q 030527          161 NGYPPFSV  168 (175)
Q Consensus       161 ~g~~pf~~  168 (175)
                      |+..||..
T Consensus       238 T~eYPYsE  245 (632)
T KOG0584|consen  238 TSEYPYSE  245 (632)
T ss_pred             hccCChhh
Confidence            99999963

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.98  E-value=4e-31  Score=193.51  Aligned_cols=154  Identities=35%  Similarity=0.598  Sum_probs=135.6

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+.+.+|++++++++|||++++++++..++..++++||+++++|..+    ..+++..+..++.|+  ++++||+.|
T Consensus        40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~  115 (279)
T cd06619          40 VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK  115 (279)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34456788999999999999999999999999999999999999988754    357888889999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      ++|+||+|+||++   +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|++++++++|+.
T Consensus       116 i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~  191 (279)
T cd06619         116 ILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSI-AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF  191 (279)
T ss_pred             EeeCCCCHHHEEE---CCCCCEEEeeCCcceeccccc-ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCC
Confidence            9999999999999   577889999999987664432 234467889999999988889999999999999999999999


Q ss_pred             CCCC
Q 030527          165 PFSV  168 (175)
Q Consensus       165 pf~~  168 (175)
                      ||..
T Consensus       192 pf~~  195 (279)
T cd06619         192 PYPQ  195 (279)
T ss_pred             Cchh
Confidence            9965

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.98  E-value=3.9e-31  Score=193.32  Aligned_cols=158  Identities=32%  Similarity=0.593  Sum_probs=138.7

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|+.++++++|||++++.+++.+++..++|+||+.|++|.+++.. +++++.++..++.++  +++++|+.+++
T Consensus        45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~iv  123 (277)
T cd06640          45 EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKI  123 (277)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            345788899999999999999999999999999999999999999999874 578899999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+|++|+||++   +.++.++++|||.+........ .....++..|+|||.+.+..++.++|+||+|+++++|++|+.|
T Consensus       124 H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p  200 (277)
T cd06640         124 HRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP  200 (277)
T ss_pred             CcCCChhhEEE---cCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCC
Confidence            99999999999   5677899999999876644332 2233567789999999888899999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |...+
T Consensus       201 ~~~~~  205 (277)
T cd06640         201 NSDMH  205 (277)
T ss_pred             CCCcC
Confidence            97544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.98  E-value=2e-31  Score=193.10  Aligned_cols=158  Identities=29%  Similarity=0.576  Sum_probs=137.1

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|+.+++.++|+||+++++.+...+..++++|++++++|.+++.+.  ..++...+..++.++  ++++||+.|+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i  124 (261)
T cd05072          45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY  124 (261)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            457888999999999999999999999999999999999999999999754  468889999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      +|+||+|+||++   +.++.++|+|||.+.........  ....++..|+|||...+..++.++|+||+|+++|++++ |
T Consensus       125 ~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g  201 (261)
T cd05072         125 IHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYG  201 (261)
T ss_pred             eccccchhhEEe---cCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccC
Confidence            999999999999   57778999999999876443221  12234567999999988889999999999999999998 9


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      ..||....
T Consensus       202 ~~p~~~~~  209 (261)
T cd05072         202 KIPYPGMS  209 (261)
T ss_pred             CCCCCCCC
Confidence            99997654

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.98  E-value=2.8e-31  Score=192.86  Aligned_cols=160  Identities=32%  Similarity=0.625  Sum_probs=138.4

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ......+.+|+++++.++|||++++++++.+.+..++++||+++++|.+++..    ...+++..+..++.|+  |+++|
T Consensus        43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L  122 (267)
T cd08228          43 AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM  122 (267)
T ss_pred             HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            34456788899999999999999999999999999999999999999988753    2458899999999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      |+.|++|+||+|+||++   +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++
T Consensus       123 H~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el  199 (267)
T cd08228         123 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM  199 (267)
T ss_pred             hhCCeeCCCCCHHHEEE---cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHH
Confidence            99999999999999999   5677899999998876643322 2234577889999999888899999999999999999


Q ss_pred             HhCCCCCCCC
Q 030527          160 LNGYPPFSVG  169 (175)
Q Consensus       160 ~~g~~pf~~~  169 (175)
                      ++|..||...
T Consensus       200 ~~g~~p~~~~  209 (267)
T cd08228         200 AALQSPFYGD  209 (267)
T ss_pred             hcCCCCCccc
Confidence            9999999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.98  E-value=3.5e-31  Score=191.18  Aligned_cols=159  Identities=35%  Similarity=0.675  Sum_probs=141.8

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+.+.+|+++++.++|+|++++.+++.+.+..++++||+++++|.+++.+.+.+++..+..++.|+  ++++||+.|++
T Consensus        45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  124 (258)
T cd06632          45 AVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV  124 (258)
T ss_pred             HHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            4567889999999999999999999999999999999999999999999888889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccC-CCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||.+.............++..|++||.+.... ++.++|+||+|++++++++|+.|
T Consensus       125 H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~p  201 (258)
T cd06632         125 HRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP  201 (258)
T ss_pred             cCCCCHHHEEE---CCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence            99999999999   567789999999987765544334556788899999987666 89999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |....
T Consensus       202 f~~~~  206 (258)
T cd06632         202 WSQLE  206 (258)
T ss_pred             cccCc
Confidence            97654

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.98  E-value=2.3e-31  Score=194.44  Aligned_cols=160  Identities=24%  Similarity=0.448  Sum_probs=134.9

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHH--H
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQL--G   76 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~~i--~   76 (175)
                      ....+.+|+.+++.++||||+++++++...+..++|+||+++++|.+++.+..          .++...+..++.|+  +
T Consensus        52 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  131 (277)
T cd05062          52 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG  131 (277)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHH
Confidence            34567889999999999999999999999999999999999999999987532          24667788888888  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc---ccccCCCCccCcccccccCCCcchhHHHHH
Q 030527           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      +++||+.|++|+|++|+||++   +.++.++|+|||++.........   ....++..|+|||.+.+..++.++|+||||
T Consensus       132 l~~lH~~~~vH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  208 (277)
T cd05062         132 MAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG  208 (277)
T ss_pred             HHHHHHCCcccCCcchheEEE---cCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHH
Confidence            999999999999999999999   56778999999998765433221   122345679999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCc
Q 030527          154 AILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       154 ~~~~~~~~-g~~pf~~~~~  171 (175)
                      ++++++++ |..||.+...
T Consensus       209 ~~l~el~~~~~~p~~~~~~  227 (277)
T cd05062         209 VVLWEIATLAEQPYQGMSN  227 (277)
T ss_pred             HHHHHHHcCCCCCCCCCCH
Confidence            99999999 7899976543

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.98  E-value=1.7e-31  Score=192.94  Aligned_cols=159  Identities=29%  Similarity=0.464  Sum_probs=138.3

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHc
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ...+.+.+|++.+++++||||+++++++.+ ...++++|++++++|.+++.+..  .+++..+..++.|+  ||++||+.
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~  116 (257)
T cd05040          38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK  116 (257)
T ss_pred             HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC
Confidence            445678899999999999999999999988 88999999999999999998764  68999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      |++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||...+..++.++|+||+|+++++|
T Consensus       117 ~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el  193 (257)
T cd05040         117 RFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM  193 (257)
T ss_pred             CccccccCcccEEE---ecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHH
Confidence            99999999999999   5668899999999887644321    1123456789999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCC
Q 030527          160 LN-GYPPFSVGE  170 (175)
Q Consensus       160 ~~-g~~pf~~~~  170 (175)
                      ++ |..||...+
T Consensus       194 ~t~g~~p~~~~~  205 (257)
T cd05040         194 FTYGEEPWAGLS  205 (257)
T ss_pred             HhCCCCCCCCCC
Confidence            99 999996543

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.98  E-value=1.5e-31  Score=209.48  Aligned_cols=162  Identities=30%  Similarity=0.540  Sum_probs=137.7

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC--------eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQ   74 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~   74 (175)
                      +.....+.+|+..+..++|+|++++.+.+....        ..++|+||+++++|.+++...    ..+++..+..++.|
T Consensus        72 ~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~q  151 (496)
T PTZ00283         72 EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ  151 (496)
T ss_pred             HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHH
Confidence            445567888999999999999999887765332        368999999999999998643    35899999999999


Q ss_pred             H--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC---CccccccCCCCccCcccccccCCCcchhH
Q 030527           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVDM  149 (175)
Q Consensus        75 i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Di  149 (175)
                      +  +|+|+|+.|++|+||||+||++   +.++.++|+|||+++.....   .......|+..|+|||.+.+..++.++|+
T Consensus       152 ll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DV  228 (496)
T PTZ00283        152 VLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADM  228 (496)
T ss_pred             HHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHH
Confidence            8  9999999999999999999999   56778999999998765432   22334568899999999998889999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCc
Q 030527          150 WSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       150 ~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ||+|+++|++++|+.||.+.+.
T Consensus       229 wSlGvilyeLltG~~Pf~~~~~  250 (496)
T PTZ00283        229 FSLGVLLYELLTLKRPFDGENM  250 (496)
T ss_pred             HHHHHHHHHHHHCCCCCCCCCH
Confidence            9999999999999999987553

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.98  E-value=3.8e-31  Score=195.26  Aligned_cols=157  Identities=32%  Similarity=0.622  Sum_probs=137.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+.+++.++|+|++++++.+...+..++|+||+++++|.+++.+ ..++..++..++.|+  ++++||+.|++|
T Consensus        61 ~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H  139 (296)
T cd06654          61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIH  139 (296)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            45678899999999999999999999999999999999999999999864 468899999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||+|+||++   +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||+|++++++++|+.||
T Consensus       140 ~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf  216 (296)
T cd06654         140 RDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY  216 (296)
T ss_pred             CCCCHHHEEE---cCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            9999999999   567789999999887653322 122345778899999998888899999999999999999999999


Q ss_pred             CCCC
Q 030527          167 SVGE  170 (175)
Q Consensus       167 ~~~~  170 (175)
                      ...+
T Consensus       217 ~~~~  220 (296)
T cd06654         217 LNEN  220 (296)
T ss_pred             CCCC
Confidence            7654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.98  E-value=6.2e-31  Score=192.73  Aligned_cols=157  Identities=31%  Similarity=0.491  Sum_probs=134.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+.+|+++++.++||||+++.+++...  ...+++||++.+++|.+++.+ ..+++.++..++.|+  ++++||+.|
T Consensus        49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~  127 (283)
T cd05080          49 NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQH  127 (283)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            456778899999999999999999987653  467899999999999999875 469999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      ++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||......++.++|+||||+++++++
T Consensus       128 i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~  204 (283)
T cd05080         128 YIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL  204 (283)
T ss_pred             eeccccChheEEE---cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHH
Confidence            9999999999999   5677899999999876644322    11223455699999998888999999999999999999


Q ss_pred             hCCCCCCCC
Q 030527          161 NGYPPFSVG  169 (175)
Q Consensus       161 ~g~~pf~~~  169 (175)
                      +|..||...
T Consensus       205 tg~~p~~~~  213 (283)
T cd05080         205 THCDSKQSP  213 (283)
T ss_pred             hCCCCCCCC
Confidence            999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.98  E-value=5.5e-31  Score=192.89  Aligned_cols=160  Identities=37%  Similarity=0.593  Sum_probs=137.1

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+.+|+++++.++|||++++.+++...+..++|+||+++++|..++.+ ..++++..+..++.|+  +|++||+.|
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~  123 (282)
T cd06643          44 EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK  123 (282)
T ss_pred             HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3455678899999999999999999999999999999999999999988765 4578999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccc-----ccCCCcchhHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~~  158 (175)
                      ++|+||+|+||++   +.++.++++|||++....... ......++..|+|||.+.     +..++.++|+||+|+++++
T Consensus       124 i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~e  200 (282)
T cd06643         124 IIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE  200 (282)
T ss_pred             eeecCCCcccEEE---ccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHH
Confidence            9999999999999   567789999999987653322 123345788899999873     3457889999999999999


Q ss_pred             HHhCCCCCCCCC
Q 030527          159 LLNGYPPFSVGE  170 (175)
Q Consensus       159 ~~~g~~pf~~~~  170 (175)
                      +++|+.||...+
T Consensus       201 l~~g~~p~~~~~  212 (282)
T cd06643         201 MAQIEPPHHELN  212 (282)
T ss_pred             HccCCCCccccC
Confidence            999999997654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.98  E-value=3.2e-31  Score=192.51  Aligned_cols=160  Identities=32%  Similarity=0.625  Sum_probs=139.1

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      .....+.+|+++++.++||||+++++++..++..++++|++++++|.+++..    ...+++..+..++.++  ++++||
T Consensus        44 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH  123 (267)
T cd08229          44 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH  123 (267)
T ss_pred             HHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3456788899999999999999999999999999999999999999998864    2458999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      +.|++|+||+|+||++   +.++.++++|||.+........ .....++..|+|||...+..++.++|+||+|+++++++
T Consensus       124 ~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~  200 (267)
T cd08229         124 SRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA  200 (267)
T ss_pred             HCCeecCCCCHHHEEE---cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHH
Confidence            9999999999999999   5677899999998876543322 22345778899999998888999999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|..||.+..
T Consensus       201 ~g~~p~~~~~  210 (267)
T cd08229         201 ALQSPFYGDK  210 (267)
T ss_pred             hCCCCccccc
Confidence            9999996543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=4.1e-31  Score=191.13  Aligned_cols=159  Identities=29%  Similarity=0.512  Sum_probs=136.3

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|+++++++.|||++++++++.. +..++++|++.+++|.+++.+...+++..+..++.|+  ++++||+.|++
T Consensus        39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~  117 (257)
T cd05060          39 GKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV  117 (257)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence            34578889999999999999999998764 4679999999999999999988889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc----cccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  161 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-  161 (175)
                      |+||+|+|+++   +.++.++|+|||.+..........    ...++..|+|||...+..++.++|+||||++++++++ 
T Consensus       118 H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~  194 (257)
T cd05060         118 HRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSY  194 (257)
T ss_pred             ccCcccceEEE---cCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcC
Confidence            99999999999   567789999999987664433211    1122356999999988889999999999999999998 


Q ss_pred             CCCCCCCCCc
Q 030527          162 GYPPFSVGEE  171 (175)
Q Consensus       162 g~~pf~~~~~  171 (175)
                      |+.||...++
T Consensus       195 g~~p~~~~~~  204 (257)
T cd05060         195 GAKPYGEMKG  204 (257)
T ss_pred             CCCCcccCCH
Confidence            9999976543

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=3.9e-31  Score=191.14  Aligned_cols=157  Identities=21%  Similarity=0.352  Sum_probs=133.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|++++++++|||++++++++.. ...++|+||+++++|.+++.+.. .++...+..++.|+  ++++||+.|++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  123 (259)
T cd05037          45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV  123 (259)
T ss_pred             HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence            5678899999999999999999999888 77899999999999999998766 78999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecC----CCceEEEeeecceeeccCCCccccccCCCCccCccccccc--CCCcchhHHHHHHHHHHHH
Q 030527           87 HRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        87 h~di~~~ni~~~~~~----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slg~~~~~~~  160 (175)
                      |+||+|+||+++...    ....++++|||++.....   .....++..|+|||.+.+.  .++.++|+||+|+++++++
T Consensus       124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~  200 (259)
T cd05037         124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC  200 (259)
T ss_pred             cccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence            999999999995221    112699999999877644   2233456679999998766  7899999999999999999


Q ss_pred             h-CCCCCCCCC
Q 030527          161 N-GYPPFSVGE  170 (175)
Q Consensus       161 ~-g~~pf~~~~  170 (175)
                      + |..||...+
T Consensus       201 ~~~~~p~~~~~  211 (259)
T cd05037         201 SNGEEPLSTLS  211 (259)
T ss_pred             hCCCCCcccCC
Confidence            9 588886653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.98  E-value=5.1e-31  Score=190.39  Aligned_cols=160  Identities=33%  Similarity=0.654  Sum_probs=140.0

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      .....+..|..+++.++|||++++.+.+.+.+..++++||+++++|.+++.+.  ..+++..+..++.|+  |+++||+.
T Consensus        40 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~  119 (255)
T cd08219          40 SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK  119 (255)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            34567788999999999999999999999999999999999999999988753  358899999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      |++|+||+|+||++   +.++.++++|||.+....... ......++..|+|||...+..++.++|+||+|+++++|++|
T Consensus       120 ~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g  196 (255)
T cd08219         120 RVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL  196 (255)
T ss_pred             CcccCCCCcceEEE---CCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhc
Confidence            99999999999999   567789999999987664432 22334577889999999888899999999999999999999


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      ..||...+
T Consensus       197 ~~p~~~~~  204 (255)
T cd08219         197 KHPFQANS  204 (255)
T ss_pred             cCCCCCCC
Confidence            99998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.98  E-value=6.1e-31  Score=194.17  Aligned_cols=158  Identities=32%  Similarity=0.637  Sum_probs=138.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+..++.++|||++++++++...+..++|+||+++++|..++.+ ..+++.++..++.++  ++++||+.|++|
T Consensus        60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H  138 (296)
T cd06655          60 KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIH  138 (296)
T ss_pred             HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            45678899999999999999999999999999999999999999998874 468999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||+|+||++   +.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|++++|+.||
T Consensus       139 ~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf  215 (296)
T cd06655         139 RDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY  215 (296)
T ss_pred             CCCCHHHEEE---CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999   5677899999998876543322 22345678899999998888999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.++
T Consensus       216 ~~~~~  220 (296)
T cd06655         216 LNENP  220 (296)
T ss_pred             CCCCH
Confidence            77543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=6e-31  Score=194.72  Aligned_cols=160  Identities=30%  Similarity=0.512  Sum_probs=137.4

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHH
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      .....+.+|+++++++ +||||+++++++...+..++++||+++++|.+++.+..  .+++.++..++.++  ++++||+
T Consensus        80 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~  159 (302)
T cd05055          80 SEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS  159 (302)
T ss_pred             HHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3345688999999999 89999999999999999999999999999999997643  38999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      .+++|+||+|+||++   +.+..++++|||.+........   .....++..|+|||.+.+..++.++|+||+|++++++
T Consensus       160 ~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el  236 (302)
T cd05055         160 KNCIHRDLAARNVLL---THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI  236 (302)
T ss_pred             CCeehhhhccceEEE---cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHH
Confidence            999999999999999   5677899999999876543321   1123345679999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCC
Q 030527          160 LN-GYPPFSVGE  170 (175)
Q Consensus       160 ~~-g~~pf~~~~  170 (175)
                      ++ |..||....
T Consensus       237 ~t~g~~p~~~~~  248 (302)
T cd05055         237 FSLGSNPYPGMP  248 (302)
T ss_pred             HhCCCCCcCCCC
Confidence            98 999987543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=5.9e-31  Score=191.26  Aligned_cols=158  Identities=33%  Similarity=0.641  Sum_probs=136.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|++++++++||||+++.+++..  .+..++++|++++++|.+++.+.+.+++.....++.|+  ++++||+.++
T Consensus        48 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i  127 (266)
T cd06651          48 VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI  127 (266)
T ss_pred             HHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4567889999999999999999998865  46788999999999999999887889999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC----ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      +|+|++|+||++   +.++.++|+|||++.......    ......++..|+|||.+.+..++.++|+||+|++++++++
T Consensus       128 ~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~  204 (266)
T cd06651         128 VHRDIKGANILR---DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT  204 (266)
T ss_pred             eeCCCCHHHEEE---CCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHH
Confidence            999999999999   567789999999987653321    1122346788999999988889999999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |+.||...+
T Consensus       205 g~~pf~~~~  213 (266)
T cd06651         205 EKPPWAEYE  213 (266)
T ss_pred             CCCCccccc
Confidence            999997653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=7.6e-31  Score=191.03  Aligned_cols=142  Identities=30%  Similarity=0.588  Sum_probs=127.4

Q ss_pred             CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecC
Q 030527           24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD  101 (175)
Q Consensus        24 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~  101 (175)
                      +|||++++++.+...+..++||||+++++|.+++.++..+++..+..++.|+  ++++||+.|++|+||+|+||++.   
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---  143 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---  143 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---
Confidence            7999999999999999999999999999999999887889999999999999  99999999999999999999994   


Q ss_pred             CCc-eEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          102 DDV-MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       102 ~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ..+ .++++|||.+.......   ...++..|+|||.+.+..++.++|+||+|++++++++|+.||....+
T Consensus       144 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~  211 (267)
T PHA03390        144 RAKDRIYLCDYGLCKIIGTPS---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED  211 (267)
T ss_pred             CCCCeEEEecCccceecCCCc---cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence            444 89999999887664332   33567889999999888899999999999999999999999985543

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=4.1e-31  Score=194.65  Aligned_cols=160  Identities=28%  Similarity=0.503  Sum_probs=138.5

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHH-
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQL-   75 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~~i-   75 (175)
                      .....+.+|++++++++|||++++++++..++..++++|++.+++|.+++.+..           .+++..+..++.|+ 
T Consensus        61 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  140 (296)
T cd05051          61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA  140 (296)
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHH
Confidence            346678889999999999999999999999999999999999999999998765           68999999999998 


Q ss_pred             -HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHH
Q 030527           76 -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWS  151 (175)
Q Consensus        76 -~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~s  151 (175)
                       |+++||+.|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||...+..++.++|+||
T Consensus       141 ~al~~LH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  217 (296)
T cd05051         141 SGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA  217 (296)
T ss_pred             HHHHHHHHcCccccccchhceee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhh
Confidence             9999999999999999999999   5668899999999876543321   22334566799999998888999999999


Q ss_pred             HHHHHHHHHh--CCCCCCCCC
Q 030527          152 VGAILFELLN--GYPPFSVGE  170 (175)
Q Consensus       152 lg~~~~~~~~--g~~pf~~~~  170 (175)
                      +|+++|++++  +..||...+
T Consensus       218 lG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         218 FGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             hHHHHHHHHhcCCCCCCCCcC
Confidence            9999999988  678886543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.9e-31  Score=191.06  Aligned_cols=156  Identities=28%  Similarity=0.562  Sum_probs=137.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .+++.+|+.+++.++|+|++++++++.+.+..++++|++++++|.+++++..  .+++..+..++.|+  ++++||+.|+
T Consensus        44 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i  123 (256)
T cd05039          44 AQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF  123 (256)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4678889999999999999999999998899999999999999999998765  68999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-CCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g~~  164 (175)
                      +|+||+|+||++   +.++.++|+|||.+........  ....+..|+|||.+.+..++.++|+||+|++++++++ |..
T Consensus       124 ~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~  198 (256)
T cd05039         124 VHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV  198 (256)
T ss_pred             cchhcccceEEE---eCCCCEEEcccccccccccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCC
Confidence            999999999999   5677899999999877633322  2234567999999988889999999999999999997 999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||....
T Consensus       199 p~~~~~  204 (256)
T cd05039         199 PYPRIP  204 (256)
T ss_pred             CCCCCC
Confidence            997654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.8e-31  Score=193.74  Aligned_cols=160  Identities=26%  Similarity=0.470  Sum_probs=136.9

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHH--H
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQL--G   76 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~~i--~   76 (175)
                      ....+.+|+++++.++|||++++++++...+..++++||+++++|.+++....          .+++..+..++.|+  |
T Consensus        52 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  131 (277)
T cd05032          52 ERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG  131 (277)
T ss_pred             HHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHH
Confidence            34567889999999999999999999999999999999999999999986432          36778889999998  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHH
Q 030527           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      +++||+.|++|+||+|+||++   +.++.++|+|||.++.......   .....++..|+|||...+..++.++|+||||
T Consensus       132 l~~lH~~~i~H~di~p~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  208 (277)
T cd05032         132 MAYLAAKKFVHRDLAARNCMV---AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFG  208 (277)
T ss_pred             HHHHHhCCccccccChheEEE---cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHH
Confidence            999999999999999999999   5778899999999876544321   1233346789999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCc
Q 030527          154 AILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       154 ~~~~~~~~-g~~pf~~~~~  171 (175)
                      ++++++++ |..||.+.+.
T Consensus       209 ~il~el~t~g~~p~~~~~~  227 (277)
T cd05032         209 VVLWEMATLAEQPYQGLSN  227 (277)
T ss_pred             HHHHHhhccCCCCCccCCH
Confidence            99999998 9999976553

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=8.6e-31  Score=191.39  Aligned_cols=159  Identities=26%  Similarity=0.379  Sum_probs=132.9

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|++++++++||||+++++++...+..++||||+++++|..++.+ .+.+++..+..++.|+  |++|||++|++
T Consensus        60 ~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ii  139 (274)
T cd05076          60 ALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLV  139 (274)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCcc
Confidence            44677889999999999999999999999999999999999999999876 4578999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeec----CCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHH-
Q 030527           87 HRDLKPENILLSGL----DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL-  160 (175)
Q Consensus        87 h~di~~~ni~~~~~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~-  160 (175)
                      |+||+|+||++...    .....++++|||.+......   ....++..|+|||.+.+ ..++.++|+||||+++++++ 
T Consensus       140 H~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~  216 (274)
T cd05076         140 HGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF  216 (274)
T ss_pred             CCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence            99999999999521    12335899999987554322   12345678999998865 56899999999999999984 


Q ss_pred             hCCCCCCCCCc
Q 030527          161 NGYPPFSVGEE  171 (175)
Q Consensus       161 ~g~~pf~~~~~  171 (175)
                      +|+.||....+
T Consensus       217 ~g~~p~~~~~~  227 (274)
T cd05076         217 DGEVPLKERTP  227 (274)
T ss_pred             CCCCCccccCh
Confidence            69999976544

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=6.9e-31  Score=200.93  Aligned_cols=159  Identities=30%  Similarity=0.526  Sum_probs=134.9

Q ss_pred             hhhhhHHHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--------------------------
Q 030527            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------------------   60 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------------------   60 (175)
                      .....+.+|+++++.+. ||||+++++++.+.+..++||||+++++|.+++.++                          
T Consensus        82 ~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (400)
T cd05105          82 SEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADE  161 (400)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccc
Confidence            34567889999999995 999999999999999999999999999999988643                          


Q ss_pred             ----------------------------------------------------------------------CCCCHHHHHH
Q 030527           61 ----------------------------------------------------------------------GRVPEQTARK   70 (175)
Q Consensus        61 ----------------------------------------------------------------------~~l~~~~~~~   70 (175)
                                                                                            ..+++..+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~  241 (400)
T cd05105         162 STRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLS  241 (400)
T ss_pred             cccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHH
Confidence                                                                                  1367777888


Q ss_pred             HHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCc
Q 030527           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  145 (175)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~  145 (175)
                      ++.|+  |++|||+.+++|+||+|+||++   +.+..++|+|||++........   .....++..|+|||.+.+..++.
T Consensus       242 ~~~qi~~aL~~LH~~~ivH~dikp~Nill---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  318 (400)
T cd05105         242 FTYQVARGMEFLASKNCVHRDLAARNVLL---AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT  318 (400)
T ss_pred             HHHHHHHHHHHHHhCCeeCCCCChHhEEE---eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc
Confidence            99998  9999999999999999999999   4677899999999876543221   22334567799999998888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCC
Q 030527          146 KVDMWSVGAILFELLN-GYPPFSVG  169 (175)
Q Consensus       146 ~~Di~slg~~~~~~~~-g~~pf~~~  169 (175)
                      ++|+||||++++++++ |..||...
T Consensus       319 ~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         319 LSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCccc
Confidence            9999999999999997 99999754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=4.6e-31  Score=194.11  Aligned_cols=160  Identities=31%  Similarity=0.517  Sum_probs=136.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc------------------------CCCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------GRVP   64 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~l~   64 (175)
                      ....+.+|+.+++.++||||+++++.+...+..++++||+.+++|.+++...                        ..++
T Consensus        46 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  125 (290)
T cd05045          46 ELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT  125 (290)
T ss_pred             HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccC
Confidence            3457888999999999999999999999999999999999999999998642                        2377


Q ss_pred             HHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCccccc
Q 030527           65 EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQ  139 (175)
Q Consensus        65 ~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~  139 (175)
                      ..++..++.|+  ++++||+.|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||...
T Consensus       126 ~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  202 (290)
T cd05045         126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF  202 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence            88889999998  9999999999999999999999   4677899999999876533221   12233456799999988


Q ss_pred             ccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          140 FQRYDEKVDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       140 ~~~~~~~~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      +..++.++|+||||++++++++ |..||.+..+
T Consensus       203 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         203 DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             cCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            8889999999999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=1.3e-30  Score=188.37  Aligned_cols=160  Identities=28%  Similarity=0.626  Sum_probs=137.4

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEee-CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ...+.+.+|++++++++|+|++++.+.+.. ++..++++|++++++|.+++...  ..+++.++..++.++  ++++||+
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~  120 (257)
T cd08223          41 RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE  120 (257)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            344567889999999999999999988764 45689999999999999998763  358999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      .|++|+||+|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++
T Consensus       121 ~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~  197 (257)
T cd08223         121 KHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT  197 (257)
T ss_pred             CCeeccCCCchhEEE---ecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHc
Confidence            999999999999999   567789999999987664332 2234456788999999998889999999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |+.||...+
T Consensus       198 g~~~~~~~~  206 (257)
T cd08223         198 LKHAFNAKD  206 (257)
T ss_pred             CCCCCCCCC
Confidence            999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=6e-31  Score=191.05  Aligned_cols=158  Identities=22%  Similarity=0.351  Sum_probs=132.1

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|+.++++++||||+++++++..+...++++||+.+++|..++.+. ..+++..+..++.|+  |++|||+.|++
T Consensus        48 ~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  127 (262)
T cd05077          48 SLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLV  127 (262)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeE
Confidence            346788899999999999999999999988999999999999999988754 568999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecC----CCceEEEeeecceeeccCCCccccccCCCCccCccccc-ccCCCcchhHHHHHHHHHHHH-
Q 030527           87 HRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELL-  160 (175)
Q Consensus        87 h~di~~~ni~~~~~~----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~~~~~~-  160 (175)
                      |+||+|+||++....    ....++++|||.+......   ....++..|+|||.+. +..++.++|+||+|+++|+++ 
T Consensus       128 H~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~  204 (262)
T cd05077         128 HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY  204 (262)
T ss_pred             CCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHh
Confidence            999999999995211    1223899999988655322   2334577899999886 456899999999999999997 


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|..||....
T Consensus       205 ~~~~p~~~~~  214 (262)
T cd05077         205 NGEIPLKDKT  214 (262)
T ss_pred             CCCCCCCCcc
Confidence            5899987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=1.9e-31  Score=207.97  Aligned_cols=159  Identities=26%  Similarity=0.480  Sum_probs=130.6

Q ss_pred             hhhHHHHHHHHhhCCCC------CeeeEeeEEeeC-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527           10 KSCLDCELNFLSSVNHP------NIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      .+.+..|+++++.++|.      +++++.+++... ++.++|++++ |++|.+++.+.+.+++..+..++.|+  ||+||
T Consensus       169 ~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yL  247 (467)
T PTZ00284        169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYF  247 (467)
T ss_pred             HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Confidence            44566788888877554      588888888764 5789999988 88999999888899999999999998  99999


Q ss_pred             HH-cCCeecCCCCCcEEEeecCC-------------CceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcc
Q 030527           81 NS-HHIIHRDLKPENILLSGLDD-------------DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK  146 (175)
Q Consensus        81 h~-~~~~h~di~~~ni~~~~~~~-------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~  146 (175)
                      |+ .|++|+||||+||++...+.             ...++|+|||.+......  .....++..|+|||.+.+..++.+
T Consensus       248 H~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~~~~  325 (467)
T PTZ00284        248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVLGLGWMYS  325 (467)
T ss_pred             HhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc--cccccCCccccCcHHhhcCCCCcH
Confidence            98 59999999999999952211             125999999987543222  234567899999999999999999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          147 VDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       147 ~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      +|+|||||++|+|++|+.||.+.++
T Consensus       326 ~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        326 TDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            9999999999999999999987654

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=3.8e-31  Score=196.86  Aligned_cols=160  Identities=26%  Similarity=0.413  Sum_probs=136.2

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ....+++.+|+.++++++||||+++++++... ..+++++++++++|.+++.+. ..++...+..++.|+  ||+|||+.
T Consensus        50 ~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~  128 (316)
T cd05108          50 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER  128 (316)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc
Confidence            34456788999999999999999999998765 467899999999999999875 468899999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc---cccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      |++|+||+|+||++   +.++.++|+|||++..........   ....+..|++||.+.+..++.++|+||||+++|+++
T Consensus       129 ~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~  205 (316)
T cd05108         129 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM  205 (316)
T ss_pred             CeeccccchhheEe---cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHH
Confidence            99999999999999   567789999999998765433211   222355799999998888999999999999999999


Q ss_pred             h-CCCCCCCCC
Q 030527          161 N-GYPPFSVGE  170 (175)
Q Consensus       161 ~-g~~pf~~~~  170 (175)
                      + |..||.+..
T Consensus       206 t~g~~p~~~~~  216 (316)
T cd05108         206 TFGSKPYDGIP  216 (316)
T ss_pred             cCCCCCCCCCC
Confidence            8 999997654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=4.7e-31  Score=191.99  Aligned_cols=161  Identities=25%  Similarity=0.509  Sum_probs=137.3

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      +.....+..|+.++++++||||+++.+++..++..++++||+++++|.+++... +.++..++..++.|+  |+++||+.
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~  125 (269)
T cd05065          46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM  125 (269)
T ss_pred             HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            445678899999999999999999999999999999999999999999999864 568999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcccc----cc--CCCCccCcccccccCCCcchhHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK----VC--GSPLYMAPEVLQFQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~----~~--~~~~~~~pe~~~~~~~~~~~Di~slg~~~~  157 (175)
                      |++|+||+|+|+++   +.+..++++|||.+...........    ..  .+..|+|||...+..++.++|+||+|++++
T Consensus       126 g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~  202 (269)
T cd05065         126 NYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW  202 (269)
T ss_pred             CEeecccChheEEE---cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHH
Confidence            99999999999999   5677899999998865543321111    11  134699999998888999999999999999


Q ss_pred             HHHh-CCCCCCCCC
Q 030527          158 ELLN-GYPPFSVGE  170 (175)
Q Consensus       158 ~~~~-g~~pf~~~~  170 (175)
                      ++++ |..||...+
T Consensus       203 e~l~~g~~p~~~~~  216 (269)
T cd05065         203 EVMSYGERPYWDMS  216 (269)
T ss_pred             HHhcCCCCCCCCCC
Confidence            9886 999997654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=4e-31  Score=195.94  Aligned_cols=159  Identities=32%  Similarity=0.545  Sum_probs=135.2

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHH
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARKFL   72 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~~   72 (175)
                      ...+..|+++++.+ +||||+++++++...+..++++||+++++|.+++.+..                .++..++..++
T Consensus        67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  146 (307)
T cd05098          67 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCA  146 (307)
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence            45678899999999 89999999999999999999999999999999997642                37888899999


Q ss_pred             HHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcch
Q 030527           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  147 (175)
Q Consensus        73 ~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~  147 (175)
                      .|+  ++++||+.|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||.+.+..++.++
T Consensus       147 ~qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  223 (307)
T cd05098         147 YQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS  223 (307)
T ss_pred             HHHHHHHHHHHHCCcccccccHHheEE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHH
Confidence            998  9999999999999999999999   5677899999999876543221   1112234579999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          148 DMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       148 Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      |+||+|+++++|++ |..||.+...
T Consensus       224 DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         224 DVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             HHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            99999999999998 8999976543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=5.5e-31  Score=193.31  Aligned_cols=155  Identities=37%  Similarity=0.590  Sum_probs=131.0

Q ss_pred             hHHHHHHHHhhC---CCCCeeeEeeEEee-----CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHH
Q 030527           12 CLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus        12 ~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~   79 (175)
                      .+.+|+++++.+   +||||+++++++..     ....++++|++. ++|.+++.+.  ..+++..+..++.|+  |+++
T Consensus        45 ~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~  123 (288)
T cd07863          45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF  123 (288)
T ss_pred             HHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence            456677777665   79999999998764     345799999996 5899988764  348999999999998  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      ||+.|++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|++++++
T Consensus       124 lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l  200 (288)
T cd07863         124 LHANCIVHRDLKPENILV---TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM  200 (288)
T ss_pred             HHhCCeecCCCCHHHEEE---CCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHH
Confidence            999999999999999999   57788999999998776544333345578889999999888899999999999999999


Q ss_pred             HhCCCCCCCCC
Q 030527          160 LNGYPPFSVGE  170 (175)
Q Consensus       160 ~~g~~pf~~~~  170 (175)
                      ++|.+||.+..
T Consensus       201 ~~g~~~f~~~~  211 (288)
T cd07863         201 FRRKPLFCGNS  211 (288)
T ss_pred             HhCCcCcCCCC
Confidence            99999997654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=4e-31  Score=192.39  Aligned_cols=160  Identities=26%  Similarity=0.497  Sum_probs=131.9

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-----CCCHHHHHHHHHHH--HHHHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----RVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ....+.+|++.++.++||||+++++.+...+..+++|||+++++|.+++.+..     ..++..+..++.|+  +++|||
T Consensus        38 ~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  117 (269)
T cd05042          38 EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH  117 (269)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            34567889999999999999999999999999999999999999999997643     24677788899998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccc-------cCCCcchhHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-------QRYDEKVDMWS  151 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~-------~~~~~~~Di~s  151 (175)
                      ++|++|+||||+||++   +.++.++++|||++........   .....++..|+|||....       ..++.++|+||
T Consensus       118 ~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws  194 (269)
T cd05042         118 QADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS  194 (269)
T ss_pred             hcCEecccccHhheEe---cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHH
Confidence            9999999999999999   5677899999999865433221   122234567999998642       35688999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCc
Q 030527          152 VGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       152 lg~~~~~~~~-g~~pf~~~~~  171 (175)
                      +|++++++++ |..||....+
T Consensus       195 lG~~l~el~~~~~~p~~~~~~  215 (269)
T cd05042         195 LGVTMWELFTAADQPYPDLSD  215 (269)
T ss_pred             HHHHHHHHHhCCCCCCCcCCH
Confidence            9999999999 7889876543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=6.3e-31  Score=192.85  Aligned_cols=161  Identities=33%  Similarity=0.576  Sum_probs=141.8

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH-c
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-H   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~-~   83 (175)
                      ......+.+|+++++.++||||+++.+++...+..++|+||+++++|.+++.+.+.+++..+..++.++  ++.+||+ .
T Consensus        44 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~  123 (284)
T cd06620          44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH  123 (284)
T ss_pred             chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            345678889999999999999999999999999999999999999999999888889999999999998  8999997 5


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +++|+|++|+|+++   +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|++++++++|.
T Consensus       124 ~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~  199 (284)
T cd06620         124 RIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINSI-ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK  199 (284)
T ss_pred             CeeccCCCHHHEEE---CCCCcEEEccCCcccchhhhc-cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCC
Confidence            89999999999999   567789999999886553322 23446788999999998888999999999999999999999


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||....+
T Consensus       200 ~p~~~~~~  207 (284)
T cd06620         200 FPFAFSNI  207 (284)
T ss_pred             CCCcccch
Confidence            99986543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.8e-31  Score=191.87  Aligned_cols=160  Identities=38%  Similarity=0.609  Sum_probs=137.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+..|++++++++|||++++.+++..++..++||||+++++|.+++.+. ..+++..+..++.|+  ++++||+.|
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~  123 (280)
T cd06611          44 EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK  123 (280)
T ss_pred             HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34456888999999999999999999999999999999999999999998764 469999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccc-----ccCCCcchhHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~~  158 (175)
                      ++|+|++|+||++   +.++.++|+|||.+....... ......++..|++||.+.     ...++.++|+||+|+++|+
T Consensus       124 i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~  200 (280)
T cd06611         124 VIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIE  200 (280)
T ss_pred             cccCCCChhhEEE---CCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHH
Confidence            9999999999999   567889999999876653322 223345788899999874     3446789999999999999


Q ss_pred             HHhCCCCCCCCC
Q 030527          159 LLNGYPPFSVGE  170 (175)
Q Consensus       159 ~~~g~~pf~~~~  170 (175)
                      +++|+.||.+.+
T Consensus       201 l~~g~~p~~~~~  212 (280)
T cd06611         201 LAQMEPPHHELN  212 (280)
T ss_pred             HHhCCCCcccCC
Confidence            999999997654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=1e-30  Score=193.01  Aligned_cols=159  Identities=31%  Similarity=0.605  Sum_probs=138.7

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|+.+++.++|+|++++++++...+..++|+||+++++|.+++.+ ..+++.++..++.++  ++.+||+.|++
T Consensus        59 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~  137 (297)
T cd06656          59 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVI  137 (297)
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            345678899999999999999999999999999999999999999999864 468889999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+|++|+||++   +.++.++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|+.|
T Consensus       138 H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~p  214 (297)
T cd06656         138 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP  214 (297)
T ss_pred             cCCCCHHHEEE---CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999   5677899999998876543322 2234567889999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |...++
T Consensus       215 f~~~~~  220 (297)
T cd06656         215 YLNENP  220 (297)
T ss_pred             CCCCCc
Confidence            976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=7.7e-31  Score=190.74  Aligned_cols=160  Identities=26%  Similarity=0.506  Sum_probs=137.9

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+.+|+.++++++||||+++.+++..++..+++|||+++++|.+++.+. +.++..++..++.|+  ++++||+.|
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  126 (267)
T cd05066          47 KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG  126 (267)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34567889999999999999999999999999999999999999999999865 468999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc----cccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      ++|+|++|+|+++   +.++.++++|||.+..........    ...++..|++||...+..++.++|+||+|+++++++
T Consensus       127 i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell  203 (267)
T cd05066         127 YVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM  203 (267)
T ss_pred             EeehhhchhcEEE---CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHh
Confidence            9999999999999   567789999999987765432211    112245699999998888999999999999999988


Q ss_pred             h-CCCCCCCCC
Q 030527          161 N-GYPPFSVGE  170 (175)
Q Consensus       161 ~-g~~pf~~~~  170 (175)
                      + |..||...+
T Consensus       204 ~~g~~p~~~~~  214 (267)
T cd05066         204 SYGERPYWEMS  214 (267)
T ss_pred             cCCCCCcccCC
Confidence            6 999997654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=6.8e-31  Score=191.21  Aligned_cols=159  Identities=27%  Similarity=0.490  Sum_probs=131.2

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-----CCCHHHHHHHHHHH--HHHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----RVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ...+.+|+.++++++||||+++++++.+....++||||+++++|.+++....     ..+...+..++.|+  |+++||+
T Consensus        39 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  118 (269)
T cd05087          39 QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK  118 (269)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence            3467889999999999999999999999999999999999999999987532     35667777888888  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCccccccc-------CCCcchhHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQ-------RYDEKVDMWSV  152 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~-------~~~~~~Di~sl  152 (175)
                      .|++|+|++|+|+++   +.+..++|+|||.+........   .....++..|+|||.+.+.       .++.++|+||+
T Consensus       119 ~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl  195 (269)
T cd05087         119 NNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSL  195 (269)
T ss_pred             CCEeccccCcceEEE---cCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHH
Confidence            999999999999999   5677899999998865433221   1123456779999987532       35789999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCc
Q 030527          153 GAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       153 g~~~~~~~~-g~~pf~~~~~  171 (175)
                      |++++++++ |..||...++
T Consensus       196 G~~l~el~~~g~~p~~~~~~  215 (269)
T cd05087         196 GVTIWELFELGSQPYRHLSD  215 (269)
T ss_pred             HHHHHHHHhCCCCCCCCCCh
Confidence            999999996 9999976543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=1.5e-30  Score=187.34  Aligned_cols=159  Identities=32%  Similarity=0.560  Sum_probs=136.4

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|++++++++|||++++++++...+..++||||+++++|.+++... ..+++..+..++.++  ++.++|+.|+
T Consensus        35 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~  114 (250)
T cd05085          35 LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC  114 (250)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3456888999999999999999999999999999999999999999998754 468899999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc--cccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      +|+|++|+||++   +.++.++|+|||++..........  ....+..|+|||...+..++.++|+||+|++++++++ |
T Consensus       115 ~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g  191 (250)
T cd05085         115 IHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLG  191 (250)
T ss_pred             eecccChheEEE---cCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCC
Confidence            999999999999   567789999999987654332211  2233556999999988889999999999999999998 9


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      ..||....
T Consensus       192 ~~p~~~~~  199 (250)
T cd05085         192 VCPYPGMT  199 (250)
T ss_pred             CCCCCCCC
Confidence            99997643

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=2.6e-31  Score=194.17  Aligned_cols=159  Identities=31%  Similarity=0.581  Sum_probs=138.6

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .....+.+|++++++++||||+++.+++..++..++|+||+++++|.+++.. +.+++..+..++.++  ++.+||+.|+
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i  122 (277)
T cd06642          44 DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERK  122 (277)
T ss_pred             HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            3445788999999999999999999999999999999999999999998864 578899999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+||+|+||++   +.++.++++|||++........ .....++..|+|||...+..++.++|+||+|++++++++|+.
T Consensus       123 vH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~  199 (277)
T cd06642         123 IHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP  199 (277)
T ss_pred             eccCCChheEEE---eCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCC
Confidence            999999999999   4677899999999876644322 223456788999999988889999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||....
T Consensus       200 p~~~~~  205 (277)
T cd06642         200 PNSDLH  205 (277)
T ss_pred             CCcccc
Confidence            996543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.3e-31  Score=190.28  Aligned_cols=158  Identities=30%  Similarity=0.603  Sum_probs=136.9

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+.+|++++++++|+||+++++++.+.  +..++++|++++++|.+++.+.+.+++..+..++.|+  ++++||+.|
T Consensus        47 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~  126 (264)
T cd06653          47 EVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM  126 (264)
T ss_pred             HHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            445788899999999999999999998664  4688999999999999999887789999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC----ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      ++|+|++|+||++   +.++.++|+|||.+.......    ......++..|+|||.+.+..++.++|+||+|+++++++
T Consensus       127 i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  203 (264)
T cd06653         127 IVHRDIKGANILR---DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML  203 (264)
T ss_pred             EecCCCCHHHEEE---cCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHH
Confidence            9999999999999   567789999999987653321    111234678899999998888999999999999999999


Q ss_pred             hCCCCCCCC
Q 030527          161 NGYPPFSVG  169 (175)
Q Consensus       161 ~g~~pf~~~  169 (175)
                      +|..||...
T Consensus       204 ~g~~p~~~~  212 (264)
T cd06653         204 TEKPPWAEY  212 (264)
T ss_pred             hCCCCCCcc
Confidence            999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=5.1e-31  Score=191.31  Aligned_cols=158  Identities=24%  Similarity=0.467  Sum_probs=134.1

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|+++++.++||||+++.+++.. ...++++|++++++|.+++.+.  ..+++..+..++.++  +++++|+.|+
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i  123 (262)
T cd05071          45 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY  123 (262)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            4568889999999999999999988754 4578999999999999999763  357889999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      +|+||+|+||++   +.++.++|+|||.+.........  ....++..|+|||...+..++.++|+||+|++++++++ |
T Consensus       124 ~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g  200 (262)
T cd05071         124 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG  200 (262)
T ss_pred             cccccCcccEEE---cCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCC
Confidence            999999999999   46778999999999766443321  12334567999999988889999999999999999999 8


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||.+..+
T Consensus       201 ~~p~~~~~~  209 (262)
T cd05071         201 RVPYPGMVN  209 (262)
T ss_pred             CCCCCCCCh
Confidence            999976543

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=4e-31  Score=193.69  Aligned_cols=160  Identities=26%  Similarity=0.575  Sum_probs=135.8

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKFL   72 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~   72 (175)
                      ....+..|.+++++++||||+++++++...+..+++++|+.+++|.+++...                ..++...+..++
T Consensus        51 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  130 (283)
T cd05091          51 LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV  130 (283)
T ss_pred             HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHH
Confidence            3566888999999999999999999999999999999999999999998532                247888889999


Q ss_pred             HHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcch
Q 030527           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  147 (175)
Q Consensus        73 ~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~  147 (175)
                      .|+  |++++|+.|++|+||||+||++   +.+..++|+|||++........   .....++..|+|||...+..++.++
T Consensus       131 ~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  207 (283)
T cd05091         131 TQIAAGMEFLSSHHVVHKDLATRNVLV---FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS  207 (283)
T ss_pred             HHHHHHHHHHHHcCccccccchhheEe---cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcch
Confidence            998  9999999999999999999999   4667799999999876543321   1233346789999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          148 DMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       148 Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      |+||+|++++++++ |..||.+...
T Consensus       208 Dv~slG~~l~el~~~g~~p~~~~~~  232 (283)
T cd05091         208 DIWSYGVVLWEVFSYGLQPYCGYSN  232 (283)
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999998 8889976543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.1e-31  Score=199.32  Aligned_cols=154  Identities=34%  Similarity=0.607  Sum_probs=131.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ...+.+|++++++++||||+++++++...      ...+++++++ +++|.++++ ...+++..+..++.|+  ||+|||
T Consensus        58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH  135 (343)
T cd07878          58 ARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIH  135 (343)
T ss_pred             HHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34567899999999999999999887543      3568999987 889988776 4679999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~  160 (175)
                      +.|++|+||+|+||++   +.++.++|+|||++.......  ....++..|+|||.+.+ ..++.++|+||+|+++++|+
T Consensus       136 ~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  210 (343)
T cd07878         136 SAGIIHRDLKPSNVAV---NEDCELRILDFGLARQADDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  210 (343)
T ss_pred             HCCeecccCChhhEEE---CCCCCEEEcCCccceecCCCc--CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHH
Confidence            9999999999999999   577889999999998764432  23457889999999876 46889999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|+.||.+.+
T Consensus       211 ~g~~pf~~~~  220 (343)
T cd07878         211 KGKALFPGND  220 (343)
T ss_pred             HCCCCCCCCC
Confidence            9999997654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.3e-31  Score=194.86  Aligned_cols=160  Identities=32%  Similarity=0.557  Sum_probs=138.4

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ..+.+..|++.++.++||+|+++++.+.+.+..++++|++.|++|.+++.+.  ..+++..+..++.|+  ++++||+.|
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  123 (316)
T cd05574          44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG  123 (316)
T ss_pred             HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4456888999999999999999999999999999999999999999998864  468999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc------------------------------cccccCCCCccC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY------------------------------AEKVCGSPLYMA  134 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~------------------------------~~~~~~~~~~~~  134 (175)
                      ++|+||+|+||++   +.++.++|+|||++........                              .....++..|+|
T Consensus       124 i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~a  200 (316)
T cd05574         124 IVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIA  200 (316)
T ss_pred             eeccCCChHHeEE---cCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcC
Confidence            9999999999999   4677899999998865432210                              112346778999


Q ss_pred             cccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          135 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       135 pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ||...+..++.++|+||+|+++|++++|+.||.+.+.
T Consensus       201 PE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         201 PEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             HHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            9999888899999999999999999999999976653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=9.1e-31  Score=190.32  Aligned_cols=161  Identities=25%  Similarity=0.471  Sum_probs=137.7

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ...+.+.+|++++++++|||++++.+++...+..+++||++++++|.+++.+. +.++..++..++.++  |+++||+.|
T Consensus        48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~  127 (268)
T cd05063          48 KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN  127 (268)
T ss_pred             HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34567889999999999999999999999999999999999999999999764 578999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc----cccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      ++|+|++|+||++   +.+..++++|||.+..........    ....+..|+|||...+..++.++|+||+|+++|+++
T Consensus       128 i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell  204 (268)
T cd05063         128 YVHRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM  204 (268)
T ss_pred             eeccccchhhEEE---cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHH
Confidence            9999999999999   567789999999987664332111    112234699999998888999999999999999999


Q ss_pred             h-CCCCCCCCCc
Q 030527          161 N-GYPPFSVGEE  171 (175)
Q Consensus       161 ~-g~~pf~~~~~  171 (175)
                      + |+.||...+.
T Consensus       205 ~~g~~p~~~~~~  216 (268)
T cd05063         205 SFGERPYWDMSN  216 (268)
T ss_pred             hCCCCCCCcCCH
Confidence            7 9999976543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.97  E-value=9.2e-31  Score=190.18  Aligned_cols=161  Identities=25%  Similarity=0.505  Sum_probs=138.5

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ...+..+..|+.++++++||||+++.+++...+..++++|++++++|.+++.+. +.++...+..++.++  ++++||+.
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~  125 (266)
T cd05033          46 DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM  125 (266)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            334567888999999999999999999999999999999999999999999765 478999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      |++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||...+..++.++|+||+|+++++++
T Consensus       126 ~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~  202 (266)
T cd05033         126 NYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM  202 (266)
T ss_pred             CcccCCCCcceEEE---cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHH
Confidence            99999999999999   5677899999999987742211   11223356799999998888999999999999999999


Q ss_pred             h-CCCCCCCCC
Q 030527          161 N-GYPPFSVGE  170 (175)
Q Consensus       161 ~-g~~pf~~~~  170 (175)
                      + |..||...+
T Consensus       203 ~~g~~p~~~~~  213 (266)
T cd05033         203 SYGERPYWDMS  213 (266)
T ss_pred             ccCCCCCCCCC
Confidence            8 999996544

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=1.7e-30  Score=191.31  Aligned_cols=160  Identities=34%  Similarity=0.561  Sum_probs=136.3

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+.+|+.+++.++|||++++.+.+..++..++||||+++++|..++.+ ...+++..+..++.|+  ++++||+.|
T Consensus        51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~  130 (292)
T cd06644          51 EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK  130 (292)
T ss_pred             HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            3456678899999999999999999999999999999999999999888765 3568999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccc-----ccCCCcchhHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~~  158 (175)
                      ++|+|++|+||++   +.++.++|+|||.+....... ......++..|+|||.+.     ...++.++|+||+|+++|+
T Consensus       131 i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~e  207 (292)
T cd06644         131 IIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE  207 (292)
T ss_pred             eeecCCCcceEEE---cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHH
Confidence            9999999999999   567789999999886643322 123445678899999874     3446788999999999999


Q ss_pred             HHhCCCCCCCCC
Q 030527          159 LLNGYPPFSVGE  170 (175)
Q Consensus       159 ~~~g~~pf~~~~  170 (175)
                      +++|..||...+
T Consensus       208 l~~g~~p~~~~~  219 (292)
T cd06644         208 MAQIEPPHHELN  219 (292)
T ss_pred             HhcCCCCCcccc
Confidence            999999997643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=1.1e-30  Score=194.26  Aligned_cols=160  Identities=31%  Similarity=0.519  Sum_probs=135.2

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHH
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF   71 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~   71 (175)
                      ....+..|+++++++ +||||+++++++...+..++++||+++++|.+++.+.                ..++..++..+
T Consensus        60 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  139 (314)
T cd05099          60 DLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC  139 (314)
T ss_pred             HHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHH
Confidence            345678899999999 6999999999999999999999999999999999753                23788888999


Q ss_pred             HHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcc
Q 030527           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK  146 (175)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~  146 (175)
                      +.|+  |+++||+.|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||.+.+..++.+
T Consensus       140 ~~qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  216 (314)
T cd05099         140 AYQVARGMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ  216 (314)
T ss_pred             HHHHHHHHHHHHHCCeeeccccceeEEE---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc
Confidence            9998  9999999999999999999999   5677899999999976543211   111223456999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          147 VDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       147 ~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      +|+||+|++++++++ |..||.+.+.
T Consensus       217 ~DiwslG~~l~el~~~g~~p~~~~~~  242 (314)
T cd05099         217 SDVWSFGILMWEIFTLGGSPYPGIPV  242 (314)
T ss_pred             chhhHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999 8999976543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=1e-30  Score=189.26  Aligned_cols=159  Identities=35%  Similarity=0.593  Sum_probs=143.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH-cCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-HHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~-~~~   85 (175)
                      ....+.+|++.+++++|+|++++.+++...+..++++||+++++|.+++.+...+++..+..++.|+  ++++||+ .|+
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~  121 (264)
T cd06623          42 FRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI  121 (264)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCC
Confidence            4678899999999999999999999999999999999999999999999988889999999999998  9999999 999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc-ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+|++|+||++   +.++.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++++|+.
T Consensus       122 ~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~  198 (264)
T cd06623         122 IHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKF  198 (264)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999   57788999999998876544332 24456788999999988889999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||....
T Consensus       199 p~~~~~  204 (264)
T cd06623         199 PFLPPG  204 (264)
T ss_pred             CCcccc
Confidence            997664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=1e-30  Score=191.72  Aligned_cols=160  Identities=34%  Similarity=0.578  Sum_probs=139.3

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .....+.+|++++++++|+||+++.+++...+..++++||+.++.+..+..+...+++..+..++.++  ++++||+.|+
T Consensus        42 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i  121 (288)
T cd07833          42 DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI  121 (288)
T ss_pred             cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567889999999999999999999999999999999999887777666666679999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC--ccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g  162 (175)
                      +|+|++|+||++   +.++.++|+|||.+.......  ......++..|+|||.+.+. .++.++|+||+|++++++++|
T Consensus       122 ~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g  198 (288)
T cd07833         122 IHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG  198 (288)
T ss_pred             ecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhC
Confidence            999999999999   568889999999987765443  22334567889999999877 789999999999999999999


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      +.||.+.+
T Consensus       199 ~~~~~~~~  206 (288)
T cd07833         199 EPLFPGDS  206 (288)
T ss_pred             CCCCCCCC
Confidence            99997643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-32  Score=219.04  Aligned_cols=161  Identities=34%  Similarity=0.627  Sum_probs=146.1

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      +......|..|-.++.--+.+=|+++...|.+.+++|+||||++||+|..++.+.+.+|++.+..+.++|  ||..+|+.
T Consensus       115 Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m  194 (1317)
T KOG0612|consen  115 KRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM  194 (1317)
T ss_pred             hchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc
Confidence            3445667888999999999999999999999999999999999999999999998999999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCccccc----c-cCCCcchhHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ----F-QRYDEKVDMWSVGAIL  156 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~----~-~~~~~~~Di~slg~~~  156 (175)
                      |+|||||||+||++   +..|.++|.|||.+-+...+..  .....|||.|.+||++.    + +.|++.+|-||+|+++
T Consensus       195 gyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~  271 (1317)
T KOG0612|consen  195 GYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFM  271 (1317)
T ss_pred             cceeccCCcceeEe---cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHH
Confidence            99999999999999   7999999999999988874433  45678999999999985    3 5689999999999999


Q ss_pred             HHHHhCCCCCCCC
Q 030527          157 FELLNGYPPFSVG  169 (175)
Q Consensus       157 ~~~~~g~~pf~~~  169 (175)
                      |||+.|..||...
T Consensus       272 YEMlyG~TPFYad  284 (1317)
T KOG0612|consen  272 YEMLYGETPFYAD  284 (1317)
T ss_pred             HHHHcCCCcchHH
Confidence            9999999999754

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=5.7e-31  Score=189.96  Aligned_cols=159  Identities=32%  Similarity=0.588  Sum_probs=139.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+..|++++++++|+|++++++++.+.+..++++|++++++|.+++.....  +++.++..++.|+  ++++||+.|
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~  123 (258)
T smart00219       44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN  123 (258)
T ss_pred             HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            456888999999999999999999999999999999999999999999986544  9999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc--cccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  161 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-  161 (175)
                      ++|+||+|+||++   +.++.++|+|||.+..........  ...++..|+|||...+..++.++|+||+|++++++++ 
T Consensus       124 ~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~  200 (258)
T smart00219      124 FIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL  200 (258)
T ss_pred             eeecccccceEEE---ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhC
Confidence            9999999999999   567789999999997775542221  1235678999999988889999999999999999998 


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |..||...+
T Consensus       201 g~~p~~~~~  209 (258)
T smart00219      201 GESPYPGMS  209 (258)
T ss_pred             CCCCCCCCC
Confidence            889987644

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=3.4e-31  Score=195.20  Aligned_cols=159  Identities=28%  Similarity=0.607  Sum_probs=138.4

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .....+.+|+.+++.++|+|++++++.+...+..++++||+++++|.+++. .+.+++..+..++.|+  ++++||+.|+
T Consensus        61 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i  139 (292)
T cd06658          61 QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGV  139 (292)
T ss_pred             HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            345567889999999999999999999999999999999999999999886 4568999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+||+|+||++   +.++.++|+|||++....... ......++..|+|||...+..++.++|+||+|++++++++|+.
T Consensus       140 vH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~  216 (292)
T cd06658         140 IHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP  216 (292)
T ss_pred             eecCCCHHHEEE---cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999   567789999999886543222 1223457888999999988889999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||...+
T Consensus       217 p~~~~~  222 (292)
T cd06658         217 PYFNEP  222 (292)
T ss_pred             CCCCCC
Confidence            997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=1.1e-30  Score=191.32  Aligned_cols=158  Identities=28%  Similarity=0.507  Sum_probs=133.9

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..++..|+..+++++||||+++++++.. ...++++|++++++|.+++.+. +.+++..+..++.|+  +++|||+.|++
T Consensus        53 ~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ii  131 (279)
T cd05111          53 FQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMV  131 (279)
T ss_pred             HHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            3466778888899999999999998764 4567899999999999999764 578999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      |+||+|+||++   +.++.++|+|||.+........   .....++..|++||...+..++.++|+||||+++|++++ |
T Consensus       132 H~dlkp~nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g  208 (279)
T cd05111         132 HRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYG  208 (279)
T ss_pred             ccccCcceEEE---cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCC
Confidence            99999999999   5678899999999976643321   122345667999999988889999999999999999998 9


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||.+...
T Consensus       209 ~~p~~~~~~  217 (279)
T cd05111         209 AEPYAGMRP  217 (279)
T ss_pred             CCCCCCCCH
Confidence            999977543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=7.3e-31  Score=189.72  Aligned_cols=157  Identities=26%  Similarity=0.523  Sum_probs=134.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEe-eCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHc
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ..+.+.+|+.++++++|++++++++++. ..+..++++||+++++|.+++.+..  .+++..+..++.++  ++++||+.
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  121 (256)
T cd05082          42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN  121 (256)
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3456889999999999999999998754 5567899999999999999998654  37899999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      |++|+||+|+||++   +.++.++|+|||++.......  .....+..|+|||...+..++.++|+||+|+++|++++ |
T Consensus       122 ~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g  196 (256)
T cd05082         122 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG  196 (256)
T ss_pred             CEeccccchheEEE---cCCCcEEecCCccceeccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCC
Confidence            99999999999999   567789999999987654332  22334567999999988889999999999999999997 9


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      ..||...+
T Consensus       197 ~~p~~~~~  204 (256)
T cd05082         197 RVPYPRIP  204 (256)
T ss_pred             CCCCCCCC
Confidence            99997644

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=6e-31  Score=190.53  Aligned_cols=159  Identities=27%  Similarity=0.510  Sum_probs=137.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|+.++++++|+|++++++++......++++|++.+++|.+++.+..  .++...+..++.++  |+++||+.|+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i  124 (261)
T cd05034          45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY  124 (261)
T ss_pred             HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4578899999999999999999999999899999999999999999997653  68999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      +|+||+|+||++   +.++.++|+|||.+.........  .....+..|+|||.+.+..++.++|+||+|++++++++ |
T Consensus       125 ~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g  201 (261)
T cd05034         125 IHRDLAARNILV---GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYG  201 (261)
T ss_pred             ccCCcchheEEE---cCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCC
Confidence            999999999999   56788999999998776433211  12223467999999988889999999999999999998 9


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      +.||.+.++
T Consensus       202 ~~p~~~~~~  210 (261)
T cd05034         202 RVPYPGMTN  210 (261)
T ss_pred             CCCCCCCCH
Confidence            999976543

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=2.4e-30  Score=187.72  Aligned_cols=160  Identities=32%  Similarity=0.604  Sum_probs=139.3

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ......+.+|++++++++|++++++++++...+..++++||+++++|.+++...    ..+++.++..++.++  ++++|
T Consensus        43 ~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l  122 (267)
T cd08224          43 AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM  122 (267)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH
Confidence            344678889999999999999999999999999999999999999999998642    358999999999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      |+.|++|+||+|+||++   +.++.++++|||.+........ .....++..|.|||...+..++.++|+||+|++++++
T Consensus       123 h~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l  199 (267)
T cd08224         123 HSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM  199 (267)
T ss_pred             HhCCEecCCcChhhEEE---CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHH
Confidence            99999999999999999   5677899999999876543321 2234567889999999888899999999999999999


Q ss_pred             HhCCCCCCCC
Q 030527          160 LNGYPPFSVG  169 (175)
Q Consensus       160 ~~g~~pf~~~  169 (175)
                      ++|+.||...
T Consensus       200 ~~g~~p~~~~  209 (267)
T cd08224         200 AALQSPFYGD  209 (267)
T ss_pred             HHCCCCcccC
Confidence            9999999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=1.6e-30  Score=190.86  Aligned_cols=158  Identities=29%  Similarity=0.607  Sum_probs=138.5

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|+.++++++|||++++++++...+..++++||+.|++|.+++.. ++++...+..++.|+  ++++||+.|++
T Consensus        59 ~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~  137 (285)
T cd06648          59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVI  137 (285)
T ss_pred             HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            345678899999999999999999999999999999999999999999886 678999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||+|++++++++|+.|
T Consensus       138 H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p  214 (285)
T cd06648         138 HRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP  214 (285)
T ss_pred             cCCCChhhEEE---cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence            99999999999   577889999999876553322 12234577889999999888899999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |...+
T Consensus       215 ~~~~~  219 (285)
T cd06648         215 YFNEP  219 (285)
T ss_pred             CcCCC
Confidence            97644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=1e-30  Score=193.43  Aligned_cols=161  Identities=30%  Similarity=0.524  Sum_probs=136.6

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHH
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~   70 (175)
                      ...+.+.+|+++++.+ +||||+++++++...+..+++|||+++++|.+++.+..                .++..++..
T Consensus        62 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (304)
T cd05101          62 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS  141 (304)
T ss_pred             HHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHH
Confidence            3346788999999999 89999999999999999999999999999999997642                367778888


Q ss_pred             HHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCc
Q 030527           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  145 (175)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~  145 (175)
                      ++.|+  |++|||+.|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||...+..++.
T Consensus       142 ~~~qi~~al~~LH~~givH~dlkp~Nili---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  218 (304)
T cd05101         142 CTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  218 (304)
T ss_pred             HHHHHHHHHHHHHHCCeeecccccceEEE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc
Confidence            99998  9999999999999999999999   5677899999999987644322   12233456799999998888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          146 KVDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       146 ~~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      ++|+||||++++++++ |..||.+.+.
T Consensus       219 ~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         219 QSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             hhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999999999999998 7888876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=8e-31  Score=203.20  Aligned_cols=153  Identities=25%  Similarity=0.399  Sum_probs=132.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|++++++++|+||+++++++...+..+++++++ .++|.+++.+. ..+++.++..++.|+  +|+|||++|++
T Consensus       204 ~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIv  282 (461)
T PHA03211        204 YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGII  282 (461)
T ss_pred             ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            345678999999999999999999999999999999998 56888888764 469999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      |+||||+||++   +..+.++|+|||+++.......   .....|+..|+|||.+.+..++.++|+||||+++|++++|.
T Consensus       283 HrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~  359 (461)
T PHA03211        283 HRDIKTENVLV---NGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHT  359 (461)
T ss_pred             ECcCCHHHEEE---CCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcC
Confidence            99999999999   5677899999999876543221   12345889999999999888999999999999999999976


Q ss_pred             CCC
Q 030527          164 PPF  166 (175)
Q Consensus       164 ~pf  166 (175)
                      .|+
T Consensus       360 ~~l  362 (461)
T PHA03211        360 ASL  362 (461)
T ss_pred             CCc
Confidence            544

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=9.8e-31  Score=193.34  Aligned_cols=157  Identities=31%  Similarity=0.543  Sum_probs=134.3

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|+++++.++||||+++++++...+..++|+||+. ++|.+++.+. ..+++..+..++.|+  |+++||+.|++
T Consensus        48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~  126 (301)
T cd07873          48 PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL  126 (301)
T ss_pred             hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3456789999999999999999999999999999999995 5898888764 468899999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      |+||+|+||++   +.++.++|+|||++....... ......++..|+|||...+. .++.++|+||+|+++++|++|+.
T Consensus       127 H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~  203 (301)
T cd07873         127 HRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP  203 (301)
T ss_pred             CCCCCHHHEEE---CCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCC
Confidence            99999999999   577789999999987654322 12234457889999987654 47889999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||.+.+
T Consensus       204 ~f~~~~  209 (301)
T cd07873         204 LFPGST  209 (301)
T ss_pred             CCCCCC
Confidence            998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=1.2e-30  Score=189.69  Aligned_cols=163  Identities=30%  Similarity=0.523  Sum_probs=136.4

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHH--HHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------GRVPEQTARKFLQQL--GLE   78 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~i--~l~   78 (175)
                      .....+.+|+++++.++||||+++++++...+..++++|++++++|.+++.+.       ..++..++..++.|+  +++
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  120 (269)
T cd05044          41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV  120 (269)
T ss_pred             hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence            34667888999999999999999999999999999999999999999998643       237788899999998  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecC--CCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~--~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      +||+.+++|+|++|+||++...+  ....++++|||++........   .....++..|+|||.+.+..++.++|+||||
T Consensus       121 ~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG  200 (269)
T cd05044         121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFG  200 (269)
T ss_pred             HHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHH
Confidence            99999999999999999995322  123799999999876543321   1233446789999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCC
Q 030527          154 AILFELLN-GYPPFSVGE  170 (175)
Q Consensus       154 ~~~~~~~~-g~~pf~~~~  170 (175)
                      +++++|++ |..||...+
T Consensus       201 ~il~ellt~g~~p~~~~~  218 (269)
T cd05044         201 VLMWEILTLGQQPYPALN  218 (269)
T ss_pred             HHHHHHHHcCCCCCcccC
Confidence            99999998 999997644

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=1.3e-30  Score=192.18  Aligned_cols=160  Identities=28%  Similarity=0.533  Sum_probs=135.5

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHH--
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQL--   75 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~~i--   75 (175)
                      ....+.+|+++++.++|+||+++++++...+..++++|++.+++|.+++.+..           .++..++..++.|+  
T Consensus        62 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  141 (296)
T cd05095          62 ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIAS  141 (296)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHH
Confidence            45678899999999999999999999999999999999999999999987642           25667889999998  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  152 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl  152 (175)
                      |+++||+.|++|+||+|+||++   +.++.++|+|||++........   ......+..|++||...+..++.++|+|||
T Consensus       142 al~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSl  218 (296)
T cd05095         142 GMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF  218 (296)
T ss_pred             HHHHHHHCCeecccCChheEEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHH
Confidence            9999999999999999999999   4677899999999876543321   122233567999998887889999999999


Q ss_pred             HHHHHHHHh--CCCCCCCCCc
Q 030527          153 GAILFELLN--GYPPFSVGEE  171 (175)
Q Consensus       153 g~~~~~~~~--g~~pf~~~~~  171 (175)
                      |+++|++++  |..||...++
T Consensus       219 G~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         219 GVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             HHHHHHHHHhCCCCCccccCh
Confidence            999999998  7788876543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.5e-30  Score=191.83  Aligned_cols=160  Identities=27%  Similarity=0.525  Sum_probs=135.2

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------RVPEQTARKFLQQL   75 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~l~~~~~~~~~~~i   75 (175)
                      .....+.+|++++++++|+|++++++++...+..++||||+.+++|.+++....            .++...+..++.++
T Consensus        59 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i  138 (295)
T cd05097          59 TARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQI  138 (295)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHH
Confidence            345578899999999999999999999999999999999999999999986432            36788889999998


Q ss_pred             --HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHH
Q 030527           76 --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMW  150 (175)
Q Consensus        76 --~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~  150 (175)
                        |+++||+.|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||...+..++.++|+|
T Consensus       139 ~~al~~lH~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw  215 (295)
T cd05097         139 ASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVW  215 (295)
T ss_pred             HHHHHHHHhcCeeccccChhhEEE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHH
Confidence              9999999999999999999999   4667799999999876543321   1222335679999999888899999999


Q ss_pred             HHHHHHHHHHh--CCCCCCCCC
Q 030527          151 SVGAILFELLN--GYPPFSVGE  170 (175)
Q Consensus       151 slg~~~~~~~~--g~~pf~~~~  170 (175)
                      |||++++++++  +..||...+
T Consensus       216 SlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         216 AFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             HHHHHHHHHHHcCCCCCCcccC
Confidence            99999999988  677887544

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=1.2e-30  Score=188.36  Aligned_cols=161  Identities=29%  Similarity=0.629  Sum_probs=140.2

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ......+.+|++++++++||||+++.+++...+..++|+||+.+++|.+++....  .+++.++..++.|+  ++++||+
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  119 (256)
T cd08218          40 PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD  119 (256)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3445678899999999999999999999999999999999999999999987643  57899999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      .|++|+|++|+||++   +.++.++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++
T Consensus       120 ~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~  196 (256)
T cd08218         120 RKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT  196 (256)
T ss_pred             CCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc
Confidence            999999999999999   5677899999999876644322 223456788999999988889999999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |+.||...+
T Consensus       197 g~~~~~~~~  205 (256)
T cd08218         197 LKHAFEAGN  205 (256)
T ss_pred             CCCCccCCC
Confidence            999997654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=8.7e-31  Score=189.67  Aligned_cols=160  Identities=26%  Similarity=0.489  Sum_probs=138.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+..|+++++.++|||++++++++.+.+..++++||+++++|.+++.+.  ..++...+..++.++  |+++||+.|
T Consensus        45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~  124 (261)
T cd05148          45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN  124 (261)
T ss_pred             hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4567888999999999999999999999999999999999999999999864  358999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc-ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      ++|+||+|+||++   +.++.++|+|||.+......... ....++..|++||...+..++.++|+||||++++++++ |
T Consensus       125 i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g  201 (261)
T cd05148         125 SIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYG  201 (261)
T ss_pred             eeccccCcceEEE---cCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence            9999999999999   57778999999998766433221 12234567999999988889999999999999999998 8


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      +.||...+.
T Consensus       202 ~~p~~~~~~  210 (261)
T cd05148         202 QVPYPGMNN  210 (261)
T ss_pred             CCCCCcCCH
Confidence            999976543

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=8.7e-31  Score=198.52  Aligned_cols=159  Identities=28%  Similarity=0.535  Sum_probs=138.5

Q ss_pred             cchhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHH--HHHHH
Q 030527            5 LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         5 ~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~~i--~l~~l   80 (175)
                      .+.+.-..+.+|+..|.+| .|.+|+++++|=..++.+|+|||+- ..+|.+++++... ++...+..++.||  |++++
T Consensus       398 ~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~I  476 (677)
T KOG0596|consen  398 ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTI  476 (677)
T ss_pred             cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHH
Confidence            4666777899999999999 7999999999999999999999964 7899999998754 5556888999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccC-----------CCcc
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR-----------YDEK  146 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~-----------~~~~  146 (175)
                      |+.||||.|+||.|+++    -.+.+||+|||.|.....+.   ......||..|++||++....           .+++
T Consensus       477 H~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~  552 (677)
T KOG0596|consen  477 HQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRK  552 (677)
T ss_pred             HHhceeecCCCcccEEE----EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCc
Confidence            99999999999999998    67889999999998886654   345788999999999985321           4688


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCC
Q 030527          147 VDMWSVGAILFELLNGYPPFSV  168 (175)
Q Consensus       147 ~Di~slg~~~~~~~~g~~pf~~  168 (175)
                      +|||||||++|+|+-|+.||..
T Consensus       553 SDvWSLGCILYqMvYgktPf~~  574 (677)
T KOG0596|consen  553 SDVWSLGCILYQMVYGKTPFGQ  574 (677)
T ss_pred             cchhhhhhHHHHHHhcCCchHH
Confidence            9999999999999999999964

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-30  Score=187.88  Aligned_cols=153  Identities=37%  Similarity=0.715  Sum_probs=132.6

Q ss_pred             HHHHHHH-HhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecC
Q 030527           13 LDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRD   89 (175)
Q Consensus        13 ~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~d   89 (175)
                      +..|..+ ..+.+|+|++++++++..++..++++||+.+++|.++++..+.+++..+..++.|+  ||.+||+.|++|+|
T Consensus        43 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~d  122 (260)
T cd05611          43 VKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD  122 (260)
T ss_pred             HHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            3444444 44559999999999999999999999999999999999988889999999999998  99999999999999


Q ss_pred             CCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030527           90 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus        90 i~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~  169 (175)
                      ++|+||++   +..+.++|+|||.+.....   .....++..|++||...+..++.++|+||+|++++++++|..||...
T Consensus       123 l~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  196 (260)
T cd05611         123 IKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE  196 (260)
T ss_pred             CCHHHeEE---CCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence            99999999   5677899999998876533   22345678899999998888899999999999999999999999765


Q ss_pred             Cc
Q 030527          170 EE  171 (175)
Q Consensus       170 ~~  171 (175)
                      +.
T Consensus       197 ~~  198 (260)
T cd05611         197 TP  198 (260)
T ss_pred             CH
Confidence            43

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=1.3e-30  Score=188.91  Aligned_cols=158  Identities=27%  Similarity=0.485  Sum_probs=133.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|+++++.++|+|++++++++.. +..+++|||+.+++|.+++.+..  .++...+..++.++  |+++||+.|+
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i  123 (260)
T cd05069          45 PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY  123 (260)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            4567889999999999999999988754 55789999999999999997643  47889999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      +|+||+|+||++   +.++.++|+|||.+.........  ....++..|+|||...+..++.++|+||+|++++++++ |
T Consensus       124 ~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g  200 (260)
T cd05069         124 IHRDLRAANILV---GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG  200 (260)
T ss_pred             eecccCcceEEE---cCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCC
Confidence            999999999999   57778999999999766443221  12234567999999988889999999999999999999 9


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||.+..+
T Consensus       201 ~~p~~~~~~  209 (260)
T cd05069         201 RVPYPGMVN  209 (260)
T ss_pred             CCCCCCCCH
Confidence            999976543

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=6.4e-31  Score=191.79  Aligned_cols=159  Identities=25%  Similarity=0.492  Sum_probs=136.7

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHH--HH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------RVPEQTARKFLQQL--GL   77 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i--~l   77 (175)
                      ....+.+|++++++++|+|++++++++.+.+..++|+||+++++|.+++....         .+++..+..++.|+  +|
T Consensus        51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l  130 (275)
T cd05046          51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM  130 (275)
T ss_pred             HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence            34678999999999999999999999999999999999999999999998665         68999999999998  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  155 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~  155 (175)
                      ++||+.|++|+||+|+||++   +..+.++++|||++........  .....++..|+|||.+.+..++.++|+||+|++
T Consensus       131 ~~LH~~~i~H~dlkp~Nili---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~  207 (275)
T cd05046         131 DHLSNARFVHRDLAARNCLV---SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVL  207 (275)
T ss_pred             HHhhhcCcccCcCccceEEE---eCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHH
Confidence            99999999999999999999   4677899999998865433221  122334566999999988888999999999999


Q ss_pred             HHHHHh-CCCCCCCCC
Q 030527          156 LFELLN-GYPPFSVGE  170 (175)
Q Consensus       156 ~~~~~~-g~~pf~~~~  170 (175)
                      ++++++ |..||....
T Consensus       208 l~~l~~~~~~p~~~~~  223 (275)
T cd05046         208 MWEVFTQGELPFYGLS  223 (275)
T ss_pred             HHHHHhCCCCCccccc
Confidence            999998 888996543

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=1.9e-30  Score=190.15  Aligned_cols=158  Identities=35%  Similarity=0.612  Sum_probs=137.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|+.++++++|||++++++++...+..++|+|++ +++|.+++... ..+++.++..++.|+  +|++||+.|+
T Consensus        42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  120 (286)
T cd07832          42 IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI  120 (286)
T ss_pred             hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3467889999999999999999999999999999999999 99999998754 568999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g  162 (175)
                      +|+||+|+||++   +..+.++++|||.+........  .....++..|+|||.+.+. .++.++|+||+|++++++++|
T Consensus       121 ~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg  197 (286)
T cd07832         121 MHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG  197 (286)
T ss_pred             ecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcC
Confidence            999999999999   4677899999999877654431  2344578889999988654 468999999999999999999


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      .+||.+.+
T Consensus       198 ~~~~~~~~  205 (286)
T cd07832         198 SPLFPGEN  205 (286)
T ss_pred             CcCcCCCC
Confidence            88887654

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=7.9e-31  Score=198.23  Aligned_cols=154  Identities=31%  Similarity=0.468  Sum_probs=132.3

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      .....|+.++++++||||+++++++...+..++|++++ .++|.+++.+. ..+++..+..++.|+  ||+|||+.|++|
T Consensus       102 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  180 (357)
T PHA03209        102 GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIH  180 (357)
T ss_pred             cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            34467999999999999999999999999999999999 56888888654 579999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC-CCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG-YPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g-~~pf  166 (175)
                      +||||+||++   +..+.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++|+++++ +.+|
T Consensus       181 rDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        181 RDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             CCCCHHHEEE---CCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence            9999999999   57778999999998754433333345678999999999888899999999999999999985 4444


Q ss_pred             CC
Q 030527          167 SV  168 (175)
Q Consensus       167 ~~  168 (175)
                      ..
T Consensus       258 ~~  259 (357)
T PHA03209        258 ED  259 (357)
T ss_pred             cC
Confidence            43

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=2e-30  Score=190.33  Aligned_cols=158  Identities=35%  Similarity=0.664  Sum_probs=139.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|++.+++++|+|++++.+.+...+..++++||+.+++|.+++.... .++...+..++.++  ++++||+.|++
T Consensus        59 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~  138 (286)
T cd06614          59 KELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI  138 (286)
T ss_pred             HHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            5678889999999999999999999999999999999999999999999876 89999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+|++|+||++   +.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||+|++++++++|+.|
T Consensus       139 H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p  215 (286)
T cd06614         139 HRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP  215 (286)
T ss_pred             eCCCChhhEEE---cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence            99999999999   567789999999876554322 12234467789999999888899999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |...+
T Consensus       216 ~~~~~  220 (286)
T cd06614         216 YLREP  220 (286)
T ss_pred             CCCCC
Confidence            97654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=2.1e-30  Score=194.48  Aligned_cols=158  Identities=32%  Similarity=0.567  Sum_probs=132.7

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEee-CCeEEEEEeccCCCChHHHHHhc---------------------------
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH---------------------------   60 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~---------------------------   60 (175)
                      .+.+..|+++++++ +|+||+++++++.. +...+++++|+++++|.+++...                           
T Consensus        54 ~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  133 (337)
T cd05054          54 YKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL  133 (337)
T ss_pred             HHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccccccc
Confidence            34667899999999 89999999998764 45688999999999999998642                           


Q ss_pred             ----------------------------------CCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCc
Q 030527           61 ----------------------------------GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV  104 (175)
Q Consensus        61 ----------------------------------~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~  104 (175)
                                                        ..++...+..++.|+  |++|||+.|++|+||||+||++   +.++
T Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~  210 (337)
T cd05054         134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENN  210 (337)
T ss_pred             ccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCC
Confidence                                              257888899999998  9999999999999999999999   4667


Q ss_pred             eEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 030527          105 MLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGE  170 (175)
Q Consensus       105 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g~~pf~~~~  170 (175)
                      .++|+|||++........   .....++..|+|||.+.+..++.++|+||+||+++++++ |..||.+..
T Consensus       211 ~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~  280 (337)
T cd05054         211 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  280 (337)
T ss_pred             cEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence            899999999987643321   122334567999999998999999999999999999998 999997643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.4e-30  Score=189.30  Aligned_cols=159  Identities=27%  Similarity=0.433  Sum_probs=136.3

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|++.+++++|||++++++++.. ...++++|++++++|.+++.+. ..+++..+..++.|+  |+++||+.|+
T Consensus        52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i  130 (279)
T cd05057          52 ANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRL  130 (279)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            34577889999999999999999999887 7789999999999999999875 468999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc---cccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  161 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-  161 (175)
                      +|+||+|+||++   +.++.++|+|||.+..........   ....+..|++||......++.++|+||+|++++++++ 
T Consensus       131 ~H~di~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~  207 (279)
T cd05057         131 VHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTF  207 (279)
T ss_pred             EecccCcceEEE---cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcC
Confidence            999999999999   567789999999997764332211   1122457999999988889999999999999999998 


Q ss_pred             CCCCCCCCCc
Q 030527          162 GYPPFSVGEE  171 (175)
Q Consensus       162 g~~pf~~~~~  171 (175)
                      |..||.+...
T Consensus       208 g~~p~~~~~~  217 (279)
T cd05057         208 GAKPYEGIPA  217 (279)
T ss_pred             CCCCCCCCCH
Confidence            9999987543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=1.4e-30  Score=188.06  Aligned_cols=158  Identities=28%  Similarity=0.575  Sum_probs=136.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|++++++++||+++++++++......++++|++.+++|.+++... +.+++..+..++.++  ++++||+.|++
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~  122 (256)
T cd05112          43 EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVI  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            356888999999999999999999999999999999999999999998764 468899999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-CC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  163 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g~  163 (175)
                      |+|++|+|+++   +.++.++|+|||.+.........  ....++..|+|||...+..++.++|+||+|+++|++++ |.
T Consensus       123 h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~  199 (256)
T cd05112         123 HRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK  199 (256)
T ss_pred             ccccccceEEE---cCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCC
Confidence            99999999999   56778999999998766433221  12224567999999988889999999999999999998 99


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||....
T Consensus       200 ~p~~~~~  206 (256)
T cd05112         200 TPYENRS  206 (256)
T ss_pred             CCCCcCC
Confidence            9997654

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=2.2e-30  Score=189.45  Aligned_cols=160  Identities=26%  Similarity=0.414  Sum_probs=135.2

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ......+.+|..+++.++||||+++++++... ..+++++++++++|.+++.+. +.+++..+..++.|+  |+++||+.
T Consensus        50 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~  128 (279)
T cd05109          50 PKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV  128 (279)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34456788899999999999999999988754 467899999999999999764 568999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc---ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      |++|+||+|+||++   +.++.++|+|||++.........   ....++..|+|||...+..++.++|+||||+++|+++
T Consensus       129 ~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~  205 (279)
T cd05109         129 RLVHRDLAARNVLV---KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELM  205 (279)
T ss_pred             CeeccccccceEEE---cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHH
Confidence            99999999999999   46677999999999876433221   1223356799999998888999999999999999999


Q ss_pred             h-CCCCCCCCC
Q 030527          161 N-GYPPFSVGE  170 (175)
Q Consensus       161 ~-g~~pf~~~~  170 (175)
                      + |..||....
T Consensus       206 t~g~~p~~~~~  216 (279)
T cd05109         206 TFGAKPYDGIP  216 (279)
T ss_pred             cCCCCCCCCCC
Confidence            8 999997644

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=2.7e-30  Score=187.22  Aligned_cols=159  Identities=31%  Similarity=0.623  Sum_probs=139.9

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+.+|+++++.++|+||+++++++...+..++++||+++++|.+++.+...+++..+..++.++  ++++||+.|+
T Consensus        41 ~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i  120 (264)
T cd06626          41 KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI  120 (264)
T ss_pred             HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCc
Confidence            35678899999999999999999999999999999999999999999999887778999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc-----cccCCCCccCcccccccC---CCcchhHHHHHHHHH
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILF  157 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~pe~~~~~~---~~~~~Di~slg~~~~  157 (175)
                      +|+|++|+||++   +.++.++|+|||.+..........     ...++..|+|||.+.+..   ++.++|+||+|++++
T Consensus       121 ~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~  197 (264)
T cd06626         121 VHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL  197 (264)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHH
Confidence            999999999999   467789999999987765433211     234677899999987665   889999999999999


Q ss_pred             HHHhCCCCCCCC
Q 030527          158 ELLNGYPPFSVG  169 (175)
Q Consensus       158 ~~~~g~~pf~~~  169 (175)
                      ++++|+.||...
T Consensus       198 ~l~~g~~pf~~~  209 (264)
T cd06626         198 EMATGKRPWSEL  209 (264)
T ss_pred             HHHhCCCCccCC
Confidence            999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=4.1e-30  Score=186.97  Aligned_cols=160  Identities=33%  Similarity=0.536  Sum_probs=135.7

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCC--CHHHHHHHHHHH--HHHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV--PEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l--~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ...+.+.+|+.++++++|+||+++++++...+..++++|++++++|.+++... ..+  ++..+..++.|+  ++++||+
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  126 (268)
T cd06624          47 RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD  126 (268)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH
Confidence            34557889999999999999999999999999999999999999999998764 455  788888899998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCccccccc--CCCcchhHHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slg~~~~~~  159 (175)
                      .|++|+|++|+||+++  ...+.++|+|||.+........ .....++..|+|||...+.  .++.++|+||+|++++++
T Consensus       127 ~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l  204 (268)
T cd06624         127 NQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEM  204 (268)
T ss_pred             CCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHH
Confidence            9999999999999994  2356899999999876543222 2234567889999998654  378899999999999999


Q ss_pred             HhCCCCCCCC
Q 030527          160 LNGYPPFSVG  169 (175)
Q Consensus       160 ~~g~~pf~~~  169 (175)
                      ++|..||...
T Consensus       205 ~~g~~p~~~~  214 (268)
T cd06624         205 ATGKPPFIEL  214 (268)
T ss_pred             HhCCCCCccc
Confidence            9999999754

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=3.5e-30  Score=185.57  Aligned_cols=160  Identities=39%  Similarity=0.696  Sum_probs=143.9

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      .....+.+|+.++++++|||++++.+.+...  +..++++|++.+++|.+++.+...+++..+..++.++  ++++||+.
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~  120 (260)
T cd06606          41 EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN  120 (260)
T ss_pred             HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3467888999999999999999999999988  8899999999999999999987789999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      |++|+|++|+||++   +.++.++|+|||.+........   .....++..|.+||...+..++.++|+||+|+++++++
T Consensus       121 ~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~  197 (260)
T cd06606         121 GIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA  197 (260)
T ss_pred             CccccCCCHHHEEE---cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH
Confidence            99999999999999   4678899999999988766543   34456788899999998888999999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|..||...+
T Consensus       198 ~g~~p~~~~~  207 (260)
T cd06606         198 TGKPPWSELG  207 (260)
T ss_pred             hCCCCCCCCC
Confidence            9999997764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=1.1e-30  Score=192.60  Aligned_cols=158  Identities=37%  Similarity=0.553  Sum_probs=136.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+..|++++++++|+|++++++++.+.+..++|+||+ +++|.+++.... .+++..+..++.|+  ||++||+.|++
T Consensus        46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~  124 (298)
T cd07841          46 NFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWIL  124 (298)
T ss_pred             hHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            445678999999999999999999999999999999999 889999998765 79999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      |+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|++++++++|..
T Consensus       125 H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~  201 (298)
T cd07841         125 HRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP  201 (298)
T ss_pred             ecCCChhhEEE---cCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCc
Confidence            99999999999   567789999999998765432 2223345678999998854 457899999999999999999988


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.++
T Consensus       202 ~~~~~~~  208 (298)
T cd07841         202 FLPGDSD  208 (298)
T ss_pred             cccCCcc
Confidence            8876553

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=8.4e-31  Score=193.52  Aligned_cols=158  Identities=28%  Similarity=0.586  Sum_probs=138.0

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|+.+++.++|||++++++++...+..++++||+++++|.+++.. ..+++..+..++.|+  ++++||+.|++
T Consensus        61 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iv  139 (297)
T cd06659          61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVI  139 (297)
T ss_pred             hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            345678899999999999999999999999999999999999999987764 568999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|++++++++|+.|
T Consensus       140 H~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p  216 (297)
T cd06659         140 HRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP  216 (297)
T ss_pred             cCCCCHHHeEE---ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999   577889999999886543322 12334578899999999888899999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |...+
T Consensus       217 ~~~~~  221 (297)
T cd06659         217 YFSDS  221 (297)
T ss_pred             CCCCC
Confidence            97554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=1.2e-30  Score=191.98  Aligned_cols=159  Identities=33%  Similarity=0.564  Sum_probs=136.1

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHH
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF   71 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~   71 (175)
                      ....+.+|+++++++ +|+||+++++++..++..+++|||+++++|.+++.+.                ..+++..+..+
T Consensus        58 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i  137 (293)
T cd05053          58 DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF  137 (293)
T ss_pred             HHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHH
Confidence            345678899999999 8999999999999999999999999999999998642                35888999999


Q ss_pred             HHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcc
Q 030527           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK  146 (175)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~  146 (175)
                      +.|+  |+++||+.|++|+||+|+||++   +.++.++|+|||.+........   .....++..|+|||...+..++.+
T Consensus       138 ~~qi~~al~~LH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  214 (293)
T cd05053         138 AYQVARGMEFLASKKCIHRDLAARNVLV---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ  214 (293)
T ss_pred             HHHHHHHHHHHHHCCccccccceeeEEE---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc
Confidence            9998  9999999999999999999999   5678899999999876644321   112223467999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCC
Q 030527          147 VDMWSVGAILFELLN-GYPPFSVGE  170 (175)
Q Consensus       147 ~Di~slg~~~~~~~~-g~~pf~~~~  170 (175)
                      +|+||+|+++|++++ |..||.+..
T Consensus       215 ~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         215 SDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             cceeehhhHHHHHhcCCCCCCCCCC
Confidence            999999999999998 999997654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.7e-30  Score=186.10  Aligned_cols=159  Identities=32%  Similarity=0.553  Sum_probs=136.4

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|++++++++|+||+++++++...+..++++|++.+++|.+++.+. ..++...+..++.++  ++++||+.|+
T Consensus        35 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i  114 (251)
T cd05041          35 LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC  114 (251)
T ss_pred             HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            4567889999999999999999999999999999999999999999999764 468899999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc---ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  161 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-  161 (175)
                      +|+||+|+||++   +.++.++|+|||.+.........   .....+..|+|||...+..++.++|+||+|++++++++ 
T Consensus       115 ~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~  191 (251)
T cd05041         115 IHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL  191 (251)
T ss_pred             ehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhc
Confidence            999999999999   57778999999998765422211   11222456999999988889999999999999999999 


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |..||....
T Consensus       192 ~~~p~~~~~  200 (251)
T cd05041         192 GDTPYPGMS  200 (251)
T ss_pred             cCCCCccCC
Confidence            899997654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=4.3e-30  Score=188.16  Aligned_cols=145  Identities=34%  Similarity=0.637  Sum_probs=127.4

Q ss_pred             hCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEee
Q 030527           22 SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSG   99 (175)
Q Consensus        22 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~   99 (175)
                      ..+||+++.+.+++...+..++||||+.+++|.+++.+.+.+++..+..++.|+  |+++||+.|++|+||+|+||++  
T Consensus        53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~--  130 (279)
T cd05633          53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL--  130 (279)
T ss_pred             hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE--
Confidence            347999999999999999999999999999999999888889999999999998  9999999999999999999999  


Q ss_pred             cCCCceEEEeeecceeeccCCCccccccCCCCccCccccc-ccCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030527          100 LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       100 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~  170 (175)
                       +.++.++|+|||++....... .....++..|+|||... +..++.++|+||+|++++++++|..||....
T Consensus       131 -~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  200 (279)
T cd05633         131 -DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (279)
T ss_pred             -CCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence             577789999999987654332 22345788999999886 4568899999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=1.9e-30  Score=190.32  Aligned_cols=156  Identities=28%  Similarity=0.490  Sum_probs=133.1

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      .....+.+|++++++++|||++++.+++...  ...++++||++|++|.+++.+.. .++...+..++.|+  +++++|+
T Consensus        48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~  127 (284)
T cd05079          48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS  127 (284)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3445788999999999999999999998775  56899999999999999997654 58999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      .|++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||.+.+..++.++|+||+|+++++
T Consensus       128 ~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~e  204 (284)
T cd05079         128 RQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE  204 (284)
T ss_pred             CCeeecccchheEEE---cCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhh
Confidence            999999999999999   4677899999999887644321    122345567999999988889999999999999999


Q ss_pred             HHhCCCCC
Q 030527          159 LLNGYPPF  166 (175)
Q Consensus       159 ~~~g~~pf  166 (175)
                      ++++..|+
T Consensus       205 llt~~~~~  212 (284)
T cd05079         205 LLTYCDSE  212 (284)
T ss_pred             hhcCCCCC
Confidence            99976654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=3.5e-30  Score=187.63  Aligned_cols=156  Identities=37%  Similarity=0.623  Sum_probs=136.7

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      ..+..|+.++++++|||++++++++...+..++|+||+++++|.+++.+.+.+++..+..++.|+  ++.+||+.|++|+
T Consensus        53 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~  132 (272)
T cd06629          53 KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHR  132 (272)
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeec
Confidence            45788999999999999999999999999999999999999999999888889999999999998  9999999999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccC--CCcchhHHHHHHHHHHHHhCC
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slg~~~~~~~~g~  163 (175)
                      ||+|+||++   +.++.++++|||.+.......   ......++..|+|||......  ++.++|+||+|++++++++|.
T Consensus       133 dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  209 (272)
T cd06629         133 DLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR  209 (272)
T ss_pred             CCChhhEEE---cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCC
Confidence            999999999   577889999999987654321   122345678899999987654  789999999999999999999


Q ss_pred             CCCCCC
Q 030527          164 PPFSVG  169 (175)
Q Consensus       164 ~pf~~~  169 (175)
                      .||...
T Consensus       210 ~p~~~~  215 (272)
T cd06629         210 RPWSDE  215 (272)
T ss_pred             CCCcCc
Confidence            999654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=1.7e-30  Score=189.21  Aligned_cols=161  Identities=28%  Similarity=0.509  Sum_probs=135.7

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ......+.+|++++++++|||++++++++.+ +..++++|++++++|.+++.+.. .++...+..++.++  ++++||+.
T Consensus        48 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~  126 (270)
T cd05056          48 PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK  126 (270)
T ss_pred             HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3456678999999999999999999998875 45689999999999999998754 58999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc--cccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      |++|+||+|+|+++   +..+.++++|||++..........  ...++..|+|||.+....++.++|+||||++++++++
T Consensus       127 ~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  203 (270)
T cd05056         127 RFVHRDIAARNVLV---SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM  203 (270)
T ss_pred             CeeccccChheEEE---ecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHH
Confidence            99999999999999   466789999999987664432211  1223457999999988889999999999999999886


Q ss_pred             -CCCCCCCCCc
Q 030527          162 -GYPPFSVGEE  171 (175)
Q Consensus       162 -g~~pf~~~~~  171 (175)
                       |..||...+.
T Consensus       204 ~g~~pf~~~~~  214 (270)
T cd05056         204 LGVKPFQGVKN  214 (270)
T ss_pred             cCCCCCCCCCH
Confidence             9999976653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.4e-30  Score=188.33  Aligned_cols=159  Identities=29%  Similarity=0.547  Sum_probs=133.9

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCe------EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHH--
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQL--   75 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i--   75 (175)
                      ...+.+|++.++.++|||++++++++...+.      .++++||+++++|..++...      ..+++..+..++.|+  
T Consensus        45 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~  124 (273)
T cd05035          45 IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL  124 (273)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHH
Confidence            4578889999999999999999998765543      78999999999999988532      258899999999998  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc---ccccCCCCccCcccccccCCCcchhHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSV  152 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~sl  152 (175)
                      ||++||+.|++|+|++|+||++   +.++.++|+|||.+.........   .....+..|++||.+.+..++.++|+||+
T Consensus       125 aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~Sl  201 (273)
T cd05035         125 GMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF  201 (273)
T ss_pred             HHHHHHhCCeeccccchheEEE---CCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHH
Confidence            9999999999999999999999   56778999999999876543321   12223567999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCc
Q 030527          153 GAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       153 g~~~~~~~~-g~~pf~~~~~  171 (175)
                      |++++++++ |..||.+.++
T Consensus       202 G~il~el~~~g~~p~~~~~~  221 (273)
T cd05035         202 GVTMWEIATRGQTPYPGVEN  221 (273)
T ss_pred             HHHHHHHHhCCCCCCCCCCH
Confidence            999999999 9999976554

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.5e-30  Score=190.84  Aligned_cols=160  Identities=30%  Similarity=0.553  Sum_probs=136.6

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHH--HHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      +.....+.+|++++++++||||+++++.+...+..++++||+++++|.+++.+.   ..+++..+..++.++  ++.+||
T Consensus        40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH  119 (286)
T cd06622          40 ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK  119 (286)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            344567889999999999999999999999999999999999999999998764   378999999999998  999999


Q ss_pred             H-cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccC------CCcchhHHHHHH
Q 030527           82 S-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR------YDEKVDMWSVGA  154 (175)
Q Consensus        82 ~-~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~------~~~~~Di~slg~  154 (175)
                      + .|++|+||+|+||++   +.++.++|+|||.+....... .....++..|+|||.+.+..      ++.++|+||+|+
T Consensus       120 ~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~  195 (286)
T cd06622         120 EEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGL  195 (286)
T ss_pred             hcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHH
Confidence            7 599999999999999   467789999999987654332 23345677899999885433      478999999999


Q ss_pred             HHHHHHhCCCCCCCCC
Q 030527          155 ILFELLNGYPPFSVGE  170 (175)
Q Consensus       155 ~~~~~~~g~~pf~~~~  170 (175)
                      +++++++|..||...+
T Consensus       196 il~~l~~g~~pf~~~~  211 (286)
T cd06622         196 SILEMALGRYPYPPET  211 (286)
T ss_pred             HHHHHHhCCCCCCCcc
Confidence            9999999999996543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=3.8e-30  Score=184.67  Aligned_cols=158  Identities=37%  Similarity=0.680  Sum_probs=142.3

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|++++++++|++++++.+++..++..++++||+++++|.+++... ..+++..+..++.++  ++++||+.|+
T Consensus        40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i  119 (253)
T cd05122          40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI  119 (253)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence            4578889999999999999999999999999999999999999999999876 579999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +|+|++|+||++   +.++.++|+|||.+.............++..|++||...+..++.++|+||+|++++++++|+.|
T Consensus       120 ~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p  196 (253)
T cd05122         120 IHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP  196 (253)
T ss_pred             ecCCCCHHHEEE---ccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence            999999999999   56788999999998877655433455678889999999888899999999999999999999999


Q ss_pred             CCCC
Q 030527          166 FSVG  169 (175)
Q Consensus       166 f~~~  169 (175)
                      |...
T Consensus       197 ~~~~  200 (253)
T cd05122         197 YSEL  200 (253)
T ss_pred             CCCC
Confidence            9866

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=1e-30  Score=189.19  Aligned_cols=160  Identities=39%  Similarity=0.679  Sum_probs=140.4

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|.+++++++|||++++.+.+...+..++++|++.+++|.+++.+.+.+++..+..++.|+  +|++||+.|++
T Consensus        36 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~  115 (265)
T cd05579          36 QVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII  115 (265)
T ss_pred             HHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCee
Confidence            4557888999999999999999999999999999999999999999999987889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---------ccccccCCCCccCcccccccCCCcchhHHHHHHHHH
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~  157 (175)
                      |+||+|+||++   +.++.++|+|||++.......         ......++..|++||.......+.++|+||+|++++
T Consensus       116 H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~  192 (265)
T cd05579         116 HRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILY  192 (265)
T ss_pred             cCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHH
Confidence            99999999999   577789999999887654331         112334567899999998888899999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030527          158 ELLNGYPPFSVGEE  171 (175)
Q Consensus       158 ~~~~g~~pf~~~~~  171 (175)
                      ++++|+.||...+.
T Consensus       193 ~l~~g~~p~~~~~~  206 (265)
T cd05579         193 EFLVGIPPFHGETP  206 (265)
T ss_pred             HHHhCCCCCCCCCH
Confidence            99999999976543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.2e-30  Score=202.34  Aligned_cols=155  Identities=27%  Similarity=0.429  Sum_probs=130.3

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHH--HHHHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ...++.+|++++++++||||+++++++...+..+++++++ ++++.+++...     .......+..++.|+  ||+|||
T Consensus       206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH  284 (501)
T PHA03210        206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH  284 (501)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            3456789999999999999999999999999999999998 56777776532     123456777889998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      ++|++|+||||+||++   +.++.++|+|||++........  .....|+..|+|||.+.+..++.++|+||+||++|+|
T Consensus       285 ~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el  361 (501)
T PHA03210        285 DKKLIHRDIKLENIFL---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM  361 (501)
T ss_pred             hCCeecCCCCHHHEEE---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence            9999999999999999   5778899999999987654322  2235688999999999988999999999999999999


Q ss_pred             HhCCC-CCC
Q 030527          160 LNGYP-PFS  167 (175)
Q Consensus       160 ~~g~~-pf~  167 (175)
                      ++|.. ||.
T Consensus       362 l~~~~~p~~  370 (501)
T PHA03210        362 LSHDFCPIG  370 (501)
T ss_pred             HHCCCCCcc
Confidence            99865 444

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=3.6e-30  Score=188.65  Aligned_cols=157  Identities=32%  Similarity=0.548  Sum_probs=134.1

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ...+.+|+.++++++|||++++++++.+++..++|+||+. ++|.+++.+.   ..+++..+..++.|+  ||++||+.|
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~  121 (285)
T cd07861          43 PSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR  121 (285)
T ss_pred             hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4567889999999999999999999999999999999996 5888888643   458999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g  162 (175)
                      ++|+||+|+||++   +.++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||+|++++++++|
T Consensus       122 i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg  198 (285)
T cd07861         122 VLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATK  198 (285)
T ss_pred             eeecCCCHHHEEE---cCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHC
Confidence            9999999999999   5778899999999876543321 2233457889999988654 468899999999999999999


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      ..||.+.+
T Consensus       199 ~~~~~~~~  206 (285)
T cd07861         199 KPLFHGDS  206 (285)
T ss_pred             CCCCCCCC
Confidence            99997653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=2.3e-30  Score=190.31  Aligned_cols=159  Identities=26%  Similarity=0.462  Sum_probs=133.3

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHH--HH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQL--GL   77 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~~i--~l   77 (175)
                      ...+.+|..+++.++|||++++++++.+.+..+++|||+++++|.+++.+..          .++...+..++.|+  |+
T Consensus        53 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l  132 (288)
T cd05061          53 RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM  132 (288)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHH
Confidence            3457789999999999999999999999999999999999999999997532          24566788888898  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc---ccccCCCCccCcccccccCCCcchhHHHHHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  154 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~  154 (175)
                      ++||+.|++|+||+|+||++   +.++.++|+|||+++........   ....++..|+|||...+..++.++|+||+|+
T Consensus       133 ~~lH~~~i~H~dikp~nili---~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~  209 (288)
T cd05061         133 AYLNAKKFVHRDLAARNCMV---AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV  209 (288)
T ss_pred             HHHHhCCCcCCCCChheEEE---cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHH
Confidence            99999999999999999999   56778999999998765433211   1223356799999998888999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCc
Q 030527          155 ILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       155 ~~~~~~~-g~~pf~~~~~  171 (175)
                      +++++++ |..||.+.+.
T Consensus       210 ~l~el~~~~~~p~~~~~~  227 (288)
T cd05061         210 VLWEITSLAEQPYQGLSN  227 (288)
T ss_pred             HHHHHHhCCCCCCCCCCH
Confidence            9999998 7889976543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=2.2e-30  Score=195.48  Aligned_cols=156  Identities=37%  Similarity=0.550  Sum_probs=134.0

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ....+.+|+.++++++|||++++++++...      ...++|+||+. ++|.+.+...  ++...+..++.|+  ||++|
T Consensus        58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~L  134 (353)
T cd07850          58 HAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHL  134 (353)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHH
Confidence            345677899999999999999999987643      35799999994 5888887643  8899999999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      |+.|++|+||+|+||++   +.++.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++++|+
T Consensus       135 H~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~  211 (353)
T cd07850         135 HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI  211 (353)
T ss_pred             HhCCeeeCCCCHHHEEE---CCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHH
Confidence            99999999999999999   577789999999998765544334455788899999999889999999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|+.||...+
T Consensus       212 ~g~~pf~~~~  221 (353)
T cd07850         212 RGTVLFPGTD  221 (353)
T ss_pred             HCCCCCCCCC
Confidence            9999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=2.7e-30  Score=190.00  Aligned_cols=156  Identities=32%  Similarity=0.540  Sum_probs=132.8

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ..+.+|++++++++|+||+++.+++.+.+..++|+||+.+ +|.+++.+. ..+++..+..++.|+  ||++||+.|++|
T Consensus        48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H  126 (291)
T cd07844          48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH  126 (291)
T ss_pred             hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            3466799999999999999999999999999999999964 899988765 468999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +||+|+||++   +.++.++|+|||.+........ .....++..|+|||...+ ..++.++|+||+|+++++|++|+.|
T Consensus       127 ~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~  203 (291)
T cd07844         127 RDLKPQNLLI---SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL  203 (291)
T ss_pred             ccCCHHHEEE---cCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999   5677899999999876533221 122335678999998865 4578899999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |.+..
T Consensus       204 ~~~~~  208 (291)
T cd07844         204 FPGST  208 (291)
T ss_pred             CCCCc
Confidence            97654

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=2.8e-30  Score=193.59  Aligned_cols=160  Identities=32%  Similarity=0.524  Sum_probs=135.7

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHH
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARKF   71 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~   71 (175)
                      ..+.+.+|+++++++ +||||+++++++...+..++++||+++++|.+++.+..                .++..++..+
T Consensus        60 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  139 (334)
T cd05100          60 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC  139 (334)
T ss_pred             HHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHH
Confidence            456788899999999 89999999999999999999999999999999997532                3677888889


Q ss_pred             HHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc---ccccCCCCccCcccccccCCCcc
Q 030527           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEK  146 (175)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~  146 (175)
                      +.|+  |+++||+.|++|+||+|+||++   +.++.++|+|||+++........   ....++..|+|||.+.+..++.+
T Consensus       140 ~~qi~~al~~LH~~givH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  216 (334)
T cd05100         140 AYQVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ  216 (334)
T ss_pred             HHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch
Confidence            9998  9999999999999999999999   56778999999998766433211   11223456999999988889999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          147 VDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       147 ~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      +|+||||++++++++ |..||.+.+.
T Consensus       217 ~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         217 SDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             hhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999998 8999976543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-30  Score=187.66  Aligned_cols=159  Identities=28%  Similarity=0.617  Sum_probs=137.4

Q ss_pred             hhhhhHHHHHHHHhhCC---CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527            8 HLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ....++.+|+.++++++   |||++++.+++......++++||+++++|.+++.. +.+++..+..++.++  ++++||+
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~  119 (277)
T cd06917          41 DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHK  119 (277)
T ss_pred             hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34456888999999996   99999999999999999999999999999999875 478999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~  160 (175)
                      .|++|+||+|+||++   +..+.++|+|||.+........ .....++..|+|||...+ ..++.++|+||+|+++|+++
T Consensus       120 ~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll  196 (277)
T cd06917         120 VGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA  196 (277)
T ss_pred             CCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHH
Confidence            999999999999999   4677899999999887654432 233457788999998864 45789999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|..||.+.+
T Consensus       197 ~g~~p~~~~~  206 (277)
T cd06917         197 TGNPPYSDVD  206 (277)
T ss_pred             hCCCCCCCCC
Confidence            9999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=2.5e-30  Score=187.30  Aligned_cols=157  Identities=26%  Similarity=0.485  Sum_probs=133.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|+.++++++|++++++++++.. +..+++||++.+++|.+++.+.  ..+++..+..++.++  ++++||+.|+
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i  123 (260)
T cd05070          45 PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY  123 (260)
T ss_pred             HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            4568899999999999999999998754 5578999999999999998764  358999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      +|+||+|+||++   +.++.++|+|||.+.........  ....++..|+|||...+..++.++|+||||++++++++ |
T Consensus       124 ~H~di~p~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g  200 (260)
T cd05070         124 IHRDLRSANILV---GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG  200 (260)
T ss_pred             ccCCCccceEEE---eCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcC
Confidence            999999999999   46778999999999776443221  12223457999999988889999999999999999999 8


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      ..||.+.+
T Consensus       201 ~~p~~~~~  208 (260)
T cd05070         201 RVPYPGMN  208 (260)
T ss_pred             CCCCCCCC
Confidence            99997644

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=3.2e-30  Score=186.67  Aligned_cols=158  Identities=21%  Similarity=0.379  Sum_probs=132.3

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|..++++++|||++++++++......++||||+.+++|.+++.+++ .+++..+..++.|+  ++++||+.|++
T Consensus        43 ~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ii  122 (258)
T cd05078          43 SESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT  122 (258)
T ss_pred             HHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4567889999999999999999999999889999999999999999998654 58999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCC-----CceEEEeeecceeeccCCCccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHH
Q 030527           87 HRDLKPENILLSGLDD-----DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        87 h~di~~~ni~~~~~~~-----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~  160 (175)
                      |+||+|+||++...+.     ...++++|||.+.......   ...++..|+|||.+.+. .++.++|+||+|+++|+++
T Consensus       123 H~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~  199 (258)
T cd05078         123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE---ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIF  199 (258)
T ss_pred             cCCCccceEEEecccccccCCCceEEecccccccccCCch---hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHH
Confidence            9999999999963221     1237999999886654332   33467789999998764 5789999999999999999


Q ss_pred             hC-CCCCCCCC
Q 030527          161 NG-YPPFSVGE  170 (175)
Q Consensus       161 ~g-~~pf~~~~  170 (175)
                      +| ..||...+
T Consensus       200 ~g~~~~~~~~~  210 (258)
T cd05078         200 SGGDKPLSALD  210 (258)
T ss_pred             cCCCCChhhcc
Confidence            98 56665543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=2.4e-30  Score=188.43  Aligned_cols=162  Identities=29%  Similarity=0.525  Sum_probs=133.7

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC------CeEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQ   74 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~   74 (175)
                      ......+..|.++++.++|+||+++++++...      ...+++++|+.+++|.+++...      ..+++..+..++.|
T Consensus        41 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  120 (272)
T cd05075          41 RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD  120 (272)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHH
Confidence            34456788899999999999999999876432      2468999999999999987421      24789999999999


Q ss_pred             H--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhH
Q 030527           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM  149 (175)
Q Consensus        75 i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di  149 (175)
                      +  |++|||+.|++|+||+|+||++   +.++.++|+|||++........   ......+..|++||...+..++.++|+
T Consensus       121 i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di  197 (272)
T cd05075         121 IASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDV  197 (272)
T ss_pred             HHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHH
Confidence            8  9999999999999999999999   5677899999999987654332   122234567999999988889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCc
Q 030527          150 WSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       150 ~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      ||+|++++++++ |+.||.+.++
T Consensus       198 ~slG~il~el~~~g~~p~~~~~~  220 (272)
T cd05075         198 WSFGVTMWEIATRGQTPYPGVEN  220 (272)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999 8999976543

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=3.2e-30  Score=186.21  Aligned_cols=157  Identities=29%  Similarity=0.548  Sum_probs=133.8

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+.+|+.+++.++|||++++.+++..++ .++++||+.+++|.+++....  .+++..+..++.|+  |+++||+.|
T Consensus        42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  120 (254)
T cd05083          42 TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK  120 (254)
T ss_pred             hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4457888999999999999999999987654 689999999999999998653  47899999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-CC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY  163 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g~  163 (175)
                      ++|+|++|+||++   +.++.++|+|||++.......  .....+..|+|||.+.+..++.++|+||+|++++++++ |.
T Consensus       121 ~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~  195 (254)
T cd05083         121 LVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGV--DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR  195 (254)
T ss_pred             eeccccCcceEEE---cCCCcEEECCCccceeccccC--CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999   567789999999987653321  12233567999999988889999999999999999997 99


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||...+.
T Consensus       196 ~p~~~~~~  203 (254)
T cd05083         196 APYPKMSL  203 (254)
T ss_pred             CCCccCCH
Confidence            99976543

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-30  Score=185.53  Aligned_cols=159  Identities=45%  Similarity=0.740  Sum_probs=142.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+..|++++++++|||++++++.+..++..+++||++++++|.+++.+...+++..+..++.|+  ++.++|+.+++
T Consensus        36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~  115 (250)
T cd05123          36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII  115 (250)
T ss_pred             HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            3447888999999999999999999999999999999999999999999988889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||.+...... .......++..|++||...+..++.++|+||||++++++++|+.|
T Consensus       116 H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p  192 (250)
T cd05123         116 YRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP  192 (250)
T ss_pred             ecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            99999999999   56778999999998776543 233445567889999999888889999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |...+
T Consensus       193 ~~~~~  197 (250)
T cd05123         193 FYAED  197 (250)
T ss_pred             CCCCC
Confidence            97665

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=1.2e-30  Score=189.17  Aligned_cols=158  Identities=35%  Similarity=0.609  Sum_probs=140.0

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH-c
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS-H   83 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~-~   83 (175)
                      ....++.+|++++++++||||+++.+.+...+..++++|++.+++|.+++.+. ..+++..+..++.|+  +++++|+ .
T Consensus        41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  120 (265)
T cd06605          41 AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH  120 (265)
T ss_pred             HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC
Confidence            45567888999999999999999999999999999999999989999999876 789999999999998  9999999 9


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      |++|+||+|+||++   +.++.++|+|||.+......... ...++..|+|||...+..++.++|+||+|++++++++|+
T Consensus       121 ~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~  196 (265)
T cd06605         121 KIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR  196 (265)
T ss_pred             CeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHHhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999999   56778999999988665433222 256778899999998888999999999999999999999


Q ss_pred             CCCCCC
Q 030527          164 PPFSVG  169 (175)
Q Consensus       164 ~pf~~~  169 (175)
                      .||...
T Consensus       197 ~p~~~~  202 (265)
T cd06605         197 FPYPPE  202 (265)
T ss_pred             CCCCcc
Confidence            999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=6.8e-30  Score=187.00  Aligned_cols=147  Identities=35%  Similarity=0.631  Sum_probs=128.8

Q ss_pred             HHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEE
Q 030527           19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENIL   96 (175)
Q Consensus        19 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~   96 (175)
                      .++...||+++.+.+.+...+..++|+||+.|++|.+++.+.+.+++..+..++.|+  ++++||+.+++|+||+|+||+
T Consensus        50 ~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nil  129 (278)
T cd05606          50 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANIL  129 (278)
T ss_pred             HHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEE
Confidence            444458999999999999999999999999999999999888889999999999998  999999999999999999999


Q ss_pred             EeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030527           97 LSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus        97 ~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~~pf~~~  169 (175)
                      +   +.++.++|+|||.+....... .....++..|+|||.+.+. .++.++|+||+|++++++++|..||...
T Consensus       130 i---~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         130 L---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             E---CCCCCEEEccCcCccccCccC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            9   567789999999987553322 2334678899999998744 6899999999999999999999999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=5.2e-30  Score=185.50  Aligned_cols=162  Identities=37%  Similarity=0.696  Sum_probs=139.6

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHH--HH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GL   77 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i--~l   77 (175)
                      ......++.+|++++++++|||++++++++..  ....++++||+++++|.+++.+.    ..+++..+..++.++  ++
T Consensus        39 ~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l  118 (265)
T cd08217          39 TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL  118 (265)
T ss_pred             CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence            34456678889999999999999999987753  45789999999999999998753    568999999999998  99


Q ss_pred             HHHH-----HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHH
Q 030527           78 EILN-----SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWS  151 (175)
Q Consensus        78 ~~lh-----~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~s  151 (175)
                      +++|     +.+++|+||+|+||++   +.++.++++|||++........ .....++..|+|||...+..++.++|+||
T Consensus       119 ~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~s  195 (265)
T cd08217         119 YECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWS  195 (265)
T ss_pred             HHHhcCccccCcceecCCCHHHEEE---ecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHH
Confidence            9999     8899999999999999   4678899999999887655432 33445788899999998888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC
Q 030527          152 VGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       152 lg~~~~~~~~g~~pf~~~~  170 (175)
                      +|++++++++|+.||...+
T Consensus       196 lG~il~~l~~g~~p~~~~~  214 (265)
T cd08217         196 LGCLIYELCALSPPFTARN  214 (265)
T ss_pred             HHHHHHHHHHCCCcccCcC
Confidence            9999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=223.67  Aligned_cols=160  Identities=32%  Similarity=0.621  Sum_probs=140.7

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+.+.+|..++..++|||+|+++++=..+...++.||||.||+|.+.++..+..++....-+..|+  +++|||+.|||
T Consensus      1277 ~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIV 1356 (1509)
T KOG4645|consen 1277 TFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIV 1356 (1509)
T ss_pred             cCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCce
Confidence            3456788999999999999999999988888899999999999999999987777777777778887  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-----ccccccCCCCccCccccccc---CCCcchhHHHHHHHHHH
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFE  158 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~---~~~~~~Di~slg~~~~~  158 (175)
                      |+||||.||++   +.++.+|+.|||.|.+..++.     ......||+.|||||.+.+.   +...++||||+||++.|
T Consensus      1357 HRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlE 1433 (1509)
T KOG4645|consen 1357 HRDIKPANILL---DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLE 1433 (1509)
T ss_pred             ecCCCccceee---ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEE
Confidence            99999999999   577799999999999887653     12357899999999999654   46789999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030527          159 LLNGYPPFSVGEE  171 (175)
Q Consensus       159 ~~~g~~pf~~~~~  171 (175)
                      |+||+.||..-++
T Consensus      1434 M~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1434 MATGKRPWAELDN 1446 (1509)
T ss_pred             eecCCCchhhccc
Confidence            9999999976543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2e-30  Score=185.75  Aligned_cols=151  Identities=31%  Similarity=0.482  Sum_probs=131.2

Q ss_pred             HHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCC
Q 030527           13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDL   90 (175)
Q Consensus        13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di   90 (175)
                      +..|.+.+....|||++++.+++.+....+++|||++|++|.+++.+...+++..+..++.|+  ++++||+.|++|+||
T Consensus        32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl  111 (237)
T cd05576          32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDL  111 (237)
T ss_pred             hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence            455666666678999999999999999999999999999999999887789999999999998  999999999999999


Q ss_pred             CCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030527           91 KPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV  168 (175)
Q Consensus        91 ~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~  168 (175)
                      +|+||++   +.++.++++|||.+.......  ....++..|+|||...+..++.++|+||+|++++++++|..||..
T Consensus       112 kp~Nil~---~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         112 NPNNILL---DDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             CHHHEEE---cCCCCEEEecccchhcccccc--ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence            9999999   567789999999876654332  233446679999999888889999999999999999999988764

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=9.7e-30  Score=186.86  Aligned_cols=158  Identities=35%  Similarity=0.598  Sum_probs=135.4

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      ....++.+|++++++++||||+++++++.+  .+..+++|||+++++|.+++.+    ...+++..+..++.|+  ++++
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~  120 (287)
T cd06621          41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY  120 (287)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            345678899999999999999999998854  4478999999999999988753    2458899999999998  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      ||+.|++|+|++|+||++   +.++.++|+|||++........ ....++..|++||...+..++.++|+||+|+++|++
T Consensus       121 lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l  196 (287)
T cd06621         121 LHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV  196 (287)
T ss_pred             HHHCCcccCCCCHHHEEE---ecCCeEEEeecccccccccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence            999999999999999999   4667799999999866543322 234467789999999888899999999999999999


Q ss_pred             HhCCCCCCCC
Q 030527          160 LNGYPPFSVG  169 (175)
Q Consensus       160 ~~g~~pf~~~  169 (175)
                      ++|+.||...
T Consensus       197 ~~g~~p~~~~  206 (287)
T cd06621         197 AQNRFPFPPE  206 (287)
T ss_pred             HhCCCCCCcc
Confidence            9999999866

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=5.3e-30  Score=185.87  Aligned_cols=160  Identities=37%  Similarity=0.632  Sum_probs=139.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ..+.+.+|+..++.++|+|++++.+.+...+..++++|++++++|.+++...   ..+++..+..++.|+  ++++||+.
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~  121 (267)
T cd06610          42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN  121 (267)
T ss_pred             HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4567889999999999999999999999999999999999999999999764   358999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc-----ccccCCCCccCccccccc-CCCcchhHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILF  157 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~  157 (175)
                      |++|+|++|+||++   +.++.++|+|||.+.........     ....++..|++||.+... .++.++|+||+|++++
T Consensus       122 ~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~  198 (267)
T cd06610         122 GQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAI  198 (267)
T ss_pred             CeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHH
Confidence            99999999999999   46678999999998766543221     233467889999998766 7899999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030527          158 ELLNGYPPFSVGEE  171 (175)
Q Consensus       158 ~~~~g~~pf~~~~~  171 (175)
                      +|++|+.||...+.
T Consensus       199 ~l~~g~~p~~~~~~  212 (267)
T cd06610         199 ELATGAAPYSKYPP  212 (267)
T ss_pred             HHHhCCCCccccCh
Confidence            99999999976543

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=4.5e-30  Score=189.02  Aligned_cols=155  Identities=32%  Similarity=0.513  Sum_probs=133.6

Q ss_pred             hHHHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           12 CLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      .+.+|+.++++++||||+++.+++...  +..++++||+. ++|.+++.... .+++..+..++.|+  ||++||+.|++
T Consensus        50 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~  128 (293)
T cd07843          50 TSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWIL  128 (293)
T ss_pred             hHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            456799999999999999999998877  88999999996 59999887654 58999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccC-CCcchhHHHHHHHHHHHHhCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      |+||+|+||++   +.++.++|+|||.+....... ......++..|+|||...+.. ++.++|+||+|++++++++|..
T Consensus       129 H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~  205 (293)
T cd07843         129 HRDLKTSNLLL---NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP  205 (293)
T ss_pred             eccCCHHHEEE---CCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCC
Confidence            99999999999   577889999999988765542 223345677899999886544 6889999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||...+
T Consensus       206 ~f~~~~  211 (293)
T cd07843         206 LFPGKS  211 (293)
T ss_pred             CCCCCC
Confidence            997654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=6.8e-30  Score=187.90  Aligned_cols=156  Identities=32%  Similarity=0.531  Sum_probs=131.5

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ..+.+|+++++.++|+||+++.+++...+..++|+||+. +++.+++... ..+++..+..++.|+  ||++||+.|++|
T Consensus        48 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H  126 (291)
T cd07870          48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH  126 (291)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            356789999999999999999999999999999999995 6787776544 567888889999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +||+|+||++   +.++.++|+|||++....... ......++..|+|||...+. .++.++|+||+|++++++++|..|
T Consensus       127 ~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~  203 (291)
T cd07870         127 RDLKPQNLLI---SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA  203 (291)
T ss_pred             CCCChHHEEE---cCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999   567789999999887543321 22234467889999988653 578899999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |.+.+
T Consensus       204 f~~~~  208 (291)
T cd07870         204 FPGVS  208 (291)
T ss_pred             CCCch
Confidence            97644

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=4.7e-30  Score=190.61  Aligned_cols=161  Identities=28%  Similarity=0.433  Sum_probs=136.9

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ......+..|++++++++|+||+++.+++.+.+..++++||+++++|.+++.+.  ..+++..+..++.|+  |++|||+
T Consensus        40 ~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~  119 (314)
T cd08216          40 KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS  119 (314)
T ss_pred             hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            345568899999999999999999999999999999999999999999999864  458899999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--------cccccCCCCccCcccccc--cCCCcchhHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQF--QRYDEKVDMWSV  152 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~--~~~~~~~Di~sl  152 (175)
                      .+++|+||+|+||++   +.++.++++||+.+........        .....++..|+|||.+.+  ..++.++|+||+
T Consensus       120 ~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~  196 (314)
T cd08216         120 KGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV  196 (314)
T ss_pred             CCeecCCCCcceEEE---ecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHH
Confidence            999999999999999   4667899999998865532211        122345667999999865  358899999999


Q ss_pred             HHHHHHHHhCCCCCCCCC
Q 030527          153 GAILFELLNGYPPFSVGE  170 (175)
Q Consensus       153 g~~~~~~~~g~~pf~~~~  170 (175)
                      |++++++++|+.||...+
T Consensus       197 G~il~el~~g~~pf~~~~  214 (314)
T cd08216         197 GITACELANGHVPFKDMP  214 (314)
T ss_pred             HHHHHHHHhCCCCCCCCC
Confidence            999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-29  Score=182.69  Aligned_cols=160  Identities=31%  Similarity=0.643  Sum_probs=142.4

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .....+.+|++++++++|||++++.+++.+.+..+++++++.+++|.+++.+.+.+++..+..++.|+  ++++||+.|+
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i  120 (254)
T cd06627          41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV  120 (254)
T ss_pred             HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence            34567899999999999999999999999999999999999999999999988889999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+||+|+||++   +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|..
T Consensus       121 ~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~  197 (254)
T cd06627         121 IHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNP  197 (254)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCC
Confidence            999999999999   4577899999999987755433 233456788999999887778999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||...+
T Consensus       198 p~~~~~  203 (254)
T cd06627         198 PYYDLN  203 (254)
T ss_pred             CCCCcc
Confidence            997543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=192.96  Aligned_cols=157  Identities=34%  Similarity=0.593  Sum_probs=146.6

Q ss_pred             HHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCC
Q 030527           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLK   91 (175)
Q Consensus        14 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~   91 (175)
                      ..|-+.|+..+||.+..+...|+...++|+||||..||.|.-++.+..-+++.....+..+|  ||.|||+++++++|+|
T Consensus       216 lTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlK  295 (516)
T KOG0690|consen  216 LTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLK  295 (516)
T ss_pred             hhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeech
Confidence            44889999999999999999999999999999999999999999988899999999999998  9999999999999999


Q ss_pred             CCcEEEeecCCCceEEEeeecceeecc-CCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030527           92 PENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus        92 ~~ni~~~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~  170 (175)
                      .+|+++   ++++.+++.|||+++... .+....+..||+.|+|||.+....|+++.|-|.+|+++|+|++|.+||.+.+
T Consensus       296 LENLlL---DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d  372 (516)
T KOG0690|consen  296 LENLLL---DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD  372 (516)
T ss_pred             hhhhee---ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence            999999   799999999999997654 4566788999999999999999999999999999999999999999999887


Q ss_pred             ccC
Q 030527          171 EHQ  173 (175)
Q Consensus       171 ~~~  173 (175)
                      .+.
T Consensus       373 h~k  375 (516)
T KOG0690|consen  373 HEK  375 (516)
T ss_pred             hhH
Confidence            543

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=3.6e-30  Score=186.49  Aligned_cols=158  Identities=26%  Similarity=0.540  Sum_probs=134.1

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|+.++++++|+|++++.+++. .+..++++|++.+++|.+++.+.  ..++..++..++.|+  ++++||+.|+
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i  123 (260)
T cd05067          45 PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY  123 (260)
T ss_pred             HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            357888999999999999999998874 45689999999999999998754  368899999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      +|+||+|+|+++   +.++.++|+|||.+.........  ....++..|+|||...+..++.++|+||+|++++++++ |
T Consensus       124 ~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g  200 (260)
T cd05067         124 IHRDLRAANILV---SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYG  200 (260)
T ss_pred             ecccccHHhEEE---cCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCC
Confidence            999999999999   56778999999998766533221  12234567999999988889999999999999999999 9


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||.+.+.
T Consensus       201 ~~p~~~~~~  209 (260)
T cd05067         201 RIPYPGMTN  209 (260)
T ss_pred             CCCCCCCCh
Confidence            999976543

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=202.89  Aligned_cols=165  Identities=28%  Similarity=0.541  Sum_probs=144.0

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      +.+.++.|..|+++|.+|+||||+.++++|..++.+++++||+..|+|.+++.+..  ........+|.+||  +++||.
T Consensus       575 ~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe  654 (807)
T KOG1094|consen  575 TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE  654 (807)
T ss_pred             chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH
Confidence            45667899999999999999999999999999999999999999999999999773  34566677899999  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc---ccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      +.+++|||+.+.|+++   +.+.++|++|||.++....++..   ....-..+|+|+|.+.-++++.++|+|++|+++||
T Consensus       655 s~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE  731 (807)
T KOG1094|consen  655 SLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE  731 (807)
T ss_pred             hhchhhccccccceee---cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHH
Confidence            9999999999999999   78999999999999877666542   23345678999999999999999999999999999


Q ss_pred             HHh--CCCCCCCCCccC
Q 030527          159 LLN--GYPPFSVGEEHQ  173 (175)
Q Consensus       159 ~~~--g~~pf~~~~~~~  173 (175)
                      +++  .+.||..-++++
T Consensus       732 ~~~~C~e~Py~~lt~e~  748 (807)
T KOG1094|consen  732 VFMLCREQPYSQLTDEQ  748 (807)
T ss_pred             HHHHHhhCchhhhhHHH
Confidence            755  788997655543

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=1.8e-30  Score=190.22  Aligned_cols=154  Identities=34%  Similarity=0.607  Sum_probs=131.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|++++++++|||++++++++.+.+..++++||+. ++|.+++.+ .+.+++..+..++.|+  |+++||+.|++
T Consensus        43 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~  121 (284)
T cd07839          43 PSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVL  121 (284)
T ss_pred             ccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            3467789999999999999999999999999999999995 588888765 4679999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccC-CCcchhHHHHHHHHHHHHhCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      |+||+|+||++   +.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+||+|+++++|++|..
T Consensus       122 H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~  198 (284)
T cd07839         122 HRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR  198 (284)
T ss_pred             cCCCCHHHEEE---cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCC
Confidence            99999999999   5678899999999876543321 22345678899999886644 6899999999999999999988


Q ss_pred             CCC
Q 030527          165 PFS  167 (175)
Q Consensus       165 pf~  167 (175)
                      ||.
T Consensus       199 p~~  201 (284)
T cd07839         199 PLF  201 (284)
T ss_pred             CCc
Confidence            853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=8.9e-30  Score=186.62  Aligned_cols=157  Identities=29%  Similarity=0.473  Sum_probs=131.4

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ...+.+.+|++++++++|||++++.+++..  ....++|+||+++++|.+++.+. ..+++..+..++.|+  ||++||+
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~  126 (284)
T cd05081          47 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS  126 (284)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH
Confidence            345578899999999999999999987643  44689999999999999999765 468999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc----ccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      .|++|+||+|+||++   +.++.++|+|||++.........    .....+..|+|||...+..++.++|+||+|+++++
T Consensus       127 ~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e  203 (284)
T cd05081         127 KRYVHRDLATRNILV---ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE  203 (284)
T ss_pred             CCceeccCCHhhEEE---CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHH
Confidence            999999999999999   56778999999998866433211    11122345899999988889999999999999999


Q ss_pred             HHhCCCCCC
Q 030527          159 LLNGYPPFS  167 (175)
Q Consensus       159 ~~~g~~pf~  167 (175)
                      +++|..|+.
T Consensus       204 l~~~~~~~~  212 (284)
T cd05081         204 LFTYSDKSC  212 (284)
T ss_pred             HhhcCCcCC
Confidence            999877654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=5.7e-30  Score=185.52  Aligned_cols=159  Identities=28%  Similarity=0.540  Sum_probs=135.3

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+.+|++++++++|+|++++.+++.. +..++++||+++++|.+++.+.  ..++...+..++.++  ++++||+.|
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~  122 (260)
T cd05073          44 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN  122 (260)
T ss_pred             HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34678889999999999999999999887 7789999999999999999764  357888889999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  161 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-  161 (175)
                      ++|+||+|+|+++   +..+.++|+|||.+.........  ....++..|+|||.+.+..++.++|+||+|++++++++ 
T Consensus       123 i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~  199 (260)
T cd05073         123 YIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY  199 (260)
T ss_pred             ccccccCcceEEE---cCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhc
Confidence            9999999999999   57788999999998766433221  12234566999999988889999999999999999999 


Q ss_pred             CCCCCCCCCc
Q 030527          162 GYPPFSVGEE  171 (175)
Q Consensus       162 g~~pf~~~~~  171 (175)
                      |..||.+.+.
T Consensus       200 g~~p~~~~~~  209 (260)
T cd05073         200 GRIPYPGMSN  209 (260)
T ss_pred             CCCCCCCCCH
Confidence            9999986543

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=5.8e-30  Score=186.37  Aligned_cols=160  Identities=22%  Similarity=0.439  Sum_probs=131.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ....+.+|+..++.++|||++++++.+......++||||+++++|.+++.+.    ...+...+..++.|+  |++|||+
T Consensus        38 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~  117 (268)
T cd05086          38 EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK  117 (268)
T ss_pred             HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence            4567888999999999999999999999999999999999999999999754    235677778888898  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccc-------cCCCcchhHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-------QRYDEKVDMWSV  152 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~-------~~~~~~~Di~sl  152 (175)
                      .+++|+||+|+||++   +.++.++|+|||++.......   ......++..|+|||....       ..++.++|+||+
T Consensus       118 ~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl  194 (268)
T cd05086         118 HNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWAL  194 (268)
T ss_pred             CCeeccCCccceEEE---cCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHH
Confidence            999999999999999   567789999999875432211   1123456778999998742       245788999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCc
Q 030527          153 GAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       153 g~~~~~~~~-g~~pf~~~~~  171 (175)
                      |++++++++ +..||...++
T Consensus       195 G~~l~el~~~~~~p~~~~~~  214 (268)
T cd05086         195 GVTLWELFENAAQPYSHLSD  214 (268)
T ss_pred             HHHHHHHHhCCCCCCCCCCH
Confidence            999999997 5778875543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=3.2e-30  Score=185.97  Aligned_cols=160  Identities=39%  Similarity=0.624  Sum_probs=140.6

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      .....+.+|++++++++|+||+++.+++.+....++++|++++++|.+++.+    ...+++..+..++.++  |+++||
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh  120 (256)
T cd08530          41 KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH  120 (256)
T ss_pred             HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence            4456778899999999999999999999999999999999999999999876    3468899999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      +.|++|+||+|+||++.   .++.++|+|||.+...... ......++..|++||...+..++.++|+||+|++++++++
T Consensus       121 ~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~  196 (256)
T cd08530         121 EQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT  196 (256)
T ss_pred             hCCcccCCCCcceEEEe---cCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh
Confidence            99999999999999994   5778999999998776554 3334556788999999988889999999999999999999


Q ss_pred             CCCCCCCCCc
Q 030527          162 GYPPFSVGEE  171 (175)
Q Consensus       162 g~~pf~~~~~  171 (175)
                      |+.||...+.
T Consensus       197 g~~p~~~~~~  206 (256)
T cd08530         197 FAPPFEARSM  206 (256)
T ss_pred             CCCCCCCCCH
Confidence            9999987654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=4.4e-30  Score=188.67  Aligned_cols=159  Identities=28%  Similarity=0.591  Sum_probs=134.9

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------------CCCH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------------RVPE   65 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~l~~   65 (175)
                      +..+++.+|+.++++++|||++++++++.+....++++||+++++|.+++....                      .+++
T Consensus        50 ~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  129 (288)
T cd05050          50 DMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC  129 (288)
T ss_pred             HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCH
Confidence            445678899999999999999999999999999999999999999999987432                      3678


Q ss_pred             HHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccc
Q 030527           66 QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF  140 (175)
Q Consensus        66 ~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~  140 (175)
                      ..+..++.|+  +++++|+.|++|+||+|+||++   +.++.++++|||.+........   ......+..|+|||...+
T Consensus       130 ~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  206 (288)
T cd05050         130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY  206 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecccccHhheEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc
Confidence            8889999998  9999999999999999999999   5677899999999876533221   112233567999999988


Q ss_pred             cCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 030527          141 QRYDEKVDMWSVGAILFELLN-GYPPFSVG  169 (175)
Q Consensus       141 ~~~~~~~Di~slg~~~~~~~~-g~~pf~~~  169 (175)
                      ..++.++|+||||++++++++ |..||.+.
T Consensus       207 ~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         207 NRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            889999999999999999998 88888654

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=6.3e-30  Score=188.49  Aligned_cols=159  Identities=32%  Similarity=0.617  Sum_probs=137.9

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|+.+++.++|||++++.+++...+..++|+||+++++|.+++.+ ..++...+..++.++  ++++||+.|++
T Consensus        59 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~  137 (293)
T cd06647          59 KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVI  137 (293)
T ss_pred             HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            345678899999999999999999999999999999999999999999874 457888999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+|++|+||++   +.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||+|++++++++|+.|
T Consensus       138 H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~p  214 (293)
T cd06647         138 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP  214 (293)
T ss_pred             eccCCHHHEEE---cCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999   567789999999886554332 22234567789999999888899999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |...++
T Consensus       215 f~~~~~  220 (293)
T cd06647         215 YLNENP  220 (293)
T ss_pred             CCCCCh
Confidence            976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.9e-31  Score=201.38  Aligned_cols=164  Identities=32%  Similarity=0.549  Sum_probs=138.3

Q ss_pred             ccccchhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHH
Q 030527            2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE   78 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~   78 (175)
                      +|.+... .++-.+|..++... +|||+++..+.+.+....++|||.+.|+.+.+.+.....+. ..+..|+.+|  |+.
T Consensus       352 vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~  429 (612)
T KOG0603|consen  352 VKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVD  429 (612)
T ss_pred             heecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHH
Confidence            3444333 44556677676666 89999999999999999999999999998888877655544 7777899998  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      +||++|++|||+||+||++.  +..+.++|+|||.+......  ...+..|..|.|||.....+++.++|+||||+++|+
T Consensus       430 ~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~  505 (612)
T KOG0603|consen  430 YLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYE  505 (612)
T ss_pred             HHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHH
Confidence            99999999999999999994  46778999999999877555  445567889999999998899999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030527          159 LLNGYPPFSVGEE  171 (175)
Q Consensus       159 ~~~g~~pf~~~~~  171 (175)
                      |++|+.||.....
T Consensus       506 ML~G~tp~~~~P~  518 (612)
T KOG0603|consen  506 MLTGRTLFAAHPA  518 (612)
T ss_pred             HHhCCCccccCCc
Confidence            9999999976543

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=1e-29  Score=186.83  Aligned_cols=156  Identities=34%  Similarity=0.587  Sum_probs=136.0

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|+++++++ .|++|+++.+.+..++..++|+||+++++|.+++.+...+++..+..++.|+  ++++||+.|++
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~  127 (290)
T cd05613          48 TEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGII  127 (290)
T ss_pred             HHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            35678899999999 6999999999999999999999999999999999988889999999999898  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCccccccc--CCCcchhHHHHHHHHHHHHhC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slg~~~~~~~~g  162 (175)
                      |+||+|+||++   +.++.++|+|||++........  .....++..|++||...+.  .++.++|+||+|++++++++|
T Consensus       128 H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g  204 (290)
T cd05613         128 YRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG  204 (290)
T ss_pred             ccCCCHHHeEE---CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcC
Confidence            99999999999   5678899999999876544321  2234577889999998653  467889999999999999999


Q ss_pred             CCCCCC
Q 030527          163 YPPFSV  168 (175)
Q Consensus       163 ~~pf~~  168 (175)
                      ..||..
T Consensus       205 ~~p~~~  210 (290)
T cd05613         205 ASPFTV  210 (290)
T ss_pred             CCCCCc
Confidence            999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=9.3e-30  Score=187.55  Aligned_cols=159  Identities=28%  Similarity=0.606  Sum_probs=138.2

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .....+.+|+.+++.++|+|++++.+.+...+..++++||+++++|.+++. ...+++..+..++.|+  ++++||+.|+
T Consensus        59 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~gi  137 (292)
T cd06657          59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGV  137 (292)
T ss_pred             hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345568889999999999999999999999999999999999999999875 4568899999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+|++|+||++   +.++.++++|||.+....... ......++..|++||...+..++.++|+||+|++++++++|..
T Consensus       138 vH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~  214 (292)
T cd06657         138 IHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP  214 (292)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999   567789999999887654332 1223456788999999888888999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||.+.+
T Consensus       215 p~~~~~  220 (292)
T cd06657         215 PYFNEP  220 (292)
T ss_pred             CCCCCC
Confidence            997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=6e-30  Score=191.76  Aligned_cols=156  Identities=35%  Similarity=0.523  Sum_probs=134.5

Q ss_pred             hHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecC
Q 030527           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRD   89 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~d   89 (175)
                      .+.+|++++++++|+||+++++++...+..++++|++. ++|.+++.....+++..+..++.|+  ++++||+.|++|+|
T Consensus        66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d  144 (335)
T PTZ00024         66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRD  144 (335)
T ss_pred             hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            46789999999999999999999999999999999995 5999999887889999999999998  99999999999999


Q ss_pred             CCCCcEEEeecCCCceEEEeeecceeeccCCC---------------ccccccCCCCccCccccccc-CCCcchhHHHHH
Q 030527           90 LKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------------YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVG  153 (175)
Q Consensus        90 i~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---------------~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg  153 (175)
                      |+|+||++   +.++.++|+|||.+.......               ......++..|+|||.+.+. .++.++|+||+|
T Consensus       145 l~~~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  221 (335)
T PTZ00024        145 LSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG  221 (335)
T ss_pred             ccHHHeEE---CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHH
Confidence            99999999   567789999999987664111               11123356789999988754 468899999999


Q ss_pred             HHHHHHHhCCCCCCCCCc
Q 030527          154 AILFELLNGYPPFSVGEE  171 (175)
Q Consensus       154 ~~~~~~~~g~~pf~~~~~  171 (175)
                      ++++++++|+.||.+.++
T Consensus       222 ~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        222 CIFAELLTGKPLFPGENE  239 (335)
T ss_pred             HHHHHHHhCCCCCCCCCH
Confidence            999999999999976543

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=9.5e-30  Score=194.64  Aligned_cols=158  Identities=30%  Similarity=0.529  Sum_probs=133.3

Q ss_pred             hhhHHHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC---------------------------
Q 030527           10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------------------------   61 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------------   61 (175)
                      ...+..|++++.++. ||||+++++++...+..++|+||+.+++|.+++.++.                           
T Consensus        84 ~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (401)
T cd05107          84 KQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQ  163 (401)
T ss_pred             HHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccc
Confidence            446888999999996 9999999999999999999999999999999986532                           


Q ss_pred             -----------------------------------------------------------------------CCCHHHHHH
Q 030527           62 -----------------------------------------------------------------------RVPEQTARK   70 (175)
Q Consensus        62 -----------------------------------------------------------------------~l~~~~~~~   70 (175)
                                                                                             .++...+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  243 (401)
T cd05107         164 RKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVG  243 (401)
T ss_pred             cccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHH
Confidence                                                                                   245666778


Q ss_pred             HHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCCCc
Q 030527           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDE  145 (175)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~  145 (175)
                      ++.|+  |++|||+.+++|+||+|+||++   +....++|+|||++.......   ......++..|+|||.+.+..++.
T Consensus       244 ~~~qi~~aL~~LH~~~ivHrdlkp~NiLl---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  320 (401)
T cd05107         244 FSYQVANGMEFLASKNCVHRDLAARNVLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT  320 (401)
T ss_pred             HHHHHHHHHHHHhcCCcCcccCCcceEEE---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc
Confidence            88888  9999999999999999999999   467789999999987653221   112234567899999998888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCC
Q 030527          146 KVDMWSVGAILFELLN-GYPPFSVGE  170 (175)
Q Consensus       146 ~~Di~slg~~~~~~~~-g~~pf~~~~  170 (175)
                      ++|+||+|++++++++ |..||....
T Consensus       321 ~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         321 LSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             HhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999998 899997643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=1.3e-29  Score=185.21  Aligned_cols=156  Identities=31%  Similarity=0.615  Sum_probs=137.0

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+..+++++|||++++++++.++...++|+||+.+++|.+++.+ +.++...+..++.++  ++++||+.|++|
T Consensus        46 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h  124 (277)
T cd06641          46 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIH  124 (277)
T ss_pred             HHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeec
Confidence            45788899999999999999999999999999999999999999999874 568899999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +|++|+||++   +.++.++++|||++........ .....++..|+|||...+..++.++|+||+|++++++++|..||
T Consensus       125 ~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  201 (277)
T cd06641         125 RDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH  201 (277)
T ss_pred             CCCCHHhEEE---CCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence            9999999999   5677899999998876644322 22345677899999998888899999999999999999999999


Q ss_pred             CCC
Q 030527          167 SVG  169 (175)
Q Consensus       167 ~~~  169 (175)
                      ...
T Consensus       202 ~~~  204 (277)
T cd06641         202 SEL  204 (277)
T ss_pred             Ccc
Confidence            754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=7.3e-30  Score=186.72  Aligned_cols=161  Identities=25%  Similarity=0.453  Sum_probs=136.0

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEee-CCeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHH--
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--------GRVPEQTARKFLQQL--   75 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~~i--   75 (175)
                      ......+.+|+++++.++|||++++++++.. ....+++++++++++|.+++.+.        ..+++..+..++.++  
T Consensus        49 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~  128 (280)
T cd05043          49 EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC  128 (280)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHH
Confidence            4445678889999999999999999998765 46788999999999999998754        348899999999998  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  152 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl  152 (175)
                      |+++||+.+++|+||+|+|+++   +.+..++++|||+++.......   .....++..|+|||...+..++.++|+||+
T Consensus       129 ~l~~LH~~~i~H~di~p~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl  205 (280)
T cd05043         129 GMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSF  205 (280)
T ss_pred             HHHHHHHCCEeecccCHhhEEE---cCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHh
Confidence            9999999999999999999999   5678899999999876543321   112334567999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCC
Q 030527          153 GAILFELLN-GYPPFSVGE  170 (175)
Q Consensus       153 g~~~~~~~~-g~~pf~~~~  170 (175)
                      |++++++++ |+.||...+
T Consensus       206 G~~l~el~~~g~~p~~~~~  224 (280)
T cd05043         206 GVLLWELMTLGQTPYVEID  224 (280)
T ss_pred             HHHHHHHhcCCCCCcCcCC
Confidence            999999999 999997644

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=1.9e-29  Score=185.72  Aligned_cols=158  Identities=32%  Similarity=0.511  Sum_probs=132.0

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|++++++++|||++++++++.+.+..++|+||+. +++.+++.....  +++..+..++.|+  ||++||+.|+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  123 (294)
T PLN00009         45 PSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV  123 (294)
T ss_pred             hHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4567889999999999999999999999999999999995 588888865543  5788888899998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +|+||+|+||++.  ..+..++++|||++........ .....++..|+|||.+.+. .++.++|+||+|++++++++|.
T Consensus       124 ~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~  201 (294)
T PLN00009        124 LHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK  201 (294)
T ss_pred             eCCCCCcceEEEE--CCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999994  3456799999999976543321 1233457789999988654 5788999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||...+
T Consensus       202 ~pf~~~~  208 (294)
T PLN00009        202 PLFPGDS  208 (294)
T ss_pred             CCCCCCC
Confidence            9997654

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=4.8e-30  Score=188.05  Aligned_cols=158  Identities=34%  Similarity=0.607  Sum_probs=136.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+++++.++|||++++.+++...+..++|+||+.++++..+......+++.++..++.|+  ++++||+.|++|
T Consensus        44 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h  123 (286)
T cd07846          44 KKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH  123 (286)
T ss_pred             hHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            456788999999999999999999999999999999999998888877766679999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +|++|+||++   +.++.++|+|||++........ .....++..|+|||...+. .++.++|+||+|++++++++|..|
T Consensus       124 ~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~  200 (286)
T cd07846         124 RDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPL  200 (286)
T ss_pred             cCCCHHHEEE---CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCC
Confidence            9999999999   5778899999999876644322 2234467889999988653 467889999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |...+
T Consensus       201 ~~~~~  205 (286)
T cd07846         201 FPGDS  205 (286)
T ss_pred             CCCCc
Confidence            97554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=206.85  Aligned_cols=161  Identities=34%  Similarity=0.576  Sum_probs=142.1

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCC--CHHHHHHHHHHH--HHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRV--PEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l--~~~~~~~~~~~i--~l~~l   80 (175)
                      +....+-+++|+.+-++|+|.|||+++|.+.+++.+-+.||-.+||+|.+++.. +|++  -+.++..+.+||  +|+||
T Consensus       612 dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYL  691 (1226)
T KOG4279|consen  612 DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYL  691 (1226)
T ss_pred             cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhh
Confidence            344456678999999999999999999999999999999999999999999874 5887  688888999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCccccccc--CCCcchhHHHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILF  157 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slg~~~~  157 (175)
                      |++.|||||||-+|+++.  .-.+.+||+|||-+++... +.-+.+..||.-|||||++..+  +|+.++|||||||++.
T Consensus       692 Hen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~v  769 (1226)
T KOG4279|consen  692 HENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMV  769 (1226)
T ss_pred             hhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeE
Confidence            999999999999999995  4578899999998887743 3346678899999999999654  4899999999999999


Q ss_pred             HHHhCCCCCCC
Q 030527          158 ELLNGYPPFSV  168 (175)
Q Consensus       158 ~~~~g~~pf~~  168 (175)
                      ||.||++||-.
T Consensus       770 EMATGrPPF~E  780 (1226)
T KOG4279|consen  770 EMATGRPPFVE  780 (1226)
T ss_pred             eeccCCCCeee
Confidence            99999999953

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=190.44  Aligned_cols=161  Identities=30%  Similarity=0.577  Sum_probs=145.9

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ++.-+++..|+.++++++.|++|++++.+.....+++|||||..|++.+.+..+ .++++.++..++...  +|+|||..
T Consensus        69 ~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~  148 (502)
T KOG0574|consen   69 DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL  148 (502)
T ss_pred             cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH
Confidence            345678888999999999999999999999999999999999999999998754 679999999999996  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      .=+|+|||+.||++   +.++..+|.|||.+....+. ....+..||++|+|||++..-.|...+|+||||++..+|..|
T Consensus       149 ~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG  225 (502)
T KOG0574|consen  149 KKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEG  225 (502)
T ss_pred             HHHHhhcccccEEE---cccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcC
Confidence            99999999999999   68899999999999777554 346678899999999999988999999999999999999999


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      ++|+.+.-
T Consensus       226 ~PPYsDIH  233 (502)
T KOG0574|consen  226 RPPYSDIH  233 (502)
T ss_pred             CCCccccc
Confidence            99997643

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=5.7e-30  Score=184.85  Aligned_cols=161  Identities=34%  Similarity=0.661  Sum_probs=138.4

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHc
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      .....+.+|+++++.++|+|++++++.+...+..++++||+++++|.+++.+..  .+++..+..++.++  ++++||+.
T Consensus        41 ~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~  120 (257)
T cd08225          41 KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR  120 (257)
T ss_pred             hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            345678899999999999999999999999999999999999999999987653  47899999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      +++|+|++|+||+++  +.+..++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|
T Consensus       121 ~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g  198 (257)
T cd08225         121 KILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL  198 (257)
T ss_pred             CcccccCCHHHEEEc--CCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence            999999999999994  2334579999998876644322 2234577889999999888899999999999999999999


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      +.||...+
T Consensus       199 ~~p~~~~~  206 (257)
T cd08225         199 KHPFEGNN  206 (257)
T ss_pred             CCCCCCcc
Confidence            99997654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=1.1e-29  Score=183.05  Aligned_cols=160  Identities=36%  Similarity=0.670  Sum_probs=142.1

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      .....+.+|++++++++|||++++.+.+...+..++++|++++++|.+++.+.    ..+++..+..++.++  ++++||
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh  120 (258)
T cd08215          41 KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH  120 (258)
T ss_pred             HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence            45667889999999999999999999999999999999999999999999764    679999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      +.|++|+|++|+||++   +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||+|+++++++
T Consensus       121 ~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~  197 (258)
T cd08215         121 SRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELC  197 (258)
T ss_pred             hCCEecccCChHHeEE---cCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHH
Confidence            9999999999999999   567889999999987765543 233455778899999988888999999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|+.||...+
T Consensus       198 ~g~~p~~~~~  207 (258)
T cd08215         198 TLKHPFEGEN  207 (258)
T ss_pred             cCCCCCCCCc
Confidence            9999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=1.6e-29  Score=184.01  Aligned_cols=158  Identities=33%  Similarity=0.618  Sum_probs=133.1

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeC------CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HH
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GL   77 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l   77 (175)
                      ....+.+|+.+++++ +|+|++++.+++...      ...++++||+.+++|.+++...  ..+++..+..++.|+  ++
T Consensus        45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l  124 (272)
T cd06637          45 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL  124 (272)
T ss_pred             cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            345678899999998 799999999998653      4679999999999999998864  358899999999998  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCccccc-----ccCCCcchhHHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWS  151 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~s  151 (175)
                      ++||+.+++|+|++|+||++   +.++.++|+|||++...... .......++..|+|||.+.     +..++.++|+||
T Consensus       125 ~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~s  201 (272)
T cd06637         125 SHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS  201 (272)
T ss_pred             HHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHH
Confidence            99999999999999999999   56778999999998765332 2223455788899999875     335788999999


Q ss_pred             HHHHHHHHHhCCCCCCCC
Q 030527          152 VGAILFELLNGYPPFSVG  169 (175)
Q Consensus       152 lg~~~~~~~~g~~pf~~~  169 (175)
                      +|++++++++|+.||...
T Consensus       202 lGv~l~el~~g~~p~~~~  219 (272)
T cd06637         202 LGITAIEMAEGAPPLCDM  219 (272)
T ss_pred             HHHHHHHHHhCCCCcccc
Confidence            999999999999999653

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=1.1e-29  Score=186.25  Aligned_cols=158  Identities=32%  Similarity=0.644  Sum_probs=132.0

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEe-----eCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HH
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GL   77 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l   77 (175)
                      ...+.+|..+++.+ +|||++++++++.     .++..+++|||++|++|.+++..    ...+++..+..++.|+  ++
T Consensus        58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l  137 (286)
T cd06638          58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL  137 (286)
T ss_pred             HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence            35678899999999 7999999999873     44578999999999999988753    2468899999999998  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccc-----ccCCCcchhHHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWS  151 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~s  151 (175)
                      .+||+.+++|+|++|+||++   +..+.++|+|||++....... ......++..|+|||.+.     +..++.++|+||
T Consensus       138 ~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s  214 (286)
T cd06638         138 QHLHVNKTIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS  214 (286)
T ss_pred             HHHHhCCccccCCCHHhEEE---CCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhh
Confidence            99999999999999999999   466779999999987664332 223345788899999874     344788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC
Q 030527          152 VGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       152 lg~~~~~~~~g~~pf~~~~  170 (175)
                      +|++++++++|+.||...+
T Consensus       215 lGvi~~el~~g~~p~~~~~  233 (286)
T cd06638         215 LGITAIELGDGDPPLADLH  233 (286)
T ss_pred             HHHHHHHHhcCCCCCCCCc
Confidence            9999999999999997653

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=2e-29  Score=183.40  Aligned_cols=158  Identities=30%  Similarity=0.614  Sum_probs=136.6

Q ss_pred             hhhHHHHHHHHhh-CCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHHH
Q 030527           10 KSCLDCELNFLSS-VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        10 ~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ..++.+|+.++++ ++|||++++++++..++..++++||+++++|.+++..    ...+++..+..++.|+  ++.+||+
T Consensus        52 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  131 (269)
T cd08528          52 IGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK  131 (269)
T ss_pred             HHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc
Confidence            3456778888875 6999999999999999999999999999999988743    3468999999999998  9999996


Q ss_pred             -cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           83 -HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        83 -~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                       .|++|+||+|+||++   +.++.++|+|||.+.............++..|++||...+..++.++|+||+|+++|++++
T Consensus       132 ~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~  208 (269)
T cd08528         132 EKRIVHRDLTPNNIML---GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT  208 (269)
T ss_pred             CCceeecCCCHHHEEE---CCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHh
Confidence             789999999999999   5677899999999987655543345567888999999988889999999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |+.||...+
T Consensus       209 g~~p~~~~~  217 (269)
T cd08528         209 LQPPFYSTN  217 (269)
T ss_pred             CCCcccccC
Confidence            999997643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=1.3e-29  Score=185.65  Aligned_cols=158  Identities=34%  Similarity=0.591  Sum_probs=134.1

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ...+.+|++++++++|+|++++++++.+.+..++|+||+.+ +|.+++...   ..+++..+..++.|+  ++++||+.|
T Consensus        42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  120 (284)
T cd07836          42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR  120 (284)
T ss_pred             hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45667899999999999999999999999999999999965 888888754   358999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g  162 (175)
                      ++|+|++|+||++   +.++.++|+|||.+........ .....++..|++||.+.+. .++.++|+||+|++++++++|
T Consensus       121 i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g  197 (284)
T cd07836         121 VLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG  197 (284)
T ss_pred             eeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            9999999999999   5677899999999876543221 1233457789999987654 468899999999999999999


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      +.||.+.+.
T Consensus       198 ~~~~~~~~~  206 (284)
T cd07836         198 RPLFPGTNN  206 (284)
T ss_pred             CCCCCCCCc
Confidence            999987653

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=2.6e-29  Score=182.02  Aligned_cols=158  Identities=31%  Similarity=0.523  Sum_probs=130.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEe-eCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+.+|..+++.++|||++++++++. .++..+++++|+.+++|.+++.+. ..++...+..++.|+  |+++||+.+
T Consensus        39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  118 (262)
T cd05058          39 EVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK  118 (262)
T ss_pred             HHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3457788999999999999999999765 456688999999999999999765 356777788888898  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      ++|+||+|+||++   +.++.++|+|||++........     .....++..|+|||...+..++.++|+||||++++++
T Consensus       119 i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el  195 (262)
T cd05058         119 FVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL  195 (262)
T ss_pred             ccccccCcceEEE---cCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHH
Confidence            9999999999999   5677899999999875533211     1123345679999999888899999999999999999


Q ss_pred             Hh-CCCCCCCC
Q 030527          160 LN-GYPPFSVG  169 (175)
Q Consensus       160 ~~-g~~pf~~~  169 (175)
                      ++ |.+||...
T Consensus       196 ~~~~~~~~~~~  206 (262)
T cd05058         196 MTRGAPPYPDV  206 (262)
T ss_pred             HcCCCCCCCCC
Confidence            99 56677643

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-29  Score=188.22  Aligned_cols=161  Identities=30%  Similarity=0.542  Sum_probs=132.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHH--HHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ...+.+|+.++++++||||+++++++.+.  ...++|+|++. +++.+++...     ..+++..+..++.|+  ++++|
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l  124 (316)
T cd07842          46 SQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL  124 (316)
T ss_pred             cHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH
Confidence            45677899999999999999999999988  78999999995 5777776432     268899999999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEee-cCCCceEEEeeecceeeccCCCc----cccccCCCCccCccccccc-CCCcchhHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGA  154 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~-~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~  154 (175)
                      |+.+++|+||+|+||++.. .+..+.++|+|||++........    .....++..|+|||...+. .++.++|+||+|+
T Consensus       125 H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  204 (316)
T cd07842         125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGC  204 (316)
T ss_pred             HhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHH
Confidence            9999999999999999941 11278899999999876543321    1233457789999987654 5789999999999


Q ss_pred             HHHHHHhCCCCCCCCCc
Q 030527          155 ILFELLNGYPPFSVGEE  171 (175)
Q Consensus       155 ~~~~~~~g~~pf~~~~~  171 (175)
                      +++++++|+.||.+...
T Consensus       205 ~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         205 IFAELLTLEPIFKGREA  221 (316)
T ss_pred             HHHHHHhcCCCCcCCcc
Confidence            99999999999986554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=1.3e-29  Score=187.53  Aligned_cols=156  Identities=26%  Similarity=0.467  Sum_probs=132.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|+.+++.++||||+++++++... ..+++++++++++|.+++.... .+++..+..++.|+  ++++||+.|++
T Consensus        53 ~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iv  131 (303)
T cd05110          53 NVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV  131 (303)
T ss_pred             HHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence            34678899999999999999999988654 4678999999999999988654 68999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc---ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      |+||+|+||++   +.++.++|+|||++.........   ....++..|++||.+.+..++.++|+||+|++++++++ |
T Consensus       132 H~dikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g  208 (303)
T cd05110         132 HRDLAARNVLV---KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG  208 (303)
T ss_pred             ccccccceeee---cCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCC
Confidence            99999999999   46677999999999766433221   12234567999999988889999999999999999997 8


Q ss_pred             CCCCCCC
Q 030527          163 YPPFSVG  169 (175)
Q Consensus       163 ~~pf~~~  169 (175)
                      ..||.+.
T Consensus       209 ~~p~~~~  215 (303)
T cd05110         209 GKPYDGI  215 (303)
T ss_pred             CCCCCCC
Confidence            9999764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-29  Score=185.96  Aligned_cols=157  Identities=36%  Similarity=0.603  Sum_probs=134.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|++++++++||+++++++++.+.+..++++||+ +++|.+++....  .+++..+..++.|+  +|++||+.++
T Consensus        42 ~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~  120 (283)
T cd07835          42 PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV  120 (283)
T ss_pred             hhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            356788999999999999999999999999999999999 568999988765  68999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +|+|++|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|++++++++|+
T Consensus       121 ~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~  197 (283)
T cd07835         121 LHRDLKPQNLLI---DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR  197 (283)
T ss_pred             eCCCCCHHHEEE---cCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999   467889999999987653322 11223457789999987654 4688999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||...+
T Consensus       198 ~pf~~~~  204 (283)
T cd07835         198 PLFPGDS  204 (283)
T ss_pred             CCCCCCC
Confidence            9997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=1.2e-29  Score=185.82  Aligned_cols=157  Identities=34%  Similarity=0.591  Sum_probs=134.1

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|++++++++||||+++++++.+.+..++++||+. ++|.+++...  ..+++..+..++.|+  |++|||+.|+
T Consensus        43 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i  121 (284)
T cd07860          43 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV  121 (284)
T ss_pred             chHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3568889999999999999999999999999999999995 6899888653  468999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccC-CCcchhHHHHHHHHHHHHhCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +|+|++|+||++   +.++.++|+|||.+........ .....++..|+|||...+.. ++.++|+||+|++++++++|+
T Consensus       122 ~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~  198 (284)
T cd07860         122 LHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR  198 (284)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            999999999999   5777899999999876543321 22334577899999876544 688999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||...+
T Consensus       199 ~p~~~~~  205 (284)
T cd07860         199 ALFPGDS  205 (284)
T ss_pred             CCCCCCC
Confidence            9997654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=3.2e-29  Score=184.35  Aligned_cols=158  Identities=35%  Similarity=0.657  Sum_probs=131.9

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeC-----CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HH
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GL   77 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l   77 (175)
                      ...+.+|..+++++ +|||++++++++...     +..++|+||+++++|.++++.    ...+++..+..++.|+  ++
T Consensus        62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al  141 (291)
T cd06639          62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL  141 (291)
T ss_pred             HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence            45677899999999 899999999998643     468999999999999998863    3568999999999998  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccccc-----CCCcchhHHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-----RYDEKVDMWS  151 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-----~~~~~~Di~s  151 (175)
                      ++||+.|++|+||+|+||++   +.++.++|+|||.+....... ......++..|+|||.+...     .++.++|+||
T Consensus       142 ~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s  218 (291)
T cd06639         142 QHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWS  218 (291)
T ss_pred             HHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHH
Confidence            99999999999999999999   567789999999987654332 12234567889999987543     3688999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC
Q 030527          152 VGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       152 lg~~~~~~~~g~~pf~~~~  170 (175)
                      +|++++++++|+.||...+
T Consensus       219 lGvi~~el~~g~~p~~~~~  237 (291)
T cd06639         219 LGITAIELGDGDPPLFDMH  237 (291)
T ss_pred             HHHHHHHHhhCCCCCCCCc
Confidence            9999999999999997654

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=2.4e-29  Score=183.97  Aligned_cols=153  Identities=35%  Similarity=0.583  Sum_probs=130.0

Q ss_pred             HHHHHHHHhhC-CCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           13 LDCELNFLSSV-NHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        13 ~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...|+..++++ +|+|++++.+++.+.  +..++|+||+. +++.+++... ..+++..+..++.|+  +|++||+.|++
T Consensus        44 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~  122 (282)
T cd07831          44 NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF  122 (282)
T ss_pred             HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            34688888888 599999999999887  88999999996 5888877754 568999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccc-ccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++.   . +.++|+|||.+.............++..|+|||... +..++.++|+||+|++++++++|..|
T Consensus       123 H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p  198 (282)
T cd07831         123 HRDIKPENILIK---D-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPL  198 (282)
T ss_pred             ecccCHHHEEEc---C-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcC
Confidence            999999999994   4 889999999998765443333445678899999764 45578899999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |.+.+
T Consensus       199 ~~~~~  203 (282)
T cd07831         199 FPGTN  203 (282)
T ss_pred             CCCCC
Confidence            97654

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2e-29  Score=183.41  Aligned_cols=158  Identities=35%  Similarity=0.649  Sum_probs=133.3

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCC------eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--   75 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--   75 (175)
                      ....+.+|+++++++ +|+|++++++++....      ..++++||+.+++|.+++..    ...+++..+..++.|+  
T Consensus        45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~  124 (275)
T cd06608          45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR  124 (275)
T ss_pred             hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHH
Confidence            346788999999999 7999999999997644      48999999999999998865    2468999999999998  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccc-----cCCCcchhH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVDM  149 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di  149 (175)
                      |+++||+.|++|+|++|+||++   +.++.++|+|||.+....... ......++..|+|||.+..     ..++.++|+
T Consensus       125 al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv  201 (275)
T cd06608         125 GLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDV  201 (275)
T ss_pred             HHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccH
Confidence            9999999999999999999999   567889999999987654332 2234456788999998743     346788999


Q ss_pred             HHHHHHHHHHHhCCCCCCCC
Q 030527          150 WSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus       150 ~slg~~~~~~~~g~~pf~~~  169 (175)
                      ||+|++++++++|+.||...
T Consensus       202 ~slG~il~~l~~g~~p~~~~  221 (275)
T cd06608         202 WSLGITAIELADGKPPLCDM  221 (275)
T ss_pred             HHhHHHHHHHHhCCCCcccc
Confidence            99999999999999999754

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.2e-31  Score=193.92  Aligned_cols=158  Identities=35%  Similarity=0.670  Sum_probs=145.2

Q ss_pred             HHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCC
Q 030527           14 DCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDL   90 (175)
Q Consensus        14 ~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di   90 (175)
                      ..|.++|... +-|.++++...|+.-.++|+||||+.||+|.-.+++-+++.+..+..++++|  +|-+||++||+++|+
T Consensus       397 m~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDL  476 (683)
T KOG0696|consen  397 MVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDL  476 (683)
T ss_pred             ehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeec
Confidence            4578888777 7789999999999999999999999999999999999999999999999998  899999999999999


Q ss_pred             CCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030527           91 KPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus        91 ~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~  169 (175)
                      |.+|+++   +.++.++|.|||++..... +.++.+..||+.|.|||++...+|+.+.|-||+|+++|||+.|++||++.
T Consensus       477 KLDNvmL---d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe  553 (683)
T KOG0696|consen  477 KLDNVML---DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE  553 (683)
T ss_pred             cccceEe---ccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence            9999999   7899999999999976644 44567889999999999999999999999999999999999999999999


Q ss_pred             CccCC
Q 030527          170 EEHQF  174 (175)
Q Consensus       170 ~~~~~  174 (175)
                      +++++
T Consensus       554 DE~el  558 (683)
T KOG0696|consen  554 DEDEL  558 (683)
T ss_pred             CHHHH
Confidence            87753

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=1e-29  Score=185.94  Aligned_cols=157  Identities=39%  Similarity=0.625  Sum_probs=136.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|++++++++|++++++.+++...+..++++||+.+ ++.+++... ..+++..+..++.++  ++++||+.|++
T Consensus        42 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  120 (283)
T cd05118          42 PKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL  120 (283)
T ss_pred             HHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45778899999999999999999999999999999999965 888887764 578999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      |+|++|+||++   +.++.++++|||.+....... ......++..|.|||...+. .++.++|+||+|++++++++|+.
T Consensus       121 H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~  197 (283)
T cd05118         121 HRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP  197 (283)
T ss_pred             ecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence            99999999999   567789999999997775543 22234467789999998766 68999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||.+.+
T Consensus       198 ~~~~~~  203 (283)
T cd05118         198 LFPGKS  203 (283)
T ss_pred             CCCCCC
Confidence            997655

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=1.8e-29  Score=184.87  Aligned_cols=158  Identities=35%  Similarity=0.579  Sum_probs=135.6

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ....+.+|++++++++|+|++++.+++...  +..++|++|+. ++|.+++.+. ..+++..+..++.|+  |+++||+.
T Consensus        41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~  119 (287)
T cd07840          41 FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN  119 (287)
T ss_pred             chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            345678899999999999999999999888  89999999996 5899888765 579999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC--ccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~  160 (175)
                      |++|+||+|+||++   +.++.++++|||.+.......  ......++..|+|||.+.+ ..++.++|+||+|+++++++
T Consensus       120 ~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~  196 (287)
T cd07840         120 GILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF  196 (287)
T ss_pred             CceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH
Confidence            99999999999999   567889999999998775543  1223445778999998764 45789999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|+.||...+
T Consensus       197 t~~~p~~~~~  206 (287)
T cd07840         197 LGKPIFQGST  206 (287)
T ss_pred             hCCCCCCCCC
Confidence            9999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=2.9e-29  Score=186.10  Aligned_cols=156  Identities=38%  Similarity=0.558  Sum_probs=132.0

Q ss_pred             hHHHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           12 CLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      .+.+|++++++++|+|++++.+++.+.  +..++|+||+. ++|.+++... ..+++.++..++.|+  ++++||+.|++
T Consensus        52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~  130 (309)
T cd07845          52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFII  130 (309)
T ss_pred             hhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            456799999999999999999998765  56899999995 5898888764 578999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      |+||+|+||++   +..+.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|++++++++|+.
T Consensus       131 H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  207 (309)
T cd07845         131 HRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP  207 (309)
T ss_pred             cCCCCHHHEEE---CCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCC
Confidence            99999999999   567789999999998765432 2222334677999998865 457899999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.++
T Consensus       208 ~f~~~~~  214 (309)
T cd07845         208 LLPGKSE  214 (309)
T ss_pred             CCCCCCH
Confidence            9986654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=3.3e-29  Score=187.34  Aligned_cols=159  Identities=24%  Similarity=0.376  Sum_probs=132.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+.+|+.+++.++||||+++++++...+..++++|++.++++.+++.+..  .+++..+..++.|+  ||++||+.|
T Consensus        42 ~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~  121 (328)
T cd08226          42 HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG  121 (328)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34678889999999999999999999999999999999999999999988653  48999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--------cccccCCCCccCccccccc--CCCcchhHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGA  154 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slg~  154 (175)
                      ++|+||||+||++   +.++.++++||+.+........        .....++..|++||.+.+.  .++.++|+||+|+
T Consensus       122 ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~  198 (328)
T cd08226         122 YIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI  198 (328)
T ss_pred             eecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHH
Confidence            9999999999999   4667899999975533321110        0112235569999998753  4789999999999


Q ss_pred             HHHHHHhCCCCCCCCC
Q 030527          155 ILFELLNGYPPFSVGE  170 (175)
Q Consensus       155 ~~~~~~~g~~pf~~~~  170 (175)
                      +++++++|+.||...+
T Consensus       199 ~l~el~~g~~p~~~~~  214 (328)
T cd08226         199 TACELATGRVPFQDML  214 (328)
T ss_pred             HHHHHHhCCCCCCCcC
Confidence            9999999999997653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.7e-29  Score=184.87  Aligned_cols=158  Identities=28%  Similarity=0.512  Sum_probs=135.8

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHc
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ....+.+|++.++.++|+|++++.+++..  ....++++||+++++|.+++.+.. .++...+..++.|+  +|++||+.
T Consensus        49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~  128 (284)
T cd05038          49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ  128 (284)
T ss_pred             HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence            35688999999999999999999999877  557899999999999999998664 58999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc----ccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      |++|+||+|+||++   +.++.++|+|||.+.........    ....++..|++||...+..++.++|+||+|++++++
T Consensus       129 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el  205 (284)
T cd05038         129 RYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL  205 (284)
T ss_pred             CeecCCCCHHhEEE---cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhhee
Confidence            99999999999999   56788999999999876533211    122334569999999888899999999999999999


Q ss_pred             HhCCCCCCCC
Q 030527          160 LNGYPPFSVG  169 (175)
Q Consensus       160 ~~g~~pf~~~  169 (175)
                      ++|..||...
T Consensus       206 ~tg~~p~~~~  215 (284)
T cd05038         206 FTYGDPSQSP  215 (284)
T ss_pred             eccCCCcccc
Confidence            9999998654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-29  Score=183.45  Aligned_cols=158  Identities=39%  Similarity=0.605  Sum_probs=133.9

Q ss_pred             hhhHHHHHHHHhhC---CCCCeeeEeeEEeeCCe-----EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HH
Q 030527           10 KSCLDCELNFLSSV---NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GL   77 (175)
Q Consensus        10 ~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l   77 (175)
                      ...+.+|+.+++++   +|||++++.+++.....     .++++|++. ++|.+++.+..  .+++..+..++.|+  |+
T Consensus        42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al  120 (287)
T cd07838          42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGV  120 (287)
T ss_pred             hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHH
Confidence            34566787777666   69999999999987766     899999995 58999887653  48999999999998  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~  157 (175)
                      ++||+.+++|+|++|+||++   +.++.++|+|||.+.............++..|+|||...+..++.++|+||+|++++
T Consensus       121 ~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~  197 (287)
T cd07838         121 DFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA  197 (287)
T ss_pred             HHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHH
Confidence            99999999999999999999   566889999999987775544333344678899999998888999999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030527          158 ELLNGYPPFSVGEE  171 (175)
Q Consensus       158 ~~~~g~~pf~~~~~  171 (175)
                      ++++|..||.+.++
T Consensus       198 ~l~~~~~~~~~~~~  211 (287)
T cd07838         198 ELFRRRPLFRGTSE  211 (287)
T ss_pred             HHHhCCCcccCCCh
Confidence            99999999986553

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=7.5e-29  Score=183.79  Aligned_cols=155  Identities=35%  Similarity=0.584  Sum_probs=132.3

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ..+.+.+|+++++.++|||++++.+++...+..++|+||+. +++.+++.. ...+++..+..++.|+  ++.+||+.|+
T Consensus        58 ~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i  136 (307)
T cd06607          58 KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER  136 (307)
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34568889999999999999999999999999999999995 577777654 4578999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccc---ccCCCcchhHHHHHHHHHHHHhC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      +|+|++|+||++   +.++.++|+|||++......   ....++..|+|||.+.   ...++.++|+||+|+++|++++|
T Consensus       137 ~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg  210 (307)
T cd06607         137 IHRDIKAGNILL---TEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  210 (307)
T ss_pred             eecCCCcccEEE---CCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcC
Confidence            999999999999   56778999999988655332   2345677899999874   34578899999999999999999


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      +.||.+.+
T Consensus       211 ~~p~~~~~  218 (307)
T cd06607         211 KPPLFNMN  218 (307)
T ss_pred             CCCCCCcc
Confidence            99997543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=4.3e-29  Score=183.33  Aligned_cols=158  Identities=30%  Similarity=0.522  Sum_probs=132.5

Q ss_pred             hhhhhHHHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHH-----hcCCCCHHHHHHHHHHH--HHHH
Q 030527            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-----LHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      .....+..|+.++.++. |+||+++++++...+..++++|++. .++.++..     ....+++..+..++.++  ++++
T Consensus        44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~  122 (288)
T cd06616          44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY  122 (288)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            34567788999999995 9999999999999889999999984 56655432     23579999999999998  9999


Q ss_pred             HHHc-CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccccc---CCCcchhHHHHHHH
Q 030527           80 LNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAI  155 (175)
Q Consensus        80 lh~~-~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~Di~slg~~  155 (175)
                      ||+. +++|+||+|+||++   +..+.++|+|||++.............++..|+|||.+.+.   .++.++|+||+|++
T Consensus       123 lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i  199 (288)
T cd06616         123 LKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGIT  199 (288)
T ss_pred             HhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHH
Confidence            9974 99999999999999   56778999999998766554444445678889999998765   68999999999999


Q ss_pred             HHHHHhCCCCCCCC
Q 030527          156 LFELLNGYPPFSVG  169 (175)
Q Consensus       156 ~~~~~~g~~pf~~~  169 (175)
                      ++++++|+.||...
T Consensus       200 l~el~~g~~p~~~~  213 (288)
T cd06616         200 LYEVATGKFPYPKW  213 (288)
T ss_pred             HHHHHhCCCCchhc
Confidence            99999999999754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-30  Score=182.22  Aligned_cols=162  Identities=31%  Similarity=0.544  Sum_probs=139.0

Q ss_pred             chhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      +.+...++...++++... .+|+||+.+++|..+...++-||.+ +.+...++++- +++|+..+-.+...+  ||.||.
T Consensus       130 Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK  208 (391)
T KOG0983|consen  130 NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLK  208 (391)
T ss_pred             CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH
Confidence            445556677777766655 6999999999999999999999988 67888888765 678888888888876  999998


Q ss_pred             H-cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc---cCCCcchhHHHHHHHHH
Q 030527           82 S-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILF  157 (175)
Q Consensus        82 ~-~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slg~~~~  157 (175)
                      + .|++|+|+||+||++   +..+.++|||||.+.+..+........|.+.|+|||.+.-   ..|..++|+||||++++
T Consensus       209 eKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlv  285 (391)
T KOG0983|consen  209 EKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLV  285 (391)
T ss_pred             HhcceeecccCccceEE---ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchh
Confidence            6 589999999999999   7899999999999999988877777889999999999853   35889999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030527          158 ELLNGYPPFSVGEE  171 (175)
Q Consensus       158 ~~~~g~~pf~~~~~  171 (175)
                      |+.||+.||.+.+.
T Consensus       286 eLaTg~yPy~~c~t  299 (391)
T KOG0983|consen  286 ELATGQYPYKGCKT  299 (391)
T ss_pred             hhhcccCCCCCCCc
Confidence            99999999988543

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.96  E-value=5.1e-29  Score=182.42  Aligned_cols=160  Identities=31%  Similarity=0.615  Sum_probs=133.0

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEee------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--H
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--G   76 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~   76 (175)
                      .....+..|..+++++ +|+|++++++++..      ....+++|||+++++|.+++...  ..+++..+..++.|+  +
T Consensus        54 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~a  133 (282)
T cd06636          54 DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG  133 (282)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHH
Confidence            3456788899999998 79999999999853      45789999999999999998754  358888899999998  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCccccc-----ccCCCcchhHH
Q 030527           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMW  150 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~  150 (175)
                      ++|||+.|++|+|++|+||++   +.++.++|+|||.+...... .......++..|+|||.+.     ...++.++|+|
T Consensus       134 l~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvw  210 (282)
T cd06636         134 LAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW  210 (282)
T ss_pred             HHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchh
Confidence            999999999999999999999   56777999999988755322 1223445788899999875     34578899999


Q ss_pred             HHHHHHHHHHhCCCCCCCCC
Q 030527          151 SVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       151 slg~~~~~~~~g~~pf~~~~  170 (175)
                      |+|++++++++|..||...+
T Consensus       211 slG~~l~el~~g~~p~~~~~  230 (282)
T cd06636         211 SLGITAIEMAEGAPPLCDMH  230 (282)
T ss_pred             HHHHHHHHHHhCCCCccccC
Confidence            99999999999999996543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.96  E-value=1.1e-29  Score=190.32  Aligned_cols=158  Identities=34%  Similarity=0.552  Sum_probs=133.8

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEe----eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ....+.+|+.++++++||||+++.+++.    .....++|+||+. ++|.+++...+.+++..+..++.|+  ||++||+
T Consensus        47 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  125 (334)
T cd07855          47 LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS  125 (334)
T ss_pred             chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3456778999999999999999998875    3356899999994 6999999877789999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc-----ccccCCCCccCcccccc-cCCCcchhHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL  156 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~  156 (175)
                      .|++|+||+|+||++   +.++.++|+|||.+.........     ....++..|.|||.+.+ ..++.++|+||+|+++
T Consensus       126 ~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l  202 (334)
T cd07855         126 ANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIF  202 (334)
T ss_pred             CCeecCCCCHHHEEE---cCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHH
Confidence            999999999999999   57788999999998766433211     23456788999998765 4578999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030527          157 FELLNGYPPFSVGE  170 (175)
Q Consensus       157 ~~~~~g~~pf~~~~  170 (175)
                      +++++|..||.+.+
T Consensus       203 ~el~~g~~pf~~~~  216 (334)
T cd07855         203 AEMLGRRQLFPGKN  216 (334)
T ss_pred             HHHHcCCCccCCCC
Confidence            99999999997654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=4.4e-29  Score=183.33  Aligned_cols=157  Identities=35%  Similarity=0.591  Sum_probs=136.2

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|+++++++ +||+++++.+.+..++..++|+||+.+++|.+++.+...+++..+..++.|+  ++++||+.|++
T Consensus        48 ~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~  127 (288)
T cd05583          48 AEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGII  127 (288)
T ss_pred             HHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45678899999999 6999999999999999999999999999999999877789999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccC--CCcchhHHHHHHHHHHHHhC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slg~~~~~~~~g  162 (175)
                      |+|++|+||++   +.++.++++|||++........  .....++..|++||...+..  ++.++|+||+|++++++++|
T Consensus       128 H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg  204 (288)
T cd05583         128 YRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG  204 (288)
T ss_pred             ccCCCHHHeEE---CCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhC
Confidence            99999999999   5677899999999876544322  12234678899999986654  78899999999999999999


Q ss_pred             CCCCCCC
Q 030527          163 YPPFSVG  169 (175)
Q Consensus       163 ~~pf~~~  169 (175)
                      ..||...
T Consensus       205 ~~p~~~~  211 (288)
T cd05583         205 ASPFTVD  211 (288)
T ss_pred             CCCcccC
Confidence            9999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=9.7e-30  Score=172.49  Aligned_cols=161  Identities=29%  Similarity=0.491  Sum_probs=137.7

Q ss_pred             chhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHH----HHhcCCCCHHHHHHHHHHH--HHH
Q 030527            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY----IRLHGRVPEQTARKFLQQL--GLE   78 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~----l~~~~~l~~~~~~~~~~~i--~l~   78 (175)
                      +.+...++.+|..+..+. .+|.+|.+++.....+..++-||.+ ..||..+    +++++..++..+-+|+..+  ||.
T Consensus        84 n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~  162 (282)
T KOG0984|consen   84 NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALE  162 (282)
T ss_pred             ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHH
Confidence            444556667788776665 8999999999999999999999998 6788766    3456789999999999998  999


Q ss_pred             HHHH-cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccc----ccCCCcchhHHHHH
Q 030527           79 ILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ----FQRYDEKVDMWSVG  153 (175)
Q Consensus        79 ~lh~-~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~----~~~~~~~~Di~slg  153 (175)
                      +||+ ..++|||+||+||++   +..+++|+||||.+....++.......|...|+|||.+.    ...|+.++|+||||
T Consensus       163 ~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLG  239 (282)
T KOG0984|consen  163 FLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLG  239 (282)
T ss_pred             HHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhh
Confidence            9996 589999999999999   789999999999998887776555678899999999874    33689999999999


Q ss_pred             HHHHHHHhCCCCCCCCC
Q 030527          154 AILFELLNGYPPFSVGE  170 (175)
Q Consensus       154 ~~~~~~~~g~~pf~~~~  170 (175)
                      +++.||+++..|++..-
T Consensus       240 ItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  240 ITMIEMAILRFPYESWG  256 (282)
T ss_pred             hhhhhhhhccccccccC
Confidence            99999999999997653

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.7e-29  Score=188.90  Aligned_cols=159  Identities=35%  Similarity=0.589  Sum_probs=138.9

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC-----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ...+.+..|+.++++++|+|++++.+++....     ..+++++|+. ++|.+++.+...+++..+..++.++  ++++|
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~L  119 (330)
T cd07834          41 IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL  119 (330)
T ss_pred             hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            34567888999999999999999999987765     7899999995 5899999877789999999999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC----ccccccCCCCccCccccccc-CCCcchhHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAI  155 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~  155 (175)
                      |+.|++|+||+|.||++   +.++.++|+|||.+.......    ......++..|+|||.+.+. .++.++|+||+|++
T Consensus       120 H~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~i  196 (330)
T cd07834         120 HSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCI  196 (330)
T ss_pred             HhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHH
Confidence            99999999999999999   566889999999998876543    12344567889999999877 78999999999999


Q ss_pred             HHHHHhCCCCCCCCC
Q 030527          156 LFELLNGYPPFSVGE  170 (175)
Q Consensus       156 ~~~~~~g~~pf~~~~  170 (175)
                      ++++++|..||.+.+
T Consensus       197 l~~l~~g~~pf~~~~  211 (330)
T cd07834         197 FAELLTRKPLFPGRD  211 (330)
T ss_pred             HHHHHcCCCCcCCCC
Confidence            999999999997654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=1.8e-28  Score=182.62  Aligned_cols=155  Identities=35%  Similarity=0.594  Sum_probs=132.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|++++++++|||++++.+++.++...++|+||+.| ++.+.+.. ..++++.++..++.++  ++.+||+.|+
T Consensus        68 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i  146 (317)
T cd06635          68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM  146 (317)
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            345688899999999999999999999999999999999965 77777654 4578999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccc---ccCCCcchhHHHHHHHHHHHHhC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      +|+|++|+||++   +.++.++|+|||++......   ....++..|+|||.+.   ...++.++|+||+|++++++++|
T Consensus       147 ~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g  220 (317)
T cd06635         147 IHRDIKAGNILL---TEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  220 (317)
T ss_pred             ccCCCCcccEEE---CCCCCEEEecCCCccccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhC
Confidence            999999999999   56778999999987654322   2345678899999874   34578899999999999999999


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      +.||...+
T Consensus       221 ~~p~~~~~  228 (317)
T cd06635         221 KPPLFNMN  228 (317)
T ss_pred             CCCCCCcc
Confidence            99986643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=2.4e-29  Score=188.77  Aligned_cols=157  Identities=34%  Similarity=0.572  Sum_probs=133.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ...+.+|+.+++.++|+||+++.+++...     ...++++||+ +++|.+++.+.+.+++..+..++.|+  |+++||+
T Consensus        48 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  126 (337)
T cd07858          48 AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS  126 (337)
T ss_pred             hHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            44567899999999999999999987644     3579999999 57999999888889999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~  160 (175)
                      .+++|+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.. ..++.++|+||+|+++++++
T Consensus       127 ~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  203 (337)
T cd07858         127 ANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL  203 (337)
T ss_pred             CCEecCCCCHHHEEE---cCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHH
Confidence            999999999999999   56778999999998766443 22233456788999998764 45889999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|+.||.+.+
T Consensus       204 ~g~~pf~~~~  213 (337)
T cd07858         204 GRKPLFPGKD  213 (337)
T ss_pred             cCCCCCCCCC
Confidence            9999997653

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=5.6e-29  Score=184.22  Aligned_cols=155  Identities=28%  Similarity=0.515  Sum_probs=129.2

Q ss_pred             hHHHHHHHHhhCCCCCeeeEeeEEeeCC--------eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHH
Q 030527           12 CLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      .+.+|++++++++||||+++++++...+        ..++|+||+. +++.+++.+. ..+++.++..++.|+  |+++|
T Consensus        57 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~l  135 (310)
T cd07865          57 TALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI  135 (310)
T ss_pred             HHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            4567999999999999999999876543        4599999995 5888887755 368999999999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc-----ccccCCCCccCccccccc-CCCcchhHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGA  154 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~  154 (175)
                      |+.|++|+||+|+||++   +.++.++|+|||.+.........     ....++..|+|||...+. .++.++|+||+|+
T Consensus       136 H~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~  212 (310)
T cd07865         136 HRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGC  212 (310)
T ss_pred             HHCCeeccCCCHHHEEE---CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHH
Confidence            99999999999999999   57788999999998766433211     233456789999987654 3688999999999


Q ss_pred             HHHHHHhCCCCCCCCC
Q 030527          155 ILFELLNGYPPFSVGE  170 (175)
Q Consensus       155 ~~~~~~~g~~pf~~~~  170 (175)
                      +++++++|..||.+.+
T Consensus       213 ~l~el~t~~~~~~~~~  228 (310)
T cd07865         213 IMAEMWTRSPIMQGNT  228 (310)
T ss_pred             HHHHHHhCCCCCCCCC
Confidence            9999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.8e-30  Score=196.78  Aligned_cols=166  Identities=28%  Similarity=0.523  Sum_probs=144.3

Q ss_pred             ccccchh--hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--
Q 030527            2 LKKLNKH--LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--   75 (175)
Q Consensus         2 lk~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--   75 (175)
                      ||.++++  ...+|..|+.+++.++|||+|+++++|.....+|+|+|||..|+|.+|+.++.  .++.-....++.||  
T Consensus       297 VKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsS  376 (1157)
T KOG4278|consen  297 VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISS  376 (1157)
T ss_pred             hhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHH
Confidence            5666544  35689999999999999999999999999999999999999999999999875  37777778889999  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcccc--ccCCCCccCcccccccCCCcchhHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      |+.||+.+++||+|+.+.|+++   .++..+++.|||+++....+..+..  ..-...|.|||.+....++.++|+|+||
T Consensus       377 aMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFG  453 (1157)
T KOG4278|consen  377 AMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFG  453 (1157)
T ss_pred             HHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHH
Confidence            9999999999999999999999   5888899999999988765543322  1224569999999999999999999999


Q ss_pred             HHHHHHHh-CCCCCCCCC
Q 030527          154 AILFELLN-GYPPFSVGE  170 (175)
Q Consensus       154 ~~~~~~~~-g~~pf~~~~  170 (175)
                      +++||+.| |..|+.+.+
T Consensus       454 VLLWEIATYGMsPYPGid  471 (1157)
T KOG4278|consen  454 VLLWEIATYGMSPYPGID  471 (1157)
T ss_pred             HHHHHHHhcCCCCCCCcc
Confidence            99999999 999998764

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=7e-31  Score=205.52  Aligned_cols=165  Identities=25%  Similarity=0.503  Sum_probs=147.1

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      .+.+++.|..|+.|+-|+.||||+.+-++....+..++|+|||++++|+.++.++ ++++..+...++.-|  +++||-+
T Consensus       670 tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd  749 (996)
T KOG0196|consen  670 TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD  749 (996)
T ss_pred             cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh
Confidence            3678999999999999999999999999999999999999999999999999877 679999999999999  8999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-cccc---ccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~---~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      .|+||||+.+.||++   +.+..+|++|||+++...++. ...+   ..-..+|.|||.+....++.++|+||+|+++||
T Consensus       750 m~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWE  826 (996)
T KOG0196|consen  750 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE  826 (996)
T ss_pred             cCchhhhhhhhheee---ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEE
Confidence            999999999999999   788899999999999876554 2222   122467999999999999999999999999999


Q ss_pred             HHh-CCCCCCCCCccC
Q 030527          159 LLN-GYPPFSVGEEHQ  173 (175)
Q Consensus       159 ~~~-g~~pf~~~~~~~  173 (175)
                      .++ |..|+.+-++.+
T Consensus       827 VmSyGERPYWdmSNQd  842 (996)
T KOG0196|consen  827 VMSYGERPYWDMSNQD  842 (996)
T ss_pred             ecccCCCcccccchHH
Confidence            888 999998766544

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=193.30  Aligned_cols=164  Identities=28%  Similarity=0.512  Sum_probs=144.5

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      .++....|.+|+.+++.++||+|++++|++.+.. .++|||+++-|.|..|++++. .++.....-+..|+  ||+|||+
T Consensus       431 t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS  509 (974)
T KOG4257|consen  431 TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES  509 (974)
T ss_pred             ChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh
Confidence            4566889999999999999999999999988764 799999999999999999874 69999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      ..++||||...||++   .....+||.|||+++.......-  ....-...|+|||.+--..++.++|+|.||+++||++
T Consensus       510 krfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl  586 (974)
T KOG4257|consen  510 KRFVHRDIAARNILV---SSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEIL  586 (974)
T ss_pred             hchhhhhhhhhheee---cCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHH
Confidence            999999999999999   46778999999999988776532  2333456799999998888999999999999999998


Q ss_pred             h-CCCCCCCCCccC
Q 030527          161 N-GYPPFSVGEEHQ  173 (175)
Q Consensus       161 ~-g~~pf~~~~~~~  173 (175)
                      . |..||.+-.+.+
T Consensus       587 ~lGvkPfqgvkNsD  600 (974)
T KOG4257|consen  587 SLGVKPFQGVKNSD  600 (974)
T ss_pred             HhcCCccccccccc
Confidence            7 999998866654

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.6e-29  Score=191.83  Aligned_cols=156  Identities=36%  Similarity=0.708  Sum_probs=139.6

Q ss_pred             HHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCC
Q 030527           13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDL   90 (175)
Q Consensus        13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di   90 (175)
                      ++.|-.||..-..+-||+++..|.++..+|+||+|++||++..++-+.+-++++.+..+++++  |++++|..|+||+||
T Consensus       676 VKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDi  755 (1034)
T KOG0608|consen  676 VKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDI  755 (1034)
T ss_pred             hhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceeccc
Confidence            466888999999999999999999999999999999999999999999999999999999999  999999999999999


Q ss_pred             CCCcEEEeecCCCceEEEeeecceeec---------cCCC----------------------------------cccccc
Q 030527           91 KPENILLSGLDDDVMLKIADFGLSCTL---------YPGN----------------------------------YAEKVC  127 (175)
Q Consensus        91 ~~~ni~~~~~~~~~~~~l~df~~~~~~---------~~~~----------------------------------~~~~~~  127 (175)
                      ||+||++   |.++.+||.|||+++-+         +.+.                                  ......
T Consensus       756 KPDNILI---DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslv  832 (1034)
T KOG0608|consen  756 KPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLV  832 (1034)
T ss_pred             CccceEE---ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhc
Confidence            9999999   79999999999998532         1100                                  001256


Q ss_pred             CCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       128 ~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ||..|+|||++....++..+|-||.|+++++|+.|+.||-+.++
T Consensus       833 gt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  833 GTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP  876 (1034)
T ss_pred             CCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence            88999999999999999999999999999999999999977654

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=3.9e-29  Score=182.43  Aligned_cols=160  Identities=38%  Similarity=0.715  Sum_probs=140.6

Q ss_pred             hhhhhHHHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+.+|.++++++. ||||+++++++...+..+++||++.+++|.+++.+.+.++...+..++.|+  ++++||+.|
T Consensus        43 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~  122 (280)
T cd05581          43 KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG  122 (280)
T ss_pred             HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            33467788999999997 999999999999999999999999999999999988889999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---------------------cccccCCCCccCcccccccCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---------------------AEKVCGSPLYMAPEVLQFQRY  143 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---------------------~~~~~~~~~~~~pe~~~~~~~  143 (175)
                      ++|+|++|+||++   +.++.++++|||.+........                     .....++..|++||......+
T Consensus       123 ~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~  199 (280)
T cd05581         123 IIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA  199 (280)
T ss_pred             eeecCCCHHHeEE---CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence            9999999999999   5677899999999876643321                     112345678999999888889


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030527          144 DEKVDMWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       144 ~~~~Di~slg~~~~~~~~g~~pf~~~~  170 (175)
                      +.++|+||+|++++++++|..||...+
T Consensus       200 ~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         200 GKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             ChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            999999999999999999999998764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=1.3e-28  Score=181.63  Aligned_cols=149  Identities=17%  Similarity=0.244  Sum_probs=122.5

Q ss_pred             HHHHhhCCCCCeeeEeeEEeeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCC
Q 030527           17 LNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDL   90 (175)
Q Consensus        17 ~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di   90 (175)
                      ...+..+.|++++++++......    ..+++++++ ..++.+.++.....++..+..++.|+  ++++||+.+++||||
T Consensus        74 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDi  152 (294)
T PHA02882         74 WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDI  152 (294)
T ss_pred             HHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            34456678999999998765443    346788877 55788887766667888899999998  999999999999999


Q ss_pred             CCCcEEEeecCCCceEEEeeecceeeccCCC--------ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           91 KPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        91 ~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      ||+||++   +..+.++|+|||+++......        ......+++.|+|||...+..++.++|+||+|+++++|++|
T Consensus       153 Kp~Nill---~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g  229 (294)
T PHA02882        153 KPENIMV---DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGI  229 (294)
T ss_pred             CHHHEEE---cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            9999999   566789999999997663221        11234588999999999988999999999999999999999


Q ss_pred             CCCCCCC
Q 030527          163 YPPFSVG  169 (175)
Q Consensus       163 ~~pf~~~  169 (175)
                      +.||.+.
T Consensus       230 ~~P~~~~  236 (294)
T PHA02882        230 KLPWKGF  236 (294)
T ss_pred             CCCCCcc
Confidence            9999766

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=4.3e-30  Score=183.54  Aligned_cols=160  Identities=33%  Similarity=0.558  Sum_probs=135.4

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEee-CCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHH--HHHHHHH
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ...-+|+.++++++|||++.+..++.. ++..++++||. ..+|++.++-.     ..++...+.+++.||  +++|||+
T Consensus        72 ~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~  150 (438)
T KOG0666|consen   72 MSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS  150 (438)
T ss_pred             HHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh
Confidence            344569999999999999999999877 88999999998 56999888522     459999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeec-CCCceEEEeeecceeeccCCCc----cccccCCCCccCccccccc-CCCcchhHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAIL  156 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~-~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~  156 (175)
                      ..++|||+||.||++... .+.+.++|.|+|+++...++-.    .....-|.+|.|||.+.+. .|+++.|+||+||++
T Consensus       151 NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIf  230 (438)
T KOG0666|consen  151 NWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIF  230 (438)
T ss_pred             hheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHH
Confidence            999999999999999522 2358899999999988866532    2234457889999999866 499999999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030527          157 FELLNGYPPFSVGEE  171 (175)
Q Consensus       157 ~~~~~g~~pf~~~~~  171 (175)
                      .|+++.++.|.+.+.
T Consensus       231 aElLtl~PlF~g~E~  245 (438)
T KOG0666|consen  231 AELLTLEPLFKGREE  245 (438)
T ss_pred             HHHHccCccccchhh
Confidence            999999999977643

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=2.5e-28  Score=181.59  Aligned_cols=154  Identities=36%  Similarity=0.607  Sum_probs=131.8

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|+++++.++|||++++.+++.+....++++||+. +++.+++.. ..++++.++..++.|+  ++++||+.|++
T Consensus        65 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~  143 (313)
T cd06633          65 WQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI  143 (313)
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3567889999999999999999999999999999999995 577777765 4578999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccc---ccCCCcchhHHHHHHHHHHHHhCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      |+|++|+||++   +.++.++|+|||.+.....   .....++..|+|||.+.   ...++.++|+||+|++++++++|.
T Consensus       144 H~dl~p~nili---~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~  217 (313)
T cd06633         144 HRDIKAGNILL---TEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  217 (313)
T ss_pred             cCCCChhhEEE---CCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999   5677899999998764322   22445678899999874   355788999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||...+
T Consensus       218 ~p~~~~~  224 (313)
T cd06633         218 PPLFNMN  224 (313)
T ss_pred             CCCCCCC
Confidence            9997654

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=5.1e-29  Score=182.36  Aligned_cols=155  Identities=33%  Similarity=0.567  Sum_probs=134.6

Q ss_pred             hHHHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        12 ~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+|++.+++++ |+|++++++++..++..++|+|++ +++|.+++.+..  .+++..+..++.|+  ++.+||+.|++
T Consensus        43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~  121 (283)
T cd07830          43 MNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF  121 (283)
T ss_pred             HHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            4456889999998 999999999999999999999999 789999887664  68999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccc-ccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||.+.............++..|+|||... +..++.++|+||+|++++++++|+.|
T Consensus       122 H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~  198 (283)
T cd07830         122 HRDLKPENLLV---SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPL  198 (283)
T ss_pred             cCCCChhhEEE---cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCc
Confidence            99999999999   567889999999998775544333445678899999875 44578999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |...+
T Consensus       199 ~~~~~  203 (283)
T cd07830         199 FPGSS  203 (283)
T ss_pred             cCCCC
Confidence            97654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=175.87  Aligned_cols=158  Identities=28%  Similarity=0.402  Sum_probs=131.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC-----CeEEEEEeccCCCChHHHHHhc---C-CCCHHHHHHHHHHH--H
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLH---G-RVPEQTARKFLQQL--G   76 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~---~-~l~~~~~~~~~~~i--~   76 (175)
                      +......+|++..++++|||+.+++++...+     ...|++++|...|+|.+.+.+.   + .+++.++..|+.++  +
T Consensus        60 ~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~g  139 (302)
T KOG2345|consen   60 EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRG  139 (302)
T ss_pred             HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHH
Confidence            3455667899999999999999999886433     3589999999999999998754   3 59999999999999  9


Q ss_pred             HHHHHHcC--CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----------cccccCCCCccCccccc---cc
Q 030527           77 LEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----------AEKVCGSPLYMAPEVLQ---FQ  141 (175)
Q Consensus        77 l~~lh~~~--~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~~~pe~~~---~~  141 (175)
                      |++||+..  +.|+||||.||+++   ..+.+++.|||++....-...          ......|..|.|||...   +.
T Consensus       140 L~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~  216 (302)
T KOG2345|consen  140 LEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHC  216 (302)
T ss_pred             HHHHhccCCcccccCCCcceeEec---CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCc
Confidence            99999999  99999999999994   577899999999876532211          11345688899999874   44


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030527          142 RYDEKVDMWSVGAILFELLNGYPPFSV  168 (175)
Q Consensus       142 ~~~~~~Di~slg~~~~~~~~g~~pf~~  168 (175)
                      ..+.++|||||||++|.|+.|..||.-
T Consensus       217 ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  217 TITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             ccccccchhhhhHHHHHHHHcCCcchH
Confidence            578999999999999999999999963

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.96  E-value=1.3e-28  Score=185.31  Aligned_cols=158  Identities=33%  Similarity=0.564  Sum_probs=130.2

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEee-CCeEEEEEeccCCCChHHHHHhcC--------------------------
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG--------------------------   61 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--------------------------   61 (175)
                      .+.+.+|+.++.++ +||||+++++++.. .+..++++||+.+++|.+++....                          
T Consensus        54 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  133 (343)
T cd05103          54 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISED  133 (343)
T ss_pred             HHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhh
Confidence            45678899999999 78999999998765 456789999999999999986431                          


Q ss_pred             -----------------------------------------CCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEe
Q 030527           62 -----------------------------------------RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS   98 (175)
Q Consensus        62 -----------------------------------------~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~   98 (175)
                                                               .++...+..++.|+  |++|||+.|++|+||||+||++ 
T Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~-  212 (343)
T cd05103         134 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL-  212 (343)
T ss_pred             hhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE-
Confidence                                                     25677778888998  9999999999999999999999 


Q ss_pred             ecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 030527           99 GLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGE  170 (175)
Q Consensus        99 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g~~pf~~~~  170 (175)
                        +.++.++|+|||++........   .....++..|+|||.+.+..++.++|+||+|++++++++ |..||....
T Consensus       213 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  286 (343)
T cd05103         213 --SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  286 (343)
T ss_pred             --cCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence              5677899999999876533211   112234567999999988889999999999999999997 999997643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-30  Score=197.60  Aligned_cols=152  Identities=37%  Similarity=0.643  Sum_probs=134.6

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      +-.+.+..|+++|++++|||.+.+.++|....+.++|||||. |+-.|++.-. .++.+..+.+|..+.  +|+|||+.+
T Consensus        68 EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~  146 (948)
T KOG0577|consen   68 EKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN  146 (948)
T ss_pred             HHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh
Confidence            346788899999999999999999999999999999999995 5888888654 578888988888886  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccc---ccCCCcchhHHHHHHHHHHHHh
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      .||+|||+.||++   ...+.++|.|||.|....+   .....||+.|+|||++.   .+.|+-++||||||+++.++..
T Consensus       147 ~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAE  220 (948)
T KOG0577|consen  147 RIHRDIKAGNILL---SEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  220 (948)
T ss_pred             HHhhhccccceEe---cCCCeeeeccccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhh
Confidence            9999999999999   5788999999998876643   44778999999999984   4569999999999999999999


Q ss_pred             CCCCC
Q 030527          162 GYPPF  166 (175)
Q Consensus       162 g~~pf  166 (175)
                      .++|.
T Consensus       221 RkPPl  225 (948)
T KOG0577|consen  221 RKPPL  225 (948)
T ss_pred             cCCCc
Confidence            99886

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=9.5e-29  Score=185.42  Aligned_cols=157  Identities=32%  Similarity=0.575  Sum_probs=130.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ....+.+|++++++++||||+++++++...     ...++++|++. +++.+++. ...+++..+..++.|+  +|++||
T Consensus        46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH  123 (336)
T cd07849          46 FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIH  123 (336)
T ss_pred             hHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            345677899999999999999999886543     35799999995 58887775 4579999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccc-cCCCcchhHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL  156 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~  156 (175)
                      +.|++|+||+|+||++   +..+.++|+|||++........    .....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus       124 ~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil  200 (336)
T cd07849         124 SANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCIL  200 (336)
T ss_pred             hCCeeccCCCHHHEEE---CCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHH
Confidence            9999999999999999   5778899999999876543321    122456788999998654 4688999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030527          157 FELLNGYPPFSVGE  170 (175)
Q Consensus       157 ~~~~~g~~pf~~~~  170 (175)
                      ++|++|+.||.+.+
T Consensus       201 ~el~~G~~~f~~~~  214 (336)
T cd07849         201 AEMLSNRPLFPGKD  214 (336)
T ss_pred             HHHHhCCCCCCCCC
Confidence            99999999997643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=2.2e-28  Score=179.00  Aligned_cols=154  Identities=31%  Similarity=0.533  Sum_probs=127.8

Q ss_pred             hhHHHHHHH-HhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527           11 SCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus        11 ~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      .++..|... ++.++|||++++++++..++..++++||++ ++|.+++...    ..+++..+..++.|+  ++++||+.
T Consensus        44 ~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  122 (283)
T cd06617          44 KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK  122 (283)
T ss_pred             HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence            344455554 566799999999999999999999999995 6888777542    468999999999999  99999997


Q ss_pred             -CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc----cCCCcchhHHHHHHHHHH
Q 030527           84 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF----QRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        84 -~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~Di~slg~~~~~  158 (175)
                       +++|+|++|+||++   +.++.++|+|||.+.............++..|+|||.+.+    ..++.++|+||+|+++++
T Consensus       123 ~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~  199 (283)
T cd06617         123 LSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE  199 (283)
T ss_pred             CCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence             99999999999999   5778899999999876644333333557788999998754    446889999999999999


Q ss_pred             HHhCCCCCCC
Q 030527          159 LLNGYPPFSV  168 (175)
Q Consensus       159 ~~~g~~pf~~  168 (175)
                      |++|+.||..
T Consensus       200 l~~g~~p~~~  209 (283)
T cd06617         200 LATGRFPYDS  209 (283)
T ss_pred             HHhCCCCCCc
Confidence            9999999965

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.7e-28  Score=184.72  Aligned_cols=154  Identities=34%  Similarity=0.604  Sum_probs=129.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ...+.+|++++++++||||+++.+++...      +..+++++++ +++|.++++ ...+++..+..++.|+  |+++||
T Consensus        60 ~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH  137 (345)
T cd07877          60 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH  137 (345)
T ss_pred             HHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45677899999999999999999987543      3467888876 889988876 4468999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~  160 (175)
                      +.|++|+||+|+||++   +.++.++|+|||++......  .....++..|+|||...+ ..++.++|+||+|+++++++
T Consensus       138 ~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  212 (345)
T cd07877         138 SADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  212 (345)
T ss_pred             HCCeeecCCChHHEEE---cCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHH
Confidence            9999999999999999   56778999999998765332  223456788999998765 46888999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|+.||.+.+
T Consensus       213 ~g~~pf~~~~  222 (345)
T cd07877         213 TGRTLFPGTD  222 (345)
T ss_pred             hCCCCCCCCC
Confidence            9999997654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=1.7e-28  Score=184.11  Aligned_cols=157  Identities=39%  Similarity=0.614  Sum_probs=131.2

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ....+..|+.+++++ +||||+++++++...  ...++|+|++. ++|.+++.+. .+++.....++.|+  +|++||+.
T Consensus        49 ~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~  126 (337)
T cd07852          49 DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG  126 (337)
T ss_pred             hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            345677899999999 999999999988643  46899999996 5999988765 77888888899998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC------ccccccCCCCccCcccccc-cCCCcchhHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL  156 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~  156 (175)
                      |++|+||+|+||++   +.++.++|+|||.+.......      ......++..|+|||.+.+ ..++.++|+||+|+++
T Consensus       127 ~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l  203 (337)
T cd07852         127 NVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCIL  203 (337)
T ss_pred             CeecCCCCHHHEEE---cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHH
Confidence            99999999999999   578889999999987664332      1123446788999998754 4578899999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030527          157 FELLNGYPPFSVGE  170 (175)
Q Consensus       157 ~~~~~g~~pf~~~~  170 (175)
                      +++++|+.||.+.+
T Consensus       204 ~el~tg~~pf~~~~  217 (337)
T cd07852         204 GEMLLGKPLFPGTS  217 (337)
T ss_pred             HHHHhCCCCCCCCC
Confidence            99999999997654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=3.3e-28  Score=179.16  Aligned_cols=158  Identities=32%  Similarity=0.515  Sum_probs=129.8

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCe-----EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHH--H
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQL--G   76 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i--~   76 (175)
                      ...+.+|+.+++.+ +|||++++++++.....     .++++||+.+ +|.+++...     ..+++..+..++.|+  +
T Consensus        44 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~  122 (295)
T cd07837          44 PPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG  122 (295)
T ss_pred             chHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence            34678899999999 56999999999877665     8999999975 898887643     347999999999999  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccc-cCCCcchhHHHHHH
Q 030527           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA  154 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~  154 (175)
                      |++||+.|++|+||+|+||+++  ..++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+
T Consensus       123 L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~  200 (295)
T cd07837         123 VAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC  200 (295)
T ss_pred             HHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHH
Confidence            9999999999999999999994  227789999999987653321 1122345778999998764 45789999999999


Q ss_pred             HHHHHHhCCCCCCCCC
Q 030527          155 ILFELLNGYPPFSVGE  170 (175)
Q Consensus       155 ~~~~~~~g~~pf~~~~  170 (175)
                      ++++|++|..||.+.+
T Consensus       201 ~l~~l~~g~~~~~~~~  216 (295)
T cd07837         201 IFAEMSRKQPLFPGDS  216 (295)
T ss_pred             HHHHHHcCCCCCCCCC
Confidence            9999999999997653

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=2.4e-28  Score=177.95  Aligned_cols=160  Identities=28%  Similarity=0.515  Sum_probs=130.6

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC------eEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQL   75 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i   75 (175)
                      ....++.+|++++++++|||++++++++....      ..+++++++.+++|.+++...      ..++...+..++.|+
T Consensus        43 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i  122 (273)
T cd05074          43 SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI  122 (273)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Confidence            34556888999999999999999999876432      247888999999998887422      247889999999998


Q ss_pred             --HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHH
Q 030527           76 --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMW  150 (175)
Q Consensus        76 --~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~  150 (175)
                        ++++||+.|++|+||+|+||++   +.+..++++|||++........   .....++..|++||......++.++|+|
T Consensus       123 ~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~  199 (273)
T cd05074         123 ASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVW  199 (273)
T ss_pred             HHHHHHHHhCCEeecccchhhEEE---cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhH
Confidence              9999999999999999999999   5677899999999876643321   1122334678999999888889999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCC
Q 030527          151 SVGAILFELLN-GYPPFSVGE  170 (175)
Q Consensus       151 slg~~~~~~~~-g~~pf~~~~  170 (175)
                      |+|++++++++ |+.||.+.+
T Consensus       200 slG~il~el~~~g~~p~~~~~  220 (273)
T cd05074         200 AFGVTMWEIMTRGQTPYAGVE  220 (273)
T ss_pred             HHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999 899997554

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=1.4e-28  Score=179.76  Aligned_cols=158  Identities=37%  Similarity=0.642  Sum_probs=136.4

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+..|+.++++++|+|++++.+++.+.+..++|+|++. ++|.+++.+. ..+++..+..++.++  ++++||+.|+
T Consensus        41 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i  119 (282)
T cd07829          41 IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI  119 (282)
T ss_pred             ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34567789999999999999999999999999999999996 5999999876 579999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +|+||+|+||++   +.++.++|+|||.+....... .......+..|+|||.+.+. .++.++|+||+|++++++++|.
T Consensus       120 ~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~  196 (282)
T cd07829         120 LHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK  196 (282)
T ss_pred             ccCCCChheEEE---cCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCC
Confidence            999999999999   567889999999887664432 12233446779999998766 7899999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||.+.+
T Consensus       197 ~~~~~~~  203 (282)
T cd07829         197 PLFPGDS  203 (282)
T ss_pred             CCCCCcc
Confidence            9997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=1.2e-28  Score=178.39  Aligned_cols=157  Identities=33%  Similarity=0.631  Sum_probs=134.9

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ..++..|+++++.++|||++++++++.+.+..++++||+++++|.+++.+    ...+++..+..++.|+  ++++||+.
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~  125 (260)
T cd08222          46 TVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR  125 (260)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence            34567789999999999999999999999999999999999999988864    3468999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      |++|+|++|+|+++.    ++.++++|||.+....... ......++..|+|||...+..++.++|+||+|++++++++|
T Consensus       126 ~i~h~~l~~~nili~----~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~  201 (260)
T cd08222         126 RILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCL  201 (260)
T ss_pred             CccccCCChhheEee----cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence            999999999999994    3459999999887664432 22344567889999998888889999999999999999999


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      ..||...+
T Consensus       202 ~~~~~~~~  209 (260)
T cd08222         202 AHAFEGQN  209 (260)
T ss_pred             CCCCCCcc
Confidence            99997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2.7e-28  Score=183.49  Aligned_cols=154  Identities=35%  Similarity=0.603  Sum_probs=131.2

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ...+.+|++++++++||||+++.+++..++      ..++|++++ |++|.+++. ...+++..+..++.|+  |+++||
T Consensus        58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH  135 (343)
T cd07880          58 AKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIH  135 (343)
T ss_pred             HHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            456788999999999999999999887553      458999998 789988876 4578999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~  160 (175)
                      +.|++|+||+|+||++   +.++.++++|||.+.......  ....++..|++||.+.+ ..++.++|+||+|+++++++
T Consensus       136 ~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~  210 (343)
T cd07880         136 AAGIIHRDLKPGNLAV---NEDCELKILDFGLARQTDSEM--TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML  210 (343)
T ss_pred             hCCeecCCCCHHHEEE---cCCCCEEEeecccccccccCc--cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            9999999999999999   567789999999987654332  23456788999998865 35788999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|..||.+.+
T Consensus       211 ~g~~pf~~~~  220 (343)
T cd07880         211 TGKPLFKGHD  220 (343)
T ss_pred             hCCCCCCCCC
Confidence            9999997654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=4.3e-28  Score=179.89  Aligned_cols=154  Identities=34%  Similarity=0.610  Sum_probs=131.2

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      .+++.+|+++++.++|+|++++.+++......++|+||+. +++.+++.. ..++++.++..++.++  ++.+||+.+++
T Consensus        59 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~  137 (308)
T cd06634          59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI  137 (308)
T ss_pred             HHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            4567789999999999999999999999999999999996 578777654 4568999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccc---ccCCCcchhHHHHHHHHHHHHhCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      |+||+|+||++   +.++.++++|||++......   ....++..|+|||.+.   ...++.++|+||+|++++++++|.
T Consensus       138 H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~  211 (308)
T cd06634         138 HRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  211 (308)
T ss_pred             cCCCCHHhEEE---CCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCC
Confidence            99999999999   56778999999988765432   2345678899999874   345788999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||...+
T Consensus       212 ~p~~~~~  218 (308)
T cd06634         212 PPLFNMN  218 (308)
T ss_pred             CCCcccc
Confidence            9986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=5.2e-28  Score=180.95  Aligned_cols=155  Identities=37%  Similarity=0.615  Sum_probs=130.8

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEee-CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+..|++++++++|||++++.+++.. .+..++++|++ +++|.++++ ...+++..+..++.|+  ++++||+.|+
T Consensus        52 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i  129 (328)
T cd07856          52 LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGV  129 (328)
T ss_pred             hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            45677889999999999999999999865 55788999998 678988876 3567888888899998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+|++|+|+++   +..+.++|+|||.+.......  ....++..|+|||.+.+ ..++.++|+||+|++++++++|+.
T Consensus       130 iH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~  204 (328)
T cd07856         130 VHRDLKPSNILI---NENCDLKICDFGLARIQDPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP  204 (328)
T ss_pred             ccCCCCHHHEeE---CCCCCEEeCccccccccCCCc--CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCC
Confidence            999999999999   567789999999887553322  22345778999998765 568999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||...+
T Consensus       205 ~f~~~~  210 (328)
T cd07856         205 LFPGKD  210 (328)
T ss_pred             CCCCCC
Confidence            997654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=4.1e-28  Score=181.72  Aligned_cols=157  Identities=34%  Similarity=0.529  Sum_probs=131.2

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEee----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      .+.+.+|+++++++ +||||+++++....    ....+++++++ +++|.+++.....+++..+..++.|+  ||++||+
T Consensus        45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~  123 (332)
T cd07857          45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS  123 (332)
T ss_pred             HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            44677899999999 69999999987532    24578888988 56999999877889999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-----cccccCCCCccCcccccc-cCCCcchhHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL  156 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~  156 (175)
                      .|++|+||+|+||++   +.++.++|+|||.+........     .....++..|+|||...+ ..++.++|+||+|+++
T Consensus       124 ~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l  200 (332)
T cd07857         124 ANVLHRDLKPGNLLV---NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL  200 (332)
T ss_pred             CCcccCCCCHHHeEE---cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHH
Confidence            999999999999999   5677899999999976643321     122356788999998765 4689999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030527          157 FELLNGYPPFSVGE  170 (175)
Q Consensus       157 ~~~~~g~~pf~~~~  170 (175)
                      +++++|+.||.+.+
T Consensus       201 ~~l~~g~~pf~~~~  214 (332)
T cd07857         201 AELLGRKPVFKGKD  214 (332)
T ss_pred             HHHHhCCcCCCCCC
Confidence            99999999997654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=2.6e-28  Score=174.05  Aligned_cols=156  Identities=49%  Similarity=0.887  Sum_probs=141.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++.+++++|+|++++.+++......++++|+..+++|.+++.....++...+..++.++  ++++||+.+++|
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h  110 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIH  110 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeec
Confidence            578899999999999999999999999999999999999888999999877668999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      +|++|+||++   +.++.++++|||.+.............++..|++||...+..++.++|+||+|++++++++|..||.
T Consensus       111 ~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~  187 (244)
T smart00220      111 RDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFP  187 (244)
T ss_pred             CCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999   4667899999999988766544455667888999999988888999999999999999999999997


Q ss_pred             C
Q 030527          168 V  168 (175)
Q Consensus       168 ~  168 (175)
                      .
T Consensus       188 ~  188 (244)
T smart00220      188 G  188 (244)
T ss_pred             C
Confidence            6

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-29  Score=193.81  Aligned_cols=161  Identities=34%  Similarity=0.561  Sum_probs=139.9

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      .+.-..+.-|++||..+.||+|+++++.|...+.++++.|+|.||-....+-.- ..|++.++.-+.+|+  ||.|||++
T Consensus        70 eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~  149 (1187)
T KOG0579|consen   70 EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ  149 (1187)
T ss_pred             hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc
Confidence            344456677999999999999999999999999999999999999998887655 579999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCccccc-----ccCCCcchhHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~  157 (175)
                      ++||+|+|+.||++   ..++.++|.|||.+..... ........||+.|+|||+.+     ..+|..++||||||+++.
T Consensus       150 ~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLI  226 (1187)
T KOG0579|consen  150 NIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLI  226 (1187)
T ss_pred             chhhhhccccceEE---EecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHH
Confidence            99999999999999   5788999999998765432 23456788999999999875     457899999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 030527          158 ELLNGYPPFSVGE  170 (175)
Q Consensus       158 ~~~~g~~pf~~~~  170 (175)
                      +|..+.+|-..-.
T Consensus       227 EMAqiEPPHheln  239 (1187)
T KOG0579|consen  227 EMAQIEPPHHELN  239 (1187)
T ss_pred             HHhccCCCccccc
Confidence            9999999876543

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=4.5e-28  Score=178.97  Aligned_cols=156  Identities=30%  Similarity=0.499  Sum_probs=129.8

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCC----------eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HH
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAEN----------CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GL   77 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l   77 (175)
                      ..+.+|++++++++|||++++.+++.+..          ..++++||+.+ ++.+++... ..+++..+..++.|+  |+
T Consensus        51 ~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL  129 (302)
T cd07864          51 ITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGL  129 (302)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence            45678999999999999999999886654          78999999965 777777654 468999999999998  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCccccccc-CCCcchhHHHHHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGA  154 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~  154 (175)
                      ++||+.|++|+|++|+||++   +.++.++|+|||.+........  ......+..|+|||.+.+. .++.++|+||+|+
T Consensus       130 ~~LH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~  206 (302)
T cd07864         130 NYCHKKNFLHRDIKCSNILL---NNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC  206 (302)
T ss_pred             HHHHhCCeecCCCCHHHEEE---CCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHH
Confidence            99999999999999999999   5778899999999876644321  1223346679999987643 4688999999999


Q ss_pred             HHHHHHhCCCCCCCCC
Q 030527          155 ILFELLNGYPPFSVGE  170 (175)
Q Consensus       155 ~~~~~~~g~~pf~~~~  170 (175)
                      +++++++|+.||...+
T Consensus       207 ~~~el~~g~~~~~~~~  222 (302)
T cd07864         207 ILGELFTKKPIFQANQ  222 (302)
T ss_pred             HHHHHHhCCCCCCCCC
Confidence            9999999999997643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=183.35  Aligned_cols=161  Identities=27%  Similarity=0.436  Sum_probs=137.0

Q ss_pred             hhhHHHHHHHHhhC--CCC----CeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHH
Q 030527           10 KSCLDCELNFLSSV--NHP----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus        10 ~~~~~~e~~~l~~l--~h~----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~   79 (175)
                      +..-..|++.++++  +.|    -++++.+||...++.|+|+|.+ |.|+.++++.+.  +++...+..+..|+  ++++
T Consensus       129 reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~f  207 (415)
T KOG0671|consen  129 REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAF  207 (415)
T ss_pred             hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHH
Confidence            33445699999999  233    4778889999999999999988 889999999864  69999999999999  9999


Q ss_pred             HHHcCCeecCCCCCcEEEee-----------------cCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccC
Q 030527           80 LNSHHIIHRDLKPENILLSG-----------------LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR  142 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~-----------------~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~  142 (175)
                      ||+.+++|.|+||+||++.+                 ..+...++++|||.|+.....  ......|+.|.|||++.+-+
T Consensus       208 Lh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLG  285 (415)
T KOG0671|consen  208 LHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLG  285 (415)
T ss_pred             HHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccC
Confidence            99999999999999999841                 112345899999999876443  34556789999999999999


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCCCccC
Q 030527          143 YDEKVDMWSVGAILFELLNGYPPFSVGEEHQ  173 (175)
Q Consensus       143 ~~~~~Di~slg~~~~~~~~g~~pf~~~~~~~  173 (175)
                      ++.++|+||+||++.|+.+|...|...++.+
T Consensus       286 wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  286 WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence            9999999999999999999999999877654

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=182.28  Aligned_cols=159  Identities=30%  Similarity=0.492  Sum_probs=132.9

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHH-----hcCCCCHHHHHHHHHHH--HHHH
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-----LHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      ....++..|.+...+- ++|+||++++..-..+..++-||++ ..|+..+-+     +...+++..+..|....  ||.|
T Consensus       104 keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~y  182 (361)
T KOG1006|consen  104 KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDY  182 (361)
T ss_pred             HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHH
Confidence            4456777777755544 8999999999999999999999998 678876543     34568888877776665  9999


Q ss_pred             HHH-cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccc--ccCCCcchhHHHHHHHH
Q 030527           80 LNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        80 lh~-~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Di~slg~~~  156 (175)
                      |-. ..++|||+||+||++   +..+.+||||||.+....++.......|...|+|||.+.  +..+..++|+||||+++
T Consensus       183 LK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL  259 (361)
T KOG1006|consen  183 LKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITL  259 (361)
T ss_pred             HHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceE
Confidence            984 689999999999999   688999999999998887766666778899999999984  34589999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030527          157 FELLNGYPPFSVGE  170 (175)
Q Consensus       157 ~~~~~g~~pf~~~~  170 (175)
                      +|++||..|++..+
T Consensus       260 ~EvAtG~fPyr~w~  273 (361)
T KOG1006|consen  260 YEVATGNFPYRKWD  273 (361)
T ss_pred             eeeecCCCCcchHH
Confidence            99999999998754

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-28  Score=177.37  Aligned_cols=156  Identities=33%  Similarity=0.693  Sum_probs=144.8

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..-.+.|...+.+- +||.+|-+..+|....++++|.||.+||+|.-+++++.++|++.+..+..+|  ||.+||++|++
T Consensus       294 idwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgii  373 (593)
T KOG0695|consen  294 IDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGII  373 (593)
T ss_pred             chhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCee
Confidence            34456788888887 8999999999999999999999999999999999999999999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeec-cCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      ++|+|.+|+++   +..+.++|.|+|.++.. .++..+.+..||+.|.|||++++..|+-+.|-|+||+++++|+.|..|
T Consensus       374 yrdlkldnvll---daeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrsp  450 (593)
T KOG0695|consen  374 YRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP  450 (593)
T ss_pred             eeeccccceEE---ccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCC
Confidence            99999999999   78999999999999765 456778899999999999999999999999999999999999999999


Q ss_pred             CCC
Q 030527          166 FSV  168 (175)
Q Consensus       166 f~~  168 (175)
                      |+.
T Consensus       451 fdi  453 (593)
T KOG0695|consen  451 FDI  453 (593)
T ss_pred             cce
Confidence            963

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-29  Score=193.95  Aligned_cols=160  Identities=24%  Similarity=0.415  Sum_probs=140.6

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....|.+|+.++.+|+||+++.++++..+ ....+|+|+++.|+|.+.+.+  ...|.......++.||  |+.||.+++
T Consensus       154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr  232 (1039)
T KOG0199|consen  154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR  232 (1039)
T ss_pred             hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence            45689999999999999999999999888 667899999999999999986  3468899999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcccccc----CCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC----GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~----~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      +||+|+...|+++.   ....+||||||+.+....+.......    -...|+|||.+....++.++|+|++|+++|||+
T Consensus       233 lvHRDLAARNllla---sprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMF  309 (1039)
T KOG0199|consen  233 LVHRDLAARNLLLA---SPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMF  309 (1039)
T ss_pred             hhhhhhhhhhheec---ccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhh
Confidence            99999999999994   57779999999999887765443322    234599999999999999999999999999999


Q ss_pred             h-CCCCCCCCCcc
Q 030527          161 N-GYPPFSVGEEH  172 (175)
Q Consensus       161 ~-g~~pf~~~~~~  172 (175)
                      + |+.||.+...-
T Consensus       310 tyGEePW~G~~g~  322 (1039)
T KOG0199|consen  310 TYGEEPWVGCRGI  322 (1039)
T ss_pred             ccCCCCCCCCCHH
Confidence            9 89999876543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=3.4e-30  Score=194.51  Aligned_cols=160  Identities=33%  Similarity=0.507  Sum_probs=140.7

Q ss_pred             hHHHHHHHHhhCCC------CCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHH--HHHHH
Q 030527           12 CLDCELNFLSSVNH------PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus        12 ~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~i--~l~~l   80 (175)
                      .=..|+++|++|+.      -+++.++..|...+++|+|+|.+ ..+|.+.+++.|.   |....+..+..|+  ||..|
T Consensus       474 tGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklL  552 (752)
T KOG0670|consen  474 TGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLL  552 (752)
T ss_pred             hhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHH
Confidence            33569999999952      27788888899999999999988 7799999998864   8899999999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      -..|++|+||||+||++.  .....++|||||.|...+.+..++. .-+.+|.|||++.+.+|+...|+||.||++||+.
T Consensus       553 K~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~~~~eneitPY-LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElY  629 (752)
T KOG0670|consen  553 KKCGVLHADIKPDNILVN--ESKNILKLCDFGSASFASENEITPY-LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELY  629 (752)
T ss_pred             HhcCeeecccCccceEec--cCcceeeeccCccccccccccccHH-HHHHhccCcceeecCcccCCccceeeceeeEEee
Confidence            999999999999999993  3456689999999998877766543 3478899999999999999999999999999999


Q ss_pred             hCCCCCCCCCccCCC
Q 030527          161 NGYPPFSVGEEHQFM  175 (175)
Q Consensus       161 ~g~~pf~~~~~~~~l  175 (175)
                      ||+..|++.++++||
T Consensus       630 tGkIlFpG~TNN~ML  644 (752)
T KOG0670|consen  630 TGKILFPGRTNNQML  644 (752)
T ss_pred             ccceecCCCCcHHHH
Confidence            999999999998875

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.96  E-value=3.2e-28  Score=180.23  Aligned_cols=156  Identities=29%  Similarity=0.532  Sum_probs=127.6

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeC--------CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHH
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~   79 (175)
                      ..+.+|++++++++||||+++.+++.+.        ...+++++|+. .++...+... ..+++.++..++.|+  +|++
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~  130 (311)
T cd07866          52 ITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINY  130 (311)
T ss_pred             hhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999887543        34699999985 5777776643 579999999999998  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc------------cccCCCCccCccccccc-CCCcc
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE------------KVCGSPLYMAPEVLQFQ-RYDEK  146 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~------------~~~~~~~~~~pe~~~~~-~~~~~  146 (175)
                      ||+.|++|+|++|+||++   +.++.++|+|||++..........            ...++..|+|||.+.+. .++.+
T Consensus       131 lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  207 (311)
T cd07866         131 LHENHILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA  207 (311)
T ss_pred             HHhCCeecCCCCHHHEEE---CCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCch
Confidence            999999999999999999   577889999999987654322111            12346779999987654 57899


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCC
Q 030527          147 VDMWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       147 ~Di~slg~~~~~~~~g~~pf~~~~  170 (175)
                      +|+||+|++++++++|+.||.+.+
T Consensus       208 ~Dv~slG~il~el~~g~~~~~~~~  231 (311)
T cd07866         208 VDIWGIGCVFAEMFTRRPILQGKS  231 (311)
T ss_pred             hHhHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999997654

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=4.3e-28  Score=182.35  Aligned_cols=159  Identities=31%  Similarity=0.641  Sum_probs=129.4

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC--------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ   73 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~   73 (175)
                      ...+.+.+|++++++++|||++++++++...              ...++++||+. ++|.+++. .+.+++..+..++.
T Consensus        44 ~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~  121 (342)
T cd07854          44 QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMY  121 (342)
T ss_pred             chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHH
Confidence            3455678899999999999999999776543              35789999995 58888876 35789999999999


Q ss_pred             HH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC----ccccccCCCCccCcccccc-cCCCcc
Q 030527           74 QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF-QRYDEK  146 (175)
Q Consensus        74 ~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~-~~~~~~  146 (175)
                      |+  |+++||+.|++|+||+|+||+++  ..+..++++|||.+.......    ......++..|.|||...+ ..++.+
T Consensus       122 qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  199 (342)
T cd07854         122 QLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA  199 (342)
T ss_pred             HHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCch
Confidence            98  99999999999999999999994  345678999999987653221    1122346778999997654 457889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCC
Q 030527          147 VDMWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       147 ~Di~slg~~~~~~~~g~~pf~~~~  170 (175)
                      +|+||+|++++++++|+.||.+..
T Consensus       200 ~DiwSlGvil~el~~g~~pf~~~~  223 (342)
T cd07854         200 IDMWAAGCIFAEMLTGKPLFAGAH  223 (342)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999997543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=8.5e-28  Score=177.26  Aligned_cols=155  Identities=31%  Similarity=0.567  Sum_probs=129.0

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH-cC
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS-HH   84 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~-~~   84 (175)
                      ...+..|..++... .||||+++++++.+.+..++++||+ ++++.+++... ..+++..+..++.++  ++++||+ .|
T Consensus        57 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~  135 (296)
T cd06618          57 NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG  135 (296)
T ss_pred             HHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence            44555666666666 6999999999999999999999998 55888877653 578999999999998  9999997 59


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccC----CCcchhHHHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELL  160 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slg~~~~~~~  160 (175)
                      ++|+||+|+||++   +.++.++|+|||.+.............++..|+|||.+.+..    ++.++|+||+|+++++++
T Consensus       136 i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~  212 (296)
T cd06618         136 VIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA  212 (296)
T ss_pred             EecCCCcHHHEEE---cCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHH
Confidence            9999999999999   567789999999987665443333445677899999986543    788999999999999999


Q ss_pred             hCCCCCCC
Q 030527          161 NGYPPFSV  168 (175)
Q Consensus       161 ~g~~pf~~  168 (175)
                      +|+.||..
T Consensus       213 ~g~~p~~~  220 (296)
T cd06618         213 TGQFPYKN  220 (296)
T ss_pred             hCCCCCCc
Confidence            99999976

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=4.8e-28  Score=182.08  Aligned_cols=153  Identities=33%  Similarity=0.553  Sum_probs=127.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ...+.+|+++++.++||||+++.+++....      ..+++++++. .++.++..  ..+++..+..++.|+  |+++||
T Consensus        58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH  134 (342)
T cd07879          58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIH  134 (342)
T ss_pred             hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH
Confidence            445778999999999999999999986543      4689999984 47776542  468899999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~  160 (175)
                      +.|++|+||+|+||++   +.++.++|+|||++......  .....++..|+|||.+.+ ..++.++|+||+|+++++++
T Consensus       135 ~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~  209 (342)
T cd07879         135 SAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML  209 (342)
T ss_pred             HCCcccCCCCHHHEEE---CCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH
Confidence            9999999999999999   56788999999998765322  223345778999999875 45889999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|+.||.+.+
T Consensus       210 ~g~~pf~~~~  219 (342)
T cd07879         210 TGKTLFKGKD  219 (342)
T ss_pred             hCCCCCCCCC
Confidence            9999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=4.2e-28  Score=182.45  Aligned_cols=155  Identities=34%  Similarity=0.597  Sum_probs=131.8

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCe------EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ....+.+|+.++++++|||++++.+++...+.      .++|++++ +++|.+++.. ..+++..+..++.|+  ++++|
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~L  134 (343)
T cd07851          57 HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYI  134 (343)
T ss_pred             HHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence            34567789999999999999999988766554      89999998 7799998874 578999999999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~  159 (175)
                      |+.|++|+||+|+||++   +.++.++|+|||++......  .....++..|+|||...+ ..++.++|+||+|++++++
T Consensus       135 H~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~el  209 (343)
T cd07851         135 HSAGIIHRDLKPSNIAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL  209 (343)
T ss_pred             HHCCeecCCCCHHHeEE---CCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHH
Confidence            99999999999999999   56778999999998776443  223346778999998864 3678899999999999999


Q ss_pred             HhCCCCCCCCC
Q 030527          160 LNGYPPFSVGE  170 (175)
Q Consensus       160 ~~g~~pf~~~~  170 (175)
                      ++|+.||.+.+
T Consensus       210 ltg~~pf~~~~  220 (343)
T cd07851         210 LTGKTLFPGSD  220 (343)
T ss_pred             HhCCCCCCCCC
Confidence            99999997654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.7e-27  Score=168.33  Aligned_cols=157  Identities=45%  Similarity=0.797  Sum_probs=139.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+..|++.++.++|+|++++++++......++++|++.+++|.+++..... +++..+..++.++  ++++||+.++
T Consensus        40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i  119 (225)
T smart00221       40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGI  119 (225)
T ss_pred             HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            467888999999999999999999999999999999999998899999987766 8999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC--ccccccCCCCccCcccc-cccCCCcchhHHHHHHHHHHHHhC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      +|+|++|.|+++   +....++|+|||.+.......  ......+...|++||.. ....++.++|+|++|++++++++|
T Consensus       120 ~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g  196 (225)
T smart00221      120 VHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG  196 (225)
T ss_pred             ecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC
Confidence            999999999999   456889999999988775543  33345567789999998 566678899999999999999999


Q ss_pred             CCCCCC
Q 030527          163 YPPFSV  168 (175)
Q Consensus       163 ~~pf~~  168 (175)
                      +.||..
T Consensus       197 ~~pf~~  202 (225)
T smart00221      197 PEPFSG  202 (225)
T ss_pred             CCCccc
Confidence            999977

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=5.2e-29  Score=189.90  Aligned_cols=152  Identities=30%  Similarity=0.613  Sum_probs=136.4

Q ss_pred             HHHHHHHHhhCC---CCCeeeEeeEEeeCCeEEEEEecc-CCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           13 LDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFC-AGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        13 ~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      +-.|++||..++   |+||++++++|++++.+|++||-. +|.+|.+++....++++.++..|++|+  ++++||++|++
T Consensus       613 Vp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~iv  692 (772)
T KOG1152|consen  613 VPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIV  692 (772)
T ss_pred             cchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCce
Confidence            456999999997   999999999999999999999854 356899999999999999999999999  89999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |||||-+|+.+   +.++.++|+|||.+....++. -....||..|.|||.+.+..| +..-|||++|+++|.+.-..+|
T Consensus       693 hrdikdenviv---d~~g~~klidfgsaa~~ksgp-fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp  768 (772)
T KOG1152|consen  693 HRDIKDENVIV---DSNGFVKLIDFGSAAYTKSGP-FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP  768 (772)
T ss_pred             ecccccccEEE---ecCCeEEEeeccchhhhcCCC-cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence            99999999999   689999999999987765554 346778999999999998886 6678999999999999999999


Q ss_pred             CCC
Q 030527          166 FSV  168 (175)
Q Consensus       166 f~~  168 (175)
                      |.+
T Consensus       769 yyn  771 (772)
T KOG1152|consen  769 YYN  771 (772)
T ss_pred             CcC
Confidence            864

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-28  Score=181.09  Aligned_cols=156  Identities=35%  Similarity=0.630  Sum_probs=136.6

Q ss_pred             HHHHHHHhhCCCCCeeeEeeEEeeC-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc--CCeec
Q 030527           14 DCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH--HIIHR   88 (175)
Q Consensus        14 ~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~--~~~h~   88 (175)
                      -+|.+|-+.|.||.||++++++.-+ ..+|.|+|||+|.+|.-|+++..-+++.++..|+.|+  ||.||.+.  .|+|.
T Consensus       515 cREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHY  594 (775)
T KOG1151|consen  515 CREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHY  594 (775)
T ss_pred             HHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeee
Confidence            4588999999999999999999754 5789999999999999999999999999999999998  99999976  49999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeeccCCC--------ccccccCCCCccCccccccc----CCCcchhHHHHHHHH
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSVGAIL  156 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~----~~~~~~Di~slg~~~  156 (175)
                      |+||.||++-+....+.++|.|||++.......        .+....||.+|++||.+.-.    ..+.+.||||+|+++
T Consensus       595 DLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIF  674 (775)
T KOG1151|consen  595 DLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF  674 (775)
T ss_pred             ccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhh
Confidence            999999999766677889999999998765432        34567899999999987432    257899999999999


Q ss_pred             HHHHhCCCCCCCC
Q 030527          157 FELLNGYPPFSVG  169 (175)
Q Consensus       157 ~~~~~g~~pf~~~  169 (175)
                      |.++-|..||+.+
T Consensus       675 yQClYGrKPFGhn  687 (775)
T KOG1151|consen  675 YQCLYGRKPFGHN  687 (775)
T ss_pred             hhhhccCCCCCCc
Confidence            9999999999875

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.95  E-value=3.9e-27  Score=197.50  Aligned_cols=145  Identities=30%  Similarity=0.494  Sum_probs=121.9

Q ss_pred             HHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH---HcCCeec
Q 030527           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN---SHHIIHR   88 (175)
Q Consensus        14 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh---~~~~~h~   88 (175)
                      ..|++.+++++||||+++++++.+.+..++||||+++++|.++++   .+++.....++.++  |++|||   +.+++||
T Consensus       731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~  807 (968)
T PLN00113        731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVG  807 (968)
T ss_pred             HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecC
Confidence            457899999999999999999999999999999999999999986   37888899999998  999999   6699999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV  168 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~  168 (175)
                      |+||+||++   +.+...++. ++........   ....++..|+|||...+..++.++||||+|+++||+++|+.||+.
T Consensus       808 dlkp~Nil~---~~~~~~~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        808 NLSPEKIII---DGKDEPHLR-LSLPGLLCTD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             CCCHHhEEE---CCCCceEEE-eccccccccC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence            999999999   444444443 4433222111   123567899999999988899999999999999999999999954

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-26  Score=185.09  Aligned_cols=161  Identities=32%  Similarity=0.570  Sum_probs=140.8

Q ss_pred             chhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHH
Q 030527            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA   68 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~   68 (175)
                      .+...+.+..|+.+++.+ +|+|++.+++++..++..++|.||+..|+|.+++.+++                .++....
T Consensus       341 ~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dL  420 (609)
T KOG0200|consen  341 SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDL  420 (609)
T ss_pred             CcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHH
Confidence            345677899999999999 79999999999999999999999999999999998766                3888899


Q ss_pred             HHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc--ccc--CCCCccCcccccccC
Q 030527           69 RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVC--GSPLYMAPEVLQFQR  142 (175)
Q Consensus        69 ~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~--~~~~~~~pe~~~~~~  142 (175)
                      ..+..|+  +++||++..++|||+.+.||++   ..+..+|++|||+++...+.....  ...  -...|+|||.+....
T Consensus       421 lsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~  497 (609)
T KOG0200|consen  421 LSFAYQIANGMEYLASVPCVHRDLAARNVLI---TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV  497 (609)
T ss_pred             HHHHHHHHHHHHHHhhCCccchhhhhhhEEe---cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc
Confidence            9999999  9999999999999999999999   577889999999998765543221  111  245599999999989


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 030527          143 YDEKVDMWSVGAILFELLN-GYPPFSVG  169 (175)
Q Consensus       143 ~~~~~Di~slg~~~~~~~~-g~~pf~~~  169 (175)
                      ++.++|+||+|+++||+++ |..|+.+-
T Consensus       498 ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  498 FTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             ccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            9999999999999999999 89999873

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.94  E-value=2.9e-26  Score=185.27  Aligned_cols=104  Identities=35%  Similarity=0.661  Sum_probs=96.4

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...++..|..+++.++||||+++++++...+..++||||+.|++|.+++...+.+++..+..++.|+  ||+|||+.|++
T Consensus        47 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIi  126 (669)
T cd05610          47 MVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGII  126 (669)
T ss_pred             HHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            3467888999999999999999999999999999999999999999999888889999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeeccee
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSC  115 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~  115 (175)
                      |+||||+||++   +.++.++|+|||+++
T Consensus       127 HrDLKP~NILl---~~~g~vkL~DFGls~  152 (669)
T cd05610         127 HRDLKPDNMLI---SNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence            99999999999   467789999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-27  Score=187.56  Aligned_cols=168  Identities=33%  Similarity=0.547  Sum_probs=140.5

Q ss_pred             CccccchhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-C---CCHHHHHHHHHHH
Q 030527            1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-R---VPEQTARKFLQQL   75 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~---l~~~~~~~~~~~i   75 (175)
                      +||++..+-.....+|++.+++- +||||+++++.=.++...|+..|+| .-+|.+++...+ .   .........+.|+
T Consensus       537 AVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~  615 (903)
T KOG1027|consen  537 AVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQI  615 (903)
T ss_pred             hHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHH
Confidence            46777777777889999999998 8999999999988999999999999 569999998631 1   1113345667776


Q ss_pred             --HHHHHHHcCCeecCCCCCcEEEeecC--CCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcch
Q 030527           76 --GLEILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKV  147 (175)
Q Consensus        76 --~l~~lh~~~~~h~di~~~ni~~~~~~--~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~  147 (175)
                        ++++||+.+++|||+||.||++...+  ...+++|+|||++++...+..    .....||-+|.|||.+.....+++.
T Consensus       616 ~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~av  695 (903)
T KOG1027|consen  616 ASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAV  695 (903)
T ss_pred             HHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCccc
Confidence              99999999999999999999997543  345789999999999866542    3356789999999999988888999


Q ss_pred             hHHHHHHHHHHHHhC-CCCCCCC
Q 030527          148 DMWSVGAILFELLNG-YPPFSVG  169 (175)
Q Consensus       148 Di~slg~~~~~~~~g-~~pf~~~  169 (175)
                      |+||+||++||+++| +.||+..
T Consensus       696 DiFslGCvfyYvltgG~HpFGd~  718 (903)
T KOG1027|consen  696 DIFSLGCVFYYVLTGGSHPFGDS  718 (903)
T ss_pred             chhhcCceEEEEecCCccCCCch
Confidence            999999999999995 9999865

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=5.9e-27  Score=161.45  Aligned_cols=163  Identities=27%  Similarity=0.476  Sum_probs=140.5

Q ss_pred             CccccchhhhhhHHHHHHHHhhCC-CCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--
Q 030527            1 MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--   75 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--   75 (175)
                      |+|.+++--+..+.+|+.+|+.|+ +|||+++++...+  +....+++|+..+.+...+   ...++...+..++.++  
T Consensus        67 ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLk  143 (338)
T KOG0668|consen   67 VIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLK  143 (338)
T ss_pred             EEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHH---hhhhchhhHHHHHHHHHH
Confidence            467888888999999999999995 9999999999865  4577899999988777765   4567888888899998  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccccc-CCCcchhHHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGA  154 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~  154 (175)
                      ||.|||+.|+.|+|+||.|++++  .....++|+|.|+|....++..-.....++.|-.||.+... .+.-+-|+||+||
T Consensus       144 ALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~Gc  221 (338)
T KOG0668|consen  144 ALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC  221 (338)
T ss_pred             HHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHH
Confidence            99999999999999999999995  45667999999999999888766666778889999998654 4788899999999


Q ss_pred             HHHHHHhCCCCCCC
Q 030527          155 ILFELLNGYPPFSV  168 (175)
Q Consensus       155 ~~~~~~~g~~pf~~  168 (175)
                      .++.|+..+.||=.
T Consensus       222 mlA~miFrkepFFh  235 (338)
T KOG0668|consen  222 MLASMIFRKEPFFH  235 (338)
T ss_pred             HHHHHHhccCcccC
Confidence            99999998888743

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=5.4e-27  Score=156.55  Aligned_cols=159  Identities=36%  Similarity=0.609  Sum_probs=139.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      .....+|+-+++.++|.||++++++.-.++.+.+|+|+| .-+|..+.... +.++.+.+.+.+.|+  ++.++|+.++.
T Consensus        45 pssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvl  123 (292)
T KOG0662|consen   45 PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVL  123 (292)
T ss_pred             cHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhh
Confidence            456678999999999999999999999999999999999 66999998865 689999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc-ccccCCCCccCcccccccC-CCcchhHHHHHHHHHHHHh-CC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLN-GY  163 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~-g~  163 (175)
                      |+|+||.|+++   +.++.+++.|||+++..+-+... ....-|.+|.+|..+.+.. |+.+.|+||-||++.|+.. |.
T Consensus       124 hrdlkpqnlli---n~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagr  200 (292)
T KOG0662|consen  124 HRDLKPQNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR  200 (292)
T ss_pred             hccCCcceEEe---ccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCC
Confidence            99999999999   78899999999999988666433 2344588999999998765 8999999999999999987 78


Q ss_pred             CCCCCCCcc
Q 030527          164 PPFSVGEEH  172 (175)
Q Consensus       164 ~pf~~~~~~  172 (175)
                      +.|++.+-+
T Consensus       201 plfpg~dvd  209 (292)
T KOG0662|consen  201 PLFPGNDVD  209 (292)
T ss_pred             CCCCCCcHH
Confidence            888887643

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=3.2e-26  Score=171.05  Aligned_cols=162  Identities=30%  Similarity=0.492  Sum_probs=137.1

Q ss_pred             CccccchhhhhhHHHHHHHHhhC--CCCCeeeEeeEEeeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHH
Q 030527            1 MLKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~   74 (175)
                      +||....+.++.+.+|.+|++..  +|+||+++++.-....    .+++|++|.+.|+|.+|++. ...+.....+++..
T Consensus       237 AVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~S  315 (534)
T KOG3653|consen  237 AVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAES  315 (534)
T ss_pred             EEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHH
Confidence            47888999999999999999976  8999999998854433    78999999999999999994 46888999999999


Q ss_pred             H--HHHHHHHc---------CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccc
Q 030527           75 L--GLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF  140 (175)
Q Consensus        75 i--~l~~lh~~---------~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~  140 (175)
                      +  +|+|||+.         .|+|||||..||++   .++.+..|+|||+|.+...+..   .....||.+|||||++.+
T Consensus       316 marGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEg  392 (534)
T KOG3653|consen  316 MARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEG  392 (534)
T ss_pred             HHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhh
Confidence            8  99999975         38999999999999   5888999999999998875532   334789999999999865


Q ss_pred             cC------CCcchhHHHHHHHHHHHHhCCCCC
Q 030527          141 QR------YDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus       141 ~~------~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      .-      .-.+.|+||+|.++||+++.=.-+
T Consensus       393 ainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  393 AINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             hcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            42      235699999999999998864333

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=3.9e-27  Score=168.56  Aligned_cols=155  Identities=38%  Similarity=0.552  Sum_probs=134.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      .++..+|...+..++|+|+++++.++...+      ..|+|||++ ..+|.+.+.  ..++=.++..++.|+  +++++|
T Consensus        59 akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lh  135 (369)
T KOG0665|consen   59 AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLH  135 (369)
T ss_pred             chhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHH
Confidence            456678999999999999999999986554      468999999 669988877  456778888999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      +.|++|||+||+|+++   ..+..++++|||+|++....-.......++.|.|||++.+..+...+|+||+||++.||++
T Consensus       136 s~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~  212 (369)
T KOG0665|consen  136 SAGIIHRDLKPSNIVV---NSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELIL  212 (369)
T ss_pred             hcceeecccCccccee---cchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhh
Confidence            9999999999999999   5788899999999988876633445566889999999998889999999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |...|.+.+
T Consensus       213 ~~Vlf~g~d  221 (369)
T KOG0665|consen  213 GTVLFPGKD  221 (369)
T ss_pred             ceEEecCch
Confidence            999998754

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=5.7e-27  Score=163.56  Aligned_cols=155  Identities=27%  Similarity=0.518  Sum_probs=131.5

Q ss_pred             HHHHHHHhhCCCCCeeeEeeEEe--------eCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527           14 DCELNFLSSVNHPNIIRLFDAFQ--------AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        14 ~~e~~~l~~l~h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      .+|+++++.|+|+|++++++.+.        +...+++|+++| ..+|.-++... -+++...+..+++++  +|.|+|.
T Consensus        64 lreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr  142 (376)
T KOG0669|consen   64 LREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR  142 (376)
T ss_pred             HHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH
Confidence            56899999999999999988763        334689999999 56999988755 579999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc-----cccCCCCccCccccccc-CCCcchhHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAIL  156 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~  156 (175)
                      ..++|||+|+.|+++   +.++.++|.|||+++..+......     ...-|.+|.+||.+.+. +++++.|+|+-||++
T Consensus       143 ~kilHRDmKaaNvLI---t~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCim  219 (376)
T KOG0669|consen  143 NKILHRDMKAANVLI---TKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIM  219 (376)
T ss_pred             hhHHhhcccHhhEEE---cCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHH
Confidence            999999999999999   688999999999997665443211     12237889999998754 699999999999999


Q ss_pred             HHHHhCCCCCCCCCcc
Q 030527          157 FELLNGYPPFSVGEEH  172 (175)
Q Consensus       157 ~~~~~g~~pf~~~~~~  172 (175)
                      .+|+++++-|.++++-
T Consensus       220 aeMwtrspimqgnteq  235 (376)
T KOG0669|consen  220 AEMWTRSPIMQGNTEQ  235 (376)
T ss_pred             HHHHccCccccCChHH
Confidence            9999999999887653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=6.2e-26  Score=163.59  Aligned_cols=161  Identities=21%  Similarity=0.325  Sum_probs=144.0

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHc
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      +...+++.|-+.++.| ..++|++++.|..+..+..+|+|++ |+||.|+..-|+ .++..++..++.|+  -++++|++
T Consensus        65 S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k  143 (449)
T KOG1165|consen   65 SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK  143 (449)
T ss_pred             CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc
Confidence            4467899999999999 7999999999999999999999988 999999999886 69999999999998  89999999


Q ss_pred             CCeecCCCCCcEEEeecC--CCceEEEeeecceeeccCCCcc--------ccccCCCCccCcccccccCCCcchhHHHHH
Q 030527           84 HIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~--~~~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      .+|+|||||+|++++..+  ....+.++|||+|+...++.+.        ....||.+||+-....+.+.+++.|+-|||
T Consensus       144 ~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLG  223 (449)
T KOG1165|consen  144 DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALG  223 (449)
T ss_pred             ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhh
Confidence            999999999999997433  3456899999999988766432        346789999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCC
Q 030527          154 AILFELLNGYPPFSVG  169 (175)
Q Consensus       154 ~~~~~~~~g~~pf~~~  169 (175)
                      -+++|.+.|++||.+-
T Consensus       224 HvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  224 HVFMYFLRGSLPWQGL  239 (449)
T ss_pred             hhhhhhccCCCccccc
Confidence            9999999999999864

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2e-25  Score=176.77  Aligned_cols=160  Identities=33%  Similarity=0.669  Sum_probs=136.5

Q ss_pred             chhhhhhHHHHHHHHhhC-CCCCeeeEeeEEee-----CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--
Q 030527            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--   75 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--   75 (175)
                      +.+...+++.|.++++.. .|||++.+++++..     ++.+++|||||.||+..|+++.-  .++.+..+.-|+..+  
T Consensus        55 ~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lr  134 (953)
T KOG0587|consen   55 TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILR  134 (953)
T ss_pred             CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHH
Confidence            455566788899999988 89999999999853     45789999999999999999854  468888888788886  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccc-----cCCCcchhH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQF-----QRYDEKVDM  149 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di  149 (175)
                      ++.+||...++|+|||-.||++   ..++.++|+|||.+..... ...+.+..||+.|+|||++..     ..|+..+|+
T Consensus       135 gl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~  211 (953)
T KOG0587|consen  135 GLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDL  211 (953)
T ss_pred             HHHHHhhcceeeecccCceEEE---eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccch
Confidence            9999999999999999999999   5788899999999876643 344567889999999999853     347788999


Q ss_pred             HHHHHHHHHHHhCCCCCCC
Q 030527          150 WSVGAILFELLNGYPPFSV  168 (175)
Q Consensus       150 ~slg~~~~~~~~g~~pf~~  168 (175)
                      ||||++..||..|.+|+-+
T Consensus       212 WsLGITaIEladG~PPl~D  230 (953)
T KOG0587|consen  212 WSLGITAIEMAEGAPPLCD  230 (953)
T ss_pred             hhccceeehhcCCCCCccC
Confidence            9999999999999999864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=182.77  Aligned_cols=162  Identities=28%  Similarity=0.472  Sum_probs=141.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      +...++..|+-.+.+++|||++++++++..+. ..+|++|+++|+|.+|++.. +++.......|..||  ++.|||++.
T Consensus       740 ~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr  818 (1177)
T KOG1025|consen  740 KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR  818 (1177)
T ss_pred             hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc
Confidence            34668889999999999999999999998776 78999999999999999865 579999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcccc---ccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~---~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      ++||||-++||++   .+.+.+++.|||++...........   ....+.|+|-|.++...++.++||||+|+++||++|
T Consensus       819 lVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmT  895 (1177)
T KOG1025|consen  819 LVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMT  895 (1177)
T ss_pred             hhhhhhhhhheee---cCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHh
Confidence            9999999999999   5777899999999988876654332   233466999999999999999999999999999999


Q ss_pred             -CCCCCCCCCccC
Q 030527          162 -GYPPFSVGEEHQ  173 (175)
Q Consensus       162 -g~~pf~~~~~~~  173 (175)
                       |+.|+.+..-++
T Consensus       896 FGa~Py~gi~~~e  908 (1177)
T KOG1025|consen  896 FGAKPYDGIPAEE  908 (1177)
T ss_pred             cCCCccCCCCHHH
Confidence             999998765444

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=3.7e-26  Score=188.05  Aligned_cols=148  Identities=18%  Similarity=0.206  Sum_probs=115.7

Q ss_pred             HhhCCC-CCeeeEeeEE-------eeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           20 LSSVNH-PNIIRLFDAF-------QAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        20 l~~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      .+.++| +||+.+++++       .....++.++|++ +++|.+++.+. ..+++..+..++.|+  ||+|||++|++||
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr  104 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH  104 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            455667 6888888887       2334667788887 77999999754 469999999999999  9999999999999


Q ss_pred             CCCCCcEEEee----------------cCCCceEEEeeecceeeccCCC-----------------ccccccCCCCccCc
Q 030527           89 DLKPENILLSG----------------LDDDVMLKIADFGLSCTLYPGN-----------------YAEKVCGSPLYMAP  135 (175)
Q Consensus        89 di~~~ni~~~~----------------~~~~~~~~l~df~~~~~~~~~~-----------------~~~~~~~~~~~~~p  135 (175)
                      ||||+||++..                .+....++++|||+++......                 ......+++.|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999942                1234457778888776432100                 00113467889999


Q ss_pred             ccccccCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030527          136 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV  168 (175)
Q Consensus       136 e~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~  168 (175)
                      |.+.+..++.++|||||||++|||++|..|+..
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence            999988999999999999999999999998764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.92  E-value=9.1e-24  Score=147.20  Aligned_cols=147  Identities=47%  Similarity=0.833  Sum_probs=128.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|.+.++.++|++++++.+++......++++|++.|++|.+++... ..++...+..++.++  ++++||+.|++
T Consensus        35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~  114 (215)
T cd00180          35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII  114 (215)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            368899999999999999999999999999999999999889999999876 578999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCC-CceEEEeeecceeeccCCC-ccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHH
Q 030527           87 HRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        87 h~di~~~ni~~~~~~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~  159 (175)
                      |+|++|.||++.   . ++.++++||+.+....... ......+...|.+||..... .++.++|+|++|++++++
T Consensus       115 H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         115 HRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             ccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            999999999994   4 6789999999998765443 12234567789999998776 788999999999999876

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.8e-26  Score=159.85  Aligned_cols=156  Identities=29%  Similarity=0.486  Sum_probs=123.1

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeE-EeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .+.|.+|...=-.| .|.+|+.-+++ |+..+.+++++|+++.|+|.+-+.. ..+.+.....++.|+  |+.++|++++
T Consensus        64 ~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknl  142 (378)
T KOG1345|consen   64 QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNL  142 (378)
T ss_pred             HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccch
Confidence            45666666555555 58899877654 6777888999999999999987654 347788889999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc---c--CCCcchhHHHHHHHHHHHH
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---Q--RYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~--~~~~~~Di~slg~~~~~~~  160 (175)
                      ||||||.+||++.+.+.. +++|||||.+...+..  .........|.+||....   .  ...+.+|+|+||+++++++
T Consensus       143 VHRdlK~eNiLif~~df~-rvKlcDFG~t~k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cl  219 (378)
T KOG1345|consen  143 VHRDLKAENILIFDADFY-RVKLCDFGLTRKVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCL  219 (378)
T ss_pred             hhcccccceEEEecCCcc-EEEeeecccccccCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeee
Confidence            999999999999754443 7999999988776433  333445667888887632   2  2467899999999999999


Q ss_pred             hCCCCCCCC
Q 030527          161 NGYPPFSVG  169 (175)
Q Consensus       161 ~g~~pf~~~  169 (175)
                      ||..||...
T Consensus       220 tG~~PWQka  228 (378)
T KOG1345|consen  220 TGKFPWQKA  228 (378)
T ss_pred             cCCCcchhh
Confidence            999999754

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2e-24  Score=160.46  Aligned_cols=157  Identities=28%  Similarity=0.432  Sum_probs=130.9

Q ss_pred             CccccchhhhhhHHHHHHHHhhC--CCCCeeeEeeEEeeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHH
Q 030527            1 MLKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~   74 (175)
                      +||.-.....+...+|.++++..  +|+||+.+++....++    .+++|++|.+.|||.||+++ ..++...+..++..
T Consensus       238 AVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS  316 (513)
T KOG2052|consen  238 AVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALS  316 (513)
T ss_pred             EEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHH
Confidence            46777788888999999999975  9999999998865443    67999999999999999996 67888888888888


Q ss_pred             H--HHHHHHHc--------CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-----ccccccCCCCccCccccc
Q 030527           75 L--GLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQ  139 (175)
Q Consensus        75 i--~l~~lh~~--------~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~  139 (175)
                      +  +|++||..        .+.|||||..||++   .+++.+.|.|+|+|.+.....     ......||.+|||||.+.
T Consensus       317 ~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLd  393 (513)
T KOG2052|consen  317 IASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLD  393 (513)
T ss_pred             HhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhh
Confidence            7  99999964        38999999999999   588999999999998775542     234678999999999985


Q ss_pred             cc------CCCcchhHHHHHHHHHHHHh
Q 030527          140 FQ------RYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus       140 ~~------~~~~~~Di~slg~~~~~~~~  161 (175)
                      ..      +.-..+||||||.++||++.
T Consensus       394 etin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  394 ETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             hhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            32      12345999999999999754

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-26  Score=163.81  Aligned_cols=158  Identities=33%  Similarity=0.539  Sum_probs=130.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCC-----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ..++-+|..++..++|.|++..++......     .+|.++|++ ..+|...+-.-..++.+.+.-.+.||  +|+|||+
T Consensus        96 ~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHs  174 (449)
T KOG0664|consen   96 CKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHT  174 (449)
T ss_pred             HHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhh
Confidence            345677999999999999999887765432     346788887 44788777766789999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc--cccCCCCccCcccccccC-CCcchhHHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFEL  159 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~  159 (175)
                      .++.|+||||.|+++   +.+-.+|+||||+++.........  ...-|..|.|||++++.. |+.+.||||.||++.|+
T Consensus       175 A~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaEL  251 (449)
T KOG0664|consen  175 ANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAEL  251 (449)
T ss_pred             cchhhccCCCccEEe---ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHH
Confidence            999999999999999   677789999999998876554322  233467899999998764 89999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030527          160 LNGYPPFSVGEE  171 (175)
Q Consensus       160 ~~g~~pf~~~~~  171 (175)
                      +..+..|....+
T Consensus       252 LgRrILFQAq~P  263 (449)
T KOG0664|consen  252 LQRKILFQAAGP  263 (449)
T ss_pred             HhhhhhhhccCh
Confidence            999988876554

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.91  E-value=2e-23  Score=153.62  Aligned_cols=166  Identities=27%  Similarity=0.475  Sum_probs=138.9

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC-CeEEEEEeccCCCChHHHHHhcC--------CCCHHHHHHHHHHH-
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHG--------RVPEQTARKFLQQL-   75 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--------~l~~~~~~~~~~~i-   75 (175)
                      ++.+...+..|.-.+.-+.|||+.++.++..++ ...+.++.+..-++|..++..+.        .++..+...+..|+ 
T Consensus       327 S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla  406 (563)
T KOG1024|consen  327 SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLA  406 (563)
T ss_pred             cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHH
Confidence            344455677788888888999999999998764 46788889988899999998442        26677778888898 


Q ss_pred             -HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc---cccCCCCccCcccccccCCCcchhHHH
Q 030527           76 -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWS  151 (175)
Q Consensus        76 -~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~Di~s  151 (175)
                       |+++||..|++|.||.+.|+++   +..-+++|+|=.+++...+.+...   .......|++||.+....++.++|+||
T Consensus       407 ~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWs  483 (563)
T KOG1024|consen  407 MAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWS  483 (563)
T ss_pred             HHHHHHHhcCcccchhhhhccee---hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHH
Confidence             9999999999999999999999   577889999999998887765432   333466799999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCCccCC
Q 030527          152 VGAILFELLN-GYPPFSVGEEHQF  174 (175)
Q Consensus       152 lg~~~~~~~~-g~~pf~~~~~~~~  174 (175)
                      ||+++||++| |+.|+..-|+.++
T Consensus       484 fGVllWELmtlg~~PyaeIDPfEm  507 (563)
T KOG1024|consen  484 FGVLLWELMTLGKLPYAEIDPFEM  507 (563)
T ss_pred             HHHHHHHHHhcCCCCccccCHHHH
Confidence            9999999999 8999998887654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=3.6e-24  Score=148.65  Aligned_cols=159  Identities=21%  Similarity=0.239  Sum_probs=137.9

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .+++.-|.++++.| ...+|+.+..+..+.....+||+++ |++|.++++-+ ..++..+++..+-|+  -++|+|.+++
T Consensus        54 hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~f  132 (341)
T KOG1163|consen   54 HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNF  132 (341)
T ss_pred             CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhcc
Confidence            35778899999999 5679999999999999999999988 99999999877 468999999999998  7999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--------ccccCCCCccCcccccccCCCcchhHHHHHHHHH
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~  157 (175)
                      +|+||||+|++.+-......+.++|||++++..+....        ..-.||.+|.+-.+..+.+.+++.|+-|+|+++.
T Consensus       133 iHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLm  212 (341)
T KOG1163|consen  133 IHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLM  212 (341)
T ss_pred             ccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceee
Confidence            99999999999965455677999999999887544221        2345788898888888888999999999999999


Q ss_pred             HHHhCCCCCCCC
Q 030527          158 ELLNGYPPFSVG  169 (175)
Q Consensus       158 ~~~~g~~pf~~~  169 (175)
                      ++-.|.+||.+-
T Consensus       213 YfnrG~LPWQgl  224 (341)
T KOG1163|consen  213 YFNRGSLPWQGL  224 (341)
T ss_pred             eeecCCCccccc
Confidence            999999999874

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.90  E-value=4.1e-23  Score=160.96  Aligned_cols=150  Identities=24%  Similarity=0.376  Sum_probs=111.9

Q ss_pred             HHHHHHhhCCCCCe-----eeEeeEEee--------CCeEEEEEeccCCCChHHHHHhcC--------------------
Q 030527           15 CELNFLSSVNHPNI-----IRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHG--------------------   61 (175)
Q Consensus        15 ~e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~--------------------   61 (175)
                      .|+.++.+++|.++     +++++++..        .+..++|+||+++++|.+++....                    
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46677777766554     566666542        356799999999999999886321                    


Q ss_pred             ----CCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc--cccCCCCcc
Q 030527           62 ----RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYM  133 (175)
Q Consensus        62 ----~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~  133 (175)
                          .++...+..++.|+  +++++|+.+++|+||||+||++   +.+..++|+|||++..........  ....++.|+
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~  377 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS  377 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence                13456677888888  9999999999999999999999   566789999999987654332211  233478899


Q ss_pred             CcccccccC----------------------CCcchhHHHHHHHHHHHHhCCC-CCC
Q 030527          134 APEVLQFQR----------------------YDEKVDMWSVGAILFELLNGYP-PFS  167 (175)
Q Consensus       134 ~pe~~~~~~----------------------~~~~~Di~slg~~~~~~~~g~~-pf~  167 (175)
                      +||.+....                      .....|+||+|+++++|+++.. ||.
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            999875322                      1124699999999999999875 775

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.90  E-value=1.9e-23  Score=165.78  Aligned_cols=130  Identities=25%  Similarity=0.413  Sum_probs=98.4

Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHH--HHHHHHHcCCeecCCCCC
Q 030527           36 QAENCIFLVVEFCAGGNLSSYIRLHGR--------------------VPEQTARKFLQQL--GLEILNSHHIIHRDLKPE   93 (175)
Q Consensus        36 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~   93 (175)
                      ......++|++|+.+++|.+++.....                    .....+..++.|+  +|+|||+.|++|+||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            355678999999999999998875421                    1123455788888  999999999999999999


Q ss_pred             cEEEeecCCCceEEEeeecceeeccCC--CccccccCCCCccCcccccccC----------------------CCcchhH
Q 030527           94 NILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQR----------------------YDEKVDM  149 (175)
Q Consensus        94 ni~~~~~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~----------------------~~~~~Di  149 (175)
                      ||+++  +..+.++|+|||++......  .......+++.|+|||.+....                      +..++|+
T Consensus       285 NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        285 NIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99994  24568999999999765332  2233456788999999653221                      2334699


Q ss_pred             HHHHHHHHHHHhCCCCCC
Q 030527          150 WSVGAILFELLNGYPPFS  167 (175)
Q Consensus       150 ~slg~~~~~~~~g~~pf~  167 (175)
                      ||+||++|+|+++..|++
T Consensus       363 wSlGviL~el~~~~~~~~  380 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             HHHHHHHHHHHhCcCCCc
Confidence            999999999999776654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-22  Score=151.02  Aligned_cols=158  Identities=27%  Similarity=0.357  Sum_probs=132.7

Q ss_pred             hHHHHHHHHhhCC----CCCeeeEeeEE-eeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHH
Q 030527           12 CLDCELNFLSSVN----HPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        12 ~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      .+..|..++..+.    .++++.+.+.+ ......++||+.+ |.+|.++....  +.++..++..+..|+  +|+++|+
T Consensus        62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~  140 (322)
T KOG1164|consen   62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS  140 (322)
T ss_pred             cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence            6788999999886    36999999998 5778899999987 99999998655  469999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecC--CCceEEEeeeccee--eccCCC------c---cccccCCCCccCcccccccCCCcchhH
Q 030527           83 HHIIHRDLKPENILLSGLD--DDVMLKIADFGLSC--TLYPGN------Y---AEKVCGSPLYMAPEVLQFQRYDEKVDM  149 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~--~~~~~~l~df~~~~--~~~~~~------~---~~~~~~~~~~~~pe~~~~~~~~~~~Di  149 (175)
                      .|++||||||.|++++...  ....+++.|||+++  +.....      .   .....||..|.+++...+.+.+++.|+
T Consensus       141 ~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl  220 (322)
T KOG1164|consen  141 KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL  220 (322)
T ss_pred             cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh
Confidence            9999999999999996332  12569999999998  421111      1   112448999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCC
Q 030527          150 WSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       150 ~slg~~~~~~~~g~~pf~~~~  170 (175)
                      ||+++++.++..|..||.+.+
T Consensus       221 es~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  221 ESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             hhHHHHHHHHhcCCCCCcccc
Confidence            999999999999999997654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=4.8e-22  Score=136.16  Aligned_cols=104  Identities=32%  Similarity=0.416  Sum_probs=90.2

Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcccccc
Q 030527           51 GNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC  127 (175)
Q Consensus        51 ~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~  127 (175)
                      |+|.+++.+. ..+++.++..++.|+  ||+|||+.+      ||+||++   +.++.+++  ||.+.......    ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence            5889999874 469999999999999  999999998      9999999   56777887  99887664432    25


Q ss_pred             CCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030527          128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus       128 ~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~  169 (175)
                      ++..|+|||.+.+..++.++||||+|+++|+|++|+.||...
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~  107 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE  107 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence            689999999999999999999999999999999999999754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.88  E-value=8.5e-23  Score=166.58  Aligned_cols=120  Identities=37%  Similarity=0.670  Sum_probs=99.4

Q ss_pred             eEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceee
Q 030527           40 CIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (175)
Q Consensus        40 ~~~lv~e~~~~~~L~~~l~~~~~l-~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~  116 (175)
                      .+|+.||||+...+.+++.++... .....++++.+|  ||+|+|++|+||||+||.|||+   +..+.++|+|||++..
T Consensus       670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATD  746 (1351)
T ss_pred             EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE---cCCCCeeecccccchh
Confidence            468999999887777777766544 578899999998  9999999999999999999999   6888899999999987


Q ss_pred             cc------C------------C-CccccccCCCCccCccccccc---CCCcchhHHHHHHHHHHHHhC
Q 030527          117 LY------P------------G-NYAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus       117 ~~------~------------~-~~~~~~~~~~~~~~pe~~~~~---~~~~~~Di~slg~~~~~~~~g  162 (175)
                      ..      .            + .......||..|+|||.+.+.   .|+.++|+||||++++||+.-
T Consensus       747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP  814 (1351)
T KOG1035|consen  747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP  814 (1351)
T ss_pred             hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc
Confidence            21      0            0 112246788999999998654   499999999999999998753

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.88  E-value=1.4e-22  Score=149.63  Aligned_cols=156  Identities=29%  Similarity=0.439  Sum_probs=130.0

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .-.++.+|++++..+ .+.||+++.+++..++...+|++|++..+..++..   .++...+..++..+  ||+++|.+||
T Consensus        77 ~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GI  153 (418)
T KOG1167|consen   77 SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGI  153 (418)
T ss_pred             CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCc
Confidence            355789999999999 79999999999999999999999998888888755   46678888888888  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccC----------------C-----------------------------
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----------------G-----------------------------  120 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~----------------~-----------------------------  120 (175)
                      +|+||||+|++++  ...+.-.|+|||+|.....                +                             
T Consensus       154 vHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~  231 (418)
T KOG1167|consen  154 VHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRP  231 (418)
T ss_pred             cccCCCccccccc--cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCcc
Confidence            9999999999995  4566678999999972210                0                             


Q ss_pred             CccccccCCCCccCcccccccC-CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030527          121 NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus       121 ~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~g~~pf~~~  169 (175)
                      .......||++|.|||++...+ .+++.|+||.|+++..++++..||-..
T Consensus       232 ~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  232 SERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             ceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccC
Confidence            0001356899999999987554 788999999999999999999988543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5.8e-21  Score=143.69  Aligned_cols=88  Identities=32%  Similarity=0.539  Sum_probs=75.4

Q ss_pred             hhhHHHHHHHHhhCC--------CCCeeeEeeEEee----CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH
Q 030527           10 KSCLDCELNFLSSVN--------HPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL   75 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~--------h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i   75 (175)
                      ...-..|+.+|++++        ..+||++++.|..    ..+.|+|+|++ |.+|..++++.  ..++...+..|+.|+
T Consensus       118 tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qv  196 (590)
T KOG1290|consen  118 TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQV  196 (590)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHH
Confidence            344567999999983        3479999999865    34889999998 99999999976  469999999999998


Q ss_pred             --HHHHHHH-cCCeecCCCCCcEEEe
Q 030527           76 --GLEILNS-HHIIHRDLKPENILLS   98 (175)
Q Consensus        76 --~l~~lh~-~~~~h~di~~~ni~~~   98 (175)
                        +|.|||. .|+||.||||+||++.
T Consensus       197 L~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  197 LTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             HHHHHHHHHhcCccccCCCcceeeee
Confidence              9999995 7999999999999983

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=1e-19  Score=134.27  Aligned_cols=159  Identities=43%  Similarity=0.714  Sum_probs=137.7

Q ss_pred             hhhhHHHHHHHHhhCCCC-CeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHH--HHHHHHH
Q 030527            9 LKSCLDCELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ....+.+|.+++..+.|+ +++++.+.+...+..+++++++.++++.+++....   .++......+..|+  +++++|+
T Consensus        40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~  119 (384)
T COG0515          40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS  119 (384)
T ss_pred             HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            456788899999999888 79999999988888899999999999998877664   78999999999998  8999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCc-eEEEeeecceeeccCCC-------ccccccCCCCccCcccccc---cCCCcchhHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGN-------YAEKVCGSPLYMAPEVLQF---QRYDEKVDMWS  151 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~-~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~s  151 (175)
                      .+++|+|++|+|+++   +... .++++|||.+.......       ......++..|.+||...+   ...+...|+||
T Consensus       120 ~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s  196 (384)
T COG0515         120 KGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS  196 (384)
T ss_pred             CCeeccCCCHHHeee---cCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHH
Confidence            999999999999999   4555 79999999987554432       2356678899999999987   57889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC
Q 030527          152 VGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       152 lg~~~~~~~~g~~pf~~~~  170 (175)
                      +|++++++++|..||....
T Consensus       197 ~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         197 LGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             HHHHHHHHHhCCCCCCCCC
Confidence            9999999999999987665

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.85  E-value=1.4e-22  Score=157.03  Aligned_cols=157  Identities=32%  Similarity=0.588  Sum_probs=136.7

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .+...-+++|+-+++.++||||+.+++.+..+...++.||||.|++|.+.=.--+++++.++....++.  +++|||+.|
T Consensus        53 ~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g  132 (829)
T KOG0576|consen   53 GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG  132 (829)
T ss_pred             CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC
Confidence            344566788999999999999999999999999999999999999999976656889999998888886  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccc---cccCCCcchhHHHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVL---QFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~---~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      =+|||||-.|+++   ...+.+++.|||.+..+... .......||+.|+|||+.   +.+.|...+|+|++|+...++.
T Consensus       133 k~hRdiKGanill---td~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~  209 (829)
T KOG0576|consen  133 KIHRDIKGANILL---TDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELG  209 (829)
T ss_pred             cccccccccceee---cccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhh
Confidence            9999999999999   57788999999998776543 345678899999999986   4567999999999999999887


Q ss_pred             hCCCCC
Q 030527          161 NGYPPF  166 (175)
Q Consensus       161 ~g~~pf  166 (175)
                      .-+.|.
T Consensus       210 eLqppl  215 (829)
T KOG0576|consen  210 ELQPPL  215 (829)
T ss_pred             hcCCcc
Confidence            777764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=1.2e-18  Score=120.82  Aligned_cols=143  Identities=18%  Similarity=0.172  Sum_probs=107.0

Q ss_pred             hhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ..+.+|++++++| .++++++++++    +..+++|+|+.|.+|.+.....       ...++.|+  +++++|+.|++|
T Consensus        46 ~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~~-------~~~~~~qi~~~L~~lH~~GIvH  114 (218)
T PRK12274         46 WLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPRG-------DLAYFRAARRLLQQLHRCGVAH  114 (218)
T ss_pred             HHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhhh-------hHHHHHHHHHHHHHHHHCcCcc
Confidence            3688999999999 56889999886    4468999999999987643211       12355565  899999999999


Q ss_pred             cCC-CCCcEEEeecCCCceEEEeeecceeeccCCCc--------------cccccCCCCccCcccccc-cCCC-cchhHH
Q 030527           88 RDL-KPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------------AEKVCGSPLYMAPEVLQF-QRYD-EKVDMW  150 (175)
Q Consensus        88 ~di-~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--------------~~~~~~~~~~~~pe~~~~-~~~~-~~~Di~  150 (175)
                      +|| +|.||++   +.++.++|+|||++........              .....+++.++.|+...- ..++ ...+-+
T Consensus       115 rDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~  191 (218)
T PRK12274        115 NDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWF  191 (218)
T ss_pred             CCCCCcceEEE---cCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHH
Confidence            999 7999999   4667899999999986654432              112345677777764432 2344 567888


Q ss_pred             HHHHHHHHHHhCCCCCC
Q 030527          151 SVGAILFELLNGYPPFS  167 (175)
Q Consensus       151 slg~~~~~~~~g~~pf~  167 (175)
                      +.|+-+|.++|+..|+.
T Consensus       192 ~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        192 ATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HhcchHHHHHhccCCcc
Confidence            99999999999877654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=3.6e-19  Score=133.87  Aligned_cols=118  Identities=22%  Similarity=0.234  Sum_probs=89.0

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      .+..+.+|++++++++|+|+++.+..   .+..++||||++|++|... .   ....   ..++.++  +|++||+.|++
T Consensus        64 ~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~~-~---~~~~---~~~~~~i~~aL~~lH~~gIi  133 (365)
T PRK09188         64 ARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHLA-R---PHGD---PAWFRSAHRALRDLHRAGIT  133 (365)
T ss_pred             HHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHHh-C---ccch---HHHHHHHHHHHHHHHHCCCe
Confidence            45678999999999999999853322   2457999999999999632 1   1111   3566676  99999999999


Q ss_pred             ecCC-CCCcEEEeecCCCceEEEeeecceeeccCCCcc---------ccccCCCCccCccccc
Q 030527           87 HRDL-KPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---------EKVCGSPLYMAPEVLQ  139 (175)
Q Consensus        87 h~di-~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~---------~~~~~~~~~~~pe~~~  139 (175)
                      |||| ||+||++   +.++.++|+|||+++........         ....++..|.+||.+.
T Consensus       134 HrDL~KP~NILv---~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        134 HNDLAKPQNWLM---GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             eCCCCCcceEEE---cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            9999 9999999   45678999999999877544311         1234566788999874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=1.6e-20  Score=149.23  Aligned_cols=154  Identities=36%  Similarity=0.587  Sum_probs=128.2

Q ss_pred             HHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCC
Q 030527           13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDL   90 (175)
Q Consensus        13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di   90 (175)
                      +..|.-+=..++|+|++..+....+.....-.||||++ +|..++...+.+....+.-+++|+  +++|+|+.|+.|+|+
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl  446 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL  446 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence            44566666678999998777776665555555999999 999999988789999999999998  999999999999999


Q ss_pred             CCCcEEEeecCCCceEEEeeecceeeccCCCc-----cccccCCCCccCcccccccCCCc-chhHHHHHHHHHHHHhCCC
Q 030527           91 KPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDE-KVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        91 ~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~-~~Di~slg~~~~~~~~g~~  164 (175)
                      |++|+++   ...+.++++|||.+.-...+-.     .....|+..|+|||.+.+.+|.+ ..|+||.|+++..|.+|+.
T Consensus       447 K~enll~---~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~  523 (601)
T KOG0590|consen  447 KLENLLV---TENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF  523 (601)
T ss_pred             ccccEEE---ecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence            9999999   5777999999998866544321     23456788899999999999876 4999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||....
T Consensus       524 ~Wk~a~  529 (601)
T KOG0590|consen  524 PWKVAK  529 (601)
T ss_pred             cccccc
Confidence            996543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.79  E-value=2.6e-19  Score=126.26  Aligned_cols=125  Identities=16%  Similarity=0.245  Sum_probs=93.3

Q ss_pred             HHHHHHHHhhCCCCCeeeEeeEEeeC--------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527           13 LDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        13 ~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      +++|++.+.++.||+|+.+.+++...        +..+++|||++|.+|.++.    .+++..    ..++  +++.+|+
T Consensus        82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~~----~~~i~~~l~~lH~  153 (232)
T PRK10359         82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISEDV----KAKIKASIESLHQ  153 (232)
T ss_pred             HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccHHH----HHHHHHHHHHHHH
Confidence            68899999999999999999886543        3578999999999998873    233332    3344  8999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      .|++|||++|+|+++.   .++ ++++|||.............           ......+..++|+||||+++....
T Consensus       154 ~gi~H~Dikp~Nili~---~~g-i~liDfg~~~~~~e~~a~d~-----------~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        154 HGMVSGDPHKGNFIVS---KNG-LRIIDLSGKRCTAQRKAKDR-----------IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cCCccCCCChHHEEEe---CCC-EEEEECCCcccccchhhHHH-----------HHHHhHhcccccccceeEeehHHH
Confidence            9999999999999994   445 99999997755422211111           222334567899999999876543

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=1.7e-17  Score=116.39  Aligned_cols=105  Identities=23%  Similarity=0.409  Sum_probs=81.3

Q ss_pred             hhhhHHHHHHHHhhC-----CCCCeeeEeeEEeeCC---eEE-EEEec--cCCCChHHHHHhcCCCCHHHHHHHHHH-H-
Q 030527            9 LKSCLDCELNFLSSV-----NHPNIIRLFDAFQAEN---CIF-LVVEF--CAGGNLSSYIRLHGRVPEQTARKFLQQ-L-   75 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-lv~e~--~~~~~L~~~l~~~~~l~~~~~~~~~~~-i-   75 (175)
                      ..+.+.+|+++++++     .||||+++++++.++.   ..+ +|+||  +.+++|.+++++. .+++. + .++.+ + 
T Consensus        39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~-~-~~~~~~L~  115 (210)
T PRK10345         39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED-V-AQLRQLLK  115 (210)
T ss_pred             hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh-H-HHHHHHHH
Confidence            456789999999999     5799999999998873   433 78999  4478999999764 56665 2 34444 4 


Q ss_pred             HH-HHHHHcCCeecCCCCCcEEEeecC-CCceEEEee-ecceee
Q 030527           76 GL-EILNSHHIIHRDLKPENILLSGLD-DDVMLKIAD-FGLSCT  116 (175)
Q Consensus        76 ~l-~~lh~~~~~h~di~~~ni~~~~~~-~~~~~~l~d-f~~~~~  116 (175)
                      ++ +|||+.+++|+||||+||++...+ .+..++|+| ||....
T Consensus       116 ~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~~  159 (210)
T PRK10345        116 KLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGESTF  159 (210)
T ss_pred             HHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcce
Confidence            65 999999999999999999996333 344799999 565443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.74  E-value=1.8e-17  Score=114.87  Aligned_cols=99  Identities=23%  Similarity=0.231  Sum_probs=79.2

Q ss_pred             HHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH-HHcCCeecCC
Q 030527           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL-NSHHIIHRDL   90 (175)
Q Consensus        14 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l-h~~~~~h~di   90 (175)
                      ..|.+.++++.++++.....+...  ..++||||++|+++.....+.+.++...+..++.|+  +++++ |+.|++|+|+
T Consensus        67 ~~E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDl  144 (190)
T cd05147          67 EKEMRNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADL  144 (190)
T ss_pred             HHHHHHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            459999999988887544433222  238999999887776654445689999999999998  99999 7999999999


Q ss_pred             CCCcEEEeecCCCceEEEeeecceeecc
Q 030527           91 KPENILLSGLDDDVMLKIADFGLSCTLY  118 (175)
Q Consensus        91 ~~~ni~~~~~~~~~~~~l~df~~~~~~~  118 (175)
                      ||+||+++    ++.++|+|||++....
T Consensus       145 kP~NIli~----~~~v~LiDFG~a~~~~  168 (190)
T cd05147         145 SEYNLLYH----DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CHHHEEEE----CCcEEEEEccccccCC
Confidence            99999994    3579999999987553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.72  E-value=3e-18  Score=132.62  Aligned_cols=147  Identities=34%  Similarity=0.525  Sum_probs=131.3

Q ss_pred             HHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCC
Q 030527           14 DCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDL   90 (175)
Q Consensus        14 ~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di   90 (175)
                      ..|-.++...+ ||.++.+...++.++..+++.++..|+.+...+.+...+.+........++  +++.+|+.+++|+|+
T Consensus        44 ~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~  123 (612)
T KOG0603|consen   44 KQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDY  123 (612)
T ss_pred             ccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcc
Confidence            44777888885 999999999999999999999999999999998888888888888888886  999999999999999


Q ss_pred             CCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030527           91 KPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV  168 (175)
Q Consensus        91 ~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~  168 (175)
                      |++||++   +.++.+++.|||.++..-..+..   .|+..|+|||++.  ....++|-||+|++.+++++|-.||..
T Consensus       124 k~enill---d~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  124 KLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             cccceee---cccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            9999999   78999999999998776554433   7899999999997  678889999999999999999999987

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.72  E-value=1.8e-18  Score=140.81  Aligned_cols=144  Identities=22%  Similarity=0.311  Sum_probs=112.7

Q ss_pred             HhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEE
Q 030527           20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILL   97 (175)
Q Consensus        20 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~   97 (175)
                      +...++||++++--+...++..|+|.+|. ..+|.|.+..+.-+...+..-|+.|+  |+..+|.+|+.|||||.+||++
T Consensus        75 ~~l~~~pn~lPfqk~~~t~kAAylvRqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi  153 (1431)
T KOG1240|consen   75 FALMKAPNCLPFQKVLVTDKAAYLVRQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI  153 (1431)
T ss_pred             HHhhcCCcccchHHHHHhhHHHHHHHHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE
Confidence            45559999999988888888889999998 66999999877667777777778887  9999999999999999999999


Q ss_pred             eecCCCceEEEeeecceeeccCCCccc--------cccCCCCccCcccccc----------cC-CCcchhHHHHHHHHHH
Q 030527           98 SGLDDDVMLKIADFGLSCTLYPGNYAE--------KVCGSPLYMAPEVLQF----------QR-YDEKVDMWSVGAILFE  158 (175)
Q Consensus        98 ~~~~~~~~~~l~df~~~~~~~~~~~~~--------~~~~~~~~~~pe~~~~----------~~-~~~~~Di~slg~~~~~  158 (175)
                         ..=+++.|+||...+...-+...+        +......|.|||..-.          .+ .+++.||||+||+++|
T Consensus       154 ---TSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaE  230 (1431)
T KOG1240|consen  154 ---TSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAE  230 (1431)
T ss_pred             ---eeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHH
Confidence               477889999997664322111111        1222345999997632          12 5789999999999999


Q ss_pred             HHh-CCCCCC
Q 030527          159 LLN-GYPPFS  167 (175)
Q Consensus       159 ~~~-g~~pf~  167 (175)
                      +++ |.+||.
T Consensus       231 Lf~Eg~PlF~  240 (1431)
T KOG1240|consen  231 LFLEGRPLFT  240 (1431)
T ss_pred             HHhcCCCccc
Confidence            988 799994

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.71  E-value=1.2e-16  Score=110.86  Aligned_cols=101  Identities=20%  Similarity=0.175  Sum_probs=80.6

Q ss_pred             HHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH-cCCeecC
Q 030527           13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-HHIIHRD   89 (175)
Q Consensus        13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~-~~~~h~d   89 (175)
                      +..|.+.+.++.++++.....+....  .++||||++|+++.........++......++.++  ++.++|+ .|++|+|
T Consensus        66 ~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrD  143 (190)
T cd05145          66 AEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGD  143 (190)
T ss_pred             HHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence            46789999999999886554443332  47999999887654443334678888899999998  9999999 9999999


Q ss_pred             CCCCcEEEeecCCCceEEEeeecceeeccC
Q 030527           90 LKPENILLSGLDDDVMLKIADFGLSCTLYP  119 (175)
Q Consensus        90 i~~~ni~~~~~~~~~~~~l~df~~~~~~~~  119 (175)
                      ++|.||+++    ++.++|+|||++.....
T Consensus       144 lkP~NIll~----~~~~~liDFG~a~~~~~  169 (190)
T cd05145         144 LSEYNILYH----DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CChhhEEEE----CCCEEEEEcccceecCC
Confidence            999999993    56799999999977643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.70  E-value=2.8e-17  Score=116.65  Aligned_cols=162  Identities=23%  Similarity=0.385  Sum_probs=125.5

Q ss_pred             cccchhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHH--HHH
Q 030527            3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLE   78 (175)
Q Consensus         3 k~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~i--~l~   78 (175)
                      +.+.....+.|.+|.-.++.+.||||+++++.+.....+.++..|++.++|...+.....  .+..++.+...++  +++
T Consensus       224 r~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargma  303 (448)
T KOG0195|consen  224 REVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMA  303 (448)
T ss_pred             hhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHH
Confidence            345667778999999999999999999999999999999999999999999999876543  5667777777777  899


Q ss_pred             HHHHcC--CeecCCCCCcEEEeecCCCceEE--EeeecceeeccCCCccccccCCCCccCcccccccCC---CcchhHHH
Q 030527           79 ILNSHH--IIHRDLKPENILLSGLDDDVMLK--IADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY---DEKVDMWS  151 (175)
Q Consensus        79 ~lh~~~--~~h~di~~~ni~~~~~~~~~~~~--l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~---~~~~Di~s  151 (175)
                      |||+..  +.-.-++..++++   +++-+.+  ..|--++-      ......+.+.|++||.+..++.   -.++|+||
T Consensus       304 flhslep~ipr~~lns~hvmi---dedltarismad~kfsf------qe~gr~y~pawmspealqrkped~n~raadmws  374 (448)
T KOG0195|consen  304 FLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSF------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWS  374 (448)
T ss_pred             HHhhcchhhhhhhcccceEEe---cchhhhheecccceeee------eccccccCcccCCHHHHhcCchhcchhhhhHHH
Confidence            999875  4445677788888   4443333  33322211      1223446788999999987664   34699999


Q ss_pred             HHHHHHHHHhCCCCCCCCCccC
Q 030527          152 VGAILFELLNGYPPFSVGEEHQ  173 (175)
Q Consensus       152 lg~~~~~~~~g~~pf~~~~~~~  173 (175)
                      |++++||+-|...||.+.++.+
T Consensus       375 faillwel~trevpfadlspme  396 (448)
T KOG0195|consen  375 FAILLWELNTREVPFADLSPME  396 (448)
T ss_pred             HHHHHHHhhccccccccCCchh
Confidence            9999999999999999887765

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=9e-16  Score=114.05  Aligned_cols=144  Identities=33%  Similarity=0.490  Sum_probs=108.9

Q ss_pred             CCCCeeeEeeEEee---------------------------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH-
Q 030527           24 NHPNIIRLFDAFQA---------------------------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL-   75 (175)
Q Consensus        24 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i-   75 (175)
                      +||||+.+..+|.+                           ..+.|+||... ..+|..++..+. .+.-...-++.|+ 
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-CchHHHHHHHHHHH
Confidence            69999999877632                           24678999876 569999988554 4455566677777 


Q ss_pred             -HHHHHHHcCCeecCCCCCcEEEe-ecCCCceEEEeeecceeeccCCCc-------cccccCCCCccCcccccccCC---
Q 030527           76 -GLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLSCTLYPGNY-------AEKVCGSPLYMAPEVLQFQRY---  143 (175)
Q Consensus        76 -~l~~lh~~~~~h~di~~~ni~~~-~~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~~~---  143 (175)
                       ++.+||.+|+.|+|+|.+||++. +.|.-..+.+.|||++-...+...       .-...|+...+|||+....+-   
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence             99999999999999999999995 334566789999999865543211       112446677899998742221   


Q ss_pred             ---CcchhHHHHHHHHHHHHhCCCCCCCC
Q 030527          144 ---DEKVDMWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus       144 ---~~~~Di~slg~~~~~~~~g~~pf~~~  169 (175)
                         -.++|.|+.|.+.||+++..+||..+
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~r  460 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKR  460 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCccccc
Confidence               13689999999999999999999774

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.67  E-value=2.3e-17  Score=125.52  Aligned_cols=116  Identities=36%  Similarity=0.622  Sum_probs=101.0

Q ss_pred             eEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecce
Q 030527           40 CIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS  114 (175)
Q Consensus        40 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~  114 (175)
                      +.++.|++|...+|.+|+.+..   ..+......++.|+  ++.|   +|.+|+|++|.||++.   .+..++|.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhhe
Confidence            5789999999999999997543   46777888899998  8888   9999999999999994   5557999999999


Q ss_pred             eeccCCC-------ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527          115 CTLYPGN-------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus       115 ~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      .......       ......||..|++||.+.+..|+.++||||||++++|++.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            8876655       3446778999999999999999999999999999999887

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.66  E-value=1.7e-16  Score=115.24  Aligned_cols=124  Identities=24%  Similarity=0.372  Sum_probs=83.8

Q ss_pred             EEEEeccCCCChHHHHHh---cCC----CCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeec
Q 030527           42 FLVVEFCAGGNLSSYIRL---HGR----VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG  112 (175)
Q Consensus        42 ~lv~e~~~~~~L~~~l~~---~~~----l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~  112 (175)
                      +++|+-+ ..+|.+.+.-   ...    +.......+-.|+  .+++||+.|++|+||+|+|+++   +.++.+.|+||+
T Consensus       115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll---~~~G~v~Lg~F~  190 (288)
T PF14531_consen  115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLL---DQDGGVFLGDFS  190 (288)
T ss_dssp             EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----TTS-EEE--GG
T ss_pred             hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEE---cCCCCEEEcChH
Confidence            6677766 5688877542   222    2222223344555  8899999999999999999999   688999999999


Q ss_pred             ceeeccCCCccccccCCCCccCcccccc--------cCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          113 LSCTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       113 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ...+.+.....  ...+..|.|||....        ..++.+.|.|+||+++|.++++..||+..++
T Consensus       191 ~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~  255 (288)
T PF14531_consen  191 SLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSP  255 (288)
T ss_dssp             GEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGG
T ss_pred             HHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCc
Confidence            88777544332  334577899997643        2478899999999999999999999987654

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=2.3e-16  Score=129.27  Aligned_cols=146  Identities=26%  Similarity=0.343  Sum_probs=118.2

Q ss_pred             HHHhhCC---CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCC
Q 030527           18 NFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKP   92 (175)
Q Consensus        18 ~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~   92 (175)
                      +++.+|+   -+.|.++...+...+.-++|++|.+.|+|.++++..+.+++..+..+..|+  .++.||..+||||||||
T Consensus       743 q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKP  822 (974)
T KOG1166|consen  743 QVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKP  822 (974)
T ss_pred             HHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCc
Confidence            3444444   345556666666777778999999999999999977889999999999998  89999999999999999


Q ss_pred             CcEEEee----cCCCceEEEeeecceeeccC---CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           93 ENILLSG----LDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        93 ~ni~~~~----~~~~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +|+++..    ......++|+|||.+.....   +.+-.....+-.+-++|+..+.+++...|.|.++-+++.|+.|+
T Consensus       823 DNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  823 DNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            9999952    12244589999999865532   22233455677789999999999999999999999999999884

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.63  E-value=9.4e-16  Score=118.06  Aligned_cols=147  Identities=27%  Similarity=0.455  Sum_probs=120.9

Q ss_pred             HhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC-eecCCCCCcE
Q 030527           20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI-IHRDLKPENI   95 (175)
Q Consensus        20 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~-~h~di~~~ni   95 (175)
                      ++++.|.|+.++.+.+.+.+..+.|.++|..|+|.+.+... ..++.-.....++++  +++|+|.-.+ .|+.++..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            46789999999999999999999999999999999999863 467777888888888  9999997654 9999999999


Q ss_pred             EEeecCCCceEEEeeecceeeccC---CCccccccCCCCccCccccccc-------CCCcchhHHHHHHHHHHHHhCCCC
Q 030527           96 LLSGLDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQFQ-------RYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        96 ~~~~~~~~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~-------~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      ++   +..-.+++.|||+......   ...........-|.|||.++..       ..+++.|+||+|++++++++.+.|
T Consensus        81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99   5777799999998866632   1111222234568999998753       147789999999999999999999


Q ss_pred             CCCC
Q 030527          166 FSVG  169 (175)
Q Consensus       166 f~~~  169 (175)
                      |+..
T Consensus       158 ~~~~  161 (484)
T KOG1023|consen  158 FDLR  161 (484)
T ss_pred             cccc
Confidence            9874

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.62  E-value=3.6e-15  Score=105.00  Aligned_cols=99  Identities=23%  Similarity=0.298  Sum_probs=84.2

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      .++.+|++++..+.+++++....++.+.+..+++|||++|++|.+++.....    ....++.++  +++++|+.|++|+
T Consensus        44 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~  119 (211)
T PRK14879         44 ERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHG  119 (211)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccC
Confidence            4577899999999999998777777777788999999999999999875432    667777887  8999999999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      |++|.|+++.    .+.++++|||.+...
T Consensus       120 Dl~p~Nil~~----~~~~~liDf~~a~~~  144 (211)
T PRK14879        120 DLTTSNMILS----GGKIYLIDFGLAEFS  144 (211)
T ss_pred             CCCcccEEEE----CCCEEEEECCcccCC
Confidence            9999999994    567899999988654

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.59  E-value=9.7e-15  Score=116.00  Aligned_cols=96  Identities=20%  Similarity=0.262  Sum_probs=82.1

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ..++.+|++++++++|++++.+..+.......++||||++|++|.+++.        ....++.++  ++++||+.|++|
T Consensus       380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiH  451 (535)
T PRK09605        380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVH  451 (535)
T ss_pred             HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCcc
Confidence            3567889999999999999988777777777899999999999999876        234566777  899999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      +|++|+||++    .++.++++|||++...
T Consensus       452 rDlkp~NILl----~~~~~~liDFGla~~~  477 (535)
T PRK09605        452 GDLTTSNFIV----RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCCChHHEEE----ECCcEEEEeCcccccC
Confidence            9999999999    3456899999998765

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.58  E-value=9.6e-15  Score=101.94  Aligned_cols=96  Identities=23%  Similarity=0.270  Sum_probs=78.5

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      .++.+|.++++.++++++.....+....+..+++||+++|++|.+++.....       .++.++  +++++|+.|++|+
T Consensus        42 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~  114 (199)
T TIGR03724        42 ERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHG  114 (199)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecC
Confidence            5667899999999888776655555666667899999999999998764321       566666  8999999999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      |++|.|+++.    ++.++++|||.+...
T Consensus       115 Dl~~~Nil~~----~~~~~liDfg~a~~~  139 (199)
T TIGR03724       115 DLTTSNIIVR----DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCCcceEEEE----CCcEEEEECCCCcCC
Confidence            9999999993    577999999987664

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=2.7e-14  Score=102.39  Aligned_cols=103  Identities=19%  Similarity=0.223  Sum_probs=78.2

Q ss_pred             hhhHHHHHHHHhhCCCCCe--eeEeeEEeeCC----eEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNI--IRLFDAFQAEN----CIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNS   82 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~----~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~~~~~i~l~~lh~   82 (175)
                      +.++.+|++++..++|+++  +.++++.....    ..++|+|+++| .+|.+++.+ .++++.....++.  +++++|+
T Consensus        84 ~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~~~~i~~--~l~~lH~  160 (239)
T PRK01723         84 RTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQWQAIGQ--LIARFHD  160 (239)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHHHHHHHH--HHHHHHH
Confidence            4567889999999998885  56666644322    23599999987 689888764 4566654333222  8999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeecc
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY  118 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~  118 (175)
                      .|++|+|++|.||++   +.++.++|+|||.+....
T Consensus       161 ~GI~HrDlkp~NILv---~~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        161 AGVYHADLNAHNILL---DPDGKFWLIDFDRGELRT  193 (239)
T ss_pred             CCCCCCCCCchhEEE---cCCCCEEEEECCCcccCC
Confidence            999999999999999   455679999999886653

>smart00090 RIO RIO-like kinase

Probab=99.57  E-value=1.4e-14  Score=103.79  Aligned_cols=102  Identities=21%  Similarity=0.209  Sum_probs=79.7

Q ss_pred             hhHHHHHHHHhhCCCCC--eeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC-C
Q 030527           11 SCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH-I   85 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~-~   85 (175)
                      ..+..|++.++++.+.+  +++++++    +..++|||++.|.++..+......+....+..++.|+  ++++||+.| +
T Consensus        95 ~~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~i  170 (237)
T smart00090       95 LWAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGEL  170 (237)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCE
Confidence            34678999999997543  4444443    2358999999998887765445566777778889998  999999999 9


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG  120 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~  120 (175)
                      +|+|++|+||++.    ++.++++|||.+.....+
T Consensus       171 iH~Dikp~NIli~----~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      171 VHGDLSEYNILVH----DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             EeCCCChhhEEEE----CCCEEEEEChhhhccCCc
Confidence            9999999999993    567999999988765443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.45  E-value=4.9e-14  Score=115.07  Aligned_cols=112  Identities=38%  Similarity=0.661  Sum_probs=90.6

Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC------------
Q 030527           54 SSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------  121 (175)
Q Consensus        54 ~~~l~~~~~l~~~~~~~~~~~i~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~------------  121 (175)
                      ...++.-++++.+.+.      +++|+|+-|++|+|++|+|.++   ..-+.+++.|||+.+......            
T Consensus       139 ~tllk~~g~lPvdmvl------a~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~  209 (1205)
T KOG0606|consen  139 ATLLKNIGPLPVDMVL------AVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKD  209 (1205)
T ss_pred             hhhcccCCCCcchhhH------HhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhccchhhhcchHHH
Confidence            3444444556655411      8999999999999999999999   578889999999986542211            


Q ss_pred             ----ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCccCC
Q 030527          122 ----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF  174 (175)
Q Consensus       122 ----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~~~~  174 (175)
                          ......+|+.|.|||++....|+...|=|++|+++|+.+-|..||.+.+++++
T Consensus       210 t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel  266 (1205)
T KOG0606|consen  210 THEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL  266 (1205)
T ss_pred             HHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence                01245789999999999999999999999999999999999999999877664

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.43  E-value=1.1e-12  Score=88.72  Aligned_cols=98  Identities=20%  Similarity=0.179  Sum_probs=76.4

Q ss_pred             hHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHcCCeecCCC
Q 030527           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLK   91 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~l~~lh~~~~~h~di~   91 (175)
                      +-.+|++++.+++--+++...-+..+.....++|||.+|..|.+.+...   .......+-.  -+.-||..|++|||++
T Consensus        45 Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~---~~~~~r~vG~--~vg~lH~~givHGDLT  119 (204)
T COG3642          45 RTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---RPDLLREVGR--LVGKLHKAGIVHGDLT  119 (204)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc---chHHHHHHHH--HHHHHHhcCeecCCCc
Confidence            4477999999998778876666666777778999999999999998865   2233333333  5688999999999999


Q ss_pred             CCcEEEeecCCCceEEEeeecceeecc
Q 030527           92 PENILLSGLDDDVMLKIADFGLSCTLY  118 (175)
Q Consensus        92 ~~ni~~~~~~~~~~~~l~df~~~~~~~  118 (175)
                      ++|+.++    +..+.++|||++....
T Consensus       120 tsNiIl~----~~~i~~IDfGLg~~s~  142 (204)
T COG3642         120 TSNIILS----GGRIYFIDFGLGEFSD  142 (204)
T ss_pred             cceEEEe----CCcEEEEECCcccccc
Confidence            9999994    3449999999987543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.42  E-value=1.6e-14  Score=115.27  Aligned_cols=155  Identities=34%  Similarity=0.579  Sum_probs=129.4

Q ss_pred             HHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHH-HhcC-CCCHHHHHHHHHHH--HHHHHH-HcCCee
Q 030527           14 DCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHG-RVPEQTARKFLQQL--GLEILN-SHHIIH   87 (175)
Q Consensus        14 ~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~~-~l~~~~~~~~~~~i--~l~~lh-~~~~~h   87 (175)
                      ..|..+-+.+. |+|++.+++........+++.++..|+++.+-+ .... ..+....-..+.|+  ++.|+| ..++.|
T Consensus        68 ~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h  147 (601)
T KOG0590|consen   68 DTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTH  147 (601)
T ss_pred             CccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccccccc
Confidence            34666777775 999999999999999999999999999999888 4443 57777888899998  999999 999999


Q ss_pred             cCCCCCcEEEeecCCCc-eEEEeeecceeeccC-CCc---cccccC-CCCccCccccccc-CCCcchhHHHHHHHHHHHH
Q 030527           88 RDLKPENILLSGLDDDV-MLKIADFGLSCTLYP-GNY---AEKVCG-SPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~-~~~l~df~~~~~~~~-~~~---~~~~~~-~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~  160 (175)
                      +|++|+|.++   +..+ .+++.|||+|..... ...   .....| +..|.+||...+. ...+..|+||+|+++..++
T Consensus       148 ~~ikP~n~~l---~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~  224 (601)
T KOG0590|consen  148 RDIKPSNSLL---DESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAML  224 (601)
T ss_pred             CCCCCccchh---ccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccc
Confidence            9999999998   4555 899999999987766 322   234556 8899999998874 4577899999999999999


Q ss_pred             hCCCCCCCCCc
Q 030527          161 NGYPPFSVGEE  171 (175)
Q Consensus       161 ~g~~pf~~~~~  171 (175)
                      +|..||.....
T Consensus       225 ~g~~p~~~~~~  235 (601)
T KOG0590|consen  225 TGELPWDFPSR  235 (601)
T ss_pred             cCCCCcccccc
Confidence            99999976543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.41  E-value=8.4e-13  Score=87.53  Aligned_cols=96  Identities=23%  Similarity=0.363  Sum_probs=78.3

Q ss_pred             hhHHHHHHHHhhCCC--CCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc---
Q 030527           11 SCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH---   83 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~---   83 (175)
                      ..+..|.++++.+++  ..+++++.+....+..++++||+.|.++..+       +......+..++  +++.+|..   
T Consensus        36 ~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~  108 (155)
T cd05120          36 ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLL  108 (155)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCce
Confidence            578899999999966  5899999888888889999999988777654       344445556666  78999974   


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceee
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~  116 (175)
                      +++|+|++|.|+++.   ..+.++++||+.+..
T Consensus       109 ~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~  138 (155)
T cd05120         109 VLCHGDLHPGNILVD---DGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence            699999999999994   467899999997643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.41  E-value=1e-12  Score=91.80  Aligned_cols=94  Identities=26%  Similarity=0.301  Sum_probs=71.6

Q ss_pred             hHHHHHHHHhhCCCCC--eeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           12 CLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ....|..++..+.+++  ++.+++    .+..+++|||++|++|......      .....++.++  ++.++|+.|++|
T Consensus        79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H  148 (198)
T cd05144          79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIH  148 (198)
T ss_pred             HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCc
Confidence            4677899999997774  444433    2456899999999988765331      2334555666  889999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeecc
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLY  118 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~  118 (175)
                      +|++|.||++   +.++.++|+|||.+....
T Consensus       149 ~Dl~p~Nill---~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         149 GDLSEFNILV---DDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCCCcccEEE---cCCCcEEEEECCccccCC
Confidence            9999999999   467889999999886553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.40  E-value=4.2e-12  Score=99.89  Aligned_cols=143  Identities=22%  Similarity=0.363  Sum_probs=108.5

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH-HcCCee
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN-SHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh-~~~~~h   87 (175)
                      ....+.+..++.++||||+++++.++..++.|+|+|...  .|..++++.+   ...+.-.+.||  ||.+|| +.+++|
T Consensus        54 ~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvH  128 (690)
T KOG1243|consen   54 ELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVH  128 (690)
T ss_pred             HHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeee
Confidence            456777888999999999999999999999999999873  6777777554   55666667777  999998 678999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +++.-..|++   +..+..+|.+|..+........ .......-.|..|+.+....  -..|.|.||+++++++.|.
T Consensus       129 gNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  129 GNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence            9999999999   6889999999988866543321 11111122245554432222  3479999999999999993

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.39  E-value=3.5e-12  Score=86.24  Aligned_cols=110  Identities=21%  Similarity=0.247  Sum_probs=85.8

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCC-CChHHHHHhcCC--CCHHHHHHHHHHH--HHHHHHHc
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGR--VPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~--l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      .+.+..+|++++.++.--+|.-..-++.+.....++|||+.| .++.+++.....  -........++.+  .+.-||..
T Consensus        53 tr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n  132 (229)
T KOG3087|consen   53 TRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN  132 (229)
T ss_pred             HHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC
Confidence            356778899999999777888777788888888899999976 588888876532  2222335666667  78999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeecc
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY  118 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~  118 (175)
                      +++|||++.+|+++.+.+....+.++|||++....
T Consensus       133 diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~  167 (229)
T KOG3087|consen  133 DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR  167 (229)
T ss_pred             CeecccccccceEEecCCCcCceEEEeecchhccc
Confidence            99999999999999754555557999999886553

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.32  E-value=1.2e-11  Score=85.60  Aligned_cols=97  Identities=15%  Similarity=0.185  Sum_probs=69.7

Q ss_pred             HHHHHHHhhCCCC--CeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH-HHcCCeec
Q 030527           14 DCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL-NSHHIIHR   88 (175)
Q Consensus        14 ~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l-h~~~~~h~   88 (175)
                      +.|.+.|+++...  .+++++++    ...++|||++.++.+....-+...++......+..++  ++..+ |..|++||
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHG  149 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHA  149 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            3799999999544  45555544    4567999999665443222222345555666667776  78877 89999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeecc
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLY  118 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~  118 (175)
                      |+++.||++.    ++.+.++|||.+....
T Consensus       150 DLs~~NIL~~----~~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWH----DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEE----CCcEEEEECCCceeCC
Confidence            9999999994    3569999999876654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.24  E-value=6.8e-11  Score=91.76  Aligned_cols=104  Identities=23%  Similarity=0.238  Sum_probs=70.3

Q ss_pred             HHHHHHHHhhC-----CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHcCCe
Q 030527           13 LDCELNFLSSV-----NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGLEILNSHHII   86 (175)
Q Consensus        13 ~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~l~~lh~~~~~   86 (175)
                      +.+|++-+.++     .++++.-..-+....+..++||||+.|.+|.+..... ...+...+.....+..+..+|..|++
T Consensus       200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~  279 (437)
T TIGR01982       200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFF  279 (437)
T ss_pred             HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCce
Confidence            44455555544     2444443333334455678999999999998876532 22333333222222257889999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  119 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~  119 (175)
                      |+|++|.|+++   +.++.++++|||++....+
T Consensus       280 H~D~hPgNilv---~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       280 HADLHPGNIFV---LKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence            99999999999   5677899999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.22  E-value=1.5e-10  Score=84.22  Aligned_cols=105  Identities=16%  Similarity=0.140  Sum_probs=78.9

Q ss_pred             hHHHHHHHHhhCCCCCee--eEeeEEee-----CCeEEEEEeccCCC-ChHHHHHhc--CCCCHHHHHHHHHHH--HHHH
Q 030527           12 CLDCELNFLSSVNHPNII--RLFDAFQA-----ENCIFLVVEFCAGG-NLSSYIRLH--GRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~--~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~   79 (175)
                      .+.+|.+.+.+|...+|.  +++.+...     ....++|+|++++. +|.+++...  .+.+......++.++  .++.
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            377899999888555555  33555543     23568999999875 799988643  345566777888888  8999


Q ss_pred             HHHcCCeecCCCCCcEEEeec----CCCceEEEeeecceee
Q 030527           80 LNSHHIIHRDLKPENILLSGL----DDDVMLKIADFGLSCT  116 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~----~~~~~~~l~df~~~~~  116 (175)
                      ||+.|++|+|++++||++...    +....+.++||+.+..
T Consensus       154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999999999999999999631    2356799999997743

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.18  E-value=1.2e-10  Score=80.39  Aligned_cols=96  Identities=21%  Similarity=0.291  Sum_probs=65.7

Q ss_pred             HHHHHHHhhCCCCC--eeeEeeEEeeCCeEEEEEeccCCCChHH-HHHhcCCCCHHHHHHHHHHH--HHHHHHH-cCCee
Q 030527           14 DCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQL--GLEILNS-HHIIH   87 (175)
Q Consensus        14 ~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~l~~~~~~~~~~~i--~l~~lh~-~~~~h   87 (175)
                      ..|.+.+.++.+.+  ++++++.    ...+++|||++++.+.. .+.... .. .....++.++  ++.++|. .|++|
T Consensus        65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH  138 (187)
T cd05119          65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVH  138 (187)
T ss_pred             HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCc
Confidence            45666777764443  4444433    23589999998844321 111111 11 5566777777  8999999 99999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP  119 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~  119 (175)
                      +|++|+|+++.    ++.++++|||.+.....
T Consensus       139 ~Dl~p~Nili~----~~~~~liDfg~a~~~~~  166 (187)
T cd05119         139 GDLSEYNILVD----DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CCCChhhEEEE----CCcEEEEECcccccccC
Confidence            99999999993    67799999998866543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=5.5e-10  Score=78.49  Aligned_cols=108  Identities=20%  Similarity=0.239  Sum_probs=82.6

Q ss_pred             hhhHHHHHHHHhhCCCCCee--eEeeEEeeCC----eEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNII--RLFDAFQAEN----CIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~--~~~~~~~~~~----~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      +.+..+|.+.+..|..-+|.  +++.+.....    ..++|+|.+++ .+|.+++......+......++.++  .++-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            45677888888888545444  5555655422    45899999987 4799998875556777778888888  79999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      |+.|++|+|+++.||++...+....+.++||+.+...
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999999964333457999999977654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.13  E-value=1.2e-10  Score=79.04  Aligned_cols=92  Identities=24%  Similarity=0.237  Sum_probs=65.4

Q ss_pred             hhHHHHHHHHhhCCCCCee-eEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC--
Q 030527           11 SCLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI--   85 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~--   85 (175)
                      ..+..|+++++.+.+.+++ +++.+..  ...++|||+++|.++.+.    ....    .....++  +++.||+.++  
T Consensus        37 ~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~----~~~~----~~~~~~l~~~l~~LH~~~~~~  106 (170)
T cd05151          37 INRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE----DFSD----PENLEKIAKLLKKLHSSPLPD  106 (170)
T ss_pred             cCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc----cccC----HHHHHHHHHHHHHHhCCCCCC
Confidence            4568899999998655544 4554433  234799999999887653    1111    1233444  7899999885  


Q ss_pred             ---eecCCCCCcEEEeecCCCceEEEeeecceee
Q 030527           86 ---IHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (175)
Q Consensus        86 ---~h~di~~~ni~~~~~~~~~~~~l~df~~~~~  116 (175)
                         +|+|++|.|++++    ++.++++||+.+..
T Consensus       107 ~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~  136 (170)
T cd05151         107 LVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM  136 (170)
T ss_pred             ceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence               9999999999994    45689999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.12  E-value=1.3e-10  Score=90.32  Aligned_cols=151  Identities=30%  Similarity=0.494  Sum_probs=123.9

Q ss_pred             HHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHH------HHHHHHHcCC
Q 030527           14 DCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQL------GLEILNSHHI   85 (175)
Q Consensus        14 ~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~~i------~l~~lh~~~~   85 (175)
                      .+|+.....+ .|++.+.....+...+..++-+|++ +.++.++...... ++...+...+.+.      |+..+|+.++
T Consensus       165 ~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~  243 (524)
T KOG0601|consen  165 LREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNI  243 (524)
T ss_pred             cchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcc
Confidence            4566666666 6999999888999999999999998 7899998876555 7788888777775      8999999999


Q ss_pred             eecCCCCCcEEEeecCCC-ceEEEeeecceeeccCCCccc------cccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           86 IHRDLKPENILLSGLDDD-VMLKIADFGLSCTLYPGNYAE------KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~-~~~~l~df~~~~~~~~~~~~~------~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      +|.|++|.|++..   .+ ...++.|||.....+++....      ...+...|++||... .-++...|++++|-++.+
T Consensus       244 ~~~~~kp~~i~~~---~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~  319 (524)
T KOG0601|consen  244 VHDDLKPANIFTT---SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILE  319 (524)
T ss_pred             cccccchhheecc---cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHh
Confidence            9999999999984   44 678999999999887765322      235677899999875 457888999999999999


Q ss_pred             HHhCCCCCCCC
Q 030527          159 LLNGYPPFSVG  169 (175)
Q Consensus       159 ~~~g~~pf~~~  169 (175)
                      ...+..+...+
T Consensus       320 ~~l~~~~~~~g  330 (524)
T KOG0601|consen  320 AILGSHLPSVG  330 (524)
T ss_pred             hHhhcccccCC
Confidence            99987777655

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=8.1e-10  Score=80.97  Aligned_cols=143  Identities=17%  Similarity=0.290  Sum_probs=103.6

Q ss_pred             HhhCCCCCeeeEeeEEeeCC-----eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHHHHHcC--Ce
Q 030527           20 LSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEILNSHH--II   86 (175)
Q Consensus        20 l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i--~l~~lh~~~--~~   86 (175)
                      +-++-|.|++++..++.+.+     ...++.+|+..+++.+++++-    ..+....-.+|+.|+  ||.|||+..  ++
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            34457999999988876543     568899999999999999754    247788888999999  999999875  99


Q ss_pred             ecCCCCCcEEEeecCCCceEEEee--ecceeeccC---CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           87 HRDLKPENILLSGLDDDVMLKIAD--FGLSCTLYP---GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~d--f~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      |++++.+.++.   ..++-+++..  +......-+   ........+.++|.+|+.=....-+.++|||++|.+..+|.-
T Consensus       201 hgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  201 HGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             cCCcchhheee---cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            99999999998   4455455432  111100000   011123445678888887666667888999999999999987


Q ss_pred             CCCC
Q 030527          162 GYPP  165 (175)
Q Consensus       162 g~~p  165 (175)
                      +..-
T Consensus       278 lEiq  281 (458)
T KOG1266|consen  278 LEIQ  281 (458)
T ss_pred             heec
Confidence            7553

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.96  E-value=6.2e-09  Score=71.86  Aligned_cols=100  Identities=21%  Similarity=0.361  Sum_probs=61.4

Q ss_pred             hhhHHHHHHHHhhCCCCC--eeeEeeEEeeCCeEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHH---HHHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCA--GGNLSSYIRLHGRVPEQTARKFLQQL---GLEILNS   82 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~l~~~~~~~~~~~i---~l~~lh~   82 (175)
                      +...+.|.+.|+++...+  +++++++  .  ...+||||+.  |..+..+....  ++......++.++   ....+|.
T Consensus        52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~--~--~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~  125 (188)
T PF01163_consen   52 REWAKKEFRNLKRLYEAGVPVPKPYDY--N--RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHK  125 (188)
T ss_dssp             HHHHHHHHHHHHHCCCTT-SS--EEEE--E--TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHCCccCCcEEEE--e--CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHh
Confidence            445678999999997765  4555544  2  3469999998  65555443322  1122233344443   3345689


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccC
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  119 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~  119 (175)
                      .|++|||+++.||++.   .+ .+.++|||.+.....
T Consensus       126 ~givHGDLs~~NIlv~---~~-~~~iIDf~qav~~~~  158 (188)
T PF01163_consen  126 AGIVHGDLSEYNILVD---DG-KVYIIDFGQAVDSSH  158 (188)
T ss_dssp             TTEEESS-STTSEEEE---TT-CEEE--GTTEEETTS
T ss_pred             cCceecCCChhhEEee---cc-eEEEEecCcceecCC
Confidence            9999999999999994   33 799999998876643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.91  E-value=1.3e-08  Score=77.21  Aligned_cols=126  Identities=17%  Similarity=0.189  Sum_probs=93.1

Q ss_pred             EEEEEeccCCC-ChHHH------HHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeee
Q 030527           41 IFLVVEFCAGG-NLSSY------IRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF  111 (175)
Q Consensus        41 ~~lv~e~~~~~-~L~~~------l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df  111 (175)
                      .-++|....|- .+..+      .+.+..+...........+  +.+.||..|.+-||++++|++++   ..+.+.|.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEcc
Confidence            55677766552 12222      2223446778888888888  89999999999999999999994   6667888886


Q ss_pred             cceeeccCCCccccccCCCCccCccccc-----ccCCCcchhHHHHHHHHHHHHhC-CCCCCCC
Q 030527          112 GLSCTLYPGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNG-YPPFSVG  169 (175)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~~~~~g-~~pf~~~  169 (175)
                      .....-.++....-..+...|++||...     +.+.+..+|.|.||+++++++.| ..||++.
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            6544444444444566788899999864     44567889999999999998885 9999763

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.90  E-value=2.3e-08  Score=77.43  Aligned_cols=132  Identities=18%  Similarity=0.333  Sum_probs=99.5

Q ss_pred             hHHHHHHHHhhCCCCCeeeEeeEEe----eCCeEEEEEeccCC-CChHHHH---------------HhcCCCCHHHHHHH
Q 030527           12 CLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAG-GNLSSYI---------------RLHGRVPEQTARKF   71 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l---------------~~~~~l~~~~~~~~   71 (175)
                      ....-.++++++.|+|++++.+++.    .+..+++|++|.++ ++|.++-               ..+...++..++.+
T Consensus       319 k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y  398 (655)
T KOG3741|consen  319 KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSY  398 (655)
T ss_pred             cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHH
Confidence            3445678999999999999999886    45678999999876 5666643               12234788999999


Q ss_pred             HHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhH
Q 030527           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDM  149 (175)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di  149 (175)
                      +.|+  ||.++|+.|+..+-+.+.+|++.   ..-++++...|..-....+.           .+|     -+--++.|.
T Consensus       399 ~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl~~d~-----------~~~-----le~~Qq~D~  459 (655)
T KOG3741|consen  399 ISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMDVLQEDP-----------TEP-----LESQQQNDL  459 (655)
T ss_pred             HHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccceeeecCCC-----------Ccc-----hhHHhhhhH
Confidence            9999  99999999999999999999994   44478877666554333322           000     112356899


Q ss_pred             HHHHHHHHHHHhC
Q 030527          150 WSVGAILFELLNG  162 (175)
Q Consensus       150 ~slg~~~~~~~~g  162 (175)
                      -.||.++..+.||
T Consensus       460 ~~lG~ll~aLAt~  472 (655)
T KOG3741|consen  460 RDLGLLLLALATG  472 (655)
T ss_pred             HHHHHHHHHHhhc
Confidence            9999999999998

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.89  E-value=3.5e-09  Score=83.73  Aligned_cols=82  Identities=20%  Similarity=0.186  Sum_probs=55.2

Q ss_pred             CCeEEEEEeccCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecC-CCceEEEeeecce
Q 030527           38 ENCIFLVVEFCAGGNLSSY--IRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLD-DDVMLKIADFGLS  114 (175)
Q Consensus        38 ~~~~~lv~e~~~~~~L~~~--l~~~~~l~~~~~~~~~~~i~l~~lh~~~~~h~di~~~ni~~~~~~-~~~~~~l~df~~~  114 (175)
                      .+..++||||+.|+.+.+.  +.+.+ .+.........+..+..+...|++|+|++|.||++...+ ..+.+.++|||++
T Consensus       233 st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGiv  311 (537)
T PRK04750        233 CSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIV  311 (537)
T ss_pred             CCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceE
Confidence            5567899999999999874  23222 222222222233344556679999999999999994211 1238999999999


Q ss_pred             eeccCC
Q 030527          115 CTLYPG  120 (175)
Q Consensus       115 ~~~~~~  120 (175)
                      ......
T Consensus       312 g~l~~~  317 (537)
T PRK04750        312 GSLNKE  317 (537)
T ss_pred             EECCHH
Confidence            887543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.85  E-value=1.6e-09  Score=89.30  Aligned_cols=147  Identities=34%  Similarity=0.562  Sum_probs=111.3

Q ss_pred             CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecC
Q 030527           24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD  101 (175)
Q Consensus        24 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~  101 (175)
                      .+|.++.....+......++++++..+++|...+..-+..+.+.....+..+  ++++||.....|+|++|.|.+.   .
T Consensus       862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~  938 (1205)
T KOG0606|consen  862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---A  938 (1205)
T ss_pred             CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---c
Confidence            3466665555556667789999999999999998876766655555555554  8999999989999999999997   4


Q ss_pred             CCceEEEeeecceeecc---------------------CC-----------CccccccCCCCccCcccccccCCCcchhH
Q 030527          102 DDVMLKIADFGLSCTLY---------------------PG-----------NYAEKVCGSPLYMAPEVLQFQRYDEKVDM  149 (175)
Q Consensus       102 ~~~~~~l~df~~~~~~~---------------------~~-----------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di  149 (175)
                      ..+...+.+|+......                     ..           .......+++.|.+||...+......+|.
T Consensus       939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen  939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred             ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence            56666677765322211                     00           01223567888999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCccC
Q 030527          150 WSVGAILFELLNGYPPFSVGEEHQ  173 (175)
Q Consensus       150 ~slg~~~~~~~~g~~pf~~~~~~~  173 (175)
                      |+.|+++++.++|..||....+.+
T Consensus      1019 ~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred             hhhhhhhhhhhcCCCCCCCcchhh
Confidence            999999999999999998766543

>PRK09902 hypothetical protein; Provisional

Probab=98.75  E-value=9.5e-08  Score=66.77  Aligned_cols=109  Identities=12%  Similarity=0.124  Sum_probs=78.8

Q ss_pred             hhhhhhHHHHHHHHhhCCCCC--eeeEeeEEe-eC----CeEEEEEeccCC-CChHHHHHhc--CCCCHHHHHHHHHHH-
Q 030527            7 KHLKSCLDCELNFLSSVNHPN--IIRLFDAFQ-AE----NCIFLVVEFCAG-GNLSSYIRLH--GRVPEQTARKFLQQL-   75 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~-~~----~~~~lv~e~~~~-~~L~~~l~~~--~~l~~~~~~~~~~~i-   75 (175)
                      +..++.|.+|.+.+++|..-+  ++++. ++. ..    -..++|+|-+.| .+|.+++.+.  .+.+......++.++ 
T Consensus        60 P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va  138 (216)
T PRK09902         60 PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVA  138 (216)
T ss_pred             CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHH
Confidence            445678899999999985444  34444 332 11    135789996643 6899888653  345777777888888 


Q ss_pred             -HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           76 -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        76 -~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                       +++-||+.|+.|+|+.+.||++... ....+.++||..++..
T Consensus       139 ~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        139 LAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRRR  180 (216)
T ss_pred             HHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccchh
Confidence             8999999999999999999999421 2335999999866543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.75  E-value=4e-08  Score=69.37  Aligned_cols=47  Identities=15%  Similarity=0.186  Sum_probs=35.2

Q ss_pred             hhhHHHHHHHHhhCCCCC--eeeEeeEEeeC---CeEEEEEeccCCCChHHH
Q 030527           10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAE---NCIFLVVEFCAGGNLSSY   56 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~   56 (175)
                      ...+..|.++++.+++.+  +++++.+....   +..++|||+++|.++.+.
T Consensus        39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~   90 (223)
T cd05154          39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDR   90 (223)
T ss_pred             cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCC
Confidence            567899999999996644  56777776654   366899999998776553

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.59  E-value=2.1e-08  Score=78.22  Aligned_cols=147  Identities=25%  Similarity=0.336  Sum_probs=106.1

Q ss_pred             HHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCC
Q 030527           16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKP   92 (175)
Q Consensus        16 e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~   92 (175)
                      |+.+...+ .|.+.+.+...+......++--|||.++++.....-...+++...+.+..|+  ++.++|+..++|.|++|
T Consensus       315 ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~p  394 (524)
T KOG0601|consen  315 EVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKP  394 (524)
T ss_pred             hhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccc
Confidence            55455555 5777777776666666667889999998887766544567888888888887  99999999999999999


Q ss_pred             CcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCc-cCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           93 ENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY-MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        93 ~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~-~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +||+..  ..+...++.||+.......... -....+..| .++.......+..+.|++|||..+.+.+++...
T Consensus       395 sni~i~--~~~~~~~~~~~~~~t~~~~~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  395 SNILIS--NDGFFSKLGDFGCWTRLAFSSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             cceeec--cchhhhhccccccccccceecc-cccccccccccchhhccccccccccccccccccccccccCccc
Confidence            999995  2236678899988765321111 111123333 245555667788999999999999988887553

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.57  E-value=2.8e-07  Score=66.40  Aligned_cols=100  Identities=19%  Similarity=0.244  Sum_probs=71.0

Q ss_pred             hhhhHHHHHHHHhhCCCC--CeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~l~~lh~~~~~   86 (175)
                      .+...++|.++|++|...  .++.++++    +.+.+|||+..|..|....- ...-+.+....++.++...+  ..|++
T Consensus       152 sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-~~en~~~il~~il~~~~~~~--~~GiV  224 (304)
T COG0478         152 SRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-DVENPDEILDKILEEVRKAY--RRGIV  224 (304)
T ss_pred             HHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC-cccCHHHHHHHHHHHHHHHH--HcCcc
Confidence            345567899999999655  77777755    78899999999877765431 11122333334444444344  79999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeecc
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLY  118 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~  118 (175)
                      |||+++-||++   +.++.+.++||.-+...+
T Consensus       225 HGDlSefNIlV---~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         225 HGDLSEFNILV---TEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             ccCCchheEEE---ecCCCEEEEeCcccccCC
Confidence            99999999999   577789999998665543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.51  E-value=4e-06  Score=58.46  Aligned_cols=102  Identities=27%  Similarity=0.396  Sum_probs=78.0

Q ss_pred             hhhHHHHHHHHhhCC------CCCeeeEeeEEeeCCeEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHH
Q 030527           10 KSCLDCELNFLSSVN------HPNIIRLFDAFQAENCIFLVVEFCAG------GNLSSYIRLHGRVPEQTARKFLQQLGL   77 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~l~~~~~~~~~~~i~l   77 (175)
                      .++..+|+..+.++.      +..|++++|+.+.+-..-+|+|...+      .+|.+++++ +.++. .....+.+ ..
T Consensus        55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~~-f~  131 (199)
T PF10707_consen   55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALDE-FK  131 (199)
T ss_pred             hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHHH-HH
Confidence            567777888777776      88999999999999888889987653      468888863 44655 44444444 56


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCc-eEEEee-ecce
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDV-MLKIAD-FGLS  114 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~-~~~l~d-f~~~  114 (175)
                      ++|-+.+++..|++|.||++...+.+. .+.++| ||..
T Consensus       132 ~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  132 RYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             HHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence            788899999999999999998655555 688888 6744

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.48  E-value=2.5e-06  Score=60.02  Aligned_cols=67  Identities=25%  Similarity=0.389  Sum_probs=49.0

Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeeccee
Q 030527           39 NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (175)
Q Consensus        39 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~  115 (175)
                      ...+++|||++|..|.+...    +++.....+..  ++..+|+.|+.|||.+|.|++++    ++.++++|++..+
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~----i~e~~~~ki~~--~ikqlH~~G~~HGD~hpgNFlv~----~~~i~iID~~~k~  182 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED----IDEDLAEKIVE--AIKQLHKHGFYHGDPHPGNFLVS----NNGIRIIDTQGKR  182 (229)
T ss_pred             eEEEEEEEEecCeecccchh----cCHHHHHHHHH--HHHHHHHcCCccCCCCcCcEEEE----CCcEEEEECcccc
Confidence            45578999999988877532    33322222222  78999999999999999999994    3449999997543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.44  E-value=3.7e-08  Score=78.39  Aligned_cols=91  Identities=20%  Similarity=0.372  Sum_probs=71.0

Q ss_pred             HHHHHHH-cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc----------cccCCCCccCcccccccCCC
Q 030527           76 GLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----------KVCGSPLYMAPEVLQFQRYD  144 (175)
Q Consensus        76 ~l~~lh~-~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~----------~~~~~~~~~~pe~~~~~~~~  144 (175)
                      ++.++|. .++||++|.|+++.+   +..+..+++.|+++.....+.-..          -......|.+||++.+..-+
T Consensus       111 gl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~  187 (700)
T KOG2137|consen  111 GLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNT  187 (700)
T ss_pred             hhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccc
Confidence            7899995 689999999999999   788899999999886654421111          11123459999999888889


Q ss_pred             cchhHHHHHHHHHHHH-hCCCCCCCC
Q 030527          145 EKVDMWSVGAILFELL-NGYPPFSVG  169 (175)
Q Consensus       145 ~~~Di~slg~~~~~~~-~g~~pf~~~  169 (175)
                      .++|++|+|++++.+. .|+.-+.+.
T Consensus       188 ~~sd~fSlG~li~~i~~~gk~i~~a~  213 (700)
T KOG2137|consen  188 PASDVFSLGVLIYTIYNGGKSIIAAN  213 (700)
T ss_pred             ccccceeeeeEEEEEecCCcchhhcc
Confidence            9999999999999887 566666544

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.30  E-value=6.6e-06  Score=65.14  Aligned_cols=104  Identities=21%  Similarity=0.264  Sum_probs=76.4

Q ss_pred             HHHHHHHhhC-----CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHcCCee
Q 030527           14 DCELNFLSSV-----NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGLEILNSHHIIH   87 (175)
Q Consensus        14 ~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i~l~~lh~~~~~h   87 (175)
                      ..|+.-+.++     ..+++.-..-+++..+...++|||+.|..+.+.... ....+...+...+.+..+..+-..|+.|
T Consensus       209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgffH  288 (517)
T COG0661         209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFFH  288 (517)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCccc
Confidence            3455444443     366666555566667778999999999999887422 2456656666666665667777799999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG  120 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~  120 (175)
                      +|.+|-|+++   +.++.+.+.|||......+.
T Consensus       289 aDpHpGNi~v---~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         289 ADPHPGNILV---RSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             cCCCccceEE---ecCCcEEEEcCcceecCCHH
Confidence            9999999999   57789999999999877543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.15  E-value=2.9e-05  Score=55.85  Aligned_cols=46  Identities=13%  Similarity=0.088  Sum_probs=35.4

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHH
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS   55 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   55 (175)
                      ...+..|+++++.+ ++--+++++++....+..++||++++|.++..
T Consensus        35 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150          35 TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            44678899999988 34456677887777677899999999877654

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.88  E-value=4.4e-06  Score=66.71  Aligned_cols=146  Identities=25%  Similarity=0.386  Sum_probs=99.5

Q ss_pred             HHHHHHHHhhCCCCC-eeeEeeEEeeCCeEEEEEeccCCC-ChHHHHHhc-CCCCHHHHHHHHH-HH-HHHHHHHcCCee
Q 030527           13 LDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLH-GRVPEQTARKFLQ-QL-GLEILNSHHIIH   87 (175)
Q Consensus        13 ~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~-~~l~~~~~~~~~~-~i-~l~~lh~~~~~h   87 (175)
                      ...++++|.+++||| .+..++.+.......+.++++.++ +-....... ..+..-+...... +. +++++|+..=+|
T Consensus       280 ~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~  359 (829)
T KOG0576|consen  280 RRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVH  359 (829)
T ss_pred             hHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccC
Confidence            345888999999999 556666666677888999998766 222211100 0111111111111 12 788888775567


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +|    |++.    .+...+..+|+.........+.....++..+++||......+....|.|++|.-..++..|.+|-
T Consensus       360 ~d----~~l~----s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  360 RD----NILG----SEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cc----cccc----cccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            76    7765    44567888999887776665666778899999999998888999999999998777777776654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.87  E-value=0.00015  Score=61.85  Aligned_cols=153  Identities=25%  Similarity=0.279  Sum_probs=108.6

Q ss_pred             HHHHHHHHhhCCCCCeeeEeeEEeeCCeE----EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           13 LDCELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      .+-|...+....|+|+..++.|..++...    .+..+++...++.+.++.-+..+..+.+.+..+.  +++++|+....
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~  308 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE  308 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence            34466777788999999999887654322    2445788888999999888888988888888887  99999998666


Q ss_pred             ecCCCCCcEEEeecCCCceEEEe--eecceeeccCCCccccccCCCCccCcccccccCC--CcchhHHHHHHHHHHHHhC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIA--DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY--DEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~--~~~~Di~slg~~~~~~~~g  162 (175)
                      |.-+..+...-...+..+.....  ||+......+.........+..+.++|.......  +...|+|.+|.....+..|
T Consensus       309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~  388 (1351)
T KOG1035|consen  309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQG  388 (1351)
T ss_pred             eeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhc
Confidence            66555553333222444445544  8888877766655545555566777777655544  4458999999999988877


Q ss_pred             CCC
Q 030527          163 YPP  165 (175)
Q Consensus       163 ~~p  165 (175)
                      ..+
T Consensus       389 ~~i  391 (1351)
T KOG1035|consen  389 EDI  391 (1351)
T ss_pred             Ccc
Confidence            553

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.81  E-value=0.00027  Score=50.50  Aligned_cols=42  Identities=17%  Similarity=0.167  Sum_probs=32.9

Q ss_pred             hhHHHHHHHHhhCCCCC--eeeEeeEEeeCCeEEEEEeccCCCC
Q 030527           11 SCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGN   52 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~   52 (175)
                      ..+.+|.++++.+..-+  +++++.+....+...++|+++.|.+
T Consensus        37 ~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172        37 ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            45788999999996444  4677878777777889999998863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.75  E-value=0.00033  Score=55.76  Aligned_cols=83  Identities=20%  Similarity=0.256  Sum_probs=60.3

Q ss_pred             eeCCeEEEEEeccCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEEeec-CCCceEEEeeec
Q 030527           36 QAENCIFLVVEFCAGGNLSSY--IRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFG  112 (175)
Q Consensus        36 ~~~~~~~lv~e~~~~~~L~~~--l~~~~~l~~~~~~~~~~~i~l~~lh~~~~~h~di~~~ni~~~~~-~~~~~~~l~df~  112 (175)
                      ...+...++|||+.|..+.|.  +++ ..++...+..-+.+..+..+-..|++|+|-+|-||++... ..+..+.+.|||
T Consensus       272 ~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhG  350 (538)
T KOG1235|consen  272 DLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHG  350 (538)
T ss_pred             hcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccc
Confidence            344567899999999776654  332 3456666666666655566667899999999999999632 246679999999


Q ss_pred             ceeeccC
Q 030527          113 LSCTLYP  119 (175)
Q Consensus       113 ~~~~~~~  119 (175)
                      +......
T Consensus       351 l~~~is~  357 (538)
T KOG1235|consen  351 LYAVISH  357 (538)
T ss_pred             ccccccH
Confidence            9877644

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.68  E-value=0.00025  Score=49.17  Aligned_cols=97  Identities=25%  Similarity=0.277  Sum_probs=71.5

Q ss_pred             HHHHHHHhhCCC-CCeeeEeeEEeeCCeEEEEEeccCCCChHH---HHHhcCCCCHHHHHHHHHHH--HHHHHHH---cC
Q 030527           14 DCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSS---YIRLHGRVPEQTARKFLQQL--GLEILNS---HH   84 (175)
Q Consensus        14 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~---~l~~~~~l~~~~~~~~~~~i--~l~~lh~---~~   84 (175)
                      .+|..+++.+.+ +++++++|++-    .+++.|+...+++..   .+.+...-++.....++.++  .+..++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458888999954 69999999973    356889987655542   12222345788888888887  7777776   34


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      +.-+|++++|+.+   +.+++++++|.+.+...
T Consensus        83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence            7889999999999   46678999999866544

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.41  E-value=0.00072  Score=48.45  Aligned_cols=30  Identities=33%  Similarity=0.534  Sum_probs=23.7

Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceee
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~  116 (175)
                      +++|+|+.+.|++++   .+....++||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~---~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQ---DGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEE---CCCEEEEEeCcccCc
Confidence            489999999999994   444457999997644

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=97.39  E-value=0.0015  Score=55.20  Aligned_cols=42  Identities=14%  Similarity=0.381  Sum_probs=32.3

Q ss_pred             hhHHHHHHHHhhCC-CCCe--eeEeeEEeeC---CeEEEEEeccCCCC
Q 030527           11 SCLDCELNFLSSVN-HPNI--IRLFDAFQAE---NCIFLVVEFCAGGN   52 (175)
Q Consensus        11 ~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~~   52 (175)
                      ..+.+|.++++.+. |+++  ++++.++.+.   +..++|||++.|..
T Consensus        83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876         83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence            46889999999995 6765  6667766553   46789999998864

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.38  E-value=0.0015  Score=46.15  Aligned_cols=54  Identities=19%  Similarity=0.231  Sum_probs=35.5

Q ss_pred             ccccchh-hhhhHHHHHHHHhhCCCCC--eeeEeeEE---eeCCeEEEEEeccCCCChHH
Q 030527            2 LKKLNKH-LKSCLDCELNFLSSVNHPN--IIRLFDAF---QAENCIFLVVEFCAGGNLSS   55 (175)
Q Consensus         2 lk~~~~~-~~~~~~~e~~~l~~l~h~~--i~~~~~~~---~~~~~~~lv~e~~~~~~L~~   55 (175)
                      ||..... ....+..|..+++.+...+  ++.++.+.   ...+..++++++++|..+..
T Consensus        25 lK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~   84 (239)
T PF01636_consen   25 LKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD   84 (239)
T ss_dssp             EEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred             EEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence            4544443 5677888999999884333  45666533   33446789999999887776

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.28  E-value=0.0013  Score=48.66  Aligned_cols=31  Identities=35%  Similarity=0.666  Sum_probs=25.1

Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceee
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~  116 (175)
                      .+++|+|+.|.|+++.   .+..+.++||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFD---GDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEe---CCceEEEeehhhhcC
Confidence            4699999999999994   455568999987654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.23  E-value=0.0014  Score=47.21  Aligned_cols=98  Identities=19%  Similarity=0.199  Sum_probs=58.1

Q ss_pred             HHHHHHHhhCCCCC--eeeEeeEEeeCCeEEEEEeccCCCCh-HHHHHhcCCCCHHHHHHHHHHH--HHHHH-HHcCCee
Q 030527           14 DCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNL-SSYIRLHGRVPEQTARKFLQQL--GLEIL-NSHHIIH   87 (175)
Q Consensus        14 ~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~l~~~~~~~~~~~i--~l~~l-h~~~~~h   87 (175)
                      ..|.+=|+++...+  +++.+.+    ....+|||++..... .-.++. -++.......+..++  .++-| +..++||
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVH  190 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVH  190 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCccc
Confidence            44777777774443  3344444    234699999843211 111111 122232444444444  33333 3489999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG  120 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~  120 (175)
                      +|+..-||++   . ++.+.++|++-+.....+
T Consensus       191 gDLSEyNiL~---~-~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         191 GDLSEYNILV---H-DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             ccchhhheEE---E-CCeEEEEECccccccCCC
Confidence            9999999999   3 677999999987666543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.23  E-value=0.0028  Score=43.36  Aligned_cols=100  Identities=18%  Similarity=0.214  Sum_probs=68.6

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHcCC
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHI   85 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~l~~lh~~~~   85 (175)
                      .++-+..+..|+++++.++-.++.+=+..+...   ++.|||+.|.+|.++....   +...+..++.  +---|...|+
T Consensus        55 ~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i~me~i~G~~L~~~~~~~---~rk~l~~vlE--~a~~LD~~GI  126 (201)
T COG2112          55 RDSPRRNLEKEAKILEILAGEGVTPEVYFYGED---FIRMEYIDGRPLGKLEIGG---DRKHLLRVLE--KAYKLDRLGI  126 (201)
T ss_pred             CCcchhhHHHHHHHHHHhhhcCCCceEEEechh---hhhhhhhcCcchhhhhhcc---cHHHHHHHHH--HHHHHHHhcc
Confidence            455577899999999999877776544333333   2459999998998875522   3444444444  3344567899


Q ss_pred             eecCCCC--CcEEEeecCCCceEEEeeecceeec
Q 030527           86 IHRDLKP--ENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        86 ~h~di~~--~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      -|+.++-  .|+++    .+..+.|+||..|+..
T Consensus       127 ~H~El~~~~k~vlv----~~~~~~iIDFd~At~k  156 (201)
T COG2112         127 EHGELSRPWKNVLV----NDRDVYIIDFDSATFK  156 (201)
T ss_pred             chhhhcCCceeEEe----cCCcEEEEEccchhhc
Confidence            9999875  56666    4447999999988744

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.82  E-value=0.0013  Score=49.34  Aligned_cols=95  Identities=21%  Similarity=0.261  Sum_probs=63.2

Q ss_pred             hHHHHHHHHhhCCCCC--eeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHcCCeecC
Q 030527           12 CLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRD   89 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~l~~lh~~~~~h~d   89 (175)
                      ....|..+++.|...+  +++.+    +.++.++||++..|-.|.+...-.   ...++..-+.. -+--|-..|+||||
T Consensus       156 aa~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~---d~~~ly~~lm~-~Iv~la~~GlIHgD  227 (465)
T KOG2268|consen  156 AATKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHVE---DPPTLYDDLMG-LIVRLANHGLIHGD  227 (465)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeeecC---ChHHHHHHHHH-HHHHHHHcCceecc
Confidence            3456888999884332  23333    447789999999988887653321   12222221111 34566789999999


Q ss_pred             CCCCcEEEeecCCCceEEEeeecceeec
Q 030527           90 LKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        90 i~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .+--||++   ..+..++++||.-....
T Consensus       228 FNEFNimv---~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  228 FNEFNIMV---KDDDKIVVIDFPQMVST  252 (465)
T ss_pred             cchheeEE---ecCCCEEEeechHhhcc
Confidence            99999999   45777999999755444

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.40  E-value=0.037  Score=40.14  Aligned_cols=30  Identities=20%  Similarity=0.340  Sum_probs=24.0

Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .++|+|+.|.|++++   .++ +.++||+.+...
T Consensus       147 ~l~H~Dl~~~Nil~~---~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       147 APLHMDVHAYNLVVT---PQG-LKLIDWEYASDG  176 (256)
T ss_pred             eeecCCCCcCcEEEe---CCC-CEEEeccccCcC
Confidence            479999999999994   333 789999877554

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.07  E-value=0.087  Score=36.99  Aligned_cols=85  Identities=21%  Similarity=0.348  Sum_probs=58.3

Q ss_pred             hhHHHHHHHHhhC---CCCCe--eeEeeEEeeCC------------------eEEEEEeccCCCChHHHHHhcCCCCHHH
Q 030527           11 SCLDCELNFLSSV---NHPNI--IRLFDAFQAEN------------------CIFLVVEFCAGGNLSSYIRLHGRVPEQT   67 (175)
Q Consensus        11 ~~~~~e~~~l~~l---~h~~i--~~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~l~~~~   67 (175)
                      .-|..|.|.+-+|   .++++  +++++|..-..                  ...+|-||.+...         .++...
T Consensus        99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~  169 (207)
T PF13095_consen   99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD  169 (207)
T ss_pred             ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH
Confidence            3578899988877   35555  88888873221                  2246666654433         345555


Q ss_pred             HHHHHHHHHHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecce
Q 030527           68 ARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS  114 (175)
Q Consensus        68 ~~~~~~~i~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~  114 (175)
                      +..+...  +..+|..|++-+|+++.|..=        =+|+|||.+
T Consensus       170 ~~~~~~d--l~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  170 IPQMLRD--LKILHKLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             HHHHHHH--HHHHHHCCeeeccCccccccC--------CEEEecccC
Confidence            5666664  478899999999999999862        278899854

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.89  E-value=0.06  Score=43.14  Aligned_cols=50  Identities=16%  Similarity=0.282  Sum_probs=40.2

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEee-CCeEEEEEeccCCCChHHHHHhcC
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG   61 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~   61 (175)
                      .++....++++.+.|++..+++++... ..+..+|+|++ +.++.+.+..+.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            355668899999999999999988754 34578899998 889999887543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.19  E-value=0.0032  Score=56.02  Aligned_cols=148  Identities=14%  Similarity=0.056  Sum_probs=97.0

Q ss_pred             HHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHH-H-HHHHHHHc---C
Q 030527           16 ELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQ-L-GLEILNSH---H   84 (175)
Q Consensus        16 e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~-i-~l~~lh~~---~   84 (175)
                      |..-.+...|+++.....=.+.  +...+..++++.+|.+.+.+-++-    ++.+.-+...-++ + ....+|++   |
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence            3334455678887765544332  334578888999999999887552    2333333322222 1 33444433   2


Q ss_pred             --CeecCCCCCcEEEeecCCCceEEEeeeccee-eccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           85 --IIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        85 --~~h~di~~~ni~~~~~~~~~~~~l~df~~~~-~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                        -+|.++++.|.++   ..+.++++.++|+.+ +.......+...+++-|+.|+..-.-.++.++|+|..++.++....
T Consensus      1359 ~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             ccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence              5799999999998   567779999999988 3333334455556666677776655567888999999999888777


Q ss_pred             CCCCC
Q 030527          162 GYPPF  166 (175)
Q Consensus       162 g~~pf  166 (175)
                      |..+|
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            76666

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.13  E-value=0.21  Score=38.55  Aligned_cols=75  Identities=21%  Similarity=0.259  Sum_probs=50.0

Q ss_pred             eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH-HHHHHHH--cCCeecCCCCCcEEEeecCCCceEEEeeecc
Q 030527           37 AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL-GLEILNS--HHIIHRDLKPENILLSGLDDDVMLKIADFGL  113 (175)
Q Consensus        37 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i-~l~~lh~--~~~~h~di~~~ni~~~~~~~~~~~~l~df~~  113 (175)
                      +....|+++++- |+++...    ..-..+++..++.+- .+-+..+  ..+-|++++-.||++   + .+.+.|+||.+
T Consensus       297 e~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfkl  367 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKL  367 (488)
T ss_pred             CceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeee
Confidence            334567888876 6666542    222345566666653 3333333  357899999999999   5 78899999999


Q ss_pred             eeeccCC
Q 030527          114 SCTLYPG  120 (175)
Q Consensus       114 ~~~~~~~  120 (175)
                      ++....+
T Consensus       368 sRl~~~q  374 (488)
T COG5072         368 SRLSYSQ  374 (488)
T ss_pred             eecccCC
Confidence            9855443

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.06  E-value=0.022  Score=40.69  Aligned_cols=81  Identities=22%  Similarity=0.224  Sum_probs=52.2

Q ss_pred             HHHHHHHhhCCCCCeeeEeeEEeeCC-eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH-HHHHHHH--cCCeecC
Q 030527           14 DCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL-GLEILNS--HHIIHRD   89 (175)
Q Consensus        14 ~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i-~l~~lh~--~~~~h~d   89 (175)
                      .++.+++.+  -.+|+++.   .+++ .+-++.|.|....            ......+.+.+ +|...|+  .+.+|||
T Consensus       106 ~nky~v~Ar--mhGilrL~---NDn~~~yGvIlE~Cy~~~------------i~~~N~i~agi~~L~~fH~~~~~~lHGD  168 (308)
T PF07387_consen  106 FNKYRVFAR--MHGILRLK---NDNNYKYGVILERCYKIK------------INFSNFITAGIKDLMDFHSENQHCLHGD  168 (308)
T ss_pred             hhhhhHHHH--hhheeEee---cCCCceeEEEEeeccCcc------------cchhHHHHHhHHHHHHhhccCCCeecCC
Confidence            445444443  34566655   2222 3456777774322            23334455556 7888884  5799999


Q ss_pred             CCCCcEEEeecCCCceEEEeeecce
Q 030527           90 LKPENILLSGLDDDVMLKIADFGLS  114 (175)
Q Consensus        90 i~~~ni~~~~~~~~~~~~l~df~~~  114 (175)
                      .+|+||+-   ++.+.+||.|-+..
T Consensus       169 ~np~NiM~---D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  169 CNPDNIMC---DKFGYLKLVDPVCL  190 (308)
T ss_pred             CChhheee---cCCCCEEecChhhh
Confidence            99999998   78889999997654

The function of this family is unknown.

>PRK05231 homoserine kinase; Provisional

Probab=94.81  E-value=0.027  Score=42.23  Aligned_cols=32  Identities=31%  Similarity=0.557  Sum_probs=25.1

Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .+++|+|+.+.|+++.   .+....++||+.+...
T Consensus       187 ~~liHgD~~~~Nil~~---~~~~~~iIDf~~~~~~  218 (319)
T PRK05231        187 RGVIHADLFRDNVLFE---GDRLSGFIDFYFACND  218 (319)
T ss_pred             cccCCCCCCCCcEEEE---CCceEEEEecccccCC
Confidence            3799999999999994   4444579999877543

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.76  E-value=0.15  Score=39.39  Aligned_cols=98  Identities=23%  Similarity=0.226  Sum_probs=63.8

Q ss_pred             HHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH-HHcCCeecCC
Q 030527           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL-NSHHIIHRDL   90 (175)
Q Consensus        14 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l-h~~~~~h~di   90 (175)
                      +.|++=|++++..+|+-.--..  -....|||+++.......-.-+.-+++...+..+-.++  -++-| +..++||.|+
T Consensus       214 EKE~RNLkRl~~aGIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADL  291 (520)
T KOG2270|consen  214 EKEMRNLKRLNNAGIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADL  291 (520)
T ss_pred             HHHHHHHHHHHhcCCCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccch
Confidence            4588888888777765333221  23457999999543332222223457766766666664  33333 4578999999


Q ss_pred             CCCcEEEeecCCCceEEEeeecceeec
Q 030527           91 KPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        91 ~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .--|+++    .++.++++|.+-+...
T Consensus       292 SEfN~Ly----hdG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  292 SEFNLLY----HDGKLYIIDVSQSVEH  314 (520)
T ss_pred             hhhhheE----ECCEEEEEEccccccC
Confidence            9999999    5678999998865443

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.44  E-value=0.21  Score=36.01  Aligned_cols=53  Identities=17%  Similarity=0.226  Sum_probs=40.8

Q ss_pred             ccccchhhhhhHHHHHHHHhhCC---CCCeeeEeeEEeeCCeEEEEEeccCCCChH
Q 030527            2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLS   54 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   54 (175)
                      ||.-..+..+.|..|+.-|+.+.   .-.+++++.+....++-++|++|++-+.+.
T Consensus        44 vK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          44 VKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             EEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            34445566678888998888873   346778999999999999999999875543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.74  E-value=0.18  Score=37.51  Aligned_cols=29  Identities=31%  Similarity=0.438  Sum_probs=23.7

Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeeccee
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~  115 (175)
                      .+++|||+++.|+++.   . +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence            4789999999999994   3 457899998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=93.67  E-value=0.061  Score=40.16  Aligned_cols=31  Identities=39%  Similarity=0.754  Sum_probs=25.1

Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceee
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~  116 (175)
                      .+++|+|+++.|+++.   .+..+.++||+.+..
T Consensus       187 ~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       187 RGVIHADLFPDNVLFD---GDSVKGVIDFYFACT  217 (307)
T ss_pred             CccCCCCCCcCcEEEE---CCceEEEeecccccC
Confidence            5799999999999994   444568999987743

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK10593 hypothetical protein; Provisional

Probab=93.55  E-value=0.32  Score=36.29  Aligned_cols=45  Identities=13%  Similarity=0.082  Sum_probs=34.5

Q ss_pred             hhhHHHHHHHHhhCCC---CCeeeEeeEEee---CCeEEEEEeccCCCChH
Q 030527           10 KSCLDCELNFLSSVNH---PNIIRLFDAFQA---ENCIFLVVEFCAGGNLS   54 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv~e~~~~~~L~   54 (175)
                      ...+..|.+.++.+.-   -.++++++++..   .+..++|||++.|.++.
T Consensus        51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~  101 (297)
T PRK10593         51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVE  101 (297)
T ss_pred             chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecC
Confidence            4588999999999843   357788877654   36689999999887653

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=93.39  E-value=0.075  Score=39.47  Aligned_cols=34  Identities=29%  Similarity=0.359  Sum_probs=25.5

Q ss_pred             CCeecCCCCCcEEEeec-CCCceEEEeeecceeec
Q 030527           84 HIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTL  117 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~-~~~~~~~l~df~~~~~~  117 (175)
                      .++|+|+.+.||++... +..+.+.++||..+...
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            57899999999999410 00367899999988654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PTZ00384 choline kinase; Provisional

Probab=93.38  E-value=0.43  Score=37.03  Aligned_cols=31  Identities=26%  Similarity=0.141  Sum_probs=24.6

Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      ..+.|.|+.+.|++.    .+..+.++||..|..-
T Consensus       227 ~VfCHNDL~~gNIL~----~~~~l~lID~EYA~~n  257 (383)
T PTZ00384        227 VLFCHNDLFFTNILD----FNQGIYFIDFDFAGFN  257 (383)
T ss_pred             eeeeeccCCcccEEe----cCCCEEEEEeccccCC
Confidence            457899999999987    3445999999887544

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=93.37  E-value=0.063  Score=38.26  Aligned_cols=31  Identities=23%  Similarity=0.384  Sum_probs=24.7

Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceee
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~  116 (175)
                      +++|+|+.+.||+++  +.+..+.++||..+..
T Consensus       171 ~l~H~Dl~~~Nil~~--~~~~~~~lIDwe~a~~  201 (235)
T cd05157         171 VFCHNDLLSGNIIYN--EEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEcCCCCcCcEEEe--CCCCCEEEEEcccCCc
Confidence            589999999999995  2145699999987643

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PHA03111 Ser/Thr kinase; Provisional

Probab=93.04  E-value=0.28  Score=37.36  Aligned_cols=37  Identities=30%  Similarity=0.489  Sum_probs=26.6

Q ss_pred             HHHHHHHHHHHHHHHHH------HcCCeecCCCCCcEEEeecC
Q 030527           65 EQTARKFLQQLGLEILN------SHHIIHRDLKPENILLSGLD  101 (175)
Q Consensus        65 ~~~~~~~~~~i~l~~lh------~~~~~h~di~~~ni~~~~~~  101 (175)
                      ..-+..+..|++|-|+-      ..+++|-|+||+||++.+.+
T Consensus       278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~  320 (444)
T PHA03111        278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD  320 (444)
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence            44566778888655532      24689999999999997544

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=93.02  E-value=0.18  Score=38.50  Aligned_cols=53  Identities=25%  Similarity=0.405  Sum_probs=35.1

Q ss_pred             HHHHHHHHHHHHHHHHH------HcCCeecCCCCCcEEEeecCCCc---------------eEEEeeecceeec
Q 030527           65 EQTARKFLQQLGLEILN------SHHIIHRDLKPENILLSGLDDDV---------------MLKIADFGLSCTL  117 (175)
Q Consensus        65 ~~~~~~~~~~i~l~~lh------~~~~~h~di~~~ni~~~~~~~~~---------------~~~l~df~~~~~~  117 (175)
                      ..-+..+..|+||-|+-      ..+++|-|+||+||++.+.+..-               ..+|-||.+++-.
T Consensus       274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence            34456777888766632      24689999999999997433332               3356677776543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.22  E-value=0.21  Score=37.84  Aligned_cols=28  Identities=46%  Similarity=0.775  Sum_probs=23.0

Q ss_pred             CeecCCCCCcEEEeecCCCc-eEEEeeeccee
Q 030527           85 IIHRDLKPENILLSGLDDDV-MLKIADFGLSC  115 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~-~~~l~df~~~~  115 (175)
                      ++|+|+.|.||++   +.+. .+.+.||+-+.
T Consensus       199 iIH~D~~~~NVl~---d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLF---DDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeE---cCCCCeeeEEEccccc
Confidence            8999999999999   4444 47899998664

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.09  E-value=0.14  Score=35.44  Aligned_cols=29  Identities=21%  Similarity=0.319  Sum_probs=23.3

Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .+|+|+.|.|++++   .++ ++++|++.+...
T Consensus        79 p~H~D~~~~N~~~~---~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         79 PLHMDVHAGNLVHS---ASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eecCCCCCccEEEE---CCC-EEEEeCCcccCC
Confidence            58999999999984   333 889999987544

>COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis]

Probab=92.05  E-value=1.1  Score=32.35  Aligned_cols=54  Identities=15%  Similarity=0.064  Sum_probs=37.0

Q ss_pred             cccchhhhhhHHHHHHHHhhCC--CCCeeeEeeEEeeCCeEEEEEeccCCCChHHH
Q 030527            3 KKLNKHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY   56 (175)
Q Consensus         3 k~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   56 (175)
                      |.....-...+.+|.+.++=+.  -=.++++.++..+.+.-+++|.-++|.++...
T Consensus        49 k~~~~~~~a~L~~Ea~RlrWla~~~l~~P~V~~~~~~~~~~wLl~salpG~~~s~~  104 (266)
T COG3231          49 KIASSGPAAELEGEAARLRWLAGQGLGCPRVLGLEDDADQAWLLMSALPGEDASHP  104 (266)
T ss_pred             EEecCcchhhhhhHHHHHHHhcccCCCCCceEeeccCcchhHHhhhhcCCCcccch
Confidence            3344444567888998888762  23455666666667788999999988876553

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=92.01  E-value=0.29  Score=35.99  Aligned_cols=31  Identities=32%  Similarity=0.377  Sum_probs=25.5

Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      -++|+|+.|.|++.   +..+.++|+||..|..-
T Consensus       154 v~cH~Dl~~~N~l~---t~~~~l~LIDWEyAg~~  184 (269)
T COG0510         154 VPCHNDLNPGNLLL---TDKGGLFLIDWEYAGLN  184 (269)
T ss_pred             eeecCCCCccceEE---cCCCcEEEEecccCCCc
Confidence            47899999999998   34588999999877443

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.94  E-value=0.16  Score=35.34  Aligned_cols=35  Identities=29%  Similarity=0.285  Sum_probs=24.9

Q ss_pred             cCCeecCCCCCcEEEeecCC--CceEEEeeecceeec
Q 030527           83 HHIIHRDLKPENILLSGLDD--DVMLKIADFGLSCTL  117 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~--~~~~~l~df~~~~~~  117 (175)
                      ..++|||+.+.|+++.....  ...+.++||..+...
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g  156 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYG  156 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCCcC
Confidence            35899999999999952111  125889999976544

subfamily of choline kinases

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=91.40  E-value=0.12  Score=38.59  Aligned_cols=31  Identities=16%  Similarity=0.188  Sum_probs=25.9

Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      +++|+|+.+.|+++   +.++.+.++||..+...
T Consensus       197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       197 VLVHGKLSLSHFLY---DETRGGYFINFEKASFA  227 (309)
T ss_pred             eeeCCCCcHHhEEE---cCCCCEEEEEhhhcccC
Confidence            69999999999999   45667889999877554

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=91.37  E-value=0.12  Score=36.30  Aligned_cols=32  Identities=34%  Similarity=0.524  Sum_probs=20.7

Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .+.|+|+.+.||++.  +.++.++++||..+..-
T Consensus       144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~~n  175 (211)
T PF01633_consen  144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAGYN  175 (211)
T ss_dssp             EEE-S--SGGGEEET--SSSSCEEE--GTT-EEE
T ss_pred             eEeeccCccccEEec--cCCCeEEEecHHHHhhc
Confidence            478999999999993  46778999999987543

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=91.28  E-value=0.2  Score=36.94  Aligned_cols=32  Identities=25%  Similarity=0.440  Sum_probs=24.1

Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .++|+|+++.|++++  +.+....++|++.+..-
T Consensus       186 ~lvHGD~~~~Nilv~--~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILID--EDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEe--CCCCEEEEECcHhcccC
Confidence            379999999999995  21334679999977544

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=90.86  E-value=0.26  Score=37.55  Aligned_cols=32  Identities=22%  Similarity=0.408  Sum_probs=25.9

Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .++|+|+++.||++.  +.++.+.++||..+...
T Consensus       201 ~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        201 GFCHNDLQYGNIMID--EETRAITIIDYEYASYN  232 (344)
T ss_pred             eEEeCCCCcCcEEEe--CCCCcEEEEeehhcccc
Confidence            578999999999995  33467999999888654

>KOG1234 consensus ABC (ATP binding cassette) 1 protein [General function prediction only]

Probab=89.81  E-value=0.4  Score=35.51  Aligned_cols=98  Identities=18%  Similarity=0.229  Sum_probs=65.4

Q ss_pred             HHHHHHHhh----C-CCCC--eeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH---HHHHHHHc
Q 030527           14 DCELNFLSS----V-NHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL---GLEILNSH   83 (175)
Q Consensus        14 ~~e~~~l~~----l-~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i---~l~~lh~~   83 (175)
                      ++|....+.    | ++|+  ++.+++  +-.....+.+|+..|..+...    ..++......|...+   .|+.+-.-
T Consensus       130 qrEA~~~~kFr~LLs~~p~f~VP~Vv~--Elct~rvlt~el~~G~pid~~----~~~sQ~~rn~i~~~~l~lcLrEif~f  203 (363)
T KOG1234|consen  130 QREAASALKFRPLLSDDPNFYVPRVVD--ELCTVRVLTLELGQGLPIDKT----AKLSQETRNYIGYKLLELCLREIFEF  203 (363)
T ss_pred             HHHHHHHhhhHHHhcCCCCcchhHHHH--hhccchhhhhhhhcCccchhh----hcccHHHHHHHHHHHHHHHHHHHHHH
Confidence            445544443    2 3777  333332  222334577788877776653    346667767777765   78888888


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  119 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~  119 (175)
                      .+...|-+=+|+++.  .....+.|.|||.++.+..
T Consensus       204 ~fMQTDPNWsNFly~--~~tk~i~LlDFGAsr~y~~  237 (363)
T KOG1234|consen  204 RFMQTDPNWSNFLYN--GRTKKIELLDFGASREYGE  237 (363)
T ss_pred             hhhcCCCCHHHhccC--CCcceEEEEeccccccccH
Confidence            888899999999994  4466799999998877643

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=89.73  E-value=0.33  Score=36.80  Aligned_cols=31  Identities=29%  Similarity=0.452  Sum_probs=25.4

Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      +.|+|+.+.||++.  +.++.++++||..|...
T Consensus       184 ~CHnDl~~~NiL~~--~~~~~l~lID~EYag~n  214 (330)
T PLN02421        184 FAHNDLLSGNLMLN--EDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             EEECCCCcccEEEe--CCCCcEEEEcccccCCC
Confidence            68999999999994  34567999999988554

>KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism]

Probab=89.36  E-value=1.5  Score=32.99  Aligned_cols=37  Identities=24%  Similarity=0.337  Sum_probs=28.9

Q ss_pred             HHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChH
Q 030527           14 DCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS   54 (175)
Q Consensus        14 ~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   54 (175)
                      ++|++.++.| .|..-+++++-|..+    ++++|++|.+|.
T Consensus       126 e~Ev~afk~L~a~G~ap~Ly~tF~NG----Lvyefi~g~tL~  163 (391)
T KOG4720|consen  126 ENEVIAFKLLAAYGFAPKLYGTFNNG----LVYEFIQGKTLE  163 (391)
T ss_pred             HHHHHHHHHHHHcCcChhhhheecCc----eEEeeecCcccC
Confidence            5688888888 677778888777655    889999887664

>PRK11768 serine/threonine protein kinase; Provisional

Probab=88.89  E-value=0.26  Score=37.24  Aligned_cols=29  Identities=28%  Similarity=0.287  Sum_probs=23.0

Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceee
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~  116 (175)
                      .+++|+|+.+.|+++.   .  .+.++||+-+..
T Consensus       196 ~~liHgD~h~~NvL~~---d--~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR---D--GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc---C--CcEEEeCCCCCC
Confidence            3689999999999993   2  367899987643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	175
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-32
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-32
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-32
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-32
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-32
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-31
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-31
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-31
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-31
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-31
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-30
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-30
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-30
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-30
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-30
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-30
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-30
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-29
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-29
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-29
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-29
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-29
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-29
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-29
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-29
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-29
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-29
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-29
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-29
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-29
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-29
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-29
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-29
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-29
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-29
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-29
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-29
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-29
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-29
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-28
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-28
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-28
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-28
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-28
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-28
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-28
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-27
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-27
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-27
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-27
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-26
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-26
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-26
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-26
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-26
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-26
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-25
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-25
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-25
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-25
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-25
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-25
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-25
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-25
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-25
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-25
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-25
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-25
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-25
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-25
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-25
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-25
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-25
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-25
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-25
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-25
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-25
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-25
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-25
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-25
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-25
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-25
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-25
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-25
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-25
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-25
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-25
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		7e-25
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		7e-25
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-25
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-25
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-25
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		7e-25
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-25
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-25
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-25
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-25
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-25
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-25
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-25
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-25
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-25
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-25
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-25
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-25
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-25
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-24
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-24
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-24
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-24
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-24
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-24
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-24
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-24
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-24
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-24
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-24
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-24
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-24
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-24
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-24
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-24
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-24
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-24
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-24
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-24
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-24
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-24
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-24
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-24
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-24
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-24
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-24
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-24
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-24
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-24
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-24
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-24
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-24
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-24
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-24
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-24
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-24
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-24
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-24
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-24
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-24
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-24
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-24
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-24
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-24
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-24
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-24
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-24
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-24
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-24
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-24
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-24
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-24
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-24
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-24
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-24
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-24
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-24
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-24
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-24
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-24
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-24
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-24
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-24
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-24
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-24
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-24
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-24
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-24
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-24
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-24
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-24
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-24
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-24
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-24
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-24
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-24
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-24
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-24
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-24
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-24
3soa_A	444	Full-Length Human Camkii Length = 444		7e-24
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-24
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-24
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-24
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-24
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-23
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-23
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-23
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-23
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-23
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-23
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-23
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-23
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-23
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-23
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-23
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-23
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-23
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-23
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-23
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-22
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-22
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-22
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-22
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-22
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-22
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-22
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-22
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-22
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-22
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-22
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-22
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-22
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-22
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-22
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-22
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-22
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-22
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-22
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-22
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-22
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-22
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-22
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-22
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-22
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-22
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-22
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-22
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-22
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-22
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-22
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-21
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-21
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-21
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-21
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-21
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-21
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-21
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-21
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-21
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-21
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-21
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-21
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-21
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-21
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-21
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-21
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-21
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-21
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-21
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-21
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-21
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-21
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-21
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-21
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-21
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-21
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-21
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-21
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-21
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-20
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-20
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-20
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-20
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-20
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-20
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-20
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-20
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-20
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-20
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-20
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-20
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-20
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-20
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-20
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-20
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-20
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-20
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-20
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-20
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-20
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-20
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		9e-20
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-19
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-19
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-19
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-19
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-19
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-19
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-19
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-19
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-19
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-19
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-19
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-19
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-18
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-18
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-18
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-18
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-18
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-18
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-18
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-18
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-18
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-18
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-18
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-18
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		9e-18
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-18
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-18
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-18
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-17
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-17
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-17
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-17
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-17
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-17
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-17
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-17
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-17
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-17
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-17
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-17
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-17
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-17
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-17
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-17
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-17
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-17
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-17
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-17
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-17
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-17
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-17
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-17
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-17
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-17
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-17
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-16
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-16
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-16
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-16
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-16
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-16
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-16
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-16
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-16
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-16
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-16
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-16
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-16
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-16
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-16
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-16
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-16
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-16
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-16
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-16
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-16
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-16
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-16
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-16
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-16
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-16
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-16
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-16
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-16
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-16
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-16
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-16
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-16
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-16
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-16
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-16
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-16
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-16
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-16
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-16
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-16
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-16
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-16
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-15
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-15
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-15
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-15
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-15
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-15
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-15
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-15
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-15
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-15
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-15
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-15
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-15
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-15
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-15
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-15
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-15
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-15
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-15
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-15
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-15
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-15
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-15
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-15
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-15
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-15
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-15
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-15
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-15
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-14
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-14
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-14
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-14
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-14
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-14
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-14
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-14
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-14
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-13
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-13
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-13
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-13
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-13
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-13
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-13
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-11
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-11
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-11
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-11
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-11
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-11
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-11
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-11
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-11
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-11
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-11
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-11
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-11
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-11
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-11
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-11
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-11
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-11
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-11
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-11
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-11
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-11
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-10
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-10
3gni_B	389	Structure Of Strad And Mo25 Length = 389		4e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-10
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-10
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-10
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-10
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		6e-10
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-10
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		7e-10
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		7e-10
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		7e-10
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		7e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-10
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-10
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		7e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-09
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-09
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-09
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-09
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-09
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-09
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-09
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-09
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-09
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-09
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-09
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-09
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-09
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-09
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-09
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-09

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  135 bits (340), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 65/155 (41%), Positives = 101/155 (65%), Gaps = 6/155 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 123
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              ++  +  +I+HRDLK EN+LL G   D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 124 VSAVQYCHQKYIVHRDLKAENLLLDG---DMNIKIADFGFSNEFTVGNKLDTFCGSPPYA 180
Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFS 167
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF 
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  133 bits (335), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 66/154 (42%), Positives = 100/154 (64%), Gaps = 6/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D+ +KIADFG S     GN  ++ CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYA 179
Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  133 bits (334), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 66/154 (42%), Positives = 99/154 (64%), Gaps = 6/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  133 bits (334), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 66/154 (42%), Positives = 99/154 (64%), Gaps = 6/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  133 bits (334), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 66/154 (42%), Positives = 99/154 (64%), Gaps = 6/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  132 bits (331), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 65/154 (42%), Positives = 99/154 (64%), Gaps = 6/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CG+P Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYA 179
Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  131 bits (330), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 63/154 (40%), Positives = 99/154 (64%), Gaps = 6/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++L++E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 120
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     G   +  CGSP Y 
Sbjct: 121 VSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYA 177
Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  131 bits (329), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 72/169 (42%), Positives = 108/169 (63%), Gaps = 9/169 (5%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +LKK + H++  ++ E+++L  + HP+II+L+D       I +V+E+ AGG L  YI   
Sbjct: 46  LLKKSDMHMR--VEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEK 102
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
            R+ E   R+F QQ+   +E  + H I+HRDLKPEN+LL   DD++ +KIADFGLS  + 
Sbjct: 103 KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMT 159
Query: 119 PGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 166
            GN+ +  CGSP Y APEV+  + Y   +VD+WS G +L+ +L G  PF
Sbjct: 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  130 bits (327), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 62/154 (40%), Positives = 99/154 (64%), Gaps = 6/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++L++E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     G   +  CG+P Y 
Sbjct: 124 VSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180
Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  130 bits (326), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 65/154 (42%), Positives = 98/154 (63%), Gaps = 6/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HG + E+ AR   +Q+
Sbjct: 56  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQI 115
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 116 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 172
Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 206

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  129 bits (323), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 65/154 (42%), Positives = 95/154 (61%), Gaps = 6/154 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+     +NHPNI++LF+  + E  ++LV E+ +GG +  Y+  HGR  E+ AR   +Q+
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQI 122
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D  +KIADFG S     GN  +  CG+P Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYA 179
Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           APE+ Q ++YD  +VD+WS+G IL+ L++G  PF
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  127 bits (320), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 66/153 (43%), Positives = 96/153 (62%), Gaps = 3/153 (1%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L++ F+ +   +LV+E   GG L   I L  +  E  A   ++Q+
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 113
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G   L+ H+I+HRDLKPEN+LL     D ++KI DFGLS     G   ++  G+  Y+
Sbjct: 114 LSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 173
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APEVL+ ++YDEK D+WS G IL+ LL GYPPF
Sbjct: 174 APEVLR-KKYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  127 bits (319), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 66/153 (43%), Positives = 96/153 (62%), Gaps = 3/153 (1%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L++ F+ +   +LV+E   GG L   I L  +  E  A   ++Q+
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 130
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G   L+ H+I+HRDLKPEN+LL     D ++KI DFGLS     G   ++  G+  Y+
Sbjct: 131 LSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 190
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APEVL+ ++YDEK D+WS G IL+ LL GYPPF
Sbjct: 191 APEVLR-KKYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  127 bits (319), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 66/153 (43%), Positives = 97/153 (63%), Gaps = 3/153 (1%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L+D F+ +   +LV+E   GG L   I    +  E  A   ++Q+
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+  L+ H+I+HRDLKPEN+LL   + D ++KI DFGLS         ++  G+  Y+
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APEVL+ ++YDEK D+WS+G ILF LL GYPPF
Sbjct: 206 APEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  126 bits (317), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 70/170 (41%), Positives = 101/170 (59%), Gaps = 14/170 (8%)
Query: 7   KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E
Sbjct: 51  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 110
Query: 66  QTARKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
           +  RK ++ L LE++ + H   I+HRDLKPENILL   DDD+ +K+ DFG SC L PG  
Sbjct: 111 KETRKIMRAL-LEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEK 166
Query: 123 AEKVCGSPLYMAPEVLQFQR------YDEKVDMWSVGAILFELLNGYPPF 166
             +VCG+P Y+APE+++         Y ++VDMWS G I++ LL G PPF
Sbjct: 167 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  126 bits (317), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 70/170 (41%), Positives = 101/170 (59%), Gaps = 14/170 (8%)
Query: 7   KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 66  QTARKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
           +  RK ++ L LE++ + H   I+HRDLKPENILL   DDD+ +K+ DFG SC L PG  
Sbjct: 124 KETRKIMRAL-LEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEK 179
Query: 123 AEKVCGSPLYMAPEVLQFQR------YDEKVDMWSVGAILFELLNGYPPF 166
             +VCG+P Y+APE+++         Y ++VDMWS G I++ LL G PPF
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  126 bits (316), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 70/170 (41%), Positives = 100/170 (58%), Gaps = 14/170 (8%)
Query: 7   KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 66  QTARKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
           +  RK ++ L LE++ + H   I+HRDLKPENILL   DDD+ +K+ DFG SC L PG  
Sbjct: 124 KETRKIMRAL-LEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEK 179
Query: 123 AEKVCGSPLYMAPEVLQFQR------YDEKVDMWSVGAILFELLNGYPPF 166
              VCG+P Y+APE+++         Y ++VDMWS G I++ LL G PPF
Sbjct: 180 LRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  124 bits (312), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 67/161 (41%), Positives = 105/161 (65%), Gaps = 7/161 (4%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 57  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 115
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
           R+F QQ+   +E  + H I+HRDLKPEN+LL   D+ + +KIADFGLS  +  GN+ +  
Sbjct: 116 RRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTS 172
Query: 127 CGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 166
           CGSP Y APEV+  + Y   +VD+WS G IL+ +L    PF
Sbjct: 173 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 213

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  124 bits (312), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 66/153 (43%), Positives = 95/153 (62%), Gaps = 3/153 (1%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L S++HPNII+LFD F+ +   +LV EF  GG L   I    +  E  A   ++Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+  L+ H+I+HRD+KPENILL   +  + +KI DFGLS             G+  Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APEVL+ ++Y+EK D+WS G I++ LL GYPPF
Sbjct: 216 APEVLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  124 bits (312), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 67/161 (41%), Positives = 105/161 (65%), Gaps = 7/161 (4%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 56  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 114
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
           R+F QQ+   +E  + H I+HRDLKPEN+LL   D+ + +KIADFGLS  +  GN+ +  
Sbjct: 115 RRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTS 171
Query: 127 CGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 166
           CGSP Y APEV+  + Y   +VD+WS G IL+ +L    PF
Sbjct: 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 212

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  124 bits (312), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 67/172 (38%), Positives = 98/172 (56%), Gaps = 4/172 (2%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           NK   + L  E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R  E
Sbjct: 62  NKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
             A + ++Q+  G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS         
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 124 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           +   G+  Y+APEVL+   YDEK D+WS G IL+ LL+G PPF    E+  +
Sbjct: 181 KDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  124 bits (312), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 67/161 (41%), Positives = 105/161 (65%), Gaps = 7/161 (4%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 47  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 105
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
           R+F QQ+   +E  + H I+HRDLKPEN+LL   D+ + +KIADFGLS  +  GN+ +  
Sbjct: 106 RRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTS 162
Query: 127 CGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 166
           CGSP Y APEV+  + Y   +VD+WS G IL+ +L    PF
Sbjct: 163 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 203

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  124 bits (311), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 71/174 (40%), Positives = 110/174 (63%), Gaps = 13/174 (7%)
Query: 2   LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK +NK       ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  
Sbjct: 38  LKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFD 96
Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           YI    ++ EQ AR+F QQ+   +E  + H I+HRDLKPEN+LL   D+ + +KIADFGL
Sbjct: 97  YIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGL 153
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 166
           S  +  GN+ +  CGSP Y APEV+  + Y   +VD+WS G IL+ +L    PF
Sbjct: 154 SNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 207

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  124 bits (311), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 64/162 (39%), Positives = 94/162 (58%), Gaps = 3/162 (1%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R  E  A + ++Q+
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS         +   G+  Y+
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           APEVL+   YDEK D+WS G IL+ LL+G PPF    E+  +
Sbjct: 191 APEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  124 bits (311), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 64/162 (39%), Positives = 94/162 (58%), Gaps = 3/162 (1%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R  E  A + ++Q+
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS         +   G+  Y+
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           APEVL+   YDEK D+WS G IL+ LL+G PPF    E+  +
Sbjct: 191 APEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  124 bits (311), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 74/180 (41%), Positives = 101/180 (56%), Gaps = 14/180 (7%)
Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LN+     LD       E+  L    HP+II+L+         F+V+E+ +GG L  
Sbjct: 41  VKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD 100
Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           YI  HGRV E  AR+  QQ+   ++  + H ++HRDLKPEN+L   LD  +  KIADFGL
Sbjct: 101 YICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGL 157
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFSVGEEH 172
           S  +  G +    CGSP Y APEV+  + Y   +VD+WS G IL+ LL G  PF   +EH
Sbjct: 158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD--DEH 215

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  124 bits (310), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 74/180 (41%), Positives = 101/180 (56%), Gaps = 14/180 (7%)
Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LN+     LD       E+  L    HP+II+L+         F+V+E+ +GG L  
Sbjct: 41  VKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD 100
Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           YI  HGRV E  AR+  QQ+   ++  + H ++HRDLKPEN+L   LD  +  KIADFGL
Sbjct: 101 YICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGL 157
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFSVGEEH 172
           S  +  G +    CGSP Y APEV+  + Y   +VD+WS G IL+ LL G  PF   +EH
Sbjct: 158 SNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD--DEH 215

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  124 bits (310), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 64/168 (38%), Positives = 100/168 (59%), Gaps = 2/168 (1%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           + KK  +  +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   
Sbjct: 51  IAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK 110
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           G   E+ A + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    
Sbjct: 111 GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 170
Query: 119 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           PG+     CG+P Y+APEVL  + Y + VD WS+G I + LL GYPPF
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  124 bits (310), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 67/160 (41%), Positives = 99/160 (61%), Gaps = 6/160 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 131 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  124 bits (310), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 67/160 (41%), Positives = 99/160 (61%), Gaps = 6/160 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 131 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  123 bits (309), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 67/160 (41%), Positives = 99/160 (61%), Gaps = 6/160 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 119
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 120 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 131 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 219

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  123 bits (309), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 67/160 (41%), Positives = 99/160 (61%), Gaps = 6/160 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 131 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  123 bits (309), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 67/160 (41%), Positives = 99/160 (61%), Gaps = 6/160 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 126
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 127 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 131 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 226

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  123 bits (308), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 62/159 (38%), Positives = 96/159 (60%), Gaps = 2/159 (1%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   G   E+ A 
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
           + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    PG+     C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G+P Y+APEVL  + Y + VD WS+G I + LL GYPPF
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  123 bits (308), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 62/159 (38%), Positives = 96/159 (60%), Gaps = 2/159 (1%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   G   E+ A 
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
           + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    PG+     C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G+P Y+APEVL  + Y + VD WS+G I + LL GYPPF
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  123 bits (308), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 67/160 (41%), Positives = 99/160 (61%), Gaps = 6/160 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 201 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 259
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 260 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 131 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 359

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  122 bits (307), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 67/160 (41%), Positives = 99/160 (61%), Gaps = 6/160 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 131 LYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            Y+APEVL       Y+  VD WS+G ILF  L+GYPPFS
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  122 bits (307), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 62/159 (38%), Positives = 96/159 (60%), Gaps = 2/159 (1%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   G   E+ A 
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
           + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    PG+     C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G+P Y+APEVL  + Y + VD WS+G I + LL GYPPF
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  122 bits (307), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 71/174 (40%), Positives = 102/174 (58%), Gaps = 12/174 (6%)
Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LN+     LD       E+  L    HP+II+L+      + IF+V+E+ +GG L  
Sbjct: 46  VKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFD 105
Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           YI  +GR+ E+ +R+  QQ+  G++  + H ++HRDLKPEN+L   LD  +  KIADFGL
Sbjct: 106 YICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGL 162
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 166
           S  +  G +    CGSP Y APEV+  + Y   +VD+WS G IL+ LL G  PF
Sbjct: 163 SNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF 216

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  120 bits (301), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 64/166 (38%), Positives = 97/166 (58%), Gaps = 2/166 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KK  K  +S ++ E+  L  + H NI+ L D +++ N ++LV++  +GG L   I   G 
Sbjct: 57  KKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGF 116
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E+ A   ++Q+   +  L+   I+HRDLKPEN+L    D++  + I+DFGLS     G
Sbjct: 117 YTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG 176
Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +     CG+P Y+APEVL  + Y + VD WS+G I + LL GYPPF
Sbjct: 177 DVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  120 bits (301), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 63/169 (37%), Positives = 102/169 (60%), Gaps = 12/169 (7%)
Query: 7   KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + ++     E + L  V  HP+II L D++++ + +FLV +    G L  Y+     + E
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE 199
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
           +  R  ++ L   +  L++++I+HRDLKPENILL   DD++ ++++DFG SC L PG   
Sbjct: 200 KETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKL 256
Query: 124 EKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPF 166
            ++CG+P Y+APE+L+         Y ++VD+W+ G ILF LL G PPF
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  120 bits (300), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 73/177 (41%), Positives = 100/177 (56%), Gaps = 3/177 (1%)
Query: 2   LKKLNKHL-KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           LK L K + K  +  E+  L  ++HPNII+L + F+    I LV+E   GG L   I   
Sbjct: 83  LKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK 142
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           G   E+ A   ++Q+   +  L+ + I+HRDLKPEN+L +    D  LKIADFGLS  + 
Sbjct: 143 GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202
Query: 119 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
                + VCG+P Y APE+L+   Y  +VDMWSVG I + LL G+ PF      QFM
Sbjct: 203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  120 bits (300), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 65/172 (37%), Positives = 96/172 (55%), Gaps = 3/172 (1%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            K  K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
             A + ++Q+  G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         
Sbjct: 126 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 124 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           +   G+  Y+APEVL    YDEK D+WS G IL+ LL+G PPF+   E+  +
Sbjct: 186 KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  120 bits (300), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 65/172 (37%), Positives = 96/172 (55%), Gaps = 3/172 (1%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            K  K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E
Sbjct: 72  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 131
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
             A + ++Q+  G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         
Sbjct: 132 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 191
Query: 124 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           +   G+  Y+APEVL    YDEK D+WS G IL+ LL+G PPF+   E+  +
Sbjct: 192 KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 242

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  119 bits (299), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 65/172 (37%), Positives = 96/172 (55%), Gaps = 3/172 (1%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            K  K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E
Sbjct: 89  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 148
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
             A + ++Q+  G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         
Sbjct: 149 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 208
Query: 124 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           +   G+  Y+APEVL    YDEK D+WS G IL+ LL+G PPF+   E+  +
Sbjct: 209 KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 259

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  119 bits (299), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 65/172 (37%), Positives = 96/172 (55%), Gaps = 3/172 (1%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            K  K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E
Sbjct: 90  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 149
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
             A + ++Q+  G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         
Sbjct: 150 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 209
Query: 124 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           +   G+  Y+APEVL    YDEK D+WS G IL+ LL+G PPF+   E+  +
Sbjct: 210 KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 260

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  119 bits (298), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 63/149 (42%), Positives = 92/149 (61%), Gaps = 7/149 (4%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGL 77
           LS V HP IIR++  FQ    IF+++++  GG L S +R   R P   A+ +  +  L L
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           E L+S  II+RDLKPENILL   D +  +KI DFG +   Y  +    +CG+P Y+APEV
Sbjct: 120 EYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAK--YVPDVTYXLCGTPDYIAPEV 174
Query: 138 LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +  + Y++ +D WS G +++E+L GY PF
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  117 bits (294), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 65/172 (37%), Positives = 94/172 (54%), Gaps = 3/172 (1%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            K  K  L  E+  L  ++HPNI +L++ F+ +   +LV E   GG L   I    R  E
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
             A + ++Q+  G+   + + I+HRDLKPEN+LL     D  ++I DFGLS         
Sbjct: 126 VDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKX 185
Query: 124 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           +   G+  Y+APEVL    YDEK D+WS G IL+ LL+G PPF+   E+  +
Sbjct: 186 KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  117 bits (292), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 66/179 (36%), Positives = 100/179 (55%), Gaps = 8/179 (4%)
Query: 3   KKLNKHLKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           KK+ K+    +D    E+  + S++HPNIIRL++ F+    I+LV+E C GG L   + +
Sbjct: 40  KKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-V 98
Query: 60  HGRV-PEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
           H RV  E  A + ++ +   +   H  ++ HRDLKPEN L      D  LK+ DFGL+  
Sbjct: 99  HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158
Query: 117 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
             PG       G+P Y++P+VL+   Y  + D WS G +++ LL GYPPFS   + + M
Sbjct: 159 FKPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM 216

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  117 bits (292), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 66/179 (36%), Positives = 100/179 (55%), Gaps = 8/179 (4%)
Query: 3   KKLNKHLKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           KK+ K+    +D    E+  + S++HPNIIRL++ F+    I+LV+E C GG L   + +
Sbjct: 57  KKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-V 115
Query: 60  HGRV-PEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
           H RV  E  A + ++ +   +   H  ++ HRDLKPEN L      D  LK+ DFGL+  
Sbjct: 116 HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 175
Query: 117 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
             PG       G+P Y++P+VL+   Y  + D WS G +++ LL GYPPFS   + + M
Sbjct: 176 FKPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM 233

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  115 bits (288), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 62/169 (36%), Positives = 102/169 (60%), Gaps = 8/169 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A 
Sbjct: 52  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 111
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +K+ DFG++  +  GN  +
Sbjct: 112 QFLKQILDGVHYLHSKRIAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHKIEAGNEFK 169
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF +GE  Q
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGETKQ 217

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  115 bits (288), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 62/169 (36%), Positives = 102/169 (60%), Gaps = 8/169 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A 
Sbjct: 59  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 118
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +K+ DFG++  +  GN  +
Sbjct: 119 QFLKQILDGVHYLHSKRIAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHKIEAGNEFK 176
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF +GE  Q
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGETKQ 224

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  115 bits (287), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 62/169 (36%), Positives = 102/169 (60%), Gaps = 8/169 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A 
Sbjct: 73  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 132
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +K+ DFG++  +  GN  +
Sbjct: 133 QFLKQILDGVHYLHSKRIAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHKIEAGNEFK 190
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF +GE  Q
Sbjct: 191 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGETKQ 238

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 91/156 (58%), Gaps = 6/156 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+R+++ F     I+L++EF   G L   ++ HGR  EQ +  F+
Sbjct: 62  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 121
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
           ++L   L   +   +IHRD+KPEN+L+    +   LKIADFG S    P      +CG+ 
Sbjct: 122 EELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHA-PSLRRRXMCGTL 177
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            Y+ PE+++ + +DEKVD+W  G + +E L G PPF
Sbjct: 178 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  113 bits (283), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 91/156 (58%), Gaps = 6/156 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+R+++ F     I+L++EF   G L   ++ HGR  EQ +  F+
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
           ++L   L   +   +IHRD+KPEN+L+    +   LKIADFG S    P      +CG+ 
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHA-PSLRRRXMCGTL 176
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            Y+ PE+++ + +DEKVD+W  G + +E L G PPF
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 62/167 (37%), Positives = 94/167 (56%), Gaps = 3/167 (1%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           +KK      S L+ E+  L  + H NI+ L D +++    +LV++  +GG L   I   G
Sbjct: 42  IKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG 101
Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
              E+ A   +QQ+   ++ L+ + I+HRDLKPEN+L    +++  + I DFGLS  +  
Sbjct: 102 VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS-KMEQ 160
Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                  CG+P Y+APEVL  + Y + VD WS+G I + LL GYPPF
Sbjct: 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  112 bits (279), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/174 (36%), Positives = 95/174 (54%), Gaps = 2/174 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
                  G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF   ++H+ 
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 215

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  112 bits (279), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/174 (36%), Positives = 95/174 (54%), Gaps = 2/174 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
                  G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF   ++H+ 
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 215

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  112 bits (279), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/174 (36%), Positives = 95/174 (54%), Gaps = 2/174 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 41  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 101 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 160
Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
                  G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF   ++H+ 
Sbjct: 161 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 214

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  112 bits (279), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/174 (36%), Positives = 95/174 (54%), Gaps = 2/174 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 65  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
                  G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF   ++H+ 
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 238

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  112 bits (279), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/176 (38%), Positives = 95/176 (53%), Gaps = 5/176 (2%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +LV +   GG L   I     
Sbjct: 40  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 99
Query: 63  VPEQTARKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
             E  A   +QQ+ LE +N  H   I+HRDLKPEN+LL+       +K+ADFGL+  +  
Sbjct: 100 YSEADASHCIQQI-LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG 158
Query: 120 GNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
              A     G+P Y++PEVL+   Y + VDMW+ G IL+ LL GYPPF   ++H+ 
Sbjct: 159 DQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRL 214

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/176 (38%), Positives = 95/176 (53%), Gaps = 5/176 (2%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +LV +   GG L   I     
Sbjct: 40  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 99
Query: 63  VPEQTARKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
             E  A   +QQ+ LE +N  H   I+HRDLKPEN+LL+       +K+ADFGL+  +  
Sbjct: 100 YSEADASHCIQQI-LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG 158
Query: 120 GNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
              A     G+P Y++PEVL+   Y + VDMW+ G IL+ LL GYPPF   ++H+ 
Sbjct: 159 DQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRL 214

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 101/162 (62%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 104 KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 162
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 163 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGATWT- 218
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 219 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 102/162 (62%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG++ S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +K+ADFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 102/162 (62%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG++ S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +K+ADFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 101/162 (62%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +K+ADFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  110 bits (276), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 97/153 (63%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 78  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 137
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D+   +++ DFG +  +    +   +CG+P Y+
Sbjct: 138 VLTFEYLHSLDLIYRDLKPENLLI---DEQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 192
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 59/169 (34%), Positives = 103/169 (60%), Gaps = 8/169 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF   E  Q
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQ 245

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 96/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+++   D    +K+ DFGL+  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGLAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  110 bits (275), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 96/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 101/162 (62%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 96/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 101/162 (62%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  110 bits (275), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 96/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 101/162 (62%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  110 bits (274), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 63/163 (38%), Positives = 96/163 (58%), Gaps = 6/163 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + L+ VNHP +++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +L
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPLY 132
             GL+ L+S  II+RDLKPENILL   D++  +K+ DFGLS   +     A   CG+  Y
Sbjct: 140 ALGLDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEY 196
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           MAPEV+  Q +    D WS G ++FE+L G  PF   +  + M
Sbjct: 197 MAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETM 239

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 96/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  110 bits (274), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 102/173 (58%), Gaps = 9/173 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 46  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 104
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 105 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 164
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +      N   + C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 165 AKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  110 bits (274), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 60/166 (36%), Positives = 102/166 (61%), Gaps = 8/166 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAEKVC 127
           +Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  + + 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           G+P ++APE++ ++    + DMWS+G I + LL+G  PF +G+  Q
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQ 223

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  110 bits (274), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 101/162 (62%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 104 KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP 162
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 163 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 218
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 219 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 101/162 (62%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  110 bits (274), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 96/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 86  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 145
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 146 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 200
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 96/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 57/162 (35%), Positives = 101/162 (62%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  109 bits (273), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 9/173 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 46  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 104
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 105 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 164
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 165 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  109 bits (273), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 9/173 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 62  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 120
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 121 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 180
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 181 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  109 bits (273), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 9/173 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 47  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 105
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 106 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 165
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 166 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  109 bits (273), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 9/173 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 52  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 110
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 111 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 170
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 171 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  109 bits (273), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 9/173 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 53  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 111
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 112 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 171
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 172 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  109 bits (273), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 60/169 (35%), Positives = 103/169 (60%), Gaps = 8/169 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF +G+  Q
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQ 223

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  109 bits (273), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 9/173 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 92  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 150
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 151 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  109 bits (273), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 9/173 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 48  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 167 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  109 bits (273), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 9/173 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 54  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 112
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 113 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 172
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 173 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  109 bits (273), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 9/173 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 48  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 167 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  109 bits (273), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 101/162 (62%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+++   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLII---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  109 bits (273), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 60/169 (35%), Positives = 103/169 (60%), Gaps = 8/169 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF +G+  Q
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQ 223

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  109 bits (272), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 60/169 (35%), Positives = 103/169 (60%), Gaps = 8/169 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF +G+  Q
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQ 223

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  109 bits (272), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 63/173 (36%), Positives = 101/173 (58%), Gaps = 9/173 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 98  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 156
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 157 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 216
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 217 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 60/169 (35%), Positives = 103/169 (60%), Gaps = 8/169 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF +G+  Q
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQ 223

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 7/162 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 60/169 (35%), Positives = 103/169 (60%), Gaps = 8/169 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF +G+  Q
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQ 223

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 95/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+++   D    +K+ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 7/162 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 60/169 (35%), Positives = 103/169 (60%), Gaps = 8/169 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF +G+  Q
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQ 223

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 60/166 (36%), Positives = 102/166 (61%), Gaps = 8/166 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAEKVC 127
           +Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  + + 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           G+P ++APE++ ++    + DMWS+G I + LL+G  PF +G+  Q
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQ 223

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 95/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E     +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +K+ADFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 7/162 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 7/162 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 99/162 (61%), Gaps = 7/162 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+++   D    +K+ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 96/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++++  GYPPF
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 96/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+++   D    +++ DFGL+  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLMI---DQQGYIQVTDFGLAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 59/173 (34%), Positives = 98/173 (56%), Gaps = 17/173 (9%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I    +    +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 64  PEQTARKFLQQLGLEILN-------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
            E+   + + QL L +          H ++HRDLKP N+ L G  +   +K+ DFGL+  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARI 165
Query: 117 L-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           L +  ++A++  G+P YM+PE +    Y+EK D+WS+G +L+EL    PPF+ 
Sbjct: 166 LNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+++   D    +K+ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWT- 198
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 59/173 (34%), Positives = 97/173 (56%), Gaps = 17/173 (9%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I    +    +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 64  PEQTARKFLQQLGLEILN-------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
            E+   + + QL L +          H ++HRDLKP N+ L G  +   +K+ DFGL+  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARI 165
Query: 117 L-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           L +  ++A+   G+P YM+PE +    Y+EK D+WS+G +L+EL    PPF+ 
Sbjct: 166 LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 69  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 127
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 128 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWT- 183
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 184 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 59/173 (34%), Positives = 97/173 (56%), Gaps = 17/173 (9%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I    +    +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 64  PEQTARKFLQQLGLEILN-------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
            E+   + + QL L +          H ++HRDLKP N+ L G  +   +K+ DFGL+  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARI 165
Query: 117 L-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           L +  ++A+   G+P YM+PE +    Y+EK D+WS+G +L+EL    PPF+ 
Sbjct: 166 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 95/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 93/153 (60%), Gaps = 6/153 (3%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 165
Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 135
           L  L+   II+RDLK +N+LL   D +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 166 LNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222
Query: 136 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           E+L+ + Y   VD W++G ++FE++ G  PF +
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 95/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/164 (37%), Positives = 96/164 (58%), Gaps = 6/164 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134
Query: 75  LGLEI--LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 131
           L L +  L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  
Sbjct: 135 LALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           YMAPEV+  + + +  D WS G ++FE+L G  PF   +  + M
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 104 KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 162
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 163 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 218
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 219 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 93/153 (60%), Gaps = 6/153 (3%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 74  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 133
Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 135
           L  L+   II+RDLK +N+LL   D +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 134 LNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 190
Query: 136 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           E+L+ + Y   VD W++G ++FE++ G  PF +
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 223

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/164 (37%), Positives = 96/164 (58%), Gaps = 6/164 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 76  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 135
Query: 75  LGLEI--LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 131
           L L +  L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  
Sbjct: 136 LALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 192
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           YMAPEV+  + + +  D WS G ++FE+L G  PF   +  + M
Sbjct: 193 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 236

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 63/175 (36%), Positives = 94/175 (53%), Gaps = 3/175 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +L+ +   GG L   I     
Sbjct: 58  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 117
Query: 63  VPEQTARKFLQQLGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +L+ H   ++HRDLKPEN+LL+       +K+ADFGL+  +   
Sbjct: 118 YSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE 177
Query: 121 NYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
             A     G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF   ++H+ 
Sbjct: 178 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 232

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 99/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P + +L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+++   D    +K+ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKGRTWX- 198
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   R  EQ    ++
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI 118
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSVHA-PSSRRDTLCGTL 174
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 99/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P + +L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+++   D    +K+ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKGRTWX- 198
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 142
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 95/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 143
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 144 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 198
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 95/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           AP ++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 206 APAIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI 119
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 175
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 62/164 (37%), Positives = 96/164 (58%), Gaps = 6/164 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134
Query: 75  LGLEI--LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 131
           L L +  L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  
Sbjct: 135 LALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           YMAPEV+  + + +  D WS G ++FE+L G  PF   +  + M
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRDTLCGTL 171
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP 142
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 198
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 99/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P + +L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 84  KQIEHTLN-EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP 142
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+++   D    +K+ DFG +  +    +  
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKGRTWX- 198
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 98/162 (60%), Gaps = 7/162 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L+ E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+++   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +CG+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/176 (37%), Positives = 94/176 (53%), Gaps = 5/176 (2%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +LV +   GG L   I     
Sbjct: 67  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 126
Query: 63  VPEQTARKFLQQLGLEILN---SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
             E  A   + Q+ LE +N    H I+HRDLKPEN+LL+       +K+ADFGL+  +  
Sbjct: 127 YSEADASHCIHQI-LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG 185
Query: 120 GNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
              A     G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF   ++H+ 
Sbjct: 186 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKL 241

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            + G+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 93/153 (60%), Gaps = 6/153 (3%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 59  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 118
Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 135
           L  L+   II+RDLK +N+LL   D +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 119 LNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 175
Query: 136 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           E+L+ + Y   VD W++G ++FE++ G  PF +
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 208

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 93/153 (60%), Gaps = 6/153 (3%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 135
           L  L+   II+RDLK +N+LL   D +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 123 LNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 179
Query: 136 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           E+L+ + Y   VD W++G ++FE++ G  PF +
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 95/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 143
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 144 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 198
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   R  EQ    ++
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI 118
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSVHA-PSSRRTTLCGTL 174
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +   ++CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTELCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  107 bits (267), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRDDLCGTL 173
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  107 bits (266), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 63/175 (36%), Positives = 94/175 (53%), Gaps = 3/175 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + H NI+RL D+   E   +LV +   GG L   I     
Sbjct: 40  KKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 99
Query: 63  VPEQTARKFLQQLGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +L+ H   ++HRDLKPEN+LL+       +K+ADFGL+  +   
Sbjct: 100 YSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD 159
Query: 121 NYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
             A     G+P Y++PEVL+ + Y + VD+W+ G IL+ LL GYPPF   ++H+ 
Sbjct: 160 QQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKL 214

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  107 bits (266), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 173
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  107 bits (266), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 91/158 (57%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 140
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRDDLCGTL 196
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  107 bits (266), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 175
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 58/156 (37%), Positives = 91/156 (58%), Gaps = 6/156 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N L  V HP I+ L  AFQ    ++L++E+ +GG L   +   G   E TA  +L +
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 75  LGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           + + + + H   II+RDLKPENI+L   +    +K+ DFGL   +++ G      CG+  
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           YMAPE+L    ++  VD WS+GA+++++L G PPF+
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  107 bits (266), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG SC   P +    + G+ 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSCHA-PSSRRTTLSGTL 171
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 173
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 95/153 (62%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +   +CG+P  +
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX--LCGTPEAL 205
Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 58/156 (37%), Positives = 91/156 (58%), Gaps = 6/156 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N L  V HP I+ L  AFQ    ++L++E+ +GG L   +   G   E TA  +L +
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 75  LGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           + + + + H   II+RDLKPENI+L   +    +K+ DFGL   +++ G      CG+  
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           YMAPE+L    ++  VD WS+GA+++++L G PPF+
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 118
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 174
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 212

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRAALCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 52  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 111
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 112 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 167
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 168 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 205

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 72  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 131
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 132 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 187
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 225

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 54  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 113
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 114 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 169
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 171
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  107 bits (266), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLCGTL 173
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  106 bits (265), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 175
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  106 bits (265), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  106 bits (265), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 100/162 (61%), Gaps = 8/162 (4%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            + G+P Y+APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 198 -LXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  106 bits (265), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  106 bits (265), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRAALCGTL 173
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  106 bits (265), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 57  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 116
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLCGTL 172
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  106 bits (265), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTXLCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  106 bits (265), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKKVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRAALCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  106 bits (265), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 92/149 (61%), Gaps = 9/149 (6%)
Query: 26  PNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLG--L 77
           P+I+ + D ++     + C+ +++E   GG L S I+  G     E+ A + ++ +G  +
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           + L+SH+I HRD+KPEN+L +  + D +LK+ DFG +      N  +  C +P Y+APEV
Sbjct: 123 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET-TQNALQTPCYTPYYVAPEV 181
Query: 138 LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           L  ++YD+  DMWS+G I++ LL G+PPF
Sbjct: 182 LGPEKYDKSCDMWSLGVIMYILLCGFPPF 210

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  106 bits (265), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 89/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 175
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE ++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  106 bits (265), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  106 bits (265), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  106 bits (265), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 92/149 (61%), Gaps = 9/149 (6%)
Query: 26  PNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLG--L 77
           P+I+ + D ++     + C+ +++E   GG L S I+  G     E+ A + ++ +G  +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           + L+SH+I HRD+KPEN+L +  + D +LK+ DFG +      N  +  C +P Y+APEV
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEV 200
Query: 138 LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           L  ++YD+  DMWS+G I++ LL G+PPF
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  106 bits (265), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 140
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 196
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  106 bits (264), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 62/175 (35%), Positives = 94/175 (53%), Gaps = 3/175 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +L+ +   GG L   I     
Sbjct: 47  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 106
Query: 63  VPEQTARKFLQQLGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +L+ H   ++HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 121 NYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
             A     G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF   ++H+ 
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  106 bits (264), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 100/168 (59%), Gaps = 6/168 (3%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C   +L    +    V 
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVT 140
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR F++Q   G++ L+++ +IHRDLK  N+ L   +DD+ +KI DFGL+  + + G 
Sbjct: 141 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGE 197
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
             + +CG+P Y+APEVL  + +  +VD+WS+G IL+ LL G PPF   
Sbjct: 198 RKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  105 bits (263), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 100/168 (59%), Gaps = 6/168 (3%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C   +L    +    V 
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVT 140
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR F++Q   G++ L+++ +IHRDLK  N+ L   +DD+ +KI DFGL+  + + G 
Sbjct: 141 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGE 197
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
             + +CG+P Y+APEVL  + +  +VD+WS+G IL+ LL G PPF   
Sbjct: 198 RKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  105 bits (263), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 100/168 (59%), Gaps = 6/168 (3%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C   +L    +    V 
Sbjct: 65  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVT 124
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR F++Q   G++ L+++ +IHRDLK  N+ L   +DD+ +KI DFGL+  + + G 
Sbjct: 125 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGE 181
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
             + +CG+P Y+APEVL  + +  +VD+WS+G IL+ LL G PPF   
Sbjct: 182 RKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  105 bits (263), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 58/168 (34%), Positives = 100/168 (59%), Gaps = 6/168 (3%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C   +L    +    V 
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVT 140
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR F++Q   G++ L+++ +IHRDLK  N+ L   +DD+ +KI DFGL+  + + G 
Sbjct: 141 EPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGE 197
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
             + +CG+P Y+APEVL  + +  +VD+WS+G IL+ LL G PPF   
Sbjct: 198 RKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 56/156 (35%), Positives = 93/156 (59%), Gaps = 7/156 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++  S ++H NI+ + D  + ++C +LV+E+  G  LS YI  HG +   TA  F  Q+
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI 120
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPL 131
             G++  +   I+HRD+KP+NIL   +D +  LKI DFG++  L   +  +   V G+  
Sbjct: 121 LDGIKHAHDMRIVHRDIKPQNIL---IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           Y +PE  + +  DE  D++S+G +L+E+L G PPF+
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 99/177 (55%), Gaps = 11/177 (6%)
Query: 1   MLKKLNKHLKSC----LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           ++K +NK         ++ E+  L S++HPNII++F+ F+  + +++V+E C GG L   
Sbjct: 51  VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER 110
Query: 57  I---RLHGR-VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           I   +  G+ + E    + ++Q+   L   +S H++H+DLKPENIL         +KI D
Sbjct: 111 IVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170
Query: 111 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           FGL+       ++    G+ LYMAPEV + +    K D+WS G +++ LL G  PF+
Sbjct: 171 FGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIA+FG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIANFGWSVHA-PSSRRTTLCGTL 173
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 90/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 57  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 116
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIA+FG S    P +    +CG+ 
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIANFGWSVHA-PSSRRTTLCGTL 172
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 95/159 (59%), Gaps = 7/159 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E++ L  V HPNII L D ++    + L++E  +GG L  ++     + E+ A  F+
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAEKVC 127
           +Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   + + 
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  104 bits (259), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/173 (35%), Positives = 97/173 (56%), Gaps = 9/173 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V E   GG L S I
Sbjct: 92  LKXLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRI 150
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A +  + +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 151 QDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +      N     C +P Y+APEVL  ++YD+  D WS+G I + LL GYPPF
Sbjct: 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  103 bits (258), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 89/158 (56%), Gaps = 6/158 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI 119
Query: 73  QQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    + G+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLXGTL 175
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            Y+ PE+++ + +DEKVD+WS+G + +E L G PPF  
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  103 bits (257), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 97/168 (57%), Gaps = 6/168 (3%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 56  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 115
Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR +L+Q  LG + L+ + +IHRDLK  N+ L   ++D+ +KI DFGL+  + Y G 
Sbjct: 116 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE 172
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
             + +CG+P Y+APEVL  + +  +VD+WS+G I++ LL G PPF   
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  103 bits (256), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 97/168 (57%), Gaps = 6/168 (3%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 56  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 115
Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR +L+Q  LG + L+ + +IHRDLK  N+ L   ++D+ +KI DFGL+  + Y G 
Sbjct: 116 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE 172
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
             + +CG+P Y+APEVL  + +  +VD+WS+G I++ LL G PPF   
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  103 bits (256), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 97/168 (57%), Gaps = 6/168 (3%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 60  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 119
Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR +L+Q  LG + L+ + +IHRDLK  N+ L   ++D+ +KI DFGL+  + Y G 
Sbjct: 120 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE 176
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
             + +CG+P Y+APEVL  + +  +VD+WS+G I++ LL G PPF   
Sbjct: 177 RKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  103 bits (256), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 91/161 (56%), Gaps = 8/161 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  103 bits (256), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 57/159 (35%), Positives = 93/159 (58%), Gaps = 11/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV---PEQTARKFL 72
           E+     + HP+I+ L++ F+  N ++LV+E C  G ++ Y++   RV    E  AR F+
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFM 118
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            Q+  G+  L+SH I+HRDL   N+LL+    ++ +KIADFGL+  L  P      +CG+
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHYTLCGT 175
Query: 130 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           P Y++PE+     +  + D+WS+G + + LL G PPF  
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  103 bits (256), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 199 QYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEY 240

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  102 bits (255), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 139 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 237

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  102 bits (255), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 97/168 (57%), Gaps = 6/168 (3%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 54  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 113
Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR +L+Q  LG + L+ + +IHRDLK  N+ L   ++D+ +KI DFGL+  + Y G 
Sbjct: 114 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE 170
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
             + +CG+P Y+APEVL  + +  +VD+WS+G I++ LL G PPF   
Sbjct: 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  102 bits (255), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 139 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 237

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  102 bits (255), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 143 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 241

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  102 bits (255), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 240

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 238

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 123
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 124 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 222

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 116
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 117 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 215

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 238

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 240

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 216

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 97/168 (57%), Gaps = 6/168 (3%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 78  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 137
Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR +L+Q  LG + L+ + +IHRDLK  N+ L   ++D+ +KI DFGL+  + Y G 
Sbjct: 138 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE 194
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
             + +CG+P Y+APEVL  + +  +VD+WS+G I++ LL G PPF   
Sbjct: 195 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 238

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 238

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 144
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 145 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 243

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 97/168 (57%), Gaps = 6/168 (3%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 80  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 139
Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR +L+Q  LG + L+ + +IHRDLK  N+ L   ++D+ +KI DFGL+  + Y G 
Sbjct: 140 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE 196
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
             + +CG+P Y+APEVL  + +  +VD+WS+G I++ LL G PPF   
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 118
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 119 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 217

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 240

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 143 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 241

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  102 bits (254), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 119
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 120 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 218

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  101 bits (252), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 91/161 (56%), Gaps = 8/161 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  101 bits (252), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 8/162 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 87  ERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 146
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 147 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            Y++PE+L  +   +  D+W++G I+++L+ G PPF  G E+
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 245

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  101 bits (252), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/160 (38%), Positives = 94/160 (58%), Gaps = 12/160 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E++ L+S +HPNI++L DAF  EN +++++EFCAGG + + +    R   ++  + + +
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 75  LGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 130
             L+ LN  H   IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRTIQRRDSFIGTP 199
Query: 131 LYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYPP 165
            +MAPEV+     + + YD K D+WS+G  L E+    PP
Sbjct: 200 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  101 bits (252), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 83/153 (54%), Gaps = 4/153 (2%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
           S+ HPNI+R  +       + +++E+ +GG L   I   GR  E  AR F QQL  G+  
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            +S  I HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+APEVL 
Sbjct: 132 CHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190
Query: 140 FQRYDEKV-DMWSVGAILFELLNGYPPFSVGEE 171
            Q YD K+ D+WS G  L+ +L G  PF   EE
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/160 (38%), Positives = 94/160 (58%), Gaps = 12/160 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E++ L+S +HPNI++L DAF  EN +++++EFCAGG + + +    R   ++  + + +
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 75  LGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 130
             L+ LN  H   IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRXIQRRDSFIGTP 199
Query: 131 LYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYPP 165
            +MAPEV+     + + YD K D+WS+G  L E+    PP
Sbjct: 200 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  100 bits (250), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 61/160 (38%), Positives = 94/160 (58%), Gaps = 12/160 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E++ L+S +HPNI++L DAF  EN +++++EFCAGG + + +    R   ++  + + +
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 75  LGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 130
             L+ LN  H   IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRXIQRRDXFIGTP 199
Query: 131 LYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYPP 165
            +MAPEV+     + + YD K D+WS+G  L E+    PP
Sbjct: 200 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 62/167 (37%), Positives = 94/167 (56%), Gaps = 9/167 (5%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KK  KH+ S  +     L +V HP ++ L  +FQ  + ++ V+++  GG L  +++    
Sbjct: 79  KKEEKHIMSERNV---LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC 135
Query: 63  VPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYP 119
             E  AR +  ++   L  L+S +I++RDLKPENILL   D    + + DFGL    +  
Sbjct: 136 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEH 192
Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +     CG+P Y+APEVL  Q YD  VD W +GA+L+E+L G PPF
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 83/153 (54%), Gaps = 4/153 (2%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL  G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            ++  + HRDLK EN LL G      LKIADFG S      +  +   G+P Y+APEVL 
Sbjct: 131 AHAMQVAHRDLKLENTLLDG-SPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLL 189
Query: 140 FQRYDEKV-DMWSVGAILFELLNGYPPFSVGEE 171
            + YD KV D+WS G  L+ +L G  PF   EE
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 55/145 (37%), Positives = 82/145 (56%), Gaps = 3/145 (2%)
Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH 84
           HPNI++L + F  +   FLV+E   GG L   I+      E  A   +++L   + + H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 85  I--IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLYMAPEVLQFQ 141
           +  +HRDLKPEN+L +  +D++ +KI DFG +    P N   K  C +  Y APE+L   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 142 RYDEKVDMWSVGAILFELLNGYPPF 166
            YDE  D+WS+G IL+ +L+G  PF
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  100 bits (248), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 95/162 (58%), Gaps = 7/162 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  100 bits (248), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 94/159 (59%), Gaps = 7/159 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A  F+
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAEKVC 127
           +Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   + + 
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  100 bits (248), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 94/159 (59%), Gaps = 7/159 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A  F+
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAEKVC 127
           +Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   + + 
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  100 bits (248), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 94/159 (59%), Gaps = 7/159 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A  F+
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAEKVC 127
           +Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   + + 
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 95/162 (58%), Gaps = 7/162 (4%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            + G+P ++APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 99.8 bits (247), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 62/167 (37%), Positives = 94/167 (56%), Gaps = 7/167 (4%)
Query: 11  SCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   LS +  HP +  +F  FQ +  +F V+E+  GG+L  +I+   +     A 
Sbjct: 63  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 122
Query: 70  KFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKV 126
            +  +  LGL+ L+S  I++RDLK +NILL   D D  +KIADFG+      G+    + 
Sbjct: 123 FYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNEF 179
Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           CG+P Y+APE+L  Q+Y+  VD WS G +L+E+L G  PF   +E +
Sbjct: 180 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 226

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 62/167 (37%), Positives = 93/167 (55%), Gaps = 7/167 (4%)
Query: 11  SCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   LS +  HP +  +F  FQ +  +F V+E+  GG+L  +I+   +     A 
Sbjct: 62  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 121
Query: 70  KFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKV 126
            +  +  LGL+ L+S  I++RDLK +NILL   D D  +KIADFG+      G+      
Sbjct: 122 FYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNXF 178
Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           CG+P Y+APE+L  Q+Y+  VD WS G +L+E+L G  PF   +E +
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/153 (40%), Positives = 83/153 (54%), Gaps = 4/153 (2%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL  G+  
Sbjct: 70  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 129
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            ++  + HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+APEVL 
Sbjct: 130 CHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 188
Query: 140 FQRYDEKV-DMWSVGAILFELLNGYPPFSVGEE 171
            + YD KV D+WS G  L+ +L G  PF   EE
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 221

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/153 (40%), Positives = 83/153 (54%), Gaps = 4/153 (2%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL  G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            ++  + HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+APEVL 
Sbjct: 131 CHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 140 FQRYDEKV-DMWSVGAILFELLNGYPPFSVGEE 171
            + YD KV D+WS G  L+ +L G  PF   EE
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/165 (37%), Positives = 91/165 (55%), Gaps = 7/165 (4%)
Query: 11  SCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   LS + NHP + +LF  FQ  + +F V+EF  GG+L  +I+   R  E  AR
Sbjct: 68  ECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR 127
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKV 126
            +  ++   L  L+   II+RDLK +N+LL   D +   K+ADFG+    +  G      
Sbjct: 128 FYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATF 184
Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           CG+P Y+APE+LQ   Y   VD W++G +L+E+L G+ PF    E
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 89/151 (58%), Gaps = 6/151 (3%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH 83
           P + +L   FQ  + ++ V+E+  GG+L  +I+  GR  E  A  +  ++  GL  L S 
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAPEVLQFQR 142
            II+RDLK +N++L   D +  +KIADFG+    ++ G   +  CG+P Y+APE++ +Q 
Sbjct: 141 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 197
Query: 143 YDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           Y + VD W+ G +L+E+L G  PF   +E +
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 40  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 99
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 156
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 58/160 (36%), Positives = 92/160 (57%), Gaps = 4/160 (2%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL-SSYIRLHGRVPEQTA 68
           K  +  E++ ++ ++H N+I+L+DAF+++N I LV+E+  GG L    I     + E   
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
             F++Q+  G+  ++  +I+H DLKPENIL    D    +KI DFGL+    P    +  
Sbjct: 190 ILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVN 248
Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            G+P ++APEV+ +       DMWSVG I + LL+G  PF
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/170 (35%), Positives = 93/170 (54%), Gaps = 15/170 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 166
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/170 (35%), Positives = 93/170 (54%), Gaps = 15/170 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 166
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 93/171 (54%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 89/151 (58%), Gaps = 6/151 (3%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH 83
           P + +L   FQ  + ++ V+E+  GG+L  +I+  GR  E  A  +  ++  GL  L S 
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAPEVLQFQR 142
            II+RDLK +N++L   D +  +KIADFG+    ++ G   +  CG+P Y+APE++ +Q 
Sbjct: 462 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 518
Query: 143 YDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           Y + VD W+ G +L+E+L G  PF   +E +
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 92/155 (59%), Gaps = 9/155 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPL 131
           Q   LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P  +   ++ G+P 
Sbjct: 127 Q--ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSEMVGTPY 181
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +MAPEV+  + Y  KVD+WS+G +  E++ G PP+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 95/167 (56%), Gaps = 7/167 (4%)
Query: 11  SCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   L+ ++ P  + +L   FQ  + ++ V+E+  GG+L  +I+  G+  E  A 
Sbjct: 64  ECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKV 126
            +  ++  GL  L+   II+RDLK +N++L   D +  +KIADFG+    +  G    + 
Sbjct: 124 FYAAEISIGLFFLHKRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMMDGVTTREF 180
Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           CG+P Y+APE++ +Q Y + VD W+ G +L+E+L G PPF   +E +
Sbjct: 181 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 227

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 90/155 (58%), Gaps = 9/155 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPL 131
           Q   LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P       + G+P 
Sbjct: 128 Q--ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSXMVGTPY 182
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +MAPEV+  + Y  KVD+WS+G +  E++ G PP+
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 91/155 (58%), Gaps = 9/155 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPL 131
           Q   LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P  +    + G+P 
Sbjct: 127 Q--ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +MAPEV+  + Y  KVD+WS+G +  E++ G PP+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 97.1 bits (240), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 90/155 (58%), Gaps = 9/155 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPL 131
           Q   LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P       + G+P 
Sbjct: 127 Q--ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSXMVGTPY 181
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +MAPEV+  + Y  KVD+WS+G +  E++ G PP+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 96.3 bits (238), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 58/173 (33%), Positives = 94/173 (54%), Gaps = 12/173 (6%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIR 58
           +KL K  +     E   L  + HPNI+R +D++++    + CI LV E    G L +Y++
Sbjct: 62  RKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLK 121
Query: 59  LHGRVPEQTARKFLQQL--GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                  +  R + +Q+  GL+ L++    IIHRDLK +NI ++G    V  KI D GL+
Sbjct: 122 RFKVXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV--KIGDLGLA 179
Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            TL   ++A+ V G+P + APE  + ++YDE VD+++ G    E      P+S
Sbjct: 180 -TLKRASFAKAVIGTPEFXAPEXYE-EKYDESVDVYAFGXCXLEXATSEYPYS 230

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 93/166 (56%), Gaps = 12/166 (7%)
Query: 10  KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K+  DC  E++ L  +NHPN+I+ + +F  +N + +V+E    G+LS  I+   +    +
Sbjct: 74  KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 133
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           PE+T  K+  QL   LE ++S  ++HRD+KP N+ ++      ++K+ D GL        
Sbjct: 134 PERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 190
Query: 122 YA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            A   + G+P YM+PE +    Y+ K D+WS+G +L+E+     PF
Sbjct: 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 93/169 (55%), Gaps = 7/169 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTA 68
           L  E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEK 125
             +++Q+   L   + ++IIHRD+KPEN+LL+  ++   +K+ DFG++  L   G  A  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGG 192
Query: 126 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
             G+P +MAPEV++ + Y + VD+W  G ILF LL+G  PF   +E  F
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 241

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Composition-based stats.
 Identities = 52/154 (33%), Positives = 89/154 (57%), Gaps = 4/154 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   H ++ E  A ++++Q
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           +  GL  ++ ++ +H DLKPENI+ +    +  LK+ DFGL+  L P    +   G+  +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEF 322
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            APEV + +      DMWSVG + + LL+G  PF
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/153 (39%), Positives = 82/153 (53%), Gaps = 4/153 (2%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL  G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            ++  + HRDLK EN LL G      LKI  FG S +    +  +   G+P Y+APEVL 
Sbjct: 131 CHAMQVCHRDLKLENTLLDG-SPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 140 FQRYDEKV-DMWSVGAILFELLNGYPPFSVGEE 171
            + YD KV D+WS G  L+ +L G  PF   EE
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 91/155 (58%), Gaps = 9/155 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPL 131
           Q   LE L+S+ +IHR++K +NILL G+D  V  K+ DFG    + P  +    + G+P 
Sbjct: 128 Q--ALEFLHSNQVIHRNIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPY 182
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +MAPEV+  + Y  KVD+WS+G +  E++ G PP+
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/153 (39%), Positives = 82/153 (53%), Gaps = 4/153 (2%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL  G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            ++  + HRDLK EN LL G      LKI  FG S +    +  +   G+P Y+APEVL 
Sbjct: 131 CHAMQVCHRDLKLENTLLDG-SPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL 189
Query: 140 FQRYDEKV-DMWSVGAILFELLNGYPPFSVGEE 171
            + YD KV D+WS G  L+ +L G  PF   EE
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/159 (35%), Positives = 92/159 (57%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  + 
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 182
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 131
            L L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 132 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 166
           Y++PEVL+ Q     Y  + D WSVG  L+E+L G  PF
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 88/158 (55%), Gaps = 8/158 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  +  + HP ++ L+ +FQ E  +F+VV+   GG+L  +++ +    E+T + F+ +L
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL 124
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              L+ L +  IIHRD+KP+NIL   LD+   + I DF ++  L        + G+  YM
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNIL---LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 134 APEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSV 168
           APE+   ++   Y   VD WS+G   +ELL G  P+ +
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/159 (35%), Positives = 92/159 (57%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  + 
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 182
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 131
            L L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 132 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 166
           Y++PEVL+ Q     Y  + D WSVG  L+E+L G  PF
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/159 (35%), Positives = 92/159 (57%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  + 
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 177
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 131
            L L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 178 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 132 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 166
           Y++PEVL+ Q     Y  + D WSVG  L+E+L G  PF
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 91/160 (56%), Gaps = 4/160 (2%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTA 68
           K  +  E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   H ++ E  A
Sbjct: 92  KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 151
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
            ++++Q+  GL  ++ ++ +H DLKPENI+ +    +  LK+ DFGL+  L P    +  
Sbjct: 152 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVT 210
Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            G+  + APEV + +      DMWSVG + + LL+G  PF
Sbjct: 211 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 81/150 (54%), Gaps = 4/150 (2%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG--LEILN 81
            HPNII L D +     ++LV E   GG L   I       E+ A   L  +G  +E L+
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 82  SHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ 139
           S  ++HRDLKP NIL +    +   L+I DFG +  L   N      C +  ++APEVL+
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 140 FQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
            Q YDE  D+WS+G +L+ +L GY PF+ G
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFANG 228

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/159 (35%), Positives = 94/159 (59%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ A+ +  + 
Sbjct: 125 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEV 183
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 131
            L L+ ++S  +IHRD+KP+N+L   LD    LK+ADFG    +      + +   G+P 
Sbjct: 184 VLALDAIHSMGLIHRDVKPDNML---LDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPD 240
Query: 132 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 166
           Y++PEVL+ Q     Y  + D WSVG  LFE+L G  PF
Sbjct: 241 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/150 (38%), Positives = 81/150 (54%), Gaps = 4/150 (2%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG--LEILN 81
            HPNII L D +     ++LV E   GG L   I       E+ A   L  +G  +E L+
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 82  SHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ 139
           S  ++HRDLKP NIL +    +   L+I DFG +  L   N      C +  ++APEVL+
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 140 FQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
            Q YDE  D+WS+G +L+ +L GY PF+ G
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFANG 228

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 92/171 (53%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+ G+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 92/171 (53%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+ G+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 92/171 (53%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+ G+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 159 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/155 (36%), Positives = 85/155 (54%), Gaps = 15/155 (9%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG--LEILNSHH 84
           NI+ L + F+ +   +LV E   GG++ ++I+      E+ A + ++ +   L+ L++  
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG 131
Query: 85  IIHRDLKPENILLSGLDDDVMLKIADFGL--------SCTLYPGNYAEKVCGSPLYMAPE 136
           I HRDLKPENIL    +    +KI DF L        SCT          CGS  YMAPE
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 137 VL-----QFQRYDEKVDMWSVGAILFELLNGYPPF 166
           V+     Q   YD++ D+WS+G +L+ +L+GYPPF
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 92/171 (53%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+ G+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 92/171 (53%), Gaps = 15/171 (8%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFS 167
           N      K+ G+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+ 
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 94/176 (53%), Gaps = 26/176 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--------LHGRVPEQT 67
           E+  +S  +HPNI+  + +F  ++ ++LV++  +GG++   I+          G + E T
Sbjct: 58  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 117
Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----- 120
               L+++  GLE L+ +  IHRD+K  NILL    +D  ++IADFG+S  L  G     
Sbjct: 118 IATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITR 174
Query: 121 NYAEKV-CGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNG------YPPFSV 168
           N   K   G+P +MAPEV+ Q + YD K D+WS G    EL  G      YPP  V
Sbjct: 175 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 230

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 94/176 (53%), Gaps = 26/176 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--------LHGRVPEQT 67
           E+  +S  +HPNI+  + +F  ++ ++LV++  +GG++   I+          G + E T
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----- 120
               L+++  GLE L+ +  IHRD+K  NILL    +D  ++IADFG+S  L  G     
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITR 179
Query: 121 NYAEKV-CGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNG------YPPFSV 168
           N   K   G+P +MAPEV+ Q + YD K D+WS G    EL  G      YPP  V
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 92/163 (56%), Gaps = 6/163 (3%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   + ++HPNI+RL++ F     I+L++E+   G L   ++      EQ     +
Sbjct: 70  LRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIM 129
Query: 73  QQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
           ++L   ++  H   +IHRD+KPEN+LL        LKIADFG S    P    + +CG+ 
Sbjct: 130 EELADALMYCHGKKVIHRDIKPENLLLGLK---GELKIADFGWSVHA-PSLRRKTMCGTL 185
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            Y+ PE+++ + ++EKVD+W +G + +ELL G PPF     ++
Sbjct: 186 DYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNE 228

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 96/172 (55%), Gaps = 13/172 (7%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + +   I  L  AFQ +N ++LV+++  GG+L + + +   R+
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL 172
Query: 64  PEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           PE+ AR +L ++ + I + H  H +HRD+KP+NIL+   D +  +++ADFG    L    
Sbjct: 173 PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG 229
Query: 122 YAEK--VCGSPLYMAPEVLQFQ-----RYDEKVDMWSVGAILFELLNGYPPF 166
             +     G+P Y++PE+LQ       RY  + D WS+G  ++E+L G  PF
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/152 (34%), Positives = 87/152 (57%), Gaps = 5/152 (3%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQL--GLEILN 81
           P +I L + ++  + I L++E+ AGG + S     L   V E    + ++Q+  G+  L+
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ 141
            ++I+H DLKP+NILLS +     +KI DFG+S  +       ++ G+P Y+APE+L + 
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 142 RYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
                 DMW++G I + LL    PF VGE++Q
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPF-VGEDNQ 239

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 6/155 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++L   D D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 6/155 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++L   D D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 6/155 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 59  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 118
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++L   D D  +KI DFGL    +  G   +  CG+P 
Sbjct: 119 IVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPE 175
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 6/155 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 57  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 116
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++L   D D  +KI DFGL    +  G   +  CG+P 
Sbjct: 117 IVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPE 173
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 174 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 6/155 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++L   D D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 6/155 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++L   D D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 6/155 (3%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++L   D D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 88/156 (56%), Gaps = 7/156 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G+   PE  A  +  
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           ++  GLE L+   I++RDLKPENILL   DD   ++I+D GL+  +  G   +   G+  
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           YMAPEV++ +RY    D W++G +L+E++ G  PF 
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 386

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 88/155 (56%), Gaps = 7/155 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G+   PE  A  +  
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           ++  GLE L+   I++RDLKPENILL   DD   ++I+D GL+  +  G   +   G+  
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           YMAPEV++ +RY    D W++G +L+E++ G  PF
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 11/162 (6%)
Query: 16  ELNFLSSVNHPNII---RLFDAFQA---ENCIFLVVEFCAGGNLSSYIRLHGR---VPEQ 66
           E+  +  +NHPN++    + D  Q     +   L +E+C GG+L  Y+        + E 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             R  L  +   L  L+ + IIHRDLKPENI+L      ++ KI D G +  L  G    
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +  G+  Y+APE+L+ ++Y   VD WS G + FE + G+ PF
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 11/162 (6%)
Query: 16  ELNFLSSVNHPNII---RLFDAFQA---ENCIFLVVEFCAGGNLSSYIRLHGR---VPEQ 66
           E+  +  +NHPN++    + D  Q     +   L +E+C GG+L  Y+        + E 
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             R  L  +   L  L+ + IIHRDLKPENI+L      ++ KI D G +  L  G    
Sbjct: 123 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 182
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +  G+  Y+APE+L+ ++Y   VD WS G + FE + G+ PF
Sbjct: 183 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 7/155 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P I R F ++     +++++E+  GG+    ++  G + E      L+++
Sbjct: 67  EITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREI 125
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 126 LKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNXFVGTPFW 182
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           MAPEV++   YD K D+WS+G    EL  G PP S
Sbjct: 183 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 217

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/157 (35%), Positives = 86/157 (54%), Gaps = 13/157 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E+ FL  + HPN I+    +  E+  +LV+E+C G + S  + +H +  ++     +   
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHG 162
Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
              GL  L+SH++IHRD+K  NILLS   +  ++K+ DFG +  + P N      G+P +
Sbjct: 163 ALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN---XFVGTPYW 216
Query: 133 MAPEV---LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           MAPEV   +   +YD KVD+WS+G    EL    PP 
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 55/157 (35%), Positives = 86/157 (54%), Gaps = 13/157 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E+ FL  + HPN I+    +  E+  +LV+E+C G + S  + +H +  ++     +   
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHG 123
Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
              GL  L+SH++IHRD+K  NILLS   +  ++K+ DFG +  + P N      G+P +
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN---XFVGTPYW 177
Query: 133 MAPEV---LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           MAPEV   +   +YD KVD+WS+G    EL    PP 
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/161 (40%), Positives = 89/161 (55%), Gaps = 18/161 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           EL  LS VNHPNI++L+ A    N + LV+E+  GG+L  Y  LHG   +P  TA   + 
Sbjct: 52  ELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSL--YNVLHGAEPLPYYTAAHAMS 107
Query: 74  -----QLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
                  G+  L+S     +IHRDLKP N+LL  +    +LKI DFG +C +       K
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQTHMTNNK 165
Query: 126 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
             GS  +MAPEV +   Y EK D++S G IL+E++    PF
Sbjct: 166 --GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/161 (40%), Positives = 89/161 (55%), Gaps = 18/161 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           EL  LS VNHPNI++L+ A    N + LV+E+  GG+L  Y  LHG   +P  TA   + 
Sbjct: 51  ELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSL--YNVLHGAEPLPYYTAAHAMS 106
Query: 74  -----QLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
                  G+  L+S     +IHRDLKP N+LL  +    +LKI DFG +C +       K
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQTHMTNNK 164
Query: 126 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
             GS  +MAPEV +   Y EK D++S G IL+E++    PF
Sbjct: 165 --GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 8/154 (5%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG--LEILN 81
            HPNII L D +     +++V E   GG L   I       E+ A   L  +   +E L+
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 82  SHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEV 137
           +  ++HRDLKP NIL    SG  + +  +I DFG +  L   N      C +  ++APEV
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESI--RICDFGFAKQLRAENGLLMTPCYTANFVAPEV 191
Query: 138 LQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           L+ Q YD   D+WS+G +L+ +L GY PF+ G +
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 91/159 (57%), Gaps = 8/159 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV---PEQTARKFL 72
           E+  L+++ HPNI++  ++F+    +++V+++C GG+L   I     V    +Q    F+
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 73  QQ-LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSP 130
           Q  L L+ ++   I+HRD+K +NI L+    D  +++ DFG++  L       + C G+P
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTP 189
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
            Y++PE+ + + Y+ K D+W++G +L+EL      F  G
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 7/155 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 133
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 134 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 190
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           MAPEV++   YD K D+WS+G    EL  G PP S
Sbjct: 191 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 225

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 7/155 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 113
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 170
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           MAPEV++   YD K D+WS+G    EL  G PP S
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 205

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/157 (35%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 132
Query: 76  --GLEILN-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 133 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID-SMANSFVGTRSY 188
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
           M+PE LQ   Y  + D+WS+G  L E+  G  P   G
Sbjct: 189 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSG 225

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 91/165 (55%), Gaps = 5/165 (3%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTA 68
           K  +  E++ ++ ++HP +I L DAF+ +  + L++EF +GG L   I     ++ E   
Sbjct: 92  KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV 151
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
             +++Q   GL+ ++ H I+H D+KPENI+         +KI DFGL+  L P    +  
Sbjct: 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCE-TKKASSVKIIDFGLATKLNPDEIVKVT 210
Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
             +  + APE++  +      DMW++G + + LL+G  PF+ GE+
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA-GED 254

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 7/155 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 113
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFW 170
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           MAPEV++   YD K D+WS+G    EL  G PP S
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 205

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 83/155 (53%), Gaps = 7/155 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  +   + + + ++   + +++++E+  GG+    +R  G   E      L+++
Sbjct: 71  EITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI 129
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 130 LKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 186
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           MAPEV+Q   YD K D+WS+G    EL  G PP S
Sbjct: 187 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 221

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 88/157 (56%), Gaps = 9/157 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ +   + P++++ + ++     +++V+E+C  G++S  IRL  +   E      LQ 
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSP 130
              GLE L+    IHRD+K  NILL   + +   K+ADFG++  L     A++  V G+P
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLT-DXMAKRNXVIGTP 189
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            +MAPEV+Q   Y+   D+WS+G    E+  G PP++
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA 226

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 7/155 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 128
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFW 185
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           MAPEV++   YD K D+WS+G    EL  G PP S
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 90/160 (56%), Gaps = 12/160 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQ 73
            E+  L++ +HP I++L  A+  +  +++++EFC GG + +  + L   + E   +   +
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR 124
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 130
           Q+   L  L+S  IIHRDLK  N+L++ L+ D+  ++ADFG+S   L      +   G+P
Sbjct: 125 QMLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKNLKTLQKRDSFIGTP 181
Query: 131 LYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPP 165
            +MAPEV+  +      YD K D+WS+G  L E+    PP
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 95/172 (55%), Gaps = 13/172 (7%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + +   I  L  AFQ EN ++LV+++  GG+L + + +   ++
Sbjct: 129 LKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL 188
Query: 64  PEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           PE  AR ++ ++ L I + H  H +HRD+KP+N+L   LD +  +++ADFG    +    
Sbjct: 189 PEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVL---LDVNGHIRLADFGSCLKMNDDG 245
Query: 122 YAEK--VCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPF 166
             +     G+P Y++PE+LQ       +Y  + D WS+G  ++E+L G  PF
Sbjct: 246 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 90/160 (56%), Gaps = 12/160 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQ 73
            E+  L++ +HP I++L  A+  +  +++++EFC GG + +  + L   + E   +   +
Sbjct: 57  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR 116
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 130
           Q+   L  L+S  IIHRDLK  N+L++ L+ D+  ++ADFG+S   L      +   G+P
Sbjct: 117 QMLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKNLKTLQKRDSFIGTP 173
Query: 131 LYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPP 165
            +MAPEV+  +      YD K D+WS+G  L E+    PP
Sbjct: 174 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 80/154 (51%), Gaps = 8/154 (5%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG--LEILN 81
            HPNII L D +     +++V E   GG L   I       E+ A   L  +   +E L+
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 82  SHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEV 137
           +  ++HRDLKP NIL    SG  + +  +I DFG +  L   N      C +  ++APEV
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESI--RICDFGFAKQLRAENGLLXTPCYTANFVAPEV 191
Query: 138 LQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           L+ Q YD   D+WS+G +L+  L GY PF+ G +
Sbjct: 192 LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD 225

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 95/172 (55%), Gaps = 13/172 (7%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + +   I  L  AFQ EN ++LV+++  GG+L + + +   ++
Sbjct: 113 LKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL 172
Query: 64  PEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           PE  AR ++ ++ L I + H  H +HRD+KP+N+L   LD +  +++ADFG    +    
Sbjct: 173 PEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVL---LDVNGHIRLADFGSCLKMNDDG 229
Query: 122 YAEK--VCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPF 166
             +     G+P Y++PE+LQ       +Y  + D WS+G  ++E+L G  PF
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTA 68
           L  E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEK 125
             +++Q+   L   + ++IIHRD+KP  +LL+  ++   +K+  FG++  L   G  A  
Sbjct: 135 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 126 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
             G+P +MAPEV++ + Y + VD+W  G ILF LL+G  PF   +E  F
Sbjct: 195 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 243

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTA 68
           L  E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEK 125
             +++Q+   L   + ++IIHRD+KP  +LL+  ++   +K+  FG++  L   G  A  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 126 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
             G+P +MAPEV++ + Y + VD+W  G ILF LL+G  PF   +E  F
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 241

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/155 (42%), Positives = 88/155 (56%), Gaps = 11/155 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E+  L  ++HPNII L DAF  ++ I LV +F    +L   I+ +  V  P       L 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 74  QL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 130
            L GLE L+ H I+HRDLKP N+L   LD++ +LK+ADFGL+ +    N  Y  +V  + 
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADFGLAKSFGSPNRAYXHQVV-TR 176
Query: 131 LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 164
            Y APE+L   R Y   VDMW+VG IL ELL   P
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 85/161 (52%), Gaps = 10/161 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 116
Query: 76  --GLEILN-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L     A +  G+  Y
Sbjct: 117 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DEMANEFVGTRSY 172
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNG---YPPFSVGE 170
           M+PE LQ   Y  + D+WS+G  L E+  G    PP ++ E
Sbjct: 173 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFE 213

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 94/173 (54%), Gaps = 30/173 (17%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 48  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG- 165
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                   +A++  G            ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 166 --------FAKETTG------------EKYDKSCDMWSLGVIMYILLCGYPPF 198

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 80/153 (52%), Gaps = 7/153 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + HPN++ L + F+ +  + LV E+C    L    R    VPE   +    Q 
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLY 132
              +   + H+ IHRD+KPENIL++      ++K+ DFG +  L  P +Y +    +  Y
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDEVATRWY 168
Query: 133 MAPEVL-QFQRYDEKVDMWSVGAILFELLNGYP 164
            +PE+L    +Y   VD+W++G +  ELL+G P
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  --GLEILN-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           M+PE LQ   Y  + D+WS+G  L E+  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  --GLEILN-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           M+PE LQ   Y  + D+WS+G  L E+  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  --GLEILN-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           M+PE LQ   Y  + D+WS+G  L E+  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  --GLEILN-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           M+PE LQ   Y  + D+WS+G  L E+  G  P 
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/160 (37%), Positives = 85/160 (53%), Gaps = 15/160 (9%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIK 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 126
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A   V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA-RIYSFQMALTSV 179
Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
             +  Y APEVL    Y   VD+WSVG I  E+    P F
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/160 (37%), Positives = 85/160 (53%), Gaps = 15/160 (9%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 126
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A   V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA-RIYSFQMALTSV 179
Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
             +  Y APEVL    Y   VD+WSVG I  E+    P F
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 76  --GLEILN-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 196
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           M+PE LQ   Y  + D+WS+G  L E+  G  P 
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/153 (36%), Positives = 82/153 (53%), Gaps = 8/153 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 175
Query: 76  --GLEILN-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 176 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 231
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNG-YP 164
           M+PE LQ   Y  + D+WS+G  L E+  G YP
Sbjct: 232 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/160 (37%), Positives = 85/160 (53%), Gaps = 15/160 (9%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 126
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A   V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA-RIYSFQMALTSV 179
Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
             +  Y APEVL    Y   VD+WSVG I  E+    P F
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/153 (36%), Positives = 82/153 (53%), Gaps = 8/153 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  --GLEILN-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNG-YP 164
           M+PE LQ   Y  + D+WS+G  L E+  G YP
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 90/154 (58%), Gaps = 7/154 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +   +H N++ ++ ++   + +++V+EF  GG L+  +  H R+  EQ A   L  
Sbjct: 92  EVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLSV 150
Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L  L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 151 LRALSYLHNQGVIHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKXLVGTPYW 207
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           MAPEV+    Y  +VD+WS+G ++ E+++G PP+
Sbjct: 208 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 241

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 91/154 (59%), Gaps = 7/154 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+  EQ A   L  
Sbjct: 71  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 129
Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 130 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 186
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           MAPE++    Y  +VD+WS+G ++ E+++G PP+
Sbjct: 187 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 220

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 91/154 (59%), Gaps = 7/154 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+  EQ A   L  
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 125
Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 126 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 182
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           MAPE++    Y  +VD+WS+G ++ E+++G PP+
Sbjct: 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 91/154 (59%), Gaps = 7/154 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+  EQ A   L  
Sbjct: 78  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 136
Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 137 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 193
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           MAPE++    Y  +VD+WS+G ++ E+++G PP+
Sbjct: 194 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 227

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 91/154 (59%), Gaps = 7/154 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+  EQ A   L  
Sbjct: 76  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 134
Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 135 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 191
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           MAPE++    Y  +VD+WS+G ++ E+++G PP+
Sbjct: 192 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 225

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/182 (35%), Positives = 96/182 (52%), Gaps = 16/182 (8%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +++K   H++S +  E+  L     H N++ L + F+ E+  +LV E   GG++ S+I  
Sbjct: 45  IIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK 104
Query: 60  HGRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--- 114
                E  A   +Q +   L+ L++  I HRDLKPENIL    +    +KI DFGL    
Sbjct: 105 RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGI 164
Query: 115 -----CTLYPGNYAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILFELLNGYP 164
                C+          CGS  YMAPEV++        YD++ D+WS+G IL+ LL+GYP
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 165 PF 166
           PF
Sbjct: 225 PF 226

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 85/156 (54%), Gaps = 9/156 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  ++HPNI+ L D   +E C+ LV EF               + +   + +L QL
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 131
             G+   + H I+HRDLKP+N+L   ++ D  LK+ADFGL+    +   +Y  +V  +  
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLL---INSDGALKLADFGLARAFGIPVRSYTHEVV-TLW 184
Query: 132 YMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y AP+VL   ++Y   VD+WS+G I  E++ G P F
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 85/156 (54%), Gaps = 9/156 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  ++HPNI+ L D   +E C+ LV EF               + +   + +L QL
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 131
             G+   + H I+HRDLKP+N+L   ++ D  LK+ADFGL+    +   +Y  +V  +  
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLL---INSDGALKLADFGLARAFGIPVRSYTHEVV-TLW 184
Query: 132 YMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y AP+VL   ++Y   VD+WS+G I  E++ G P F
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 99/171 (57%), Gaps = 10/171 (5%)
Query: 2   LKKLN---KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           +KK++   +  +  L  E+  +    H N++ +++++   + +++V+EF  GG L+  + 
Sbjct: 104 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV- 162
Query: 59  LHGRV-PEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
            H R+  EQ A   L  L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    
Sbjct: 163 THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQ 219
Query: 117 LYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +       K + G+P +MAPE++    Y  +VD+WS+G ++ E+++G PP+
Sbjct: 220 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 270

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 87/153 (56%), Gaps = 7/153 (4%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-- 74
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  +  
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 75  LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
           LGLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 303 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 358
Query: 135 PEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 166
           PEVLQ    YD   D +S+G +LF+LL G+ PF
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 87/153 (56%), Gaps = 7/153 (4%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-- 74
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  +  
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 301
Query: 75  LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
           LGLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 302 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 357
Query: 135 PEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 166
           PEVLQ    YD   D +S+G +LF+LL G+ PF
Sbjct: 358 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 87/153 (56%), Gaps = 7/153 (4%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-- 74
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  +  
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 75  LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
           LGLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 303 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 358
Query: 135 PEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 166
           PEVLQ    YD   D +S+G +LF+LL G+ PF
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 87/153 (56%), Gaps = 7/153 (4%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-- 74
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  +  
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 75  LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
           LGLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 303 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 358
Query: 135 PEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 166
           PEVLQ    YD   D +S+G +LF+LL G+ PF
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 84/156 (53%), Gaps = 7/156 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256
Query: 75  L--GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 130
           +   L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 84/156 (53%), Gaps = 7/156 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 200 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 259
Query: 75  L--GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 130
           +   L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 260 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTP 316
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 84/156 (53%), Gaps = 7/156 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 58  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 117
Query: 75  L--GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 130
           +   L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 118 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTP 174
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 84/156 (53%), Gaps = 7/156 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 57  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 116
Query: 75  L--GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 130
           +   L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 117 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTP 173
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 174 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 91/154 (59%), Gaps = 7/154 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+  EQ A   L  
Sbjct: 198 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 256
Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 257 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 313
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           MAPE++    Y  +VD+WS+G ++ E+++G PP+
Sbjct: 314 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 84/156 (53%), Gaps = 7/156 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 59  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 118
Query: 75  L--GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 130
           +   L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 119 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTP 175
Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            Y+APEVL+   Y   VD W +G +++E++ G  PF
Sbjct: 176 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/152 (34%), Positives = 85/152 (55%), Gaps = 9/152 (5%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGLEILNSH 83
           P ++ L  AFQ E  + L++++  GG L +++    R  E   + ++ +  L LE L+  
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 178
Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQF- 140
            II+RD+K ENILL   D +  + + DFGLS          A   CG+  YMAP++++  
Sbjct: 179 GIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 235
Query: 141 -QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
              +D+ VD WS+G +++ELL G  PF+V  E
Sbjct: 236 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 98/181 (54%), Gaps = 12/181 (6%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E     +L   + +  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE 94
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-- 116
           G +   TA+ FL QL  G+   +   ++HRDLKP+N+L+   + +  LKIADFGL+    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFG 151
Query: 117 LYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF-SVGEEHQF 174
           +    Y  +V  +  Y AP+VL   ++Y   +D+WSVG I  E++NG P F  V E  Q 
Sbjct: 152 IPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
Query: 175 M 175
           M
Sbjct: 211 M 211

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 98/181 (54%), Gaps = 12/181 (6%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E     +L   + +  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE 94
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-- 116
           G +   TA+ FL QL  G+   +   ++HRDLKP+N+L+   + +  LKIADFGL+    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFG 151
Query: 117 LYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF-SVGEEHQF 174
           +    Y  +V  +  Y AP+VL   ++Y   +D+WSVG I  E++NG P F  V E  Q 
Sbjct: 152 IPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQL 210
Query: 175 M 175
           M
Sbjct: 211 M 211

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 88/163 (53%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +  + A + 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 72  LQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK-- 125
           +     + LN  H   IIHRD+KP NIL+S  +    +K+ DFG++  +   GN   +  
Sbjct: 122 IAD-ACQALNFSHQNGIIHRDVKPANILISATN---AVKVVDFGIARAIADSGNSVXQTA 177
Query: 126 -VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 95/180 (52%), Gaps = 10/180 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E     +L   + +  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE 94
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 117
           G +   TA+ FL QL  G+   +   ++HRDLKP+N+L+   + +  LKIADFGL+    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFG 151
Query: 118 YPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF-SVGEEHQFM 175
            P         +  Y AP+VL   ++Y   +D+WSVG I  E++NG P F  V E  Q M
Sbjct: 152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 84/154 (54%), Gaps = 4/154 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
           E++ L+   H NI+ L ++F++   + ++ EF +G ++   I      + E+    ++ Q
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           +   L+ L+SH+I H D++PENI+         +KI +FG +  L PG+    +  +P Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSST-IKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            APEV Q        DMWS+G +++ LL+G  PF
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/154 (35%), Positives = 80/154 (51%), Gaps = 7/154 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++   R+PE+   K    +
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 123
Query: 76  --GLEILN-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 124 LRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 179
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           MAPE LQ   Y  + D+WS+G  L EL  G  P 
Sbjct: 180 MAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 86/153 (56%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLS-MDLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 86/153 (56%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLS-MDLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 56/158 (35%), Positives = 87/158 (55%), Gaps = 10/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 128
             Q+  GLE L+  +II+RDLKPEN+LL   DDD  ++I+D GL+  L  G    K   G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +P +MAPE+L  + YD  VD +++G  L+E++    PF
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/160 (36%), Positives = 85/160 (53%), Gaps = 7/160 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQ 74
           E+  LS V H NII++ D F+ +    LV+E    G +L ++I  H R+ E  A    +Q
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           L   +  L    IIHRD+K ENI+++   +D  +K+ DFG +  L  G      CG+  Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 133 MAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFSVGEE 171
            APEVL    Y   +++MWS+G  L+ L+    PF   EE
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 56/158 (35%), Positives = 87/158 (55%), Gaps = 10/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 128
             Q+  GLE L+  +II+RDLKPEN+LL   DDD  ++I+D GL+  L  G    K   G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +P +MAPE+L  + YD  VD +++G  L+E++    PF
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 56/158 (35%), Positives = 87/158 (55%), Gaps = 10/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 128
             Q+  GLE L+  +II+RDLKPEN+LL   DDD  ++I+D GL+  L  G    K   G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +P +MAPE+L  + YD  VD +++G  L+E++    PF
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 92/174 (52%), Gaps = 15/174 (8%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           L +   SC   E + L + +   I +L  AFQ EN ++LV+E+  GG+L + +   G R+
Sbjct: 100 LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERI 159
Query: 64  PEQTARKFLQQLGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           P + AR +L ++ + I + H +  +HRD+KP+NIL   LD    +++ADFG    L    
Sbjct: 160 PAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL---LDRCGHIRLADFGSCLKLRADG 216
Query: 122 YAEKV--CGSPLYMAPEVLQ-------FQRYDEKVDMWSVGAILFELLNGYPPF 166
               +   G+P Y++PE+LQ          Y  + D W++G   +E+  G  PF
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A  +L Q 
Sbjct: 116 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 175
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 127
             GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 176 LEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 233
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           G+  +MAPEV+  +  D KVD+WS   ++  +LNG  P++
Sbjct: 234 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 273

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 92/170 (54%), Gaps = 9/170 (5%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLS---SYI 57
           M+    +  +  L  E+  +    H N++ ++ ++     +++++EF  GG L+   S +
Sbjct: 77  MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV 136
Query: 58  RLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           RL+           LQ L    L++  +IHRD+K ++ILL+ LD  V  K++DFG    +
Sbjct: 137 RLNEEQIATVCEAVLQALAY--LHAQGVIHRDIKSDSILLT-LDGRV--KLSDFGFCAQI 191
Query: 118 YPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                  K + G+P +MAPEV+    Y  +VD+WS+G ++ E+++G PP+
Sbjct: 192 SKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A  +L Q 
Sbjct: 114 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 173
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 127
             GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 174 LEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 231
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           G+  +MAPEV+  +  D KVD+WS   ++  +LNG  P++
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 271

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A  +L Q 
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 159
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 127
             GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           G+  +MAPEV+  +  D KVD+WS   ++  +LNG  P++
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 56/158 (35%), Positives = 87/158 (55%), Gaps = 10/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 128
             Q+  GLE L+  +II+RDLKPEN+LL   DDD  ++I+D GL+  L  G    K   G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +P +MAPE+L  + YD  VD +++G  L+E++    PF
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + +  P I+ L+ A +    + + +E   GG+L   ++  G +PE  A  +L Q 
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA 194
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 127
             GLE L+S  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 195 LEGLEYLHSRRILHGDVKADNVLLS--SDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP 252
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           G+  +MAPEV+  +  D KVD+WS   ++  +LNG  P++
Sbjct: 253 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWT 292

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 91/169 (53%), Gaps = 29/169 (17%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-----------VP 64
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH             + 
Sbjct: 70  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIA 126
Query: 65  EQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNY 122
            QTAR      G++ L++  IIHRDLK  NI    L +D  +KI DFGL+   + + G++
Sbjct: 127 RQTAR------GMDYLHAKSIIHRDLKSNNIF---LHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 123 A-EKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
             E++ GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +  + A + 
Sbjct: 79  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 138
Query: 72  LQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK-- 125
           +     + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +  
Sbjct: 139 IAD-ACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTA 194
Query: 126 -VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+
Sbjct: 195 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 237

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + +  P I+ L+ A +    + + +E   GG+L   ++  G +PE  A  +L Q 
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA 175
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 127
             GLE L+S  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 176 LEGLEYLHSRRILHGDVKADNVLLS--SDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP 233
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           G+  +MAPEV+  +  D KVD+WS   ++  +LNG  P++
Sbjct: 234 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWT 273

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +  + A + 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 72  LQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK-- 125
           +     + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +  
Sbjct: 122 IAD-ACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTA 177
Query: 126 -VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +  + A + 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 72  LQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK-- 125
           +     + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +  
Sbjct: 122 IAD-ACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTA 177
Query: 126 -VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 88/163 (53%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +  + A + 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 72  LQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK-- 125
           +     + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +  
Sbjct: 122 IAD-ACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTA 177
Query: 126 -VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/170 (34%), Positives = 85/170 (50%), Gaps = 15/170 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPE----QTAR 69
           E++ +  + H NI+RL+D    EN + LV EF    +L  Y+  R  G  P        +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKV 126
            F  QL  GL   + + I+HRDLKP+N+L   ++    LK+ DFGL+     P N     
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLL---INKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 127 CGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF-SVGEEHQF 174
             +  Y AP+VL   R Y   +D+WS G IL E++ G P F    +E Q 
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL 218

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 91/169 (53%), Gaps = 29/169 (17%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-----------VP 64
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH             + 
Sbjct: 58  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIA 114
Query: 65  EQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNY 122
            QTAR      G++ L++  IIHRDLK  NI L    +D  +KI DFGL+   + + G++
Sbjct: 115 RQTAR------GMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATVKSRWSGSH 165
Query: 123 A-EKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
             E++ GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 166 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 214

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 87/165 (52%), Gaps = 7/165 (4%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +K +K     E+  L  + H N++ L +  + +   +LV EF     L         +  
Sbjct: 64  DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDY 123
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNY 122
           Q  +K+L Q+  G+   +SH+IIHRD+KPENIL+S      ++K+ DFG + TL  PG  
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEV 180
Query: 123 AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 166
            +    +  Y APE+L    +Y + VD+W++G ++ E+  G P F
Sbjct: 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 53/152 (34%), Positives = 83/152 (54%), Gaps = 10/152 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++       +P    + +L 
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF 111
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 130
           QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         + 
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVTL 168
Query: 131 LYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
            Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 90/169 (53%), Gaps = 11/169 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
           E+     + H NI++   +F     I + +E   GG+LS+ +R      +  EQT   + 
Sbjct: 69  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGS 129
           +Q+  GL+ L+ + I+HRD+K +N+L++      +LKI+DFG S  L   N   E   G+
Sbjct: 129 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPCTETFTGT 186
Query: 130 PLYMAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPF-SVGEEHQFM 175
             YMAPE++    + Y +  D+WS+G  + E+  G PPF  +GE    M
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 78/153 (50%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++       +  
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL 131
Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
            +   +G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T            +
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 130 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
             Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 93/183 (50%), Gaps = 13/183 (7%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG- 61
           + L   LK+    E   L   +HPNI+RL      +  I++V+E   GG+  +++R  G 
Sbjct: 149 ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA 208
Query: 62  RVPEQTARKFL--QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           R+  +T  + +     G+E L S   IHRDL   N L++   +  +LKI+DFG+S     
Sbjct: 209 RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEAD 265
Query: 120 GNYAEK--VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEEH 172
           G YA    +   P+ + APE L + RY  + D+WS G +L+E      + YP  S  +  
Sbjct: 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR 325
Query: 173 QFM 175
           +F+
Sbjct: 326 EFV 328

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/182 (34%), Positives = 95/182 (52%), Gaps = 16/182 (8%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +++K   H++S +  E+  L     H N++ L + F+ E+  +LV E   GG++ S+I  
Sbjct: 45  IIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK 104
Query: 60  HGRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--- 114
                E  A   +Q +   L+ L++  I HRDLKPENIL    +    +KI DF L    
Sbjct: 105 RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164
Query: 115 -----CTLYPGNYAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILFELLNGYP 164
                C+          CGS  YMAPEV++        YD++ D+WS+G IL+ LL+GYP
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 165 PF 166
           PF
Sbjct: 225 PF 226

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 111
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKDFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 78/153 (50%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++       +  
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL 131
Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
            +   +G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T            +
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 130 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
             Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 116
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 173
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 174 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 90/169 (53%), Gaps = 11/169 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
           E+     + H NI++   +F     I + +E   GG+LS+ +R      +  EQT   + 
Sbjct: 55  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 114
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGS 129
           +Q+  GL+ L+ + I+HRD+K +N+L++      +LKI+DFG S  L   N   E   G+
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPCTETFTGT 172
Query: 130 PLYMAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPF-SVGEEHQFM 175
             YMAPE++    + Y +  D+WS+G  + E+  G PPF  +GE    M
Sbjct: 173 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 221

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 86/153 (56%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLS-MDLKDFMDASALTG-IPLPLIKSYL 111
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 84/152 (55%), Gaps = 10/152 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++       +P    + +L 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLS-MDLKDFMDASALTGIPLPLIKSYLF 113
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 130
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         + 
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 131 LYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
            Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 90/169 (53%), Gaps = 29/169 (17%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-----------VP 64
           E+  L    H NI+ LF  +     + +V ++C G +L  Y  LH             + 
Sbjct: 70  EVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIA 126
Query: 65  EQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNY 122
            QTAR      G++ L++  IIHRDLK  NI L    +D  +KI DFGL+   + + G++
Sbjct: 127 RQTAR------GMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSH 177
Query: 123 A-EKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
             E++ GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 84/152 (55%), Gaps = 10/152 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF    +L +++       +P    + +L 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKTFMDASALTGIPLPLIKSYLF 113
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 130
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         + 
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 131 LYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
            Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/165 (37%), Positives = 82/165 (49%), Gaps = 15/165 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  VNH NII L + F  +        ++LV+E     NL   I  H  +  +   
Sbjct: 71  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--HMELDHERMS 127
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 128 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTASTNFMMTPYV 184
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            +  Y APEV+    Y E VD+WSVG I+ EL+ G   F  G +H
Sbjct: 185 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ-GTDH 228

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLSFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 78/153 (50%), Gaps = 10/153 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++       +  
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL 131
Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
            +   +G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T            +
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 130 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
             Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 167
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 116
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 173
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 83/152 (54%), Gaps = 10/152 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++       +P    + +L 
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF 114
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 130
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         + 
Sbjct: 115 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVTL 171
Query: 131 LYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
            Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 83/152 (54%), Gaps = 10/152 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++       +P    + +L 
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF 109
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 130
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         + 
Sbjct: 110 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVTL 166
Query: 131 LYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
            Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 111
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 165
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 83/152 (54%), Gaps = 10/152 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++       +P    + +L 
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF 111
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 130
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         + 
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVTL 168
Query: 131 LYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
            Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 83/152 (54%), Gaps = 10/152 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++       +P    + +L 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF 110
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 130
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         + 
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVTL 167
Query: 131 LYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
            Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 113
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 170
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 83/152 (54%), Gaps = 10/152 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++       +P    + +L 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF 113
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 130
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         + 
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 131 LYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
            Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 111
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 46/126 (36%), Positives = 73/126 (57%), Gaps = 7/126 (5%)
Query: 39  NCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPEN 94
            C+F+ +EFC  G L  +I  R   ++ +  A +  +Q+  G++ ++S  +IHRDLKP N
Sbjct: 107 KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSN 166
Query: 95  ILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 154
           I L    D   +KI DFGL  +L       +  G+  YM+PE +  Q Y ++VD++++G 
Sbjct: 167 IFLV---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGL 223
Query: 155 ILFELL 160
           IL ELL
Sbjct: 224 ILAELL 229

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/155 (36%), Positives = 80/155 (51%), Gaps = 14/155 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 118 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 174
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 175 DFGLA--RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 231
Query: 169 GEEH 172
           G +H
Sbjct: 232 GTDH 235

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/184 (33%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL+K  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 64  VKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 123 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 179
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 180 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 236
Query: 169 GEEH 172
           G +H
Sbjct: 237 GTDH 240

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/155 (36%), Positives = 80/155 (51%), Gaps = 14/155 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 92/163 (56%), Gaps = 17/163 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 74  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 132
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 133 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLS 187
Query: 128 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 188 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 230

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 118 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 174
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 175 DFGLA--RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 231
Query: 169 GEEH 172
           G +H
Sbjct: 232 GTDH 235

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 118 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 174
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 175 DFGLA--RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 231
Query: 169 GEEH 172
           G +H
Sbjct: 232 GTDH 235

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 92/163 (56%), Gaps = 17/163 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 81  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 139
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 140 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 194
Query: 128 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 195 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 237

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 92/163 (56%), Gaps = 17/163 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 82  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 141 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 195
Query: 128 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 196 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 238

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 92/163 (56%), Gaps = 17/163 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 82  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 141 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLS 195
Query: 128 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 196 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 238

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 92/163 (56%), Gaps = 17/163 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 54  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 113 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLS 167
Query: 128 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 86/162 (53%), Gaps = 15/162 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  ++HP +++ +     E  I++V E+ + G L +Y+R HG+  E +  + L+  
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPS--QLLEMC 110
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
                G+  L SH  IHRDL   N L   +D D+ +K++DFG++  +    Y   V G+ 
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCL---VDRDLCVKVSDFGMTRYVLDDQYVSSV-GTK 166
Query: 131 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSV 168
               + APEV  + +Y  K D+W+ G +++E+ + G  P+ +
Sbjct: 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 92/163 (56%), Gaps = 17/163 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 54  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 113 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 128 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 92/163 (56%), Gaps = 17/163 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 56  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 114
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI    L +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 115 TAQ--GMDYLHAKSIIHRDLKSNNIF---LHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 169
Query: 128 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 170 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 212

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 116 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKIL 172
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 173 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 229
Query: 169 GEEH 172
           G +H
Sbjct: 230 GTDH 233

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 92/163 (56%), Gaps = 17/163 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 59  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 117
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 118 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 128 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 173 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 215

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 92/163 (56%), Gaps = 17/163 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 59  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 117
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 118 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 128 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 173 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 215

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 116 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKIL 172
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 173 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 229
Query: 169 GEEH 172
           G +H
Sbjct: 230 GTDH 233

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 63  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 121
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 122 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKIL 178
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 179 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 235
Query: 169 GEEH 172
           G +H
Sbjct: 236 GTDH 239

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 107 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 163
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 164 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 220
Query: 169 GEEH 172
           G +H
Sbjct: 221 GTDH 224

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 117 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKIL 173
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 174 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 230
Query: 169 GEEH 172
           G +H
Sbjct: 231 GTDH 234

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 117 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 173
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 174 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 230
Query: 169 GEEH 172
           G +H
Sbjct: 231 GTDH 234

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 87/165 (52%), Gaps = 23/165 (13%)
Query: 16  ELNFLSSVNHPNIIRL---FDAFQAE-------------NCIFLVVEFCAGGNLSSYI-- 57
           E+  L+ ++H NI+     +D F  +              C+F+ +EFC  G L  +I  
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 58  RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
           R   ++ +  A +  +Q+  G++ ++S  +I+RDLKP NI L    D   +KI DFGL  
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVT 170
Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           +L       +  G+  YM+PE +  Q Y ++VD++++G IL ELL
Sbjct: 171 SLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 116 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 172
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 173 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 229
Query: 169 GEEH 172
           G +H
Sbjct: 230 GTDH 233

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLA--RHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 107 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 163
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 164 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 220
Query: 169 GEEH 172
           G +H
Sbjct: 221 GTDH 224

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 56/155 (36%), Positives = 80/155 (51%), Gaps = 14/155 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 49  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 107
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 108 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 164
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 165 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 221
Query: 169 GEEH 172
           G +H
Sbjct: 222 GTDH 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 50  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 108
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 109 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 165
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 166 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 222
Query: 169 GEEH 172
           G +H
Sbjct: 223 GTDH 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 116 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 172
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 173 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 229
Query: 169 GEEH 172
           G +H
Sbjct: 230 GTDH 233

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 113 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKIL 169
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 170 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 226
Query: 169 GEEH 172
           G +H
Sbjct: 227 GTDH 230

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 113 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 169
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 170 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 226
Query: 169 GEEH 172
           G +H
Sbjct: 227 GTDH 230

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 51  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 109
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 110 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 166
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 167 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 223
Query: 169 GEEH 172
           G +H
Sbjct: 224 GTDH 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 118 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 174
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 175 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 231
Query: 169 GEEH 172
           G +H
Sbjct: 232 GTDH 235

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 64  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 123 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 179
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 180 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 236
Query: 169 GEEH 172
           G +H
Sbjct: 237 GTDH 240

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 63  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 121
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 122 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 178
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 179 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 235
Query: 169 GEEH 172
           G +H
Sbjct: 236 GTDH 239

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 64  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 123 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 179
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 180 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 236
Query: 169 GEEH 172
           G +H
Sbjct: 237 GTDH 240

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 130
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 131 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 187
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 188 DFGLA--RHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 244
Query: 169 GEEH 172
           G +H
Sbjct: 245 GTDH 248

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 75  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 133
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 134 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 190
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 191 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 247
Query: 169 GEEH 172
           G +H
Sbjct: 248 GTDH 251

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 117 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 173
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 174 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 230
Query: 169 GEEH 172
           G +H
Sbjct: 231 GTDH 234

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 107 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 163
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 164 DFGLA--RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 220
Query: 169 GEEH 172
           G +H
Sbjct: 221 GTDH 224

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 87/163 (53%), Gaps = 15/163 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++   +AE       ++V+E+  G  L   +   G +  + A + 
Sbjct: 62  EAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 72  LQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK-- 125
           +     + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +  
Sbjct: 122 IAD-ACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTA 177
Query: 126 -VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLA--RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 49  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 107
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 108 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 164
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 165 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 221
Query: 169 GEEH 172
           G +H
Sbjct: 222 GTDH 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 117 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 173
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 174 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 230
Query: 169 GEEH 172
           G +H
Sbjct: 231 GTDH 234

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 130
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 131 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 187
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 188 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 244
Query: 169 GEEH 172
           G +H
Sbjct: 245 GTDH 248

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLA--RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 113 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 169
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 170 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 226
Query: 169 GEEH 172
           G +H
Sbjct: 227 GTDH 230

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 113 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 169
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 170 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 226
Query: 169 GEEH 172
           G +H
Sbjct: 227 GTDH 230

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 71  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 129
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 130 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 186
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 187 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 243
Query: 169 GEEH 172
           G +H
Sbjct: 244 GTDH 247

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 62  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 120
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 121 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 177
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 178 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 234
Query: 169 GEEH 172
           G +H
Sbjct: 235 GTDH 238

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV E     +L +++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVH-QDLKTFMDASALTG-IPLPLIKSYL 108
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 130 PLYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
             Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 91/163 (55%), Gaps = 17/163 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +     + +V ++C G +L  ++ +     E       AR+
Sbjct: 54  EVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 113 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 128 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
           GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 71  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 129
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 130 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 186
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 187 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 243
Query: 169 GEEH 172
           G +H
Sbjct: 244 GTDH 247

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 130
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 131 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 187
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 188 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 244
Query: 169 GEEH 172
           G +H
Sbjct: 245 GTDH 248

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 75  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 133
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 134 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 190
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 191 DFGLA--RHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 247
Query: 169 GEEH 172
           G +H
Sbjct: 248 GTDH 251

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 97/185 (52%), Gaps = 22/185 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 107 ADLNNIVKC-AKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 162
Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F 
Sbjct: 163 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220
Query: 168 VGEEH 172
            G +H
Sbjct: 221 -GTDH 224

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 92/183 (50%), Gaps = 13/183 (7%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG- 61
           + L   LK+    E   L   +HPNI+RL      +  I++V+E   GG+  +++R  G 
Sbjct: 149 ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA 208
Query: 62  RVPEQTARKFL--QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           R+  +T  + +     G+E L S   IHRDL   N L++   +  +LKI+DFG+S     
Sbjct: 209 RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEAD 265
Query: 120 GNYAEK--VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEEH 172
           G  A    +   P+ + APE L + RY  + D+WS G +L+E      + YP  S  +  
Sbjct: 266 GVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR 325
Query: 173 QFM 175
           +F+
Sbjct: 326 EFV 328

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/170 (32%), Positives = 87/170 (51%), Gaps = 24/170 (14%)
Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIR-LHGRVPEQT 67
           E+N L   +H  NI   + AF  +N       ++LV+EFC  G+++  I+   G   ++ 
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129
Query: 68  -----ARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
                 R+ L+  GL  L+ H +IHRD+K +N+LL+   ++  +K+ DFG+S  L     
Sbjct: 130 WIAYICREILR--GLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVG 184
Query: 122 YAEKVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 166
                 G+P +MAPEV+         YD K D+WS+G    E+  G PP 
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/184 (33%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL C  +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGL-CR-HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 96/194 (49%), Gaps = 38/194 (19%)
Query: 11  SCLDCELNFLSSVNHPNIIRLFDAF-------------QAENCIFLVVEFCAGGNLSSYI 57
           S +  E+  L+S+NH  ++R + A+             + ++ +F+ +E+C  G L   I
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 58  RLHG--RVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                 +  ++  R F Q L  L  ++S  IIHRDLKP NI +   D+   +KI DFGL+
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLA 163
Query: 115 CTLY-------------PGNYAE--KVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 158
             ++             PG+        G+ +Y+A EVL     Y+EK+DM+S+G I FE
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
Query: 159 LLNGYPPFSVGEEH 172
           ++    PFS G E 
Sbjct: 224 MIY---PFSTGMER 234

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 82/152 (53%), Gaps = 10/152 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV E     +L  ++       +P    + +L 
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLF 113
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 130
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         + 
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 131 LYMAPEV-LQFQRYDEKVDMWSVGAILFELLN 161
            Y APE+ L  + Y   VD+WS+G I  E++ 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 27/178 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 26/164 (15%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQTAR--- 69
            H NII L  A   +  ++++VE+ + GNL  Y+R              RVPE+      
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 70  ----KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
                +    G+E L S   IHRDL   N+L++   ++ ++KIADFGL+  +   +Y +K
Sbjct: 146 LVSCTYQLARGMEYLASQKCIHRDLTARNVLVT---ENNVMKIADFGLARDINNIDYYKK 202
Query: 126 VCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
                L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 203 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 246

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 27/178 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 27/178 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 26/164 (15%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQTAR--- 69
            H NII L  A   +  ++++VE+ + GNL  Y+R              RVPE+      
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 70  ----KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
                +    G+E L S   IHRDL   N+L++   ++ ++KIADFGL+  +   +Y +K
Sbjct: 151 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 207
Query: 126 VCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
                L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 208 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 251

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 27/178 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 247
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 248 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           D+GL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DYGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 26/164 (15%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQTAR--- 69
            H NII L  A   +  ++++VE+ + GNL  Y+R              RVPE+      
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 70  ----KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
                +    G+E L S   IHRDL   N+L++   ++ ++KIADFGL+  +   +Y +K
Sbjct: 148 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYKK 204
Query: 126 VCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
                L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 205 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 248

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 50/214 (23%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--- 58
           ++++N      +  E+  +  ++HPNI RL++ ++ E  I LV+E C GG+L   +    
Sbjct: 64  IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 59  ------------------------------LHG-------RVPEQTARKFLQQL--GLEI 79
                                         +HG          E+     ++Q+   L  
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMA 134
           L++  I HRD+KPEN L S  +    +K+ DFGLS   Y  N  E        G+P ++A
Sbjct: 184 LHNQGICHRDIKPENFLFS-TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 135 PEVLQF--QRYDEKVDMWSVGAILFELLNGYPPF 166
           PEVL    + Y  K D WS G +L  LL G  PF
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 7/160 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+RL D   ++  + LV EFC       +   +G +  +  + FL QL
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 132
             GL   +S +++HRDLKP+N+L   ++ +  LK+ADFGL+     P         +  Y
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLADFGLARAFGIPVRCYSAEVVTLWY 167
Query: 133 MAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
             P+VL   + Y   +DMWS G I  EL N   P   G +
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGND 207

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 89/176 (50%), Gaps = 23/176 (13%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F     I       +V    G 
Sbjct: 58  VKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA 117
Query: 52  NLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           +L++ ++      E       Q L GL+ ++S  IIHRDLKP N+    +++D  L+I D
Sbjct: 118 DLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDSELRILD 174
Query: 111 FGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 162
           FGL+         E++ G   +  Y APE+ L +  Y++ VD+WSVG I+ ELL G
Sbjct: 175 FGLAR-----QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/155 (37%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  VNH NII L + F  +        ++LV+E     NL   I  H  +  +   
Sbjct: 73  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVI--HMELDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
            +  Y APEV+    Y   VD+WSVG I+ EL+ G
Sbjct: 187 VTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 89/176 (50%), Gaps = 23/176 (13%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F     I       +V    G 
Sbjct: 58  VKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA 117
Query: 52  NLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           +L++ ++      E       Q L GL+ ++S  IIHRDLKP N+    +++D  L+I D
Sbjct: 118 DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDSELRILD 174
Query: 111 FGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 162
           FGL+         E++ G   +  Y APE+ L +  Y++ VD+WSVG I+ ELL G
Sbjct: 175 FGLA-----RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L    Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 89/176 (50%), Gaps = 23/176 (13%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F     I       +V    G 
Sbjct: 50  VKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA 109
Query: 52  NLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           +L++ ++      E       Q L GL+ ++S  IIHRDLKP N+    +++D  L+I D
Sbjct: 110 DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRILD 166
Query: 111 FGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 162
           FGL+         E++ G   +  Y APE+ L +  Y++ VD+WSVG I+ ELL G
Sbjct: 167 FGLA-----RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 27/178 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ +++IADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMRIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++       +  
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYL 131
Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
            +    G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T            +
Sbjct: 132 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 130 PLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
             Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 92/190 (48%), Gaps = 31/190 (16%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 135
Query: 65  ---------EQTARKFLQQ------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + K L         G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           DFGL+  ++  +Y +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 165 PFSVGEEHQF 174
              V  E  F
Sbjct: 253 YPGVPVEELF 262

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 86/176 (48%), Gaps = 30/176 (17%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP--------------EQTAR 69
            H NII L  A   +  ++++VE+ + GNL  Y  L  R P              EQ + 
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEYSYNPSHNPEEQLSS 141
Query: 70  KFLQQ------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
           K L         G+E L S   IHRDL   N+L++   +D ++KIADFGL+  ++  +Y 
Sbjct: 142 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 198
Query: 124 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYPPFSVGEEHQF 174
           +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P   V  E  F
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 254

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 86/176 (48%), Gaps = 30/176 (17%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP--------------EQTAR 69
            H NII L  A   +  ++++VE+ + GNL  Y  L  R P              EQ + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEYCYNPSHNPEEQLSS 134
Query: 70  KFLQQ------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
           K L         G+E L S   IHRDL   N+L++   +D ++KIADFGL+  ++  +Y 
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 191
Query: 124 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYPPFSVGEEHQF 174
           +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P   V  E  F
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 86/176 (48%), Gaps = 30/176 (17%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP--------------EQTAR 69
            H NII L  A   +  ++++VE+ + GNL  Y  L  R P              EQ + 
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEYSYNPSHNPEEQLSS 142
Query: 70  KFLQQ------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
           K L         G+E L S   IHRDL   N+L++   +D ++KIADFGL+  ++  +Y 
Sbjct: 143 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 199
Query: 124 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYPPFSVGEEHQF 174
           +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P   V  E  F
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 255

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 86/176 (48%), Gaps = 30/176 (17%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP--------------EQTAR 69
            H NII L  A   +  ++++VE+ + GNL  Y  L  R P              EQ + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEYCYNPSHNPEEQLSS 149
Query: 70  KFLQQ------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
           K L         G+E L S   IHRDL   N+L++   +D ++KIADFGL+  ++  +Y 
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 206
Query: 124 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYPPFSVGEEHQF 174
           +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P   V  E  F
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 86/176 (48%), Gaps = 30/176 (17%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP--------------EQTAR 69
            H NII L  A   +  ++++VE+ + GNL  Y  L  R P              EQ + 
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEYSYNPSHNPEEQLSS 138
Query: 70  KFLQQ------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
           K L         G+E L S   IHRDL   N+L++   +D ++KIADFGL+  ++  +Y 
Sbjct: 139 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 195
Query: 124 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYPPFSVGEEHQF 174
           +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P   V  E  F
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 251

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 86/160 (53%), Gaps = 14/160 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E+  L  ++HPN+++L +      E+ +++V E    G +     L   + E  AR + Q
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQARFYFQ 144
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGS 129
            L  G+E L+   IIHRD+KP N+L+    +D  +KIADFG+S   + G+ A      G+
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVS-NEFKGSDALLSNTVGT 200
Query: 130 PLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPF 166
           P +MAPE L   R     + +D+W++G  L+  + G  PF
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 130
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 187
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 81  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM-G 139
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 140 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 196
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DFGL+   +  +       +  Y APE+ L +  Y+  VD+WSVG I+ ELL G   F  
Sbjct: 197 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFP- 253
Query: 169 GEEH 172
           G +H
Sbjct: 254 GTDH 257

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 92/190 (48%), Gaps = 31/190 (16%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQAREPPGLEY 135
Query: 65  ---------EQTARKFLQQ------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + K L         G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           DFGL+  ++  +Y +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 165 PFSVGEEHQF 174
              V  E  F
Sbjct: 253 YPGVPVEELF 262

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/190 (32%), Positives = 92/190 (48%), Gaps = 31/190 (16%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 176
Query: 65  ---------EQTARK------FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + K      +    G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 233
Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           DFGL+  ++  +Y +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P
Sbjct: 234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
Query: 165 PFSVGEEHQF 174
              V  E  F
Sbjct: 294 YPGVPVEELF 303

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 81/161 (50%), Gaps = 12/161 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E    + + HPNII L      E  + LV+EF  GG L+  +    R+P      +  Q+
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQI 114
Query: 76  --GLEILNSHHI---IHRDLKPENILL-----SGLDDDVMLKIADFGLSCTLYPGNYAEK 125
             G+  L+   I   IHRDLK  NIL+     +G   + +LKI DFGL+   +       
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMS 173
Query: 126 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
             G+  +MAPEV++   + +  D+WS G +L+ELL G  PF
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 93/189 (49%), Gaps = 40/189 (21%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------------IFLVVEFCAGGNLSSYIRLHGRV 63
           E+  L+ + HP I+R F+A+  +N             +++ ++ C   NL  +  ++GR 
Sbjct: 53  EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDW--MNGRC 110
Query: 64  P-EQTARK-----FLQ-QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
             E+  R      FLQ    +E L+S  ++HRDLKP NI  + +DD  ++K+ DFGL   
Sbjct: 111 TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDD--VVKVGDFGLVTA 167
Query: 117 LYPGNYAEKV-------------CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 163
           +      + V              G+ LYM+PE +    Y  KVD++S+G ILFELL   
Sbjct: 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-- 225
Query: 164 PPFSVGEEH 172
            PFS   E 
Sbjct: 226 -PFSTQMER 233

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPEV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++       +  
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYL 124
Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
            +    G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T            +
Sbjct: 125 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 130 PLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
             Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++       +  
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYL 131
Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
            +    G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T            +
Sbjct: 132 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVT 188
Query: 130 PLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
             Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGR--VPEQTAR 69
           L  L +  HPN++RL D            + LV E     +L +Y+       +P +T +
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 115
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+         + V 
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALDPVV 172
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +  Y APEVL    Y   VDMWSVG I  E+    P F
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 91/167 (54%), Gaps = 25/167 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---------VPEQ 66
           E+  L    H NI+ LF  +  ++ + +V ++C G +L  ++ +            +  Q
Sbjct: 82  EVAVLRKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQ 140
Query: 67  TARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGN-YA 123
           TA+      G++ L++ +IIHRD+K  NI    L + + +KI DFGL+   + + G+   
Sbjct: 141 TAQ------GMDYLHAKNIIHRDMKSNNIF---LHEGLTVKIGDFGLATVKSRWSGSQQV 191
Query: 124 EKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
           E+  GS L+MAPEV++ Q    +  + D++S G +L+EL+ G  P+S
Sbjct: 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
            FGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 GFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 27/178 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           GL+  +   +Y +      L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           D GL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DAGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 79/153 (51%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T       E   
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 219

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 75  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 131
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 132 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMVPFV 188
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
            +  Y APEV+    Y E VD+WSVG I+ E++ G
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 27/178 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++V + + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           D GL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DRGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 84/164 (51%), Gaps = 23/164 (14%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGR--VPEQTAR 69
           L  L +  HPN++RL D            + LV E     +L +Y+       +P +T +
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+       Y+ ++ 
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARI-----YSYQMA 175
Query: 128 GSPL-----YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +P+     Y APEVL    Y   VDMWSVG I  E+    P F
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 219

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 79/153 (51%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T       E   
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 27/178 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           GL+  +   +  +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQME--LDHERMS 167
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 224
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 130
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 187
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 27/178 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           GL+  +   +  +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           D GL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DGGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 180
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQME--LDHERMS 167
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 224
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 130
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 187
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 72  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 128
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 129 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 185
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 186 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 84/164 (51%), Gaps = 23/164 (14%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGR--VPEQTAR 69
           L  L +  HPN++RL D            + LV E     +L +Y+       +P +T +
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 115
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+       Y+ ++ 
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARI-----YSYQMA 167
Query: 128 GSPL-----YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            +P+     Y APEVL    Y   VDMWSVG I  E+    P F
Sbjct: 168 LAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 180
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S +NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 92  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S +NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 78  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 247

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           DF L+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F  
Sbjct: 168 DFYLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP- 224
Query: 169 GEEH 172
           G +H
Sbjct: 225 GTDH 228

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/185 (33%), Positives = 95/185 (51%), Gaps = 22/185 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +  +      +LV+ F  G
Sbjct: 55  IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-G 113
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L   ++ H ++ E   +  + Q+  GL  +++  IIHRDLKP N+    +++D  LKI
Sbjct: 114 TDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL---AVNEDCELKI 169
Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            DFGL+           V  +  Y APEV L + RY + VD+WSVG I+ E++ G   F 
Sbjct: 170 LDFGLARQADSEMXGXVV--TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227
Query: 168 VGEEH 172
            G +H
Sbjct: 228 -GSDH 231

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 122
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 179
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 27/178 (15%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++V + + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           GL+  +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+  L G P
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 80/160 (50%), Gaps = 7/160 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+RL D   ++  + LV EFC       +   +G +  +  + FL QL
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 132
             GL   +S +++HRDLKP+N+L   ++ +  LK+A+FGL+     P         +  Y
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167
Query: 133 MAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
             P+VL   + Y   +DMWS G I  EL N   P   G +
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 82/152 (53%), Gaps = 9/152 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  ++RL+     E  I+++ E+ A G+L  +++    G+V       F  
Sbjct: 58  EANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 117
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
           Q+  G+  +   + IHRDL+  N+L+S   + +M KIADFGL+  +    Y A +    P
Sbjct: 118 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 174
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           + + APE + F  +  K D+WS G +L+E++ 
Sbjct: 175 IKWTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           K+ NK +   LD     L S + P I++ F  F     +F+ +E           R+ G 
Sbjct: 64  KEENKRILMDLDV---VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP 120
Query: 63  VPEQTARKFLQQLGLEILNS-------HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
           +PE    + L ++ + I+ +       H +IHRD+KP NILL   D+   +K+ DFG+S 
Sbjct: 121 IPE----RILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISG 173
Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPF 166
            L      ++  G   YMAPE +         YD + D+WS+G  L EL  G  P+
Sbjct: 174 RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 38/194 (19%)
Query: 11  SCLDCELNFLSSVNHPNIIRLFDAF-------------QAENCIFLVVEFCAGGNLSSYI 57
           S +  E+  L+S+NH  ++R + A+             + ++ +F+ +E+C    L   I
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI 106
Query: 58  RLHG--RVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                 +  ++  R F Q L  L  ++S  IIHRDLKP NI +   D+   +KI DFGL+
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLA 163
Query: 115 CTLY-------------PGNYAE--KVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 158
             ++             PG+        G+ +Y+A EVL     Y+EK+DM+S+G I FE
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
Query: 159 LLNGYPPFSVGEEH 172
           ++    PFS G E 
Sbjct: 224 MIY---PFSTGMER 234

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 82/152 (53%), Gaps = 9/152 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  ++RL+     E  I+++ EF A G+L  +++    G+V       F  
Sbjct: 57  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA 116
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
           Q+  G+  +   + IHRDL+  N+L+S   + +M KIADFGL+  +    Y A +    P
Sbjct: 117 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 173
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           + + APE + F  +  K ++WS G +L+E++ 
Sbjct: 174 IKWTAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 94  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 153
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 154 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 213
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 214 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 263

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRA 197
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 247

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 104 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 163
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 164 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 223
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 224 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 273

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 151
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 136
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 84  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 143
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 144 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 203
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 204 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 253

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 247

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 69  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 128
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 129 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 188
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 189 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 238

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 79/170 (46%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 79/170 (46%), Gaps = 19/170 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 95  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 154
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 155 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 214
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            Y  K   + L   +M PE      +  K D WS G +L+E+ + GY P+
Sbjct: 215 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 264

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/165 (34%), Positives = 82/165 (49%), Gaps = 25/165 (15%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGR--VPEQTAR 69
           L  L +  HPN++RL D            + LV E     +L +Y+       +P +T +
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 115
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS------CTLYPGN 121
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+        L+P  
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALFP-- 170
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               V  +  Y APEVL    Y   VDMWSVG I  E+    P F
Sbjct: 171 ----VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 85/176 (48%), Gaps = 30/176 (17%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP--------------EQTAR 69
            H NII L  A   +  ++++VE+ + GNL  Y  L  R P              EQ + 
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEFSFNPSHNPEEQLSS 149
Query: 70  KFLQQ------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
           K L         G+E L S   IHRDL   N+L++   +D ++KIADFGL+  ++  +  
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDXX 206
Query: 124 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYPPFSVGEEHQF 174
           +K     L   +MAPE L  + Y  + D+WS G +L+E+  L G P   V  E  F
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 78  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 134
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 135 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 191
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 192 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 67  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 180
Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            +  Y APEV+    Y E VD+WSVG I+ E++
Sbjct: 181 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 87/184 (47%), Gaps = 39/184 (21%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 481
Query: 58  RLHGRVPEQTARKFLQQLG------------LEILNSHHIIHRDLKPENILLSGLDDDVM 105
           ++         RKF   L             L  L S   +HRD+   N+L+S  D    
Sbjct: 482 QV---------RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATD---C 529
Query: 106 LKIADFGLSCTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNG 162
           +K+ DFGLS  +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G
Sbjct: 530 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 589
Query: 163 YPPF 166
             PF
Sbjct: 590 VKPF 593

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 96/199 (48%), Gaps = 31/199 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 66  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 126 RSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 184
Query: 100 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAIL 156
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 185 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 242
Query: 157 FELL----NGYPPFSVGEE 171
           +E+     + YP   + EE
Sbjct: 243 WEIFSLGASPYPGVKIDEE 261

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 93/185 (50%), Gaps = 24/185 (12%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK  + + +     E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG
Sbjct: 51  LKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHG 110
Query: 62  -------------RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVML 106
                         + +       QQ+  G+  L S H +HRDL   N L+    +++++
Sbjct: 111 PDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLV 167
Query: 107 KIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN- 161
           KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + D+WS+G +L+E+   
Sbjct: 168 KIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 226
Query: 162 GYPPF 166
           G  P+
Sbjct: 227 GKQPW 231

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 87/184 (47%), Gaps = 39/184 (21%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHGRVPEQTARKFLQQLG------------LEILNSHHIIHRDLKPENILLSGLDDDVM 105
           ++         RKF   L             L  L S   +HRD+   N+L+S  D    
Sbjct: 102 QV---------RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATD---C 149
Query: 106 LKIADFGLSCTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNG 162
           +K+ DFGLS  +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G
Sbjct: 150 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 209
Query: 163 YPPF 166
             PF
Sbjct: 210 VKPF 213

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 95/199 (47%), Gaps = 31/199 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 182
Query: 100 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAIL 156
             +  ++KI DFGL+  +Y  P    +     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 183 --EKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 157 FELL----NGYPPFSVGEE 171
           +E+     + YP   + EE
Sbjct: 241 WEIFSLGASPYPGVKIDEE 259

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 96/199 (48%), Gaps = 31/199 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 101 MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 160
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 161 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 219
Query: 100 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAIL 156
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 220 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277
Query: 157 FELL----NGYPPFSVGEE 171
           +E+     + YP   + EE
Sbjct: 278 WEIFSLGASPYPGVKIDEE 296

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 96/199 (48%), Gaps = 31/199 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 182
Query: 100 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAIL 156
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 183 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 157 FELL----NGYPPFSVGEE 171
           +E+     + YP   + EE
Sbjct: 241 WEIFSLGASPYPGVKIDEE 259

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 90/173 (52%), Gaps = 22/173 (12%)
Query: 20  LSSVNHPNIIRLFD-----AFQAENCIFLVVEFCAGGNLSSYIRLHGR-------VPEQT 67
           +   +HPN+IRL       + Q      +++ F   G+L +Y+ L+ R       +P QT
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQT 148
Query: 68  ARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE- 124
             KF+    LG+E L++ + +HRDL   N +L    DD+ + +ADFGLS  +Y G+Y   
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLSKKIYSGDYYRQ 205
Query: 125 -KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFEL-LNGYPPFSVGEEHQF 174
            ++   P+ ++A E L  + Y  K D+W+ G  ++E+   G  P+   + H+ 
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 82/160 (51%), Gaps = 12/160 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLHGRVPEQTARKFLQQ 74
           E   +  +++P I+RL    QAE  + LV+E   GG L  + +     +P     + L Q
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS- 129
             +G++ L   + +HRDL   N+LL    +    KI+DFGLS  L   +  Y  +  G  
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 167
           PL + APE + F+++  + D+WS G  ++E L+ G  P+ 
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 84/161 (52%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 124
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 125 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 84/161 (52%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGFVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 84/161 (52%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 141
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 142 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 198
Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 199 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 239

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 98/182 (53%), Gaps = 27/182 (14%)
Query: 16  ELNFLSSVNHPNIIRLFD--------------AFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           E+  +  ++H NI+++F+              +    N +++V E+    +L++ +   G
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-QG 115
Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
            + E+ AR F+ QL  GL+ ++S +++HRDLKP N+ ++   +D++LKI DFGL+  + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDP 173
Query: 120 -----GNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
                G+ +E +  +  Y +P  +L    Y + +DMW+ G I  E+L G   F+   E +
Sbjct: 174 HYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232
Query: 174 FM 175
            M
Sbjct: 233 QM 234

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 84/161 (52%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 84/161 (52%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 84/161 (52%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 84/161 (52%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 13/158 (8%)
Query: 19  FLSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL- 75
            +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+ 
Sbjct: 102 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 161
Query: 76  -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL- 131
            G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L 
Sbjct: 162 KGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 218
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 219 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 256

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 95/195 (48%), Gaps = 27/195 (13%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RLHGR--VPEQTARK------------FLQQLGLEILNSHHIIHRDLKPENILLSGLDDD 103
           R      VP +   K            F    G+E L S   IHRDL   NILLS   + 
Sbjct: 124 RSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EK 180
Query: 104 VMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L+E+ 
Sbjct: 181 NVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240
Query: 161 ----NGYPPFSVGEE 171
               + YP   + EE
Sbjct: 241 SLGASPYPGVKIDEE 255

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 84/161 (52%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 151
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 152 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 208
Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 209 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 249

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 21/175 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 40  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 98
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 99  QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 155
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPF 166
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF
Sbjct: 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 140 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 87/184 (47%), Gaps = 39/184 (21%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 481
Query: 58  RLHGRVPEQTARKFLQQLG------------LEILNSHHIIHRDLKPENILLSGLDDDVM 105
           ++         RKF   L             L  L S   +HRD+   N+L+S  D    
Sbjct: 482 QV---------RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---C 529
Query: 106 LKIADFGLSCTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNG 162
           +K+ DFGLS  +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G
Sbjct: 530 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 589
Query: 163 YPPF 166
             PF
Sbjct: 590 VKPF 593

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 21/175 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 102 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 158
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPF 166
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 21/175 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 102 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 158
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPF 166
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 145 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 77  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 136
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 137 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 193
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 194 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 230

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 145 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 82  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 141
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 142 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 198
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 21/175 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 46  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 104
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 105 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 161
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPF 166
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF
Sbjct: 162 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 216

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 11/164 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E++ L  + H NI+ L D    E  + LV E+    +L  Y+   G +      + FL Q
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPL 131
           L  GL   +   ++HRDLKP+N+L++   +   LK+ADFGL+     P    +    +  
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 132 YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYP--PFSVGEEH 172
           Y  P++L     Y  ++DMW VG I +E+  G P  P S  EE 
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ 209

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 21/175 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 71  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 129
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 130 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 186
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPF 166
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF
Sbjct: 187 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 241

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 142
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 143 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 199
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 236

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 21/175 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 45  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 103
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 104 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 160
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPF 166
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF
Sbjct: 161 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 215

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 13/158 (8%)
Query: 19  FLSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL- 75
            +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+ 
Sbjct: 103 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 162
Query: 76  -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL- 131
            G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L 
Sbjct: 163 KGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 219
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 220 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 257

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 143
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 144 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 200
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 21/175 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 48  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 106
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 107 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 163
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNGYPPF 166
             +    Y +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G  PF
Sbjct: 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 95/199 (47%), Gaps = 31/199 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++ EFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 100 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAIL 156
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 174 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 157 FELL----NGYPPFSVGEE 171
           +E+     + YP   + EE
Sbjct: 232 WEIFSLGASPYPGVKIDEE 250

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 10/153 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNIIRL           +V E+   G+L +++R H G+         L+
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSP 130
            +  G+  L+    +HRDL   N+L   +D +++ K++DFGLS  L    + A    G  
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVL---VDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGK 215
Query: 131 L---YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           +   + APE + F+ +    D+WS G +++E+L
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 91/183 (49%), Gaps = 36/183 (19%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----------- 63
            E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V           
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 64  -------PEQTAR------KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
                  P++ A        F  Q+  G++ L    ++HRDL   NIL++   +   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKI 191
Query: 109 ADFGLSCTLY-PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----N 161
           +DFGLS  +Y   +Y ++  G  P+ +MA E L    Y  + D+WS G +L+E++    N
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 162 GYP 164
            YP
Sbjct: 252 PYP 254

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/147 (38%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQL--GL 77
           N  N+I + + F   N I +  E  +  NL   I+ +      +P    RKF   +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           + L+ + IIH DLKPENILL        +K+ DFG SC  Y          S  Y APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSC--YEHQRVYTXIQSRFYRAPEV 270
Query: 138 LQFQRYDEKVDMWSVGAILFELLNGYP 164
           +   RY   +DMWS+G IL ELL GYP
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/147 (38%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQL--GL 77
           N  N+I + + F   N I +  E  +  NL   I+ +      +P    RKF   +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           + L+ + IIH DLKPENILL        +K+ DFG SC  Y          S  Y APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSC--YEHQRVYTXIQSRFYRAPEV 270
Query: 138 LQFQRYDEKVDMWSVGAILFELLNGYP 164
           +   RY   +DMWS+G IL ELL GYP
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 95/198 (47%), Gaps = 30/198 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 65  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 124
Query: 58  R------LHGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSGL 100
           R      +  + PE   + FL              G+E L S   IHRDL   NILLS  
Sbjct: 125 RSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-- 182
Query: 101 DDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILF 157
            +  ++KI DFGL+  +   P    +     PL +MAPE +  + Y  + D+WS G +L+
Sbjct: 183 -EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 158 ELL----NGYPPFSVGEE 171
           E+     + YP   + EE
Sbjct: 242 EIFSLGASPYPGVKIDEE 259

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 95/199 (47%), Gaps = 31/199 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++ EFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 100 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAIL 156
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 174 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 157 FELL----NGYPPFSVGEE 171
           +E+     + YP   + EE
Sbjct: 232 WEIFSLGASPYPGVKIDEE 250

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 89/174 (51%), Gaps = 27/174 (15%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV----PEQTA 68
           E    + + HPN++ L      +  + ++  +C+ G+L  ++ +   H  V     ++T 
Sbjct: 79  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 138
Query: 69  RKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           +  L+             G+E L+SHH++H+DL   N+L+    D + +KI+D GL   +
Sbjct: 139 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLFREV 195
Query: 118 YPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           Y  +Y  K+ G+ L    +MAPE + + ++    D+WS G +L+E+ + G  P+
Sbjct: 196 YAADYY-KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 248

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 95/195 (48%), Gaps = 27/195 (13%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RLHGR--VPEQTARK------------FLQQLGLEILNSHHIIHRDLKPENILLSGLDDD 103
           R      VP +   K            F    G+E L S   IHRDL   NILLS   + 
Sbjct: 124 RSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLS---EK 180
Query: 104 VMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            ++KI DFGL+  +Y   +Y  K     PL +MAPE +  + Y  + D+WS G +L+E+ 
Sbjct: 181 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240
Query: 161 ----NGYPPFSVGEE 171
               + YP   + EE
Sbjct: 241 SLGASPYPGVKIDEE 255

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/147 (38%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQL--GL 77
           N  N+I + + F   N I +  E  +  NL   I+ +      +P    RKF   +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           + L+ + IIH DLKPENILL        +K+ DFG SC  Y          S  Y APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSC--YEHQRVYXXIQSRFYRAPEV 270
Query: 138 LQFQRYDEKVDMWSVGAILFELLNGYP 164
           +   RY   +DMWS+G IL ELL GYP
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 19/164 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFL 72
           E+  L  + H N+I+L D    + +  +++V+E+C  G       +   R P   A  + 
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC--- 127
            QL  GLE L+S  I+H+D+KP N+LL+       LKI+  G++  L+P   A+  C   
Sbjct: 116 CQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALGVAEALHP-FAADDTCRTS 171
Query: 128 -GSPLYMAPEVLQ----FQRYDEKVDMWSVGAILFELLNGYPPF 166
            GSP +  PE+      F  +  KVD+WS G  L+ +  G  PF
Sbjct: 172 QGSPAFQPPEIANGLDTFSGF--KVDIWSAGVTLYNITTGLYPF 213

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 87/174 (50%), Gaps = 27/174 (15%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------RVPEQT 67
           E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG          P Q 
Sbjct: 67  EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 68  ARKF-LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
             +  L Q+         G+  L S H +HRDL   N L+     ++++KI DFG+S  +
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMSRDV 183
Query: 118 YPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           Y  +Y  +V G  +    +M PE + ++++  + D+WS G IL+E+   G  P+
Sbjct: 184 YSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 89/176 (50%), Gaps = 31/176 (17%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP---------EQ 66
           E    + + HPN++ L      +  + ++  +C+ G+L  ++ +  R P         ++
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM--RSPHSDVGSTDDDR 119
Query: 67  TARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
           T +  L+             G+E L+SHH++H+DL   N+L+    D + +KI+D GL  
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLFR 176
Query: 116 TLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +Y  +Y  K+ G+ L    +MAPE + + ++    D+WS G +L+E+ + G  P+
Sbjct: 177 EVYAADYY-KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 84/161 (52%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGL+  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLARVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 145
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 146 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 202
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 203 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 239

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 145 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 10/153 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNIIRL           +V E+   G+L +++R H G+         L+
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSP 130
            +  G+  L+    +HRDL   N+L   +D +++ K++DFGLS  L    + A    G  
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVL---VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 131 L---YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           +   + APE + F+ +    D+WS G +++E+L
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 90  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 149
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 150 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 206
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 207 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 243

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 145 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 142
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 143 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 199
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 236

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E    G+L S++R H    + T  + +  L
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--AQFTVIQLVGML 124
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 125 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 13/158 (8%)
Query: 19  FLSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL- 75
            +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+ 
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 202
Query: 76  -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL- 131
            G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L 
Sbjct: 203 KGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E    G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGAVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/178 (37%), Positives = 83/178 (46%), Gaps = 24/178 (13%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-- 58
           +L+ +NKH     D E+ +        I+ L   F   N + LV E  +  NL   +R  
Sbjct: 103 LLELMNKH-----DTEMKYY-------IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT 149
Query: 59  -LHGRVPEQTARKFLQQLGLEIL----NSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
              G V     RKF QQ+   +L        IIH DLKPENILL        +KI DFG 
Sbjct: 150 NFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGS 207
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           SC L  G    +   S  Y +PEVL    YD  +DMWS+G IL E+  G P FS   E
Sbjct: 208 SCQL--GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/178 (37%), Positives = 83/178 (46%), Gaps = 24/178 (13%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-- 58
           +L+ +NKH     D E+ +        I+ L   F   N + LV E  +  NL   +R  
Sbjct: 103 LLELMNKH-----DTEMKYY-------IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT 149
Query: 59  -LHGRVPEQTARKFLQQLGLEIL----NSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
              G V     RKF QQ+   +L        IIH DLKPENILL        +KI DFG 
Sbjct: 150 NFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRXAIKIVDFGS 207
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           SC L  G    +   S  Y +PEVL    YD  +DMWS+G IL E+  G P FS   E
Sbjct: 208 SCQL--GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGL   L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E +A   L   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 171
Query: 131 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
               + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/178 (37%), Positives = 83/178 (46%), Gaps = 24/178 (13%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-- 58
           +L+ +NKH     D E+ +        I+ L   F   N + LV E  +  NL   +R  
Sbjct: 84  LLELMNKH-----DTEMKYY-------IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT 130
Query: 59  -LHGRVPEQTARKFLQQLGLEIL----NSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
              G V     RKF QQ+   +L        IIH DLKPENILL        +KI DFG 
Sbjct: 131 NFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGS 188
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           SC L  G    +   S  Y +PEVL    YD  +DMWS+G IL E+  G P FS   E
Sbjct: 189 SCQL--GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 244

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 53  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 112
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 113 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 168
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +  PEVL + ++  K D+W+ G +++E+ + G  P+
Sbjct: 169 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 206

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E    G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 114 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 169
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +  PEVL + ++  K D+W+ G +++E+ + G  P+
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 49  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 108
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 109 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 164
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +  PEVL + ++  K D+W+ G +++E+ + G  P+
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 202

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 60  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 119
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 120 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 175
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +  PEVL + ++  K D+W+ G +++E+ + G  P+
Sbjct: 176 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 213

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 31/199 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 100 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAIL 156
             +  ++KI DFGL+  +   P    +     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 174 --EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 157 FELL----NGYPPFSVGEE 171
           +E+     + YP   + EE
Sbjct: 232 WEIFSLGASPYPGVKIDEE 250

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 93/197 (47%), Gaps = 29/197 (14%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 66  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
Query: 58  RLHGR-----VPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSGLD 101
           R          PE   + FL              G+E L S   IHRDL   NILLS   
Sbjct: 126 RSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS--- 182
Query: 102 DDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFE 158
           +  ++KI DFGL+  +   P    +     PL +MAPE +  + Y  + D+WS G +L+E
Sbjct: 183 EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 242
Query: 159 LL----NGYPPFSVGEE 171
           +     + YP   + EE
Sbjct: 243 IFSLGASPYPGVKIDEE 259

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 88/162 (54%), Gaps = 17/162 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQ- 73
           E+  +S++NHPNI++L+      N   +V+EF   G+L  Y RL  +  P + + K    
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL--YHRLLDKAHPIKWSVKLRLM 128
Query: 74  ---QLGLEILNSHH--IIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLYPGNYAEKV 126
               LG+E + + +  I+HRDL+  NI L  LD++  V  K+ADFGLS      +    +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGL 186
Query: 127 CGSPLYMAPEVL--QFQRYDEKVDMWSVGAILFELLNGYPPF 166
            G+  +MAPE +  + + Y EK D +S   IL+ +L G  PF
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 83/158 (52%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 184
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +  PEVL + ++  K D+W+ G +++E+ + G  P+
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 36/183 (19%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----------- 63
            E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V           
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 64  -------PEQTAR------KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
                  P++ A        F  Q+  G++ L    ++HRDL   NIL++   +   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKI 191
Query: 109 ADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL----N 161
           +DFGLS  +Y  +   K     +   +MA E L    Y  + D+WS G +L+E++    N
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 162 GYP 164
            YP
Sbjct: 252 PYP 254

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTA 68
           E+  L  + HPN+I L   F   A+  ++L+ ++ A  +L   I+ H      + P Q  
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 126
Query: 69  RKFLQQL------GLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 117
           R  ++ L      G+  L+++ ++HRDLKP NIL+ G   +   +KIAD G +      L
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            P    + V  +  Y APE+L   R Y + +D+W++G I  ELL   P F   +E
Sbjct: 187 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 31/199 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 182
Query: 100 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAIL 156
             +  ++KI DFGL+  +   P    +     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 183 --EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 157 FELL----NGYPPFSVGEE 171
           +E+     + YP   + EE
Sbjct: 241 WEIFSLGASPYPGVKIDEE 259

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 36/183 (19%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----------- 63
            E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V           
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 64  -------PEQTAR------KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
                  P++ A        F  Q+  G++ L    ++HRDL   NIL++   +   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVA---EGRKMKI 191
Query: 109 ADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL----N 161
           +DFGLS  +Y  +   K     +   +MA E L    Y  + D+WS G +L+E++    N
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 162 GYP 164
            YP
Sbjct: 252 PYP 254

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 171
Query: 131 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
               + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 85/160 (53%), Gaps = 12/160 (7%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           +S    E++ L ++ H +II+       Q E  + LV+E+   G+L  Y+  H     Q 
Sbjct: 60  RSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL 119
Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
              F QQ+  G+  L+S H IHR+L   N+LL   D+D ++KI DFGL+  +  G+   +
Sbjct: 120 LL-FAQQICEGMAYLHSQHYIHRNLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 126 V---CGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           V     SP+ + APE L+  ++    D+WS G  L+ELL 
Sbjct: 176 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 82/160 (51%), Gaps = 13/160 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  + HPNI+    A      + +V E+ + G+L   +   G   +   R+ L   
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 76  -----GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKV 126
                G+  L++ +  I+HRDLK  N+L+   D    +K+ DFGLS  L    +  ++  
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLS-RLKASXFLXSKXA 199
Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            G+P +MAPEVL+ +  +EK D++S G IL+EL     P+
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 11/165 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 49  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 107
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 124
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 108 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 164
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 165 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 209

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E  A   L   
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 118
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 174
Query: 131 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
               + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 11/165 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 119
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 124
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 120 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 176
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 82/160 (51%), Gaps = 11/160 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
           CE + +   +HPN++ L         + +V+EF   G L +++R H G+         L+
Sbjct: 93  CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR 152
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCG 128
            +  G+  L     +HRDL   NIL   ++ +++ K++DFGLS  +       Y      
Sbjct: 153 GIAAGMRYLADMGYVHRDLAARNIL---VNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGK 209
Query: 129 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            P+ + APE +Q++++    D+WS G +++E+++ G  P+
Sbjct: 210 IPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 249

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLHGRVPEQTARKFLQQ 74
           E   +  +++P I+RL    QAE  + LV+E   GG L  + +     +P     + L Q
Sbjct: 386 EAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444
Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS- 129
             +G++ L   + +HR+L   N+LL    +    KI+DFGLS  L   +  Y  +  G  
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           PL + APE + F+++  + D+WS G  ++E L+ G  P+
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 122
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 11/165 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 51  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 109
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 124
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 110 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 166
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 11/165 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 129
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 124
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 130 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKA 186
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 187 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 11/165 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 129
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 124
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 130 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKA 186
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 187 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 86/184 (46%), Gaps = 39/184 (21%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHGRVPEQTARKFLQQLG------------LEILNSHHIIHRDLKPENILLSGLDDDVM 105
           ++         RKF   L             L  L S   +HRD+   N+L+S  D    
Sbjct: 102 QV---------RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---C 149
Query: 106 LKIADFGLSCTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFE-LLNG 162
           +K+ DFGLS  +      +   G  P+ +MAPE + F+R+    D+W  G  ++E L++G
Sbjct: 150 VKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 209
Query: 163 YPPF 166
             PF
Sbjct: 210 VKPF 213

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 11/165 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 113
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP--GNYAE 124
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 114 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENXYKA 170
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 171 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 11/165 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 113
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 124
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 114 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 170
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 171 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 11/165 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 69  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 127
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 124
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 128 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 184
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 185 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 19  FLSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL- 75
            +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+ 
Sbjct: 83  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 142
Query: 76  -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL- 131
            G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y           G+ L 
Sbjct: 143 KGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLP 199
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 200 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 119
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTFTAHAGAK 171
Query: 131 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
               + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 119
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAPAGAKF 176
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 118
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAPAGAKF 175
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 176 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 119
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 31/199 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++ EFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 100 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAIL 156
             +  ++KI DFGL+  +   P    +     PL +MAPE +  + Y  + D+WS G +L
Sbjct: 174 --EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 157 FELL----NGYPPFSVGEE 171
           +E+     + YP   + EE
Sbjct: 232 WEIFSLGASPYPGVKIDEE 250

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 117
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 78/157 (49%), Gaps = 7/157 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + H NII L       + + L+ E+ A  +L  Y+  +  V  +  + FL QL
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTL-YPGNYAEKVCGSP 130
             G+   +S   +HRDLKP+N+LLS  D  +  +LKI DFGL+     P         + 
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 131 LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 166
            Y  PE+L   R Y   VD+WS+  I  E+L   P F
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 38/194 (19%)
Query: 11  SCLDCELNFLSSVNHPNIIRLFDAF-------------QAENCIFLVVEFCAGGNLSSYI 57
           S +  E+  L+S+NH  ++R + A+             + ++ +F+  E+C    L   I
Sbjct: 47  STILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLI 106
Query: 58  RLHG--RVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                 +  ++  R F Q L  L  ++S  IIHR+LKP NI    +D+   +KI DFGL+
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIF---IDESRNVKIGDFGLA 163
Query: 115 CTLY-------------PGNYAE--KVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 158
             ++             PG+        G+  Y+A EVL     Y+EK+D +S+G I FE
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223
Query: 159 LLNGYPPFSVGEEH 172
            +    PFS G E 
Sbjct: 224 XIY---PFSTGXER 234

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 72  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 130
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 131 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 187
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 188 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 117
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 11/165 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 414 LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 472
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 124
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 473 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 529
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 530 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 80/163 (49%), Gaps = 21/163 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E+  +  + HPN+++       +  +  + E+  GG L   I+ +  + P      F + 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------- 125
           +  G+  L+S +IIHRDL   N L+    ++  + +ADFGL+  +       +       
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 126 --------VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
                   V G+P +MAPE++  + YDEKVD++S G +L E++
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 178
Query: 131 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
               + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 86/159 (54%), Gaps = 13/159 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL+          K+   
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--- 176
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L+ +++  K D+WS G +L+E+ + G  P+
Sbjct: 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 11/165 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 413 LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 471
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 124
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 472 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 528
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +  G  P+ + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 82/160 (51%), Gaps = 13/160 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  + HPNI+    A      + +V E+ + G+L   +   G   +   R+ L   
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 76  -----GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKV 126
                G+  L++ +  I+HR+LK  N+L+   D    +K+ DFGLS  L    +  ++  
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLS-RLKASTFLSSKSA 199
Query: 127 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            G+P +MAPEVL+ +  +EK D++S G IL+EL     P+
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 84/162 (51%), Gaps = 19/162 (11%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L      E   +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEK 125
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL    S T   G    K
Sbjct: 108 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 164
Query: 126 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
                 + APE L+ +++  K D+WS G +L+E+ + G  P+
Sbjct: 165 ------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 85/160 (53%), Gaps = 12/160 (7%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           +S    E++ L ++ H +II+       Q E  + LV+E+   G+L  Y+  H     Q 
Sbjct: 60  RSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL 119
Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
              F QQ+  G+  L++ H IHR+L   N+LL   D+D ++KI DFGL+  +  G+   +
Sbjct: 120 LL-FAQQICEGMAYLHAQHYIHRNLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 126 V---CGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           V     SP+ + APE L+  ++    D+WS G  L+ELL 
Sbjct: 176 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 121
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 87/162 (53%), Gaps = 17/162 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQ- 73
           E+  +S++NHPNI++L+      N   +V+EF   G+L  Y RL  +  P + + K    
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL--YHRLLDKAHPIKWSVKLRLM 128
Query: 74  ---QLGLEILNSHH--IIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLYPGNYAEKV 126
               LG+E + + +  I+HRDL+  NI L  LD++  V  K+ADFG S      +    +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV--HSVSGL 186
Query: 127 CGSPLYMAPEVL--QFQRYDEKVDMWSVGAILFELLNGYPPF 166
            G+  +MAPE +  + + Y EK D +S   IL+ +L G  PF
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   ++V E+   GNL  Y+R   R  E TA   L   
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNR-EEVTAVVLLYMA 136
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 137 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHVVKVADFGLSRLMTGDTYTAHAGAKF 193
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L +  +  K D+W+ G +L+E+   G  P+
Sbjct: 194 PIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 83/163 (50%), Gaps = 17/163 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L    H NII + D  +A        ++LV     G +L   ++      +     
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSNDHICY- 148
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 205
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 86/159 (54%), Gaps = 13/159 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL+          K+   
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL--- 348
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L+ +++  K D+WS G +L+E+ + G  P+
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y     GS   
Sbjct: 114 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSR-GSKFP 169
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +  PEVL + ++  K D+W+ G +++E+ + G  P+
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 145
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +    +       G+ L  
Sbjct: 146 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV 202
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 203 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 239

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 87/162 (53%), Gaps = 17/162 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQ- 73
           E+  +S++NHPNI++L+      N   +V+EF   G+L  Y RL  +  P + + K    
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL--YHRLLDKAHPIKWSVKLRLM 128
Query: 74  ---QLGLEILNSHH--IIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLYPGNYAEKV 126
               LG+E + + +  I+HRDL+  NI L  LD++  V  K+ADF LS      +    +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV--HSVSGL 186
Query: 127 CGSPLYMAPEVL--QFQRYDEKVDMWSVGAILFELLNGYPPF 166
            G+  +MAPE +  + + Y EK D +S   IL+ +L G  PF
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 52  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 111
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 112 VCEGMAYLEEASVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 167
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 168 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 16/162 (9%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLF----DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +S    E++ L ++ H +II+      DA  A   + LV+E+   G+L  Y+  H     
Sbjct: 77  RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS--LQLVMEYVPLGSLRDYLPRHSIGLA 134
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
           Q    F QQ+  G+  L++ H IHRDL   N+L   LD+D ++KI DFGL+  +  G+  
Sbjct: 135 QLLL-FAQQICEGMAYLHAQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEX 190
Query: 124 EKV---CGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            +V     SP+ + APE L+  ++    D+WS G  L+ELL 
Sbjct: 191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 85/162 (52%), Gaps = 13/162 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPN+I L         + ++ EF   G+L S++R + G+         L+
Sbjct: 83  SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 142
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVC 127
            +  G++ L   + +HRDL   NIL   ++ +++ K++DFGLS  L        Y   + 
Sbjct: 143 GIAAGMKYLADMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 199
Query: 128 GS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           G  P+ + APE +Q++++    D+WS G +++E+++ G  P+
Sbjct: 200 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 241

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 10/153 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F 
Sbjct: 232 AEANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
            Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y  +     
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVIEDNEYTAREGAKF 347
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           P+ + APE + F  +  K D+WS G +L E++ 
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 53  EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 168
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F 
Sbjct: 59  AEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 117
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGS 129
            Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y A +    
Sbjct: 118 AQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVIEDNEYTAREGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           P+ + APE + F  +  K D+WS G +L E++ 
Sbjct: 175 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 12/162 (7%)
Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            L+S    E+  L ++ H +I++       Q E  + LV+E+   G+L  Y+  H  V  
Sbjct: 53  QLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGL 111
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
                F QQ+  G+  L++ H IHR L   N+LL   D+D ++KI DFGL+  +  G+  
Sbjct: 112 AQLLLFAQQICEGMAYLHAQHYIHRALAARNVLL---DNDRLVKIGDFGLAKAVPEGHEY 168
Query: 124 EKV---CGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            +V     SP+ + APE L+  ++    D+WS G  L+ELL 
Sbjct: 169 YRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 12/162 (7%)
Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            L+S    E+  L ++ H +I++       Q E  + LV+E+   G+L  Y+  H  V  
Sbjct: 52  QLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGL 110
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
                F QQ+  G+  L++ H IHR L   N+LL   D+D ++KI DFGL+  +  G+  
Sbjct: 111 AQLLLFAQQICEGMAYLHAQHYIHRALAARNVLL---DNDRLVKIGDFGLAKAVPEGHEY 167
Query: 124 EKV---CGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            +V     SP+ + APE L+  ++    D+WS G  L+ELL 
Sbjct: 168 YRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +    HPNIIRL         + ++ EF   G L S++RL+ G+         L+
Sbjct: 64  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 123
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVC 127
            +  G+  L     +HRDL   NIL   ++ +++ K++DFGLS  L   +    Y   + 
Sbjct: 124 GIASGMRYLAEMSYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 128 GS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           G  P+ + APE + F+++    D WS G +++E+++ G  P+
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY 222

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 80/165 (48%), Gaps = 28/165 (16%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE---------QTARKFLQQ 74
           +HPNII L  A +    ++L +E+   GNL  ++R   RV E          TA     Q
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQ 142
Query: 75  ----------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
                      G++ L+    IHRDL   NIL+    ++ + KIADFGLS       Y +
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRG--QEVYVK 197
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           K  G  P+ +MA E L +  Y    D+WS G +L+E+++ G  P+
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 91/175 (52%), Gaps = 22/175 (12%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F   + +      +LV+ F   
Sbjct: 54  IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT 113
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L   + L  +  E+  +  + Q+  GL+ ++S  ++HRDLKP N+    +++D  LKI
Sbjct: 114 -DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKI 167
Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 162
            DFGL+   +          +  Y APEV L +  Y++ VD+WSVG I+ E+L G
Sbjct: 168 LDFGLA--RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 26/187 (13%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R HG
Sbjct: 79  LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 138
Query: 62  RVPEQTARK--------FLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDV 104
              +  A           L QL         G+  L   H +HRDL   N L+      +
Sbjct: 139 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGL 195
Query: 105 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + D+WS G +L+E+ 
Sbjct: 196 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
Query: 161 N-GYPPF 166
             G  P+
Sbjct: 255 TYGKQPW 261

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 324
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHR+L   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 381
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 80/165 (48%), Gaps = 28/165 (16%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE---------QTARKFLQQ 74
           +HPNII L  A +    ++L +E+   GNL  ++R   RV E          TA     Q
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQ 132
Query: 75  ----------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
                      G++ L+    IHRDL   NIL+    ++ + KIADFGLS       Y +
Sbjct: 133 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRG--QEVYVK 187
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           K  G  P+ +MA E L +  Y    D+WS G +L+E+++ G  P+
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 232

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 13/160 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 52  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 109
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 110 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 166
Query: 129 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            P+ + APE + +  +  K D+WS G +L E++  G  P+
Sbjct: 167 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 206

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 50  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 165
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 55  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 114
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 115 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 170
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 171 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 208

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 13/160 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 171
Query: 129 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            P+ + APE + +  +  K D+WS G +L E++  G  P+
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 52  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 111
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 112 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 167
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 168 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 72  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 131
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 132 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 187
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 188 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 225

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 67  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 124
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 125 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 181
Query: 129 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 182 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 26/187 (13%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R HG
Sbjct: 50  LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 109
Query: 62  RVPEQTARK--------FLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDV 104
              +  A           L QL         G+  L   H +HRDL   N L+      +
Sbjct: 110 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGL 166
Query: 105 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + D+WS G +L+E+ 
Sbjct: 167 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 225
Query: 161 N-GYPPF 166
             G  P+
Sbjct: 226 TYGKQPW 232

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 63  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 120
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y  +    
Sbjct: 121 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 177
Query: 130 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 26/187 (13%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R HG
Sbjct: 56  LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 115
Query: 62  RVPEQTARK--------FLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDV 104
              +  A           L QL         G+  L   H +HRDL   N L+      +
Sbjct: 116 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGL 172
Query: 105 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + D+WS G +L+E+ 
Sbjct: 173 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 231
Query: 161 N-GYPPF 166
             G  P+
Sbjct: 232 TYGKQPW 238

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 62  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 119
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y  +    
Sbjct: 120 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 176
Query: 130 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 177 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +        V GS   
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEETSSV-GSKFP 184
Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +  PEVL + ++  K D+W+ G +++E+ + G  P+
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 19/162 (11%)
Query: 15  CELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 54  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 113
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEK 125
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL    S T   G    K
Sbjct: 114 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 170
Query: 126 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
                 + APE L+   +  K D+WS G +L+E+ + G  P+
Sbjct: 171 ------WTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 20/151 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 138
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 139 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSD---LKICDFGLARVADPDHDHTGFLT 187
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 20/151 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 305 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 363
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHR+L   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 364 TQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 420
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 421 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 459

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFLT 185
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++EF   G+L  Y++ H  R+
Sbjct: 56  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI 114
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 171
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 15/163 (9%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +    HPNIIRL         + ++ EF   G L S++RL+ G+         L+
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 125
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
            +  G+  L     +HRDL   NIL   ++ +++ K++DFGLS  L   N ++    S L
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEE-NSSDPTETSSL 181
Query: 132 -------YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
                  + APE + F+++    D WS G +++E+++ G  P+
Sbjct: 182 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY 224

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 90/175 (51%), Gaps = 22/175 (12%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F   + +      +LV+ F   
Sbjct: 72  IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT 131
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L   + +     E+  +  + Q+  GL+ ++S  ++HRDLKP N+    +++D  LKI
Sbjct: 132 -DLQKIMGME--FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKI 185
Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 162
            DFGL+   +          +  Y APEV L +  Y++ VD+WSVG I+ E+L G
Sbjct: 186 LDFGLA--RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 56  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI 114
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 171
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 185
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 185
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 189
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 34/181 (18%)
Query: 14  DCELNFLSSVNHPNI-IRLFDAFQAENCI------------FLVVEFCAGGNLSSYIR-- 58
           D  L+  S ++ P++ IR  D F  +N +            ++ ++ C   NL  ++   
Sbjct: 96  DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155
Query: 59  --LHGRVPEQTARKFLQ-QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
             L  R        F+Q    +E L+S  ++HRDLKP NI  + +DD  ++K+ DFGL  
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDD--VVKVGDFGLVT 212
Query: 116 TLYPGNYAEKV-------------CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
            +      + V              G+ LYM+PE +    Y  KVD++S+G ILFELL  
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
Query: 163 Y 163
           +
Sbjct: 273 F 273

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 189
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 11/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ E+   G+L +++R + GR         L+ 
Sbjct: 59  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRG 118
Query: 75  LG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 129
           +G  ++ L+    +HRDL   NIL+   + +++ K++DFG+S  L       Y  +    
Sbjct: 119 IGSGMKYLSDMSYVHRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 175
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE + ++++    D+WS G +++E+++ G  P+
Sbjct: 176 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 214

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 11/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ E+   G+L +++R + GR         L+ 
Sbjct: 80  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRG 139
Query: 75  LG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 129
           +G  ++ L+    +HRDL   NIL+   + +++ K++DFG+S  L       Y  +    
Sbjct: 140 IGSGMKYLSDMSAVHRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 196
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE + ++++    D+WS G +++E+++ G  P+
Sbjct: 197 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 235

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 83/159 (52%), Gaps = 11/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + +V E+   G+L ++++ + G+         L+ 
Sbjct: 73  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRG 132
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 129
           +  G++ L+    +HRDL   NIL+   + +++ K++DFGLS  L       Y  +    
Sbjct: 133 ISAGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 189
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE + F+++    D+WS G +++E+++ G  P+
Sbjct: 190 PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPY 228

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 11/159 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ E+   G+L +++R + GR         L+ 
Sbjct: 65  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRG 124
Query: 75  LG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 129
           +G  ++ L+    +HRDL   NIL+   + +++ K++DFG+S  L       Y  +    
Sbjct: 125 IGSGMKYLSDMSYVHRDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 181
Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE + ++++    D+WS G +++E+++ G  P+
Sbjct: 182 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 220

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 28/165 (16%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE---------QTARKFLQQ 74
           +HPNII L  A +    ++L +E+   GNL  ++R   RV E          TA     Q
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQ 139
Query: 75  ----------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
                      G++ L+    IHR+L   NIL+    ++ + KIADFGLS       Y +
Sbjct: 140 QLLHFAADVARGMDYLSQKQFIHRNLAARNILVG---ENYVAKIADFGLSRG--QEVYVK 194
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           K  G  P+ +MA E L +  Y    D+WS G +L+E+++ G  P+
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 239

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 20/151 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y   Y  K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV 196
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 71  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 129
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 130 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 186
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 187 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 76/139 (54%), Gaps = 17/139 (12%)
Query: 42  FLVVEFCAGGNLSSYIRLHGRV-------PEQTARKFLQQL--GLEILNSHHIIHRDLKP 92
            +++ F   G+L +++ L  R+       P QT  +F+  +  G+E L+S + IHRDL  
Sbjct: 107 MVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAA 165
Query: 93  ENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDM 149
            N +L+   +D+ + +ADFGLS  +Y G+Y  + C S L   ++A E L    Y    D+
Sbjct: 166 RNCMLA---EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDV 222
Query: 150 WSVGAILFELLN-GYPPFS 167
           W+ G  ++E++  G  P++
Sbjct: 223 WAFGVTMWEIMTRGQTPYA 241

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 60  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 118
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 119 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 175
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 176 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 51  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 109
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 110 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 166
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 167 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 71  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 129
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 130 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 186
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 187 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 53  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 168
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 84  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 142
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 143 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 199
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 200 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 57  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 115
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 116 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 172
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 173 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 53  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 168
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 52  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 110
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 111 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 167
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 168 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 21/155 (13%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 142
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 177 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 143 YDEK-----------VDMWSVGAILFELLNGYPPF 166
              +            D+WS+G IL+ +  G  PF
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 59  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 117
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 118 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 174
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 175 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 53  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 110
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHR+L+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 111 AAQIAEGMAFIEERNYIHRNLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 167
Query: 129 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 168 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 21/155 (13%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 71  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 129
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 142
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 130 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 143 YDEK-----------VDMWSVGAILFELLNGYPPF 166
              +            D+WS+G IL+ +  G  PF
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 21/155 (13%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 90  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 142
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 149 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 143 YDEK-----------VDMWSVGAILFELLNGYPPF 166
              +            D+WS+G IL+ +  G  PF
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 58  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 116
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 117 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 173
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 174 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 21/155 (13%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 142
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 177 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 143 YDEK-----------VDMWSVGAILFELLNGYPPF 166
              +            D+WS+G IL+ +  G  PF
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 187
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 187
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 185
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 189
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 134 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 190
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 191 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 219

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 84/161 (52%), Gaps = 13/161 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPN+I L         + ++ EF   G+L S++R + G+         L+ 
Sbjct: 58  EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 117
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCG 128
           +  G++ L   + +HR L   NIL   ++ +++ K++DFGLS  L        Y   + G
Sbjct: 118 IAAGMKYLADMNYVHRALAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 174
Query: 129 S-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             P+ + APE +Q++++    D+WS G +++E+++ G  P+
Sbjct: 175 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 215

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 189
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 190
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 191 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 127 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 183
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 135 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 191
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 192 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 126 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 182
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 183 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 189
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 56  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 114
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 171
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP+ + APE L   ++    D+WS G +L+EL  
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 127 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 183
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 20/160 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L    H NII + D  +          +++V++     +L   I     +  +  R
Sbjct: 103 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVR 161
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGN--- 121
            FL QL  GL+ ++S  +IHRDLKP N+L   ++++  LKI DFG++   CT  P     
Sbjct: 162 YFLYQLLRGLKYMHSAQVIHRDLKPSNLL---VNENCELKIGDFGMARGLCT-SPAEHQY 217
Query: 122 YAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELL 160
           +  +   +  Y APE +L    Y + +D+WSVG I  E+L
Sbjct: 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 21/155 (13%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 142
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 177 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 143 YDEK-----------VDMWSVGAILFELLNGYPPF 166
              +            D+WS+G IL+ +  G  PF
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLX 189
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 190 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLX 190
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 191 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 137 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 193
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 194 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 185
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 12/183 (6%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+  ++   H N++ L       + + LV  +   G+L   +   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 61  GRVPEQTAR---KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 113
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 181
Query: 114 -SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            S          ++ G+  YMAPE L+ +    K D++S G +L E++ G P      E 
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 173 QFM 175
           Q +
Sbjct: 241 QLL 243

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 177 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 233
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 262

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 205
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 21/155 (13%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 74  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 132
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 142
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 133 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 188
Query: 143 YDEK-----------VDMWSVGAILFELLNGYPPF 166
              +            D+WS+G IL+ +  G  PF
Sbjct: 189 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 223

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 21/155 (13%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 70  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 128
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQR 142
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++   
Sbjct: 129 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 184
Query: 143 YDEK-----------VDMWSVGAILFELLNGYPPF 166
              +            D+WS+G IL+ +  G  PF
Sbjct: 185 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 219

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 18/168 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI---FLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           E   L  +NH NI++LF A + E       L++EFC  G+L + +            +FL
Sbjct: 57  EFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 73  QQL-----GLEILNSHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
             L     G+  L  + I+HR++KP NI+ + G D   + K+ DFG +  L        +
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL 175
Query: 127 CGSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPF 166
            G+  Y+ P++ +         ++Y   VD+WS+G   +    G  PF
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 20/151 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 140
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HR+L   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 141 ADGMAYLNAKKFVHRNLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 177 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 233
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 262

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 20/160 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L    H NII + D  +          +++V++     +L   I     +  +  R
Sbjct: 104 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVR 162
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGN--- 121
            FL QL  GL+ ++S  +IHRDLKP N+L   ++++  LKI DFG++   CT  P     
Sbjct: 163 YFLYQLLRGLKYMHSAQVIHRDLKPSNLL---VNENCELKIGDFGMARGLCT-SPAEHQY 218
Query: 122 YAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELL 160
           +  +   +  Y APE +L    Y + +D+WSVG I  E+L
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 258

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 130 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 186
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 215

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 247

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 20/151 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HR+L   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 140 ADGMAYLNAKKFVHRNLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 135 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 191
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 220

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNX 129
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 130 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 186
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 215

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 248

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 247

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 248

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 247

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 73  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 132
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 133 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 189
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 190 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 218

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 177 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 233
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 234 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 262

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 97  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 156
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 157 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 213
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 214 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 242

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 135 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 191
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 220

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 130 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 186
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 215

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 74  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 134 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 190
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 191 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 219

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 248

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 219 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 247

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 122 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 181
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 182 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 238
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 239 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 267

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 149 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 205
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 206 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 234

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 220 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 248

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +       +    
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDAEXTAREGAK 171
Query: 130 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 12/183 (6%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+  ++   H N++ L       + + LV  +   G+L   +   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 61  GRVPEQTAR---KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 113
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 181
Query: 114 -SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            S          ++ G+  YMAPE L+ +    K D++S G +L E++ G P      E 
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 173 QFM 175
           Q +
Sbjct: 241 QLL 243

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 19  FLSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE---------QTA 68
            +  +NHPN++ L       E    +++ +   G+L  +IR   R P          Q A
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVA 134
Query: 69  RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AE 124
           R      G+E L     +HRDL   N +L   D+   +K+ADFGL+  +    Y      
Sbjct: 135 R------GMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDREYYSVQQH 185
Query: 125 KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +    P+ + A E LQ  R+  K D+WS G +L+ELL  G PP+
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 150 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 206
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 235

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 150 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 206
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 235

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 149 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 205
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 206 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 234

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 135 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 191
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 192 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 220

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 18/168 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI---FLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           E   L  +NH NI++LF A + E       L++EFC  G+L + +            +FL
Sbjct: 57  EFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 73  QQL-----GLEILNSHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
             L     G+  L  + I+HR++KP NI+ + G D   + K+ DFG +  L        +
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXL 175
Query: 127 CGSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPF 166
            G+  Y+ P++ +         ++Y   VD+WS+G   +    G  PF
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 12/183 (6%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+  ++   H N++ L       + + LV  +   G+L   +   
Sbjct: 59  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 118
Query: 61  GRVPEQTAR---KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 113
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 119 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 175
Query: 114 -SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            S          ++ G+  YMAPE L+ +    K D++S G +L E++ G P      E 
Sbjct: 176 ASEKFAQXVMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREP 234
Query: 173 QFM 175
           Q +
Sbjct: 235 QLL 237

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 150 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 206
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 207 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 235

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 168
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 169 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 225
Query: 144 DEK-VDMWSVGAILFELLNGYPPFSVGEE 171
             +   +WS+G +L++++ G  PF   EE
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFEHDEE 254

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 22/166 (13%)
Query: 24  NHPNIIRL----FDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQL--- 75
           NHPNI+RL         A++  +L++ F   G L + I RL  +    T  + L  L   
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------NYAEK 125
             GLE +++    HRDLKP NILL      V++ +     +C    G        ++A +
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 126 VCGSPLYMAPEVLQFQRY---DEKVDMWSVGAILFELLNGYPPFSV 168
            C +  Y APE+   Q +   DE+ D+WS+G +L+ ++ G  P+ +
Sbjct: 204 RC-TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  L   N      G+
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA-RLIEDNEXTAREGA 170
Query: 130 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
                + APE + +  +  K D+WS G +L E++  G  P+
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 14/155 (9%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 59  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 116
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  L   N      G+
Sbjct: 117 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA-RLIEDNEXTAREGA 172
Query: 130 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
                + APE + +  +  K D+WS G +L E++ 
Sbjct: 173 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 58  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 115
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  L   N      G+
Sbjct: 116 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA-RLIEDNEXTAREGA 171
Query: 130 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
                + APE + +  +  K D+WS G +L E++  G  P+
Sbjct: 172 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 212

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 66  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 123
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 124 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 180
Query: 129 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 33/181 (18%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----------------L 59
           E   ++  ++PNI++L         + L+ E+ A G+L+ ++R                 
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 60  HGRV--PEQTARKFLQQL--------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
             RV  P        +QL        G+  L+    +HRDL   N L+    +++++KIA
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIA 216
Query: 110 DFGLSCTLYPGNY--AEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 165
           DFGLS  +Y  +Y  A+     P+ +M PE + + RY  + D+W+ G +L+E+ + G  P
Sbjct: 217 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
Query: 166 F 166
           +
Sbjct: 277 Y 277

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 65  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 122
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 123 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 179
Query: 129 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 180 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 61/103 (59%), Gaps = 10/103 (9%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----GNYAE 124
           FL Q+  GL+ ++S +++HRDLKP N+L++   D   LKI DFGL+    P      +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLINTTCD---LKICDFGLARIADPEHDHTGFLT 205
Query: 125 KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +   +  Y APE+ L  + Y + +D+WSVG IL E+L+  P F
Sbjct: 206 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 21/155 (13%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 90  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQR 142
           +H DLKP N L+     D MLK+ DFG++  + P       +   G+  YM PE ++   
Sbjct: 149 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMS 204
Query: 143 YDEK-----------VDMWSVGAILFELLNGYPPF 166
              +            D+WS+G IL+ +  G  PF
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 14/155 (9%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  L   N      G+
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA-RLIEDNEXTAREGA 170
Query: 130 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
                + APE + +  +  K D+WS G +L E++ 
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 63  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 120
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +       +    
Sbjct: 121 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 177
Query: 130 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            P+ + APE + +  +  K D+WS G +L E++ 
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 63/118 (53%), Gaps = 5/118 (4%)
Query: 53  LSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           L S+IR    +P      ++ QL   +  ++S  I HRD+KP+N+L++  D+   LK+ D
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLKLCD 185
Query: 111 FGLSCTLYPGNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           FG +  L P   +     S  Y APE +L    Y   +D+WS+G +  EL+ G P FS
Sbjct: 186 FGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 17/157 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQT 67
           E+  L+  +HPNI+ L D F      A + ++LV E     +L+  I  H +   +  Q 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQH 135
Query: 68  ARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
            + F+    LGL +L+   ++HRDL P NILL+  +D   + I DF L+           
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTH 192
Query: 126 VCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLN 161
                 Y APE V+QF+ + + VDMWS G ++ E+ N
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 7/152 (4%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNS 82
            HP +IRL D F+ +    LV+E      +L  YI   G + E  +R F  Q+   I + 
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 83  HH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF 140
           H   ++HRD+K ENIL+         K+ DFG    L+   Y +   G+ +Y  PE +  
Sbjct: 156 HSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWISR 212
Query: 141 QRYDE-KVDMWSVGAILFELLNGYPPFSVGEE 171
            +Y      +WS+G +L++++ G  PF   +E
Sbjct: 213 HQYHALPATVWSLGILLYDMVCGDIPFERDQE 244

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 84/175 (48%), Gaps = 21/175 (12%)
Query: 20  LSSVNHPNIIRLFDAF-----QAENCIFL--VVEFCAGG---NLSSYIRLHGRVPEQTAR 69
           L+ ++HPNI++L   F     +    I+L  V+E+          +Y R     P    +
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132
Query: 70  KFLQQLGLEI----LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
            FL QL   I    L S ++ HRD+KP N+L++  + D  LK+ DFG +  L P      
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 126 VCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF----SVGEEHQFM 175
              S  Y APE +   Q Y   VD+WSVG I  E++ G P F    S G+ H+ +
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 17/157 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQT 67
           E+  L+  +HPNI+ L D F      A + ++LV E     +L+  I  H +   +  Q 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQH 135
Query: 68  ARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
            + F+    LGL +L+   ++HRDL P NILL+  +D   + I DF L+           
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTH 192
Query: 126 VCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLN 161
                 Y APE V+QF+ + + VDMWS G ++ E+ N
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 16/152 (10%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL---- 75
           LS   HP+++ L       N + L+ ++   GNL  +  L+G      +  + Q+L    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRLEICI 146
Query: 76  ----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGNYAEKVCG 128
               GL  L++  IIHRD+K  NILL   D++ + KI DFG+S     L   +    V G
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           +  Y+ PE     R  EK D++S G +LFE+L
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 43/199 (21%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KK+N+  +  +DC     E+  L+ +    IIRL D    E+ +     ++V+E  A  
Sbjct: 58  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEI-ADS 116
Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L    +    + EQ  +  L  L  G + ++   IIHRDLKP N L   L+ D  +KI 
Sbjct: 117 DLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCL---LNQDCSVKIC 173
Query: 110 DFGLSCTL-------------------YPG----NYAEKVCG---SPLYMAPEVLQFQR- 142
           DFGL+ T+                    PG    N  +++     +  Y APE++  Q  
Sbjct: 174 DFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN 233
Query: 143 YDEKVDMWSVGAILFELLN 161
           Y   +D+WS G I  ELLN
Sbjct: 234 YTNSIDIWSTGCIFAELLN 252

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 67/139 (48%), Gaps = 8/139 (5%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ--LGLEIL 80
            HP  +RL  A++    ++L  E C G +L  +    G  +PE     +L+   L L  L
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 81  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF 140
           +S  ++H D+KP NI L         K+ DFGL   L      E   G P YMAPE+LQ 
Sbjct: 174 HSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230
Query: 141 QRYDEKVDMWSVGAILFEL 159
             Y    D++S+G  + E+
Sbjct: 231 S-YGTAADVFSLGLTILEV 248

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 45/201 (22%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+ +  +  +DC     E+  L+ +NH +++++ D    ++      +++V+E  A  
Sbjct: 83  IKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI-ADS 141
Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +     R    + E   +  L  L  G++ ++S  I+HRDLKP N L   ++ D  +K+ 
Sbjct: 142 DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL---VNQDCSVKVC 198
Query: 110 DFGLSCTL-YPGNYAEKVCGSP---------------------------LYMAPEVLQFQ 141
           DFGL+ T+ YP N   ++  SP                            Y APE++  Q
Sbjct: 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ 258
Query: 142 R-YDEKVDMWSVGAILFELLN 161
             Y E +D+WS+G I  ELLN
Sbjct: 259 ENYTEAIDVWSIGCIFAELLN 279

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 53  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL+   +++  +KI DFGL+  L    
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDK 168
Query: 122 YAEKV---CGSPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
              KV     SP++  APE L   ++    D+WS G +L+EL  
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 76/152 (50%), Gaps = 16/152 (10%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL---- 75
           LS   HP+++ L       N + L+ ++   GNL  +  L+G      +  + Q+L    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRLEICI 146
Query: 76  ----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGNYAEKVCG 128
               GL  L++  IIHRD+K  NILL   D++ + KI DFG+S     L   +    V G
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLXXVVKG 203
Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           +  Y+ PE     R  EK D++S G +LFE+L
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 23/174 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +   +H NIIRL         + ++ E+   G L  ++R      E+     + QL
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR------EKDGEFSVLQL 149
Query: 76  ---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYA 123
                    G++ L + + +HRDL   NIL+   + +++ K++DFGLS  L       Y 
Sbjct: 150 VGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 124 EKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEHQFM 175
                 P+ + APE + ++++    D+WS G +++E++  G  P+     H+ M
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 260

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 73/163 (44%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE---------NCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL   F +          N +   V          Y R    +P  
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 123
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 124 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 181
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 182 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS---YIRLHGRVPEQ 66
           EL  +  V HPN++ L   F      + E  + LV+E+       +   Y +L   +P  
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML 141
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL       +LK+ DFG +  L  G    
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPNV 199
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G ++ EL+ G P F
Sbjct: 200 SXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 130
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 131 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 188
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 189 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 141
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 142 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 199
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 200 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 126
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 127 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 184
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 185 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 73/163 (44%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE---------NCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL   F +          N +   V          Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 73/163 (44%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE---------NCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL   F +          N +   V          Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 76/169 (44%), Gaps = 14/169 (8%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAE---------NCIFLVVEFCAGGNLSSYIRLH 60
           K+  + EL  +  ++H NI+RL   F +          N +   V          Y R  
Sbjct: 57  KAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
             +P    + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L 
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLV 174
Query: 119 PGNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            G        S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 135 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 192
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 193 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 135 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 192
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 193 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 135
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 136 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 193
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 194 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 76/169 (44%), Gaps = 14/169 (8%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAE---------NCIFLVVEFCAGGNLSSYIRLH 60
           K+  + EL  +  ++H NI+RL   F +          N +   V          Y R  
Sbjct: 57  KAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
             +P    + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L 
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLV 174
Query: 119 PGNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            G        S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 73/163 (44%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE---------NCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL   F +          N +   V          Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKIRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 215 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 83/158 (52%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V+E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 85/165 (51%), Gaps = 15/165 (9%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 54  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 112
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHR+L   NIL+   +++  +KI DFGL+  L P +
Sbjct: 113 DHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILV---ENENRVKIGDFGLTKVL-PQD 168
Query: 122 ---YAEKVCG-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
              Y  K  G SP+ + APE L   ++    D+WS G +L+EL  
Sbjct: 169 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 127
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 128 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 185
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 186 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 14/158 (8%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEI 79
           + S + P I++ + A   E   ++ +E  +      Y  ++  + +    + L ++ L  
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 80  LNSHH-------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           + + +       IIHRD+KP NILL   D    +K+ DFG+S  L       +  G   Y
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPY 191
Query: 133 MAPEVL----QFQRYDEKVDMWSVGAILFELLNGYPPF 166
           MAPE +      Q YD + D+WS+G  L+EL  G  P+
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 150
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 151 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 208
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 209 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 18/152 (11%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F 
Sbjct: 226 AEANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 284
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL         A      P
Sbjct: 285 AQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGL---------ARVGAKFP 332
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           + + APE + F  +  K D+WS G +L E++ 
Sbjct: 333 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 201
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 202 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 259
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 260 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 158
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 159 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 216
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 217 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 160
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 161 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 218
Query: 125 KVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               S  Y APE +     Y   +D+WS G +L ELL G P F
Sbjct: 219 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 229 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 229 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 84/179 (46%), Gaps = 27/179 (15%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-- 66
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   RV E   
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 67  ---------TARKFLQ-----QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
                    + R  L        G+  L S + IHRD+   N+LL+   +  + KI DFG
Sbjct: 153 AFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFG 209
Query: 113 LSCTLY-PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNGYP 164
           L+  +    NY  K     P+ +MAPE +    Y  + D+WS G +L+E+    LN YP
Sbjct: 210 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 40/196 (20%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KK+N+  +  +DC     E+  L+ +    IIRL+D    ++ +     ++V+E  A  
Sbjct: 56  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADS 114
Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L    +    + E+  +  L  L  G   ++   IIHRDLKP N L   L+ D  +K+ 
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL---LNQDCSVKVC 171
Query: 110 DFGLSCTL----------------YPGNYAEKV-------CGSPLYMAPEVLQFQR-YDE 145
           DFGL+ T+                 PG + + +         +  Y APE++  Q  Y +
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231
Query: 146 KVDMWSVGAILFELLN 161
            +D+WS G I  ELLN
Sbjct: 232 SIDIWSTGCIFAELLN 247

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 86/179 (48%), Gaps = 27/179 (15%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE--- 65
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   RV E   
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 66  ------QTARK-----FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
                  TA       F  Q+  G+  L S + IHRD+   N+LL+   +  + KI DFG
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFG 209
Query: 113 LSCTLY-PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNGYP 164
           L+  +    NY  K     P+ +MAPE +    Y  + D+WS G +L+E+    LN YP
Sbjct: 210 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 52  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 110
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 167
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           + + APE   + R+  K D+WS G +L EL  
Sbjct: 168 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 54  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 112
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 169
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           + + APE   + R+  K D+WS G +L EL  
Sbjct: 170 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 78/152 (51%), Gaps = 10/152 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 56  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 114
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 171
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           + + APE   + R+  K D+WS G +L EL  
Sbjct: 172 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 13/179 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEF-CAGGNLSSYIRL--HG 61
           K L+   D +     S+   +I++L D F  +  N + +V+ F   G NL + I+   H 
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 126
Query: 62  RVPEQTARKFLQQL--GLEILNSH-HIIHRDLKPENILLSGLDDD---VMLKIADFGLSC 115
            +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D     + +KIAD G +C
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
             Y  +Y   +  +  Y +PEVL    +    D+WS   ++FEL+ G   F   E H +
Sbjct: 187 -WYDEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 13/179 (7%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEF-CAGGNLSSYIRL--HG 61
           K L+   D +     S+   +I++L D F  +  N + +V+ F   G NL + I+   H 
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 126
Query: 62  RVPEQTARKFLQQL--GLEILNSH-HIIHRDLKPENILLSGLDDD---VMLKIADFGLSC 115
            +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D     + +KIAD G +C
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
             Y  +Y   +  +  Y +PEVL    +    D+WS   ++FEL+ G   F   E H +
Sbjct: 187 -WYDEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 41/150 (27%), Positives = 79/150 (52%), Gaps = 10/150 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 312 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           + + APE   + R+  K D+WS G +L EL
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTEL 457

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 20/151 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +   +   K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 230 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 288
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL   +    Y A +    P
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLGRLIEDNEYTARQGAKFP 345
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 346 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 383

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 20/151 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 136
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +   +   K     L  
Sbjct: 137 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 193
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 20/151 (13%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +   +   K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
            +MAPE L+   +    DMWS G +L+E+ +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 12/183 (6%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+   +   H N++ L       + + LV  +   G+L   +   
Sbjct: 56  MVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL 115
Query: 61  GRVPEQTAR---KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 113
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 116 DGTPPLSWHXRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 172
Query: 114 -SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
            S          ++ G+  Y APE L+ +    K D++S G +L E++ G P      E 
Sbjct: 173 ASEKFAQXVXXSRIVGTTAYXAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREP 231
Query: 173 QFM 175
           Q +
Sbjct: 232 QLL 234

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 84/157 (53%), Gaps = 15/157 (9%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G 76
           + S++H +I+RL       + + LV ++   G+L  ++R H G +  Q    +  Q+  G
Sbjct: 69  IGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPL- 131
           +  L  H ++HR+L   N+LL        +++ADFG++  L P +    Y+E    +P+ 
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSE--AKTPIK 182
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 167
           +MA E + F +Y  + D+WS G  ++EL+  G  P++
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 30/168 (17%)
Query: 25  HPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG-LEILN 81
           H NI+ L +  +A+N   ++LV ++    +L + IR +   P        Q +  ++ L+
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLH 126
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---------PGNYAEKV------ 126
           S  ++HRD+KP NILL+    +  +K+ADFGLS +           P +  E        
Sbjct: 127 SGGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 127 -------CGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                    +  Y APE+ L   +Y + +DMWS+G IL E+L G P F
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 84/157 (53%), Gaps = 15/157 (9%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G 76
           + S++H +I+RL       + + LV ++   G+L  ++R H G +  Q    +  Q+  G
Sbjct: 87  IGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 145
Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPL- 131
           +  L  H ++HR+L   N+LL        +++ADFG++  L P +    Y+E    +P+ 
Sbjct: 146 MYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSE--AKTPIK 200
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 167
           +MA E + F +Y  + D+WS G  ++EL+  G  P++
Sbjct: 201 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 237

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+   G+L  +++       R+P+      
Sbjct: 60  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 175
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 78/152 (51%), Gaps = 10/152 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL   NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLAAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           + + APE   + R+  K D+WS G +L EL  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 229 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 87/180 (48%), Gaps = 19/180 (10%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L+  +  + + L  EL+     NHPNI+     F A+N +++V  F A G+    I  H 
Sbjct: 46  LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 105
Query: 61  --GRVPEQTARKFLQQLGLEILNS-HHI--IHRDLKPENILLSGLDDDVMLKIADFGLSC 115
             G    + A  ++ Q  L+ L+  HH+  +HR +K  +IL+S +D  V L      LS 
Sbjct: 106 MDGM--NELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSM 162
Query: 116 TLYPGNYAEKVCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 166
             + G     V   P Y       ++PEVLQ   Q YD K D++SVG    EL NG+ PF
Sbjct: 163 ISH-GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 221

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 82/158 (51%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V+E+ + G L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 87/180 (48%), Gaps = 19/180 (10%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L+  +  + + L  EL+     NHPNI+     F A+N +++V  F A G+    I  H 
Sbjct: 62  LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 121
Query: 61  --GRVPEQTARKFLQQLGLEILNS-HHI--IHRDLKPENILLSGLDDDVMLKIADFGLSC 115
             G    + A  ++ Q  L+ L+  HH+  +HR +K  +IL+S +D  V L      LS 
Sbjct: 122 MDGM--NELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSM 178
Query: 116 TLYPGNYAEKVCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 166
             + G     V   P Y       ++PEVLQ   Q YD K D++SVG    EL NG+ PF
Sbjct: 179 ISH-GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 22/161 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 129
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 186
Query: 122 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 187 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V+E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  L   N      G+  
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA-RLIEDNEXTARQGAKF 177
Query: 132 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
              + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 216

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 22/161 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 157
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 158 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 214
Query: 122 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 215 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 22/161 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 69  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 126
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 127 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 183
Query: 122 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 184 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 22/161 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 122
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 179
Query: 122 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 22/161 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 128
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 185
Query: 122 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 22/161 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 128
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 185
Query: 122 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 18/159 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------HGRVPEQTA 68
           E + +   N  +++RL           +++E    G+L SY+R        +  +   + 
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 69  RKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
            K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y 
Sbjct: 128 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 184
Query: 124 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
            K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           Q YD  +DMWS+G +   ++    PF  G ++ 
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 233

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 129
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHXVMQEHRK 175
Query: 130 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            P  + APE L+ + +    D W  G  L+E+      F+ G+E
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM------FTYGQE 213

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 22/161 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 135
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 192
Query: 122 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           Q YD  +DMWS+G +   ++    PF  G ++ 
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 233

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 144
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 145 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 202
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           Q YD  +DMWS+G +   ++    PF  G ++ 
Sbjct: 203 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 235

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           Q YD  +DMWS+G +   ++    PF  G ++ 
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 233

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           Q YD  +DMWS+G +   ++    PF  G ++ 
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 233

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 144 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 201
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           Q YD  +DMWS+G +   ++    PF  G ++ 
Sbjct: 202 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 234

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           Q YD  +DMWS+G +   ++    PF  G ++ 
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 233

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 82  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 139
           S  I+HRD+KP N+++   D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 144 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 200
Query: 140 FQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            Q YD  +DMWS+G +   ++    PF  G ++ 
Sbjct: 201 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 234

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+L+    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVLIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+   G+L  +++       R+P+      
Sbjct: 60  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    + A +    P
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEWTARQGAKFP 175
Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L   
Sbjct: 143 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 200
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           Q YD  +DMWS+G +   ++    PF  G ++ 
Sbjct: 201 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 233

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 163
Query: 82  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 139
           S  I+HRD+KP N+++   D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 164 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 220
Query: 140 FQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            Q YD  +DMWS+G +   ++    PF  G ++ 
Sbjct: 221 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 254

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 87/181 (48%), Gaps = 23/181 (12%)
Query: 11  SCLDCELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----GRVP 64
           S  D E+  L  S  HPN+IR F   +     ++ +E CA   L  Y+        G  P
Sbjct: 62  SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEP 120
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLK--IADFGLSCTLYPG 120
                  LQQ   GL  L+S +I+HRDLKP NIL+S  +    +K  I+DFGL   L  G
Sbjct: 121 ----ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176
Query: 121 NYA----EKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEH 172
            ++      V G+  ++APE+L     +     VD++S G + + +++ G  PF    + 
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR 236
Query: 173 Q 173
           Q
Sbjct: 237 Q 237

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 18/159 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------HGRVPEQTA 68
           E + +   N  +++RL           +++E    G+L SY+R        +  +   + 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 69  RKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
            K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y 
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 194
Query: 124 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
            K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 129
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHXVMQEHRK 185
Query: 130 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            P  + APE L+ + +    D W  G  L+E+      F+ G+E
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM------FTYGQE 223

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 123
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 129
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 124 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHYVMQEHRK 179
Query: 130 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            P  + APE L+ + +    D W  G  L+E+      F+ G+E
Sbjct: 180 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM------FTYGQE 217

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 129
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHYVMQEHRK 175
Query: 130 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            P  + APE L+ + +    D W  G  L+E+      F+ G+E
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM------FTYGQE 213

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 129
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHYVMQEHRK 175
Query: 130 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            P  + APE L+ + +    D W  G  L+E+      F+ G+E
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM------FTYGQE 213

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 28/180 (15%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFT 122
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 117
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 179
Query: 118 -YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSVG-EEHQF 174
             P  Y  +V  +  Y  PE+L  +R Y   +D+W  G I+ E+    P      E+HQ 
Sbjct: 180 SQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 122
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N  ++   +D  +KI DFG++  +Y  +
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVA---EDFTVKIGDFGMTRDIYETD 179
Query: 122 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           Y  K     L   +M+PE L+   +    D+WS G +L+E+
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 123
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 129
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 124 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHYVMQEHRK 179
Query: 130 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            P  + APE L+ + +    D W  G  L+E+      F+ G+E
Sbjct: 180 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM------FTYGQE 217

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 146
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 147 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/94 (42%), Positives = 56/94 (59%), Gaps = 8/94 (8%)
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-Y 132
           G+E L+S   IHRDL   NILLS   ++ ++KI DFGL+  +Y   +Y  K     PL +
Sbjct: 211 GMEFLSSRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKW 267
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 164
           MAPE +  + Y  K D+WS G +L+E+  L G P
Sbjct: 268 MAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP 301

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 28/180 (15%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFT 123
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 117
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 180
Query: 118 -YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSVG-EEHQF 174
             P  Y  +V  +  Y  PE+L  +R Y   +D+W  G I+ E+    P      E+HQ 
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 239

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 148 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 148 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 129
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL   L P N    V      
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRAL-PQNDDHYVMQEHRK 185
Query: 130 -PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            P  + APE L+ + +    D W  G  L+E+      F+ G+E
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEM------FTYGQE 223

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 153
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 154 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 211
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 212 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 242

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 28/180 (15%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFT 123
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 117
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 180
Query: 118 -YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSVG-EEHQF 174
             P  Y  +V  +  Y  PE+L  +R Y   +D+W  G I+ E+    P      E+HQ 
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 239

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 28/180 (15%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--------IFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL---VKFT 123
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 117
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 180
Query: 118 -YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSVG-EEHQF 174
             P  Y  +V  +  Y  PE+L  +R Y   +D+W  G I+ E+    P      E+HQ 
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 239

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 92/181 (50%), Gaps = 21/181 (11%)
Query: 3   KKLNKHLKSCL-DCELN----------FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K+N  +K+C  DC L+           + +++HP+I++L    + E   ++++E    G
Sbjct: 35  EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYG 93
Query: 52  NLSSYI-RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            L  Y+ R    +   T   +  Q+   +  L S + +HRD+   NIL++  +    +K+
Sbjct: 94  ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKL 150
Query: 109 ADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 165
            DFGLS  +   +Y +  V   P+ +M+PE + F+R+    D+W     ++E+L+ G  P
Sbjct: 151 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210
Query: 166 F 166
           F
Sbjct: 211 F 211

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 92/181 (50%), Gaps = 21/181 (11%)
Query: 3   KKLNKHLKSCL-DCELN----------FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K+N  +K+C  DC L+           + +++HP+I++L    + E   ++++E    G
Sbjct: 51  EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYG 109
Query: 52  NLSSYI-RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            L  Y+ R    +   T   +  Q+   +  L S + +HRD+   NIL++  +    +K+
Sbjct: 110 ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKL 166
Query: 109 ADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 165
            DFGLS  +   +Y +  V   P+ +M+PE + F+R+    D+W     ++E+L+ G  P
Sbjct: 167 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 226
Query: 166 F 166
           F
Sbjct: 227 F 227

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 92/181 (50%), Gaps = 21/181 (11%)
Query: 3   KKLNKHLKSCL-DCELN----------FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K+N  +K+C  DC L+           + +++HP+I++L    + E   ++++E    G
Sbjct: 39  EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYG 97
Query: 52  NLSSYI-RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            L  Y+ R    +   T   +  Q+   +  L S + +HRD+   NIL++  +    +K+
Sbjct: 98  ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKL 154
Query: 109 ADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 165
            DFGLS  +   +Y +  V   P+ +M+PE + F+R+    D+W     ++E+L+ G  P
Sbjct: 155 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
Query: 166 F 166
           F
Sbjct: 215 F 215

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 23/175 (13%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQ 66
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R      + ++
Sbjct: 85  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 144
Query: 67  TARK--------FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
             R         F  Q+  G+  L S + IHRD+   N+LL+   +  + KI DFGL+  
Sbjct: 145 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARD 201
Query: 117 LY-PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNGYP 164
           +    NY  K     P+ +MAPE +    Y  + D+WS G +L+E+    LN YP
Sbjct: 202 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 256

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L   + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLRQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           Q YD  +DMWS+G +L  ++    PF  G +
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTA 68
           L  E+  L ++ H NI++ +     E   N I L++EF   G+L  Y+ +   ++  +  
Sbjct: 70  LKKEIEILRNLYHENIVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
            K+  Q+  G++ L S   +HRDL   N+L+   + +  +KI DFGL+  +        V
Sbjct: 129 LKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEXXTV 185
Query: 127 CG---SPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
                SP++  APE L   ++    D+WS G  L ELL 
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTA 68
           L  E+  L ++ H NI++ +     E   N I L++EF   G+L  Y+ +   ++  +  
Sbjct: 58  LKKEIEILRNLYHENIVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 116
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
            K+  Q+  G++ L S   +HRDL   N+L+   + +  +KI DFGL+  +        V
Sbjct: 117 LKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEXXTV 173
Query: 127 CG---SPLYM-APEVLQFQRYDEKVDMWSVGAILFELLN 161
                SP++  APE L   ++    D+WS G  L ELL 
Sbjct: 174 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 27  NIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS 82
           NII+L D  +        LV E+    N + + +L+  + +   R ++ +L   L+  +S
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYI---NNTDFKQLYQILTDFDIRFYMYELLKALDYCHS 155
Query: 83  HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QFQ 141
             I+HRD+KP N+++        L++ D+GL+   +P         S  +  PE+L  +Q
Sbjct: 156 KGIMHRDVKPHNVMID--HQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQ 213
Query: 142 RYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            YD  +DMWS+G +L  ++    PF  G++
Sbjct: 214 MYDYSLDMWSLGCMLASMIFRREPFFHGQD 243

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 37/202 (18%)
Query: 1   MLK-KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           MLK K +   +  L  EL  ++ + +H NI+ L  A      I+L+ E+C  G+L +Y+R
Sbjct: 82  MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 141
Query: 59  L--------------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPE 93
                            R+ E+     L              G+E L     +HRDL   
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201
Query: 94  NILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMW 150
           N+L++      ++KI DFGL+  +    NY  +     P+ +MAPE L    Y  K D+W
Sbjct: 202 NVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 258
Query: 151 SVGAILFEL----LNGYPPFSV 168
           S G +L+E+    +N YP   V
Sbjct: 259 SYGILLWEIFSLGVNPYPGIPV 280

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 23/175 (13%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQ 66
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R      + ++
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 152
Query: 67  TARK--------FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
             R         F  Q+  G+  L S + IHRD+   N+LL+   +  + KI DFGL+  
Sbjct: 153 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARD 209
Query: 117 LY-PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNGYP 164
           +    NY  K     P+ +MAPE +    Y  + D+WS G +L+E+    LN YP
Sbjct: 210 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 264

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 27  NIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS 82
           NII+L D  +        LV E+    N + + +L+  + +   R ++ +L   L+  +S
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYI---NNTDFKQLYQILTDFDIRFYMYELLKALDYCHS 150
Query: 83  HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QFQ 141
             I+HRD+KP N+++        L++ D+GL+   +P         S  +  PE+L  +Q
Sbjct: 151 KGIMHRDVKPHNVMIDH--QQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQ 208
Query: 142 RYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
            YD  +DMWS+G +L  ++    PF  G++
Sbjct: 209 MYDYSLDMWSLGCMLASMIFRREPFFHGQD 238

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 12/127 (9%)
Query: 43  LVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSG 99
           LV+E+   G L  +++ H  R+       +  Q+  G+E L S   +HRDL   NIL+  
Sbjct: 87  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV-- 144
Query: 100 LDDDVMLKIADFGLSCTLYPGNYAEKVCGSP-----LYMAPEVLQFQRYDEKVDMWSVGA 154
            + +  +KIADFGL+  L P +    V   P      + APE L    +  + D+WS G 
Sbjct: 145 -ESEAHVKIADFGLA-KLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 202
Query: 155 ILFELLN 161
           +L+EL  
Sbjct: 203 VLYELFT 209

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 13/159 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGR---VPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+   G+L  +++   GR   +P       
Sbjct: 54  EAQIMKKLKHDKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAA 112
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
               G+  +   + IHRDL+  NIL+    + ++ KIADFGL+  L   N      G+  
Sbjct: 113 QVAAGMAYIERMNYIHRDLRSANILVG---NGLICKIADFGLA-RLIEDNEXTARQGAKF 168
Query: 132 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
              + APE   + R+  K D+WS G +L EL+  G  P+
Sbjct: 169 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 207

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 73/155 (47%), Gaps = 7/155 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E      +  P+++ + D  + +  +++      G +L++ +R  G +    A   ++Q+
Sbjct: 84  EARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQI 143
Query: 76  G--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPL 131
           G  L+  ++    HRD+KPENIL+S    D    + DFG++         +     G+  
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSA---DDFAYLVDFGIASATTDEKLTQLGNTVGTLY 200
Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y APE         + D++++  +L+E L G PP+
Sbjct: 201 YXAPERFSESHATYRADIYALTCVLYECLTGSPPY 235

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 13/159 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I +V E+ + G+L  +++       R+P+      
Sbjct: 53  EAQVMKKLRHEKLVQLY-AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 111
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  L   N      G+  
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA-RLIEDNEXTARQGAKF 167
Query: 132 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
              + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 168 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 206

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 57/103 (55%), Gaps = 10/103 (9%)
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-Y 132
           G+E L S   IHRDL   NILLS   +  ++KI DFGL+  +Y   +Y  K     PL +
Sbjct: 203 GMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 259
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEE 171
           MAPE +  + Y  + D+WS G +L+E+     + YP   + EE
Sbjct: 260 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 302

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 57/103 (55%), Gaps = 10/103 (9%)
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-Y 132
           G+E L S   IHRDL   NILLS   +  ++KI DFGL+  +Y   +Y  K     PL +
Sbjct: 205 GMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEE 171
           MAPE +  + Y  + D+WS G +L+E+     + YP   + EE
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 14/166 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------PEQTA 68
            E+  +S   H N++RL           LV  + A G+++S +R           P++  
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 69  RKFLQQLGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAE 124
                  GL  L+ H    IIHRD+K  NILL   D++    + DFGL+  + Y   +  
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDXHVX 200
Query: 125 -KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
             V G+  ++APE L   +  EK D++  G +L EL+ G   F + 
Sbjct: 201 XAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 246

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 57/103 (55%), Gaps = 10/103 (9%)
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-Y 132
           G+E L S   IHRDL   NILLS   +  ++KI DFGL+  +Y   +Y  K     PL +
Sbjct: 212 GMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 268
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEE 171
           MAPE +  + Y  + D+WS G +L+E+     + YP   + EE
Sbjct: 269 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 311

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 31/182 (17%)
Query: 10  KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP---- 64
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   R P    
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKRPPGLEY 151
Query: 65  ---------EQTARK----FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + +    F  Q+  G+  L S + IHRD+   N+LL+   +  + KI 
Sbjct: 152 SYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIG 208
Query: 110 DFGLSCTLY-PGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNG 162
           DFGL+  +    NY  K     P+ +MAPE +    Y  + D+WS G +L+E+    LN 
Sbjct: 209 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 268
Query: 163 YP 164
           YP
Sbjct: 269 YP 270

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 57/103 (55%), Gaps = 10/103 (9%)
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-Y 132
           G+E L S   IHRDL   NILLS   +  ++KI DFGL+  +Y   +Y  K     PL +
Sbjct: 210 GMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 266
Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEE 171
           MAPE +  + Y  + D+WS G +L+E+     + YP   + EE
Sbjct: 267 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 309

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 16  ELNFLSSVNHPNIIRLF-----DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L    H NII +F     D+F+  N ++++ E     +L   I       +     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYF 117
Query: 71  FLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YPGNYAE--- 124
             Q L  +++L+  ++IHRDLKP N+L++   D   LK+ DFGL+  +     + +E   
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---LKVCDFGLARIIDESAADNSEPTG 174
Query: 125 ------KVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                 +   +  Y APEV L   +Y   +D+WS G IL EL    P F
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 16  ELNFLSSVNHPNIIRLF-----DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L    H NII +F     D+F+  N ++++ E     +L   I       +     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYF 117
Query: 71  FLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YPGNYAEKV- 126
             Q L  +++L+  ++IHRDLKP N+L++   D   LK+ DFGL+  +     + +E   
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---LKVCDFGLARIIDESAADNSEPTG 174
Query: 127 --------CGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                     +  Y APEV L   +Y   +D+WS G IL EL    P F
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 16  ELNFLSSVNHPNIIRLF-----DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L    H NII +F     D+F+  N ++++ E     +L   I       +     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYF 117
Query: 71  FLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YPGNYAEKV- 126
             Q L  +++L+  ++IHRDLKP N+L++   D   LK+ DFGL+  +     + +E   
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---LKVCDFGLARIIDESAADNSEPTG 174
Query: 127 --------CGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                     +  Y APEV L   +Y   +D+WS G IL EL    P F
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 64/133 (48%), Gaps = 12/133 (9%)
Query: 37  AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPE 93
               + LV+E+   G L  +++ H  R+       +  Q+  G+E L S   +HRDL   
Sbjct: 84  GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR 143
Query: 94  NILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP-----LYMAPEVLQFQRYDEKVD 148
           NIL+   + +  +KIADFGL+  L P +    V   P      + APE L    +  + D
Sbjct: 144 NILV---ESEAHVKIADFGLA-KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 199
Query: 149 MWSVGAILFELLN 161
           +WS G +L+EL  
Sbjct: 200 VWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 12/127 (9%)
Query: 43  LVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSG 99
           LV+E+   G L  +++ H  R+       +  Q+  G+E L S   +HRDL   NIL+  
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV-- 160
Query: 100 LDDDVMLKIADFGLSCTLYPGNYAEKVCGSP-----LYMAPEVLQFQRYDEKVDMWSVGA 154
            + +  +KIADFGL+  L P +    V   P      + APE L    +  + D+WS G 
Sbjct: 161 -ESEAHVKIADFGLA-KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 218
Query: 155 ILFELLN 161
           +L+EL  
Sbjct: 219 VLYELFT 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 12/127 (9%)
Query: 43  LVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSG 99
           LV+E+   G L  +++ H  R+       +  Q+  G+E L S   +HRDL   NIL+  
Sbjct: 91  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV-- 148
Query: 100 LDDDVMLKIADFGLSCTLYPGNYAEKVCGSP-----LYMAPEVLQFQRYDEKVDMWSVGA 154
            + +  +KIADFGL+  L P +    V   P      + APE L    +  + D+WS G 
Sbjct: 149 -ESEAHVKIADFGLA-KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 206
Query: 155 ILFELLN 161
           +L+EL  
Sbjct: 207 VLYELFT 213
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	175
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-66
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-65
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-64
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-64
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-64
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-64
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-64
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-64
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-63
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-63
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-63
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-63
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-62
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-62
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-61
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-61
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-61
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-60
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-60
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-60
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-60
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-59
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-59
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-59
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-59
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-59
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-59
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-59
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-59
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-59
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-59
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-59
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-59
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-58
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-58
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-58
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-58
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-57
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-57
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-56
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-56
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-56
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-56
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-56
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-56
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-56
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-56
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-56
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-55
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-55
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-55
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-55
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-55
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-55
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-54
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-54
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-53
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-53
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-53
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-53
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-52
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-52
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-51
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-51
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-50
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-50
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-49
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-49
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-48
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-48
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-48
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-47
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-47
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-46
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-46
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-46
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-46
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-45
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-44
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-44
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-44
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-44
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-44
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-43
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-43
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-43
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-43
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-43
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-43
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-43
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-43
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-42
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-42
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-42
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-42
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-42
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-42
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-41
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-41
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-41
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-41
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-40
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-40
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-40
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-39
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-39
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-39
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-39
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-38
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-38
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-38
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-38
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-38
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-38
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-38
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-38
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-38
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-37
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-37
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-37
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-37
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-37
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-36
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-36
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-36
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-36
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-36
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-36
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-35
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-35
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-34
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-34
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-34
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-34
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-33
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-33
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-33
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-33
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-32
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-32
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-32
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-31
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-31
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-31
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-31
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-30
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-30
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-30
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-30
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-30
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-30
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-30
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-30
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-30
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-29
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-29
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-29
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-29
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-29
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-29
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-29
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-29
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-29
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-28
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-28
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-28
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-28
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-27
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-27
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-27
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-27
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-27
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-27
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-27
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-27
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-26
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-26
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-26
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-26
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-26
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-25
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-25
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-25
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-25
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-25
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-25
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-25
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-24
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-24
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-23
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-23
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-19
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-19
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-05

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  213 bits (543), Expect = 2e-66
 Identities = 53/182 (29%), Positives = 87/182 (47%), Gaps = 11/182 (6%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSY 56
           ++L+   +     E+  +  +NHPN++   +       +       L +E+C GG+L  Y
Sbjct: 49  QELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKY 108

Query: 57  IRLHGR---VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
           +        + E   R  L  +   L  L+ + IIHRDLKPENI+L      ++ KI D 
Sbjct: 109 LNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168

Query: 112 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           G +  L  G    +  G+  Y+APE+L+ ++Y   VD WS G + FE + G+ PF    +
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228

Query: 172 HQ 173
             
Sbjct: 229 PV 230

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  202 bits (515), Expect = 1e-65
 Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 17/180 (9%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLH 60
               + +      E   L  +NH NI++LF   +        L++EFC  G+L + +   
Sbjct: 45  ISFLRPVDV-QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP 103

Query: 61  GR---VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLS 114
                +PE      L+ +  G+  L  + I+HR++KP NI+   G D   + K+ DFG +
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPF 166
             L        + G+  Y+ P++ +         ++Y   VD+WS+G   +    G  PF
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  199 bits (509), Expect = 1e-64
 Identities = 67/163 (41%), Positives = 98/163 (60%), Gaps = 7/163 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + +  Q+
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183

Query: 134 APEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           APEVL       Y+  VD WS+G ILF  L+GYPPFS     Q
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS-EHRTQ 225

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  198 bits (505), Expect = 2e-64
 Identities = 56/165 (33%), Positives = 91/165 (55%), Gaps = 10/165 (6%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
            +   L+     E+   S + HPNI+RL+  F     ++L++E+   G +   ++   + 
Sbjct: 51  GVEHQLRR----EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF 106

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
            EQ    ++ +L   L   +S  +IHRD+KPEN+L   L     LKIADFG S    P +
Sbjct: 107 DEQRTATYITELANALSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGWS-VHAPSS 162

Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               +CG+  Y+ PE+++ + +DEKVD+WS+G + +E L G PPF
Sbjct: 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  201 bits (514), Expect = 3e-64
 Identities = 66/157 (42%), Positives = 97/157 (61%), Gaps = 6/157 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + +  Q+
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308

Query: 134 APEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFS 167
           APEVL       Y+  VD WS+G ILF  L+GYPPFS
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  198 bits (505), Expect = 8e-64
 Identities = 54/154 (35%), Positives = 93/154 (60%), Gaps = 6/154 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++   S+ H +++     F+  + +F+V+E C   +L    +    + E  AR +L+Q+
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 132
             G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G   + +CG+P Y
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +APEVL  + +  +VD+WS+G I++ LL G PPF
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  196 bits (501), Expect = 8e-64
 Identities = 59/165 (35%), Positives = 92/165 (55%), Gaps = 10/165 (6%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
            +   L+     E+   S + HPNI+R+++ F     I+L++EF   G L   ++ HGR 
Sbjct: 56  GVEHQLRR----EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF 111

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
            EQ +  F+++L   L   +   +IHRD+KPEN+L   +     LKIADFG S    P  
Sbjct: 112 DEQRSATFMEELADALHYCHERKVIHRDIKPENLL---MGYKGELKIADFGWS-VHAPSL 167

Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
               +CG+  Y+ PE+++ + +DEKVD+W  G + +E L G PPF
Sbjct: 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  196 bits (500), Expect = 9e-64
 Identities = 56/153 (36%), Positives = 85/153 (55%), Gaps = 3/153 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  + S++HPNIIRL++ F+    I+LV+E C GG L   +       E  A + ++ +
Sbjct: 56  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   +  ++ HRDLKPEN L      D  LK+ DFGL+    PG       G+P Y+
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV 175

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +P+VL+   Y  + D WS G +++ LL GYPPF
Sbjct: 176 SPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPF 207

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  196 bits (501), Expect = 1e-63
 Identities = 54/154 (35%), Positives = 93/154 (60%), Gaps = 6/154 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++   S+ H +++     F+  + +F+V+E C   +L    +    + E  AR +L+Q+
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 132
             G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G   + +CG+P Y
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +APEVL  + +  +VD+WS+G I++ LL G PPF
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 215

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  196 bits (500), Expect = 1e-63
 Identities = 62/166 (37%), Positives = 91/166 (54%), Gaps = 2/166 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                  G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  199 bits (507), Expect = 2e-63
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 16/167 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGR---VPEQTARK 70
           E   L  +NH NI++LF   +        L++EFC  G+L + +        +PE     
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
            L+ +  G+  L  + I+HR++KP NI+   G D   + K+ DFG +  L        + 
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176

Query: 128 GSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPF 166
           G+  Y+ P++ +         ++Y   VD+WS+G   +    G  PF
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  197 bits (502), Expect = 5e-63
 Identities = 62/166 (37%), Positives = 91/166 (54%), Gaps = 2/166 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 65  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                  G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  193 bits (494), Expect = 1e-62
 Identities = 64/166 (38%), Positives = 93/166 (56%), Gaps = 3/166 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
                   S +  E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R
Sbjct: 58  ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A + ++Q+  G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS      
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
              +   G+  Y+APEVL+   YDEK D+WS G IL+ LL+G PPF
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  192 bits (489), Expect = 6e-62
 Identities = 56/170 (32%), Positives = 92/170 (54%), Gaps = 7/170 (4%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----R 58
           K  ++     ++ E+  L S++HPNII++F+ F+  + +++V+E C GG L   I     
Sbjct: 57  KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA 116

Query: 59  LHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
               + E    + ++Q+   L   +S H++H+DLKPENIL         +KI DFGL+  
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176

Query: 117 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                ++    G+ LYMAPEV + +    K D+WS G +++ LL G  PF
Sbjct: 177 FKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPF 225

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  190 bits (486), Expect = 3e-61
 Identities = 63/168 (37%), Positives = 95/168 (56%), Gaps = 3/168 (1%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            +KK      S L+ E+  L  + H NI+ L D +++    +LV++  +GG L   I   
Sbjct: 41  CIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER 100

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           G   E+ A   +QQ+   ++ L+ + I+HRDLKPEN+L    +++  + I DFGLS    
Sbjct: 101 GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160

Query: 119 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            G  +   CG+P Y+APEVL  + Y + VD WS+G I + LL GYPPF
Sbjct: 161 NGIMST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  194 bits (496), Expect = 7e-61
 Identities = 64/166 (38%), Positives = 93/166 (56%), Gaps = 3/166 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
                   S +  E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R
Sbjct: 58  ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A + ++Q+  G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS      
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
              +   G+  Y+APEVL+   YDEK D+WS G IL+ LL+G PPF
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  191 bits (486), Expect = 8e-61
 Identities = 68/162 (41%), Positives = 93/162 (57%), Gaps = 2/162 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNII+L + F+    I LV+E   GG L   I   G   E+ A   ++Q+
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +  L+ + I+HRDLKPEN+L +    D  LKIADFGLS  +      + VCG+P Y 
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           APE+L+   Y  +VDMWSVG I + LL G+ PF      QFM
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  194 bits (494), Expect = 2e-60
 Identities = 61/153 (39%), Positives = 89/153 (58%), Gaps = 3/153 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E  A + ++Q+
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         +   G+  Y+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APEVL    YDEK D+WS G IL+ LL+G PPF
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPF 227

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  193 bits (493), Expect = 3e-60
 Identities = 66/153 (43%), Positives = 95/153 (62%), Gaps = 3/153 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L S++HPNII+LFD F+ +   +LV EF  GG L   I    +  E  A   ++Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+  L+ H+I+HRD+KPENILL   +  + +KI DFGLS             G+  Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APEVL+ ++Y+EK D+WS G I++ LL GYPPF
Sbjct: 216 APEVLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  193 bits (492), Expect = 4e-60
 Identities = 68/175 (38%), Positives = 104/175 (59%), Gaps = 3/175 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
             ++    S L  E+  L  ++HPNI++L+D F+ +   +LV+E   GG L   I    +
Sbjct: 73  TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK 132

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   ++Q+  G+  L+ H+I+HRDLKPEN+LL   + D ++KI DFGLS      
Sbjct: 133 FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
              ++  G+  Y+APEVL+ ++YDEK D+WS+G ILF LL GYPPF    + + +
Sbjct: 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL 246

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  186 bits (476), Expect = 5e-60
 Identities = 55/155 (35%), Positives = 90/155 (58%), Gaps = 7/155 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+     + HP+I+ L++ F+  N ++LV+E C  G ++ Y++       E  AR F+ Q
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 131
           +  G+  L+SH I+HRDL   N+LL     ++ +KIADFGL+  L  P      +CG+P 
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           Y++PE+     +  + D+WS+G + + LL G PPF
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  186 bits (474), Expect = 1e-59
 Identities = 67/161 (41%), Positives = 96/161 (59%), Gaps = 12/161 (7%)

Query: 16  ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E+  RK ++ 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           L   +  L+  +I+HRDLKPENILL   DDD+ +K+ DFG SC L PG    +VCG+P Y
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 189

Query: 133 MAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPFS 167
           +APE+++         Y ++VDMWS G I++ LL G PPF 
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  186 bits (475), Expect = 2e-59
 Identities = 57/169 (33%), Positives = 93/169 (55%), Gaps = 4/169 (2%)

Query: 2   LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +K ++K +++    E+  L     HPNI++L + F  +   FLV+E   GG L   I+  
Sbjct: 41  VKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK 100

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
               E  A   +++L   +  ++   ++HRDLKPEN+L +  +D++ +KI DFG +    
Sbjct: 101 KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160

Query: 119 PGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           P N   +  C +  Y APE+L    YDE  D+WS+G IL+ +L+G  PF
Sbjct: 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  185 bits (472), Expect = 2e-59
 Identities = 56/154 (36%), Positives = 92/154 (59%), Gaps = 3/154 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A +FL+Q+
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117

Query: 76  --GLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             G+  L+S  I H DLKPENI+L      +  +K+ DFG++  +  GN  + + G+P +
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  186 bits (475), Expect = 2e-59
 Identities = 55/176 (31%), Positives = 96/176 (54%), Gaps = 6/176 (3%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RL 59
           ++  +  ++ +  E+  L      P +I L + ++  + I L++E+ AGG + S     L
Sbjct: 65  RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
              V E    + ++Q+  G+  L+ ++I+H DLKP+NILLS +     +KI DFG+S  +
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
                  ++ G+P Y+APE+L +       DMW++G I + LL    PF VGE++Q
Sbjct: 185 GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF-VGEDNQ 239

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  187 bits (476), Expect = 3e-59
 Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 23/184 (12%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           L++ +         E+ +L+ +   +  IIRL+D    +  I++V+E C   +L+S+++ 
Sbjct: 43  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 101

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
              +     + + + +   +  ++ H I+H DLKP N L+     D MLK+ DFG++  +
Sbjct: 102 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 157

Query: 118 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 163
            P       +   G+  YM PE ++             +   K D+WS+G IL+ +  G 
Sbjct: 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

Query: 164 PPFS 167
            PF 
Sbjct: 218 TPFQ 221

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  187 bits (477), Expect = 3e-59
 Identities = 60/151 (39%), Positives = 95/151 (62%), Gaps = 11/151 (7%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
            HP+II L D++++ + +FLV +    G L  Y+     + E+  R  ++ L   +  L+
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH 217

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-- 139
           +++I+HRDLKPENILL   DD++ ++++DFG SC L PG    ++CG+P Y+APE+L+  
Sbjct: 218 ANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 274

Query: 140 ----FQRYDEKVDMWSVGAILFELLNGYPPF 166
                  Y ++VD+W+ G ILF LL G PPF
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  185 bits (473), Expect = 3e-59
 Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 23/184 (12%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           L++ +         E+ +L+ +   +  IIRL+D    +  I++V+E C   +L+S+++ 
Sbjct: 62  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 120

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
              +     + + + +   +  ++ H I+H DLKP N L+     D MLK+ DFG++  +
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 176

Query: 118 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 163
            P       +   G+  YM PE ++             +   K D+WS+G IL+ +  G 
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

Query: 164 PPFS 167
            PF 
Sbjct: 237 TPFQ 240

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  186 bits (474), Expect = 3e-59
 Identities = 55/154 (35%), Positives = 92/154 (59%), Gaps = 3/154 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL+Q+
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123

Query: 76  --GLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             G+  L+S  I H DLKPENI+L         +KI DFGL+  +  GN  + + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  189 bits (482), Expect = 4e-59
 Identities = 59/167 (35%), Positives = 88/167 (52%), Gaps = 3/167 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +L+ +   GG L   I     
Sbjct: 47  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 106

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +   ++HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166

Query: 121 NYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
             A     G+P Y++PEVL+   Y + VD+W+ G IL+ LL GYPPF
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  185 bits (473), Expect = 4e-59
 Identities = 51/154 (33%), Positives = 88/154 (57%), Gaps = 3/154 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A  F++Q+
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124

Query: 76  --GLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             G+  L++  I H DLKPENI+L         +K+ DFGL+  +  G   + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  186 bits (474), Expect = 6e-59
 Identities = 50/158 (31%), Positives = 86/158 (54%), Gaps = 7/158 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----EQTARKF 71
           E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A  +
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCG 128
           ++Q+   L   + ++IIHRD+KP  +LL+  ++   +K+  FG++  L   G  A    G
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195

Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +P +MAPEV++ + Y + VD+W  G ILF LL+G  PF
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  186 bits (474), Expect = 7e-59
 Identities = 53/154 (34%), Positives = 89/154 (57%), Gaps = 3/154 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  V HPNII L D ++    + L++E  +GG L  ++     + E+ A  F++Q+
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124

Query: 76  --GLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             G+  L++  I H DLKPENI+L         +K+ DFGL+  +  G   + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  186 bits (473), Expect = 2e-58
 Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 23/184 (12%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           L++ +         E+ +L+ +   +  IIRL+D    +  I++V+E C   +L+S+++ 
Sbjct: 90  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 148

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
              +     + + + +   +  ++ H I+H DLKP N L+     D MLK+ DFG++  +
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 204

Query: 118 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 163
            P       +   G+  YM PE ++             +   K D+WS+G IL+ +  G 
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

Query: 164 PPFS 167
            PF 
Sbjct: 265 TPFQ 268

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  183 bits (466), Expect = 5e-58
 Identities = 65/167 (38%), Positives = 103/167 (61%), Gaps = 6/167 (3%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
            +LN      L  E+  +  +NHPNI++LF+  + E  ++L++E+ +GG +  Y+  HGR
Sbjct: 51  TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR 110

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           + E+ AR   +Q+   ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     G
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVG 167

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
              +  CG+P Y APE+ Q ++YD  +VD+WS+G IL+ L++G  PF
Sbjct: 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  183 bits (467), Expect = 6e-58
 Identities = 53/153 (34%), Positives = 79/153 (51%), Gaps = 4/153 (2%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL 80
             HPNII L D +     +++V E   GG L   I       E+ A   L  +   +E L
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132

Query: 81  NSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVL 138
           ++  ++HRDLKP NIL      +   ++I DFG +  L   N      C +  ++APEVL
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192

Query: 139 QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           + Q YD   D+WS+G +L+ +L GY PF+ G +
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  181 bits (461), Expect = 9e-58
 Identities = 67/154 (43%), Positives = 91/154 (59%), Gaps = 6/154 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L    HP+II+L+         F+V+E+ +GG L  YI  HGRV E  AR+  QQ+
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              ++  + H ++HRDLKPEN+L   LD  +  KIADFGLS  +  G +    CGSP Y 
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177

Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           APEV+  + Y   +VD+WS G IL+ LL G  PF
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  181 bits (460), Expect = 6e-57
 Identities = 33/164 (20%), Positives = 70/164 (42%), Gaps = 17/164 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------RVPEQT 67
           EL  ++ + +   +         + ++++ E+    ++  +              +P Q 
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 68  ARKFLQQL--GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            +  ++ +      +++  +I HRD+KP NIL   +D +  +K++DFG S         +
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL---MDKNGRVKLSDFGES-EYMVDKKIK 208

Query: 125 KVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPF 166
              G+  +M PE    +      KVD+WS+G  L+ +     PF
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  178 bits (454), Expect = 8e-57
 Identities = 57/157 (36%), Positives = 89/157 (56%), Gaps = 9/157 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+     +NH N+++ +   +  N  +L +E+C+GG L   I     +PE  A++F  QL
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 130
             G+  L+   I HRD+KPEN+L   LD+   LKI+DFGL+      N      K+CG+ 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 131 LYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
            Y+APE+L+ + +  E VD+WS G +L  +L G  P+
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  180 bits (459), Expect = 1e-56
 Identities = 44/170 (25%), Positives = 90/170 (52%), Gaps = 8/170 (4%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           + +++   +     E+  L+++ HPNI++  ++F+    +++V+++C GG+L   I    
Sbjct: 59  ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK 118

Query: 61  -GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
                E     +  Q+   L+ ++   I+HRD+K +NI L     D  +++ DFG++  L
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVL 175

Query: 118 YPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                 A    G+P Y++PE+ + + Y+ K D+W++G +L+EL      F
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF 225

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  180 bits (458), Expect = 3e-56
 Identities = 57/154 (37%), Positives = 90/154 (58%), Gaps = 4/154 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
           E++ ++ ++H N+I+L+DAF+++N I LV+E+  GG L   I      + E     F++Q
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ 195

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           +  G+  ++  +I+H DLKPENIL    D    +KI DFGL+    P    +   G+P +
Sbjct: 196 ICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEF 254

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +APEV+ +       DMWSVG I + LL+G  PF
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  180 bits (458), Expect = 3e-56
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 4/154 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ ++ ++HP +I L DAF+ +  + L++EF +GG L   I        E     +++Q
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
              GL+ ++ H I+H D+KPENI+         +KI DFGL+  L P    +    +  +
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEF 216

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            APE++  +      DMW++G + + LL+G  PF
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  184 bits (469), Expect = 3e-56
 Identities = 52/154 (33%), Positives = 89/154 (57%), Gaps = 4/154 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   H ++ E  A ++++Q
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           +  GL  ++ ++ +H DLKPENI+ +    +  LK+ DFGL+  L P    +   G+  +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEF 322

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            APEV + +      DMWSVG + + LL+G  PF
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  178 bits (453), Expect = 4e-56
 Identities = 57/157 (36%), Positives = 89/157 (56%), Gaps = 9/157 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+     +NH N+++ +   +  N  +L +E+C+GG L   I     +PE  A++F  QL
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 130
             G+  L+   I HRD+KPEN+L   LD+   LKI+DFGL+      N      K+CG+ 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 131 LYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
            Y+APE+L+ + +  E VD+WS G +L  +L G  P+
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  180 bits (458), Expect = 5e-56
 Identities = 55/151 (36%), Positives = 87/151 (57%), Gaps = 8/151 (5%)

Query: 24  NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQL-- 75
             P+I+R+ D ++       C+ +V+E   GG L S I  R      E+ A + ++ +  
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 135
            ++ L+S +I HRD+KPEN+L +    + +LK+ DFG +      N     C +P Y+AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232

Query: 136 EVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           EVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  179 bits (455), Expect = 6e-56
 Identities = 61/154 (39%), Positives = 82/154 (53%), Gaps = 4/154 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+    S+ HPNI+R  +       + +++E+ +GG L   I   GR  E  AR F QQL
Sbjct: 66  EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL 125

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+   +S  I HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 184

Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           APEVL  Q YD +  D+WS G  L+ +L G  PF
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF 218

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  177 bits (451), Expect = 9e-56
 Identities = 48/154 (31%), Positives = 84/154 (54%), Gaps = 4/154 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
           E++ L+   H NI+ L ++F++   + ++ EF +G ++   I      + E+    ++ Q
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           +   L+ L+SH+I H D++PENI+         +KI +FG +  L PG+    +  +P Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEY 169

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            APEV Q        DMWS+G +++ LL+G  PF
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  177 bits (450), Expect = 1e-55
 Identities = 57/158 (36%), Positives = 83/158 (52%), Gaps = 15/158 (9%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
            H N++ L + F+ E+  +LV E   GG++ S+I       E  A   +Q +   L+ L+
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--------CGSPLYM 133
           +  I HRDLKPENIL    +    +KI DF L   +        +        CGS  YM
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 134 APEVL-----QFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APEV+     +   YD++ D+WS+G IL+ LL+GYPPF
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  177 bits (451), Expect = 1e-55
 Identities = 56/155 (36%), Positives = 83/155 (53%), Gaps = 7/155 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E+  LS V H NII++ D F+ +    LV+E   +G +L ++I  H R+ E  A    +Q
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           L   +  L    IIHRD+K ENI++    +D  +K+ DFG +  L  G      CG+  Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195

Query: 133 MAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
            APEVL    Y   +++MWS+G  L+ L+    PF
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  175 bits (447), Expect = 1e-55
 Identities = 51/185 (27%), Positives = 91/185 (49%), Gaps = 24/185 (12%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE----------------NCIFLVV 45
           +K++  + +     E+  L+ ++H NI+     +                    C+F+ +
Sbjct: 41  IKRVKYNNEKAER-EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM 99

Query: 46  EFCAGGNLSSYI--RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD 101
           EFC  G L  +I  R   ++ +  A +  +Q+  G++ ++S  +I+RDLKP NI L    
Sbjct: 100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---V 156

Query: 102 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           D   +KI DFGL  +L       +  G+  YM+PE +  Q Y ++VD++++G IL ELL+
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216

Query: 162 GYPPF 166
                
Sbjct: 217 VCDTA 221

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  180 bits (459), Expect = 2e-55
 Identities = 66/154 (42%), Positives = 95/154 (61%), Gaps = 6/154 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L    HP+II+L+      + IF+V+E+ +GG L  YI  +GR+ E+ +R+  QQ+
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G++  + H ++HRDLKPEN+L   LD  +  KIADFGLS  +  G +    CGSP Y 
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 182

Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           APEV+  + Y   +VD+WS G IL+ LL G  PF
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPF 216

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  175 bits (447), Expect = 5e-55
 Identities = 68/154 (44%), Positives = 98/154 (63%), Gaps = 7/154 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+++L  + HP+II+L+D       I +V+E+ AGG L  YI    R+ E   R+F QQ+
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI 117

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +E  + H I+HRDLKPEN+LL   DD++ +KIADFGLS  +  GN+ +  CGSP Y 
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 174

Query: 134 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           APEV+  + Y   +VD+WS G +L+ +L G  PF
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  175 bits (446), Expect = 7e-55
 Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 50/214 (23%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           ++++N      +  E+  +  ++HPNI RL++ ++ E  I LV+E C GG+L   + +  
Sbjct: 64  IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123

Query: 62  RVP----------------------------------------EQTARKFLQQL--GLEI 79
                                                      E+     ++Q+   L  
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183

Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMA 134
           L++  I HRD+KPEN L S  +    +K+ DFGLS   Y  N  E        G+P ++A
Sbjct: 184 LHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242

Query: 135 PEVLQF--QRYDEKVDMWSVGAILFELLNGYPPF 166
           PEVL    + Y  K D WS G +L  LL G  PF
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  173 bits (441), Expect = 2e-54
 Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 14/183 (7%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K+     +   D      E+     V  HP  +RL  A++    ++L  E C G +L  
Sbjct: 87  VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQ 145

Query: 56  YIRLHG-RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
           +    G  +PE     +L+     L  L+S  ++H D+KP NI L         K+ DFG
Sbjct: 146 HCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFG 202

Query: 113 LSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
           L   L      E   G P YMAPE+LQ   Y    D++S+G  + E+         GE  
Sbjct: 203 LLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGW 261

Query: 173 QFM 175
           Q +
Sbjct: 262 QQL 264

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  173 bits (441), Expect = 4e-54
 Identities = 54/151 (35%), Positives = 90/151 (59%), Gaps = 9/151 (5%)

Query: 24  NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQL-- 75
             P+I+ + D ++     + C+ +++E   GG L S I  R      E+ A + ++ +  
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 135
            ++ L+SH+I HRD+KPEN+L +  + D +LK+ DFG +      N  +  C +P Y+AP
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-KETTQNALQTPCYTPYYVAP 198

Query: 136 EVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           EVL  ++YD+  DMWS+G I++ LL G+PPF
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  171 bits (435), Expect = 2e-53
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFL 72
           E+  L  V+     +IRL D F+  +   L++E      +L  +I   G + E+ AR F 
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGS 129
            Q+   +   ++  ++HRD+K ENIL   +D +   LK+ DFG    L          G+
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 211

Query: 130 PLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
            +Y  PE +++ RY      +WS+G +L++++ G  PF
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  170 bits (434), Expect = 2e-53
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 38/192 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN-------------CIFLVVEFCAGGNLSSYIRLHGR 62
           E+  L+S+NH  ++R + A+                  +F+ +E+C  G L   I     
Sbjct: 52  EVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL 111

Query: 63  -VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-- 117
                   +  +Q+   L  ++S  IIHRDLKP NI    +D+   +KI DFGL+  +  
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF---IDESRNVKIGDFGLAKNVHR 168

Query: 118 -------------YPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 163
                           +      G+ +Y+A EVL     Y+EK+DM+S+G I FE++  Y
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--Y 226

Query: 164 PPFSVGEEHQFM 175
           P  + G E   +
Sbjct: 227 PFST-GMERVNI 237

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  169 bits (431), Expect = 2e-53
 Identities = 59/179 (32%), Positives = 94/179 (52%), Gaps = 17/179 (9%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRL 59
              + +  K  L  E+N L  + HPNI+R +D         +++V+E+C GG+L+S I  
Sbjct: 41  YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 100

Query: 60  HGR----VPEQTARKFLQQL--GLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 108
             +    + E+   + + QL   L+         H ++HRDLKP N+ L   D    +K+
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKL 157

Query: 109 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            DFGL+  L     +A+   G+P YM+PE +    Y+EK D+WS+G +L+EL    PPF
Sbjct: 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  168 bits (429), Expect = 9e-53
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 12/159 (7%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E+  L  ++HPN+++L +      E+ +++V E    G +         + E  AR + Q
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQ 144

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSP 130
            L  G+E L+   IIHRD+KP N+L   + +D  +KIADFG+S      +       G+P
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLL---VGEDGHIKIADFGVSNEFKGSDALLSNTVGTP 201

Query: 131 LYMAPEVLQFQR--YD-EKVDMWSVGAILFELLNGYPPF 166
            +MAPE L   R  +  + +D+W++G  L+  + G  PF
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  168 bits (428), Expect = 2e-52
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 7/150 (4%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQL--GL 77
           +   HP +IRL D F+ +    LV+E      +L  YI   G + E  +R F  Q+   +
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152

Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           +  +S  ++HRD+K ENIL+         K+ DFG    L          G+ +Y  PE 
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSG-ALLHDEPYTDFDGTRVYSPPEW 209

Query: 138 LQFQRYD-EKVDMWSVGAILFELLNGYPPF 166
           +   +Y      +WS+G +L++++ G  PF
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPF 239

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  167 bits (425), Expect = 5e-52
 Identities = 51/158 (32%), Positives = 88/158 (55%), Gaps = 10/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
           E++ L  +NHPN+I+ + +F  +N + +V+E    G+LS  I+   +    +PE+T  K+
Sbjct: 82  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCG 128
             QL   LE ++S  ++HRD+KP N+ +       ++K+ D GL          A  + G
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVG 198

Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +P YM+PE +    Y+ K D+WS+G +L+E+     PF
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  166 bits (422), Expect = 1e-51
 Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 15/162 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGN--LSSYIRLHGRVPEQTARKF 71
           E+  L  + H N+I+L D    E    +++V+E+C  G   +   +    R P   A  +
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGY 114

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKV 126
             QL  GLE L+S  I+H+D+KP N+L   L     LKI+  G++  L+P    +     
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLL---LTTGGTLKISALGVAEALHPFAADDTCRTS 171

Query: 127 CGSPLYMAPEVLQFQR-YD-EKVDMWSVGAILFELLNGYPPF 166
            GSP +  PE+      +   KVD+WS G  L+ +  G  PF
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  164 bits (417), Expect = 8e-51
 Identities = 52/156 (33%), Positives = 88/156 (56%), Gaps = 8/156 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  + 
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 130
              LE L+   IIHRDLKPENILL   ++D+ ++I DFG +  L P +   +     G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196

Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            Y++PE+L  +   +  D+W++G I+++L+ G PPF
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  166 bits (421), Expect = 3e-50
 Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 15/187 (8%)

Query: 3   KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           K++     S  D E+  L  S  HPN+IR F   +     ++ +E C    L  Y+    
Sbjct: 54  KRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112

Query: 62  RV-PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCT 116
                      LQQ   GL  L+S +I+HRDLKP NIL+S       +   I+DFGL   
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172

Query: 117 LYPGNYAEK----VCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELL-NGYPPFSV 168
           L  G ++      V G+  ++APE+L     +     VD++S G + + ++  G  PF  
Sbjct: 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232

Query: 169 GEEHQFM 175
             + Q  
Sbjct: 233 SLQRQAN 239

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  164 bits (416), Expect = 7e-50
 Identities = 52/156 (33%), Positives = 87/156 (55%), Gaps = 8/156 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           EL  +  + HP ++ L+ +FQ E  +F+VV+   GG+L  +++ +    E+T + F+ + 
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL 124

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            + L+ L +  IIHRD+KP+NIL   LD+   + I DF ++  L        + G+  YM
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNIL---LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181

Query: 134 APEVLQFQR---YDEKVDMWSVGAILFELLNGYPPF 166
           APE+   ++   Y   VD WS+G   +ELL G  P+
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  163 bits (415), Expect = 2e-49
 Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 34/198 (17%)

Query: 3   KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           K++          E+  L+ S +HPN+IR + +   +  +++ +E C   NL   +    
Sbjct: 45  KRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKN 103

Query: 62  -------RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS----------GLDD 102
                     E      L+Q+  G+  L+S  IIHRDLKP+NIL+S             +
Sbjct: 104 VSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163

Query: 103 DVMLKIADFGLSCTLYPGNYAEK-----VCGSPLYMAPEVLQ-------FQRYDEKVDMW 150
           ++ + I+DFGL   L  G  + +       G+  + APE+L+        +R    +D++
Sbjct: 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223

Query: 151 SVGAILFELL-NGYPPFS 167
           S+G + + +L  G  PF 
Sbjct: 224 SMGCVFYYILSKGKHPFG 241

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  159 bits (405), Expect = 9e-49
 Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 10/167 (5%)

Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           L+     EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A
Sbjct: 93  LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA 152

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK- 125
             +L Q   GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +  
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSL 210

Query: 126 -----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
                + G+  +MAPEV+  +  D KVD+WS   ++  +LNG  P++
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  158 bits (402), Expect = 1e-48
 Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 37/202 (18%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------------IFLVVEFCA 49
           L       +  +  E+  L+ + HP I+R F+A+  +N             +++ ++ C 
Sbjct: 40  LPNRELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR 98

Query: 50  GGNLSSYIRLHGRV---PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV 104
             NL  ++     +             Q+   +E L+S  ++HRDLKP NI       D 
Sbjct: 99  KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD 155

Query: 105 MLKIADFGLSCTL-------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWS 151
           ++K+ DFGL   +                       G+ LYM+PE +    Y  KVD++S
Sbjct: 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS 215

Query: 152 VGAILFELLNGYPPFSVGEEHQ 173
           +G ILFELL    PFS   E  
Sbjct: 216 LGLILFELLY---PFSTQMERV 234

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  158 bits (400), Expect = 7e-48
 Identities = 38/193 (19%), Positives = 72/193 (37%), Gaps = 18/193 (9%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           + K  N          +  L        ++ + A   +N   LV E  + G L + I L+
Sbjct: 102 VQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161

Query: 61  GR-----VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILL--------SGLDDDVM 105
                  +P+     F  ++   +E ++   IIH D+KP+N +L           D    
Sbjct: 162 KNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221

Query: 106 LKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
           L + D G S  +     G      C +  +   E+L  + ++ ++D + V A ++ +L G
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281

Query: 163 YPPFSVGEEHQFM 175
                  E  +  
Sbjct: 282 TYMKVKNEGGECK 294

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  156 bits (397), Expect = 8e-48
 Identities = 49/191 (25%), Positives = 80/191 (41%), Gaps = 29/191 (15%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLS 54
           LK++  H +   +    E +     NHPNI+RL      E    +  +L++ F   G L 
Sbjct: 59  LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118

Query: 55  SYI----RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
           + I         + E      L  +  GLE +++    HRDLKP NIL   L D+    +
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL---LGDEGQPVL 175

Query: 109 ADFGLSCTL--YPGNYAE--------KVCGSPLYMAPEVLQFQRY---DEKVDMWSVGAI 155
            D G       +     +            +  Y APE+   Q +   DE+ D+WS+G +
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235

Query: 156 LFELLNGYPPF 166
           L+ ++ G  P+
Sbjct: 236 LYAMMFGEGPY 246

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  156 bits (397), Expect = 1e-47
 Identities = 64/153 (41%), Positives = 93/153 (60%), Gaps = 7/153 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   LS V HP IIR++  FQ    IF+++++  GG L S +R   R P   A+ +  + 
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L LE L+S  II+RDLKPENILL   D +  +KI DFG +   Y  +    +CG+P Y+
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFA--KYVPDVTYTLCGTPDYI 170

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APEV+  + Y++ +D WS G +++E+L GY PF
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  157 bits (399), Expect = 1e-47
 Identities = 54/153 (35%), Positives = 94/153 (61%), Gaps = 7/153 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L+   D    +++ DFG +  +        +CG+P  +
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV--KGRTWTLCGTPEAL 205

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           APE++  + Y++ VD W++G +++E+  GYPPF
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  153 bits (390), Expect = 1e-46
 Identities = 61/167 (36%), Positives = 93/167 (55%), Gaps = 7/167 (4%)

Query: 12  CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
               E N L  V HP I+ L  AFQ    ++L++E+ +GG L   +   G   E TA  +
Sbjct: 67  HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126

Query: 72  LQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCG 128
           L +  + L  L+   II+RDLKPENI+L   +    +K+ DFGL   +++ G      CG
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCG 183

Query: 129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           +  YMAPE+L    ++  VD WS+GA+++++L G PPF+ GE  +  
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKT 229

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  153 bits (389), Expect = 2e-46
 Identities = 57/180 (31%), Positives = 94/180 (52%), Gaps = 10/180 (5%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           L+K   + K   +    E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++ 
Sbjct: 38  LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97

Query: 59  LHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-C 115
                 E+ AR +  +    LE L+S  +++RD+K EN++L   D D  +KI DFGL   
Sbjct: 98  RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKE 154

Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
            +  G   +  CG+P Y+APEVL+   Y   VD W +G +++E++ G  PF   ++H+ +
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERL 213

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  151 bits (383), Expect = 5e-46
 Identities = 59/174 (33%), Positives = 97/174 (55%), Gaps = 12/174 (6%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF----QAENCIFLVVEFCAGGNLSSYI 57
            +KL K  +     E   L  + HPNI+R +D++    + + CI LV E    G L +Y+
Sbjct: 61  DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120

Query: 58  RLHGRVPEQTARKFLQQL--GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +    +  +  R + +Q+  GL+ L++    IIHRDLK +NI ++G    V  KI D GL
Sbjct: 121 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV--KIGDLGL 178

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
             TL   ++A+ V G+P +MAPE+ + ++YDE VD+++ G  + E+     P+S
Sbjct: 179 -ATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYS 230

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  151 bits (385), Expect = 9e-46
 Identities = 62/163 (38%), Positives = 97/163 (59%), Gaps = 7/163 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L + 
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLY 132
            L L+ L+S  II+RDLKPENILL   D++  +K+ DFGLS  ++     A   CG+  Y
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           MAPEV+  + + +  D WS G ++FE+L G  PF  G++ +  
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ-GKDRKET 234

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  154 bits (391), Expect = 6e-45
 Identities = 60/175 (34%), Positives = 93/175 (53%), Gaps = 13/175 (7%)

Query: 2   LKKLNK-HLKS-----CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
            KKL K  +K          E   L  VN   ++ L  A++ ++ + LV+    GG+L  
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 273

Query: 56  YIRLHGRV--PEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
           +I   G+   PE  A  +  +   GLE L+   I++RDLKPENILL   DD   ++I+D 
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDL 330

Query: 112 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           GL+  +  G   +   G+  YMAPEV++ +RY    D W++G +L+E++ G  PF
Sbjct: 331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  151 bits (384), Expect = 1e-44
 Identities = 57/182 (31%), Positives = 94/182 (51%), Gaps = 11/182 (6%)

Query: 1   MLKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +LKK   + K   +    E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 239

Query: 58  RLHGRVPEQTARKFLQQ--LGLEILNSHH-IIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                  E  AR +  +    L+ L+S   +++RDLK EN++L   D D  +KI DFGL 
Sbjct: 240 SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLC 296

Query: 115 -CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
              +  G   +  CG+P Y+APEVL+   Y   VD W +G +++E++ G  PF   ++H+
Sbjct: 297 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHE 355

Query: 174 FM 175
            +
Sbjct: 356 KL 357

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  148 bits (375), Expect = 3e-44
 Identities = 63/181 (34%), Positives = 96/181 (53%), Gaps = 11/181 (6%)

Query: 2   LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   L      C   E      +  HP +  +F  FQ +  +F V+E+  GG+L  +I
Sbjct: 50  LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 109

Query: 58  RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 114
           +   +     A  +  +  LGL+ L+S  I++RDLK +NILL   D D  +KIADFG+  
Sbjct: 110 QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCK 166

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
             +         CG+P Y+APE+L  Q+Y+  VD WS G +L+E+L G  PF  G++ + 
Sbjct: 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEE 225

Query: 175 M 175
           +
Sbjct: 226 L 226

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  146 bits (371), Expect = 3e-44
 Identities = 41/180 (22%), Positives = 79/180 (43%), Gaps = 27/180 (15%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARK 70
           E+   + +  H +++R F A+  ++ + +  E+C GG+L+  I  + R+     E   + 
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFG 112
            L Q+  GL  ++S  ++H D+KP NI +S                   + VM KI D G
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 113 LSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
               +   +  +   G   ++A EVLQ    +  K D++++   +       P    G++
Sbjct: 180 HVTRI---SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  146 bits (370), Expect = 7e-44
 Identities = 47/160 (29%), Positives = 80/160 (50%), Gaps = 11/160 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E+  +  + HPNI+    A      + +V E+ + G+L   +   G   +   R+ L   
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143

Query: 75  ----LGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVC 127
                G+  L++ +  I+HR+LK  N+L+   D    +K+ DFGLS         ++   
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAA 200

Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           G+P +MAPEVL+ +  +EK D++S G IL+EL     P+ 
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  147 bits (374), Expect = 9e-44
 Identities = 63/172 (36%), Positives = 95/172 (55%), Gaps = 10/172 (5%)

Query: 2   LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           L+K   L K  +  +  E N  L +V HP ++ L  +FQ  + ++ V+++  GG L  ++
Sbjct: 71  LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL 130

Query: 58  RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 114
           +      E  AR +  +    L  L+S +I++RDLKPENILL   D    + + DFGL  
Sbjct: 131 QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCK 187

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
             +   +     CG+P Y+APEVL  Q YD  VD W +GA+L+E+L G PPF
Sbjct: 188 ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  145 bits (368), Expect = 1e-43
 Identities = 48/151 (31%), Positives = 77/151 (50%), Gaps = 29/151 (19%)

Query: 24  NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQL-- 75
             P+I+R+ D ++       C+ +V+E   GG L S I  R      E+ A + ++ +  
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 135
            ++ L+S +I HRD+KPEN+L +    + +LK+ DFG                     A 
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AK 168

Query: 136 EVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           E    ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 169 ETTG-EKYDKSCDMWSLGVIMYILLCGYPPF 198

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  145 bits (368), Expect = 2e-43
 Identities = 59/160 (36%), Positives = 85/160 (53%), Gaps = 14/160 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  LS VNHPNI++L+ A     C+  V+E+  GG+L + +     +P  TA   +   
Sbjct: 51  ELRQLSRVNHPNIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108

Query: 76  -----GLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
                G+  L+S     +IHRDLKP N+LL       +LKI DFG +C +    +     
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNK 164

Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           GS  +MAPEV +   Y EK D++S G IL+E++    PF 
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  146 bits (370), Expect = 2e-43
 Identities = 62/182 (34%), Positives = 99/182 (54%), Gaps = 13/182 (7%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   +      C   E   L+     P + +L   FQ  + ++ V+E+  GG+L  +I
Sbjct: 53  LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 112

Query: 58  RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
           +  GR  E  A  +  +  +GL  L S  II+RDLK +N++L   D +  +KIADFG+ C
Sbjct: 113 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGM-C 168

Query: 116 --TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
              ++ G   +  CG+P Y+APE++ +Q Y + VD W+ G +L+E+L G  PF  GE+  
Sbjct: 169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDED 227

Query: 174 FM 175
            +
Sbjct: 228 EL 229

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  146 bits (371), Expect = 4e-43
 Identities = 61/179 (34%), Positives = 99/179 (55%), Gaps = 18/179 (10%)

Query: 2   LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L+K   +K    +    E + ++  N P +++LF AFQ +  +++V+E+  GG+L +
Sbjct: 99  MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 158

Query: 56  YIRLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
            +  +  VPE+ AR +  +  L L+ ++S   IHRD+KP+N+L   LD    LK+ADFG 
Sbjct: 159 LMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGT 214

Query: 114 S--CTLYPGNYAEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 166
                       +   G+P Y++PEVL+ Q     Y  + D WSVG  L+E+L G  PF
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  143 bits (362), Expect = 5e-43
 Identities = 55/163 (33%), Positives = 78/163 (47%), Gaps = 14/163 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E    + + HPNII L      E  + LV+EF  GG L+    L G+ +P      +  Q
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRV--LSGKRIPPDILVNWAVQ 113

Query: 75  LG-----LEILNSHHIIHRDLKPENILLS-----GLDDDVMLKIADFGLSCTLYPGNYAE 124
           +      L       IIHRDLK  NIL+      G   + +LKI DFGL+   +      
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKM 172

Query: 125 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
              G+  +MAPEV++   + +  D+WS G +L+ELL G  PF 
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  145 bits (367), Expect = 6e-43
 Identities = 55/158 (34%), Positives = 93/158 (58%), Gaps = 6/158 (3%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAP 135
           L  L+   II+RDLK +N+LL   D +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 123 LNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 179

Query: 136 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           E+L+ + Y   VD W++G ++FE++ G  PF +     
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  148 bits (376), Expect = 6e-43
 Identities = 55/175 (31%), Positives = 87/175 (49%), Gaps = 13/175 (7%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
           L K     +        E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I 
Sbjct: 218 LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277

Query: 58  ---RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
                +    E  A  +  Q   GLE L+  +II+RDLKPEN+LL   DDD  ++I+D G
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLG 334

Query: 113 LSC-TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           L+          +   G+P +MAPE+L  + YD  VD +++G  L+E++    PF
Sbjct: 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  144 bits (366), Expect = 8e-43
 Identities = 66/181 (36%), Positives = 94/181 (51%), Gaps = 11/181 (6%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   L      C   E   LS   NHP + +LF  FQ  + +F V+EF  GG+L  +I
Sbjct: 56  LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115

Query: 58  RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 114
           +   R  E  AR +  +    L  L+   II+RDLK +N+LL   D +   K+ADFG+  
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCK 172

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
             +  G      CG+P Y+APE+LQ   Y   VD W++G +L+E+L G+ PF   E    
Sbjct: 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE-AENEDD 231

Query: 175 M 175
           +
Sbjct: 232 L 232

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  146 bits (369), Expect = 1e-42
 Identities = 59/182 (32%), Positives = 102/182 (56%), Gaps = 21/182 (11%)

Query: 2   LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LNK   LK    +C   E + L + +   I  L  AFQ +N ++LV+++  GG+L +
Sbjct: 104 MKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT 163

Query: 56  YI-RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
            + +   R+PE+ AR +L +  + ++ ++  H +HRD+KP+NIL   +D +  +++ADFG
Sbjct: 164 LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG 220

Query: 113 LSCTLYPGNYAEK---VCGSPLYMAPEVLQFQ-----RYDEKVDMWSVGAILFELLNGYP 164
             C     +   +     G+P Y++PE+LQ       RY  + D WS+G  ++E+L G  
Sbjct: 221 S-CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

Query: 165 PF 166
           PF
Sbjct: 280 PF 281

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  143 bits (363), Expect = 2e-42
 Identities = 55/165 (33%), Positives = 88/165 (53%), Gaps = 10/165 (6%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E   L  +   P ++ L  AFQ E  + L++++  GG L +++    R  E   + ++ +
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167

Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 130
             L LE L+   II+RD+K ENIL   LD +  + + DFGLS          A   CG+ 
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224

Query: 131 LYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            YMAP++++     +D+ VD WS+G +++ELL G  PF+V  E  
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  144 bits (365), Expect = 2e-42
 Identities = 55/158 (34%), Positives = 93/158 (58%), Gaps = 6/158 (3%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 165

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAP 135
           L  L+   II+RDLK +N+LL   D +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 166 LNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222

Query: 136 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           E+L+ + Y   VD W++G ++FE++ G  PF +     
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  148 bits (375), Expect = 3e-42
 Identities = 59/177 (33%), Positives = 92/177 (51%), Gaps = 16/177 (9%)

Query: 2   LKKLNK-HLKS-----CLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGN 52
           +K L+K  +K          E   LS V+    P I+ +  AF   + +  +++   GG+
Sbjct: 219 MKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 278

Query: 53  LSSYIRLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           L  ++  HG   E   R +  +  LGLE +++  +++RDLKP NIL   LD+   ++I+D
Sbjct: 279 LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISD 335

Query: 111 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 166
            GL+C            G+  YMAPEVLQ    YD   D +S+G +LF+LL G+ PF
Sbjct: 336 LGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  141 bits (357), Expect = 5e-42
 Identities = 52/163 (31%), Positives = 86/163 (52%), Gaps = 10/163 (6%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVP--EQTAR 69
           L  E+     + H NI++   +F     I + +E   GG+LS+ +R   G +   EQT  
Sbjct: 66  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-V 126
            + +Q+  GL+ L+ + I+HRD+K +N+L++     +  KI+DFG S  L   N   +  
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVL--KISDFGTSKRLAGINPCTETF 183

Query: 127 CGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFS 167
            G+  YMAPE++      Y +  D+WS+G  + E+  G PPF 
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  142 bits (359), Expect = 6e-42
 Identities = 40/182 (21%), Positives = 70/182 (38%), Gaps = 21/182 (11%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLH 60
             +         ++  +   +  N +        +  +++ ++ C   NL  ++      
Sbjct: 99  LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 117
                        Q+   +E L+S  ++HRDLKP NI       D ++K+ DFGL   + 
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMD 215

Query: 118 ------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 165
                                 G+ LYM+PE +    Y  KVD++S+G ILFELL  +  
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275

Query: 166 FS 167
             
Sbjct: 276 QM 277

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  140 bits (354), Expect = 1e-41
 Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 13/161 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  +S++NHPNI++L+        +  V+EF   G+L   +      +      + +  
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130

Query: 75  --LGLEILNSHH--IIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYAEKVCG 128
             LG+E + + +  I+HRDL+  NI L  LD    V  K+ADFGLS      +    + G
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLG 188

Query: 129 SPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLNGYPPFS 167
           +  +MAPE +  +   Y EK D +S   IL+ +L G  PF 
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  141 bits (358), Expect = 1e-41
 Identities = 55/155 (35%), Positives = 81/155 (52%), Gaps = 7/155 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140

Query: 76  --GLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 196

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           M+PE LQ   Y  + D+WS+G  L E+  G  P  
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  142 bits (361), Expect = 2e-41
 Identities = 55/183 (30%), Positives = 95/183 (51%), Gaps = 21/183 (11%)

Query: 2   LKKLNKHL---KSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K +NK     +  + C   E + L + +   I +L  AFQ EN ++LV+E+  GG+L +
Sbjct: 91  MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLT 150

Query: 56  YIRLHG-RVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
            +   G R+P + AR +L +  + ++ ++    +HRD+KP+NIL   LD    +++ADFG
Sbjct: 151 LLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL---LDRCGHIRLADFG 207

Query: 113 LSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-------RYDEKVDMWSVGAILFELLNGY 163
               L       +    G+P Y++PE+LQ          Y  + D W++G   +E+  G 
Sbjct: 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

Query: 164 PPF 166
            PF
Sbjct: 268 TPF 270

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  145 bits (366), Expect = 5e-41
 Identities = 62/182 (34%), Positives = 99/182 (54%), Gaps = 13/182 (7%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   +      C   E   L+     P + +L   FQ  + ++ V+E+  GG+L  +I
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433

Query: 58  RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
           +  GR  E  A  +  +  +GL  L S  II+RDLK +N++L   D +  +KIADFG+ C
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGM-C 489

Query: 116 --TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
              ++ G   +  CG+P Y+APE++ +Q Y + VD W+ G +L+E+L G  PF  GE+  
Sbjct: 490 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDED 548

Query: 174 FM 175
            +
Sbjct: 549 EL 550

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  139 bits (351), Expect = 8e-41
 Identities = 48/199 (24%), Positives = 79/199 (39%), Gaps = 37/199 (18%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSV-NHPNIIRLFDAF-------QAENCIFLVVEFCAG 50
           LK+L  + +        E+ F+  +  HPNI++   A              FL++     
Sbjct: 58  LKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117

Query: 51  GNLSSYI---RLHGRVPEQTARKFLQQL--GLEILNSHH--IIHRDLKPENILLSGLDDD 103
           G L  ++      G +   T  K   Q    ++ ++     IIHRDLK EN+LL    + 
Sbjct: 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQ 174

Query: 104 VMLKIADFGLSCTLYPGNYAEK-------------VCGSPLYMAPEVLQFQR---YDEKV 147
             +K+ DFG + T+                        +P+Y  PE++         EK 
Sbjct: 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234

Query: 148 DMWSVGAILFELLNGYPPF 166
           D+W++G IL+ L     PF
Sbjct: 235 DIWALGCILYLLCFRQHPF 253

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  137 bits (348), Expect = 9e-41
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 15/162 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQ 73
           E+  L    H NI+       A    I  V ++C G +L  ++     +   +      +
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTAPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC---TLYPGNYAEKVCG 128
           Q   G++ L++  IIHRDLK  NI    L +D  +KI DFGL+         +  E++ G
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIF---LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184

Query: 129 SPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFS 167
           S L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  137 bits (346), Expect = 4e-40
 Identities = 37/170 (21%), Positives = 70/170 (41%), Gaps = 22/170 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+       H N++    A  +   + ++   C G  L S +R    V      R+  Q+
Sbjct: 79  EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------V 126
           +  G+  L++  I+H+DLK +N+      D+  + I DFGL           +       
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQ 194

Query: 127 CGSPLYMAPEVLQFQR---------YDEKVDMWSVGAILFELLNGYPPFS 167
            G   ++APE+++            + +  D++++G I +EL     PF 
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  136 bits (344), Expect = 6e-40
 Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 21/169 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  +  + HPN+++       +  +  + E+  GG L   I+      P      F + 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116

Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------- 125
              G+  L+S +IIHRDL   N L+    ++  + +ADFGL+  +       +       
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173

Query: 126 --------VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                   V G+P +MAPE++  + YDEKVD++S G +L E++      
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  137 bits (346), Expect = 9e-40
 Identities = 24/172 (13%), Positives = 52/172 (30%), Gaps = 27/172 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCA------GGNLSSYIRLHGRVPEQT 67
             + +       +IR+    +       F +           G  L S+   H  +    
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207

Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
             +   Q+   L  L+ + ++H  L+P +I+L   D    + +  F              
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLV---RDGARVV 261

Query: 126 VCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGYPPF 166
              S  +  PE+   +                 D W++G +++ +     P 
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  136 bits (344), Expect = 2e-39
 Identities = 23/162 (14%), Positives = 43/162 (26%), Gaps = 17/162 (10%)

Query: 24  NHPNIIRLFDAFQAENC--IFLVVEFCAG------GNLSSYIRLHGRVPEQTARKFLQQL 75
           + P   +L             L++   +         L       G            QL
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
                 L S  ++H    P+N+ +     D  L + D         G           Y 
Sbjct: 204 IRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSAL--WKVGTRGPASSVPVTYA 258

Query: 134 APEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
             E L      +   ++ W +G  ++ +   + PF +     
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  134 bits (340), Expect = 4e-39
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 27/167 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + H NII L       + + L+ E+    +L  Y+  +  V  +  + FL QL
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 76  --GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
             G+   +S   +HRDLKP+N+LLS     +  +LKI DFGL+          +  G P+
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA----------RAFGIPI 191

Query: 132 -----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
                      Y  PE+L   + Y   VD+WS+  I  E+L   P F
Sbjct: 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  132 bits (335), Expect = 1e-38
 Identities = 57/157 (36%), Positives = 90/157 (57%), Gaps = 14/157 (8%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE 78
           S ++H NI+ + D  + ++C +LV+E+  G  LS YI  HG +   TA  F  Q+  G++
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125

Query: 79  ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYM 133
             +   I+HRD+KP+NIL   +D +  LKI DFG+       +L        V G+  Y 
Sbjct: 126 HAHDMRIVHRDIKPQNIL---IDSNKTLKIFDFGIAKALSETSL---TQTNHVLGTVQYF 179

Query: 134 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 170
           +PE  + +  DE  D++S+G +L+E+L G PPF+ GE
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN-GE 215

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  132 bits (334), Expect = 2e-38
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 29/166 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L  + HPN++ L + F+ +  + LV E+C    +   +  + R VPE   +    Q
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQ 110

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
               +   + H+ IHRD+KPENIL   +    ++K+ DFG +          ++   P  
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENIL---ITKHSVIKLCDFGFA----------RLLTGPSD 157

Query: 132 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
                     Y +PE+L    +Y   VD+W++G +  ELL+G P +
Sbjct: 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW 203

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  132 bits (334), Expect = 2e-38
 Identities = 55/166 (33%), Positives = 86/166 (51%), Gaps = 29/166 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L  ++HPNI+ L D   +E C+ LV EF    +L   +  +     +   + +L Q
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQ 127

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           L  G+   + H I+HRDLKP+N+L   ++ D  LK+ADFGL+          +  G P+ 
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLL---INSDGALKLADFGLA----------RAFGIPVR 174

Query: 132 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
                     Y AP+VL   ++Y   VD+WS+G I  E++ G P F
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  132 bits (333), Expect = 3e-38
 Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 12/161 (7%)

Query: 16  ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           +L+ +  S + P I++ F  F     +F+ +E           R+ G +PE+   K    
Sbjct: 73  DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVA 132

Query: 75  L--GLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           +   L  L   H +IHRD+KP NILL        +K+ DFG+S  L      ++  G   
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAA 189

Query: 132 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFS 167
           YMAPE +         YD + D+WS+G  L EL  G  P+ 
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  131 bits (331), Expect = 4e-38
 Identities = 53/166 (31%), Positives = 84/166 (50%), Gaps = 29/166 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L  + H NI++L+D    +  + LV E     +L   + +        TA+ FL Q
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           L  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+          +  G P+ 
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLA----------RAFGIPVR 155

Query: 132 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
                     Y AP+VL   ++Y   +D+WSVG I  E++NG P F
Sbjct: 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  131 bits (333), Expect = 5e-38
 Identities = 63/166 (37%), Positives = 86/166 (51%), Gaps = 29/166 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L  ++HPNII L DAF  ++ I LV +F    +L   I+ +  V      + ++  
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
              GLE L+ H I+HRDLKP N+L   LD++ +LK+ADFGL+          K  GSP  
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADFGLA----------KSFGSPNR 167

Query: 132 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
                     Y APE+L   + Y   VDMW+VG IL ELL   P  
Sbjct: 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 213

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  131 bits (331), Expect = 5e-38
 Identities = 51/163 (31%), Positives = 90/163 (55%), Gaps = 13/163 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPE-QTA---RK 70
           E++ +   + P++++ + ++     +++V+E+C  G++S  IRL    + E + A   + 
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133

Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGS 129
            L+  GLE L+    IHRD+K  NILL+  +     K+ADFG++  L         V G+
Sbjct: 134 TLK--GLEYLHFMRKIHRDIKAGNILLN-TEGHA--KLADFGVAGQLTDTMAKRNTVIGT 188

Query: 130 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
           P +MAPEV+Q   Y+   D+WS+G    E+  G PP++  + H
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA--DIH 229

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  130 bits (328), Expect = 7e-38
 Identities = 37/163 (22%), Positives = 70/163 (42%), Gaps = 18/163 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
           E   L   +HPN++ +  A Q+       L+  +   G+L + +       V +  A KF
Sbjct: 57  ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF 116

Query: 72  LQQL--GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
              +  G+  L++    I    L   ++++   D+D+  +I+   +  +           
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQSPG----RM 169

Query: 128 GSPLYMAPEVLQFQRYD---EKVDMWSVGAILFELLNGYPPFS 167
            +P ++APE LQ +  D      DMWS   +L+EL+    PF+
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  130 bits (330), Expect = 9e-38
 Identities = 45/160 (28%), Positives = 88/160 (55%), Gaps = 9/160 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ ++ ++     +++++EF  GG L+  +    R+ E+      + +
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAV 150

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
              L  L++  +IHRD+K ++ILL+ LD  V  K++DFG    +       K + G+P +
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLT-LDGRV--KLSDFGFCAQISKDVPKRKSLVGTPYW 207

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
           MAPEV+    Y  +VD+WS+G ++ E+++G PP+    + 
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF--SDS 245

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  130 bits (328), Expect = 1e-37
 Identities = 51/160 (31%), Positives = 89/160 (55%), Gaps = 9/160 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +     + E       ++ 
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCREC 125

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
              LE L+S+ +IHRD+K +NILL  +D  V  K+ DFG    + P       + G+P +
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLG-MDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
           MAPEV+  + Y  KVD+WS+G +  E++ G PP+    E+
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NEN 220

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  130 bits (328), Expect = 1e-37
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 7/155 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 128

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 185

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           MAPEV++   YD K D+WS+G    EL  G PP S
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  130 bits (328), Expect = 3e-37
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 29/166 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L  + H N++ L +  + +   +LV EF     +   + L    +  Q  +K+L Q
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQ 132

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+   +SH+IIHRD+KPENIL   +    ++K+ DFG +          +   +P  
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENIL---VSQSGVVKLCDFGFA----------RTLAAPGE 179

Query: 132 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
                     Y APE+L    +Y + VD+W++G ++ E+  G P F
Sbjct: 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  128 bits (323), Expect = 7e-37
 Identities = 53/166 (31%), Positives = 79/166 (47%), Gaps = 29/166 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L  + H NI+RL D   ++  + LV EFC   +L  Y          +  + FL Q
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           L  GL   +S +++HRDLKP+N+L   ++ +  LK+A+FGL+          +  G P+ 
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLA----------RAFGIPVR 156

Query: 132 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
                     Y  P+VL   + Y   +DMWS G I  EL N   P 
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  129 bits (325), Expect = 9e-37
 Identities = 58/164 (35%), Positives = 81/164 (49%), Gaps = 17/164 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTA---RKF 71
           E+ FL  + HPN I+    +  E+  +LV+E+C G            + E + A      
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA 163

Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           LQ  GL  L+SH++IHRD+K  NILLS     V  K+ DFG +  + P N      G+P 
Sbjct: 164 LQ--GLAYLHSHNMIHRDVKAGNILLS-EPGLV--KLGDFGSASIMAPAN---SFVGTPY 215

Query: 132 YMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
           +MAPEV+       YD KVD+WS+G    EL    PP      +
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--NMN 257

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  128 bits (323), Expect = 1e-36
 Identities = 55/166 (33%), Positives = 80/166 (48%), Gaps = 33/166 (19%)

Query: 20  LSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFL 72
           L +  HPN++RLFD         E  + LV E     +L++Y+        P +T +  +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            QL  GL+ L+SH ++HRDLKP+NIL+        +K+ADFGL+          ++    
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLA----------RIYSFQ 173

Query: 131 L----------YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +          Y APEVL    Y   VD+WSVG I  E+    P F
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  127 bits (322), Expect = 1e-36
 Identities = 50/166 (30%), Positives = 77/166 (46%), Gaps = 29/166 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L  + H NI+ L D    E  + LV E+    +L  Y+   G +      + FL Q
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQ 108

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           L  GL   +   ++HRDLKP+N+L   +++   LK+ADFGL+          +    P  
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLL---INERGELKLADFGLA----------RAKSIPTK 155

Query: 132 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
                     Y  P++L     Y  ++DMW VG I +E+  G P F
Sbjct: 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  127 bits (321), Expect = 2e-36
 Identities = 54/169 (31%), Positives = 78/169 (46%), Gaps = 33/169 (19%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRV--PEQTAR 69
           L  L +  HPN++RL D            + LV E     +L +Y+        P +T +
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             ++Q   GL+ L+++ I+HRDLKPENIL+        +K+ADFGL+          ++ 
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLA----------RIY 170

Query: 128 GSPL----------YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
              +          Y APEVL    Y   VDMWSVG I  E+    P F
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 219

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  127 bits (320), Expect = 2e-36
 Identities = 54/168 (32%), Positives = 91/168 (54%), Gaps = 18/168 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L++ +HP I++L  A+  +  +++++EFC GG + + +    R   E   +   +Q
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGS 129
           +   L  L+S  IIHRDLK  N+L++ L+ D+  ++ADFG+S         +K     G+
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKN--LKTLQKRDSFIGT 180

Query: 130 PLYMAPEV-----LQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
           P +MAPEV     ++   YD K D+WS+G  L E+    PP    E +
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH--ELN 226

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  127 bits (321), Expect = 2e-36
 Identities = 53/171 (30%), Positives = 80/171 (46%), Gaps = 34/171 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------PEQTAR 69
           E++ +  + H NI+RL+D    EN + LV EF    +L  Y+                 +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVK 111

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
            F  QL  GL   + + I+HRDLKP+N+L   ++    LK+ DFGL+          +  
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLL---INKRGQLKLGDFGLA----------RAF 158

Query: 128 GSPL-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
           G P+           Y AP+VL   + Y   +D+WS G IL E++ G P F
Sbjct: 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  126 bits (319), Expect = 3e-36
 Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 20/169 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF---- 71
           E+  +S  +HPNI+  + +F  ++ ++LV++  +GG++   I+      E  +       
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122

Query: 72  ----LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
               L+++  GLE L+ +  IHRD+K  NIL   L +D  ++IADFG+S  L  G    +
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNIL---LGEDGSVQIADFGVSAFLATGGDITR 179

Query: 126 ------VCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFS 167
                   G+P +MAPEV+ Q + YD K D+WS G    EL  G  P+ 
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  128 bits (322), Expect = 4e-36
 Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 17/166 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           EL+     NHPNI+     F A+N +++V  F A G+    I  H    + E      LQ
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---- 127
            +   L+ ++    +HR +K  +IL+S  D  V   ++    + ++      ++V     
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISV-DGKV--YLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 128 ----GSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFS 167
                   +++PEVLQ   Q YD K D++SVG    EL NG+ PF 
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  126 bits (319), Expect = 2e-35
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 19/179 (10%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
           +KK+ +  +     EL  +  ++H NI+RL   F      + E  + LV+++     +  
Sbjct: 84  IKKVLQDKRFKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYR 141

Query: 56  YIRLHGR----VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
             R + R    +P    + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ 
Sbjct: 142 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLC 199

Query: 110 DFGLSCTLYPGN-YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           DFG +  L  G      +C S  Y APE+      Y   +D+WS G +L ELL G P F
Sbjct: 200 DFGSAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  124 bits (314), Expect = 2e-35
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 14/160 (8%)

Query: 21  SSVNHPNIIRLFD----AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL- 75
           +++NHP I+ ++D       A    ++V+E+  G  L   +   G +  + A + +    
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126

Query: 76  -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEKVCGSP 130
             L   + + IIHRD+KP NI++S       +K+ DFG+    + +         V G+ 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 170
            Y++PE  +    D + D++S+G +L+E+L G PPF+ G+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-GD 222

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  125 bits (315), Expect = 5e-35
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 40/181 (22%)

Query: 15  CELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR---------V 63
            E+  L  + HPN+I L   F   A+  ++L+ ++    +L   I+ H           +
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG 120
           P    +  L Q+  G+  L+++ ++HRDLKP NIL+ G   +   +KIAD G +      
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------ 179

Query: 121 NYAEKVCGSPL--------------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPP 165
               ++  SPL              Y APE+L   + Y + +D+W++G I  ELL   P 
Sbjct: 180 ----RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 235

Query: 166 F 166
           F
Sbjct: 236 F 236

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  123 bits (311), Expect = 6e-35
 Identities = 38/153 (24%), Positives = 73/153 (47%), Gaps = 13/153 (8%)

Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
            +  P+++ + D  + +  +++ +    G +L++ +R  G +    A   ++Q+   L+ 
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149

Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYMA 134
            ++    HRD+KPENIL+S  DD     + DFG+        L          G+  YMA
Sbjct: 150 AHAAGATHRDVKPENILVSA-DDFA--YLVDFGIASATTDEKL---TQLGNTVGTLYYMA 203

Query: 135 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           PE         + D++++  +L+E L G PP+ 
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPPYQ 236

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  122 bits (309), Expect = 6e-35
 Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 14/163 (8%)

Query: 16  ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKF 71
           +L+  + +V+ P  +  + A   E  +++ +E         Y   I     +PE    K 
Sbjct: 55  DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114

Query: 72  LQQL--GLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 128
              +   LE L+S   +IHRD+KP N+L++     V  K+ DFG+S  L      +   G
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQV--KMCDFGISGYLVDDVAKDIDAG 171

Query: 129 SPLYMAPEV----LQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
              YMAPE     L  + Y  K D+WS+G  + EL     P+ 
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  123 bits (312), Expect = 2e-34
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 18/165 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLHGR----VPE 65
           EL  +  V HPN++ L   F      + E  + LV+E+     +    R + +    +P 
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPM 140

Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-Y 122
              + ++ QL   L  ++S  I HRD+KP+N+LL       +LK+ DFG +  L  G   
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPN 198

Query: 123 AEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
              +C S  Y APE+      Y   +D+WS G ++ EL+ G P F
Sbjct: 199 VSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  123 bits (309), Expect = 4e-34
 Identities = 24/168 (14%), Positives = 53/168 (31%), Gaps = 20/168 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI--FLVVEFCAG------GNLSSYIRLHGRVPEQT 67
             + +       +IR+    +    +  F +              L S+   H  +    
Sbjct: 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 212

Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE- 124
             +   Q+   L  L+ + ++H  L+P +I+L   D    + +  F           +  
Sbjct: 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGASAVSPI 269

Query: 125 -KVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 166
            +    P   A  +L F +          D W++G  ++ +     P 
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  125 bits (316), Expect = 4e-34
 Identities = 40/156 (25%), Positives = 79/156 (50%), Gaps = 17/156 (10%)

Query: 19  FLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           FL+ V HP+I+++F+  +  +       ++V+E+  G +L        ++P   A  +L 
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLL 189

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           ++   L  L+S  +++ DLKPENI+L+  ++ +  K+ D G    +   N    + G+P 
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT--EEQL--KLIDLGAVSRI---NSFGYLYGTPG 242

Query: 132 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           + APE+++        D+++VG  L  L    P  +
Sbjct: 243 FQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRN 277

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  120 bits (303), Expect = 5e-34
 Identities = 43/183 (23%), Positives = 76/183 (41%), Gaps = 29/183 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           EL     + H NI+    +      +   ++L+  +   G+L  Y++L   +   +  + 
Sbjct: 52  ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRI 110

Query: 72  LQQL--GLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  +  GL  L+           I HRDLK +NIL+     +    IAD GL+       
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQST 167

Query: 122 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 170
               V      G+  YMAPEVL            ++VD+W+ G +L+E+        + E
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

Query: 171 EHQ 173
           +++
Sbjct: 228 DYK 230

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  121 bits (305), Expect = 6e-34
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 15/164 (9%)

Query: 16  ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARK 70
           +L+  + S + P I++ + A   E   ++ +E  +      Y      L   +PE+   K
Sbjct: 70  DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129

Query: 71  FLQQL--GLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
                   L  L     IIHRD+KP NILL     ++  K+ DFG+S  L       +  
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNI--KLCDFGISGQLVDSIAKTRDA 186

Query: 128 GSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLNGYPPFS 167
           G   YMAPE +        YD + D+WS+G  L+EL  G  P+ 
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  120 bits (302), Expect = 2e-33
 Identities = 42/185 (22%), Positives = 73/185 (39%), Gaps = 29/185 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+     + H NI+    A          ++LV ++   G+L  Y+  +  V  +   K 
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKL 144

Query: 72  LQQL--GLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 GL  L+           I HRDLK +NIL+     +    IAD GL+       
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSAT 201

Query: 122 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 170
               +      G+  YMAPEVL      +     ++ D++++G + +E+        + E
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

Query: 171 EHQFM 175
           ++Q  
Sbjct: 262 DYQLP 266

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  119 bits (300), Expect = 3e-33
 Identities = 45/184 (24%), Positives = 74/184 (40%), Gaps = 29/184 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+     + H NI+    A      +   ++L+ ++   G+L  Y++    +  ++  K 
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKL 139

Query: 72  LQQL--GL-----EILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 GL     EI ++     I HRDLK +NIL+     +    IAD GL+       
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDT 196

Query: 122 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 170
               +      G+  YM PEVL         +     DM+S G IL+E+        + E
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256

Query: 171 EHQF 174
           E+Q 
Sbjct: 257 EYQL 260

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  119 bits (299), Expect = 4e-33
 Identities = 56/171 (32%), Positives = 86/171 (50%), Gaps = 24/171 (14%)

Query: 16  ELNFLSSV-NHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLHGRVP---E 65
           E+N L    +H NI   + AF        ++ ++LV+EFC  G+++  I+         E
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129

Query: 66  QTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
             A   R+ L+  GL  L+ H +IHRD+K +N+LL+  + +V  K+ DFG+S  L     
Sbjct: 130 WIAYICREILR--GLSHLHQHKVIHRDIKGQNVLLT-ENAEV--KLVDFGVSAQLDRTVG 184

Query: 123 AEK-VCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFS 167
                 G+P +MAPEV+         YD K D+WS+G    E+  G PP  
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  118 bits (298), Expect = 1e-32
 Identities = 59/178 (33%), Positives = 88/178 (49%), Gaps = 19/178 (10%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  ++         EL  +  VNH NII L + F  +        +++V+E    
Sbjct: 55  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MD 113

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            NL   I++   +  +     L Q+  G++ L+S  IIHRDLKP NI++     D  LKI
Sbjct: 114 ANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKI 168

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            DFGL+ T            +  Y APEV+    Y E VD+WSVG I+ E++ G   F
Sbjct: 169 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  119 bits (299), Expect = 2e-32
 Identities = 59/178 (33%), Positives = 86/178 (48%), Gaps = 19/178 (10%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  ++         EL  +  VNH NII L + F  +        ++LV+E    
Sbjct: 92  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MD 150

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            NL   I+    +  +     L Q+  G++ L+S  IIHRDLKP NI++     D  LKI
Sbjct: 151 ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKI 205

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            DFGL+ T            +  Y APEV+    Y E VD+WSVG I+ E++     F
Sbjct: 206 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  117 bits (294), Expect = 5e-32
 Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 37/187 (19%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +         +LV+ F  G
Sbjct: 55  IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-MG 113

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L   ++ H ++ E   +  + Q+  GL  +++  IIHRDLKP N+ +   ++D  LKI
Sbjct: 114 TDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKI 169

Query: 109 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFEL 159
            DFGL+          +   S +        Y APEV L + RY + VD+WSVG I+ E+
Sbjct: 170 LDFGLA----------RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219

Query: 160 LNGYPPF 166
           + G   F
Sbjct: 220 ITGKTLF 226

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  115 bits (290), Expect = 1e-31
 Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 22/179 (12%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F   +        +LV+ F   
Sbjct: 54  IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-MQ 112

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L   +    +  E+  +  + Q+  GL+ ++S  ++HRDLKP N+ +   ++D  LKI
Sbjct: 113 TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKI 167

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            DFGL+           V  +  Y APEV L +  Y++ VD+WSVG I+ E+L G   F
Sbjct: 168 LDFGLARHADA-EMTGYV-VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  115 bits (290), Expect = 2e-31
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 30/189 (15%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+       L       E+  L    H NII +F+  + ++      ++++ E     
Sbjct: 41  IKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-MQT 98

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L   I     + +   + F+ Q    +++L+  ++IHRDLKP N+L+   + +  LK+ 
Sbjct: 99  DLHRVIS-TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVC 154

Query: 110 DFGLSCTLYPGNYAEKVCGSPL-----------YMAPEV-LQFQRYDEKVDMWSVGAILF 157
           DFGL+  +                         Y APEV L   +Y   +D+WS G IL 
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214

Query: 158 ELLNGYPPF 166
           EL    P F
Sbjct: 215 ELFLRRPIF 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  113 bits (285), Expect = 5e-31
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 12/155 (7%)

Query: 24  NHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
             PNII L D  +        LV E     +     +    + +   R ++ ++   L+ 
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDY 145

Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVL 138
            +S  I+HRD+KP N+++        L++ D+GL+   +PG  Y  +V  S  +  PE+L
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELL 202

Query: 139 -QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
             +Q YD  +DMWS+G +L  ++    PF  G ++
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  113 bits (285), Expect = 8e-31
 Identities = 53/168 (31%), Positives = 80/168 (47%), Gaps = 21/168 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQA-------ENCIFLVVEFCAGGNLSSYIRLHGR----VP 64
            +  L+ ++HPNI++L   F         +  + +V+E+     L    R + R     P
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPP 127

Query: 65  EQTARKFLQQL--GLEIL--NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
               + FL QL   +  L   S ++ HRD+KP N+L++  D    LK+ DFG +  L P 
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDFGSAKKLSPS 185

Query: 121 N-YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                 +C S  Y APE+    Q Y   VD+WSVG I  E++ G P F
Sbjct: 186 EPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  113 bits (284), Expect = 1e-30
 Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 37/187 (19%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F           ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 117

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 118 ADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKI 173

Query: 109 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFEL 159
            DFGL+          +     +        Y APE+ L +  Y++ VD+WSVG I+ EL
Sbjct: 174 LDFGLA----------RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223

Query: 160 LNGYPPF 166
           L G   F
Sbjct: 224 LTGRTLF 230

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  114 bits (286), Expect = 1e-30
 Identities = 54/200 (27%), Positives = 86/200 (43%), Gaps = 40/200 (20%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+N+  +  +DC     E+  L+ +    IIRL+D    ++      +++V+E  A  
Sbjct: 56  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADS 114

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L    +    + E+  +  L  L  G   ++   IIHRDLKP N L   L+ D  +K+ 
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL---LNQDCSVKVC 171

Query: 110 DFGLSCTLYPGNYAEKVCGSPL-----------------------YMAPEV-LQFQRYDE 145
           DFGL+ T+        V                            Y APE+ L  + Y +
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231

Query: 146 KVDMWSVGAILFELLNGYPP 165
            +D+WS G I  ELLN    
Sbjct: 232 SIDIWSTGCIFAELLNMLQS 251

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  112 bits (283), Expect = 2e-30
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 31/186 (16%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK++   +    C     E+  L    H NII + D  +A        +++V +     
Sbjct: 57  IKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-MET 114

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L   ++    +       FL Q+  GL+ ++S +++HRDLKP N+LL   +    LKI 
Sbjct: 115 DLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKIC 170

Query: 110 DFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELL 160
           DFGL+    P    +      L        Y APE+ L  + Y + +D+WSVG IL E+L
Sbjct: 171 DFGLARVADP----DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

Query: 161 NGYPPF 166
           +  P F
Sbjct: 227 SNRPIF 232

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  112 bits (282), Expect = 2e-30
 Identities = 42/171 (24%), Positives = 79/171 (46%), Gaps = 27/171 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYI-RLHGRVPEQ 66
           E+  L  + H N++ L +  + +          I+LV +FC   +L+  +  +  +    
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124

Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             ++ +Q L  GL  ++ + I+HRD+K  N+L+     D +LK+ADFGL+   +  + A+
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLA-RAF--SLAK 178

Query: 125 KVCGSPL--------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 166
               +          Y  PE+L   + Y   +D+W  G I+ E+    P  
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  112 bits (283), Expect = 2e-30
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 38/198 (19%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVN-HPNIIRLFDAFQAENC--IFLVVEFCAGGNL 53
           +KK+    ++  D      E+  L+ ++ H NI+ L +  +A+N   ++LV ++    +L
Sbjct: 39  VKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-METDL 97

Query: 54  SSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
            + IR    +     +  + QL   ++ L+S  ++HRD+KP NILL   + +  +K+ADF
Sbjct: 98  HAVIR-ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADF 153

Query: 112 GLSCTLYPGNYAEKVCGSPL----------------------YMAPEV-LQFQRYDEKVD 148
           GLS +              +                      Y APE+ L   +Y + +D
Sbjct: 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGID 213

Query: 149 MWSVGAILFELLNGYPPF 166
           MWS+G IL E+L G P F
Sbjct: 214 MWSLGCILGEILCGKPIF 231

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  111 bits (280), Expect = 2e-30
 Identities = 48/176 (27%), Positives = 87/176 (49%), Gaps = 33/176 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--------------IFLVVEFCAGGNLSSYIRLHG 61
           E+  +  ++H NI+++F+                     +++V E+    +L++ +   G
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDLANVLE-QG 115

Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
            + E+ AR F+ QL  GL+ ++S +++HRDLKP N+ ++   +D++LKI DFGL+  + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDP 173

Query: 120 GNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                      L        Y +P + L    Y + +DMW+ G I  E+L G   F
Sbjct: 174 ----HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  113 bits (285), Expect = 2e-30
 Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 45/205 (21%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+ +  +  +DC     E+  L+ +NH +++++ D    ++      +++V+E  A  
Sbjct: 83  IKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI-ADS 141

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +     R    + E   +  L  L  G++ ++S  I+HRDLKP N L   ++ D  +K+ 
Sbjct: 142 DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL---VNQDCSVKVC 198

Query: 110 DFGLSCTLYPGNYAEKVCGSPL----------------------------YMAPEV-LQF 140
           DFGL+ T+                                          Y APE+ L  
Sbjct: 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ 258

Query: 141 QRYDEKVDMWSVGAILFELLNGYPP 165
           + Y E +D+WS+G I  ELLN    
Sbjct: 259 ENYTEAIDVWSIGCIFAELLNMIKE 283

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  111 bits (279), Expect = 3e-30
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 23/170 (13%)

Query: 16  ELNFLSSVNHPNIIRLF------DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           E   +   +HP++ +L        A        +++ F   G+L +++    R+ E    
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFN 133

Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             LQ L         G+E L+S + IHRDL   N +L+   +D+ + +ADFGLS  +Y G
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSG 190

Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +Y  + C S L   ++A E L    Y    D+W+ G  ++E++  G  P+
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  111 bits (280), Expect = 4e-30
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 15/161 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVP--EQTA 68
           E+  L+  +HPNI+ L D F          ++LV E     +L+  I    R+    Q  
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDLAQVIH-DQRIVISPQHI 136

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
           + F+  +  GL +L+   ++HRDL P NILL    D+  + I DF L+            
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHY 193

Query: 127 CGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                Y APE+ +QF+ + + VDMWS G ++ E+ N    F
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  110 bits (278), Expect = 4e-30
 Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 24/186 (12%)

Query: 1   MLKKLNKHLKSCLD--CELNFLSSVNHPNIIRLF-----DAFQAENCIFLVVEFCAGGNL 53
            +K  N   +   +   E   +   +HPN+IRL       + Q      +++ F   G+L
Sbjct: 69  TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128

Query: 54  SSYIRLHGRVPEQTARKFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDV 104
            +Y+    R+        LQ L         G+E L++ + +HRDL   N +L   DD  
Sbjct: 129 HTYLLYS-RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR--DDMT 185

Query: 105 MLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           +  +ADFGLS  +Y G+Y  +   + +   ++A E L  + Y  K D+W+ G  ++E+  
Sbjct: 186 V-CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

Query: 162 -GYPPF 166
            G  P+
Sbjct: 245 RGMTPY 250

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  109 bits (274), Expect = 1e-29
 Identities = 50/162 (30%), Positives = 82/162 (50%), Gaps = 13/162 (8%)

Query: 15  CELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFL 72
            E   +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F 
Sbjct: 75  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCG 128
            Q+  G++ L S   +HRDL   N +L   +   + K+ADFGL+  +Y   Y       G
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEYYSVHNKTG 191

Query: 129 SPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + L   +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  109 bits (275), Expect = 1e-29
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 28/176 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+  L  + H NI++   A +    +    +L+  F   G+LS +++ +  V        
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHI 126

Query: 72  LQQL--GLEILNSH----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
            + +  GL  L+             I HRD+K +N+L   L +++   IADFGL+     
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEA 183

Query: 120 GNYAEK---VCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILFELLNGYPPFS 167
           G  A       G+  YMAPEVL+      +    ++DM+++G +L+EL +      
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  110 bits (277), Expect = 1e-29
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 51/211 (24%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------------------------ 37
           LKK+ +  +     EL+ +  ++H NII+L D F                          
Sbjct: 37  LKKVLQDPRYKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNG 95

Query: 38  --------------ENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKFLQQL--GL 77
                            + +++E+     L   ++   R    +P      ++ QL   +
Sbjct: 96  VNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154

Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPE 136
             ++S  I HRD+KP+N+L++  D+   LK+ DFG +  L P       +C S  Y APE
Sbjct: 155 GFIHSLGICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPE 211

Query: 137 V-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           + L    Y   +D+WS+G +  EL+ G P F
Sbjct: 212 LMLGATEYTPSIDLWSIGCVFGELILGKPLF 242

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  110 bits (277), Expect = 1e-29
 Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 22/179 (12%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSY 56
           +L+++N    +  D            +I++L D F  +      + +V E   G NL + 
Sbjct: 68  LLQRVNDADNTKEDSM-------GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLAL 119

Query: 57  IRL--HGRVPEQTARKFLQQL--GLEILNSH-HIIHRDLKPENILLSGLDD---DVMLKI 108
           I+   H  +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D     + +KI
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           AD G +C  +   +      +  Y +PEVL    +    D+WS   ++FEL+ G   F 
Sbjct: 180 ADLGNAC--WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (274), Expect = 2e-29
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   ++SV++P++ RL       + + L+ +    G L  Y+R H   +  Q    +  Q
Sbjct: 67  EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 130
           +  G+  L    ++HRDL   N+L+        +KI DFGL+  L          G   P
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + +MA E +  + Y  + D+WS G  ++EL+  G  P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  110 bits (276), Expect = 2e-29
 Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 13/161 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
           E   +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 129
           Q+  G++ L S   +HRDL   N +L   +   + K+ADFGL+  +Y   +       G+
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEFDSVHNKTGA 256

Query: 130 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            L   +MA E LQ Q++  K D+WS G +L+EL+  G PP+
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  108 bits (273), Expect = 2e-29
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 12/156 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +S  NH NI+R           F+++E  AGG+L S++R     P Q +   +  L
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142

Query: 76  ---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
                    G + L  +H IHRD+   N LL+      + KI DFG++  +Y  +Y  K 
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202

Query: 127 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
             + L   +M PE      +  K D WS G +L+E+
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  108 bits (271), Expect = 3e-29
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 13/161 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
           E   +  +NHPN++ L       E    +++ +   G+L  +IR   R P  +    F  
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 129
           Q+  G+E L     +HRDL   N +L    +   +K+ADFGL+  +    Y   ++   +
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDILDREYYSVQQHRHA 188

Query: 130 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            L   + A E LQ  R+  K D+WS G +L+ELL  G PP+
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  109 bits (273), Expect = 5e-29
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 12/156 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +S  NH NI+R           F+++E  AGG+L S++R     P Q +   +  L
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183

Query: 76  ---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
                    G + L  +H IHRD+   N LL+      + KI DFG++  +Y   Y  K 
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243

Query: 127 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
             + L   +M PE      +  K D WS G +L+E+
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  109 bits (273), Expect = 8e-29
 Identities = 60/177 (33%), Positives = 78/177 (44%), Gaps = 20/177 (11%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+ L K  K             N  N+I + + F   N I +  E     NL   I+ +
Sbjct: 146 ILEHLRKQDKD------------NTMNVIHMLENFTFRNHICMTFE-LLSMNLYELIKKN 192

Query: 61  G--RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                     RKF   +   L+ L+ + IIH DLKPENILL        +K+ DFG SC 
Sbjct: 193 KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ-QGRSGIKVIDFGSSC- 250

Query: 117 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            Y          S  Y APEV+   RY   +DMWS+G IL ELL GYP     +E  
Sbjct: 251 -YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  106 bits (268), Expect = 1e-28
 Identities = 40/167 (23%), Positives = 74/167 (44%), Gaps = 19/167 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF---L 72
           E + +   N  +++RL           +++E    G+L SY+R                L
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137

Query: 73  QQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
            ++         G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y 
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 194

Query: 124 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            K     L   +M+PE L+   +    D+WS G +L+E+      P+
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  107 bits (268), Expect = 1e-28
 Identities = 42/158 (26%), Positives = 79/158 (50%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
            +  + S++H +I+RL       + + LV ++   G+L  ++R H G +  Q    +  Q
Sbjct: 65  HMLAIGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L  H ++HR+L   N+LL        +++ADFG++  L P +       +   
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180

Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +MA E + F +Y  + D+WS G  ++EL+  G  P+
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  106 bits (266), Expect = 2e-28
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   ++SV++P++ RL       + + L+ +    G L  Y+R H   +  Q    +  Q
Sbjct: 67  EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L    ++HRDL   N+L+        +KI DFGL+  L          G  + 
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +MA E +  + Y  + D+WS G  ++EL+  G  P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  105 bits (264), Expect = 2e-28
 Identities = 43/151 (28%), Positives = 81/151 (53%), Gaps = 12/151 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFL 72
           E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR         KF 
Sbjct: 64  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
             +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL+          K+   P
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 177

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           + + APE L+ +++  K D+WS G +L+E+ 
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIY 208

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  107 bits (269), Expect = 4e-28
 Identities = 43/151 (28%), Positives = 82/151 (54%), Gaps = 12/151 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF 
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
             +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL+          K+   P
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 349

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           + + APE L+ +++  K D+WS G +L+E+ 
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIY 380

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  105 bits (265), Expect = 5e-28
 Identities = 50/180 (27%), Positives = 81/180 (45%), Gaps = 27/180 (15%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--- 71
           EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   RV E         
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 72  ----LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
                + L         G+  L S + IHRD+   N+LL+   +  + KI DFGL+  + 
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIM 215

Query: 119 PGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNGYPPFSVGEE 171
             +       + L   +MAPE +    Y  + D+WS G +L+E+    LN YP   V  +
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  104 bits (261), Expect = 1e-27
 Identities = 47/190 (24%), Positives = 73/190 (38%), Gaps = 36/190 (18%)

Query: 15  CELNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
             +  +  + H NI R                 LV+E+   G+L  Y+ LH      ++ 
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114

Query: 70  KFLQQL--GL-----EILNSHH----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           +    +  GL     E+    H    I HRDL   N+L   + +D    I+DFGLS  L 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL---VKNDGTCVISDFGLSMRLT 171

Query: 119 PGNYAEK---------VCGSPLYMAPEVLQ-------FQRYDEKVDMWSVGAILFELLNG 162
                             G+  YMAPEVL+        +   ++VDM+++G I +E+   
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

Query: 163 YPPFSVGEEH 172
                 GE  
Sbjct: 232 CTDLFPGESV 241

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  105 bits (263), Expect = 1e-27
 Identities = 62/179 (34%), Positives = 76/179 (42%), Gaps = 22/179 (12%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+ +NKH                   I+ L   F   N + LV E     NL   +R  
Sbjct: 103 LLELMNKHDTE------------MKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNT 149

Query: 61  GRVP--EQTARKFLQQL--GLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                     RKF QQ+   L  L +    IIH DLKPENILL        +KI DFG S
Sbjct: 150 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSS 208

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           C    G    +   S  Y +PEVL    YD  +DMWS+G IL E+  G P FS   E  
Sbjct: 209 C--QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  105 bits (263), Expect = 2e-27
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 10/150 (6%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQL--GLEIL 80
           +HPNI+RL      +  I++V+E   GG+  +++R  G  +  +T  + +     G+E L
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229

Query: 81  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEV 137
            S   IHRDL   N L++   +  +LKI+DFG+S     G YA       +   + APE 
Sbjct: 230 ESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286

Query: 138 LQFQRYDEKVDMWSVGAILFELL-NGYPPF 166
           L + RY  + D+WS G +L+E    G  P+
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPY 316

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  103 bits (258), Expect = 2e-27
 Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 11/152 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R             
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           Q+   +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+  
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 174

Query: 132 ---YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
              + APE L + ++  K D+W+ G +L+E+ 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  103 bits (258), Expect = 3e-27
 Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 23/180 (12%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R H
Sbjct: 78  ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137

Query: 61  GRVPEQTARKF--------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDD 103
           G   +  A           L QL         G+  L   H +HRDL   N L+      
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QG 194

Query: 104 VMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           +++KI DFG+S  +Y  +Y      + L   +M PE + ++++  + D+WS G +L+E+ 
Sbjct: 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  103 bits (258), Expect = 4e-27
 Identities = 56/183 (30%), Positives = 85/183 (46%), Gaps = 30/183 (16%)

Query: 16  ELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF-- 71
           EL  L  + +H N++ L  A  +    + ++VEFC  GNLS+Y+R               
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139

Query: 72  -------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
                  L+ L         G+E L S   IHRDL   NILLS   +  ++KI DFGL+ 
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLAR 196

Query: 116 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSV 168
            +Y      +   + L   +MAPE +  + Y  + D+WS G +L+E+     + YP   +
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256

Query: 169 GEE 171
            EE
Sbjct: 257 DEE 259

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  105 bits (263), Expect = 4e-27
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 12/159 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  V          
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           Q+   +E L   + IHR+L   N L+    ++ ++K+ADFGLS  L  G+      G+  
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 381

Query: 132 ---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPF 166
              + APE L + ++  K D+W+ G +L+E+   G  P+
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  105 bits (263), Expect = 4e-27
 Identities = 40/158 (25%), Positives = 78/158 (49%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   +  + H  +++L+     E  I++V E+ + G+L  +++       +  +      
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 130
           Q+  G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y  +     P
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 427

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  101 bits (253), Expect = 7e-27
 Identities = 44/157 (28%), Positives = 82/157 (52%), Gaps = 9/157 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E   +  ++HP +++ +     E  I++V E+ + G L +Y+R HG+ +      +    
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 131
           +  G+  L SH  IHRDL   N L+     D+ +K++DFG++  +    Y   V    P+
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169

Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            + APEV  + +Y  K D+W+ G +++E+ + G  P+
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  101 bits (254), Expect = 8e-27
 Identities = 42/182 (23%), Positives = 82/182 (45%), Gaps = 25/182 (13%)

Query: 1   MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
            LK      L+     E    + + HPN++ L      +  + ++  +C+ G+L  ++ +
Sbjct: 46  TLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM 105

Query: 60  HGRVPEQTARKF---------LQQL---------GLEILNSHHIIHRDLKPENILLSGLD 101
                +  +                         G+E L+SHH++H+DL   N+L+    
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY--- 162

Query: 102 DDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFE 158
           D + +KI+D GL   +Y  +Y + +  S L   +MAPE + + ++    D+WS G +L+E
Sbjct: 163 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 222

Query: 159 LL 160
           + 
Sbjct: 223 VF 224

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  100 bits (252), Expect = 9e-27
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 9/157 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 53  EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y        P+
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169

Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            + +PEV  F RY  K D+WS G +++E+ + G  P+
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  101 bits (255), Expect = 9e-27
 Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 32/173 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF---- 71
           E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V            
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135

Query: 72  -------------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                        +  L         G++ L    ++HRDL   NIL++  +   M KI+
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA--EGRKM-KIS 192

Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           DFGLS  +Y  +   K     +   +MA E L    Y  + D+WS G +L+E+
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  101 bits (254), Expect = 9e-27
 Identities = 44/181 (24%), Positives = 82/181 (45%), Gaps = 24/181 (13%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            LK      +     E   L+++ H +I++ +      + + +V E+   G+L+ ++R H
Sbjct: 52  ALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111

Query: 61  GRVPEQTARKF---------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDD 102
           G                   L Q+         G+  L S H +HRDL   N L+     
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---A 168

Query: 103 DVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           ++++KI DFG+S  +Y  +Y      + L   +M PE + ++++  + D+WS G IL+E+
Sbjct: 169 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228

Query: 160 L 160
            
Sbjct: 229 F 229

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  103 bits (259), Expect = 1e-26
 Identities = 40/158 (25%), Positives = 78/158 (49%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   +  + H  +++L+     E  I++V E+ + G+L  +++       +  +      
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 130
           Q+  G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y  +     P
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 344

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE   + R+  K D+WS G +L EL   G  P+
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  101 bits (253), Expect = 1e-26
 Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 12/155 (7%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
            E+  L ++ H NI++          N I L++EF   G+L  Y+  +  ++  +   K+
Sbjct: 72  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 127
             Q+  G++ L S   +HRDL   N+L+     +  +KI DFGL+  +      Y  K  
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEYYTVKDD 188

Query: 128 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
             SP+ + APE L   ++    D+WS G  L ELL
Sbjct: 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  101 bits (253), Expect = 2e-26
 Identities = 57/201 (28%), Positives = 83/201 (41%), Gaps = 34/201 (16%)

Query: 1   MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           MLK  + HL        EL  LS + NH NI+ L  A        ++ E+C  G+L +++
Sbjct: 60  MLKP-SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118

Query: 58  RLHGRVPEQTARKF-----------LQQL---------GLEILNSHHIIHRDLKPENILL 97
           R        +               L+ L         G+  L S + IHRDL   NILL
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178

Query: 98  SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGA 154
           +     +  KI DFGL+  +   +       + L   +MAPE +    Y  + D+WS G 
Sbjct: 179 T--HGRIT-KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235

Query: 155 ILFEL--LNG--YPPFSVGEE 171
            L+EL  L    YP   V  +
Sbjct: 236 FLWELFSLGSSPYPGMPVDSK 256

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  100 bits (252), Expect = 2e-26
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 12/154 (7%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
            E++ L ++ H +II+            + LV+E+   G+L  Y+  H  +       F 
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFA 140

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-- 128
           QQ+  G+  L++ H IHRDL   N+LL    +D ++KI DFGL+  +  G+   +V    
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDG 197

Query: 129 -SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
            SP+ + APE L+  ++    D+WS G  L+ELL
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 99.2 bits (248), Expect = 5e-26
 Identities = 41/152 (26%), Positives = 76/152 (50%), Gaps = 12/152 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    +     +      
Sbjct: 58  EANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y  +  G+  
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTARE-GAKF 172

Query: 132 ---YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
              + APE + +  +  K D+WS G +L E++
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  100 bits (251), Expect = 5e-26
 Identities = 50/190 (26%), Positives = 80/190 (42%), Gaps = 36/190 (18%)

Query: 15  CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF-- 71
            EL  ++ + +H NI+ L  A      I+L+ E+C  G+L +Y+R       +   ++  
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156

Query: 72  --------------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
                          + L         G+E L     +HRDL   N+L++     V+ KI
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT--HGKVV-KI 213

Query: 109 ADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNG- 162
            DFGL+  +   +       + L   +MAPE L    Y  K D+WS G +L+E+  L   
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273

Query: 163 -YPPFSVGEE 171
            YP   V   
Sbjct: 274 PYPGIPVDAN 283

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  102 bits (255), Expect = 6e-26
 Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 10/157 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +HP+I++L         +++++E C  G L S++++    +   +   +  Q
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 131
           L   L  L S   +HRD+   N+L+S    +  +K+ DFGLS  +    Y +   G  P+
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556

Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MAPE + F+R+    D+W  G  ++E+L  G  PF
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 99.7 bits (249), Expect = 6e-26
 Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 13/170 (7%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
           E+  L +++   I++            + LV+E+   G L  +++ H  R+       + 
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG- 128
            Q+  G+E L S   +HRDL   NIL+     +  +KIADFGL+  L    +Y       
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKDYYVVREPG 190

Query: 129 -SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEHQFM 175
            SP+ + APE L    +  + D+WS G +L+EL        S   E   M
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 240

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 98.8 bits (247), Expect = 7e-26
 Identities = 46/172 (26%), Positives = 86/172 (50%), Gaps = 15/172 (8%)

Query: 7   KHLKSCLDCELNFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           K +K     E  F+       +++H  +++L+     +  IF++ E+ A G L +Y+R  
Sbjct: 54  KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113

Query: 61  -GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
             R   Q   +  + +   +E L S   +HRDL   N L++   D  ++K++DFGLS  +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYV 170

Query: 118 YPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
               Y   V    P+ +  PEVL + ++  K D+W+ G +++E+ + G  P+
Sbjct: 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 98.9 bits (247), Expect = 8e-26
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 11/158 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E N +  +++P I+R+    +AE+   LV+E    G L+ Y++ +  V ++   + + Q+
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS--P 130
             G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY +       P
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWP 183

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           + + APE + + ++  K D+WS G +++E  + G  P+
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 99.7 bits (249), Expect = 1e-25
 Identities = 44/193 (22%), Positives = 76/193 (39%), Gaps = 35/193 (18%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +LKK+ +  K             N    + + D F     + +  E   G N   +++ +
Sbjct: 69  VLKKIKEKDKE------------NKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKEN 115

Query: 61  GRV--PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVM----------- 105
                P    R    QL   L  L+ + + H DLKPENIL    + + +           
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175

Query: 106 -----LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
                +++ADFG +   +   +   +  +  Y  PEV+    + +  D+WS+G ILFE  
Sbjct: 176 VKNTSIRVADFGSAT--FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233

Query: 161 NGYPPFSVGEEHQ 173
            G+  F   E  +
Sbjct: 234 RGFTLFQTHENRE 246

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 99.3 bits (248), Expect = 1e-25
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 11/159 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL           +V E+   G+L +++R H G+         L+ 
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 129
           +  G+  L+    +HRDL   N+L+     +++ K++DFGLS  L     A         
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216

Query: 130 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           P+ + APE + F+ +    D+WS G +++E+L  G  P+
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 98.5 bits (246), Expect = 1e-25
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 17/163 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 71  EVNAMHSLDHRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 131
           +  G+  L S   IHRDL   N+LL+      ++KI DFGL   L    ++        +
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 132 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
              + APE L+ + +    D W  G  L+E+      F+ G+E
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEM------FTYGQE 223

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 99.0 bits (247), Expect = 1e-25
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 12/155 (7%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
            E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+      ++
Sbjct: 91  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 127
             Q+  G+E L +   IHRDL   NIL+    ++  +KI DFGL+  L      Y  K  
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEYYKVKEP 207

Query: 128 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           G SP+ + APE L   ++    D+WS G +L+EL 
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 98.5 bits (246), Expect = 1e-25
 Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 12/155 (7%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
            E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+      ++
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 127
             Q+  G+E L +   IHRDL   NIL+    ++  +KI DFGL+  L      +  K  
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEFFKVKEP 176

Query: 128 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           G SP+ + APE L   ++    D+WS G +L+EL 
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  100 bits (251), Expect = 2e-25
 Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 10/151 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E N + ++ H  +++L  A   +  I+++ EF A G+L  +++      +   +   F  
Sbjct: 233 EANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 130
           Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y  +     P
Sbjct: 292 QIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFP 348

Query: 131 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 160
           + + APE + F  +  K D+WS G +L E++
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 97.7 bits (244), Expect = 2e-25
 Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 10/157 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +HP+I++L         +++++E C  G L S++++    +   +   +  Q
Sbjct: 66  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 131
           L   L  L S   +HRD+   N+L+S    +  +K+ DFGLS  +    Y +   G  P+
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181

Query: 132 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
            +MAPE + F+R+    D+W  G  ++E+L  G  PF
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 98.1 bits (245), Expect = 3e-25
 Identities = 43/186 (23%), Positives = 76/186 (40%), Gaps = 35/186 (18%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+ LN    +            +    +++ + F+    I +V E   G +   +I+ +
Sbjct: 64  VLEHLNTTDPN------------STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN 110

Query: 61  GRV--PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILL----------------SGL 100
           G +       RK   Q+   +  L+S+ + H DLKPENIL                    
Sbjct: 111 GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170

Query: 101 DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 160
             +  +K+ DFG +   Y   +   +  +  Y APEV+    + +  D+WS+G IL E  
Sbjct: 171 LINPDIKVVDFGSAT--YDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228

Query: 161 NGYPPF 166
            G+  F
Sbjct: 229 LGFTVF 234

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 96.7 bits (241), Expect = 4e-25
 Identities = 26/149 (17%), Positives = 44/149 (29%), Gaps = 31/149 (20%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL-GLE 78
           LS ++ P + R+ D         +V E+  GG+L          P    R         +
Sbjct: 85  LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-TSPSPVGAIRAMQSLAAAAD 143

Query: 79  ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 138
             +   +      P  + +S  D DV   +A                       M     
Sbjct: 144 AAHRAGVALSIDHPSRVRVSI-DGDV--VLAYPA-------------------TMPDA-- 179

Query: 139 QFQRYDEKVDMWSVGAILFELLNGYPPFS 167
                + + D+  +GA L+ LL    P  
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLP 203

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.8 bits (244), Expect = 6e-25
 Identities = 43/190 (22%), Positives = 83/190 (43%), Gaps = 33/190 (17%)

Query: 1   MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           MLK+  +  +++    E   ++  ++PNI++L         + L+ E+ A G+L+ ++R 
Sbjct: 84  MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 143

Query: 60  HGRVPEQTARKF-----------------LQQL---------GLEILNSHHIIHRDLKPE 93
                  +                       +          G+  L+    +HRDL   
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203

Query: 94  NILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMW 150
           N L+   ++ V+ KIADFGLS  +Y  +Y +      +   +M PE + + RY  + D+W
Sbjct: 204 NCLVG--ENMVV-KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260

Query: 151 SVGAILFELL 160
           + G +L+E+ 
Sbjct: 261 AYGVVLWEIF 270

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 96.5 bits (241), Expect = 7e-25
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 12/159 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  +++P I+RL         + LV+E   GG L  ++      +P     + L Q
Sbjct: 60  EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 131
           +  G++ L   + +HRDL   N+LL    +    KI+DFGLS  L    +Y         
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 175

Query: 132 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
              + APE + F+++  + D+WS G  ++E L+ G  P+
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 97.8 bits (244), Expect = 7e-25
 Identities = 43/160 (26%), Positives = 81/160 (50%), Gaps = 11/160 (6%)

Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSP 130
            +  G++ L+    +HRDL   NIL++    +++ K++DFGL   L     A     G  
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211

Query: 131 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
           +   + +PE + ++++    D+WS G +L+E+++ G  P+
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 97.0 bits (242), Expect = 7e-25
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 25/166 (15%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--- 71
           E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R       + +      
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149

Query: 72  ------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                  + L         G+E L S   IHRDL   N+L++   ++ ++KIADFGL+  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARD 206

Query: 117 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 97.0 bits (242), Expect = 9e-25
 Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 11/159 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +H NIIRL         + ++ E+   G L  ++R   G          L+ 
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSPL 131
           +  G++ L + + +HRDL   NIL++    +++ K++DFGLS  L     A     G  +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212

Query: 132 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
              + APE + ++++    D+WS G +++E++  G  P+
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 97.4 bits (243), Expect = 9e-25
 Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 25/166 (15%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--- 71
           E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R       + +      
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195

Query: 72  ------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                  + L         G+E L S   IHRDL   N+L++  +++VM KIADFGL+  
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARD 252

Query: 117 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           +   +Y +K     L   +MAPE L  + Y  + D+WS G +++E+
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 95.7 bits (239), Expect = 9e-25
 Identities = 41/158 (25%), Positives = 79/158 (50%), Gaps = 12/158 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   + +++HP+I++L    + E   ++++E    G L  Y+  +   +   T   +  Q
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +  L S + +HRD+   NIL++       +K+ DFGLS  +   +Y  K   + L 
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDY-YKASVTRLP 177

Query: 132 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
             +M+PE + F+R+    D+W     ++E+L+ G  PF
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 96.2 bits (240), Expect = 1e-24
 Identities = 51/167 (30%), Positives = 74/167 (44%), Gaps = 28/167 (16%)

Query: 15  CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF-- 71
            EL  L  + +HPNII L  A +    ++L +E+   GNL  ++R    +    A     
Sbjct: 74  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 72  -------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
                   QQL         G++ L+    IHRDL   NIL+    ++ + KIADFGLS 
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSR 190

Query: 116 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
                    K     L   +MA E L +  Y    D+WS G +L+E+
Sbjct: 191 G---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 96.6 bits (241), Expect = 2e-24
 Identities = 43/182 (23%), Positives = 69/182 (37%), Gaps = 34/182 (18%)

Query: 16  ELNFLSSVNH-----PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTA 68
           E + L  + +      NI++    F   + + L+ E   G +L   I  +       +  
Sbjct: 81  EADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI 139

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILL----------------------SGLDDDV 104
           + +  ++   L  L    + H DLKPENILL                             
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 105 MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 164
            +K+ DFG +   +  +Y   +  +  Y APEV+    +D   DMWS G +L EL  G  
Sbjct: 200 GIKLIDFGCAT--FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257

Query: 165 PF 166
            F
Sbjct: 258 LF 259

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 95.9 bits (239), Expect = 3e-24
 Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--- 71
           E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y++       + +      
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 72  ------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                  + L         G+E L S   IHRDL   N+L++   +D ++KIADFGL+  
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARD 240

Query: 117 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 159
           ++  +Y +K     L   +MAPE L  + Y  + D+WS G +L+E+
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 96.6 bits (240), Expect = 6e-24
 Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 12/159 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  +++P I+RL         + LV+E   GG L  ++      +P     + L Q
Sbjct: 386 EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 131
           +  G++ L   + +HR+L   N+LL    +    KI+DFGLS  L    +Y         
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 501

Query: 132 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 166
              + APE + F+++  + D+WS G  ++E L+ G  P+
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 92.4 bits (230), Expect = 3e-23
 Identities = 36/177 (20%), Positives = 82/177 (46%), Gaps = 15/177 (8%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L K +++         + +S ++H +++  +      +   LV EF   G+L +Y++ +
Sbjct: 47  VLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN 106

Query: 61  -GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD-----DDVMLKIADFG 112
              +      +  +QL   +  L  + +IH ++  +NILL   +     +   +K++D G
Sbjct: 107 KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166

Query: 113 LSCTLYPGNYAEKVCGSPL-YMAPEVLQ-FQRYDEKVDMWSVGAILFELL-NGYPPF 166
           +S T+ P +  ++     + ++ PE ++  +  +   D WS G  L+E+   G  P 
Sbjct: 167 ISITVLPKDILQE----RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 91.5 bits (228), Expect = 7e-23
 Identities = 50/162 (30%), Positives = 76/162 (46%), Gaps = 18/162 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS   HP+++ L       N + L+ ++   GNL  +  L+G      +  + Q+L
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRL 142

Query: 76  --------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--- 124
                   GL  L++  IIHRD+K  NIL   LD++ + KI DFG+S             
Sbjct: 143 EICIGAARGLHYLHTRAIIHRDVKSINIL---LDENFVPKITDFGIS-KKGTELDQTHLS 198

Query: 125 -KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 165
             V G+  Y+ PE     R  EK D++S G +LFE+L     
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 82.6 bits (205), Expect = 1e-19
 Identities = 48/182 (26%), Positives = 71/182 (39%), Gaps = 44/182 (24%)

Query: 16  ELNFLSSVNHPNIIRL--FDAFQAENCI-----FLVVEFCAGGNLSSYIRLHGRVPEQ-- 66
           E+  ++   H N++ L  F               LV  +   G+L    RL         
Sbjct: 80  EIKVMAKCQHENLVELLGF-------SSDGDDLCLVYVYMPNGSLLD--RLSCLDGTPPL 130

Query: 67  -----------TARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
                       A       G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL+ 
Sbjct: 131 SWHMRCKIAQGAAN------GINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLA- 180

Query: 116 TLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
                        ++ G+  YMAPE L+      K D++S G +L E++ G P      E
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

Query: 172 HQ 173
            Q
Sbjct: 240 PQ 241

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 82.2 bits (204), Expect = 2e-19
 Identities = 51/173 (29%), Positives = 73/173 (42%), Gaps = 36/173 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E+  +S   H N++RL           LV  + A G+++S   L  R   Q         
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS--CLRERPESQPPLDWPKRQ 134

Query: 67  -----TARKFLQQLGLEILNSH-----HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                +AR      GL  L  H      IIHRD+K  NIL   LD++    + DFGL+  
Sbjct: 135 RIALGSAR------GLAYL--HDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLA-K 182

Query: 117 LYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           L           V G+  ++APE L   +  EK D++  G +L EL+ G   F
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 79.6 bits (196), Expect = 3e-18
 Identities = 57/233 (24%), Positives = 88/233 (37%), Gaps = 72/233 (30%)

Query: 2   LK--KLNKHLKSCLDCELNFLSSV-----NHPN---IIRLFDAFQAEN------CIFLVV 45
           +K  K  +H       E+  L SV     N PN   +++L D F+         C  +V 
Sbjct: 67  MKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC--MVF 124

Query: 46  EFCAGGNLSSYIRL--HGRVPEQTARKFLQQL--GLEILNSH-HIIHRDLKPENILLSGL 100
           E   G +L  +I    +  +P    +K +QQ+  GL+ L++   IIH D+KPENILLS  
Sbjct: 125 EV-LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183

Query: 101 DDDVM----------------------------------------------LKIADFGLS 114
           +  +                                               +KIAD G +
Sbjct: 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA 243

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           C  +   +  +   +  Y + EVL    Y+   D+WS   + FEL  G   F 
Sbjct: 244 C--WVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 76.1 bits (187), Expect = 5e-17
 Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 10/103 (9%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---Y 132
           G+E L S   IHRDL   NILLS   +  ++KI DFGL+  +Y      +   + L   +
Sbjct: 205 GMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEE 171
           MAPE +  + Y  + D+WS G +L+E+     + YP   + EE
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 42.6 bits (100), Expect = 2e-05
 Identities = 29/134 (21%), Positives = 47/134 (35%), Gaps = 5/134 (3%)

Query: 1   MLKK-LNKHLKSCLDCELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+         L  EL  L  + +H N++ L  A  +    + ++VEFC  GNLS+Y 
Sbjct: 59  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY- 117

Query: 58  RLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
            L  +  E    K       +  +    I  DLK     ++           +      +
Sbjct: 118 -LRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176

Query: 118 YPGNYAEKVCGSPL 131
                 E +    L
Sbjct: 177 EEEEAPEDLYKDFL 190

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.9 bits (135), Expect = 5e-10
 Identities = 26/117 (22%), Positives = 50/117 (42%), Gaps = 5/117 (4%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRL-FDAFQAENCIFLVVEFCAGGNLSSYIRL 59
             +++ K        E   L  +  P         F+  +  F+V+E   G +L      
Sbjct: 86  FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           +G   + T  +   ++   LE ++ +  +H D+K  N+LL G  +   + +AD+GLS
Sbjct: 145 NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL-GYKNPDQVYLADYGLS 200

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 54.4 bits (131), Expect = 2e-09
 Identities = 32/192 (16%), Positives = 68/192 (35%), Gaps = 32/192 (16%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI-------------------FLV 44
           K+       L  EL F      P  I+ +   +    +                   F++
Sbjct: 71  KVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI 130

Query: 45  VEFCAGGNLSSYIRLHGRV-PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD 101
           ++   G +L      + +    +T  +   ++   LE ++ H  +H D+K  N+LL    
Sbjct: 131 MDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL-NYK 188

Query: 102 DDVMLKIADFGLSCTLYPGN------YAEKVC--GSPLYMAPEVLQFQRYDEKVDMWSVG 153
           +   + + D+GL+    P           K C  G+  + + +         + D+  +G
Sbjct: 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILG 248

Query: 154 AILFELLNGYPP 165
             + + L G+ P
Sbjct: 249 YCMIQWLTGHLP 260

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 52.7 bits (126), Expect = 1e-08
 Identities = 35/156 (22%), Positives = 58/156 (37%), Gaps = 18/156 (11%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQL--GLEIL 80
               I  +       +   LV++   G +L        R    +T      Q+   +E +
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119

Query: 81  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEK--VCGSPLY 132
           +S   +HRD+KP+N L+        + I DFGL+      +      Y E   + G+  Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

Query: 133 MAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPP 165
            +          R D   D+ S+G +L   L G  P
Sbjct: 180 ASVNTHLGIEQSRRD---DLESLGYVLMYFLRGSLP 212

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.0 bits (125), Expect = 1e-08
 Identities = 35/154 (22%), Positives = 58/154 (37%), Gaps = 18/154 (11%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQL--GLEILNS 82
             I  +       +   +V+E   G +L        R    +T      Q+   +E ++S
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123

Query: 83  HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEK--VCGSPLYMA 134
            + IHRD+KP+N L+       ++ I DFGL+             Y E   + G+  Y +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183

Query: 135 PEVLQFQ---RYDEKVDMWSVGAILFELLNGYPP 165
                     R D   D+ S+G +L     G  P
Sbjct: 184 INTHLGIEQSRRD---DLESLGYVLMYFNLGSLP 214

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 48.5 bits (116), Expect = 2e-07
 Identities = 33/153 (21%), Positives = 65/153 (42%), Gaps = 14/153 (9%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQL--GLEILNS 82
             I  ++   Q      LV++   G +L   + L GR    +T     +Q+   ++ ++ 
Sbjct: 66  TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 83  HHIIHRDLKPENILL--SGLDDDVMLKIADFGLS------CTLYPGNYAEK--VCGSPLY 132
             +++RD+KP+N L+      +  M+ + DFG+        T     Y EK  + G+  Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 165
           M+      +    + D+ ++G +    L G  P
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 48.6 bits (116), Expect = 2e-07
 Identities = 18/77 (23%), Positives = 39/77 (50%), Gaps = 6/77 (7%)

Query: 42  FLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILL 97
           FLV+    G +L S + +  +  + E++  +   +L   LE L+ +  +H ++  ENI +
Sbjct: 134 FLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192

Query: 98  SGLDDDVMLKIADFGLS 114
              +D   + +A +G +
Sbjct: 193 -DPEDQSQVTLAGYGFA 208

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 48.1 bits (115), Expect = 3e-07
 Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 22/157 (14%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQL--GLEILNS 82
             I +++          +V+E   G +L     L  R    +T      QL   +E ++S
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123

Query: 83  HHIIHRDLKPENILL--SGLDDDVMLKIADFGLSCTLY--PGN-----YAEK--VCGSPL 131
            ++I+RD+KPEN L+   G     ++ I DF L+   Y  P       Y E   + G+  
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA-KEYIDPETKKHIPYREHKSLTGTAR 182

Query: 132 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPP 165
           YM+      +   R D   D+ ++G +    L G  P
Sbjct: 183 YMSINTHLGKEQSRRD---DLEALGHMFMYFLRGSLP 216

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 42.2 bits (98), Expect = 3e-05
 Identities = 18/87 (20%), Positives = 30/87 (34%), Gaps = 5/87 (5%)

Query: 38  ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL-GLEIL-NSHHIIHRDLKPENI 95
           ++ +F+V+EF  GG     +R              Q    L +   S    HRDL   N+
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193

Query: 96  LLSGLDDDVMLKIADFGLSCTLYPGNY 122
           L   L    + K+       +    + 
Sbjct: 194 L---LKKTSLKKLHYTLNGKSSTIPSC 217

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	175
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.98
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.98
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.98
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.98
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.98
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.98
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.98
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.74
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.55
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.02
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.9
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.84
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.5
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.49
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.34
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.86
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.72
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.4
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.0
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.98
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.26
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.25
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	94.99
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	93.13
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.96
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	92.88
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.12
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	88.82
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	88.8
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	86.67
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	85.53
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	84.28
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.97
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	83.3
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	83.12
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	82.33
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.24

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.7e-48  Score=283.71  Aligned_cols=161  Identities=34%  Similarity=0.677  Sum_probs=148.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+.+.+|++++++++||||+++++++.+++.+|+||||+.||+|.+++++.+.+++..+..++.|+  ||+|||++|++
T Consensus        75 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~Ii  154 (311)
T 4aw0_A           75 KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGII  154 (311)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            3567899999999999999999999999999999999999999999999999999999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      ||||||+||++   +.++.++|+|||+|+......   ...+..||+.|+|||.+.+..++.++|+||+||++|+|++|+
T Consensus       155 HRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~  231 (311)
T 4aw0_A          155 HRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL  231 (311)
T ss_dssp             CSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999   678899999999998775432   344567999999999999999999999999999999999999


Q ss_pred             CCCCCCCcc
Q 030527          164 PPFSVGEEH  172 (175)
Q Consensus       164 ~pf~~~~~~  172 (175)
                      .||.+.+..
T Consensus       232 ~PF~~~~~~  240 (311)
T 4aw0_A          232 PPFRAGNEG  240 (311)
T ss_dssp             CSSCCSSHH
T ss_pred             CCCCCCCHH
Confidence            999876643

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-46  Score=272.86  Aligned_cols=160  Identities=41%  Similarity=0.783  Sum_probs=135.4

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....++.+|++++++++||||+++++++.+.+..++||||+ +++|.+++.+.+++++..+..++.|+  ||+|||++|+
T Consensus        55 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~I  133 (275)
T 3hyh_A           55 DMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI  133 (275)
T ss_dssp             -CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34567899999999999999999999999999999999999 77999999999999999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +||||||+||++   +.++.++|+|||+|+............||+.|+|||.+.+..+ +.++|+||+||++|+|++|+.
T Consensus       134 iHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~  210 (275)
T 3hyh_A          134 VHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL  210 (275)
T ss_dssp             CCCCCCTTTEEE---CTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccccCChHHeEE---CCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCC
Confidence            999999999999   6778899999999988766665667789999999999988876 579999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.+.
T Consensus       211 PF~~~~~  217 (275)
T 3hyh_A          211 PFDDESI  217 (275)
T ss_dssp             SSCCSSH
T ss_pred             CCCCCCH
Confidence            9987654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1e-46  Score=281.14  Aligned_cols=164  Identities=27%  Similarity=0.598  Sum_probs=147.1

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      +.....++.+|++++++|+||||+++++++.+++..|+||||++|++|.+++...  ..+++.++..++.|+  ||+|||
T Consensus        63 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH  142 (350)
T 4b9d_A           63 SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH  142 (350)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3455678999999999999999999999999999999999999999999999754  357999999999999  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      ++|++||||||+||++   +.++.+||+|||+|+...... ......||+.|+|||.+.+..++.++|+|||||++|+|+
T Consensus       143 ~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyeml  219 (350)
T 4b9d_A          143 DRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELC  219 (350)
T ss_dssp             HTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             HCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence            9999999999999999   677889999999998765432 234567999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCcc
Q 030527          161 NGYPPFSVGEEH  172 (175)
Q Consensus       161 ~g~~pf~~~~~~  172 (175)
                      +|+.||.+.+..
T Consensus       220 tG~~PF~~~~~~  231 (350)
T 4b9d_A          220 TLKHAFEAGSMK  231 (350)
T ss_dssp             HSSCSCCCSSHH
T ss_pred             HCCCCCCCcCHH
Confidence            999999876543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-46  Score=279.84  Aligned_cols=161  Identities=27%  Similarity=0.587  Sum_probs=146.8

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ......+.+|++++++++||||+++++++.+.+.+|+||||+.|++|.+++.+ +.+++..+..++.|+  ||+|||++|
T Consensus       112 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~  190 (346)
T 4fih_A          112 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG  190 (346)
T ss_dssp             CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34456788999999999999999999999999999999999999999999875 579999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      ++||||||+||++   +.++.+||+|||+++..... .......||+.|+|||.+.+..|+.++|+||+||++|+|++|+
T Consensus       191 IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~  267 (346)
T 4fih_A          191 VIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE  267 (346)
T ss_dssp             EECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             cccccCCHHHEEE---CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            9999999999999   67889999999999887544 3345678999999999999999999999999999999999999


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||.+.++
T Consensus       268 ~PF~~~~~  275 (346)
T 4fih_A          268 PPYFNEPP  275 (346)
T ss_dssp             CTTTTSCH
T ss_pred             CCCCCcCH
Confidence            99987654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-46  Score=278.97  Aligned_cols=167  Identities=31%  Similarity=0.515  Sum_probs=144.8

Q ss_pred             ccccchhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 030527            2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      +|.++.+.  ...+|++++++++||||+++++++.+.+.+++||||++|++|.+++++.+.+++..+..++.|+  ||+|
T Consensus        88 iK~i~~~~--~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~y  165 (336)
T 4g3f_A           88 VKKVRLEV--FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEY  165 (336)
T ss_dssp             EEEEETTT--CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             EEEECHHH--hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence            55554432  2357999999999999999999999999999999999999999999998999999999999999  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCc-eEEEeeecceeeccCCCc------cccccCCCCccCcccccccCCCcchhHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGNY------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  152 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~-~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl  152 (175)
                      ||++|++||||||+||++   +.++ .+||+|||+|+.......      .....||+.|+|||.+.+..++.++|+||+
T Consensus       166 lH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl  242 (336)
T 4g3f_A          166 LHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS  242 (336)
T ss_dssp             HHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             HHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHH
Confidence            999999999999999999   4554 699999999987754322      223468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCccC
Q 030527          153 GAILFELLNGYPPFSVGEEHQ  173 (175)
Q Consensus       153 g~~~~~~~~g~~pf~~~~~~~  173 (175)
                      ||++|+|++|+.||.+.+..+
T Consensus       243 GvilyemltG~~Pf~~~~~~~  263 (336)
T 4g3f_A          243 CCMMLHMLNGCHPWTQYFRGP  263 (336)
T ss_dssp             HHHHHHHHHSSCSSTTTCCSC
T ss_pred             HHHHHHHHHCcCCCCCCCHHH
Confidence            999999999999998876544

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.2e-47  Score=278.83  Aligned_cols=161  Identities=38%  Similarity=0.620  Sum_probs=140.7

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...++.+|++++++++||||+++++++.+++..++||||++|++|.+++.+.+.+++..+..++.|+  ||+|||++|++
T Consensus        69 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~Ii  148 (304)
T 3ubd_A           69 DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII  148 (304)
T ss_dssp             ECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            3457888999999999999999999999999999999999999999999999999999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      ||||||+||++   +.++.++|+|||+|+..... .......||+.|+|||.+.+..++.++|+||+||++|+|++|+.|
T Consensus       149 HRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~P  225 (304)
T 3ubd_A          149 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP  225 (304)
T ss_dssp             CSSCCGGGEEE---CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCCHHHeEE---cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCC
Confidence            99999999999   67888999999999865443 334567799999999999999999999999999999999999999


Q ss_pred             CCCCCcc
Q 030527          166 FSVGEEH  172 (175)
Q Consensus       166 f~~~~~~  172 (175)
                      |.+.+..
T Consensus       226 F~~~~~~  232 (304)
T 3ubd_A          226 FQGKDRK  232 (304)
T ss_dssp             SCCSSHH
T ss_pred             CCCcCHH
Confidence            9887654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.5e-45  Score=268.06  Aligned_cols=161  Identities=33%  Similarity=0.643  Sum_probs=142.2

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEee----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      ......+|.+|++++++++||||+++++++.+    .+.+++||||++|++|.+++.+.+.+++..+..++.|+  ||+|
T Consensus        65 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~y  144 (290)
T 3fpq_A           65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  144 (290)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            44556789999999999999999999999865    35689999999999999999998999999999999999  9999


Q ss_pred             HHHcC--CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHH
Q 030527           80 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        80 lh~~~--~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~  157 (175)
                      ||++|  ++||||||+||+++  +.++.+||+|||+|+... ........||+.|+|||.+.+ .++.++||||+||++|
T Consensus       145 lH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvily  220 (290)
T 3fpq_A          145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML  220 (290)
T ss_dssp             HHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred             HHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCEeCC-CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHH
Confidence            99998  99999999999994  346789999999997543 334456789999999998864 6999999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 030527          158 ELLNGYPPFSVGE  170 (175)
Q Consensus       158 ~~~~g~~pf~~~~  170 (175)
                      +|+||+.||.+.+
T Consensus       221 elltg~~Pf~~~~  233 (290)
T 3fpq_A          221 EMATSEYPYSECQ  233 (290)
T ss_dssp             HHHHSSCTTTTCS
T ss_pred             HHHHCCCCCCCCC
Confidence            9999999997654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=280.81  Aligned_cols=161  Identities=27%  Similarity=0.587  Sum_probs=146.7

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ...+..+.+|++++++++||||+++++++.+.+.+|+|||||.||+|.++++. +.+++.++..++.|+  ||+|||++|
T Consensus       189 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~  267 (423)
T 4fie_A          189 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG  267 (423)
T ss_dssp             CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            44466789999999999999999999999999999999999999999999874 579999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      ++||||||+||++   +.++.+||+|||+|...... .......||+.|+|||++.+..|+.++|||||||++|+|++|+
T Consensus       268 IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~  344 (423)
T 4fie_A          268 VIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE  344 (423)
T ss_dssp             EECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             eecccCCHHHEEE---cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            9999999999999   67888999999999887544 3345677999999999999999999999999999999999999


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||.+.++
T Consensus       345 ~PF~~~~~  352 (423)
T 4fie_A          345 PPYFNEPP  352 (423)
T ss_dssp             CTTTTSCH
T ss_pred             CCCCCcCH
Confidence            99987654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.6e-46  Score=272.55  Aligned_cols=164  Identities=25%  Similarity=0.588  Sum_probs=146.3

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------------GRVPEQTARKFL   72 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~~~   72 (175)
                      +...+++|.+|++++++++||||+++++++.+.+..++||||+++|+|.+++.+.             ..+++.++..++
T Consensus        55 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~  134 (299)
T 4asz_A           55 SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA  134 (299)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHH
Confidence            4556778999999999999999999999999999999999999999999999764             259999999999


Q ss_pred             HHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcch
Q 030527           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  147 (175)
Q Consensus        73 ~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~  147 (175)
                      .|+  ||+|||+++++||||||+||++   +.+..+||+|||+++.......   .....+|+.|+|||.+.+..++.++
T Consensus       135 ~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~  211 (299)
T 4asz_A          135 QQIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES  211 (299)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHhCCcccCccCHhhEEE---CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchh
Confidence            999  9999999999999999999999   6788999999999986644332   2234578999999999999999999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030527          148 DMWSVGAILFELLN-GYPPFSVGEEH  172 (175)
Q Consensus       148 Di~slg~~~~~~~~-g~~pf~~~~~~  172 (175)
                      ||||||+++|||+| |+.||.+.++.
T Consensus       212 DVwS~Gvvl~Ellt~G~~Pf~~~~~~  237 (299)
T 4asz_A          212 DVWSLGVVLWEIFTYGKQPWYQLSNN  237 (299)
T ss_dssp             HHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999 89999886654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=268.90  Aligned_cols=164  Identities=25%  Similarity=0.536  Sum_probs=139.4

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc---------------CCCCHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------------GRVPEQTARK   70 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~   70 (175)
                      +...+++|.+|++++++++||||+++++++.+.+..++||||+++|+|.+++.+.               +++++.++..
T Consensus        83 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~  162 (329)
T 4aoj_A           83 SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA  162 (329)
T ss_dssp             SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHH
Confidence            4556778999999999999999999999999999999999999999999999753               3589999999


Q ss_pred             HHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCCCc
Q 030527           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDE  145 (175)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~  145 (175)
                      ++.|+  ||+|||+++++||||||+||++   +.+..+||+|||+++......   ......+|+.|+|||.+.+..++.
T Consensus       163 i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~  239 (329)
T 4aoj_A          163 VASQVAAGMVYLAGLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT  239 (329)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCH
T ss_pred             HHHHHHHHHHHHhcCCeecccccHhhEEE---CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCc
Confidence            99999  9999999999999999999999   578899999999998764432   223456899999999999999999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030527          146 KVDMWSVGAILFELLN-GYPPFSVGEEH  172 (175)
Q Consensus       146 ~~Di~slg~~~~~~~~-g~~pf~~~~~~  172 (175)
                      ++||||||+++|||+| |+.||.+.++.
T Consensus       240 ~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~  267 (329)
T 4aoj_A          240 ESDVWSFGVVLWEIFTYGKQPWYQLSNT  267 (329)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred             cccccchHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999999999 89999876543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.2e-44  Score=261.83  Aligned_cols=162  Identities=28%  Similarity=0.506  Sum_probs=137.9

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      +++..+.|.+|++++++++||||+++++++.+ +..++||||++|++|.+++... +++++.++..++.|+  ||+|||+
T Consensus        72 ~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~  150 (307)
T 3omv_A           72 TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA  150 (307)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34556789999999999999999999998765 4579999999999999999765 579999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC---CccccccCCCCccCcccccc---cCCCcchhHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAIL  156 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slg~~~  156 (175)
                      ++++||||||+||++   +.++.+||+|||+|+.....   .......||+.|+|||.+.+   ..++.++||||||+++
T Consensus       151 ~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl  227 (307)
T 3omv_A          151 KNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVL  227 (307)
T ss_dssp             TTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHH
T ss_pred             CCccCCccCHHHEEE---CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHH
Confidence            999999999999999   57889999999999765432   22345679999999999864   3589999999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030527          157 FELLNGYPPFSVGEE  171 (175)
Q Consensus       157 ~~~~~g~~pf~~~~~  171 (175)
                      |||+||+.||.+.++
T Consensus       228 ~Elltg~~Pf~~~~~  242 (307)
T 3omv_A          228 YELMTGELPYSHINN  242 (307)
T ss_dssp             HHHHHSSCTTTTCCC
T ss_pred             HHHHHCCCCCCCCCh
Confidence            999999999987543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.9e-44  Score=264.10  Aligned_cols=162  Identities=25%  Similarity=0.561  Sum_probs=144.0

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF   71 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~   71 (175)
                      ..+++|.+|++++++++||||+++++++.+++..++||||+++|+|.+++...                ..+++..+..+
T Consensus        71 ~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i  150 (308)
T 4gt4_A           71 PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL  150 (308)
T ss_dssp             -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHH
Confidence            34678999999999999999999999999999999999999999999999643                35899999999


Q ss_pred             HHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCCCcc
Q 030527           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEK  146 (175)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~  146 (175)
                      +.|+  ||+|||+++++||||||+||++   +.++.+||+|||+++......   ......||+.|+|||.+.+..++.+
T Consensus       151 ~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k  227 (308)
T 4gt4_A          151 VAQIAAGMEYLSSHHVVHKDLATRNVLV---YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID  227 (308)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCccccceEE---CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc
Confidence            9999  9999999999999999999999   678889999999998664332   2334567899999999999999999


Q ss_pred             hhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030527          147 VDMWSVGAILFELLN-GYPPFSVGEEH  172 (175)
Q Consensus       147 ~Di~slg~~~~~~~~-g~~pf~~~~~~  172 (175)
                      +||||||+++|||+| |..||.+.++.
T Consensus       228 sDVwSfGvvl~El~t~g~~Pf~~~~~~  254 (308)
T 4gt4_A          228 SDIWSYGVVLWEVFSYGLQPYCGYSNQ  254 (308)
T ss_dssp             HHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred             chhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999998 89999876644

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-41  Score=250.25  Aligned_cols=156  Identities=33%  Similarity=0.608  Sum_probs=128.3

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC------------eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKF   71 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~   71 (175)
                      +..+.++.+|++++++++||||+++++++.+.+            ..++||||+.|++|.+++.+.+.   .+...+..+
T Consensus        44 ~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i  123 (299)
T 4g31_A           44 ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI  123 (299)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHH
Confidence            344567899999999999999999999987544            37999999999999999987654   455678889


Q ss_pred             HHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-------------cccccCCCCccCcc
Q 030527           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-------------AEKVCGSPLYMAPE  136 (175)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-------------~~~~~~~~~~~~pe  136 (175)
                      +.|+  ||+|||++|++||||||+||++   +.++.+||+|||+|+.......             .....||+.|+|||
T Consensus       124 ~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE  200 (299)
T 4g31_A          124 FLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE  200 (299)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCCCC--------------------------CCCTTSCHH
T ss_pred             HHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence            9998  9999999999999999999999   5778899999999987654321             12346899999999


Q ss_pred             cccccCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 030527          137 VLQFQRYDEKVDMWSVGAILFELLNGYPPFSV  168 (175)
Q Consensus       137 ~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~  168 (175)
                      .+.+..++.++|+||+||++|+|++   ||.+
T Consensus       201 ~~~~~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          201 QIHGNSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             HHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            9999999999999999999999996   7764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=258.67  Aligned_cols=160  Identities=31%  Similarity=0.519  Sum_probs=139.4

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEee------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      ....++.+|++++++++||||+++++++..      .+..|+||||+. ++|.+++.+.+.+++..+..++.|+  ||+|
T Consensus        95 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~y  173 (398)
T 4b99_A           95 TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY  173 (398)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            345677889999999999999999998753      367899999995 6899999988899999999999999  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-----CccccccCCCCccCccccccc-CCCcchhHHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVG  153 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg  153 (175)
                      ||++|++||||||+||++   +.++.++++|||+++.....     .......||+.|+|||++.+. .++.++|+||+|
T Consensus       174 lH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG  250 (398)
T 4b99_A          174 MHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVG  250 (398)
T ss_dssp             HHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHH
T ss_pred             HHHCcCcCCCcCcccccc---CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhH
Confidence            999999999999999999   67888999999999876432     223456799999999998775 469999999999


Q ss_pred             HHHHHHHhCCCCCCCCCc
Q 030527          154 AILFELLNGYPPFSVGEE  171 (175)
Q Consensus       154 ~~~~~~~~g~~pf~~~~~  171 (175)
                      |++|+|++|+.||.+.++
T Consensus       251 ~il~ell~G~~pF~g~~~  268 (398)
T 4b99_A          251 CIFGEMLARRQLFPGKNY  268 (398)
T ss_dssp             HHHHHHHHTSCSSCCSSH
T ss_pred             HHHHHHHHCCCCCCCCCH
Confidence            999999999999988754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1e-41  Score=255.24  Aligned_cols=161  Identities=32%  Similarity=0.537  Sum_probs=140.4

Q ss_pred             hhhhhHHHHHHHHhhCCC-CCeeeEeeEEee-CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNH-PNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTAR   69 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~   69 (175)
                      ...+.|.+|++++++++| |||+++++++.. ++..++|||||++|+|.+++++.                ..+++..+.
T Consensus       109 ~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~  188 (353)
T 4ase_A          109 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI  188 (353)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHH
Confidence            446678999999999965 899999999866 45789999999999999999753                238899999


Q ss_pred             HHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCC
Q 030527           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD  144 (175)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~  144 (175)
                      .++.|+  ||+|||+++++||||||+||++   +.++.+||+|||+|+.......   .....+|+.|+|||.+.+..++
T Consensus       189 ~~~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~  265 (353)
T 4ase_A          189 CYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  265 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHhHhhCCeecCccCccceee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC
Confidence            999999  9999999999999999999999   6788999999999987654332   2345678899999999999999


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          145 EKVDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       145 ~~~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      .++|||||||++|||+| |+.||.+.+.
T Consensus       266 ~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          266 IQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             CcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999998 8999987553

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.6e-41  Score=266.43  Aligned_cols=152  Identities=34%  Similarity=0.619  Sum_probs=138.2

Q ss_pred             HHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCC
Q 030527           16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPE   93 (175)
Q Consensus        16 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~   93 (175)
                      ++.+++.++||||+++++++.+.+.+|+||||++||+|.+++.+.+.+++..+..++.||  ||+|||++||+||||||+
T Consensus       242 ~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPe  321 (689)
T 3v5w_A          242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA  321 (689)
T ss_dssp             HHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGG
T ss_pred             HHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchH
Confidence            456677789999999999999999999999999999999999999999999999999999  999999999999999999


Q ss_pred             cEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527           94 NILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus        94 ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ||++   +.++.++|+|||+|....... ..+..||+.|+|||++.+ ..++.++|+||+||++|+|++|+.||.+.+.
T Consensus       322 NILl---d~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~  396 (689)
T 3v5w_A          322 NILL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT  396 (689)
T ss_dssp             GEEE---CTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred             HeEE---eCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            9999   688899999999998775543 445689999999999964 5799999999999999999999999976543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.2e-41  Score=267.77  Aligned_cols=166  Identities=32%  Similarity=0.585  Sum_probs=149.7

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ....+..+.+|++++++++||||+++++++.+.+.+++||||+.|++|.+++.+ .+.+++..+..++.|+  ||+|||+
T Consensus       194 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~  273 (573)
T 3uto_A          194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE  273 (573)
T ss_dssp             SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            344567788999999999999999999999999999999999999999999964 4679999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      +|++||||||+||++.. +..+.++|+|||+++............||+.|+|||.+.+..++.++|+||+||++|+|++|
T Consensus       274 ~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G  352 (573)
T 3uto_A          274 NNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG  352 (573)
T ss_dssp             TTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred             CCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            99999999999999941 13468999999999988777666677899999999999999999999999999999999999


Q ss_pred             CCCCCCCCcc
Q 030527          163 YPPFSVGEEH  172 (175)
Q Consensus       163 ~~pf~~~~~~  172 (175)
                      +.||.+.++.
T Consensus       353 ~~Pf~~~~~~  362 (573)
T 3uto_A          353 LSPFGGENDD  362 (573)
T ss_dssp             CCSSCCSSHH
T ss_pred             CCCCCCcCHH
Confidence            9999876643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-40  Score=250.60  Aligned_cols=157  Identities=25%  Similarity=0.439  Sum_probs=136.1

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...++.+|+++++.+ +||||+++++++.+.+..++||||++|++|.++++   .+++.++..++.|+  ||+|||++|+
T Consensus        62 ~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gI  138 (361)
T 4f9c_A           62 HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGI  138 (361)
T ss_dssp             CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345678899999998 79999999999999999999999999999999884   58999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-----------------------------cccccCCCCccCcc
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----------------------------AEKVCGSPLYMAPE  136 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-----------------------------~~~~~~~~~~~~pe  136 (175)
                      +||||||+||+++  ...+.++|+|||+|+...+...                             .....||+.|+|||
T Consensus       139 iHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE  216 (361)
T 4f9c_A          139 VHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE  216 (361)
T ss_dssp             ECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred             EeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence            9999999999995  3447899999999976543211                             12346899999999


Q ss_pred             ccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030527          137 VLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       137 ~~~~~-~~~~~~Di~slg~~~~~~~~g~~pf~~~~  170 (175)
                      .+.+. .++.++|+||+||++|+|++|+.||...+
T Consensus       217 ~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          217 VLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             HHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             HHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            99765 48999999999999999999999996554

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.2e-40  Score=245.42  Aligned_cols=165  Identities=25%  Similarity=0.356  Sum_probs=134.5

Q ss_pred             CccccchhhhhhHHH--HHHHHhhCCCCCeeeEeeEEeeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHH
Q 030527            1 MLKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~--e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~   74 (175)
                      +||.++....+.+..  |+..+.+++||||+++++++.+++    ..++||||+++++|.+++++ .++++..+..++.|
T Consensus        30 AvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~  108 (303)
T 3hmm_A           30 AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALS  108 (303)
T ss_dssp             EEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHH
T ss_pred             EEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHH
Confidence            367776666665554  455556789999999999997653    57999999999999999985 56899999999999


Q ss_pred             H--HHHHHHHc--------CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-----cccccCCCCccCccccc
Q 030527           75 L--GLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQ  139 (175)
Q Consensus        75 i--~l~~lh~~--------~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~  139 (175)
                      +  ||+|||+.        +++||||||+||++   +.++.+||+|||+++.......     .....||+.|+|||.+.
T Consensus       109 ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~  185 (303)
T 3hmm_A          109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD  185 (303)
T ss_dssp             HHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHT
T ss_pred             HHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhc
Confidence            8  99999987        89999999999999   6788999999999987654322     22356899999999986


Q ss_pred             cc------CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030527          140 FQ------RYDEKVDMWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus       140 ~~------~~~~~~Di~slg~~~~~~~~g~~pf~~~  169 (175)
                      +.      .++.++|||||||++|||+||..||...
T Consensus       186 ~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~  221 (303)
T 3hmm_A          186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  221 (303)
T ss_dssp             TCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred             ccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence            53      4678999999999999999998877543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.9e-39  Score=238.89  Aligned_cols=162  Identities=39%  Similarity=0.747  Sum_probs=147.8

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+++.+|++++++++||||+++++++...+..++||||++|++|.+++.+.+.+++..+..++.|+  ||+|||+.|
T Consensus        55 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~  134 (328)
T 3fe3_A           55 PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR  134 (328)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345567889999999999999999999999999999999999999999999988999999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCC-cchhHHHHHHHHHHHHhCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slg~~~~~~~~g~  163 (175)
                      ++||||||+||++   +.++.++|+|||++.............+++.|+|||.+.+..+. .++|+||+|+++++|++|+
T Consensus       135 ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  211 (328)
T 3fe3_A          135 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS  211 (328)
T ss_dssp             CCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSS
T ss_pred             EeccCCCHHHEEE---cCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCC
Confidence            9999999999999   67888999999999877666556667789999999999877764 7899999999999999999


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||.+.+.
T Consensus       212 ~pf~~~~~  219 (328)
T 3fe3_A          212 LPFDGQNL  219 (328)
T ss_dssp             CSSCCSSH
T ss_pred             CCCCCCCH
Confidence            99987653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.7e-38  Score=238.17  Aligned_cols=165  Identities=36%  Similarity=0.612  Sum_probs=148.6

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+.+.+|++++++++||||+++++++.+.+..++||||+.|++|.+++.+...+++..+..++.|+  ||+|||+.|
T Consensus        69 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~  148 (362)
T 2bdw_A           69 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG  148 (362)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345567889999999999999999999999999999999999999999999888889999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      ++|+||+|+||++...+.+..++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++|+|++|+.
T Consensus       149 ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  228 (362)
T 2bdw_A          149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP  228 (362)
T ss_dssp             CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCC
Confidence            99999999999996434456799999999988766555556678999999999998889999999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.+.
T Consensus       229 Pf~~~~~  235 (362)
T 2bdw_A          229 PFWDEDQ  235 (362)
T ss_dssp             SSCCSSH
T ss_pred             CCCCCCH
Confidence            9987653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-38  Score=236.63  Aligned_cols=160  Identities=33%  Similarity=0.567  Sum_probs=145.0

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|.++++.++||||+++++++...+..++||||++|++|.+++.+.+.+++..+..++.|+  ||++||++|++
T Consensus        48 ~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  127 (337)
T 1o6l_A           48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV  127 (337)
T ss_dssp             CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3456788999999999999999999999999999999999999999999988899999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      ||||||+||++   +.++.++|+|||++..... ........||+.|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus       128 HrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P  204 (337)
T 1o6l_A          128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  204 (337)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             cCcCCHHHEEE---CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCC
Confidence            99999999999   6778999999999976433 3334456789999999999988999999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.+.
T Consensus       205 f~~~~~  210 (337)
T 1o6l_A          205 FYNQDH  210 (337)
T ss_dssp             SCCSSH
T ss_pred             CCCCCH
Confidence            987654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=236.48  Aligned_cols=158  Identities=34%  Similarity=0.619  Sum_probs=145.1

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      .+.+.+|+++++.++||||+++++++.+.+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||+|||+.|++|
T Consensus        59 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH  138 (384)
T 4fr4_A           59 VRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIH  138 (384)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            457788999999999999999999999999999999999999999999988899999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc---cCCCcchhHHHHHHHHHHHHhCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +||||+||++   +.++.++|+|||++.............||+.|+|||.+.+   ..++.++|+||||+++|+|++|+.
T Consensus       139 rDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~  215 (384)
T 4fr4_A          139 RDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR  215 (384)
T ss_dssp             CCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             ccCcHHHeEE---CCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCC
Confidence            9999999999   6788999999999988766665667789999999999863   458999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||...+
T Consensus       216 Pf~~~~  221 (384)
T 4fr4_A          216 PYHIRS  221 (384)
T ss_dssp             SSCCCT
T ss_pred             CCCCCC
Confidence            997654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=237.86  Aligned_cols=161  Identities=39%  Similarity=0.636  Sum_probs=141.2

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+..|.++++.+ +||||+++++++.+.+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||+|||++|+
T Consensus        66 ~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gi  145 (353)
T 3txo_A           66 DVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGI  145 (353)
T ss_dssp             THHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            345677899999988 7999999999999999999999999999999999988999999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +||||||+||++   +.++.++|+|||++..... ........||+.|+|||.+.+..++.++|+||+|+++|+|++|+.
T Consensus       146 vHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~  222 (353)
T 3txo_A          146 IYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA  222 (353)
T ss_dssp             BCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSC
T ss_pred             cccCCCHHHEEE---CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCC
Confidence            999999999999   6788899999999976433 233445678999999999998889999999999999999999999


Q ss_pred             CCCCCCcc
Q 030527          165 PFSVGEEH  172 (175)
Q Consensus       165 pf~~~~~~  172 (175)
                      ||.+.+..
T Consensus       223 Pf~~~~~~  230 (353)
T 3txo_A          223 PFEAENED  230 (353)
T ss_dssp             SSCCSSHH
T ss_pred             CCCCCCHH
Confidence            99876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.3e-38  Score=241.28  Aligned_cols=166  Identities=33%  Similarity=0.565  Sum_probs=148.6

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      .....+.+.+|++++++++||||+++++++.+.+..++||||+.|++|.+++...+.+++..+..++.|+  ||+|||++
T Consensus        50 ~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~  129 (444)
T 3soa_A           50 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM  129 (444)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3445677899999999999999999999999999999999999999999999988899999999999999  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      |++|+||||+||++.....++.++|+|||++........ .....|++.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       130 givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G  209 (444)
T 3soa_A          130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG  209 (444)
T ss_dssp             TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhC
Confidence            999999999999996444567899999999977654432 3346789999999999988899999999999999999999


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||.+.+.
T Consensus       210 ~~Pf~~~~~  218 (444)
T 3soa_A          210 YPPFWDEDQ  218 (444)
T ss_dssp             SCSCCCSSH
T ss_pred             CCCCCCccH
Confidence            999977654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.2e-38  Score=236.52  Aligned_cols=162  Identities=33%  Similarity=0.634  Sum_probs=146.0

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+.++++++||||+++++++.+.+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||+|||+.|++|
T Consensus        59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  138 (361)
T 2yab_A           59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH  138 (361)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            467899999999999999999999999999999999999999999999988899999999999999  999999999999


Q ss_pred             cCCCCCcEEEeecCC-CceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||+|+||++...+. ...++|+|||++.............|++.|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus       139 rDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf  218 (361)
T 2yab_A          139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF  218 (361)
T ss_dssp             CCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred             CCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999952111 1279999999998876665555677899999999999889999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       219 ~~~~~  223 (361)
T 2yab_A          219 LGDTK  223 (361)
T ss_dssp             CCSSH
T ss_pred             CCCCH
Confidence            87654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.2e-38  Score=229.12  Aligned_cols=162  Identities=35%  Similarity=0.628  Sum_probs=141.4

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....++.+|++++++++||||+++++++...+..++||||+.|++|.+++.+.+++++..+..++.|+  +|++||+.|
T Consensus        52 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  131 (294)
T 4eqm_A           52 EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR  131 (294)
T ss_dssp             HHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            445678899999999999999999999999999999999999999999999988899999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      ++|+||+|+||++   +.++.++|+|||++........  .....+++.|+|||.+.+..++.++|+||+|+++|++++|
T Consensus       132 i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g  208 (294)
T 4eqm_A          132 IVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG  208 (294)
T ss_dssp             CCCCCCCGGGEEE---CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             cccCCCCHHHEEE---CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence            9999999999999   5778899999999976644322  2345689999999999988899999999999999999999


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      +.||.+.+.
T Consensus       209 ~~pf~~~~~  217 (294)
T 4eqm_A          209 EPPFNGETA  217 (294)
T ss_dssp             SCSSCSSCH
T ss_pred             CCCCCCCCh
Confidence            999987653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-37  Score=231.49  Aligned_cols=170  Identities=34%  Similarity=0.617  Sum_probs=132.2

Q ss_pred             CccccchhhhhhHHHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HH
Q 030527            1 MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GL   77 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l   77 (175)
                      ++|.++......+.+|+++++++. ||||+++++++.+.+..++||||+.|++|.+++.+.+.+++..+..++.|+  +|
T Consensus        40 avK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l  119 (325)
T 3kn6_A           40 AVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV  119 (325)
T ss_dssp             EEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHH
T ss_pred             EEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHH
Confidence            367777777888999999999996 999999999999999999999999999999999988899999999999999  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~  156 (175)
                      ++||++|++|+||+|+||++...+....++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++
T Consensus       120 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il  199 (325)
T 3kn6_A          120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVIL  199 (325)
T ss_dssp             HHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHH
T ss_pred             HHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHH
Confidence            99999999999999999999643334479999999998664432 23455678999999999988999999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030527          157 FELLNGYPPFSVGE  170 (175)
Q Consensus       157 ~~~~~g~~pf~~~~  170 (175)
                      +++++|..||.+.+
T Consensus       200 ~~ll~g~~pf~~~~  213 (325)
T 3kn6_A          200 YTMLSGQVPFQSHD  213 (325)
T ss_dssp             HHHHHSSCTTC---
T ss_pred             HHHHhCCCCCCCCc
Confidence            99999999998654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.5e-38  Score=237.43  Aligned_cols=156  Identities=34%  Similarity=0.705  Sum_probs=142.7

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+..|..+++++ +||||+++++++.+.+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||++||++|++
T Consensus        96 ~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~giv  175 (396)
T 4dc2_A           96 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII  175 (396)
T ss_dssp             CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            45578899999887 8999999999999999999999999999999999988899999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeec-cCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      ||||||+||++   +.++.++|+|||++... ..........||+.|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus       176 HrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~P  252 (396)
T 4dc2_A          176 YRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP  252 (396)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eccCCHHHEEE---CCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999   67889999999999763 333445567789999999999999999999999999999999999999


Q ss_pred             CCC
Q 030527          166 FSV  168 (175)
Q Consensus       166 f~~  168 (175)
                      |..
T Consensus       253 f~~  255 (396)
T 4dc2_A          253 FDI  255 (396)
T ss_dssp             STT
T ss_pred             Ccc
Confidence            964

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.9e-38  Score=232.30  Aligned_cols=162  Identities=34%  Similarity=0.656  Sum_probs=145.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++++++++||||+++++++...+..++||||+.+++|.+++.+.+.+++..+..++.|+  ||++||+.|++|
T Consensus        58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH  137 (326)
T 2y0a_A           58 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH  137 (326)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEc
Confidence            567899999999999999999999999999999999999999999999888889999999999999  999999999999


Q ss_pred             cCCCCCcEEEeecC-CCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||+|+||++...+ ....++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++++|++|..||
T Consensus       138 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf  217 (326)
T 2y0a_A          138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF  217 (326)
T ss_dssp             CCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred             CCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence            99999999994221 12379999999998876555555667899999999998888999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       218 ~~~~~  222 (326)
T 2y0a_A          218 LGDTK  222 (326)
T ss_dssp             CCSSH
T ss_pred             CCCCH
Confidence            77543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-37  Score=230.38  Aligned_cols=157  Identities=39%  Similarity=0.717  Sum_probs=143.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|..+++.++||||+++++++.+.+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||++||++|++|
T Consensus        50 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH  129 (318)
T 1fot_A           50 VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIY  129 (318)
T ss_dssp             HHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            456778999999999999999999999999999999999999999999988899999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      +||+|+||++   +.++.++|+|||++......  .....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.
T Consensus       130 rDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  204 (318)
T 1fot_A          130 RDLKPENILL---DKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY  204 (318)
T ss_dssp             CCCCGGGEEE---CTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             cCCChheEEE---cCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence            9999999999   67889999999999876443  335578999999999998899999999999999999999999998


Q ss_pred             CCCc
Q 030527          168 VGEE  171 (175)
Q Consensus       168 ~~~~  171 (175)
                      +.+.
T Consensus       205 ~~~~  208 (318)
T 1fot_A          205 DSNT  208 (318)
T ss_dssp             CSSH
T ss_pred             CCCH
Confidence            7653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.1e-37  Score=231.17  Aligned_cols=159  Identities=42%  Similarity=0.775  Sum_probs=144.8

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+++++.++||||+++++++...+..++||||+ +++|.+++.+.+.+++..+..++.|+  |++|||+.|++|
T Consensus        53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  131 (336)
T 3h4j_B           53 HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVH  131 (336)
T ss_dssp             SHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            357889999999999999999999999999999999999 78999999888899999999999999  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||+|+||++   +.++.++|+|||++.....+.......|++.|+|||.+.+..+ ++++|+||+|+++|+|++|..||
T Consensus       132 ~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf  208 (336)
T 3h4j_B          132 RDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF  208 (336)
T ss_dssp             CCCSTTTEEE---CTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCCchhhEEE---cCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCC
Confidence            9999999999   5778899999999987766665666778999999999987775 78999999999999999999999


Q ss_pred             CCCCcc
Q 030527          167 SVGEEH  172 (175)
Q Consensus       167 ~~~~~~  172 (175)
                      .+....
T Consensus       209 ~~~~~~  214 (336)
T 3h4j_B          209 DDEFIP  214 (336)
T ss_dssp             BCSSST
T ss_pred             CCccHH
Confidence            876443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.4e-37  Score=232.88  Aligned_cols=159  Identities=38%  Similarity=0.665  Sum_probs=143.7

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+..|.++++.+ +||||+++++++.+.+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||++||++|++
T Consensus        61 ~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  140 (345)
T 1xjd_A           61 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV  140 (345)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            45677899999877 9999999999999999999999999999999999988899999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      ||||||+||++   +.++.++|+|||++...... .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus       141 HrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P  217 (345)
T 1xjd_A          141 YRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP  217 (345)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eCCCChhhEEE---CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCC
Confidence            99999999999   67788999999999765332 334456789999999999988899999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.+.
T Consensus       218 f~~~~~  223 (345)
T 1xjd_A          218 FHGQDE  223 (345)
T ss_dssp             SCCSSH
T ss_pred             CCCCCH
Confidence            987654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2e-37  Score=232.72  Aligned_cols=159  Identities=36%  Similarity=0.651  Sum_probs=144.2

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+..|.+++..+ +||+|+++.+++.+.+..++||||++|++|.+++.+.+.+++..+..++.|+  ||++||++|++
T Consensus        64 ~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~giv  143 (353)
T 2i0e_A           64 VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGII  143 (353)
T ss_dssp             HHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            45677899999988 8999999999999999999999999999999999988899999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      ||||||+||++   +.++.++|+|||++..... ........|++.|+|||.+.+..++.++|+||||+++|+|++|+.|
T Consensus       144 HrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P  220 (353)
T 2i0e_A          144 YRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP  220 (353)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eccCCHHHEEE---cCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCC
Confidence            99999999999   6788999999999976432 3334556789999999999988999999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.+.
T Consensus       221 f~~~~~  226 (353)
T 2i0e_A          221 FEGEDE  226 (353)
T ss_dssp             SCCSSH
T ss_pred             CCCCCH
Confidence            987654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.8e-37  Score=238.58  Aligned_cols=158  Identities=34%  Similarity=0.658  Sum_probs=142.0

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ..+.+|..+++.++||||+++++++.+.+..++||||++|++|.+++.+ .+.+++..+..++.|+  ||+|||++|++|
T Consensus       119 ~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiH  198 (437)
T 4aw2_A          119 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH  198 (437)
T ss_dssp             CCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence            3488999999999999999999999999999999999999999999987 4689999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCccccc-----ccCCCcchhHHHHHHHHHHHH
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~~~~  160 (175)
                      |||||+||++   +.++.++|+|||++........  .....||+.|+|||.+.     ...++.++|+||+|+++|+|+
T Consensus       199 rDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ell  275 (437)
T 4aw2_A          199 RDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML  275 (437)
T ss_dssp             CCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHH
T ss_pred             cccCHHHeeE---cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHH
Confidence            9999999999   6788999999999977654432  23357899999999986     456899999999999999999


Q ss_pred             hCCCCCCCCCc
Q 030527          161 NGYPPFSVGEE  171 (175)
Q Consensus       161 ~g~~pf~~~~~  171 (175)
                      +|+.||.+.+.
T Consensus       276 tG~~Pf~~~~~  286 (437)
T 4aw2_A          276 YGETPFYAESL  286 (437)
T ss_dssp             HSSCTTCCSSH
T ss_pred             hCCCCCCCCCh
Confidence            99999987654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-37  Score=230.29  Aligned_cols=164  Identities=29%  Similarity=0.524  Sum_probs=146.6

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ......+.+|++++++++||||+++++++.+.+..++||||+.|++|.+++... ..+++..+..++.|+  ||+|||+.
T Consensus        42 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~  121 (321)
T 1tki_A           42 GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH  121 (321)
T ss_dssp             THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            344567889999999999999999999999999999999999999999999865 479999999999999  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      |++|+||+|+||++.. +.++.++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus       122 givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  200 (321)
T 1tki_A          122 NIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI  200 (321)
T ss_dssp             TEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred             CCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999941 126789999999998886665555677899999999998888899999999999999999999


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||.+.++
T Consensus       201 ~pf~~~~~  208 (321)
T 1tki_A          201 NPFLAETN  208 (321)
T ss_dssp             CTTCCSSH
T ss_pred             CCCcCCCH
Confidence            99987654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.8e-37  Score=228.36  Aligned_cols=157  Identities=34%  Similarity=0.695  Sum_probs=142.8

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ..+.+.+|.++++++ +||||+++++++.+.+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||++||++|+
T Consensus        52 ~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i  131 (345)
T 3a8x_A           52 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI  131 (345)
T ss_dssp             HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            455678899999988 8999999999999999999999999999999999988899999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeecc-CCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +||||||+||++   +.++.++|+|||++.... .........|++.|+|||.+.+..++.++|+||+|+++|+|++|+.
T Consensus       132 vHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  208 (345)
T 3a8x_A          132 IYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS  208 (345)
T ss_dssp             BCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             eecCCCHHHEEE---CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCC
Confidence            999999999999   678899999999997643 2333455678999999999998899999999999999999999999


Q ss_pred             CCCC
Q 030527          165 PFSV  168 (175)
Q Consensus       165 pf~~  168 (175)
                      ||..
T Consensus       209 pf~~  212 (345)
T 3a8x_A          209 PFDI  212 (345)
T ss_dssp             TTTT
T ss_pred             CcCC
Confidence            9965

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=223.92  Aligned_cols=163  Identities=27%  Similarity=0.498  Sum_probs=144.3

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      +....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.++++.. ..+++..+..++.|+  ||++||+
T Consensus        47 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~  126 (310)
T 3s95_A           47 DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS  126 (310)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            5667788999999999999999999999999999999999999999999999874 679999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc---------------ccccCCCCccCcccccccCCCcch
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---------------EKVCGSPLYMAPEVLQFQRYDEKV  147 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~---------------~~~~~~~~~~~pe~~~~~~~~~~~  147 (175)
                      .|++|+||+|+||++   +.++.++|+|||++.........               ....|++.|+|||.+.+..++.++
T Consensus       127 ~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  203 (310)
T 3s95_A          127 MNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKV  203 (310)
T ss_dssp             TTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHH
T ss_pred             CCccCCCCCcCeEEE---CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHH
Confidence            999999999999999   57788999999999876443221               134688999999999999999999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          148 DMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       148 Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      |+||+|++++++++|..||.....
T Consensus       204 Di~slG~~l~el~~g~~~~~~~~~  227 (310)
T 3s95_A          204 DVFSFGIVLCEIIGRVNADPDYLP  227 (310)
T ss_dssp             HHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred             HHHHHHHHHHHHhcCCCCCcchhh
Confidence            999999999999999999976443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.6e-37  Score=224.31  Aligned_cols=159  Identities=31%  Similarity=0.611  Sum_probs=143.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|+.++++++||||+++++++...+..++||||+.|++|.+++.+. .+++..+..++.|+  ||++||+.|++
T Consensus        60 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~  138 (297)
T 3fxz_A           60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVI  138 (297)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence            3566889999999999999999999999999999999999999999999854 68999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus       139 H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  215 (297)
T 3fxz_A          139 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP  215 (297)
T ss_dssp             CCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             eCCCCHHHEEE---CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999   577889999999988765443 23455789999999999988999999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.++
T Consensus       216 f~~~~~  221 (297)
T 3fxz_A          216 YLNENP  221 (297)
T ss_dssp             TTTSCH
T ss_pred             CCCCCH
Confidence            977543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.5e-37  Score=229.19  Aligned_cols=160  Identities=36%  Similarity=0.620  Sum_probs=135.7

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|++++++++||||+++++++...+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||++||++|++
T Consensus        64 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv  143 (327)
T 3a62_A           64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGII  143 (327)
T ss_dssp             -------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            3456788999999999999999999999999999999999999999999988899999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||++...... .......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus       144 H~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p  220 (327)
T 3a62_A          144 YRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP  220 (327)
T ss_dssp             CCCCCTTTEEE---CTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccCCHHHeEE---CCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCC
Confidence            99999999999   57788999999998764332 233455689999999999988899999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.+.
T Consensus       221 f~~~~~  226 (327)
T 3a62_A          221 FTGENR  226 (327)
T ss_dssp             CCCSSH
T ss_pred             CCCCCH
Confidence            987653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-37  Score=237.12  Aligned_cols=158  Identities=35%  Similarity=0.648  Sum_probs=141.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|.++++.++||||+++++++.+.+..++||||++|++|.+++.+ ..+++..+..++.|+  ||+|||++|++|
T Consensus       113 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givH  191 (410)
T 3v8s_A          113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIH  191 (410)
T ss_dssp             CSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            34578999999999999999999999999999999999999999999875 579999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccC----CCcchhHHHHHHHHHHHHh
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slg~~~~~~~~  161 (175)
                      |||||+||++   +.++.++|+|||++........  .....||+.|+|||.+.+..    ++.++|+||+|+++|+|++
T Consensus       192 rDLKp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~  268 (410)
T 3v8s_A          192 RDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV  268 (410)
T ss_dssp             CCCSGGGEEE---CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH
T ss_pred             ccCCHHHeeE---CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh
Confidence            9999999999   6788999999999987755432  33567899999999997655    7889999999999999999


Q ss_pred             CCCCCCCCCc
Q 030527          162 GYPPFSVGEE  171 (175)
Q Consensus       162 g~~pf~~~~~  171 (175)
                      |+.||.+.+.
T Consensus       269 G~~Pf~~~~~  278 (410)
T 3v8s_A          269 GDTPFYADSL  278 (410)
T ss_dssp             SSCTTCCSSH
T ss_pred             CCCCCCCCCh
Confidence            9999987654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.3e-37  Score=230.71  Aligned_cols=157  Identities=34%  Similarity=0.654  Sum_probs=144.0

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|.++++.++||||+++++++.+.+..++||||++|++|.+++.+.+.+++..+..++.|+  ||++||++|++|
T Consensus        85 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH  164 (350)
T 1rdq_E           85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY  164 (350)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            456788999999999999999999999999999999999999999999988899999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      |||||+||++   +.++.++|+|||++......  .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus       165 rDlkp~NIll---~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  239 (350)
T 1rdq_E          165 RDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF  239 (350)
T ss_dssp             CCCSGGGEEE---CTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccCccceEEE---CCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCC
Confidence            9999999999   67788999999999876543  234567999999999998899999999999999999999999998


Q ss_pred             CCCc
Q 030527          168 VGEE  171 (175)
Q Consensus       168 ~~~~  171 (175)
                      +.+.
T Consensus       240 ~~~~  243 (350)
T 1rdq_E          240 ADQP  243 (350)
T ss_dssp             CSSH
T ss_pred             CCCH
Confidence            7654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-36  Score=221.22  Aligned_cols=163  Identities=35%  Similarity=0.685  Sum_probs=147.5

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++...+.+++..+..++.|+  ++++||+.|+
T Consensus        48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  127 (277)
T 3f3z_A           48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV  127 (277)
T ss_dssp             SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34567899999999999999999999999999999999999999999999988899999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +|+||+|+||++...+.++.++|+|||++.............+++.|+|||.+.+ .++.++|+||+|++++++++|+.|
T Consensus       128 ~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p  206 (277)
T 3f3z_A          128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPP  206 (277)
T ss_dssp             ECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCC
Confidence            9999999999995445677899999999988776666666778999999998865 489999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |...++
T Consensus       207 ~~~~~~  212 (277)
T 3f3z_A          207 FSAPTD  212 (277)
T ss_dssp             SCCSSH
T ss_pred             CCCCCH
Confidence            987654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=232.09  Aligned_cols=170  Identities=41%  Similarity=0.627  Sum_probs=132.9

Q ss_pred             ccccch-hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHH
Q 030527            2 LKKLNK-HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE   78 (175)
Q Consensus         2 lk~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~   78 (175)
                      +|.+.. ...+.+.+|++++++++||||+++++++...+..++||||+.+++|.+++.+.+.+++..+..++.|+  ||+
T Consensus        83 vK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~  162 (349)
T 2w4o_A           83 LKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVA  162 (349)
T ss_dssp             EEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHH
T ss_pred             EEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Confidence            444432 24556788999999999999999999999999999999999999999999988889999999999999  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      +||+.|++|+||+|+||++...+.++.++|+|||++.............+++.|+|||.+.+..++.++|+||||+++|+
T Consensus       163 ~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  242 (349)
T 2w4o_A          163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYI  242 (349)
T ss_dssp             HHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred             HHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHH
Confidence            99999999999999999995434478899999999987755544455678999999999998889999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030527          159 LLNGYPPFSVGEE  171 (175)
Q Consensus       159 ~~~g~~pf~~~~~  171 (175)
                      +++|..||.....
T Consensus       243 ll~g~~pf~~~~~  255 (349)
T 2w4o_A          243 LLCGFEPFYDERG  255 (349)
T ss_dssp             HHHSSCTTCCTTC
T ss_pred             HHhCCCCCCCCcc
Confidence            9999999976543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.6e-37  Score=229.40  Aligned_cols=160  Identities=31%  Similarity=0.584  Sum_probs=141.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ...+.+|++++++++||||+++++++.+.+..++||||+.|++|.+++.+.    ..+++..+..++.|+  ||+|||++
T Consensus        70 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~  149 (351)
T 3c0i_A           70 TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN  149 (351)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            567899999999999999999999999999999999999999998887643    248999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      |++|+||||+||++...+....++|+|||++........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       150 ~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  229 (351)
T 3c0i_A          150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG  229 (351)
T ss_dssp             TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHC
Confidence            999999999999996433445699999999987765433 3455689999999999988899999999999999999999


Q ss_pred             CCCCCCC
Q 030527          163 YPPFSVG  169 (175)
Q Consensus       163 ~~pf~~~  169 (175)
                      ..||.+.
T Consensus       230 ~~pf~~~  236 (351)
T 3c0i_A          230 CLPFYGT  236 (351)
T ss_dssp             SCSSCSS
T ss_pred             CCCCCCc
Confidence            9999764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.3e-37  Score=231.57  Aligned_cols=163  Identities=36%  Similarity=0.605  Sum_probs=146.2

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++.+. ..+++..+..++.|+  ||+|||+.|
T Consensus       128 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  207 (373)
T 2x4f_A          128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY  207 (373)
T ss_dssp             HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45678899999999999999999999999999999999999999999988755 469999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      ++|+||+|+||++.. +..+.++|+|||++.............+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus       208 ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~  286 (373)
T 2x4f_A          208 ILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS  286 (373)
T ss_dssp             EECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cccccCCHHHEEEec-CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence            999999999999842 3456899999999988766655556678999999999988889999999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.++
T Consensus       287 pf~~~~~  293 (373)
T 2x4f_A          287 PFLGDND  293 (373)
T ss_dssp             TTCCSSH
T ss_pred             CCCCCCH
Confidence            9987654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-37  Score=234.15  Aligned_cols=160  Identities=33%  Similarity=0.623  Sum_probs=142.9

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|.+++..++||||+++++++.+.+..++||||++|++|.+++.+.+ .+++..+..++.|+  ||+|||++|+
T Consensus       104 ~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi  183 (412)
T 2vd5_A          104 EVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY  183 (412)
T ss_dssp             GGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34568899999999999999999999999999999999999999999998764 79999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCccccc-------ccCCCcchhHHHHHHHH
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-------FQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~-------~~~~~~~~Di~slg~~~  156 (175)
                      +||||||+||++   +.++.++|+|||++........  .....||+.|+|||.+.       ...++.++|+||+|+++
T Consensus       184 iHrDLKp~NILl---d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvil  260 (412)
T 2vd5_A          184 VHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA  260 (412)
T ss_dssp             ECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHH
T ss_pred             eecccCHHHeee---cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHH
Confidence            999999999999   6788999999999987755432  23457899999999986       35689999999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030527          157 FELLNGYPPFSVGEE  171 (175)
Q Consensus       157 ~~~~~g~~pf~~~~~  171 (175)
                      |+|++|+.||.+.+.
T Consensus       261 yelltG~~Pf~~~~~  275 (412)
T 2vd5_A          261 YEMFYGQTPFYADST  275 (412)
T ss_dssp             HHHHHSSCTTCCSSH
T ss_pred             HHHHhCCCCCCCCCH
Confidence            999999999987654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.1e-36  Score=220.40  Aligned_cols=165  Identities=36%  Similarity=0.612  Sum_probs=148.2

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+.+.+|++++++++||||+++++++...+..++++|++.+++|.+++.....+++..+..++.|+  ++++||+.|
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  125 (284)
T 3kk8_A           46 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG  125 (284)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            344567889999999999999999999999999999999999999999999988889999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      ++|+||+|+||+++..+....++|+|||.+.............+++.|+|||.+.+..++.++|+||+|++++++++|..
T Consensus       126 i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~  205 (284)
T 3kk8_A          126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP  205 (284)
T ss_dssp             EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCC
Confidence            99999999999996434455699999999988766655556678999999999998889999999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.+.
T Consensus       206 pf~~~~~  212 (284)
T 3kk8_A          206 PFWDEDQ  212 (284)
T ss_dssp             SSCCSSH
T ss_pred             CCCCCch
Confidence            9976543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.9e-37  Score=239.21  Aligned_cols=164  Identities=41%  Similarity=0.731  Sum_probs=147.7

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .....+.+|++++++++||||+++++++.+.+..++||||+.|++|.+++.+...+++..+..++.|+  ||+|||+.|+
T Consensus        78 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  157 (494)
T 3lij_A           78 SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI  157 (494)
T ss_dssp             CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34567889999999999999999999999999999999999999999999988899999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +|+||||+||++...+....++|+|||++.............+++.|+|||.+. ..++.++|+||+|+++|+|++|..|
T Consensus       158 vH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~p  236 (494)
T 3lij_A          158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP  236 (494)
T ss_dssp             ECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCC
Confidence            999999999999644445679999999998877666556677899999999886 5689999999999999999999999


Q ss_pred             CCCCCcc
Q 030527          166 FSVGEEH  172 (175)
Q Consensus       166 f~~~~~~  172 (175)
                      |.+.++.
T Consensus       237 f~~~~~~  243 (494)
T 3lij_A          237 FGGQTDQ  243 (494)
T ss_dssp             SCCSSHH
T ss_pred             CCCCCHH
Confidence            9876543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.1e-37  Score=231.25  Aligned_cols=169  Identities=21%  Similarity=0.301  Sum_probs=146.4

Q ss_pred             CccccchhhhhhHHHHHHHHhhCC---CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHH
Q 030527            1 MLKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFL   72 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~   72 (175)
                      ++|.++......+..|.+++++++   |+|++.+++++...+..++||||+.+++|.+++..     ...+++..+..++
T Consensus        99 avK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~  178 (365)
T 3e7e_A           99 VLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA  178 (365)
T ss_dssp             EEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHH
T ss_pred             EEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHH
Confidence            367777777788999999999996   99999999999999999999999999999999974     3569999999999


Q ss_pred             HHH--HHHHHHHcCCeecCCCCCcEEEee--------cCCCceEEEeeecceeecc---CCCccccccCCCCccCccccc
Q 030527           73 QQL--GLEILNSHHIIHRDLKPENILLSG--------LDDDVMLKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQ  139 (175)
Q Consensus        73 ~~i--~l~~lh~~~~~h~di~~~ni~~~~--------~~~~~~~~l~df~~~~~~~---~~~~~~~~~~~~~~~~pe~~~  139 (175)
                      .|+  ||+|||+.|++||||||+||+++.        .+..+.++|+|||++....   .........||..|+|||.+.
T Consensus       179 ~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  258 (365)
T 3e7e_A          179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS  258 (365)
T ss_dssp             HHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT
T ss_pred             HHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc
Confidence            999  999999999999999999999942        1116789999999997653   222334566899999999999


Q ss_pred             ccCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030527          140 FQRYDEKVDMWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus       140 ~~~~~~~~Di~slg~~~~~~~~g~~pf~~~  169 (175)
                      +..++.++|+||||+++|+|++|+.||...
T Consensus       259 ~~~~~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          259 NKPWNYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             TCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             CCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence            888999999999999999999999999644

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1e-36  Score=229.53  Aligned_cols=162  Identities=40%  Similarity=0.613  Sum_probs=131.0

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|+.++++++||||+++++++...+..++||||+.+++|.+++.+.+.+++..+..++.|+  ||+|||+.|++
T Consensus        59 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~iv  138 (361)
T 3uc3_A           59 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC  138 (361)
T ss_dssp             SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3467889999999999999999999999999999999999999999999888899999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcc-hhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK-VDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||||+||++.. +..+.++|+|||++.............+++.|+|||.+.+..++.+ +|+||+|+++|+|++|+.|
T Consensus       139 H~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~P  217 (361)
T 3uc3_A          139 HRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP  217 (361)
T ss_dssp             SCCCCGGGEEECS-SSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCCHHHEEEcC-CCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCC
Confidence            9999999999941 1233599999999976554444455678999999999988777655 8999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.++
T Consensus       218 f~~~~~  223 (361)
T 3uc3_A          218 FEDPEE  223 (361)
T ss_dssp             CC----
T ss_pred             CCCCcc
Confidence            987543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.4e-37  Score=238.57  Aligned_cols=162  Identities=40%  Similarity=0.709  Sum_probs=144.3

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|++++++++||||+++++++.+.+..++|+||+.|++|.+++.+.+.+++..+..++.|+  ||+|||+.|++
T Consensus        64 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv  143 (486)
T 3mwu_A           64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV  143 (486)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            3567889999999999999999999999999999999999999999999888899999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |+||||+||++...+.+..++|+|||++.............+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||
T Consensus       144 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf  222 (486)
T 3mwu_A          144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF  222 (486)
T ss_dssp             CSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999996444566799999999987766555556678999999999875 5899999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       223 ~~~~~  227 (486)
T 3mwu_A          223 YGKNE  227 (486)
T ss_dssp             CCSSH
T ss_pred             CCCCH
Confidence            87654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.2e-37  Score=226.48  Aligned_cols=159  Identities=33%  Similarity=0.651  Sum_probs=145.0

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++.+.+.+++..+..++.|+  ||++||+.|++|
T Consensus        59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH  138 (321)
T 2a2a_A           59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH  138 (321)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            567899999999999999999999999999999999999999999999988889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCc----eEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           88 RDLKPENILLSGLDDDV----MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +||+|+||++.   .++    .++|+|||++.............+++.|+|||.+.+..++.++|+||+|++++++++|.
T Consensus       139 ~dikp~NIl~~---~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  215 (321)
T 2a2a_A          139 FDLKPENIMLL---DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA  215 (321)
T ss_dssp             CCCSGGGEEES---CTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred             CCCChHHEEEe---cCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCC
Confidence            99999999994   333    79999999998876655555667899999999999888999999999999999999999


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||.+.+.
T Consensus       216 ~pf~~~~~  223 (321)
T 2a2a_A          216 SPFLGDTK  223 (321)
T ss_dssp             CSSCCSSH
T ss_pred             CCCCCCCH
Confidence            99987543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3e-36  Score=228.76  Aligned_cols=163  Identities=28%  Similarity=0.420  Sum_probs=142.7

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ......+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++...  ..+++..+..++.|+  ||+|||+
T Consensus        67 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  146 (389)
T 3gni_B           67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH  146 (389)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            445677888999999999999999999999999999999999999999999876  679999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC--------ccccccCCCCccCcccccc--cCCCcchhHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSV  152 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~sl  152 (175)
                      .|++|+||||+||++   +.++.++|+|||.+.......        ......++..|+|||.+.+  ..++.++|+||+
T Consensus       147 ~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  223 (389)
T 3gni_B          147 MGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV  223 (389)
T ss_dssp             TTEECCCCSGGGEEE---CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHH
T ss_pred             CCeecCCCCHHHEEE---cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHH
Confidence            999999999999999   577899999999886553221        1223467888999999987  578999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcc
Q 030527          153 GAILFELLNGYPPFSVGEEH  172 (175)
Q Consensus       153 g~~~~~~~~g~~pf~~~~~~  172 (175)
                      |+++++|++|+.||.+.+..
T Consensus       224 G~il~el~~g~~pf~~~~~~  243 (389)
T 3gni_B          224 GITACELANGHVPFKDMPAT  243 (389)
T ss_dssp             HHHHHHHHHSSCTTTTCCST
T ss_pred             HHHHHHHHHCCCCCCCCCHH
Confidence            99999999999999876543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.6e-36  Score=239.11  Aligned_cols=158  Identities=35%  Similarity=0.592  Sum_probs=144.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|.+++++++||||+++++++.+.+..++||||+.|++|.+++...+.  +++..+..++.|+  ||+|||++|+
T Consensus       228 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gI  307 (576)
T 2acx_A          228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI  307 (576)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            44578899999999999999999999999999999999999999999987543  9999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +|+||||+||++   +.++.++|+|||++.............||+.|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus       308 vHrDLKPeNILl---d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~P  384 (576)
T 2acx_A          308 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP  384 (576)
T ss_dssp             ECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCS
T ss_pred             eccCCchheEEE---eCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence            999999999999   67789999999999887666555556789999999999988899999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |.+.+
T Consensus       385 F~~~~  389 (576)
T 2acx_A          385 FQQRK  389 (576)
T ss_dssp             SSCSS
T ss_pred             Ccccc
Confidence            98764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.4e-36  Score=224.75  Aligned_cols=167  Identities=22%  Similarity=0.283  Sum_probs=145.1

Q ss_pred             ccccc-hhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--H
Q 030527            2 LKKLN-KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G   76 (175)
Q Consensus         2 lk~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~   76 (175)
                      ||.+. ....+.+..|+++++++ +||||+++++++...+..++|||++ +++|.+++... ..+++..+..++.|+  |
T Consensus        39 vK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~  117 (330)
T 2izr_A           39 IKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISR  117 (330)
T ss_dssp             EEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHH
T ss_pred             EEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHH
Confidence            44442 23455789999999999 9999999999999999999999999 99999999874 679999999999999  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeecCCCce-----EEEeeecceeeccCCCc--------cccccCCCCccCcccccccCC
Q 030527           77 LEILNSHHIIHRDLKPENILLSGLDDDVM-----LKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRY  143 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~~~~~~-----~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~  143 (175)
                      |++||+.|++|+||||+||+++   .++.     ++|+|||++........        .....|++.|+|||.+.+..+
T Consensus       118 l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  194 (330)
T 2izr_A          118 MEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ  194 (330)
T ss_dssp             HHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred             HHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCC
Confidence            9999999999999999999994   4444     99999999987654332        235668999999999999999


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030527          144 DEKVDMWSVGAILFELLNGYPPFSVGEEH  172 (175)
Q Consensus       144 ~~~~Di~slg~~~~~~~~g~~pf~~~~~~  172 (175)
                      +.++|+||||+++++|++|..||.+.+..
T Consensus       195 ~~~~Di~slG~il~ell~g~~Pf~~~~~~  223 (330)
T 2izr_A          195 SRRDDLEALGHMFMYFLRGSLPWQGLKAD  223 (330)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred             CchhHHHHHHHHHHHHhcCCCCccccccc
Confidence            99999999999999999999999876543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.5e-37  Score=230.50  Aligned_cols=158  Identities=37%  Similarity=0.657  Sum_probs=136.3

Q ss_pred             hhHHHHHHH-HhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           11 SCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ..+..|..+ ++.++||||+++++++.+.+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||++||++|++|
T Consensus        83 ~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH  162 (373)
T 2r5t_A           83 KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY  162 (373)
T ss_dssp             --------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            345556665 56789999999999999999999999999999999999988899999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |||||+||++   +.++.++|+|||++..... ........||+.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       163 rDlkp~NIll---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf  239 (373)
T 2r5t_A          163 RDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF  239 (373)
T ss_dssp             CCCCGGGEEE---CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCHHHEEE---CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence            9999999999   6788999999999976433 33445667899999999999889999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       240 ~~~~~  244 (373)
T 2r5t_A          240 YSRNT  244 (373)
T ss_dssp             CCSBH
T ss_pred             CCCCH
Confidence            87654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-36  Score=237.97  Aligned_cols=163  Identities=40%  Similarity=0.742  Sum_probs=146.3

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+.+.+|++++++++||||+++++++.+.+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||+|||+.|++
T Consensus        89 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  168 (504)
T 3q5i_A           89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIV  168 (504)
T ss_dssp             THHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            3567889999999999999999999999999999999999999999999988899999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |+||+|+||++...+....++|+|||++.............+++.|+|||.+. ..++.++|+||+|+++|+|++|..||
T Consensus       169 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf  247 (504)
T 3q5i_A          169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPF  247 (504)
T ss_dssp             CSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             eCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999533333469999999998877665556677899999999986 46899999999999999999999999


Q ss_pred             CCCCcc
Q 030527          167 SVGEEH  172 (175)
Q Consensus       167 ~~~~~~  172 (175)
                      .+.+..
T Consensus       248 ~~~~~~  253 (504)
T 3q5i_A          248 GGQNDQ  253 (504)
T ss_dssp             CCSSHH
T ss_pred             CCCCHH
Confidence            876543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.6e-37  Score=239.81  Aligned_cols=163  Identities=39%  Similarity=0.701  Sum_probs=148.0

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .....+.+|++++++++||||+++++++.+.+..++|+|++.+++|.+++...+.+++..+..++.|+  ||+|||++|+
T Consensus        68 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  147 (484)
T 3nyv_A           68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI  147 (484)
T ss_dssp             SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34667899999999999999999999999999999999999999999999988899999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +|+||||+||++...+.++.++|+|||++.............+++.|+|||.+.+ .++.++|+||+|+++|+|++|..|
T Consensus       148 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p  226 (484)
T 3nyv_A          148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP  226 (484)
T ss_dssp             CCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCC
Confidence            9999999999996445677899999999988766655556778999999999875 689999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.++
T Consensus       227 f~~~~~  232 (484)
T 3nyv_A          227 FNGANE  232 (484)
T ss_dssp             SCCSSH
T ss_pred             CCCCCH
Confidence            987654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-36  Score=235.76  Aligned_cols=159  Identities=42%  Similarity=0.762  Sum_probs=145.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+++++.++||||+++++++...+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||+|||+.|++|
T Consensus        60 ~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  139 (476)
T 2y94_A           60 VGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVH  139 (476)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCc
Confidence            457889999999999999999999999999999999999999999999988889999999999999  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||||+||++   +.++.++|+|||++.............|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||
T Consensus       140 rDLkp~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf  216 (476)
T 2y94_A          140 RDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF  216 (476)
T ss_dssp             SCCSGGGEEE---CTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccccHHHEEE---ecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCC
Confidence            9999999999   5778899999999988766655566778999999999987765 78999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       217 ~~~~~  221 (476)
T 2y94_A          217 DDDHV  221 (476)
T ss_dssp             CCSSS
T ss_pred             CCCCH
Confidence            87643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-36  Score=230.07  Aligned_cols=163  Identities=30%  Similarity=0.586  Sum_probs=145.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+.+|++++++++||||+++++++.+.+..++||||+.|++|.+++...+ .+++..+..++.|+  ||++||+.|
T Consensus        90 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  169 (387)
T 1kob_A           90 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS  169 (387)
T ss_dssp             HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345678999999999999999999999999999999999999999999987654 79999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      ++|+||+|+||++.. +..+.++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus       170 ivHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~  248 (387)
T 1kob_A          170 IVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS  248 (387)
T ss_dssp             EECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred             eeecccchHHeEEec-CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCC
Confidence            999999999999941 1346799999999988866655556678999999999998889999999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.++
T Consensus       249 Pf~~~~~  255 (387)
T 1kob_A          249 PFAGEDD  255 (387)
T ss_dssp             SSCCSSH
T ss_pred             CCCCCCH
Confidence            9987653

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.4e-37  Score=236.72  Aligned_cols=159  Identities=32%  Similarity=0.553  Sum_probs=135.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH-cCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-HHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~-~~~~   86 (175)
                      ...+.+|+++++.++||||+++++++...+..++||||+.+++|.+++.+.+.+++..+..++.|+  ||+|||+ .|++
T Consensus       192 ~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~gii  271 (446)
T 4ejn_A          192 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV  271 (446)
T ss_dssp             ---------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEE
Confidence            356678999999999999999999999999999999999999999999988899999999999998  9999998 9999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||||+||++   +.++.++|+|||++...... .......||+.|+|||.+.+..++.++|+||+|+++++|++|..|
T Consensus       272 HrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P  348 (446)
T 4ejn_A          272 YRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  348 (446)
T ss_dssp             CCCCCGGGEEE---CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ECCCCHHHEEE---CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCC
Confidence            99999999999   57788999999999764332 334456789999999999989999999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.+.
T Consensus       349 f~~~~~  354 (446)
T 4ejn_A          349 FYNQDH  354 (446)
T ss_dssp             SCCSSH
T ss_pred             CCCCCH
Confidence            987654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.2e-36  Score=230.44  Aligned_cols=168  Identities=35%  Similarity=0.659  Sum_probs=135.7

Q ss_pred             ccccchhhhhhHHHHHHHHhh-CCCCCeeeEeeEEee----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHH
Q 030527            2 LKKLNKHLKSCLDCELNFLSS-VNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQ   74 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~   74 (175)
                      +|.++.  ...+.+|++++.+ .+||||+++++++..    .+..++||||+.|++|.+++.+.+  .+++..+..++.|
T Consensus        92 iK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~q  169 (400)
T 1nxk_A           92 LKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS  169 (400)
T ss_dssp             EEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHH
T ss_pred             EEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHH
Confidence            455443  2456788888754 599999999999875    667899999999999999998654  5999999999999


Q ss_pred             H--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHH
Q 030527           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  152 (175)
Q Consensus        75 i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl  152 (175)
                      +  ||+|||+.|++|+||||+||+++..+.++.++|+|||++.............+++.|+|||.+.+..++.++|+|||
T Consensus       170 i~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  249 (400)
T 1nxk_A          170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL  249 (400)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHH
T ss_pred             HHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHH
Confidence            9  99999999999999999999995333367899999999987765554556678999999999988899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCc
Q 030527          153 GAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       153 g~~~~~~~~g~~pf~~~~~  171 (175)
                      |+++|+|++|..||.+...
T Consensus       250 G~il~ell~g~~pf~~~~~  268 (400)
T 1nxk_A          250 GVIMYILLCGYPPFYSNHG  268 (400)
T ss_dssp             HHHHHHHHHSSCSCCCCTT
T ss_pred             HHHHHHHHhCCCCCCCCcc
Confidence            9999999999999977654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.6e-36  Score=222.96  Aligned_cols=162  Identities=28%  Similarity=0.469  Sum_probs=135.4

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHH--HHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ....+.+.+|++++++++||||+++++++...+..++||||+.+++|.+++.+.+.   +++..+..++.|+  ||++||
T Consensus        75 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  154 (309)
T 3p86_A           75 AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH  154 (309)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            44456788999999999999999999999999999999999999999999987653   9999999999998  999999


Q ss_pred             HcC--CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           82 SHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        82 ~~~--~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      +.|  ++|+||||+||++   +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+
T Consensus       155 ~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  231 (309)
T 3p86_A          155 NRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWE  231 (309)
T ss_dssp             TSSSCCCCTTCCGGGEEE---CTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             cCCCCEECCCCChhhEEE---eCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHH
Confidence            999  9999999999999   577889999999997654432 2335568999999999998899999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030527          159 LLNGYPPFSVGEE  171 (175)
Q Consensus       159 ~~~g~~pf~~~~~  171 (175)
                      +++|..||.+.++
T Consensus       232 lltg~~Pf~~~~~  244 (309)
T 3p86_A          232 LATLQQPWGNLNP  244 (309)
T ss_dssp             HHHCCCTTTTSCH
T ss_pred             HHhCCCCCCCCCH
Confidence            9999999987654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.9e-36  Score=226.97  Aligned_cols=162  Identities=31%  Similarity=0.528  Sum_probs=142.2

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHH
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~   70 (175)
                      .....+.+|+++++++ +||||+++++++...+..++||||+.+++|.+++....                .++...+..
T Consensus       128 ~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  207 (370)
T 2psq_A          128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS  207 (370)
T ss_dssp             HHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHH
Confidence            3456789999999999 89999999999999999999999999999999998653                378899999


Q ss_pred             HHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCc
Q 030527           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  145 (175)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~  145 (175)
                      ++.|+  ||+|||++|++|+||||+||++   +.++.++|+|||++........   .....+++.|+|||.+.+..++.
T Consensus       208 i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  284 (370)
T 2psq_A          208 CTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  284 (370)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCH
T ss_pred             HHHHHHHHHHHHHhCCeeccccchhhEEE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCc
Confidence            99998  9999999999999999999999   5778899999999987654322   22344567899999999889999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030527          146 KVDMWSVGAILFELLN-GYPPFSVGEEH  172 (175)
Q Consensus       146 ~~Di~slg~~~~~~~~-g~~pf~~~~~~  172 (175)
                      ++|+||||+++|+|++ |..||.+.+..
T Consensus       285 ~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          285 QSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999999999 99999876543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=225.62  Aligned_cols=158  Identities=35%  Similarity=0.577  Sum_probs=143.8

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|++++++++||||+++++++.+.+..++|||++.++ +|.+++.+.+.+++..+..++.|+  +|++||+.|+
T Consensus        72 ~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i  151 (335)
T 3dls_A           72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDI  151 (335)
T ss_dssp             TTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4456788999999999999999999999999999999988666 999999988899999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+||||+||++   +.++.++|+|||++.............+++.|+|||.+.+..+ +.++|+||+|+++|++++|..
T Consensus       152 vH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~  228 (335)
T 3dls_A          152 IHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN  228 (335)
T ss_dssp             ECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred             EEeccCHHHEEE---cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCC
Confidence            999999999999   5778899999999988876665666778999999999987776 889999999999999999999


Q ss_pred             CCCCC
Q 030527          165 PFSVG  169 (175)
Q Consensus       165 pf~~~  169 (175)
                      ||...
T Consensus       229 pf~~~  233 (335)
T 3dls_A          229 PFCEL  233 (335)
T ss_dssp             SCSSG
T ss_pred             chhhH
Confidence            99753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.7e-37  Score=226.86  Aligned_cols=161  Identities=27%  Similarity=0.527  Sum_probs=134.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      .....+.+|++++++++||||+++++++....    ..++||||+.|++|.+++...+.+++..+..++.|+  +|++||
T Consensus        54 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH  133 (311)
T 3ork_A           54 SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH  133 (311)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34557889999999999999999999987654    349999999999999999988899999999999999  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC----ccccccCCCCccCcccccccCCCcchhHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~  157 (175)
                      ++|++|+||+|+||++   +.++.++|+|||++.......    ......++..|+|||.+.+..++.++|+||+|+++|
T Consensus       134 ~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~  210 (311)
T 3ork_A          134 QNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY  210 (311)
T ss_dssp             HTTCCCCCCCGGGEEE---ETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred             HCCCCcCCCCHHHEEE---cCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHH
Confidence            9999999999999999   467789999999997664432    122345799999999999889999999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030527          158 ELLNGYPPFSVGEE  171 (175)
Q Consensus       158 ~~~~g~~pf~~~~~  171 (175)
                      +|++|+.||.+.+.
T Consensus       211 ~ll~g~~pf~~~~~  224 (311)
T 3ork_A          211 EVLTGEPPFTGDSP  224 (311)
T ss_dssp             HHHHSSCSCCCSSH
T ss_pred             HHHhCCCCCCCCCh
Confidence            99999999987654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-36  Score=221.61  Aligned_cols=161  Identities=28%  Similarity=0.520  Sum_probs=140.2

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCC--eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHH--HHHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      .+.+.+|++++++++||||+++++++...+  ..++||||+.+++|.+++.....   +++..+..++.|+  ||++||+
T Consensus        51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~  130 (319)
T 4euu_A           51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE  130 (319)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            466788999999999999999999988755  78999999999999999986533   9999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEee-cCCCceEEEeeecceeeccCCCccccccCCCCccCccccc--------ccCCCcchhHHHHH
Q 030527           83 HHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--------FQRYDEKVDMWSVG  153 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~-~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~Di~slg  153 (175)
                      .|++|+||||+||++.. .+....++|+|||++.............++..|+|||.+.        +..++.++|+||+|
T Consensus       131 ~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG  210 (319)
T 4euu_A          131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG  210 (319)
T ss_dssp             TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHH
T ss_pred             CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHH
Confidence            99999999999999732 2356679999999998876665555667899999999885        46789999999999


Q ss_pred             HHHHHHHhCCCCCCCCC
Q 030527          154 AILFELLNGYPPFSVGE  170 (175)
Q Consensus       154 ~~~~~~~~g~~pf~~~~  170 (175)
                      +++|+|++|+.||...+
T Consensus       211 ~il~el~~g~~pf~~~~  227 (319)
T 4euu_A          211 VTFYHAATGSLPFRPFE  227 (319)
T ss_dssp             HHHHHHHHSSCSEECTT
T ss_pred             HHHHHHHhCCCCCCCCC
Confidence            99999999999997543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.3e-36  Score=217.77  Aligned_cols=162  Identities=35%  Similarity=0.679  Sum_probs=140.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++++++++||||+++++++.+.+..++|+|++.+++|.+++.+...+++..+..++.|+  +|++||+.|++|
T Consensus        52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  131 (283)
T 3bhy_A           52 REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH  131 (283)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence            567899999999999999999999999999999999999999999999988899999999999999  999999999999


Q ss_pred             cCCCCCcEEEeecC-CCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||+|+||++...+ ....++|+|||.+.............++..|+|||.+.+..++.++|+||+|++++++++|..||
T Consensus       132 ~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  211 (283)
T 3bhy_A          132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF  211 (283)
T ss_dssp             SCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCC
Confidence            99999999995221 12379999999998876555445566889999999998888999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       212 ~~~~~  216 (283)
T 3bhy_A          212 LGETK  216 (283)
T ss_dssp             CCSSH
T ss_pred             CCcch
Confidence            87543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-36  Score=226.20  Aligned_cols=159  Identities=36%  Similarity=0.665  Sum_probs=140.8

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|+.++++++||||+++++++.+.+..++||||+.|++|.+++.....+++..+..++.|+  ||++||+.|++|
T Consensus        49 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH  128 (323)
T 3tki_A           49 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH  128 (323)
T ss_dssp             --CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            467889999999999999999999999999999999999999999999887889999999999999  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHhCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~g~  163 (175)
                      +||+|+||++   +.++.++|+|||++.......   ......+++.|+|||.+.+..+ +.++|+||+|+++++|++|.
T Consensus       129 ~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  205 (323)
T 3tki_A          129 RDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE  205 (323)
T ss_dssp             SCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSS
T ss_pred             cccchHHEEE---eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCC
Confidence            9999999999   577889999999997654322   2234568999999999987665 77899999999999999999


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||...++
T Consensus       206 ~pf~~~~~  213 (323)
T 3tki_A          206 LPWDQPSD  213 (323)
T ss_dssp             CSCSSSCT
T ss_pred             CCCCCCch
Confidence            99986554

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-35  Score=232.74  Aligned_cols=158  Identities=35%  Similarity=0.526  Sum_probs=142.9

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ...+.+|.+++++++||||+++++++...+..++||||+.|++|.+++.+.    ..+++..+..++.|+  ||+|||+.
T Consensus       229 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~  308 (543)
T 3c4z_A          229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR  308 (543)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc
Confidence            356788999999999999999999999999999999999999999999764    369999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      |++|+||||+||++   +.++.++|+|||++........ .....||+.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus       309 gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG  385 (543)
T 3c4z_A          309 NIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA  385 (543)
T ss_dssp             TEECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CCcccCCChHHEEE---eCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhC
Confidence            99999999999999   6788999999999987755433 3345789999999999988999999999999999999999


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      +.||.+..
T Consensus       386 ~~PF~~~~  393 (543)
T 3c4z_A          386 RGPFRARG  393 (543)
T ss_dssp             SCSSCCTT
T ss_pred             CCCCCCCc
Confidence            99998754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.4e-36  Score=225.96  Aligned_cols=167  Identities=34%  Similarity=0.599  Sum_probs=143.5

Q ss_pred             ccccchhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHH
Q 030527            2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE   78 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~   78 (175)
                      +|.++.. .....+|++++.++ +||||+++++++.+.+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||+
T Consensus        52 vK~~~~~-~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~  130 (342)
T 2qr7_A           52 VKIIDKS-KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVE  130 (342)
T ss_dssp             EEEEETT-TCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHH
T ss_pred             EEEEEcc-cCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHH
Confidence            4555443 33456788888888 8999999999999999999999999999999999988889999999999999  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCC-CceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~~-~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~  156 (175)
                      |||+.|++|+||||+||++.+.+. ...++|+|||++...... .......+++.|+|||.+.+..++.++|+||+|+++
T Consensus       131 ~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  210 (342)
T 2qr7_A          131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL  210 (342)
T ss_dssp             HHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHH
Confidence            999999999999999999853222 245999999999876543 234456789999999999888899999999999999


Q ss_pred             HHHHhCCCCCCCC
Q 030527          157 FELLNGYPPFSVG  169 (175)
Q Consensus       157 ~~~~~g~~pf~~~  169 (175)
                      |+|++|..||.+.
T Consensus       211 ~ell~g~~Pf~~~  223 (342)
T 2qr7_A          211 YTMLTGYTPFANG  223 (342)
T ss_dssp             HHHHHSSCSSCSS
T ss_pred             HHHhcCCCCCCCC
Confidence            9999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9.7e-36  Score=217.38  Aligned_cols=160  Identities=34%  Similarity=0.670  Sum_probs=136.8

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ...+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++...    ..+++..+..++.|+  ||++||+.
T Consensus        64 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~  143 (285)
T 3is5_A           64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ  143 (285)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            467899999999999999999999999999999999999999999988543    679999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      |++|+||+|+||++...+..+.++|+|||++.............++..|+|||.+. ..++.++|+||+|+++++|++|.
T Consensus       144 ~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~  222 (285)
T 3is5_A          144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGC  222 (285)
T ss_dssp             TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCC
Confidence            99999999999999644456789999999998776655555667899999999875 56899999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||.+.+
T Consensus       223 ~pf~~~~  229 (285)
T 3is5_A          223 LPFTGTS  229 (285)
T ss_dssp             CSSCCSS
T ss_pred             CCCCCCC
Confidence            9998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-36  Score=228.55  Aligned_cols=167  Identities=26%  Similarity=0.453  Sum_probs=143.1

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHH--H
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQL--G   76 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~~i--~   76 (175)
                      .......+.+|+.++++++||||+++++++...+..++||||+.|++|.+++....       .++...+..++.|+  |
T Consensus       114 ~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a  193 (367)
T 3l9p_A          114 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG  193 (367)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHH
T ss_pred             ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHH
Confidence            34455678899999999999999999999999999999999999999999998653       48999999999998  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC---CccccccCCCCccCcccccccCCCcchhHHHHH
Q 030527           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      |++||++|++||||||+||+++..+.+..++|+|||++......   .......+++.|+|||.+.+..++.++|+||||
T Consensus       194 L~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG  273 (367)
T 3l9p_A          194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG  273 (367)
T ss_dssp             HHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             HHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHH
Confidence            99999999999999999999953334556999999999754322   223345568899999999888999999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCcc
Q 030527          154 AILFELLN-GYPPFSVGEEH  172 (175)
Q Consensus       154 ~~~~~~~~-g~~pf~~~~~~  172 (175)
                      +++++|++ |..||.+.+..
T Consensus       274 ~il~ellt~g~~pf~~~~~~  293 (367)
T 3l9p_A          274 VLLWEIFSLGYMPYPSKSNQ  293 (367)
T ss_dssp             HHHHHHHTTSCCSSTTCCHH
T ss_pred             HHHHHHHhCCCCCCCCCCHH
Confidence            99999998 99999876543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-35  Score=239.15  Aligned_cols=161  Identities=35%  Similarity=0.645  Sum_probs=145.6

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+..|.+++..+ +||+|+++.+++.+.+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||+|||++|+
T Consensus       384 ~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gI  463 (674)
T 3pfq_A          384 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI  463 (674)
T ss_dssp             TTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSE
T ss_pred             HHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            345677899999988 8999999999999999999999999999999999988899999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeecc-CCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +||||||+||++   +.++.++|+|||++.... .........||+.|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus       464 iHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~  540 (674)
T 3pfq_A          464 IYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA  540 (674)
T ss_dssp             ECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred             EeccCChhhEEE---cCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCC
Confidence            999999999999   678899999999998643 3334456778999999999999999999999999999999999999


Q ss_pred             CCCCCCcc
Q 030527          165 PFSVGEEH  172 (175)
Q Consensus       165 pf~~~~~~  172 (175)
                      ||.+.+..
T Consensus       541 Pf~~~~~~  548 (674)
T 3pfq_A          541 PFEGEDED  548 (674)
T ss_dssp             SSCCSSHH
T ss_pred             CCCCCCHH
Confidence            99886643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.7e-35  Score=223.15  Aligned_cols=158  Identities=40%  Similarity=0.821  Sum_probs=143.8

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      .+.+.+|+.+++++ +||||+++++++...+..++||||+.|++|.+++.....+++..+..++.|+  ||++||+.|++
T Consensus       143 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~  222 (365)
T 2y7j_A          143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIV  222 (365)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            56788999999999 8999999999999999999999999999999999988889999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc------cCCCcchhHHHHHHHHHHHH
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~Di~slg~~~~~~~  160 (175)
                      |+||+|+||++   +.++.++|+|||++.............+++.|+|||.+.+      ..++.++|+||||+++|+|+
T Consensus       223 H~Dlkp~NIl~---~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell  299 (365)
T 2y7j_A          223 HRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL  299 (365)
T ss_dssp             CSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEE---CCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHH
Confidence            99999999999   5778899999999988776655556778999999998853      35788999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|..||.+.+
T Consensus       300 ~g~~pf~~~~  309 (365)
T 2y7j_A          300 AGSPPFWHRR  309 (365)
T ss_dssp             HSSCSSCCSS
T ss_pred             HCCCCCCCCC
Confidence            9999997754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-35  Score=214.81  Aligned_cols=160  Identities=34%  Similarity=0.692  Sum_probs=122.8

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      .+.+.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++... ..+++..+..++.|+  ++++||+.|++
T Consensus        55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  134 (278)
T 3cok_A           55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGIL  134 (278)
T ss_dssp             HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            367889999999999999999999999999999999999999999999875 579999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus       135 H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  211 (278)
T 3cok_A          135 HRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP  211 (278)
T ss_dssp             CSSCCGGGEEE---CTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCCHHHEEE---cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999   577889999999998765332 22345678899999999888899999999999999999999999


Q ss_pred             CCCCCcc
Q 030527          166 FSVGEEH  172 (175)
Q Consensus       166 f~~~~~~  172 (175)
                      |...+..
T Consensus       212 ~~~~~~~  218 (278)
T 3cok_A          212 FDTDTVK  218 (278)
T ss_dssp             SCCCSCC
T ss_pred             CCChhHH
Confidence            9876543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.7e-36  Score=222.50  Aligned_cols=163  Identities=27%  Similarity=0.501  Sum_probs=140.8

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ....+..+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++... +.+++..+..++.|+  ||++||+
T Consensus        90 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~  169 (325)
T 3kul_A           90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD  169 (325)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3445678899999999999999999999999999999999999999999999755 579999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      .|++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||.+.+..++.++|+||+|+++++
T Consensus       170 ~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e  246 (325)
T 3kul_A          170 LGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE  246 (325)
T ss_dssp             TTEECSCCSGGGEEE---CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred             CCeeCCCCCcceEEE---CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHH
Confidence            999999999999999   5778899999999987654322    122334667999999988889999999999999999


Q ss_pred             HHh-CCCCCCCCCc
Q 030527          159 LLN-GYPPFSVGEE  171 (175)
Q Consensus       159 ~~~-g~~pf~~~~~  171 (175)
                      +++ |..||.+.+.
T Consensus       247 ll~~g~~p~~~~~~  260 (325)
T 3kul_A          247 VLAYGERPYWNMTN  260 (325)
T ss_dssp             HHTTSCCTTTTSCH
T ss_pred             HHcCCCCCcccCCH
Confidence            999 9999976544

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.2e-35  Score=218.10  Aligned_cols=159  Identities=34%  Similarity=0.594  Sum_probs=138.5

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|++++++++||||+++++++.+.+..++||||+.+ +|.+++.+. ..+++..+..++.|+  ||++||+.|++
T Consensus        63 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv  141 (311)
T 3niz_A           63 PSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRIL  141 (311)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            46788999999999999999999999999999999999964 888888765 459999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHhCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      |+||||+||++   +.++.++|+|||++....... ......+++.|+|||.+.+ ..++.++|+||+|+++++|++|..
T Consensus       142 H~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  218 (311)
T 3niz_A          142 HRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP  218 (311)
T ss_dssp             CCCCCGGGEEE---CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCchHhEEE---CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCC
Confidence            99999999999   577889999999998765432 2334567999999999876 468999999999999999999999


Q ss_pred             CCCCCCcc
Q 030527          165 PFSVGEEH  172 (175)
Q Consensus       165 pf~~~~~~  172 (175)
                      ||.+.++.
T Consensus       219 pf~~~~~~  226 (311)
T 3niz_A          219 LFPGVTDD  226 (311)
T ss_dssp             SCCCSSTT
T ss_pred             CCCCCChH
Confidence            99876554

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.9e-35  Score=214.01  Aligned_cols=158  Identities=35%  Similarity=0.651  Sum_probs=140.0

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++.+...+++..+..++.|+  ++++||+.|++|
T Consensus        53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H  132 (279)
T 3fdn_A           53 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH  132 (279)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEE
T ss_pred             HHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            556889999999999999999999999999999999999999999999988899999999999999  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      +||+|+||++   +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|++++++++|..||.
T Consensus       133 ~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  208 (279)
T 3fdn_A          133 RDIKPENLLL---GSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE  208 (279)
T ss_dssp             CCCCGGGEEE---CTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ccCChHhEEE---cCCCCEEEEeccccccCCccc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCC
Confidence            9999999999   577889999999886554332 334567899999999998889999999999999999999999998


Q ss_pred             CCCc
Q 030527          168 VGEE  171 (175)
Q Consensus       168 ~~~~  171 (175)
                      ..+.
T Consensus       209 ~~~~  212 (279)
T 3fdn_A          209 ANTY  212 (279)
T ss_dssp             CSSH
T ss_pred             CCcH
Confidence            7653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.8e-35  Score=218.44  Aligned_cols=158  Identities=27%  Similarity=0.574  Sum_probs=142.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|+.++++++||||+++++++...+..++||||+.+++|.+++.+ ..+++..+..++.|+  ||++||+.|++
T Consensus        85 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iv  163 (321)
T 2c30_A           85 RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVI  163 (321)
T ss_dssp             SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            355688999999999999999999999999999999999999999998874 579999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |+||+|+||++   +.++.++|+|||++....... ......+++.|+|||.+.+..++.++|+||+|+++++|++|..|
T Consensus       164 H~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p  240 (321)
T 2c30_A          164 HRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP  240 (321)
T ss_dssp             CCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999   577889999999998765432 23455689999999999988899999999999999999999999


Q ss_pred             CCCCC
Q 030527          166 FSVGE  170 (175)
Q Consensus       166 f~~~~  170 (175)
                      |...+
T Consensus       241 f~~~~  245 (321)
T 2c30_A          241 YFSDS  245 (321)
T ss_dssp             TTTSC
T ss_pred             CCCCC
Confidence            97654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.2e-35  Score=213.11  Aligned_cols=161  Identities=33%  Similarity=0.650  Sum_probs=145.3

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ...+..+.+|++++++++||||+++++++.+.+..++|+|++.+++|.+++.+.+.+++..+..++.|+  |+++||+.|
T Consensus        56 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  135 (294)
T 2rku_A           56 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR  135 (294)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345678889999999999999999999999999999999999999999999988899999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      ++|+||+|+||++   +.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|++++++++|+
T Consensus       136 i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  212 (294)
T 2rku_A          136 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK  212 (294)
T ss_dssp             EECCCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccCCChHhEEE---cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999   57788999999999876533 2234456789999999998888999999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||....
T Consensus       213 ~p~~~~~  219 (294)
T 2rku_A          213 PPFETSC  219 (294)
T ss_dssp             CTTCCSS
T ss_pred             CCCCCCC
Confidence            9998754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.4e-35  Score=217.57  Aligned_cols=161  Identities=33%  Similarity=0.650  Sum_probs=145.5

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ...+..+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++.+...+++..+..++.|+  +|++||+.|
T Consensus        82 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  161 (335)
T 2owb_A           82 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR  161 (335)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345678899999999999999999999999999999999999999999999988899999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      ++|+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||||+++++|++|+
T Consensus       162 ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  238 (335)
T 2owb_A          162 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK  238 (335)
T ss_dssp             EECSCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CEecCCCchhEEE---cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCc
Confidence            9999999999999   57778999999999876533 2234456889999999998888999999999999999999999


Q ss_pred             CCCCCCC
Q 030527          164 PPFSVGE  170 (175)
Q Consensus       164 ~pf~~~~  170 (175)
                      .||....
T Consensus       239 ~pf~~~~  245 (335)
T 2owb_A          239 PPFETSC  245 (335)
T ss_dssp             CTTCCSS
T ss_pred             CCCCCCC
Confidence            9998754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.5e-35  Score=218.29  Aligned_cols=158  Identities=33%  Similarity=0.551  Sum_probs=138.8

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHH--HHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ...+.+|++++++++||||+++++++...+..++||||+. ++|.+++...      ..+++..+..++.|+  ||++||
T Consensus        47 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH  125 (317)
T 2pmi_A           47 PSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH  125 (317)
T ss_dssp             CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999999999999999999996 5999998754      358999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~  159 (175)
                      +.|++|+||||+||++   +.++.++|+|||++....... ......+++.|+|||.+.+. .++.++|+||+|+++++|
T Consensus       126 ~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  202 (317)
T 2pmi_A          126 ENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM  202 (317)
T ss_dssp             HTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             HCCeeeCCCChHHeEE---cCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHH
Confidence            9999999999999999   577889999999998765432 23345678999999998764 589999999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030527          160 LNGYPPFSVGEE  171 (175)
Q Consensus       160 ~~g~~pf~~~~~  171 (175)
                      ++|+.||.+.++
T Consensus       203 ~~g~~pf~~~~~  214 (317)
T 2pmi_A          203 ITGKPLFPGTND  214 (317)
T ss_dssp             HHSSCSCCCSSH
T ss_pred             HhCCCCCCCCCh
Confidence            999999987654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.8e-35  Score=215.59  Aligned_cols=158  Identities=37%  Similarity=0.693  Sum_probs=143.2

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++++++++||||+++++++.+.+..++|+|++.+++|.+++.+.+.+++..+..++.|+  |+++||+.|++|
T Consensus        58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  137 (284)
T 2vgo_A           58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIH  137 (284)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            467889999999999999999999999999999999999999999999988899999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      +||+|+||++   +.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|++++++++|..||.
T Consensus       138 ~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  213 (284)
T 2vgo_A          138 RDIKPENLLM---GYKGELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD  213 (284)
T ss_dssp             CCCSGGGEEE---CTTCCEEECCCTTCEECSSSC-BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             cCCCHHHEEE---cCCCCEEEecccccccCcccc-cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCC
Confidence            9999999999   577789999999987664432 334567899999999998889999999999999999999999998


Q ss_pred             CCCc
Q 030527          168 VGEE  171 (175)
Q Consensus       168 ~~~~  171 (175)
                      ..+.
T Consensus       214 ~~~~  217 (284)
T 2vgo_A          214 SPSH  217 (284)
T ss_dssp             CSSH
T ss_pred             CCCH
Confidence            7543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.8e-36  Score=215.50  Aligned_cols=160  Identities=27%  Similarity=0.521  Sum_probs=140.9

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ..+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++... +.+++..+..++.|+  ++++||+.|+
T Consensus        48 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  127 (269)
T 4hcu_A           48 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV  127 (269)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3567899999999999999999999999999999999999999999999754 468999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC--ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      +|+||+|+||++   +.++.++|+|||++.......  ......++..|+|||.+.+..++.++|+||+|++++++++ |
T Consensus       128 ~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g  204 (269)
T 4hcu_A          128 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG  204 (269)
T ss_dssp             CCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             ecCCcchheEEE---cCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCC
Confidence            999999999999   577889999999997664432  1223345667999999988899999999999999999999 9


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||...+.
T Consensus       205 ~~p~~~~~~  213 (269)
T 4hcu_A          205 KIPYENRSN  213 (269)
T ss_dssp             CCTTTTCCH
T ss_pred             CCCCCCCCH
Confidence            999987654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.7e-35  Score=218.72  Aligned_cols=164  Identities=37%  Similarity=0.610  Sum_probs=137.0

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+.+|+++++++ +||||+++++++.+.+..++||||+.+++|.+++.+...+++..+..++.|+  ||++||+.|
T Consensus        52 ~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  131 (316)
T 2ac3_A           52 HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG  131 (316)
T ss_dssp             CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3466788999999985 8999999999999999999999999999999999988899999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC--------ccccccCCCCccCcccccc-----cCCCcchhHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWS  151 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~s  151 (175)
                      ++|+||+|+||+++..+....++|+|||++.......        ......++..|+|||.+.+     ..++.++|+||
T Consensus       132 ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws  211 (316)
T 2ac3_A          132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS  211 (316)
T ss_dssp             CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHH
T ss_pred             ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHh
Confidence            9999999999999532333449999999987653221        1123458899999999864     45889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCc
Q 030527          152 VGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       152 lg~~~~~~~~g~~pf~~~~~  171 (175)
                      +|+++++|++|+.||.+...
T Consensus       212 lG~il~~l~~g~~pf~~~~~  231 (316)
T 2ac3_A          212 LGVILYILLSGYPPFVGRCG  231 (316)
T ss_dssp             HHHHHHHHHHSSCSCCCCCC
T ss_pred             HHHHHHHHHHCCCCCccccc
Confidence            99999999999999987643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-35  Score=215.10  Aligned_cols=160  Identities=27%  Similarity=0.564  Sum_probs=141.4

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|++++++++||||+++++++.+.+..++|||++++++|.+++...+ .+++..+..++.|+  |+++||+.|+
T Consensus        46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  125 (268)
T 3sxs_A           46 SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF  125 (268)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            35678999999999999999999999999999999999999999999998764 59999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      +|+||+|+||++   +.++.++|+|||.+.........  ....++..|+|||.+.+..++.++|+||+|++++++++ |
T Consensus       126 ~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g  202 (268)
T 3sxs_A          126 IHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG  202 (268)
T ss_dssp             EESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTT
T ss_pred             ecCCcCcceEEE---CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCC
Confidence            999999999999   57788999999999876554322  22334567999999988889999999999999999999 9


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||...+.
T Consensus       203 ~~p~~~~~~  211 (268)
T 3sxs_A          203 KMPYDLYTN  211 (268)
T ss_dssp             CCTTTTSCH
T ss_pred             CCCccccCh
Confidence            999976543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-35  Score=229.73  Aligned_cols=159  Identities=36%  Similarity=0.523  Sum_probs=133.0

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GL   77 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l   77 (175)
                      ......++.+|+++++.++||||+++++++...      ...++||||+.+ ++.+.+.  ..+++..+..++.|+  ||
T Consensus       101 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL  177 (464)
T 3ttj_A          101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGI  177 (464)
T ss_dssp             SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHH
Confidence            344566788999999999999999999998654      467999999955 6766664  358999999999998  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~  157 (175)
                      +|||+.|++||||||+||++   +.++.++|+|||++.............+|+.|+|||.+.+..++.++|+||+|++++
T Consensus       178 ~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  254 (464)
T 3ttj_A          178 KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG  254 (464)
T ss_dssp             HHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             HHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHH
Confidence            99999999999999999999   677889999999998876665555677899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 030527          158 ELLNGYPPFSVGE  170 (175)
Q Consensus       158 ~~~~g~~pf~~~~  170 (175)
                      +|++|+.||.+.+
T Consensus       255 ell~g~~pF~g~~  267 (464)
T 3ttj_A          255 EMVRHKILFPGRD  267 (464)
T ss_dssp             HHHHSSCSSCCSS
T ss_pred             HHHhCCCCCCCCC
Confidence            9999999998765

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=218.22  Aligned_cols=157  Identities=36%  Similarity=0.577  Sum_probs=138.4

Q ss_pred             hhHHHHHHHHhhC---CCCCeeeEeeEEeeCC-----eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHH--HHH
Q 030527           11 SCLDCELNFLSSV---NHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLE   78 (175)
Q Consensus        11 ~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~i--~l~   78 (175)
                      ..+.+|+++++++   +||||+++++++....     ..++++|++. ++|.+++.+...  +++..+..++.|+  ||+
T Consensus        56 ~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~  134 (308)
T 3g33_A           56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD  134 (308)
T ss_dssp             HHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence            4567788877776   4999999999998755     5799999995 699999987654  9999999999999  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      +||+.|++|+||||+||++   +.++.++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++++
T Consensus       135 ~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~  211 (308)
T 3g33_A          135 FLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE  211 (308)
T ss_dssp             HHHHTTCCCSCCCTTTEEE---CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHH
T ss_pred             HHHHCCcccCCCCHHHEEE---cCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHH
Confidence            9999999999999999999   5778899999999987766555566778999999999998899999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030527          159 LLNGYPPFSVGEE  171 (175)
Q Consensus       159 ~~~g~~pf~~~~~  171 (175)
                      |++|..||.+.++
T Consensus       212 l~~g~~pf~~~~~  224 (308)
T 3g33_A          212 MFRRKPLFCGNSE  224 (308)
T ss_dssp             TTTSSCSCCCSSH
T ss_pred             HHhCCCCCCCCCH
Confidence            9999999987654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-35  Score=217.63  Aligned_cols=161  Identities=30%  Similarity=0.583  Sum_probs=138.2

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .....+.+|++++++++||||+++++++...+..++||||+.+++|.+++...+.+++..+..++.|+  |+++||+.|+
T Consensus        44 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~i  123 (311)
T 4agu_A           44 VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC  123 (311)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            34567889999999999999999999999999999999999999999998878889999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHhCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +|+||+|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|++++++++|.
T Consensus       124 vH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~  200 (311)
T 4agu_A          124 IHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV  200 (311)
T ss_dssp             ECCCCSGGGEEE---CTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCChhhEEE---cCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence            999999999999   577889999999998765332 2344567889999999875 56799999999999999999999


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||.+.++
T Consensus       201 ~p~~~~~~  208 (311)
T 4agu_A          201 PLWPGKSD  208 (311)
T ss_dssp             CSCCCSSH
T ss_pred             CCCCCCCH
Confidence            99987654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.9e-35  Score=212.88  Aligned_cols=158  Identities=42%  Similarity=0.764  Sum_probs=134.3

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++++++++||||+++++++...+..++|+|++.+++|.+++.+.+.+++..+..++.|+  +|++||+.|++|
T Consensus        55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  134 (276)
T 2h6d_A           55 VGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVH  134 (276)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSC
T ss_pred             HHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            457889999999999999999999999999999999999999999999988899999999999999  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      +||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..+ +.++|+||+|++++++++|..||
T Consensus       135 ~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  211 (276)
T 2h6d_A          135 RDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF  211 (276)
T ss_dssp             CCCCGGGEEE---CTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCChhhEEE---CCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            9999999999   5777899999999987766554555678899999999987665 68999999999999999999999


Q ss_pred             CCCC
Q 030527          167 SVGE  170 (175)
Q Consensus       167 ~~~~  170 (175)
                      ...+
T Consensus       212 ~~~~  215 (276)
T 2h6d_A          212 DDEH  215 (276)
T ss_dssp             CCSS
T ss_pred             CCCc
Confidence            7654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.2e-35  Score=220.06  Aligned_cols=162  Identities=28%  Similarity=0.408  Sum_probs=142.1

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHH--HHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      .....+.+|++++++++||||+++++++...+..++||||+.+++|.+++....    .+++..+..++.|+  ||++||
T Consensus        77 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH  156 (321)
T 2qkw_B           77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH  156 (321)
T ss_dssp             SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc
Confidence            445678999999999999999999999999999999999999999999986543    48999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      +.|++|+||+|+||++   +.++.++|+|||++.......   ......++..|+|||.+.+..++.++|+||+|+++++
T Consensus       157 ~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  233 (321)
T 2qkw_B          157 TRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE  233 (321)
T ss_dssp             HTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHH
T ss_pred             CCCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHH
Confidence            9999999999999999   577889999999997654322   1223447889999999988889999999999999999


Q ss_pred             HHhCCCCCCCCCcc
Q 030527          159 LLNGYPPFSVGEEH  172 (175)
Q Consensus       159 ~~~g~~pf~~~~~~  172 (175)
                      +++|..||....+.
T Consensus       234 ll~g~~p~~~~~~~  247 (321)
T 2qkw_B          234 VLCARSAIVQSLPR  247 (321)
T ss_dssp             HHHCCTTCSCSSSS
T ss_pred             HHhCCCcccccCcH
Confidence            99999999876543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.9e-36  Score=228.65  Aligned_cols=160  Identities=41%  Similarity=0.731  Sum_probs=132.9

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      ..+.+|++++++++||||+++++++.. +..++||||+.+++|.+++.+.+.+++..+..++.|+  ||+|||++|++|+
T Consensus       185 ~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr  263 (419)
T 3i6u_A          185 LNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR  263 (419)
T ss_dssp             CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            368899999999999999999999754 4579999999999999999888889999999999999  9999999999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc---cCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      ||||+||++...+....++|+|||++.............+++.|+|||.+.+   ..++.++|+||+|+++++|++|+.|
T Consensus       264 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p  343 (419)
T 3i6u_A          264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP  343 (419)
T ss_dssp             CCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            9999999996444455699999999988766555556778999999999853   5678899999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.....
T Consensus       344 f~~~~~  349 (419)
T 3i6u_A          344 FSEHRT  349 (419)
T ss_dssp             SCCCSS
T ss_pred             CCCCcc
Confidence            986543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-35  Score=224.79  Aligned_cols=162  Identities=25%  Similarity=0.492  Sum_probs=132.2

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ...++.+.+|++++++++||||+++++++...+..++||||+++++|.+++.+.+ .+++.++..++.|+  ||++||+.
T Consensus        87 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  166 (373)
T 2qol_A           87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM  166 (373)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4456789999999999999999999999999999999999999999999998764 69999999999999  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      |++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||.+.+..++.++|+||||++++++
T Consensus       167 ~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~el  243 (373)
T 2qol_A          167 GYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV  243 (373)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             CeeCCCCCcceEEE---cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHH
Confidence            99999999999999   5778899999999987654321    1122346679999999988999999999999999999


Q ss_pred             Hh-CCCCCCCCCc
Q 030527          160 LN-GYPPFSVGEE  171 (175)
Q Consensus       160 ~~-g~~pf~~~~~  171 (175)
                      ++ |..||...+.
T Consensus       244 lt~g~~P~~~~~~  256 (373)
T 2qol_A          244 MSYGERPYWEMSN  256 (373)
T ss_dssp             HTTC-CTTTTCCH
T ss_pred             HhCCCCCCCCCCH
Confidence            98 9999976543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.2e-35  Score=217.12  Aligned_cols=162  Identities=38%  Similarity=0.668  Sum_probs=142.8

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|++++++++||||+++++++.+.+..++|+|++.+++|.+++.+.+.+++..+..++.|+  ||++||+.|++
T Consensus        49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  128 (304)
T 2jam_A           49 RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV  128 (304)
T ss_dssp             ---HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3456889999999999999999999999999999999999999999999888899999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |+||+|+||++...+.++.++|+|||++...... ......++..|+|||.+.+..++.++|+||+|++++++++|..||
T Consensus       129 H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  207 (304)
T 2jam_A          129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF  207 (304)
T ss_dssp             CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            9999999999954456778999999998655332 233456899999999999888999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      ...+.
T Consensus       208 ~~~~~  212 (304)
T 2jam_A          208 YEETE  212 (304)
T ss_dssp             TTSCH
T ss_pred             CCCCH
Confidence            76543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.1e-35  Score=226.51  Aligned_cols=166  Identities=27%  Similarity=0.519  Sum_probs=141.3

Q ss_pred             ccccch-hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC-eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHH--
Q 030527            2 LKKLNK-HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--   75 (175)
Q Consensus         2 lk~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~i--   75 (175)
                      ||.++. ...+.+.+|++++++++||||+++++++...+ ..++||||+.+++|.+++.+.+.  +++..+..++.|+  
T Consensus       221 vK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~  300 (450)
T 1k9a_A          221 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE  300 (450)
T ss_dssp             EEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHH
T ss_pred             EEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHH
Confidence            454432 34667899999999999999999999987654 79999999999999999987654  7999999999999  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  155 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~  155 (175)
                      ||+|||++|++|+||+|+||++   +.++.++|+|||++.......  ....++..|+|||.+.+..++.++|+||||++
T Consensus       301 ~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~  375 (450)
T 1k9a_A          301 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGIL  375 (450)
T ss_dssp             HHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHH
T ss_pred             HHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHH
Confidence            9999999999999999999999   577889999999998654332  23356788999999998899999999999999


Q ss_pred             HHHHHh-CCCCCCCCCcc
Q 030527          156 LFELLN-GYPPFSVGEEH  172 (175)
Q Consensus       156 ~~~~~~-g~~pf~~~~~~  172 (175)
                      ++++++ |..||.+.+..
T Consensus       376 l~el~t~g~~P~~~~~~~  393 (450)
T 1k9a_A          376 LWEIYSFGRVPYPRIPLK  393 (450)
T ss_dssp             HHHHHTTTCCSSTTSCTT
T ss_pred             HHHHHhCCCCCCCCCCHH
Confidence            999998 99999876544

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-35  Score=221.80  Aligned_cols=162  Identities=25%  Similarity=0.529  Sum_probs=141.4

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc------------------------CC
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------GR   62 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~   62 (175)
                      ......+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++.+.                        ..
T Consensus        91 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (343)
T 1luf_A           91 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP  170 (343)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCC
Confidence            344677899999999999999999999999999999999999999999999864                        46


Q ss_pred             CCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCccc
Q 030527           63 VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEV  137 (175)
Q Consensus        63 l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~  137 (175)
                      +++..+..++.|+  +|++||+.|++|+||+|+||++   +.++.++|+|||++.......   ......++..|+|||.
T Consensus       171 l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  247 (343)
T 1luf_A          171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  247 (343)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhh
Confidence            8999999999999  9999999999999999999999   577889999999997654332   1233456788999999


Q ss_pred             ccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          138 LQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       138 ~~~~~~~~~~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      +.+..++.++|+||||+++|+|++ |..||.+.+.
T Consensus       248 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          248 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             hccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            988889999999999999999999 9999987543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.5e-35  Score=220.06  Aligned_cols=167  Identities=27%  Similarity=0.404  Sum_probs=143.9

Q ss_pred             ccccc--hhhhhhHHHHHHHHhhCC-----CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHH
Q 030527            2 LKKLN--KHLKSCLDCELNFLSSVN-----HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFL   72 (175)
Q Consensus         2 lk~~~--~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~   72 (175)
                      ||.+.  ....+.+..|.++++.+.     ||||+++++++...+..++|||++ +++|.+++.+..  .+++..+..++
T Consensus        65 vK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~  143 (360)
T 3llt_A           65 VKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYC  143 (360)
T ss_dssp             EEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHH
T ss_pred             EEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHH
Confidence            45543  444567788999999996     999999999999999999999999 999999998764  59999999999


Q ss_pred             HHH--HHHHHHHcCCeecCCCCCcEEEeec----------------------CCCceEEEeeecceeeccCCCccccccC
Q 030527           73 QQL--GLEILNSHHIIHRDLKPENILLSGL----------------------DDDVMLKIADFGLSCTLYPGNYAEKVCG  128 (175)
Q Consensus        73 ~~i--~l~~lh~~~~~h~di~~~ni~~~~~----------------------~~~~~~~l~df~~~~~~~~~~~~~~~~~  128 (175)
                      .|+  ||+|||+.|++|+||||+||++...                      ...+.++|+|||++......  .....+
T Consensus       144 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~g  221 (360)
T 3llt_A          144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIIN  221 (360)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCS
T ss_pred             HHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccC
Confidence            998  9999999999999999999999421                      12667999999999875443  335567


Q ss_pred             CCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          129 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       129 ~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ++.|+|||.+.+..++.++|+||+|+++++|++|+.||...++
T Consensus       222 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  264 (360)
T 3llt_A          222 TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH  264 (360)
T ss_dssp             CGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence            9999999999999999999999999999999999999987653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.3e-35  Score=217.58  Aligned_cols=163  Identities=30%  Similarity=0.503  Sum_probs=142.6

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCC------------------------
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR------------------------   62 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------   62 (175)
                      ....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++.+...                        
T Consensus        67 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (314)
T 2ivs_A           67 PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA  146 (314)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CE
T ss_pred             HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccC
Confidence            34457788999999999999999999999999999999999999999999987543                        


Q ss_pred             CCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCccc
Q 030527           63 VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEV  137 (175)
Q Consensus        63 l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~  137 (175)
                      +++..+..++.|+  ||++||+.|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||.
T Consensus       147 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  223 (314)
T 2ivs_A          147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES  223 (314)
T ss_dssp             ECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence            8899999999999  9999999999999999999999   4677899999999987654332   223445677999999


Q ss_pred             ccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030527          138 LQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEH  172 (175)
Q Consensus       138 ~~~~~~~~~~Di~slg~~~~~~~~-g~~pf~~~~~~  172 (175)
                      +.+..++.++|+||+|+++++|++ |..||.+.+..
T Consensus       224 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  259 (314)
T 2ivs_A          224 LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE  259 (314)
T ss_dssp             HHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            988889999999999999999999 99999876543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.5e-35  Score=213.41  Aligned_cols=168  Identities=18%  Similarity=0.268  Sum_probs=143.7

Q ss_pred             ccccc-hhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--H
Q 030527            2 LKKLN-KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--G   76 (175)
Q Consensus         2 lk~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~   76 (175)
                      +|.+. ......+.+|+++++++ +|++++++++++......++|+|++ +++|.+++...+ .+++..+..++.|+  |
T Consensus        40 vK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~  118 (298)
T 1csn_A           40 IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLAR  118 (298)
T ss_dssp             EEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHH
T ss_pred             EEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHH
Confidence            44442 34456789999999999 8999999999999999999999999 999999998764 59999999999999  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeec--CCCceEEEeeecceeeccCCCc--------cccccCCCCccCcccccccCCCcc
Q 030527           77 LEILNSHHIIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEK  146 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~--~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~  146 (175)
                      |++||+.|++|+||+|+||+++..  .....++|+|||++........        .....++..|+|||.+.+..++.+
T Consensus       119 l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  198 (298)
T 1csn_A          119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR  198 (298)
T ss_dssp             HHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH
T ss_pred             HHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChH
Confidence            999999999999999999999522  1223499999999987754422        234568899999999998889999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCC
Q 030527          147 VDMWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       147 ~Di~slg~~~~~~~~g~~pf~~~~  170 (175)
                      +|+||||+++++|++|+.||.+.+
T Consensus       199 ~Di~slG~il~el~~g~~pf~~~~  222 (298)
T 1csn_A          199 DDLEALGHVFMYFLRGSLPWQGLK  222 (298)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             HHHHHHHHHHHHHHcCCCCcchhh
Confidence            999999999999999999998754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.5e-35  Score=215.90  Aligned_cols=160  Identities=26%  Similarity=0.513  Sum_probs=141.0

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ..+++.+|++++++++||||+++++++.+.+..++||||+.+++|.+++.. ...+++..+..++.|+  +|++||++|+
T Consensus        62 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  141 (283)
T 3gen_A           62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF  141 (283)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            356789999999999999999999999999999999999999999999986 4679999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      +|+||+|+||++   +.++.++|+|||++........  .....++..|+|||.+.+..++.++|+||+|++++++++ |
T Consensus       142 ~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g  218 (283)
T 3gen_A          142 LHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG  218 (283)
T ss_dssp             CCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTT
T ss_pred             cCCCCccceEEE---cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence            999999999999   5777899999999976644321  223345667999999998889999999999999999998 9


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||...+.
T Consensus       219 ~~p~~~~~~  227 (283)
T 3gen_A          219 KMPYERFTN  227 (283)
T ss_dssp             CCTTTTSCH
T ss_pred             CCCccccCh
Confidence            999986543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.3e-35  Score=215.63  Aligned_cols=159  Identities=34%  Similarity=0.573  Sum_probs=136.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|++++++++||||+++++++...+..++|||++.+ +|.+++... +.+++..+..++.|+  ||++||+.|+
T Consensus        43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  121 (288)
T 1ob3_A           43 IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV  121 (288)
T ss_dssp             CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             cchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            346788999999999999999999999999999999999965 999998865 679999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +|+||+|+||++   +.++.++|+|||++....... ......+++.|+|||.+.+. .++.++|+||+|+++++|++|.
T Consensus       122 ~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~  198 (288)
T 1ob3_A          122 LHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT  198 (288)
T ss_dssp             CCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCCHHHEEE---cCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999   577889999999997664332 22345678999999998754 5899999999999999999999


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||.+.++
T Consensus       199 ~pf~~~~~  206 (288)
T 1ob3_A          199 PLFPGVSE  206 (288)
T ss_dssp             CSCCCSSH
T ss_pred             CCCCCCCH
Confidence            99987543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.8e-35  Score=212.58  Aligned_cols=155  Identities=34%  Similarity=0.585  Sum_probs=134.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+.+|++++++++||||+++++++.+.+..++||||+.+ ++.+++.. .+.+++..+..++.|+  ||++||++|
T Consensus        43 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~  121 (292)
T 3o0g_A           43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN  121 (292)
T ss_dssp             THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3456788999999999999999999999999999999999965 66665554 5789999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccC-CCcchhHHHHHHHHHHHHhC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~g  162 (175)
                      ++|+||||+||++   +.++.++|+|||++....... ......++..|+|||.+.+.. ++.++|+||+|+++++|++|
T Consensus       122 ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~  198 (292)
T 3o0g_A          122 VLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA  198 (292)
T ss_dssp             EECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred             eecCCCCHHHEEE---cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHc
Confidence            9999999999999   577889999999998765432 234456789999999997665 79999999999999999998


Q ss_pred             CCCC
Q 030527          163 YPPF  166 (175)
Q Consensus       163 ~~pf  166 (175)
                      ..||
T Consensus       199 ~~p~  202 (292)
T 3o0g_A          199 GRPL  202 (292)
T ss_dssp             SCCS
T ss_pred             CCCC
Confidence            7775

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.7e-35  Score=218.04  Aligned_cols=162  Identities=31%  Similarity=0.503  Sum_probs=139.0

Q ss_pred             hhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHH
Q 030527            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~   69 (175)
                      ....+.+.+|+++++++ +||||+++++++.+.+..++|||++++++|.+++.+..                .+++..+.
T Consensus        66 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (327)
T 1fvr_A           66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL  145 (327)
T ss_dssp             ----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHH
Confidence            34566789999999999 99999999999999999999999999999999998654                69999999


Q ss_pred             HHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcch
Q 030527           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV  147 (175)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~  147 (175)
                      .++.|+  ||++||+.|++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++
T Consensus       146 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  222 (327)
T 1fvr_A          146 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS  222 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHH
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchh
Confidence            999999  9999999999999999999999   57778999999998755433333345567889999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          148 DMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       148 Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      |+||+|++++++++ |..||.+.+.
T Consensus       223 Di~slG~il~ellt~g~~pf~~~~~  247 (327)
T 1fvr_A          223 DVWSYGVLLWEIVSLGGTPYCGMTC  247 (327)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             cchHHHHHHHHHHcCCCCCCCCCcH
Confidence            99999999999998 9999977543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.3e-35  Score=221.75  Aligned_cols=162  Identities=33%  Similarity=0.569  Sum_probs=143.4

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      +....+.+.+|++++++++||||+++++++...+..++||||+.+++|.+++.+.+.+++..+..++.++  ++++||+.
T Consensus        71 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~  150 (360)
T 3eqc_A           71 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK  150 (360)
T ss_dssp             CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            3455678899999999999999999999999999999999999999999999988899999999999998  99999996


Q ss_pred             -CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           84 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        84 -~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                       |++|+||+|+||++   +.++.++|+|||++....... .....+++.|+|||.+.+..++.++|+||+|+++++|++|
T Consensus       151 ~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  226 (360)
T 3eqc_A          151 HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG  226 (360)
T ss_dssp             HCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHHC-----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEcCCccHHHEEE---CCCCCEEEEECCCCccccccc-ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence             99999999999999   577889999999986553322 2345678999999999988999999999999999999999


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||...+.
T Consensus       227 ~~pf~~~~~  235 (360)
T 3eqc_A          227 RYPIPPPDA  235 (360)
T ss_dssp             SCCSSCCCH
T ss_pred             CCCCCCCCH
Confidence            999987553

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-35  Score=219.45  Aligned_cols=167  Identities=27%  Similarity=0.431  Sum_probs=139.4

Q ss_pred             ccccchh--hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 030527            2 LKKLNKH--LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (175)
Q Consensus         2 lk~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i   75 (175)
                      ||.+...  .......|+.++++++||||+++++++...+    ..++||||+++++|.+++++ ..+++..+..++.|+
T Consensus        52 vK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi  130 (322)
T 3soc_A           52 VKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETM  130 (322)
T ss_dssp             EEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred             EEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHH
Confidence            5555433  3345566888899999999999999998743    47999999999999999975 469999999999999


Q ss_pred             --HHHHHHHc----------CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccc
Q 030527           76 --GLEILNSH----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF  140 (175)
Q Consensus        76 --~l~~lh~~----------~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~  140 (175)
                        ||+|||+.          |++|+||||+||++   +.++.++|+|||++........   .....+++.|+|||.+.+
T Consensus       131 ~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  207 (322)
T 3soc_A          131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG  207 (322)
T ss_dssp             HHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred             HHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEccCCcccccccccCccccccCccCccccCHhhccc
Confidence              99999999          99999999999999   5778899999999987654432   223568999999999876


Q ss_pred             -----cCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030527          141 -----QRYDEKVDMWSVGAILFELLNGYPPFSVGEEH  172 (175)
Q Consensus       141 -----~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~~  172 (175)
                           ..++.++|+||+|+++|+|++|..||.+..+.
T Consensus       208 ~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  244 (322)
T 3soc_A          208 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE  244 (322)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred             ccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence                 34567889999999999999999999876543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.3e-35  Score=214.71  Aligned_cols=159  Identities=23%  Similarity=0.463  Sum_probs=133.0

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|++++++++||||+++++++...+..++++|++.+++|.+++.+.+.+++..+..++.|+  ++++||+.|++
T Consensus        77 ~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  156 (309)
T 2h34_A           77 FRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGAT  156 (309)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCC
Confidence            3577889999999999999999999999999999999999999999999988899999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      |+||+|+||++   +.++.++|+|||++........  .....++..|+|||.+.+..++.++|+||||++++++++|+.
T Consensus       157 H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  233 (309)
T 2h34_A          157 HRDVKPENILV---SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP  233 (309)
T ss_dssp             CSCCCGGGEEE---CTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSC
T ss_pred             cCCCChHHEEE---cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCC
Confidence            99999999999   5778899999999876644321  234567889999999988889999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||.+.+
T Consensus       234 pf~~~~  239 (309)
T 2h34_A          234 PYQGDQ  239 (309)
T ss_dssp             SSCSCH
T ss_pred             CCCCch
Confidence            998654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-35  Score=222.46  Aligned_cols=161  Identities=30%  Similarity=0.513  Sum_probs=142.1

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHH
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~   70 (175)
                      ....++.+|+++++++ +||||+++++++...+..++||||+.+++|.+++....                .+++..+..
T Consensus       116 ~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  195 (382)
T 3tt0_A          116 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS  195 (382)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHH
Confidence            3456788999999999 99999999999999999999999999999999998754                489999999


Q ss_pred             HHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCCCc
Q 030527           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDE  145 (175)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~  145 (175)
                      ++.|+  ||++||+.|++|+||||+||++   +.++.++|+|||++.......   ......++..|+|||.+.+..++.
T Consensus       196 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  272 (382)
T 3tt0_A          196 CAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH  272 (382)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCH
T ss_pred             HHHHHHHHHHHHHhCCEecCCCCcceEEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCc
Confidence            99999  9999999999999999999999   577889999999998765432   122344567899999999889999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          146 KVDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       146 ~~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      ++|+||||++++++++ |..||.+.+.
T Consensus       273 ~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          273 QSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999 9999987653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.5e-35  Score=221.41  Aligned_cols=160  Identities=32%  Similarity=0.521  Sum_probs=135.8

Q ss_pred             hhhhhhHHHHHHHHhhCC-CCCeeeEeeEEeeCC--eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      .....++.+|+.+++++. ||||+++++++...+  ..++||||+. ++|.+++.. +.+++..+..++.|+  ||+|||
T Consensus        49 ~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH  126 (388)
T 3oz6_A           49 STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLH  126 (388)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence            445567788999999996 999999999997544  7899999995 589998875 578999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC----------------------CccccccCCCCccCccccc
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----------------------NYAEKVCGSPLYMAPEVLQ  139 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~----------------------~~~~~~~~~~~~~~pe~~~  139 (175)
                      +.|++||||||+||++   +.++.++|+|||+++.....                      .......+|+.|+|||.+.
T Consensus       127 ~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  203 (388)
T 3oz6_A          127 SGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL  203 (388)
T ss_dssp             HTTEECCCCCGGGEEE---CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHT
T ss_pred             hCCEEeCCCCHHHeEE---cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhc
Confidence            9999999999999999   67788999999999865331                      1122346889999999987


Q ss_pred             c-cCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          140 F-QRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       140 ~-~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      + ..++.++|+||+||++++|++|+.||.+.+.
T Consensus       204 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          204 GSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            6 5789999999999999999999999987654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.1e-34  Score=212.66  Aligned_cols=160  Identities=43%  Similarity=0.812  Sum_probs=143.8

Q ss_pred             hhhhHHHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .+..+.+|+++++++. ||||+++++++...+..++|+|++.+++|.+++.+...+++..+..++.|+  +|++||+.|+
T Consensus        66 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  145 (298)
T 1phk_A           66 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNI  145 (298)
T ss_dssp             HHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            3567788999999995 999999999999999999999999999999999988899999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccc------ccCCCcchhHHHHHHHHHHH
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~------~~~~~~~~Di~slg~~~~~~  159 (175)
                      +|+||+|+||++   +.++.++|+|||.+.............++..|+|||.+.      ...++.++|+||||++++++
T Consensus       146 ~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l  222 (298)
T 1phk_A          146 VHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL  222 (298)
T ss_dssp             ECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred             ccCCCCcceEEE---cCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHH
Confidence            999999999999   577789999999998876665555667899999999875      34578899999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030527          160 LNGYPPFSVGEE  171 (175)
Q Consensus       160 ~~g~~pf~~~~~  171 (175)
                      ++|..||.+.+.
T Consensus       223 ~~g~~p~~~~~~  234 (298)
T 1phk_A          223 LAGSPPFWHRKQ  234 (298)
T ss_dssp             HHSSCSSCCSSH
T ss_pred             HHCCCCCcCccH
Confidence            999999976543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.2e-35  Score=222.31  Aligned_cols=153  Identities=16%  Similarity=0.246  Sum_probs=131.0

Q ss_pred             HHHHHHhhCCCCCeeeEeeEEeeC----CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           15 CELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        15 ~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      .|+..++.++||||+++++++...    ...++||||+ |++|.+++... +.+++..+..++.|+  ||+|||+.|++|
T Consensus        97 ~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiH  175 (364)
T 3op5_A           97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVH  175 (364)
T ss_dssp             HHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEE
Confidence            345556677899999999998764    5689999999 99999999876 579999999999999  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--------ccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      +||||+||+++. +.++.++|+|||++.........        ....+|+.|+|||.+.+..++.++|+||||+++|+|
T Consensus       176 rDlkp~Nill~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el  254 (364)
T 3op5_A          176 GDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQW  254 (364)
T ss_dssp             CCCCGGGEEEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ecCCHHHEEEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHH
Confidence            999999999941 25678999999999776433211        233489999999999988999999999999999999


Q ss_pred             HhCCCCCCCC
Q 030527          160 LNGYPPFSVG  169 (175)
Q Consensus       160 ~~g~~pf~~~  169 (175)
                      ++|+.||.+.
T Consensus       255 ~~g~~Pf~~~  264 (364)
T 3op5_A          255 LTGHLPWEDN  264 (364)
T ss_dssp             HHSCCTTGGG
T ss_pred             HhCCCCcccc
Confidence            9999999863

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.9e-35  Score=215.98  Aligned_cols=158  Identities=30%  Similarity=0.561  Sum_probs=135.0

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC-----------------------------------------------
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----------------------------------------------   39 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----------------------------------------------   39 (175)
                      +...+.+.+|++++++++||||+++++++.+.+                                               
T Consensus        45 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  124 (332)
T 3qd2_B           45 ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV  124 (332)
T ss_dssp             TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------------------
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccc
Confidence            345678899999999999999999999986543                                               


Q ss_pred             ----------eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCc
Q 030527           40 ----------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV  104 (175)
Q Consensus        40 ----------~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~  104 (175)
                                ..++||||+.+++|.+++.+...   .+...+..++.|+  ||++||++|++|+||||+||++   +.++
T Consensus       125 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~  201 (332)
T 3qd2_B          125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD  201 (332)
T ss_dssp             -------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTC
T ss_pred             ccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCC
Confidence                      38999999999999999987643   5566788999998  9999999999999999999999   5778


Q ss_pred             eEEEeeecceeeccCCC-------------ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527          105 MLKIADFGLSCTLYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus       105 ~~~l~df~~~~~~~~~~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      .++|+|||++.......             ......+++.|+|||.+.+..++.++|+||+|++++++++|..|+.
T Consensus       202 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~  277 (332)
T 3qd2_B          202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM  277 (332)
T ss_dssp             CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred             CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence            89999999998775542             1223468899999999998899999999999999999999987763

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.1e-35  Score=215.93  Aligned_cols=164  Identities=28%  Similarity=0.482  Sum_probs=144.3

Q ss_pred             CccccchhhhhhHHHHHHHHhhCC-CCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--
Q 030527            1 MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--   75 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--   75 (175)
                      ++|.++....+.+.+|++++++++ ||||+++++++.+  ....++|||++.+++|.++++   .+++..+..++.|+  
T Consensus        65 avK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~  141 (330)
T 3nsz_A           65 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILK  141 (330)
T ss_dssp             EEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHH
T ss_pred             EEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHH
Confidence            367777777888999999999996 9999999999987  667899999999999999875   48899999999998  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA  154 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~  154 (175)
                      ||++||+.|++|+||+|+||+++  ..+..++|+|||++.............++..|+|||.+.+ ..++.++|+||+|+
T Consensus       142 ~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  219 (330)
T 3nsz_A          142 ALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC  219 (330)
T ss_dssp             HHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred             HHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHH
Confidence            99999999999999999999995  3444899999999988766655556678899999999876 56899999999999


Q ss_pred             HHHHHHhCCCCCCCC
Q 030527          155 ILFELLNGYPPFSVG  169 (175)
Q Consensus       155 ~~~~~~~g~~pf~~~  169 (175)
                      ++++|++|..||...
T Consensus       220 il~~ll~g~~p~~~~  234 (330)
T 3nsz_A          220 MLASMIFRKEPFFHG  234 (330)
T ss_dssp             HHHHHHHTCSSSSCC
T ss_pred             HHHHHHhCCCCcccC
Confidence            999999999999544

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4e-35  Score=218.00  Aligned_cols=161  Identities=26%  Similarity=0.425  Sum_probs=138.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+.+|++++++++||||+++++++...+ .+++++++.+++|.+++.+. +.+++..+..++.|+  ||+|||+.|
T Consensus        59 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  137 (327)
T 3poz_A           59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR  137 (327)
T ss_dssp             -CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            44567899999999999999999999998765 67899999999999999874 579999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc---ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      ++|+||||+||++   +.++.++|+|||++.........   ....++..|+|||.+.+..++.++|+||||++++++++
T Consensus       138 ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  214 (327)
T 3poz_A          138 LVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             CCCSCCCGGGEEE---EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eeCCCCChheEEE---CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHh
Confidence            9999999999999   46678999999999876544322   23345678999999999999999999999999999999


Q ss_pred             -CCCCCCCCCcc
Q 030527          162 -GYPPFSVGEEH  172 (175)
Q Consensus       162 -g~~pf~~~~~~  172 (175)
                       |..||.+.+..
T Consensus       215 ~g~~p~~~~~~~  226 (327)
T 3poz_A          215 FGSKPYDGIPAS  226 (327)
T ss_dssp             TSCCTTTTCCGG
T ss_pred             cCCCCccCCCHH
Confidence             99999876543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.1e-35  Score=216.44  Aligned_cols=161  Identities=41%  Similarity=0.744  Sum_probs=139.6

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++++++++||||+++++++.... .++||||+.+++|.+++.....+++..+..++.|+  ||++||+.|++|
T Consensus        59 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  137 (322)
T 2ycf_A           59 ALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH  137 (322)
T ss_dssp             --CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            346889999999999999999999987665 89999999999999999888889999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccc---ccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +||+|+||++...+....++|+|||++.............++..|+|||.+.   ...++.++|+||||++++++++|..
T Consensus       138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~  217 (322)
T 2ycf_A          138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP  217 (322)
T ss_dssp             CCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999533334469999999998876554444566899999999874   4568899999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.....
T Consensus       218 pf~~~~~  224 (322)
T 2ycf_A          218 PFSEHRT  224 (322)
T ss_dssp             SSCSTTC
T ss_pred             CCcccch
Confidence            9976543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4e-34  Score=209.08  Aligned_cols=161  Identities=33%  Similarity=0.653  Sum_probs=140.5

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEee----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      .....+.+.+|++++++++||||+++++++..    .+..++||||+.+++|.+++.+.+.+++..+..++.|+  ||++
T Consensus        65 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~  144 (290)
T 1t4h_A           65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  144 (290)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHH
Confidence            45566788999999999999999999998865    45689999999999999999988899999999999999  9999


Q ss_pred             HHHcC--CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHH
Q 030527           80 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        80 lh~~~--~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~  157 (175)
                      ||+.|  ++|+||+|+||++.  +.++.++|+|||++...... ......+++.|+|||.+. ..++.++|+||+|++++
T Consensus       145 lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~  220 (290)
T 1t4h_A          145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCML  220 (290)
T ss_dssp             HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHH
T ss_pred             HHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHH
Confidence            99999  99999999999993  35778999999998655433 233456899999999876 45899999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 030527          158 ELLNGYPPFSVGE  170 (175)
Q Consensus       158 ~~~~g~~pf~~~~  170 (175)
                      ++++|..||....
T Consensus       221 ~l~~g~~pf~~~~  233 (290)
T 1t4h_A          221 EMATSEYPYSECQ  233 (290)
T ss_dssp             HHHHSSCTTTTCS
T ss_pred             HHHhCCCCCCCcC
Confidence            9999999997643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.4e-35  Score=212.91  Aligned_cols=162  Identities=28%  Similarity=0.542  Sum_probs=129.9

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      +.....+.+|++++++++||||+++++++. .+..++||||+.+++|.+++.... .+++..+..++.|+  +|++||+.
T Consensus        57 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  135 (281)
T 1mp8_A           57 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK  135 (281)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345677899999999999999999999985 456789999999999999998664 69999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      |++|+||+|+||+++   .++.++|+|||++........  .....+++.|+|||.+.+..++.++|+||+|++++++++
T Consensus       136 ~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~  212 (281)
T 1mp8_A          136 RFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM  212 (281)
T ss_dssp             TCCCSCCSGGGEEEE---ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred             CeecccccHHHEEEC---CCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHh
Confidence            999999999999994   567899999999987654332  223445678999999988889999999999999999996


Q ss_pred             -CCCCCCCCCcc
Q 030527          162 -GYPPFSVGEEH  172 (175)
Q Consensus       162 -g~~pf~~~~~~  172 (175)
                       |..||.+.+..
T Consensus       213 ~g~~pf~~~~~~  224 (281)
T 1mp8_A          213 HGVKPFQGVKNN  224 (281)
T ss_dssp             TSCCTTTTCCGG
T ss_pred             cCCCCCCcCCHH
Confidence             99999876543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-34  Score=215.87  Aligned_cols=161  Identities=30%  Similarity=0.548  Sum_probs=137.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.++......+++..+..++.|+  +|++||+.|+
T Consensus        66 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i  145 (331)
T 4aaa_A           66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI  145 (331)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            34566789999999999999999999999999999999999998898888777889999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +|+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.+. .++.++|+||+|+++++|++|.
T Consensus       146 vH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~  222 (331)
T 4aaa_A          146 IHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE  222 (331)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred             EccCcChheEEE---cCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCC
Confidence            999999999999   57778999999999766443 223455688999999998765 6899999999999999999999


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||.+.++
T Consensus       223 ~pf~~~~~  230 (331)
T 4aaa_A          223 PLFPGDSD  230 (331)
T ss_dssp             CSCCCSSH
T ss_pred             CCCCCCCc
Confidence            99987654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.3e-35  Score=216.67  Aligned_cols=163  Identities=26%  Similarity=0.484  Sum_probs=132.4

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHG------RVPEQTARKFLQQ   74 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~   74 (175)
                      ....+.+.+|++++++++||||+++++++...+..      ++++||+.+++|.+++....      .+++..+..++.|
T Consensus        66 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~q  145 (323)
T 3qup_A           66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD  145 (323)
T ss_dssp             CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHH
Confidence            34467789999999999999999999999877655      99999999999999986542      5899999999999


Q ss_pred             H--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc---ccccCCCCccCcccccccCCCcchhH
Q 030527           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDM  149 (175)
Q Consensus        75 i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di  149 (175)
                      +  ||++||+.|++|+||||+||++   +.++.++|+|||++.........   ....++..|+|||.+.+..++.++|+
T Consensus       146 i~~al~~LH~~~ivH~Dikp~NIli---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  222 (323)
T 3qup_A          146 IACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDV  222 (323)
T ss_dssp             HHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHcCCcccCCCCcceEEE---cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccch
Confidence            8  9999999999999999999999   57788999999999876444321   23345677999999998889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCCcc
Q 030527          150 WSVGAILFELLN-GYPPFSVGEEH  172 (175)
Q Consensus       150 ~slg~~~~~~~~-g~~pf~~~~~~  172 (175)
                      ||+|++++++++ |..||.+.+..
T Consensus       223 ~slG~il~ell~~g~~p~~~~~~~  246 (323)
T 3qup_A          223 WAFGVTMWEIMTRGQTPYAGIENA  246 (323)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             hhHHHHHHHHHhCCCCCccccChH
Confidence            999999999999 99999876543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-35  Score=222.51  Aligned_cols=166  Identities=30%  Similarity=0.535  Sum_probs=139.0

Q ss_pred             ccccchhhhhhHHHHHHHHhhCCCCCeeeEeeEEee--------------------------------------CCeEEE
Q 030527            2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--------------------------------------ENCIFL   43 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------------------------------------~~~~~l   43 (175)
                      +|.+..+ .....+|+++++.++||||+++++++..                                      ....++
T Consensus        37 iK~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  115 (383)
T 3eb0_A           37 LKKVLQD-PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV  115 (383)
T ss_dssp             EEEEECC-TTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEE
T ss_pred             EEEEecC-cchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEE
Confidence            4544333 3344679999999999999999999843                                      334889


Q ss_pred             EEeccCCCChHHHHH----hcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           44 VVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        44 v~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      ||||+++ +|.+.+.    ....+++..+..++.|+  ||+|||+.|++|+||||+||++.  ..++.++|+|||++...
T Consensus       116 v~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~  192 (383)
T 3eb0_A          116 IMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKL  192 (383)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEEC
T ss_pred             EEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCccc
Confidence            9999964 7666654    34679999999999999  99999999999999999999994  35778999999999887


Q ss_pred             cCCCccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          118 YPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       118 ~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ..........+++.|+|||.+.+. .++.++|+||+|+++++|++|+.||.+.++
T Consensus       193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  247 (383)
T 3eb0_A          193 IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS  247 (383)
T ss_dssp             CTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh
Confidence            666656667789999999998765 489999999999999999999999987654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.5e-35  Score=217.94  Aligned_cols=154  Identities=30%  Similarity=0.447  Sum_probs=138.4

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHH--HHHHHHHc-
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQL--GLEILNSH-   83 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i--~l~~lh~~-   83 (175)
                      ..+.+|++++++++||||+++++++...+..++||||+.+++|.+++....    .+++..+..++.|+  ||++||+. 
T Consensus        72 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  151 (326)
T 3uim_A           72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC  151 (326)
T ss_dssp             CHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred             HHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            368999999999999999999999999999999999999999999998653    38999999999998  99999999 


Q ss_pred             --CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           84 --HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        84 --~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                        |++|+||+|+||++   +.++.++|+|||++........  .....++..|+|||.+.+..++.++|+||+|+++++|
T Consensus       152 ~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l  228 (326)
T 3uim_A          152 DPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL  228 (326)
T ss_dssp             SSCEECCCCSGGGEEE---CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHH
T ss_pred             CCCeEeCCCchhhEEE---CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHH
Confidence              99999999999999   5778899999999987654322  2334589999999999888899999999999999999


Q ss_pred             HhCCCCCC
Q 030527          160 LNGYPPFS  167 (175)
Q Consensus       160 ~~g~~pf~  167 (175)
                      ++|..||.
T Consensus       229 ~~g~~pf~  236 (326)
T 3uim_A          229 ITGQRAFD  236 (326)
T ss_dssp             HHCCCSBC
T ss_pred             HhCCCccc
Confidence            99999995

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=8.4e-35  Score=225.10  Aligned_cols=159  Identities=29%  Similarity=0.488  Sum_probs=132.4

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEee-----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ....++.+|+++++.++||||+++++++..     .+..++|||++ +++|.+++.....+++..+..++.|+  ||+||
T Consensus        94 ~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~L  172 (458)
T 3rp9_A           94 IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYV  172 (458)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            345678899999999999999999999843     35789999998 67999999988889999999999999  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC----------------------------ccccccCCCCc
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------------------YAEKVCGSPLY  132 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~----------------------------~~~~~~~~~~~  132 (175)
                      |+.|++||||||+||++   +.++.++|+|||+++......                            ......+|+.|
T Consensus       173 H~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  249 (458)
T 3rp9_A          173 HSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWY  249 (458)
T ss_dssp             HHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTT
T ss_pred             HhCCcCCCCCChhhEEE---CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccc
Confidence            99999999999999999   677889999999998764321                            11234578999


Q ss_pred             cCcccc-cccCCCcchhHHHHHHHHHHHHh-----------CCCCCCCCC
Q 030527          133 MAPEVL-QFQRYDEKVDMWSVGAILFELLN-----------GYPPFSVGE  170 (175)
Q Consensus       133 ~~pe~~-~~~~~~~~~Di~slg~~~~~~~~-----------g~~pf~~~~  170 (175)
                      +|||.+ .+..++.++|+||+||++|+|++           |.++|.+.+
T Consensus       250 ~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~  299 (458)
T 3rp9_A          250 RAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS  299 (458)
T ss_dssp             CCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred             cChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCc
Confidence            999976 45679999999999999999998           677776643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.5e-35  Score=224.34  Aligned_cols=162  Identities=33%  Similarity=0.584  Sum_probs=141.0

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ......+.+|++++++++||||+++++++...+..++||||+++++|.+++.+.+ .++...+..++.|+  |++|||+.
T Consensus       153 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~  232 (377)
T 3cbl_A          153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK  232 (377)
T ss_dssp             HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3455678899999999999999999999999999999999999999999998654 69999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccc---cccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      |++|+||+|+||++   +.++.++|+|||++..........   ...++..|+|||.+.+..++.++|+||||+++|+++
T Consensus       233 ~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~  309 (377)
T 3cbl_A          233 CCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF  309 (377)
T ss_dssp             TEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             CcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHH
Confidence            99999999999999   577889999999998754432211   122356799999998888999999999999999999


Q ss_pred             h-CCCCCCCCCc
Q 030527          161 N-GYPPFSVGEE  171 (175)
Q Consensus       161 ~-g~~pf~~~~~  171 (175)
                      + |..||.+.+.
T Consensus       310 t~g~~p~~~~~~  321 (377)
T 3cbl_A          310 SLGASPYPNLSN  321 (377)
T ss_dssp             TTSCCSSTTSCH
T ss_pred             hCCCCCCCCCCH
Confidence            8 9999987543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-34  Score=218.68  Aligned_cols=159  Identities=35%  Similarity=0.529  Sum_probs=129.3

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE   78 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~   78 (175)
                      ......+.+|+++++.++||||+++++++...+      ..++||||+. ++|.+++.  ..+++..+..++.|+  ||+
T Consensus        65 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~  141 (371)
T 2xrw_A           65 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIK  141 (371)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHH
Confidence            344567889999999999999999999997655      7899999995 58888876  468999999999998  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      +||++|++|+||||+||++   +.++.++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++++
T Consensus       142 ~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  218 (371)
T 2xrw_A          142 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  218 (371)
T ss_dssp             HHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             HHHHCCeecccCCHHHEEE---cCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHH
Confidence            9999999999999999999   5778899999999987765544445678999999999998889999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030527          159 LLNGYPPFSVGEE  171 (175)
Q Consensus       159 ~~~g~~pf~~~~~  171 (175)
                      |++|..||.+.+.
T Consensus       219 l~~g~~pf~~~~~  231 (371)
T 2xrw_A          219 MIKGGVLFPGTDH  231 (371)
T ss_dssp             HHHSSCSSCCSSH
T ss_pred             HHhCCCCCCCCCH
Confidence            9999999987653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-34  Score=212.99  Aligned_cols=157  Identities=32%  Similarity=0.603  Sum_probs=136.4

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+|++++++++||||+++++++.+  .+..++||||+.+++|.+++. ...+++..+..++.|+  ||++||+.|+
T Consensus        80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i  158 (298)
T 2zv2_A           80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKI  158 (298)
T ss_dssp             -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4568899999999999999999999986  568999999999999988654 4579999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccC---CCcchhHHHHHHHHHHHHh
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~---~~~~~Di~slg~~~~~~~~  161 (175)
                      +|+||+|+||++   +.++.++|+|||++....... ......+++.|+|||.+.+..   .+.++|+||+|+++++|++
T Consensus       159 vH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~  235 (298)
T 2zv2_A          159 IHRDIKPSNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF  235 (298)
T ss_dssp             ECCCCCGGGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred             eccCCCHHHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence            999999999999   577889999999998765443 233456899999999987655   3778999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |..||.+.+
T Consensus       236 g~~pf~~~~  244 (298)
T 2zv2_A          236 GQCPFMDER  244 (298)
T ss_dssp             SSCSSCCSS
T ss_pred             CCCCCCCcc
Confidence            999997654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.5e-35  Score=210.99  Aligned_cols=160  Identities=36%  Similarity=0.658  Sum_probs=141.5

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|++++++++||||+++++++.+.+..++|+|++.+++|.+++.+...+++..+..++.|+  +|++||+.|++
T Consensus        48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  127 (276)
T 2yex_A           48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT  127 (276)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3567889999999999999999999999999999999999999999999877789999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHhC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~g  162 (175)
                      |+||+|+||++   +.++.++|+|||.+.......   ......++..|+|||.+.+..+ +.++|+||+|++++++++|
T Consensus       128 H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  204 (276)
T 2yex_A          128 HRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  204 (276)
T ss_dssp             CSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             ccCCChHHEEE---ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhC
Confidence            99999999999   577889999999997654322   2234567889999999987665 7789999999999999999


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||...+.
T Consensus       205 ~~p~~~~~~  213 (276)
T 2yex_A          205 ELPWDQPSD  213 (276)
T ss_dssp             SCCCSCSCT
T ss_pred             CCCCCCCch
Confidence            999987553

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.7e-35  Score=217.20  Aligned_cols=163  Identities=31%  Similarity=0.556  Sum_probs=139.6

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ....+.+|+.+++++ .||||+++++++...+..++||||+.+++|.+++...  ..+++..+..++.|+  ||++||++
T Consensus        71 ~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~  150 (327)
T 3lm5_A           71 CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN  150 (327)
T ss_dssp             CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            356788999999999 6799999999999999999999999999999998643  579999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      |++|+||+|+||+++.....+.++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++++|++|.
T Consensus       151 givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  230 (327)
T 3lm5_A          151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT  230 (327)
T ss_dssp             TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999999999533336789999999998876655555667899999999999889999999999999999999999


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||.+.+.
T Consensus       231 ~pf~~~~~  238 (327)
T 3lm5_A          231 SPFVGEDN  238 (327)
T ss_dssp             CSSCCSSH
T ss_pred             CCCCCCCc
Confidence            99977653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-35  Score=218.60  Aligned_cols=161  Identities=30%  Similarity=0.514  Sum_probs=140.1

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-----------------------CC
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------------------RV   63 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~l   63 (175)
                      .....+.+|+++++++ +||||+++++++...+..++||||+++++|.+++....                       .+
T Consensus        90 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  169 (344)
T 1rjb_A           90 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL  169 (344)
T ss_dssp             --CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------C
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccC
Confidence            4456789999999999 99999999999999999999999999999999998653                       27


Q ss_pred             CHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccc
Q 030527           64 PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVL  138 (175)
Q Consensus        64 ~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~  138 (175)
                      ++..+..++.|+  ||++||+.|++|+||+|+||++   +.++.++|+|||++........   .....+++.|+|||.+
T Consensus       170 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  246 (344)
T 1rjb_A          170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL  246 (344)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh
Confidence            899999999999  9999999999999999999999   4677899999999986644332   2234457789999999


Q ss_pred             cccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          139 QFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       139 ~~~~~~~~~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      .+..++.++|+||||+++++|++ |..||.+...
T Consensus       247 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          247 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            88889999999999999999998 9999987643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.3e-34  Score=222.61  Aligned_cols=155  Identities=30%  Similarity=0.501  Sum_probs=131.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ....++.+|++++++++||||+++++++...     +..++|||++ +++|.++++....+++..+..++.|+  ||+||
T Consensus        67 ~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~L  145 (432)
T 3n9x_A           67 IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFI  145 (432)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecC-CcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3456788999999999999999999998766     5789999998 56999999988889999999999999  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-----------------------cccccCCCCccCccc
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----------------------AEKVCGSPLYMAPEV  137 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-----------------------~~~~~~~~~~~~pe~  137 (175)
                      |+.|++||||||+||++   +.++.++|+|||+++.......                       .....+|+.|+|||.
T Consensus       146 H~~givHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  222 (432)
T 3n9x_A          146 HESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL  222 (432)
T ss_dssp             HHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHH
T ss_pred             HHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHH
Confidence            99999999999999999   6778899999999987644321                       245668999999998


Q ss_pred             c-cccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527          138 L-QFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus       138 ~-~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      + .+..++.++|+||+||++++|++|..||
T Consensus       223 ~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          223 ILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             HTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             HhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            6 5566999999999999999999854444

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9.8e-35  Score=216.08  Aligned_cols=161  Identities=31%  Similarity=0.482  Sum_probs=133.3

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++++++++||||+++++++.+.+..++||||+. ++|.+++.+...+++..+..++.|+  ||++||++|++|
T Consensus        77 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH  155 (329)
T 3gbz_A           77 PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLH  155 (329)
T ss_dssp             ---CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             chhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEC
Confidence            4567789999999999999999999999999999999996 5999999988899999999999999  999999999999


Q ss_pred             cCCCCCcEEEeec--CCCceEEEeeecceeeccCCC-ccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCC
Q 030527           88 RDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        88 ~di~~~ni~~~~~--~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +||||+||++...  +....++|+|||++....... ......++..|+|||.+.+. .++.++|+||+|++++++++|.
T Consensus       156 ~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  235 (329)
T 3gbz_A          156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT  235 (329)
T ss_dssp             SCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            9999999999532  234569999999997764332 23345678999999999764 4799999999999999999999


Q ss_pred             CCCCCCCc
Q 030527          164 PPFSVGEE  171 (175)
Q Consensus       164 ~pf~~~~~  171 (175)
                      .||.+.++
T Consensus       236 ~pf~~~~~  243 (329)
T 3gbz_A          236 PLFPGDSE  243 (329)
T ss_dssp             CSSCCSSH
T ss_pred             CCcCCCCH
Confidence            99987653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.5e-35  Score=219.82  Aligned_cols=161  Identities=32%  Similarity=0.546  Sum_probs=138.9

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCC-eEEEEEeccCCCChHHHHHhcCC-----------------------
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR-----------------------   62 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-----------------------   62 (175)
                      ...+.+.+|+++++++ +||||+++++++.+.+ ..++||||+.+++|.+++.....                       
T Consensus        67 ~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (359)
T 3vhe_A           67 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP  146 (359)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------
T ss_pred             HHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccc
Confidence            3456789999999999 8999999999988755 48999999999999999986543                       


Q ss_pred             -------------------------------------------CCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEE
Q 030527           63 -------------------------------------------VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILL   97 (175)
Q Consensus        63 -------------------------------------------l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~   97 (175)
                                                                 +++..+..++.|+  ||+|||++|++|+||||+||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll  226 (359)
T 3vhe_A          147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  226 (359)
T ss_dssp             -------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             hhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence                                                       8899999999999  9999999999999999999999


Q ss_pred             eecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527           98 SGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus        98 ~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                         +.++.++|+|||++.......   ......++..|+|||.+.+..++.++|+||+|+++++|++ |..||.+...
T Consensus       227 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  301 (359)
T 3vhe_A          227 ---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  301 (359)
T ss_dssp             ---CGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ---cCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence               577889999999998664432   1233456778999999998899999999999999999998 9999987653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.3e-35  Score=228.24  Aligned_cols=161  Identities=27%  Similarity=0.490  Sum_probs=141.7

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+.+|++++++++||||+++++++...+..++||||+.+++|.+++.+.  ..+++..+..++.|+  ||+|||++|
T Consensus       259 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~  338 (495)
T 1opk_A          259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN  338 (495)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4567899999999999999999999999999999999999999999999865  358999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  161 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-  161 (175)
                      ++|+||+|+||++   +.++.++|+|||++.........  ....++..|+|||.+.+..++.++|+||||+++|+|++ 
T Consensus       339 ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~  415 (495)
T 1opk_A          339 FIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY  415 (495)
T ss_dssp             EECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             cccCCCChhhEEE---CCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhC
Confidence            9999999999999   57788999999999876543321  22334567999999988889999999999999999999 


Q ss_pred             CCCCCCCCCcc
Q 030527          162 GYPPFSVGEEH  172 (175)
Q Consensus       162 g~~pf~~~~~~  172 (175)
                      |..||.+.+..
T Consensus       416 g~~p~~~~~~~  426 (495)
T 1opk_A          416 GMSPYPGIDLS  426 (495)
T ss_dssp             SCCSSTTCCGG
T ss_pred             CCCCCCCCCHH
Confidence            99999876543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5e-35  Score=214.05  Aligned_cols=159  Identities=28%  Similarity=0.517  Sum_probs=139.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+++.+|++++++++||||+++++++ ..+..++|+|++.+++|.+++.+.+.+++..+..++.|+  +|++||+.|++
T Consensus        61 ~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~  139 (291)
T 1xbb_A           61 LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV  139 (291)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            467789999999999999999999999 566789999999999999999988889999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc----ccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  161 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-  161 (175)
                      |+||+|+||+++   .++.++|+|||++.........    ....++..|+|||.+.+..++.++|+||+|++++++++ 
T Consensus       140 H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~  216 (291)
T 1xbb_A          140 HRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY  216 (291)
T ss_dssp             CSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred             cCCCCcceEEEe---CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhc
Confidence            999999999994   6678999999999876544321    12334677999999988888999999999999999999 


Q ss_pred             CCCCCCCCCc
Q 030527          162 GYPPFSVGEE  171 (175)
Q Consensus       162 g~~pf~~~~~  171 (175)
                      |+.||.+.+.
T Consensus       217 g~~p~~~~~~  226 (291)
T 1xbb_A          217 GQKPYRGMKG  226 (291)
T ss_dssp             TCCSSTTCCH
T ss_pred             CCCCCCCCCH
Confidence            9999987553

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-35  Score=224.44  Aligned_cols=160  Identities=28%  Similarity=0.511  Sum_probs=138.8

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCC--eEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHH--HHHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ...+.+|++++++++||||+++++++.+.+  ..++||||+.+++|.+++.+..   .+++..+..++.|+  ||+|||+
T Consensus        51 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  130 (396)
T 4eut_A           51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE  130 (396)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            456788999999999999999999988755  7899999999999999997653   39999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEee-cCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc--------cCCCcchhHHHHH
Q 030527           83 HHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSVG  153 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~-~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Di~slg  153 (175)
                      .|++|+||||+||++.. .+....++|+|||++.............++..|+|||.+.+        ..++.++|+||+|
T Consensus       131 ~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG  210 (396)
T 4eut_A          131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG  210 (396)
T ss_dssp             TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHH
T ss_pred             CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHH
Confidence            99999999999999732 23566799999999988766555556678999999999864        5678899999999


Q ss_pred             HHHHHHHhCCCCCCCC
Q 030527          154 AILFELLNGYPPFSVG  169 (175)
Q Consensus       154 ~~~~~~~~g~~pf~~~  169 (175)
                      +++|+|++|+.||...
T Consensus       211 ~il~el~tg~~Pf~~~  226 (396)
T 4eut_A          211 VTFYHAATGSLPFRPF  226 (396)
T ss_dssp             HHHHHHHHSSCSEECT
T ss_pred             HHHHHHHHCCCCCCCC
Confidence            9999999999999653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-35  Score=219.33  Aligned_cols=164  Identities=35%  Similarity=0.624  Sum_probs=134.7

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--------------------------
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------------------   60 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------------------   60 (175)
                      ......+.+|++++++++||||+++++++.+.+..++||||+.|++|.+++...                          
T Consensus        69 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (345)
T 3hko_A           69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE  148 (345)
T ss_dssp             -CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccc
Confidence            344578899999999999999999999999999999999999999999988521                          


Q ss_pred             --------------CCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---
Q 030527           61 --------------GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---  121 (175)
Q Consensus        61 --------------~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---  121 (175)
                                    ..+++..+..++.|+  ||++||+.|++|+||+|+||+++. +....++|+|||++.......   
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~  227 (345)
T 3hko_A          149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGE  227 (345)
T ss_dssp             HHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-
T ss_pred             ccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccc
Confidence                          113577788899998  999999999999999999999941 122379999999998664321   


Q ss_pred             --ccccccCCCCccCcccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          122 --YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       122 --~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                        ......+++.|+|||.+.+  ..++.++|+||||+++++|++|+.||.+.++
T Consensus       228 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  281 (345)
T 3hko_A          228 YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND  281 (345)
T ss_dssp             -------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh
Confidence              1235568899999999865  5789999999999999999999999987554

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.7e-35  Score=212.84  Aligned_cols=162  Identities=27%  Similarity=0.490  Sum_probs=142.3

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHc
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ...+.+.+|++++++++||||+++++++.+.+..++|||++.+++|.+++.+..  .+++..+..++.|+  +|++||+.
T Consensus        51 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  130 (288)
T 3kfa_A           51 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK  130 (288)
T ss_dssp             THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC
Confidence            345678899999999999999999999999999999999999999999998753  48999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      |++|+||+|+||++   +.++.++|+|||.+........  .....++..|+|||.+.+..++.++|+||+|++++++++
T Consensus       131 ~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~  207 (288)
T 3kfa_A          131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT  207 (288)
T ss_dssp             TCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CccCCCCCcceEEE---cCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence            99999999999999   5778899999999977654432  223345678999999988899999999999999999999


Q ss_pred             -CCCCCCCCCcc
Q 030527          162 -GYPPFSVGEEH  172 (175)
Q Consensus       162 -g~~pf~~~~~~  172 (175)
                       |..||.+.+..
T Consensus       208 ~g~~p~~~~~~~  219 (288)
T 3kfa_A          208 YGMSPYPGIDLS  219 (288)
T ss_dssp             TSCCSSTTCCGG
T ss_pred             CCCCCCCCCCHH
Confidence             99999876543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.9e-35  Score=210.55  Aligned_cols=160  Identities=28%  Similarity=0.541  Sum_probs=140.6

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ..+.+.+|++++++++||||+++++++.+.+..+++||++++++|.+++.+. +.+++..+..++.|+  |+++||+.|+
T Consensus        46 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  125 (267)
T 3t9t_A           46 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV  125 (267)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            3467899999999999999999999999999999999999999999999875 468999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      +|+||+|+||++   +.++.++|+|||++........  .....++..|+|||.+.+..++.++|+||+|++++++++ |
T Consensus       126 ~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g  202 (267)
T 3t9t_A          126 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG  202 (267)
T ss_dssp             CCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             ccCCCchheEEE---CCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccC
Confidence            999999999999   5778899999999876643221  123345678999999988889999999999999999999 8


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||...+.
T Consensus       203 ~~p~~~~~~  211 (267)
T 3t9t_A          203 KIPYENRSN  211 (267)
T ss_dssp             CCTTTTCCH
T ss_pred             CCCCCCCCH
Confidence            999987543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.5e-34  Score=210.39  Aligned_cols=162  Identities=31%  Similarity=0.584  Sum_probs=141.0

Q ss_pred             ccccchhhhhhHHHHHHHHhhCCCCCeeeEeeEEee----------------CCeEEEEEeccCCCChHHHHHhc--CCC
Q 030527            2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----------------ENCIFLVVEFCAGGNLSSYIRLH--GRV   63 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~l~~~--~~l   63 (175)
                      +|.+... ...+.+|++++++++||||+++++++..                .+..++||||+.+++|.+++.+.  ..+
T Consensus        41 vK~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  119 (284)
T 2a19_B           41 IKRVKYN-NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL  119 (284)
T ss_dssp             EEEEECC-SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCC
T ss_pred             EEEeccc-cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCC
Confidence            4544333 3567889999999999999999998854                45689999999999999999754  579


Q ss_pred             CHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccccc
Q 030527           64 PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ  141 (175)
Q Consensus        64 ~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  141 (175)
                      ++..+..++.|+  ||++||+.|++|+||+|+||++.   .++.++|+|||++.............++..|+|||.+.+.
T Consensus       120 ~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (284)
T 2a19_B          120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ  196 (284)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc---CCCCEEECcchhheeccccccccccCCcccccChhhhccC
Confidence            999999999998  99999999999999999999994   6678999999999887666555566789999999999988


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527          142 RYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus       142 ~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      .++.++|+||+|++++++++|..||.
T Consensus       197 ~~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          197 DYGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             CCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             CCcchhhhHHHHHHHHHHHhcCCcch
Confidence            89999999999999999999988874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.5e-35  Score=219.78  Aligned_cols=155  Identities=18%  Similarity=0.216  Sum_probs=135.6

Q ss_pred             hHHHHHHHHhhCCCCCeeeEeeEEee----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           12 CLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .+.+|+..++.++||||+++++++..    .+..++|||++ +++|.+++.+.+.+++..+..++.|+  ||+|||+.|+
T Consensus        94 ~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  172 (345)
T 2v62_A           94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEY  172 (345)
T ss_dssp             HHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            46678888999999999999999987    78899999999 99999999887889999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC--------ccccccCCCCccCcccccccCCCcchhHHHHHHHHH
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~  157 (175)
                      +|+||+|+||+++. +..+.++|+|||++.......        ......++..|+|||.+.+..++.++|+||||+++|
T Consensus       173 vH~Dlkp~NIll~~-~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  251 (345)
T 2v62_A          173 VHGDIKAANLLLGY-KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCML  251 (345)
T ss_dssp             ECSCCSGGGEEEES-SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred             eCCCcCHHHEEEcc-CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHH
Confidence            99999999999952 112389999999997764321        113456899999999999888999999999999999


Q ss_pred             HHHhCCCCCCC
Q 030527          158 ELLNGYPPFSV  168 (175)
Q Consensus       158 ~~~~g~~pf~~  168 (175)
                      +|++|+.||.+
T Consensus       252 ell~g~~pf~~  262 (345)
T 2v62_A          252 RWLCGKLPWEQ  262 (345)
T ss_dssp             HHHHSSCTTGG
T ss_pred             HHHhCCCCccc
Confidence            99999999965

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-34  Score=217.49  Aligned_cols=159  Identities=33%  Similarity=0.586  Sum_probs=139.1

Q ss_pred             hhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|+++++++ .||||+++++++...+..++||||+.+++|.+++.+...+++..+..++.|+  ||+|||++|+
T Consensus       101 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  180 (355)
T 1vzo_A          101 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI  180 (355)
T ss_dssp             SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            345677899999999 7999999999999999999999999999999999988899999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC--ccccccCCCCccCcccccc--cCCCcchhHHHHHHHHHHHHh
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slg~~~~~~~~  161 (175)
                      +|+||||+||++   +.++.++|+|||++.......  ......+++.|+|||.+.+  ..++.++|+||||+++|+|++
T Consensus       181 vH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~  257 (355)
T 1vzo_A          181 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT  257 (355)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred             ccCCCCHHHEEE---CCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH
Confidence            999999999999   577889999999998764332  2234568999999999975  347899999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |..||....
T Consensus       258 g~~pf~~~~  266 (355)
T 1vzo_A          258 GASPFTVDG  266 (355)
T ss_dssp             SSCTTSCTT
T ss_pred             CCCCCccCC
Confidence            999997543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.8e-35  Score=214.00  Aligned_cols=160  Identities=28%  Similarity=0.478  Sum_probs=134.2

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~l   80 (175)
                      .....+.+.+|++++++++||||+++++++..  ....++||||+.+++|.+++.+.. .+++..+..++.|+  ||++|
T Consensus        51 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l  130 (295)
T 3ugc_A           51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL  130 (295)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHH
Confidence            34445678999999999999999999999854  356899999999999999998764 59999999999999  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~  156 (175)
                      |+.|++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||.+.+..++.++|+||+|+++
T Consensus       131 H~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l  207 (295)
T 3ugc_A          131 GTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL  207 (295)
T ss_dssp             HHTTCCCSCCSGGGEEE---EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             hcCCcccCCCCHhhEEE---cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHH
Confidence            99999999999999999   4667899999999987644321    2233456679999999988999999999999999


Q ss_pred             HHHHhCCCCCCC
Q 030527          157 FELLNGYPPFSV  168 (175)
Q Consensus       157 ~~~~~g~~pf~~  168 (175)
                      +++++|..||..
T Consensus       208 ~~l~~g~~~~~~  219 (295)
T 3ugc_A          208 YELFTYIEKSKS  219 (295)
T ss_dssp             HHHHHTTCTTCS
T ss_pred             HHHHhcccccCC
Confidence            999999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-34  Score=218.39  Aligned_cols=158  Identities=33%  Similarity=0.573  Sum_probs=138.4

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE   78 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~   78 (175)
                      .....++.+|++++++++||||+++++++...+      ..++|||++ +++|.++++. ..+++..+..++.|+  ||+
T Consensus        65 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~  142 (367)
T 1cm8_A           65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLR  142 (367)
T ss_dssp             HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            344567889999999999999999999987653      469999999 8899999885 679999999999998  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILF  157 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~  157 (175)
                      |||+.|++|+||||+||++   +.++.++|+|||++......  .....+++.|+|||.+.+ ..++.++|+||+||+++
T Consensus       143 ~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  217 (367)
T 1cm8_A          143 YIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA  217 (367)
T ss_dssp             HHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred             HHHHCCccccCcCHHHEEE---cCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHH
Confidence            9999999999999999999   57788999999999876443  234567899999999876 67899999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030527          158 ELLNGYPPFSVGEE  171 (175)
Q Consensus       158 ~~~~g~~pf~~~~~  171 (175)
                      +|++|+.||.+.+.
T Consensus       218 ell~g~~pf~~~~~  231 (367)
T 1cm8_A          218 EMITGKTLFKGSDH  231 (367)
T ss_dssp             HHHHSSCSSCCSSH
T ss_pred             HHHhCCCCCCCCCH
Confidence            99999999987653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.3e-34  Score=210.37  Aligned_cols=161  Identities=30%  Similarity=0.483  Sum_probs=141.2

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ...+.+.+|++++++++||||+++++++.+.+..+++||++++++|.+++...   ..+++..+..++.|+  ||++||+
T Consensus        72 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  151 (307)
T 2nru_A           72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE  151 (307)
T ss_dssp             THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            45678899999999999999999999999999999999999999999998743   458999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      .|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||.+.+ .++.++|+||||++++++
T Consensus       152 ~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l  227 (307)
T 2nru_A          152 NHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEI  227 (307)
T ss_dssp             TTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHH
T ss_pred             CCeecCCCCHHHEEE---cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHH
Confidence            999999999999999   5778899999999987654321   234567899999998864 578999999999999999


Q ss_pred             HhCCCCCCCCCcc
Q 030527          160 LNGYPPFSVGEEH  172 (175)
Q Consensus       160 ~~g~~pf~~~~~~  172 (175)
                      ++|..||......
T Consensus       228 ~~g~~p~~~~~~~  240 (307)
T 2nru_A          228 ITGLPAVDEHREP  240 (307)
T ss_dssp             HHCCCSBCTTBSS
T ss_pred             HHCCCCcccCcch
Confidence            9999999876544

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.1e-35  Score=212.21  Aligned_cols=160  Identities=23%  Similarity=0.397  Sum_probs=135.4

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ......+.+|++++++++||||+++++++...+..++||||+.+++|.+++.+.+. +++..+..++.|+  ||++||++
T Consensus        53 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~  132 (289)
T 4fvq_A           53 RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN  132 (289)
T ss_dssp             GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            34556788999999999999999999999999999999999999999999987654 9999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCC-----ceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILF  157 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~-----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~  157 (175)
                      |++|+||+|+||+++.....     ..++|+|||.+......   ....++..|+|||.+.+ ..++.++|+||+|++++
T Consensus       133 ~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  209 (289)
T 4fvq_A          133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLW  209 (289)
T ss_dssp             TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHH
T ss_pred             CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHH
Confidence            99999999999999532211     12999999998655332   23346788999999987 67899999999999999


Q ss_pred             HHHhC-CCCCCCC
Q 030527          158 ELLNG-YPPFSVG  169 (175)
Q Consensus       158 ~~~~g-~~pf~~~  169 (175)
                      +|++| ..||...
T Consensus       210 el~~g~~~~~~~~  222 (289)
T 4fvq_A          210 EICSGGDKPLSAL  222 (289)
T ss_dssp             HHHTTTCCTTTTS
T ss_pred             HHHcCCCCCcccc
Confidence            99995 5555543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.2e-34  Score=213.62  Aligned_cols=161  Identities=31%  Similarity=0.485  Sum_probs=141.7

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC------------------CCCHHHH
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQTA   68 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~   68 (175)
                      .....+.+|+++++++ +||||+++++++...+..++||||+.+++|.+++....                  .+++..+
T Consensus        68 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (313)
T 1t46_A           68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL  147 (313)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred             HHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHH
Confidence            3467789999999999 99999999999999999999999999999999998654                  3899999


Q ss_pred             HHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCC
Q 030527           69 RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY  143 (175)
Q Consensus        69 ~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~  143 (175)
                      ..++.|+  ||++||+.|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||.+.+..+
T Consensus       148 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  224 (313)
T 1t46_A          148 LSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY  224 (313)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCccceEEE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence            9999999  9999999999999999999999   4678899999999987655432   223345678999999988889


Q ss_pred             CcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          144 DEKVDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       144 ~~~~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      +.++|+||+|+++++|++ |..||.+...
T Consensus       225 ~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          225 TFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            999999999999999999 9999987543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.5e-35  Score=212.18  Aligned_cols=162  Identities=40%  Similarity=0.709  Sum_probs=143.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|++++++++||||+++++++...+..++|+|++.+++|.+++.+...+++..+..++.|+  +|++||+.|++
T Consensus        64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~  143 (287)
T 2wei_A           64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV  143 (287)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4567889999999999999999999999999999999999999999999888899999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |+||+|+||++...+....++|+|||++.............++..|+|||.+.+ .++.++|+||+|++++++++|..||
T Consensus       144 H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~  222 (287)
T 2wei_A          144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF  222 (287)
T ss_dssp             CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCC
Confidence            999999999996434455799999999987655544444557888999998875 4899999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       223 ~~~~~  227 (287)
T 2wei_A          223 YGKNE  227 (287)
T ss_dssp             CCSSH
T ss_pred             CCCCH
Confidence            87543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4e-34  Score=211.14  Aligned_cols=159  Identities=31%  Similarity=0.583  Sum_probs=142.3

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|++++++++||||+++++++...+..++|+||+.+++|.+++.. ...+++..+..++.++  |+++||+.|+
T Consensus        67 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  146 (314)
T 3com_A           67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK  146 (314)
T ss_dssp             CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence            356788999999999999999999999999999999999999999999974 4679999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+||+|+||++   +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus       147 ~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  223 (314)
T 3com_A          147 IHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP  223 (314)
T ss_dssp             ECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCcCHHHEEE---CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCC
Confidence            999999999999   577789999999997765442 2334567889999999988889999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||...+
T Consensus       224 p~~~~~  229 (314)
T 3com_A          224 PYADIH  229 (314)
T ss_dssp             TTTTSC
T ss_pred             CCCCCC
Confidence            997653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.8e-35  Score=216.91  Aligned_cols=158  Identities=27%  Similarity=0.481  Sum_probs=136.3

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...+.+|+.++++++||||+++++++.+ +..++|+||+.+++|.+++.+. +.+++..+..++.|+  ||+|||+.|++
T Consensus        59 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  137 (325)
T 3kex_A           59 FQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV  137 (325)
T ss_dssp             BCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            4567889999999999999999999864 5688999999999999999865 579999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-C
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G  162 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-g  162 (175)
                      |+||||+||++   +.++.++|+|||++.......   ......++..|+|||.+.+..++.++|+||+|+++|++++ |
T Consensus       138 H~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g  214 (325)
T 3kex_A          138 HRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG  214 (325)
T ss_dssp             CSCCSSTTEEE---SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             CCccchheEEE---CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCC
Confidence            99999999999   577889999999998764432   2234456778999999998899999999999999999999 9


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||.+...
T Consensus       215 ~~p~~~~~~  223 (325)
T 3kex_A          215 AEPYAGLRL  223 (325)
T ss_dssp             CCTTTTSCT
T ss_pred             CCCccccCH
Confidence            999987654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.8e-34  Score=210.10  Aligned_cols=160  Identities=26%  Similarity=0.477  Sum_probs=136.0

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ...+.+.+|++++++++||||+++++++.+. ..++|+|++.+++|.+++.+.+ .+++..+..++.|+  +|++||+.|
T Consensus        55 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  133 (281)
T 3cc6_A           55 DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN  133 (281)
T ss_dssp             HHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4567889999999999999999999998754 4689999999999999998764 59999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  161 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-  161 (175)
                      ++|+||+|+||+++   .++.++|+|||++........  .....++..|+|||.+.+..++.++|+||||++++++++ 
T Consensus       134 i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~  210 (281)
T 3cc6_A          134 CVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSF  210 (281)
T ss_dssp             CCCCCCSGGGEEEE---ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             cccCCCccceEEEC---CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhC
Confidence            99999999999994   667899999999977654322  223445678999999988889999999999999999998 


Q ss_pred             CCCCCCCCCc
Q 030527          162 GYPPFSVGEE  171 (175)
Q Consensus       162 g~~pf~~~~~  171 (175)
                      |..||...+.
T Consensus       211 g~~p~~~~~~  220 (281)
T 3cc6_A          211 GKQPFFWLEN  220 (281)
T ss_dssp             TCCTTTTSCG
T ss_pred             CCCCcccCCh
Confidence            9999976544

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.2e-34  Score=215.96  Aligned_cols=161  Identities=31%  Similarity=0.531  Sum_probs=141.3

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHH
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~   70 (175)
                      ...+.+.+|+++++++ +||||+++++++...+..++|+||+.+++|.+++....                .++...+..
T Consensus        82 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (334)
T 2pvf_A           82 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS  161 (334)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHH
Confidence            3456788999999999 99999999999999999999999999999999998654                388999999


Q ss_pred             HHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCc
Q 030527           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  145 (175)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~  145 (175)
                      ++.|+  ||++||+.|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||.+.+..++.
T Consensus       162 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  238 (334)
T 2pvf_A          162 CTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  238 (334)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHhCCeeCCCCccceEEE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh
Confidence            99998  9999999999999999999999   5778899999999987654432   22334567899999998888999


Q ss_pred             chhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          146 KVDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       146 ~~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      ++|+||+|++++++++ |..||.+.+.
T Consensus       239 ~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          239 QSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            9999999999999999 9999987643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.8e-35  Score=233.71  Aligned_cols=160  Identities=28%  Similarity=0.526  Sum_probs=137.6

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|++++++++||||+++++++.. +..++||||+.+++|.+++.+...+++..+..++.|+  ||+|||++|++
T Consensus       413 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ii  491 (635)
T 4fl3_A          413 LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV  491 (635)
T ss_dssp             GHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            35789999999999999999999999865 4578999999999999999988889999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  161 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-  161 (175)
                      |+||||+||+++   .++.++|+|||++........    .....++..|+|||.+.+..++.++|+||||+++++|++ 
T Consensus       492 HrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~  568 (635)
T 4fl3_A          492 HRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY  568 (635)
T ss_dssp             CSCCSGGGEEEE---ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCCCChHhEEEe---CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence            999999999994   667899999999986644321    122345678999999998899999999999999999998 


Q ss_pred             CCCCCCCCCcc
Q 030527          162 GYPPFSVGEEH  172 (175)
Q Consensus       162 g~~pf~~~~~~  172 (175)
                      |+.||.+.+..
T Consensus       569 G~~Pf~~~~~~  579 (635)
T 4fl3_A          569 GQKPYRGMKGS  579 (635)
T ss_dssp             TCCSSTTCCHH
T ss_pred             CCCCCCCCCHH
Confidence            99999876543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.6e-34  Score=209.95  Aligned_cols=159  Identities=30%  Similarity=0.595  Sum_probs=142.5

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+.+|++++++++||||+++++++...+..++||||+.+++|.+++.+ +++++..+..++.|+  +|++||+.|+
T Consensus        62 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i  140 (303)
T 3a7i_A           62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK  140 (303)
T ss_dssp             TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3457789999999999999999999999999999999999999999999874 679999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus       141 ~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  217 (303)
T 3a7i_A          141 IHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP  217 (303)
T ss_dssp             ECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCCCChheEEE---CCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCC
Confidence            999999999999   577889999999998765543 2334567889999999998889999999999999999999999


Q ss_pred             CCCCCC
Q 030527          165 PFSVGE  170 (175)
Q Consensus       165 pf~~~~  170 (175)
                      ||....
T Consensus       218 p~~~~~  223 (303)
T 3a7i_A          218 PHSELH  223 (303)
T ss_dssp             TTTTSC
T ss_pred             CCCCcC
Confidence            997654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-34  Score=215.06  Aligned_cols=162  Identities=24%  Similarity=0.462  Sum_probs=136.0

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ...+..+.+|++++++++||||+++++++...+..++|||++.+++|.+++.+. +.+++..+..++.|+  ||++||+.
T Consensus        87 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  166 (333)
T 1mqb_A           87 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM  166 (333)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            344567889999999999999999999999999999999999999999999865 579999999999999  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      |++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||.+.+..++.++|+||+|++++++
T Consensus       167 ~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  243 (333)
T 1mqb_A          167 NYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV  243 (333)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred             CeeCCCCChheEEE---CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHH
Confidence            99999999999999   5778899999999987644321    1223346779999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCCc
Q 030527          160 LN-GYPPFSVGEE  171 (175)
Q Consensus       160 ~~-g~~pf~~~~~  171 (175)
                      ++ |..||.+.+.
T Consensus       244 lt~g~~pf~~~~~  256 (333)
T 1mqb_A          244 MTYGERPYWELSN  256 (333)
T ss_dssp             HTTSCCTTTTCCH
T ss_pred             HcCCCCCcccCCH
Confidence            99 9999976543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.7e-35  Score=217.39  Aligned_cols=156  Identities=31%  Similarity=0.559  Sum_probs=131.9

Q ss_pred             hHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      .+.+|++++++++||||+++++++...+..++||||+. ++|.+++...+ .+++..+..++.|+  ||++||+.|++|+
T Consensus        46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~  124 (324)
T 3mtl_A           46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR  124 (324)
T ss_dssp             CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            44579999999999999999999999999999999996 59999988764 58999999999998  9999999999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      ||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||
T Consensus       125 Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  201 (324)
T 3mtl_A          125 DLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF  201 (324)
T ss_dssp             SCCGGGEEE---CTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CcCHHHEEE---CCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999   577889999999997664332 2334567899999999876 56899999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       202 ~~~~~  206 (324)
T 3mtl_A          202 PGSTV  206 (324)
T ss_dssp             CCSSH
T ss_pred             CCCCH
Confidence            87653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-34  Score=212.32  Aligned_cols=165  Identities=26%  Similarity=0.434  Sum_probs=139.1

Q ss_pred             CccccchhhhhhHHHHHHHHhh--CCCCCeeeEeeEEee----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHH
Q 030527            1 MLKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~   74 (175)
                      +||.+.......+..|.+++..  ++||||+++++++..    .+..++||||+.+++|.++++ ...+++..+..++.|
T Consensus        35 avK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~  113 (301)
T 3q4u_A           35 AVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLS  113 (301)
T ss_dssp             EEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHH
T ss_pred             EEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHH
Confidence            4677777777777788888777  799999999998654    356899999999999999996 457999999999999


Q ss_pred             H--HHHHHH--------HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc-----ccccCCCCccCccccc
Q 030527           75 L--GLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQ  139 (175)
Q Consensus        75 i--~l~~lh--------~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~pe~~~  139 (175)
                      +  ||++||        +.|++|+||||+||++   +.++.++|+|||++.........     ....+++.|+|||.+.
T Consensus       114 i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  190 (301)
T 3q4u_A          114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD  190 (301)
T ss_dssp             HHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHT
T ss_pred             HHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhc
Confidence            9  999999        9999999999999999   57788999999999766544321     2346899999999997


Q ss_pred             cc------CCCcchhHHHHHHHHHHHHhC----------CCCCCCC
Q 030527          140 FQ------RYDEKVDMWSVGAILFELLNG----------YPPFSVG  169 (175)
Q Consensus       140 ~~------~~~~~~Di~slg~~~~~~~~g----------~~pf~~~  169 (175)
                      +.      .++.++|+||+|+++|+|++|          +.||...
T Consensus       191 ~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          191 ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             TCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            66      455789999999999999999          8888654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-34  Score=222.26  Aligned_cols=166  Identities=32%  Similarity=0.507  Sum_probs=136.2

Q ss_pred             ccccchhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC------CeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHH
Q 030527            2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF   71 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~   71 (175)
                      +|.+... .+...+|++++++++||||+++++++...      ...++|+||+.+ ++.+.+.    ....+++..+..+
T Consensus        84 iK~~~~~-~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~  161 (420)
T 1j1b_A           84 IKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY  161 (420)
T ss_dssp             EEEEECC-TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHH
T ss_pred             EEEeccc-chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHH
Confidence            4544332 33456799999999999999999988532      246799999965 6666554    2467999999999


Q ss_pred             HHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccccc-CCCcchh
Q 030527           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVD  148 (175)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~D  148 (175)
                      +.|+  ||+|||+.|++|+||||+||+++  .....++|+|||+++............+++.|+|||.+.+. .++.++|
T Consensus       162 ~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  239 (420)
T 1j1b_A          162 MYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSID  239 (420)
T ss_dssp             HHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHH
T ss_pred             HHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhh
Confidence            9998  99999999999999999999994  34567899999999887655555566789999999998765 6899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCc
Q 030527          149 MWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       149 i~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      +||+||++|+|++|+.||.+.+.
T Consensus       240 iwSlG~il~ell~G~~pf~~~~~  262 (420)
T 1j1b_A          240 VWSAGCVLAELLLGQPIFPGDSG  262 (420)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999987653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-34  Score=213.98  Aligned_cols=158  Identities=28%  Similarity=0.562  Sum_probs=134.0

Q ss_pred             hhhhhhHHHHHHHHhhCCC--CCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ......+.+|++++++++|  |||+++++++...+..++|||+ .+++|.+++.+.+.+++..+..++.|+  ||+|||+
T Consensus        48 ~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~  126 (343)
T 3dbq_A           48 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ  126 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3445678899999999976  9999999999999999999995 588999999988899999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccc-----------cCCCcchh
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-----------QRYDEKVD  148 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~-----------~~~~~~~D  148 (175)
                      .|++|+||||+||++.    ++.++|+|||++........   .....|++.|+|||.+.+           ..++.++|
T Consensus       127 ~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  202 (343)
T 3dbq_A          127 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD  202 (343)
T ss_dssp             TTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHH
T ss_pred             CCeecCCCCcceEEEE----CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhh
Confidence            9999999999999994    46799999999987654322   234568999999999864           56889999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCC
Q 030527          149 MWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus       149 i~slg~~~~~~~~g~~pf~~~  169 (175)
                      +||+|+++++|++|..||...
T Consensus       203 iwslG~il~ell~g~~pf~~~  223 (343)
T 3dbq_A          203 VWSLGCILYYMTYGKTPFQQI  223 (343)
T ss_dssp             HHHHHHHHHHHHHSSCTTTTC
T ss_pred             HHHHHHHHHHHHhCCCcchhh
Confidence            999999999999999999764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.4e-34  Score=209.16  Aligned_cols=160  Identities=32%  Similarity=0.621  Sum_probs=131.6

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ......+.+|++++++++||||+++++++...+..++|+|++.+++|.+++..    ...+++..+..++.|+  +|++|
T Consensus        73 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  152 (310)
T 2wqm_A           73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM  152 (310)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence            45567889999999999999999999999999999999999999999999874    3568999999999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      |+.|++|+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||++++++
T Consensus       153 H~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l  229 (310)
T 2wqm_A          153 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM  229 (310)
T ss_dssp             HHTTCCCCCCCGGGEEE---CTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hhCCeeCCCCcHHHEEE---cCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHH
Confidence            99999999999999999   577889999999987664432 22345678899999999888899999999999999999


Q ss_pred             HhCCCCCCCC
Q 030527          160 LNGYPPFSVG  169 (175)
Q Consensus       160 ~~g~~pf~~~  169 (175)
                      ++|..||.+.
T Consensus       230 ~~g~~p~~~~  239 (310)
T 2wqm_A          230 AALQSPFYGD  239 (310)
T ss_dssp             HHSSCTTC--
T ss_pred             HhCCCCCccc
Confidence            9999999764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2e-34  Score=208.67  Aligned_cols=159  Identities=34%  Similarity=0.552  Sum_probs=131.3

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC---
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH---   84 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~---   84 (175)
                      .+.+.+|++++++++||||+++++++...+..++||||+.+++|.+++. ...+++..+..++.|+  ++++||+.|   
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~  128 (271)
T 3dtc_A           50 IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVP  128 (271)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Confidence            4678899999999999999999999999999999999999999999886 5679999999999998  999999999   


Q ss_pred             CeecCCCCCcEEEeecC-----CCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLD-----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~-----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      ++|+||+|+||+++...     .++.++|+|||++........ ....++..|+|||.+.+..++.++|+||+|++++++
T Consensus       129 i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l  207 (271)
T 3dtc_A          129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWEL  207 (271)
T ss_dssp             CCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred             eeecCCchHHEEEecccccccccCcceEEccCCcccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHH
Confidence            88999999999995211     266799999999976654432 245678999999999888899999999999999999


Q ss_pred             HhCCCCCCCCC
Q 030527          160 LNGYPPFSVGE  170 (175)
Q Consensus       160 ~~g~~pf~~~~  170 (175)
                      ++|+.||.+.+
T Consensus       208 ~~g~~p~~~~~  218 (271)
T 3dtc_A          208 LTGEVPFRGID  218 (271)
T ss_dssp             HHCCCTTTTSC
T ss_pred             HhCCCCCCCCC
Confidence            99999998754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-34  Score=215.11  Aligned_cols=162  Identities=27%  Similarity=0.426  Sum_probs=134.5

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ......+.+|++++++++||||+++++++...+ .+++++++.+++|.+++.+. +.+++..+..++.|+  ||++||+.
T Consensus        58 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  136 (327)
T 3lzb_A           58 PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR  136 (327)
T ss_dssp             CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            345678899999999999999999999998765 77899999999999999875 579999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      |++|+||||+||++   +.++.++|+|||++........   .....++..|+|||.+.+..++.++|+||||+++|+++
T Consensus       137 ~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell  213 (327)
T 3lzb_A          137 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM  213 (327)
T ss_dssp             TCCCSCCCGGGEEE---EETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCcCCCCCHHHEEE---cCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHH
Confidence            99999999999999   4667899999999987644332   22334566799999999889999999999999999999


Q ss_pred             h-CCCCCCCCCcc
Q 030527          161 N-GYPPFSVGEEH  172 (175)
Q Consensus       161 ~-g~~pf~~~~~~  172 (175)
                      + |..||.+.+..
T Consensus       214 ~~g~~p~~~~~~~  226 (327)
T 3lzb_A          214 TFGSKPYDGIPAS  226 (327)
T ss_dssp             TTSCCTTTTCCGG
T ss_pred             HCCCCCCCCCCHH
Confidence            9 99999876544

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-34  Score=220.71  Aligned_cols=169  Identities=30%  Similarity=0.560  Sum_probs=132.3

Q ss_pred             ccccch-hhhhhHHHHHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHH
Q 030527            2 LKKLNK-HLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTAR   69 (175)
Q Consensus         2 lk~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---------~~l~~~~~~   69 (175)
                      +|.+.. .....+.+|++++++++||||+++++++..  ....++||||+. ++|.+++...         ..+++..+.
T Consensus        53 iK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~  131 (405)
T 3rgf_A           53 LKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVK  131 (405)
T ss_dssp             EEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHH
T ss_pred             EEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHH
Confidence            444432 234568899999999999999999999954  678999999995 5888877532         249999999


Q ss_pred             HHHHHH--HHHHHHHcCCeecCCCCCcEEEeec-CCCceEEEeeecceeeccCC----CccccccCCCCccCccccccc-
Q 030527           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQFQ-  141 (175)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~-~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~-  141 (175)
                      .++.|+  ||+|||+.|++|+||||+||++... +..+.++|+|||++......    .......+++.|+|||.+.+. 
T Consensus       132 ~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  211 (405)
T 3rgf_A          132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR  211 (405)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCC
Confidence            999999  9999999999999999999999533 34678999999999876443    122345679999999999764 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          142 RYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       142 ~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      .++.++|+||+||++|+|++|..||.+...
T Consensus       212 ~~~~~~DiwSlG~il~ell~g~~pf~~~~~  241 (405)
T 3rgf_A          212 HYTKAIDIWAIGCIFAELLTSEPIFHCRQE  241 (405)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             cccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence            489999999999999999999999976553

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-34  Score=212.67  Aligned_cols=161  Identities=35%  Similarity=0.609  Sum_probs=128.9

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHH--HH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--GL   77 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~~~~~i--~l   77 (175)
                      ...+.+.+|++++++++||||+++++++...+..++|+||+.+++|.+++..        .+.+++..+..++.|+  ||
T Consensus        55 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  134 (303)
T 2vwi_A           55 TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL  134 (303)
T ss_dssp             -----------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHH
Confidence            3456778899999999999999999999999999999999999999999874        3569999999999999  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC------ccccccCCCCccCcccccc-cCCCcchhHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVDMW  150 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~  150 (175)
                      ++||+.|++|+||+|+||++   +.++.++|+|||.+.......      ......+++.|+|||.+.+ ..++.++|+|
T Consensus       135 ~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~  211 (303)
T 2vwi_A          135 EYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW  211 (303)
T ss_dssp             HHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHH
T ss_pred             HHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHH
Confidence            99999999999999999999   577889999999987654321      1234567899999999865 5689999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCc
Q 030527          151 SVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       151 slg~~~~~~~~g~~pf~~~~~  171 (175)
                      |+|++++++++|..||....+
T Consensus       212 slG~il~~l~~g~~pf~~~~~  232 (303)
T 2vwi_A          212 SFGITAIELATGAAPYHKYPP  232 (303)
T ss_dssp             HHHHHHHHHHHSSCTTTTSCG
T ss_pred             HHHHHHHHHHhCCCCCccCch
Confidence            999999999999999987543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.7e-34  Score=211.95  Aligned_cols=156  Identities=28%  Similarity=0.471  Sum_probs=136.4

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ....+.+|++++++++||||+++++++...  +..++||||+.+++|.+++.+. ..+++..+..++.|+  +|++||+.
T Consensus        66 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  145 (302)
T 4e5w_A           66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR  145 (302)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC
Confidence            346788999999999999999999999876  6689999999999999999654 579999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      |++|+||+|+||+++   .++.++|+|||++........    .....++..|+|||.+.+..++.++|+||+|++++++
T Consensus       146 ~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  222 (302)
T 4e5w_A          146 QYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL  222 (302)
T ss_dssp             TEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred             CcccCCCchheEEEc---CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHH
Confidence            999999999999994   667899999999987755432    2344567779999999888899999999999999999


Q ss_pred             HhCCCCCC
Q 030527          160 LNGYPPFS  167 (175)
Q Consensus       160 ~~g~~pf~  167 (175)
                      ++|..|+.
T Consensus       223 ~~g~~p~~  230 (302)
T 4e5w_A          223 LTYCDSDS  230 (302)
T ss_dssp             HTTTCGGG
T ss_pred             HHccCCCc
Confidence            99998864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.4e-35  Score=216.44  Aligned_cols=161  Identities=29%  Similarity=0.505  Sum_probs=140.5

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHH
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------GRVPEQTARKFL   72 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~l~~~~~~~~~   72 (175)
                      .....+.+|+++++++ +||||+++++++...+..++||||+.+++|.+++.+.              ..+++..+..++
T Consensus        91 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (333)
T 2i1m_A           91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS  170 (333)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHH
Confidence            3567789999999999 8999999999999999999999999999999998753              357999999999


Q ss_pred             HHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcch
Q 030527           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  147 (175)
Q Consensus        73 ~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~  147 (175)
                      .|+  ||++||+.|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||.+.+..++.++
T Consensus       171 ~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  247 (333)
T 2i1m_A          171 SQVAQGMAFLASKNCIHRDVAARNVLL---TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS  247 (333)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGCEE---EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHhcCCcccCCcccceEEE---CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHH
Confidence            998  9999999999999999999999   4678899999999986644322   2233456789999999888899999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          148 DMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       148 Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      |+||||+++++|++ |..||.+...
T Consensus       248 Di~slG~il~el~t~g~~p~~~~~~  272 (333)
T 2i1m_A          248 DVWSYGILLWEIFSLGLNPYPGILV  272 (333)
T ss_dssp             HHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred             HHHHHHHHHHHHHcCCCCCCcccch
Confidence            99999999999998 9999987543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1e-34  Score=215.62  Aligned_cols=166  Identities=27%  Similarity=0.455  Sum_probs=141.9

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHH--H
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQL--G   76 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~~i--~   76 (175)
                      ......++.+|+.++++++||||+++++++...+..++||||+.+++|.+++....       .++...+..++.|+  |
T Consensus        73 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a  152 (327)
T 2yfx_A           73 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG  152 (327)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHH
Confidence            34456678899999999999999999999999999999999999999999998763       38899999999998  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCCCcchhHHHHH
Q 030527           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      |++||+.|++|+||+|+||++...+....++|+|||++.......   ......++..|+|||.+.+..++.++|+||||
T Consensus       153 l~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  232 (327)
T 2yfx_A          153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG  232 (327)
T ss_dssp             HHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             HHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHH
Confidence            999999999999999999999533345679999999987553332   22344567889999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCc
Q 030527          154 AILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       154 ~~~~~~~~-g~~pf~~~~~  171 (175)
                      ++++++++ |..||...+.
T Consensus       233 ~il~ellt~g~~p~~~~~~  251 (327)
T 2yfx_A          233 VLLWEIFSLGYMPYPSKSN  251 (327)
T ss_dssp             HHHHHHHTTSCCSSTTCCH
T ss_pred             HHHHHHHcCCCCCCCCcCH
Confidence            99999998 9999987643

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.6e-35  Score=225.57  Aligned_cols=166  Identities=27%  Similarity=0.532  Sum_probs=140.9

Q ss_pred             ccccch--hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--
Q 030527            2 LKKLNK--HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--   75 (175)
Q Consensus         2 lk~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--   75 (175)
                      ||.++.  .....+.+|++++++++||||+++++++. .+..++||||+.+++|.+++.+.  ..++...+..++.|+  
T Consensus       217 vK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~  295 (454)
T 1qcf_A          217 VKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE  295 (454)
T ss_dssp             EEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHH
T ss_pred             EEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHH
Confidence            444432  34668899999999999999999999986 56789999999999999999754  368999999999998  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      ||+|||++|++|+||+|+||++   +.++.++|+|||+++.......  .....++..|+|||.+....++.++|+||||
T Consensus       296 ~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG  372 (454)
T 1qcf_A          296 GMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG  372 (454)
T ss_dssp             HHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred             HHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHH
Confidence            9999999999999999999999   5778899999999977643321  1223346779999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCc
Q 030527          154 AILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       154 ~~~~~~~~-g~~pf~~~~~  171 (175)
                      ++++++++ |..||.+.+.
T Consensus       373 ~~l~el~t~g~~P~~~~~~  391 (454)
T 1qcf_A          373 ILLMEIVTYGRIPYPGMSN  391 (454)
T ss_dssp             HHHHHHHTTSCCSSTTCCH
T ss_pred             HHHHHHHhCCCCCCCCCCH
Confidence            99999999 9999987654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-34  Score=210.26  Aligned_cols=161  Identities=27%  Similarity=0.521  Sum_probs=139.6

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ......+.+|++++++++||||+++++++ ..+..++|+|++.+++|.+++.+. ..+++..+..++.|+  +|++||+.
T Consensus        51 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  129 (287)
T 1u59_A           51 KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK  129 (287)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34567789999999999999999999999 556689999999999999999754 469999999999999  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      |++|+||+|+||+++   .++.++|+|||++........    .....++..|+|||.+.+..++.++|+||+|++++++
T Consensus       130 ~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  206 (287)
T 1u59_A          130 NFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA  206 (287)
T ss_dssp             TEECCCCSGGGEEEE---ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred             CEeeCCCchheEEEc---CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence            999999999999994   667899999999987754322    1233457789999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCCc
Q 030527          160 LN-GYPPFSVGEE  171 (175)
Q Consensus       160 ~~-g~~pf~~~~~  171 (175)
                      ++ |..||...+.
T Consensus       207 lt~g~~p~~~~~~  219 (287)
T 1u59_A          207 LSYGQKPYKKMKG  219 (287)
T ss_dssp             HTTSCCTTTTCCT
T ss_pred             HcCCCCCcccCCH
Confidence            98 9999987654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.1e-34  Score=216.80  Aligned_cols=158  Identities=28%  Similarity=0.560  Sum_probs=135.2

Q ss_pred             hhhhhhHHHHHHHHhhCC--CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ......+.+|++++++++  ||||+++++++...+..++|||+ .+++|.+++.+...+++..+..++.|+  ||+|||+
T Consensus        95 ~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~  173 (390)
T 2zmd_A           95 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ  173 (390)
T ss_dssp             HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            445678899999999996  59999999999999999999994 588999999988899999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccc-----------cCCCcchh
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-----------QRYDEKVD  148 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~-----------~~~~~~~D  148 (175)
                      .|++|+||||+||++.    ++.++|+|||++.......   ......|++.|+|||.+.+           ..++.++|
T Consensus       174 ~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  249 (390)
T 2zmd_A          174 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD  249 (390)
T ss_dssp             TTCCCCCCCGGGEEES----SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHH
T ss_pred             CCeeecCCCHHHEEEE----CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhh
Confidence            9999999999999993    4679999999998765432   1234568999999999864           36889999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCC
Q 030527          149 MWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus       149 i~slg~~~~~~~~g~~pf~~~  169 (175)
                      +||||+++|+|++|+.||...
T Consensus       250 iwSlGvil~ell~G~~Pf~~~  270 (390)
T 2zmd_A          250 VWSLGCILYYMTYGKTPFQQI  270 (390)
T ss_dssp             HHHHHHHHHHHHHSSCTTTTC
T ss_pred             HHHHHHHHHHHHHCCCcchhh
Confidence            999999999999999999764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.1e-34  Score=211.76  Aligned_cols=163  Identities=29%  Similarity=0.543  Sum_probs=132.7

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC-----eEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRL------HGRVPEQTARKFLQQL   75 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~~~~~i   75 (175)
                      ....+.+.+|++++++++||||+++++++...+     ..++|+|++.+++|.+++..      ...+++..+..++.|+
T Consensus        77 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi  156 (313)
T 3brb_A           77 QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI  156 (313)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHH
Confidence            334567889999999999999999999987755     34999999999999999842      2469999999999999


Q ss_pred             --HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHH
Q 030527           76 --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMW  150 (175)
Q Consensus        76 --~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~  150 (175)
                        ||++||+.|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||.+.+..++.++|+|
T Consensus       157 ~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  233 (313)
T 3brb_A          157 ALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW  233 (313)
T ss_dssp             HHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHH
T ss_pred             HHHHHHHHhCCcccCCCCcceEEE---cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhH
Confidence              9999999999999999999999   5777899999999977644321   2234457789999999988899999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCCcc
Q 030527          151 SVGAILFELLN-GYPPFSVGEEH  172 (175)
Q Consensus       151 slg~~~~~~~~-g~~pf~~~~~~  172 (175)
                      |||++++++++ |..||.+.+..
T Consensus       234 slG~il~el~~~g~~p~~~~~~~  256 (313)
T 3brb_A          234 AFGVTMWEIATRGMTPYPGVQNH  256 (313)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             HHHHHHHHHHhcCCCCCccCCHH
Confidence            99999999999 89999876544

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.4e-34  Score=212.97  Aligned_cols=156  Identities=34%  Similarity=0.600  Sum_probs=136.9

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ...+.+.+|++++++++||||+++++++...+..++||||+. +++.+++.. ...+++..+..++.|+  ||++||+.|
T Consensus        96 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  174 (348)
T 1u5q_A           96 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN  174 (348)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            344678899999999999999999999999999999999996 588888754 4679999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccc---ccCCCcchhHHHHHHHHHHHHh
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      ++|+||+|+||++   +.++.++|+|||++......   ....+++.|+|||.+.   ...++.++|+||||+++++|++
T Consensus       175 ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~  248 (348)
T 1u5q_A          175 MIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  248 (348)
T ss_dssp             CBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHH
T ss_pred             eeeCCCCHHHEEE---CCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHh
Confidence            9999999999999   47788999999999766432   2456899999999984   4568999999999999999999


Q ss_pred             CCCCCCCCC
Q 030527          162 GYPPFSVGE  170 (175)
Q Consensus       162 g~~pf~~~~  170 (175)
                      |..||.+.+
T Consensus       249 g~~p~~~~~  257 (348)
T 1u5q_A          249 RKPPLFNMN  257 (348)
T ss_dssp             SSCTTTTSC
T ss_pred             CCCCCCCCC
Confidence            999997654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.8e-34  Score=219.49  Aligned_cols=157  Identities=31%  Similarity=0.509  Sum_probs=133.0

Q ss_pred             hHHHHHHHHhhCCCCCeeeEeeEEeeCC------eEEEEEeccCCCChHHHH----HhcCCCCHHHHHHHHHHH--HHHH
Q 030527           12 CLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus        12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      ...+|+++++.++||||+++++++...+      ..++||||+.++ +.+.+    .....+++..+..++.|+  ||+|
T Consensus        78 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~  156 (394)
T 4e7w_A           78 FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY  156 (394)
T ss_dssp             SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            3457999999999999999999985543      378999999764 43333    234679999999999998  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccccc-CCCcchhHHHHHHHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE  158 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~  158 (175)
                      ||+.|++||||||+||+++  ..++.++|+|||++.............+++.|+|||.+.+. .++.++|+||+|+++|+
T Consensus       157 LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~e  234 (394)
T 4e7w_A          157 IHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAE  234 (394)
T ss_dssp             HHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             HHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHH
Confidence            9999999999999999994  36778999999999887666555566789999999998765 58999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030527          159 LLNGYPPFSVGEE  171 (175)
Q Consensus       159 ~~~g~~pf~~~~~  171 (175)
                      |++|+.||.+.+.
T Consensus       235 ll~g~~pf~~~~~  247 (394)
T 4e7w_A          235 LMQGQPLFPGESG  247 (394)
T ss_dssp             HHHSSCSSCCSSH
T ss_pred             HHhCCCCCCCCCH
Confidence            9999999987653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.7e-34  Score=212.74  Aligned_cols=158  Identities=31%  Similarity=0.510  Sum_probs=138.4

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      .....+.+|++++++++||||+++++++.+.  ...++||||+.+++|.+++.+. .+++..+..++.|+  +|++||+.
T Consensus        75 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~  153 (318)
T 3lxp_A           75 QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ  153 (318)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4466789999999999999999999999874  6789999999999999999754 58999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      |++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||.+.+..++.++|+||+|++++++
T Consensus       154 ~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  230 (318)
T 3lxp_A          154 HYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL  230 (318)
T ss_dssp             TEECSCCSGGGEEE---CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred             CccCCCCchheEEE---cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHH
Confidence            99999999999999   5778899999999987755432    2334567779999999888899999999999999999


Q ss_pred             HhCCCCCCCC
Q 030527          160 LNGYPPFSVG  169 (175)
Q Consensus       160 ~~g~~pf~~~  169 (175)
                      ++|..||...
T Consensus       231 l~g~~p~~~~  240 (318)
T 3lxp_A          231 LTHCDSSQSP  240 (318)
T ss_dssp             HTTTCGGGSH
T ss_pred             HhCCCccccc
Confidence            9999999653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-33  Score=208.27  Aligned_cols=154  Identities=31%  Similarity=0.473  Sum_probs=129.2

Q ss_pred             hhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ..+...|...+.++ +||||+++++++.+.+..++|||++ +++|.+++...+ .+++..+..++.|+  ||+|||+.|+
T Consensus       100 ~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  178 (311)
T 3p1a_A          100 RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL  178 (311)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            33444555555544 9999999999999999999999999 779999887654 69999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +|+||||+||++   +.++.++|+|||++.............+++.|+|||.+.+ .++.++|+||+|++++++++|..|
T Consensus       179 vH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~  254 (311)
T 3p1a_A          179 VHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMEL  254 (311)
T ss_dssp             ECCCCSGGGEEE---CGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCC
T ss_pred             ecCCCCHHHEEE---CCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999   6778899999999988766655556678999999998875 789999999999999999999766


Q ss_pred             CCC
Q 030527          166 FSV  168 (175)
Q Consensus       166 f~~  168 (175)
                      |.+
T Consensus       255 ~~~  257 (311)
T 3p1a_A          255 PHG  257 (311)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=217.41  Aligned_cols=156  Identities=19%  Similarity=0.306  Sum_probs=136.3

Q ss_pred             hhHHHHHHHHhhCCCCCeee---------------EeeEEee-CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHH
Q 030527           11 SCLDCELNFLSSVNHPNIIR---------------LFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL   72 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~   72 (175)
                      ..+.+|++++++++||||++               +++++.. ++..++||||+ +++|.+++...  ..+++..+..++
T Consensus        87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~  165 (352)
T 2jii_A           87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA  165 (352)
T ss_dssp             STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred             chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence            57889999999999999887               5667765 77899999999 99999999976  689999999999


Q ss_pred             HHH--HHHHHHHcCCeecCCCCCcEEEeecCCCc--eEEEeeecceeeccCCC--------ccccccCCCCccCcccccc
Q 030527           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF  140 (175)
Q Consensus        73 ~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~--~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~  140 (175)
                      .|+  ||++||++|++|+||+|+||+++   .++  .++|+|||++.......        ......+++.|+|||.+.+
T Consensus       166 ~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  242 (352)
T 2jii_A          166 CRLLDALEFLHENEYVHGNVTAENIFVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG  242 (352)
T ss_dssp             HHHHHHHHHHHHTTCBCSCCCGGGEEEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred             HHHHHHHHHHHhCCccCCCCCHHHEEEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence            999  99999999999999999999994   555  89999999997664332        1123468899999999998


Q ss_pred             cCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030527          141 QRYDEKVDMWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       141 ~~~~~~~Di~slg~~~~~~~~g~~pf~~~~  170 (175)
                      ..++.++|+||||+++++|++|+.||....
T Consensus       243 ~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          243 CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            899999999999999999999999998653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.3e-34  Score=209.57  Aligned_cols=161  Identities=29%  Similarity=0.501  Sum_probs=128.6

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      .....+.+.+|++++++++||||++++++. ..+..++|+||+.+++|.+++... ..+++..+..++.|+  +|++||+
T Consensus        60 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~  138 (289)
T 3og7_A           60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA  138 (289)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            345567889999999999999999999965 455688999999999999999654 569999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC---CccccccCCCCccCccccc---ccCCCcchhHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~  156 (175)
                      .|++|+||+|+||++   +.++.++|+|||++......   .......++..|+|||.+.   +..++.++|+||+|+++
T Consensus       139 ~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il  215 (289)
T 3og7_A          139 KSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL  215 (289)
T ss_dssp             TTCCCSCCCGGGEEE---ETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHH
T ss_pred             CCcccccCccceEEE---CCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHH
Confidence            999999999999999   46778999999999765432   2223456899999999986   56688899999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030527          157 FELLNGYPPFSVGE  170 (175)
Q Consensus       157 ~~~~~g~~pf~~~~  170 (175)
                      +++++|+.||.+..
T Consensus       216 ~el~~g~~p~~~~~  229 (289)
T 3og7_A          216 YELMTGQLPYSNIN  229 (289)
T ss_dssp             HHHHHSSCTTSSCC
T ss_pred             HHHHHCCCCccccc
Confidence            99999999997754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.5e-35  Score=223.00  Aligned_cols=158  Identities=14%  Similarity=0.185  Sum_probs=127.9

Q ss_pred             hhhhhHHHHH---HHHhhCCCCCeeeEe-------eEEeeCCe-----------------EEEEEeccCCCChHHHHHhc
Q 030527            8 HLKSCLDCEL---NFLSSVNHPNIIRLF-------DAFQAENC-----------------IFLVVEFCAGGNLSSYIRLH   60 (175)
Q Consensus         8 ~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~~~~~~~-----------------~~lv~e~~~~~~L~~~l~~~   60 (175)
                      ...+.+.+|+   +++++++||||++++       +++.+.+.                 .+++|||+ +++|.+++.+.
T Consensus       115 ~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~  193 (377)
T 3byv_A          115 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL  193 (377)
T ss_dssp             THHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc
Confidence            4557888999   455556899999988       66665532                 78999999 67999999876


Q ss_pred             CCCCH-------HHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCC
Q 030527           61 GRVPE-------QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL  131 (175)
Q Consensus        61 ~~l~~-------~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  131 (175)
                      +.+++       ..+..++.|+  ||+|||+.|++|+||||+||++   +.++.++|+|||++.....  ......+ +.
T Consensus       194 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~  267 (377)
T 3byv_A          194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--RVVSSVS-RG  267 (377)
T ss_dssp             HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTC--EEECCCC-TT
T ss_pred             cccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEechhheecCC--cccCCCC-cC
Confidence            55555       7778899998  9999999999999999999999   5778899999999986533  2334456 89


Q ss_pred             ccCccccccc-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030527          132 YMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGYPPFSVGEEH  172 (175)
Q Consensus       132 ~~~pe~~~~~-----------~~~~~~Di~slg~~~~~~~~g~~pf~~~~~~  172 (175)
                      |+|||.+.+.           .++.++|+||||+++|+|++|+.||.+.+..
T Consensus       268 y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~  319 (377)
T 3byv_A          268 FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAAL  319 (377)
T ss_dssp             CCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccc
Confidence            9999999877           8999999999999999999999999876543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-34  Score=230.51  Aligned_cols=161  Identities=27%  Similarity=0.514  Sum_probs=136.5

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+.+|++++++++||||+++++++.. +..++||||+.+++|.+++... ..+++..+..++.|+  ||+|||++|
T Consensus       378 ~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  456 (613)
T 2ozo_A          378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN  456 (613)
T ss_dssp             TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            356788999999999999999999999876 5589999999999999999755 469999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      ++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus       457 iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ell  533 (613)
T 2ozo_A          457 FVHRNLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL  533 (613)
T ss_dssp             CCCSCCSGGGEEE---EETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             EEcCcCCHHHEEE---cCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence            9999999999999   4677899999999977643321    12233457899999998889999999999999999999


Q ss_pred             h-CCCCCCCCCcc
Q 030527          161 N-GYPPFSVGEEH  172 (175)
Q Consensus       161 ~-g~~pf~~~~~~  172 (175)
                      + |..||.+.+..
T Consensus       534 t~G~~Pf~~~~~~  546 (613)
T 2ozo_A          534 SYGQKPYKKMKGP  546 (613)
T ss_dssp             TTSCCTTTTCCSH
T ss_pred             HCCCCCCCCCCHH
Confidence            8 99999876543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-34  Score=209.62  Aligned_cols=162  Identities=36%  Similarity=0.592  Sum_probs=131.9

Q ss_pred             cccc-chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHH--
Q 030527            2 LKKL-NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQL--   75 (175)
Q Consensus         2 lk~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i--   75 (175)
                      +|.+ .....+.+.+|++++++++||||+++++++.+.  .++||||+++++|.+++....   .++...+..++.|+  
T Consensus        36 vK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~  113 (307)
T 2eva_A           36 IKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ  113 (307)
T ss_dssp             EEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHH
T ss_pred             EEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHH
Confidence            4555 334567889999999999999999999987743  689999999999999998664   37889999999998  


Q ss_pred             HHHHHHH---cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHH
Q 030527           76 GLEILNS---HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  152 (175)
Q Consensus        76 ~l~~lh~---~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl  152 (175)
                      ++++||+   +|++|+||+|+||++.  ..+..++|+|||++.......  ....++..|+|||.+.+..++.++|+|||
T Consensus       114 ~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  189 (307)
T 2eva_A          114 GVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEGSNYSEKCDVFSW  189 (307)
T ss_dssp             HHHHHHTCSSSCCCCCCCSGGGEEEE--TTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHH
T ss_pred             HHHHHHhCCCCCeecCCCChhHEEEe--CCCCEEEEccccccccccccc--ccCCCCCceEChhhhCCCCCCcHHHHHHH
Confidence            9999999   8999999999999995  333458999999997654332  23458999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCCC
Q 030527          153 GAILFELLNGYPPFSVG  169 (175)
Q Consensus       153 g~~~~~~~~g~~pf~~~  169 (175)
                      |++++++++|+.||...
T Consensus       190 G~il~el~~g~~p~~~~  206 (307)
T 2eva_A          190 GIILWEVITRRKPFDEI  206 (307)
T ss_dssp             HHHHHHHHHTCCTTTTT
T ss_pred             HHHHHHHHHCCCCchhh
Confidence            99999999999999754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-33  Score=205.83  Aligned_cols=160  Identities=25%  Similarity=0.406  Sum_probs=136.5

Q ss_pred             hhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHH
Q 030527            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i--~l~~   79 (175)
                      ......+.+|+..+.++ +||||+++++++.+.+..++||||+++++|.+++.+.    ..+++..+..++.|+  ||++
T Consensus        51 ~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~  130 (289)
T 1x8b_A           51 SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY  130 (289)
T ss_dssp             SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHH
Confidence            34466778899999999 9999999999999999999999999999999999765    669999999999999  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecC----------------CCceEEEeeecceeeccCCCccccccCCCCccCccccccc-C
Q 030527           80 LNSHHIIHRDLKPENILLSGLD----------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-R  142 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~----------------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~  142 (175)
                      ||++|++|+||+|+||+++..+                ....++|+|||.+.......   ...++..|+|||.+.+. .
T Consensus       131 lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~  207 (289)
T 1x8b_A          131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYT  207 (289)
T ss_dssp             HHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCT
T ss_pred             HHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCC
Confidence            9999999999999999995221                34469999999998775443   33478999999999765 5


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 030527          143 YDEKVDMWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus       143 ~~~~~Di~slg~~~~~~~~g~~pf~~~  169 (175)
                      ++.++|+||+|++++++++|..|+...
T Consensus       208 ~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          208 HLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             THHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             CCchhhHHHHHHHHHHHhcCCCCCcch
Confidence            668999999999999999998877543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.7e-34  Score=212.62  Aligned_cols=161  Identities=26%  Similarity=0.432  Sum_probs=139.7

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEe--eCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      .....+.+.+|++++++++||||+++++++.  +.+..++||||+.+++|.+++.+. ..+++..+..++.|+  ||++|
T Consensus        64 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l  143 (327)
T 3lxl_A           64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL  143 (327)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            3445667899999999999999999999886  456789999999999999999874 569999999999999  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~  156 (175)
                      |+.|++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||.+.+..++.++|+||+|+++
T Consensus       144 H~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  220 (327)
T 3lxl_A          144 GSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL  220 (327)
T ss_dssp             HHTTEECSCCSGGGEEE---EETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred             HhCCccCCCCChhhEEE---CCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHH
Confidence            99999999999999999   4677899999999987654432    2234567779999999888899999999999999


Q ss_pred             HHHHhCCCCCCCC
Q 030527          157 FELLNGYPPFSVG  169 (175)
Q Consensus       157 ~~~~~g~~pf~~~  169 (175)
                      +++++|..||...
T Consensus       221 ~~ll~g~~p~~~~  233 (327)
T 3lxl_A          221 YELFTYCDKSCSP  233 (327)
T ss_dssp             HHHHTTTCGGGSH
T ss_pred             HHHHhCCCCCccc
Confidence            9999999998653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.2e-34  Score=223.91  Aligned_cols=166  Identities=24%  Similarity=0.456  Sum_probs=136.9

Q ss_pred             ccccch--hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--
Q 030527            2 LKKLNK--HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--   75 (175)
Q Consensus         2 lk~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--   75 (175)
                      ||.++.  .....+.+|++++++++||||+++++++.+ +..++||||+.+++|.+++.+.  ..+++..+..++.|+  
T Consensus       213 vK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~  291 (452)
T 1fmk_A          213 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS  291 (452)
T ss_dssp             EEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHH
T ss_pred             EEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH
Confidence            455543  234678999999999999999999999876 6689999999999999999753  569999999999999  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      ||+|||++|++|+||+|+||++   +.++.++|+|||++........  .....++..|+|||.+.+..++.++|+||||
T Consensus       292 ~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG  368 (452)
T 1fmk_A          292 GMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG  368 (452)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred             HHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHH
Confidence            9999999999999999999999   5778899999999987644322  2233456789999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCc
Q 030527          154 AILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       154 ~~~~~~~~-g~~pf~~~~~  171 (175)
                      ++++++++ |..||.+.+.
T Consensus       369 ~~l~el~t~g~~P~~~~~~  387 (452)
T 1fmk_A          369 ILLTELTTKGRVPYPGMVN  387 (452)
T ss_dssp             HHHHHHHTTTCCSSTTCCH
T ss_pred             HHHHHHHhCCCCCCCCCCH
Confidence            99999999 9999987553

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.2e-34  Score=207.42  Aligned_cols=161  Identities=20%  Similarity=0.241  Sum_probs=137.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeE-EeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ..+.+.+|++++++++|+++++.+.+ ....+..++|+|++ +++|.+++... ..+++..+..++.|+  ||++||++|
T Consensus        47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  125 (296)
T 3uzp_A           47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN  125 (296)
T ss_dssp             SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            44678999999999988776555544 46778889999999 89999999854 579999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--------cccccCCCCccCcccccccCCCcchhHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~  156 (175)
                      ++|+||+|+||+++..+.++.++|+|||++........        .....++..|+|||.+.+..++.++|+||+|+++
T Consensus       126 ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il  205 (296)
T 3uzp_A          126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL  205 (296)
T ss_dssp             EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHH
Confidence            99999999999995334567899999999987655432        2345688999999999988999999999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 030527          157 FELLNGYPPFSVGE  170 (175)
Q Consensus       157 ~~~~~g~~pf~~~~  170 (175)
                      +++++|+.||.+.+
T Consensus       206 ~~l~~g~~pf~~~~  219 (296)
T 3uzp_A          206 MYFNLGSLPWQGLK  219 (296)
T ss_dssp             HHHHHSSCTTSSCC
T ss_pred             HHHHhCCCCCCCcC
Confidence            99999999998744

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2e-34  Score=209.46  Aligned_cols=165  Identities=27%  Similarity=0.521  Sum_probs=133.4

Q ss_pred             ccccch-hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC-CeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHH--
Q 030527            2 LKKLNK-HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--   75 (175)
Q Consensus         2 lk~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~i--   75 (175)
                      +|.++. ...+.+.+|++++++++||||+++++++.+. +..++|+|++.+++|.+++.+.+.  +++..+..++.|+  
T Consensus        49 vK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~  128 (278)
T 1byg_A           49 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE  128 (278)
T ss_dssp             EEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHH
Confidence            444432 3456789999999999999999999987544 578999999999999999986643  8999999999998  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  155 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~  155 (175)
                      ++++||+.|++|+||+|+||++   +.++.++|+|||++.......  ....++..|+|||.+.+..++.++|+||+|++
T Consensus       129 ~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  203 (278)
T 1byg_A          129 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGIL  203 (278)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             HHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccccccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHH
Confidence            9999999999999999999999   577889999999987654432  23456788999999988889999999999999


Q ss_pred             HHHHHh-CCCCCCCCCc
Q 030527          156 LFELLN-GYPPFSVGEE  171 (175)
Q Consensus       156 ~~~~~~-g~~pf~~~~~  171 (175)
                      ++++++ |..||...+.
T Consensus       204 l~~l~t~g~~p~~~~~~  220 (278)
T 1byg_A          204 LWEIYSFGRVPYPRIPL  220 (278)
T ss_dssp             HHHHHTTSCCSCTTSCG
T ss_pred             HHHHHhCCCCCCCCCCH
Confidence            999998 9999987543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5e-34  Score=211.29  Aligned_cols=161  Identities=24%  Similarity=0.451  Sum_probs=139.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHH--
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQL--   75 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~i--   75 (175)
                      .....+.+|++++++++||||+++++++.+.+..++|||++.+++|.+++...          ..+++..+..++.|+  
T Consensus        70 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  149 (322)
T 1p4o_A           70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD  149 (322)
T ss_dssp             HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHH
Confidence            34556889999999999999999999999999999999999999999998753          356899999999998  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  152 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl  152 (175)
                      ||++||++|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||.+.+..++.++|+||+
T Consensus       150 ~l~~lH~~~i~H~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  226 (322)
T 1p4o_A          150 GMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF  226 (322)
T ss_dssp             HHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHCCCccCCCccceEEE---cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence            9999999999999999999999   5778899999999976543321   223345778999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCCc
Q 030527          153 GAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       153 g~~~~~~~~-g~~pf~~~~~  171 (175)
                      |++++++++ |..||.+.+.
T Consensus       227 G~il~el~~~g~~p~~~~~~  246 (322)
T 1p4o_A          227 GVVLWEIATLAEQPYQGLSN  246 (322)
T ss_dssp             HHHHHHHHHTSCCTTTTSCH
T ss_pred             HHHHHHHHhcCCCccccCCH
Confidence            999999999 8999987543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8e-34  Score=212.69  Aligned_cols=158  Identities=27%  Similarity=0.499  Sum_probs=134.8

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEee--------CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLE   78 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~   78 (175)
                      ...+.+|++++++++||||+++++++..        .+..++||||+.+ ++.+.+... ..+++..+..++.|+  ||+
T Consensus        60 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~  138 (351)
T 3mi9_A           60 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLY  138 (351)
T ss_dssp             CHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence            4567889999999999999999999877        4568999999965 777777654 579999999999999  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-----CccccccCCCCccCcccccc-cCCCcchhHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSV  152 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~sl  152 (175)
                      +||+.|++|+||+|+||++   +.++.++|+|||++......     .......+++.|+|||.+.+ ..++.++|+||+
T Consensus       139 ~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  215 (351)
T 3mi9_A          139 YIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA  215 (351)
T ss_dssp             HHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHH
T ss_pred             HHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHH
Confidence            9999999999999999999   57788999999999876432     12234567889999999875 457999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCc
Q 030527          153 GAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       153 g~~~~~~~~g~~pf~~~~~  171 (175)
                      |+++++|++|..||.+.++
T Consensus       216 G~il~ell~g~~pf~~~~~  234 (351)
T 3mi9_A          216 GCIMAEMWTRSPIMQGNTE  234 (351)
T ss_dssp             HHHHHHHHHSSCSCCCSSH
T ss_pred             HHHHHHHHhCCCCCCCCCh
Confidence            9999999999999987654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.9e-34  Score=214.60  Aligned_cols=157  Identities=22%  Similarity=0.453  Sum_probs=140.4

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHH--HHHHH
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY------IRL--HGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ..+.+|++++++++||||+++++++.+.+..++||||+.+++|.++      +.+  ...+++..+..++.|+  |+++|
T Consensus        88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  167 (348)
T 2pml_X           88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI  167 (348)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            7889999999999999999999999999999999999999999998      665  4679999999999999  99999


Q ss_pred             HH-cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccccc-CCCc-chhHHHHHHHHH
Q 030527           81 NS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDE-KVDMWSVGAILF  157 (175)
Q Consensus        81 h~-~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~-~~Di~slg~~~~  157 (175)
                      |+ .|++|+||+|+||++   +.++.++|+|||.+...... ......++..|+|||.+.+. .++. ++|+||+|++++
T Consensus       168 H~~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~  243 (348)
T 2pml_X          168 HNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY  243 (348)
T ss_dssp             HHTSCEECCCCCGGGEEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHH
T ss_pred             hccCCEeecCCChHhEEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHH
Confidence            99 999999999999999   57788999999999876544 33455678999999999876 5555 899999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030527          158 ELLNGYPPFSVGEE  171 (175)
Q Consensus       158 ~~~~g~~pf~~~~~  171 (175)
                      ++++|..||...++
T Consensus       244 ~l~~g~~pf~~~~~  257 (348)
T 2pml_X          244 VMFYNVVPFSLKIS  257 (348)
T ss_dssp             HHHHSSCSSCCSSC
T ss_pred             HHHhCCCCCCCCCc
Confidence            99999999987654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-34  Score=214.18  Aligned_cols=158  Identities=37%  Similarity=0.560  Sum_probs=138.2

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      .+.+.+|++++++++||||+++++++...+..++|+||+.+ +|.+++... ..+++..+..++.|+  ||++||+.|++
T Consensus        56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  134 (346)
T 1ua2_A           56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL  134 (346)
T ss_dssp             CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             hHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            35678999999999999999999999999999999999965 898888765 468999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      |+||+|+||++   +.++.++|+|||++....... ......+++.|+|||.+.+. .++.++|+||+|+++++|++|..
T Consensus       135 H~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  211 (346)
T 1ua2_A          135 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP  211 (346)
T ss_dssp             CCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCCHHHEEE---cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            99999999999   577889999999998764432 23445679999999998654 47899999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.++
T Consensus       212 ~~~~~~~  218 (346)
T 1ua2_A          212 FLPGDSD  218 (346)
T ss_dssp             SSCCSSH
T ss_pred             CCCCCCH
Confidence            9987653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.8e-34  Score=208.72  Aligned_cols=159  Identities=26%  Similarity=0.524  Sum_probs=138.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ....+.+|++++++++||||+++++++.. +..++|+|++.+++|.+++....  .+++..+..++.|+  +|++||+.|
T Consensus        51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  129 (279)
T 1qpc_A           51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN  129 (279)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45678999999999999999999999864 45789999999999999987543  69999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh-
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-  161 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-  161 (175)
                      ++|+||+|+||++   +.++.++|+|||.+........  .....++..|+|||.+.+..++.++|+||+|++++++++ 
T Consensus       130 i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~  206 (279)
T 1qpc_A          130 YIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH  206 (279)
T ss_dssp             EECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             eeccCCCHhhEEE---cCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhC
Confidence            9999999999999   5778899999999987754432  223345678999999988889999999999999999999 


Q ss_pred             CCCCCCCCCc
Q 030527          162 GYPPFSVGEE  171 (175)
Q Consensus       162 g~~pf~~~~~  171 (175)
                      |..||.+.+.
T Consensus       207 g~~p~~~~~~  216 (279)
T 1qpc_A          207 GRIPYPGMTN  216 (279)
T ss_dssp             TCCSSTTCCH
T ss_pred             CCCCCcccCH
Confidence            9999987553

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.1e-34  Score=215.23  Aligned_cols=157  Identities=33%  Similarity=0.585  Sum_probs=124.2

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      ....++.+|+++++.++||||+++++++...      +..+++++++ +++|.++++. ..+++..+..++.|+  ||+|
T Consensus        70 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~  147 (367)
T 2fst_X           70 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKY  147 (367)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            3456788999999999999999999998654      5679999998 7899998875 679999999999999  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~  158 (175)
                      ||+.|++|+||||+||++   +.++.++|+|||+++.....  .....+++.|+|||.+.+ ..++.++|+||+|+++++
T Consensus       148 LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  222 (367)
T 2fst_X          148 IHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE  222 (367)
T ss_dssp             HHHTTCCCCCCCGGGEEE---CTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHH
T ss_pred             HHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHH
Confidence            999999999999999999   57788999999999776433  234567899999999876 678999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030527          159 LLNGYPPFSVGEE  171 (175)
Q Consensus       159 ~~~g~~pf~~~~~  171 (175)
                      |++|+.||.+.+.
T Consensus       223 ll~g~~pf~~~~~  235 (367)
T 2fst_X          223 LLTGRTLFPGTDH  235 (367)
T ss_dssp             HHHSSCSCCCSSH
T ss_pred             HHhCCCCCCCCCH
Confidence            9999999987653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-33  Score=206.31  Aligned_cols=157  Identities=31%  Similarity=0.526  Sum_probs=133.1

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC--C
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH--I   85 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~--~   85 (175)
                      +.+.+|++++++++||||+++++++.+..  ++||||+.+++|.+++.+. ..+++..+..++.|+  ++++||+.|  +
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i  145 (287)
T 4f0f_A           68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI  145 (287)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred             HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence            67889999999999999999999987766  5899999999999888655 479999999999998  999999999  9


Q ss_pred             eecCCCCCcEEEeecC--CCceEEEeeecceeeccCCCccccccCCCCccCccccc--ccCCCcchhHHHHHHHHHHHHh
Q 030527           86 IHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      +|+||+|+||+++..+  ....++|+|||++......  .....++..|+|||.+.  ...++.++|+||+|+++|++++
T Consensus       146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~  223 (287)
T 4f0f_A          146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT  223 (287)
T ss_dssp             BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc
Confidence            9999999999994221  1123999999999765432  33456889999999983  4557899999999999999999


Q ss_pred             CCCCCCCCCc
Q 030527          162 GYPPFSVGEE  171 (175)
Q Consensus       162 g~~pf~~~~~  171 (175)
                      |..||...+.
T Consensus       224 g~~pf~~~~~  233 (287)
T 4f0f_A          224 GEGPFDEYSY  233 (287)
T ss_dssp             SSCTTTTCCC
T ss_pred             CCCCCccccc
Confidence            9999986543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-34  Score=216.41  Aligned_cols=162  Identities=30%  Similarity=0.510  Sum_probs=130.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEe-eCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ...+++.+|++++++++||||+++++++. ..+..++||||+.+++|.+++.+. ..+++..+..++.|+  ||+|||++
T Consensus       132 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  211 (373)
T 3c1x_A          132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK  211 (373)
T ss_dssp             HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            45678899999999999999999999864 456789999999999999999865 458899999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-----cccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      |++|+||+|+||++   +.++.++|+|||++........     .....++..|+|||.+.+..++.++|+||||+++|+
T Consensus       212 ~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~e  288 (373)
T 3c1x_A          212 KFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE  288 (373)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             CEecCccchheEEE---CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHH
Confidence            99999999999999   5778899999999976643321     123345678999999998899999999999999999


Q ss_pred             HHh-CCCCCCCCCcc
Q 030527          159 LLN-GYPPFSVGEEH  172 (175)
Q Consensus       159 ~~~-g~~pf~~~~~~  172 (175)
                      +++ |.+||.+.+..
T Consensus       289 llt~~~~p~~~~~~~  303 (373)
T 3c1x_A          289 LMTRGAPPYPDVNTF  303 (373)
T ss_dssp             HHTTSCCSCTTSCSS
T ss_pred             HHhCcCCCCCCCCHH
Confidence            999 78888766543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.9e-34  Score=218.84  Aligned_cols=164  Identities=37%  Similarity=0.557  Sum_probs=140.1

Q ss_pred             ccccc--hhhhhhHHHHHHHHhhC------CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHH
Q 030527            2 LKKLN--KHLKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKF   71 (175)
Q Consensus         2 lk~~~--~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~   71 (175)
                      ||.+.  ....+.+.+|+++++.+      +|+||+++++++...+..++|||++ +++|.+++....  .+++..+..+
T Consensus       127 vK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i  205 (429)
T 3kvw_A          127 LKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKF  205 (429)
T ss_dssp             EEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHH
T ss_pred             EEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHH
Confidence            45443  33356778899988887      5779999999999999999999999 569999998764  4999999999


Q ss_pred             HHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCce--EEEeeecceeeccCCCccccccCCCCccCcccccccCCCcch
Q 030527           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVM--LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV  147 (175)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~  147 (175)
                      +.|+  ||+|||+.|++|+||||+||+++   .++.  ++|+|||++......  .....+++.|+|||.+.+..++.++
T Consensus       206 ~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~  280 (429)
T 3kvw_A          206 AHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPI  280 (429)
T ss_dssp             HHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHH
T ss_pred             HHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhCCCCCchH
Confidence            9999  99999999999999999999994   4444  999999999765433  3345678999999999998999999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          148 DMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       148 Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      |+||||+++++|++|+.||.+.++
T Consensus       281 DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          281 DMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999988764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2e-34  Score=209.41  Aligned_cols=163  Identities=36%  Similarity=0.681  Sum_probs=138.6

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHH--HH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GL   77 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i--~l   77 (175)
                      .+..++.+.+|++++++++||||+++++++.+  .+..++||||+.+++|.+++.+.    ..+++..+..++.|+  +|
T Consensus        45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l  124 (279)
T 2w5a_A           45 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL  124 (279)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHH
Confidence            34566788999999999999999999998754  67899999999999999999754    249999999999999  99


Q ss_pred             HHHHHcC-----CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccCCCcchhHHH
Q 030527           78 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWS  151 (175)
Q Consensus        78 ~~lh~~~-----~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~s  151 (175)
                      ++||+.|     ++|+||+|+||++   +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||
T Consensus       125 ~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  201 (279)
T 2w5a_A          125 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWS  201 (279)
T ss_dssp             HHHHHHC------CCCCCSGGGEEE---CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHH
T ss_pred             HHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHH
Confidence            9999999     9999999999999   5778899999999876644322 23456789999999998888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCc
Q 030527          152 VGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       152 lg~~~~~~~~g~~pf~~~~~  171 (175)
                      +|++++++++|..||...+.
T Consensus       202 lG~il~~l~~g~~p~~~~~~  221 (279)
T 2w5a_A          202 LGCLLYELCALMPPFTAFSQ  221 (279)
T ss_dssp             HHHHHHHHHHSSCSSCCSSH
T ss_pred             HHHHHHHHHHCCCCCcccCH
Confidence            99999999999999987653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-33  Score=207.13  Aligned_cols=161  Identities=30%  Similarity=0.521  Sum_probs=137.0

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEE-eeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      .....+.+|++++++++||||+++++++ ..++..+++|||+.+++|.+++.+. ..+++..+..++.|+  ||++||+.
T Consensus        68 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~  147 (298)
T 3f66_A           68 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK  147 (298)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4456788999999999999999999985 4566789999999999999999864 468999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-----cccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      |++|+||+|+||++   +.++.++|+|||++........     .....++..|+|||.+.+..++.++|+||+|+++++
T Consensus       148 ~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  224 (298)
T 3f66_A          148 KFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE  224 (298)
T ss_dssp             TCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             CccCCCCchheEEE---CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHH
Confidence            99999999999999   5778899999999976644321     123345677999999988899999999999999999


Q ss_pred             HHh-CCCCCCCCCc
Q 030527          159 LLN-GYPPFSVGEE  171 (175)
Q Consensus       159 ~~~-g~~pf~~~~~  171 (175)
                      +++ +.+||.+.+.
T Consensus       225 l~~~~~~~~~~~~~  238 (298)
T 3f66_A          225 LMTRGAPPYPDVNT  238 (298)
T ss_dssp             HHTTSCCSSTTSCT
T ss_pred             HHhCCCCCCccCCH
Confidence            999 6777766544

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.7e-33  Score=205.97  Aligned_cols=164  Identities=20%  Similarity=0.243  Sum_probs=137.5

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeE-EeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ....+.+..|.++++.++|++++..+.. +...+..++|||++ +++|.+++... ..+++..+..++.|+  ||++||+
T Consensus        45 ~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  123 (296)
T 4hgt_A           45 KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS  123 (296)
T ss_dssp             ---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3445678999999999987776655554 46778889999999 99999999854 579999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--------cccccCCCCccCcccccccCCCcchhHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  154 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~  154 (175)
                      .|++|+||+|+||++...+.++.++|+|||++........        .....++..|+|||.+.+..++.++|+||+|+
T Consensus       124 ~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~  203 (296)
T 4hgt_A          124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY  203 (296)
T ss_dssp             TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred             CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHH
Confidence            9999999999999995334667799999999987654422        22456789999999999889999999999999


Q ss_pred             HHHHHHhCCCCCCCCCc
Q 030527          155 ILFELLNGYPPFSVGEE  171 (175)
Q Consensus       155 ~~~~~~~g~~pf~~~~~  171 (175)
                      +++++++|+.||.+.+.
T Consensus       204 il~~l~~g~~pf~~~~~  220 (296)
T 4hgt_A          204 VLMYFNLGSLPWQGLKA  220 (296)
T ss_dssp             HHHHHHHSSCTTSSCCC
T ss_pred             HHHHHhcCCCCCcccch
Confidence            99999999999987543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.5e-34  Score=213.57  Aligned_cols=157  Identities=29%  Similarity=0.477  Sum_probs=128.0

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEee-----CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHH
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      .+.+.+|++++++++||||+++++++..     ....++|||++. ++|.+++... ..+++..+..++.|+  ||++||
T Consensus        73 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  151 (362)
T 3pg1_A           73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH  151 (362)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            4778999999999999999999999843     347899999996 5888887754 469999999999999  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~  160 (175)
                      +.|++|+||+|+||++   +.++.++|+|||++.............+++.|+|||.+.+ ..++.++|+||+|+++++++
T Consensus       152 ~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  228 (362)
T 3pg1_A          152 EAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF  228 (362)
T ss_dssp             HTTCCCCCCCGGGEEE---CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred             HCcCEecCCChHHEEE---cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH
Confidence            9999999999999999   5778899999999986655555555678899999999876 67899999999999999999


Q ss_pred             hCCCCCCCCC
Q 030527          161 NGYPPFSVGE  170 (175)
Q Consensus       161 ~g~~pf~~~~  170 (175)
                      +|+.||.+.+
T Consensus       229 ~g~~pf~~~~  238 (362)
T 3pg1_A          229 NRKALFRGST  238 (362)
T ss_dssp             HSSCSCCCSS
T ss_pred             hCCCCCCCCC
Confidence            9999998765

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-34  Score=219.59  Aligned_cols=168  Identities=32%  Similarity=0.523  Sum_probs=135.9

Q ss_pred             CccccchhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--H
Q 030527            1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--G   76 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~   76 (175)
                      +||.+..+....+.+|+++++++ +||||+++++++.+.+..++|||++. ++|.+++.... .+++..+..++.|+  |
T Consensus        52 AvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~a  130 (432)
T 3p23_A           52 AVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSG  130 (432)
T ss_dssp             EEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHH
T ss_pred             EEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHH
Confidence            36777666667788999999999 89999999999999999999999995 59999998654 45556677888998  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeecC--CCceEEEeeecceeeccCCC----ccccccCCCCccCccccc---ccCCCcch
Q 030527           77 LEILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQ---FQRYDEKV  147 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~~--~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~pe~~~---~~~~~~~~  147 (175)
                      |+|||+.|++|+||||+||++...+  ....++|+|||++.......    ......||+.|+|||.+.   ...++.++
T Consensus       131 L~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~  210 (432)
T 3p23_A          131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV  210 (432)
T ss_dssp             HHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHH
T ss_pred             HHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHH
Confidence            9999999999999999999995322  23458899999998765432    223456899999999987   45678899


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCC
Q 030527          148 DMWSVGAILFELLN-GYPPFSVG  169 (175)
Q Consensus       148 Di~slg~~~~~~~~-g~~pf~~~  169 (175)
                      |+||+|++++++++ |..||...
T Consensus       211 DiwSlG~il~ellt~g~~pf~~~  233 (432)
T 3p23_A          211 DIFSAGCVFYYVISEGSHPFGKS  233 (432)
T ss_dssp             HHHHHHHHHHHHHTTSCBTTBST
T ss_pred             HHHHHHHHHHHHHcCCCCCcchh
Confidence            99999999999999 99999654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.4e-33  Score=212.43  Aligned_cols=160  Identities=31%  Similarity=0.513  Sum_probs=137.0

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ...+.+.+|++++++++||||+++++++...     ...++|+|++. ++|.++++. +.+++..+..++.|+  ||++|
T Consensus        67 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~L  144 (364)
T 3qyz_A           67 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYI  144 (364)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHH
Confidence            3456788999999999999999999998654     46899999995 599998874 579999999999999  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccc-cCCCcchhHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAI  155 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~  155 (175)
                      |+.|++|+||+|+||++   +.++.++|+|||++........    .....+++.|+|||.+.+ ..++.++|+||+|++
T Consensus       145 H~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  221 (364)
T 3qyz_A          145 HSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI  221 (364)
T ss_dssp             HHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHH
T ss_pred             HHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHH
Confidence            99999999999999999   5778899999999987644321    234468899999998754 458999999999999


Q ss_pred             HHHHHhCCCCCCCCCcc
Q 030527          156 LFELLNGYPPFSVGEEH  172 (175)
Q Consensus       156 ~~~~~~g~~pf~~~~~~  172 (175)
                      +++|++|..||.+.+..
T Consensus       222 l~ell~g~~pf~~~~~~  238 (364)
T 3qyz_A          222 LAEMLSNRPIFPGKHYL  238 (364)
T ss_dssp             HHHHHHSSCSSCCSSGG
T ss_pred             HHHHHHCCCCCCCCChH
Confidence            99999999999877643

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.6e-33  Score=208.75  Aligned_cols=158  Identities=37%  Similarity=0.588  Sum_probs=137.5

Q ss_pred             hhhHHHHHHHHhhC---CCCCeeeEeeEEe-----eCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HH
Q 030527           10 KSCLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GL   77 (175)
Q Consensus        10 ~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l   77 (175)
                      ...+.+|+++++.+   +||||+++++++.     ..+..++|+|++. ++|.+++.+..  .+++..+..++.|+  ||
T Consensus        55 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l  133 (326)
T 1blx_A           55 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL  133 (326)
T ss_dssp             BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHH
T ss_pred             CchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence            34677888877766   8999999999987     5567899999996 69999998754  49999999999998  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~  157 (175)
                      ++||+.|++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|++++
T Consensus       134 ~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  210 (326)
T 1blx_A          134 DFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA  210 (326)
T ss_dssp             HHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred             HHHHHCCceeccCCHHHeEE---cCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHH
Confidence            99999999999999999999   577889999999998765544444567889999999998888999999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030527          158 ELLNGYPPFSVGEE  171 (175)
Q Consensus       158 ~~~~g~~pf~~~~~  171 (175)
                      ++++|+.||.+.++
T Consensus       211 ~l~~g~~pf~~~~~  224 (326)
T 1blx_A          211 EMFRRKPLFRGSSD  224 (326)
T ss_dssp             HHHHSSCSCCCSSH
T ss_pred             HHHcCCCCCCCCCH
Confidence            99999999987653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-33  Score=206.07  Aligned_cols=161  Identities=27%  Similarity=0.467  Sum_probs=136.9

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeE-EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI-FLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      .....+.+|++++++++||||+++++++...+.. +++++++.+++|.+++... ..+++..+..++.|+  ||++||+.
T Consensus        64 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  143 (298)
T 3pls_A           64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ  143 (298)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4456788999999999999999999999776554 8999999999999999864 568999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-----ccccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      |++|+||+|+||++   +.++.++|+|||++.......     ......++..|+|||.+.+..++.++|+||+|+++++
T Consensus       144 ~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  220 (298)
T 3pls_A          144 KFVHRDLAARNCML---DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWE  220 (298)
T ss_dssp             TCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             CcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHH
Confidence            99999999999999   577789999999997654322     2223456778999999998899999999999999999


Q ss_pred             HHhC-CCCCCCCCc
Q 030527          159 LLNG-YPPFSVGEE  171 (175)
Q Consensus       159 ~~~g-~~pf~~~~~  171 (175)
                      |++| .+||...+.
T Consensus       221 l~~g~~~~~~~~~~  234 (298)
T 3pls_A          221 LLTRGAPPYRHIDP  234 (298)
T ss_dssp             HHHTSCCTTTTSCG
T ss_pred             HhhCCCCCCccCCH
Confidence            9995 555555443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.4e-33  Score=205.87  Aligned_cols=155  Identities=28%  Similarity=0.433  Sum_probs=122.2

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHHHc-
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILNSH-   83 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l~~lh~~-   83 (175)
                      +.+.++...++.++||||+++++++.+.+..++||||+. ++|.+++..    ...+++..+..++.|+  |+++||++ 
T Consensus        51 ~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  129 (290)
T 3fme_A           51 RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL  129 (290)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence            344555556788899999999999999999999999996 588777653    4679999999999999  99999998 


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccc----cccCCCcchhHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~----~~~~~~~~~Di~slg~~~~~~  159 (175)
                      |++|+||+|+||++   +.++.++|+|||++.............+++.|+|||.+    .+..++.++|+||+|++++++
T Consensus       130 ~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l  206 (290)
T 3fme_A          130 SVIHRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL  206 (290)
T ss_dssp             CCCCCCCSGGGCEE---CTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEE---CCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHH
Confidence            99999999999999   57778999999999877665555556789999999996    456789999999999999999


Q ss_pred             HhCCCCCCCC
Q 030527          160 LNGYPPFSVG  169 (175)
Q Consensus       160 ~~g~~pf~~~  169 (175)
                      ++|..||...
T Consensus       207 ~~g~~p~~~~  216 (290)
T 3fme_A          207 AILRFPYDSW  216 (290)
T ss_dssp             HHTSCSSCCC
T ss_pred             HHCCCCcccc
Confidence            9999999753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.4e-33  Score=209.64  Aligned_cols=161  Identities=27%  Similarity=0.462  Sum_probs=138.9

Q ss_pred             hhhhhHHHHHHHHhhCCCC------CeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HH
Q 030527            8 HLKSCLDCELNFLSSVNHP------NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GL   77 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l   77 (175)
                      .....+.+|+++++.++|+      +++++++++...+..++|||++ +++|.+++...+  ++++..+..++.|+  ||
T Consensus        53 ~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l  131 (339)
T 1z57_A           53 RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV  131 (339)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence            3456788899999988665      4999999999999999999999 889999998765  68899999999999  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCC----------------CceEEEeeecceeeccCCCccccccCCCCccCccccccc
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDD----------------DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ  141 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~----------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  141 (175)
                      ++||+.|++|+||+|+||++...+.                ++.++|+|||++......  .....++..|+|||.+.+.
T Consensus       132 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~  209 (339)
T 1z57_A          132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILAL  209 (339)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTS
T ss_pred             HHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCC
Confidence            9999999999999999999952111                456999999999775433  3345678999999999988


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          142 RYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       142 ~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      .++.++|+||+|++++++++|..||...+.
T Consensus       210 ~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          210 GWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence            999999999999999999999999987654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.7e-33  Score=205.87  Aligned_cols=161  Identities=33%  Similarity=0.562  Sum_probs=136.4

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHH--HHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ....+.+.+|+++++.++||||+++++++...+..++|+|++++++|.+++....   .+++..+..++.|+  |+++||
T Consensus        60 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  139 (295)
T 2clq_A           60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH  139 (295)
T ss_dssp             C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH
Confidence            3445678899999999999999999999999999999999999999999998652   46688889999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccC--CCcchhHHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFE  158 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slg~~~~~  158 (175)
                      +.|++|+||+|+||+++  ..++.++|+|||.+....... ......++..|+|||.+.+..  ++.++|+||||+++++
T Consensus       140 ~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~  217 (295)
T 2clq_A          140 DNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE  217 (295)
T ss_dssp             HTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHH
T ss_pred             hCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHH
Confidence            99999999999999995  336789999999998765432 233456788999999987543  8899999999999999


Q ss_pred             HHhCCCCCCCC
Q 030527          159 LLNGYPPFSVG  169 (175)
Q Consensus       159 ~~~g~~pf~~~  169 (175)
                      +++|..||...
T Consensus       218 l~~g~~pf~~~  228 (295)
T 2clq_A          218 MATGKPPFYEL  228 (295)
T ss_dssp             HHHTSCTTGGG
T ss_pred             HHHCCCCccCC
Confidence            99999999653

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.9e-34  Score=209.53  Aligned_cols=160  Identities=33%  Similarity=0.553  Sum_probs=138.9

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCC-eEEEEEeccCCCChHHHHHhcCC----------------CCHHHHH
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR----------------VPEQTAR   69 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------l~~~~~~   69 (175)
                      ...+.+.+|+++++++ +||||+++++++...+ ..++|+||+.+++|.+++.....                +++..+.
T Consensus        72 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (316)
T 2xir_A           72 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI  151 (316)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHH
T ss_pred             HHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHH
Confidence            3456788999999999 7999999999987654 58999999999999999987654                8899999


Q ss_pred             HHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCC
Q 030527           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD  144 (175)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~  144 (175)
                      .++.|+  ||++||+.|++|+||+|+||++   +.++.++|+|||++........   .....++..|+|||.+.+..++
T Consensus       152 ~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  228 (316)
T 2xir_A          152 CYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  228 (316)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc
Confidence            999998  9999999999999999999999   5778899999999987644322   2234457789999999888899


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCCC
Q 030527          145 EKVDMWSVGAILFELLN-GYPPFSVGE  170 (175)
Q Consensus       145 ~~~Di~slg~~~~~~~~-g~~pf~~~~  170 (175)
                      .++|+||+|++++++++ |..||.+..
T Consensus       229 ~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          229 IQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             chhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            99999999999999998 999997754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-33  Score=206.39  Aligned_cols=165  Identities=27%  Similarity=0.401  Sum_probs=136.4

Q ss_pred             CccccchhhhhhHHHHHHHHhhC--CCCCeeeEeeEEeeC----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHH
Q 030527            1 MLKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~   74 (175)
                      +||.+.......+..|.+++..+  +||||+++++++...    +..++||||+.+++|.+++++ ..+++..+..++.|
T Consensus        64 avK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~  142 (337)
T 3mdy_A           64 AVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYS  142 (337)
T ss_dssp             EEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHH
T ss_pred             EEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHH
Confidence            35666666666666777777665  999999999999877    789999999999999999975 47999999999999


Q ss_pred             H--HHHHHHHc--------CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc-----ccccCCCCccCccccc
Q 030527           75 L--GLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQ  139 (175)
Q Consensus        75 i--~l~~lh~~--------~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~pe~~~  139 (175)
                      +  ||++||+.        |++|+||||+||++   +.++.++|+|||++.........     ....++..|+|||.+.
T Consensus       143 i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  219 (337)
T 3mdy_A          143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD  219 (337)
T ss_dssp             HHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHT
T ss_pred             HHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcc
Confidence            8  99999998        99999999999999   57778999999999766443221     2446889999999998


Q ss_pred             ccCCCcc------hhHHHHHHHHHHHHhC----------CCCCCCC
Q 030527          140 FQRYDEK------VDMWSVGAILFELLNG----------YPPFSVG  169 (175)
Q Consensus       140 ~~~~~~~------~Di~slg~~~~~~~~g----------~~pf~~~  169 (175)
                      +...+..      +|+||+|+++|+|++|          +.||...
T Consensus       220 ~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          220 ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             TCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             cccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            7666555      9999999999999999          6777553

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.2e-34  Score=208.79  Aligned_cols=160  Identities=29%  Similarity=0.461  Sum_probs=137.1

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ...+.+.+|++++++++||||+++++++.... .++|+|++.+++|.+++.+. +.+++..+..++.|+  ||++||+.|
T Consensus        63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  141 (291)
T 1u46_A           63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR  141 (291)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence            44567889999999999999999999998765 78999999999999999865 569999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      ++|+||+|+||+++   .++.++|+|||++........    .....++..|+|||.+.+..++.++|+||+|+++++++
T Consensus       142 i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  218 (291)
T 1u46_A          142 FIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF  218 (291)
T ss_dssp             EECSCCCGGGEEEE---ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             cccCCCchheEEEc---CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHH
Confidence            99999999999994   667899999999987754432    22344567799999998888899999999999999999


Q ss_pred             h-CCCCCCCCCc
Q 030527          161 N-GYPPFSVGEE  171 (175)
Q Consensus       161 ~-g~~pf~~~~~  171 (175)
                      + |..||.+.+.
T Consensus       219 ~~g~~p~~~~~~  230 (291)
T 1u46_A          219 TYGQEPWIGLNG  230 (291)
T ss_dssp             TTSCCTTTTCCH
T ss_pred             hCCCCCcccCCH
Confidence            9 9999987543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.7e-33  Score=209.89  Aligned_cols=166  Identities=26%  Similarity=0.375  Sum_probs=142.3

Q ss_pred             CccccchhhhhhHHHHHHHHhh--CCCCCeeeEeeEEeeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHH
Q 030527            1 MLKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~   74 (175)
                      ++|.++....+.+..|.++++.  ++||||+++++++...+    ..++|+||+.+++|.+++.+ ..+++..+..++.|
T Consensus        69 avK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~  147 (342)
T 1b6c_B           69 AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALS  147 (342)
T ss_dssp             EEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHH
T ss_pred             EEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHH
Confidence            4677777777888899999988  69999999999998776    78999999999999999975 46899999999999


Q ss_pred             H--HHHHHH--------HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-----cccccCCCCccCccccc
Q 030527           75 L--GLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQ  139 (175)
Q Consensus        75 i--~l~~lh--------~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~  139 (175)
                      +  +|++||        +.|++|+||+|+||++   +.++.++|+|||++........     .....++..|+|||.+.
T Consensus       148 i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  224 (342)
T 1b6c_B          148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD  224 (342)
T ss_dssp             HHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhc
Confidence            8  999999        8999999999999999   5777899999999987655432     23456889999999987


Q ss_pred             cc------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 030527          140 FQ------RYDEKVDMWSVGAILFELLNG----------YPPFSVGE  170 (175)
Q Consensus       140 ~~------~~~~~~Di~slg~~~~~~~~g----------~~pf~~~~  170 (175)
                      +.      .++.++|+||||+++|+|++|          +.||....
T Consensus       225 ~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          225 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             SCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             ccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            55      234789999999999999999          78887643

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.3e-33  Score=215.89  Aligned_cols=168  Identities=30%  Similarity=0.548  Sum_probs=132.9

Q ss_pred             CccccchhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCC-------HHHHHHHH
Q 030527            1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP-------EQTARKFL   72 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~-------~~~~~~~~   72 (175)
                      +||.+..+....+.+|+++++++ +||||+++++++.+.+..++|||++. ++|.+++.......       +..+..++
T Consensus        43 AvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~  121 (434)
T 2rio_A           43 AVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLL  121 (434)
T ss_dssp             EEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHH
T ss_pred             EEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHH
Confidence            36777666667788999999986 89999999999999999999999995 69999998654322       22346788


Q ss_pred             HHH--HHHHHHHcCCeecCCCCCcEEEeec----------CCCceEEEeeecceeeccCCCc-----cccccCCCCccCc
Q 030527           73 QQL--GLEILNSHHIIHRDLKPENILLSGL----------DDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAP  135 (175)
Q Consensus        73 ~~i--~l~~lh~~~~~h~di~~~ni~~~~~----------~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~p  135 (175)
                      .|+  ||+|||++|++|+||||+||+++..          +....++|+|||++........     .....+++.|+||
T Consensus       122 ~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aP  201 (434)
T 2rio_A          122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAP  201 (434)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCH
T ss_pred             HHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCH
Confidence            898  9999999999999999999999632          2345799999999987754422     2245689999999


Q ss_pred             ccccc-------cCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 030527          136 EVLQF-------QRYDEKVDMWSVGAILFELLN-GYPPFSVG  169 (175)
Q Consensus       136 e~~~~-------~~~~~~~Di~slg~~~~~~~~-g~~pf~~~  169 (175)
                      |.+.+       ..++.++|+||+|+++++|++ |..||...
T Consensus       202 E~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          202 ELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             HHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             HHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence            99865       568999999999999999999 99999764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-33  Score=209.83  Aligned_cols=162  Identities=29%  Similarity=0.523  Sum_probs=121.6

Q ss_pred             chhhhhhHHHHHHHHhhCC-CCCeeeEeeEEe--------eCCeEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--------AENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFLQ   73 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~   73 (175)
                      .....+.+.+|+.+++++. ||||+++++++.        .....++++|++ +++|.+++.+   .+.+++..+..++.
T Consensus        65 ~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~  143 (337)
T 3ll6_A           65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFY  143 (337)
T ss_dssp             SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHH
Confidence            3445667889999999995 999999999983        445689999999 4699998865   45699999999999


Q ss_pred             HH--HHHHHHHcC--CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc-------------ccccCCCCccCcc
Q 030527           74 QL--GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-------------EKVCGSPLYMAPE  136 (175)
Q Consensus        74 ~i--~l~~lh~~~--~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~-------------~~~~~~~~~~~pe  136 (175)
                      |+  +|++||+.|  ++|+||+|+||++   +.++.++|+|||++.........             ....+++.|+|||
T Consensus       144 qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE  220 (337)
T 3ll6_A          144 QTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE  220 (337)
T ss_dssp             HHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCCTTCBCCSSCC----------------------------
T ss_pred             HHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChh
Confidence            99  999999999  9999999999999   57778999999999876543211             1345788999999


Q ss_pred             cc---cccCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          137 VL---QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       137 ~~---~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      .+   .+..++.++|+||||++++++++|+.||.....
T Consensus       221 ~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          221 IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             ---CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             hhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            98   566789999999999999999999999976544

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9e-34  Score=204.88  Aligned_cols=158  Identities=23%  Similarity=0.372  Sum_probs=136.0

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC--CeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ....+.+.+|++++++++||||+++++++.+.  +..++|+||+++++|.+++.+..  .+++..+..++.|+  ||++|
T Consensus        48 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  127 (271)
T 3kmu_A           48 TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL  127 (271)
T ss_dssp             HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence            44566789999999999999999999999877  78899999999999999998765  48999999999999  99999


Q ss_pred             HHcC--CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCc---chhHHHHHHH
Q 030527           81 NSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDE---KVDMWSVGAI  155 (175)
Q Consensus        81 h~~~--~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~---~~Di~slg~~  155 (175)
                      |+.|  ++|+||+|+||++   +.++.++++|||++.....    ....+++.|+|||.+.+..++.   ++|+||+|++
T Consensus       128 H~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~i  200 (271)
T 3kmu_A          128 HTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL  200 (271)
T ss_dssp             TTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHH
T ss_pred             hcCCCceecCCCccceEEE---cCCcceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHH
Confidence            9999  9999999999999   5777889998887654322    2345688999999997655443   7999999999


Q ss_pred             HHHHHhCCCCCCCCCc
Q 030527          156 LFELLNGYPPFSVGEE  171 (175)
Q Consensus       156 ~~~~~~g~~pf~~~~~  171 (175)
                      ++++++|+.||.+.+.
T Consensus       201 l~el~~g~~p~~~~~~  216 (271)
T 3kmu_A          201 LWELVTREVPFADLSN  216 (271)
T ss_dssp             HHHHHHCSCTTTTSCH
T ss_pred             HHHHHhCCCCccccCh
Confidence            9999999999986543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.7e-33  Score=206.91  Aligned_cols=160  Identities=29%  Similarity=0.429  Sum_probs=136.0

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEe----eCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--   75 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--   75 (175)
                      +......+.+|++++++++||||+++++++.    ..+..++|+||+.+++|.+++.+    ...+++..+..++.|+  
T Consensus        66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~  145 (317)
T 2buj_A           66 EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR  145 (317)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence            4456678899999999999999999999986    34478999999999999999876    3579999999999999  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----------cccccCCCCccCcccccccC---
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----------AEKVCGSPLYMAPEVLQFQR---  142 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~~~pe~~~~~~---  142 (175)
                      ||++||+.|++|+||+|+||++   +.++.++|+|||.+........          .....++..|+|||.+.+..   
T Consensus       146 ~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  222 (317)
T 2buj_A          146 GLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV  222 (317)
T ss_dssp             HHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEE
T ss_pred             HHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcC
Confidence            9999999999999999999999   5778899999998876532211          11344688999999986543   


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCC
Q 030527          143 YDEKVDMWSVGAILFELLNGYPPFSV  168 (175)
Q Consensus       143 ~~~~~Di~slg~~~~~~~~g~~pf~~  168 (175)
                      ++.++|+||||++++++++|+.||..
T Consensus       223 ~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          223 IDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             ECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCChhh
Confidence            68899999999999999999999953

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-33  Score=207.47  Aligned_cols=160  Identities=31%  Similarity=0.559  Sum_probs=135.7

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+.+|++++++++||||+++++++...+..++|+|++++++|.+++.+. ..+++..+..++.|+  |+++||+.|
T Consensus        58 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  137 (302)
T 2j7t_A           58 EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR  137 (302)
T ss_dssp             CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            34567888999999999999999999999999999999999999999998764 579999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCccccc-----ccCCCcchhHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~~  158 (175)
                      ++|+||+|+||++   +.++.++|+|||++...... .......++..|+|||.+.     +..++.++|+||+|+++++
T Consensus       138 i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~  214 (302)
T 2j7t_A          138 IIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE  214 (302)
T ss_dssp             CCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHH
T ss_pred             cccCCCCHHHEEE---CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHH
Confidence            9999999999999   57788999999987543221 1223446788999999883     5668899999999999999


Q ss_pred             HHhCCCCCCCCC
Q 030527          159 LLNGYPPFSVGE  170 (175)
Q Consensus       159 ~~~g~~pf~~~~  170 (175)
                      +++|..||...+
T Consensus       215 l~~g~~p~~~~~  226 (302)
T 2j7t_A          215 MAQIEPPHHELN  226 (302)
T ss_dssp             HHHSSCTTTTSC
T ss_pred             HhcCCCCCccCC
Confidence            999999998654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2e-33  Score=210.95  Aligned_cols=161  Identities=31%  Similarity=0.478  Sum_probs=134.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCe-------EEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHH-
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-------IFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQL-   75 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~i-   75 (175)
                      .......+|++.++.++||||+++++++...+.       .++||||+.+ ++.+.+.    ....+++..+..++.|+ 
T Consensus        61 ~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~  139 (360)
T 3e3p_A           61 RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI  139 (360)
T ss_dssp             TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHH
T ss_pred             cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHH
Confidence            344567778888899999999999999865433       7899999965 5554433    45678999999999998 


Q ss_pred             -HHHHHH--HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccC-CCcchhHHH
Q 030527           76 -GLEILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWS  151 (175)
Q Consensus        76 -~l~~lh--~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~s  151 (175)
                       |+++||  +.|++|+||||+||+++  ..++.++|+|||++.............+++.|+|||.+.+.. ++.++|+||
T Consensus       140 ~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s  217 (360)
T 3e3p_A          140 RSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWS  217 (360)
T ss_dssp             HHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred             HHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHH
Confidence             999999  99999999999999995  337789999999998876665555667899999999986554 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCc
Q 030527          152 VGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       152 lg~~~~~~~~g~~pf~~~~~  171 (175)
                      +|++++++++|+.||.+.+.
T Consensus       218 lG~il~ell~g~~pf~~~~~  237 (360)
T 3e3p_A          218 VGCIFAEMMLGEPIFRGDNS  237 (360)
T ss_dssp             HHHHHHHHHHSSCSSCCSSH
T ss_pred             HHHHHHHHHhCCCCcCCCCh
Confidence            99999999999999987654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-33  Score=207.21  Aligned_cols=160  Identities=33%  Similarity=0.610  Sum_probs=132.2

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEee------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--H
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--G   76 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~   76 (175)
                      .....+.+|+++++++ +||||+++++++..      .+..++||||+.+++|.+++...  ..+++..+..++.|+  |
T Consensus        62 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~  141 (326)
T 2x7f_A           62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG  141 (326)
T ss_dssp             STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHH
Confidence            3466889999999999 89999999999976      56889999999999999999864  569999999999998  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccc-----ccCCCcchhHH
Q 030527           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMW  150 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~  150 (175)
                      |++||+.|++|+||+|+||++   +.++.++|+|||++....... ......++..|+|||.+.     +..++.++|+|
T Consensus       142 l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~  218 (326)
T 2x7f_A          142 LSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW  218 (326)
T ss_dssp             HHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHH
T ss_pred             HHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHH
Confidence            999999999999999999999   577889999999987664332 233456789999999986     55689999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCC
Q 030527          151 SVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       151 slg~~~~~~~~g~~pf~~~~  170 (175)
                      |||++++++++|..||....
T Consensus       219 slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          219 SLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             HHHHHHHHHHHSSCTTTTSC
T ss_pred             HHHHHHHHHHhCCCCCCCCc
Confidence            99999999999999997654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.6e-33  Score=211.69  Aligned_cols=168  Identities=32%  Similarity=0.489  Sum_probs=138.5

Q ss_pred             ccccc--hhhhhhHHHHHHHHhhCC--------CCCeeeEeeEEe----eCCeEEEEEeccCCCChHHHHHhc--CCCCH
Q 030527            2 LKKLN--KHLKSCLDCELNFLSSVN--------HPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLH--GRVPE   65 (175)
Q Consensus         2 lk~~~--~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~   65 (175)
                      ||.+.  ......+.+|++++++++        |+||+++++++.    .....++|||++ ++++.+++.+.  ..+++
T Consensus        67 vK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~  145 (397)
T 1wak_A           67 MKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPL  145 (397)
T ss_dssp             EEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCH
T ss_pred             EEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCH
Confidence            45443  334567889999999985        788999999987    556889999999 66777777654  46999


Q ss_pred             HHHHHHHHHH--HHHHHHHc-CCeecCCCCCcEEEeecC-----------------------------------------
Q 030527           66 QTARKFLQQL--GLEILNSH-HIIHRDLKPENILLSGLD-----------------------------------------  101 (175)
Q Consensus        66 ~~~~~~~~~i--~l~~lh~~-~~~h~di~~~ni~~~~~~-----------------------------------------  101 (175)
                      ..+..++.|+  ||+|||++ |++|+||||+||+++..+                                         
T Consensus       146 ~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (397)
T 1wak_A          146 PCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPL  225 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTT
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccc
Confidence            9999999999  99999998 999999999999994111                                         


Q ss_pred             -----CCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030527          102 -----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH  172 (175)
Q Consensus       102 -----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~~  172 (175)
                           ....++|+|||.+......  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus       226 ~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  299 (397)
T 1wak_A          226 EPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGE  299 (397)
T ss_dssp             SGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred             ccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCccc
Confidence                 0127999999999876543  23456799999999999888999999999999999999999999876543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.3e-34  Score=225.57  Aligned_cols=166  Identities=24%  Similarity=0.456  Sum_probs=140.7

Q ss_pred             ccccch--hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--
Q 030527            2 LKKLNK--HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--   75 (175)
Q Consensus         2 lk~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--   75 (175)
                      ||.++.  .....|.+|++++++++||||+++++++.+ +..++||||+.+++|.+++.+.  ..+++..+..++.|+  
T Consensus       296 vK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~  374 (535)
T 2h8h_A          296 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS  374 (535)
T ss_dssp             EEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHH
Confidence            455433  234678999999999999999999999876 6689999999999999999753  569999999999999  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      +|+|||++|++|+||+|+||++   +.++.++|+|||++........  .....++..|+|||.+.+..++.++||||||
T Consensus       375 ~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG  451 (535)
T 2h8h_A          375 GMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG  451 (535)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred             HHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHH
Confidence            9999999999999999999999   5778899999999976643221  1223356779999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCc
Q 030527          154 AILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       154 ~~~~~~~~-g~~pf~~~~~  171 (175)
                      +++|+|++ |..||.+.+.
T Consensus       452 v~l~el~t~g~~P~~~~~~  470 (535)
T 2h8h_A          452 ILLTELTTKGRVPYPGMVN  470 (535)
T ss_dssp             HHHHHHTTTTCCSSTTCCH
T ss_pred             HHHHHHHhCCCCCCCCCCH
Confidence            99999999 9999987553

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.8e-33  Score=215.13  Aligned_cols=162  Identities=20%  Similarity=0.243  Sum_probs=139.7

Q ss_pred             hhhhHHHHHHHHhhCCC-CCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ...++..|.++++.++| ++++.+..++...+..++||||+ +++|.+++... ..+++..+..++.|+  +|+|||++|
T Consensus        45 ~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g  123 (483)
T 3sv0_A           45 KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS  123 (483)
T ss_dssp             SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34578899999999966 66777777778888999999999 99999999864 579999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc--------ccccCCCCccCcccccccCCCcchhHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~  156 (175)
                      ++|+||||+||+++..+..+.++|+|||++.........        ....++..|+|||.+.+..++.++||||||+++
T Consensus       124 IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil  203 (483)
T 3sv0_A          124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVL  203 (483)
T ss_dssp             EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHH
Confidence            999999999999953346778999999999877554321        245689999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030527          157 FELLNGYPPFSVGEE  171 (175)
Q Consensus       157 ~~~~~g~~pf~~~~~  171 (175)
                      |+|++|+.||.+...
T Consensus       204 ~elltG~~Pf~~~~~  218 (483)
T 3sv0_A          204 MYFLRGSLPWQGLKA  218 (483)
T ss_dssp             HHHHHSSCTTSSCCC
T ss_pred             HHHHhCCCCCccccc
Confidence            999999999987543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.7e-33  Score=203.80  Aligned_cols=162  Identities=30%  Similarity=0.599  Sum_probs=135.7

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEe--------------eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------------AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF   71 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~   71 (175)
                      +....+.+.+|++++++++||||+++++++.              +.+..++|+||+. ++|.+++. .+++++..+..+
T Consensus        48 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~  125 (320)
T 2i6l_A           48 DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLF  125 (320)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHH
Confidence            3455677889999999999999999998873              4467899999996 59999987 467999999999


Q ss_pred             HHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC----CccccccCCCCccCcccccc-cCCC
Q 030527           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQF-QRYD  144 (175)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~-~~~~  144 (175)
                      +.|+  ||++||+.|++|+||+|+||+++  ..+..++|+|||++......    .......++..|+|||.+.+ ..++
T Consensus       126 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  203 (320)
T 2i6l_A          126 MYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT  203 (320)
T ss_dssp             HHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCC
T ss_pred             HHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCC
Confidence            9998  99999999999999999999995  35678999999999866432    12234556888999998865 6789


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          145 EKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       145 ~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      .++|+||||++++++++|+.||.+.++
T Consensus       204 ~~~Di~slG~il~el~~g~~pf~~~~~  230 (320)
T 2i6l_A          204 KAIDMWAAGCIFAEMLTGKTLFAGAHE  230 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             chhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999999987653

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.4e-33  Score=222.19  Aligned_cols=164  Identities=32%  Similarity=0.616  Sum_probs=144.5

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEee------CCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHH-
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQL-   75 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i-   75 (175)
                      .......+.+|++++++++||||+++++++..      .+..++||||+.|++|.+++.+..   .+++..+..++.++ 
T Consensus        52 ~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl  131 (676)
T 3qa8_A           52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS  131 (676)
T ss_dssp             CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHH
Confidence            44556778999999999999999999998765      667899999999999999998654   58999999999998 


Q ss_pred             -HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHH
Q 030527           76 -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  154 (175)
Q Consensus        76 -~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~  154 (175)
                       ||++||+.|++|+||+|+||+++..+....++|+|||.+.............++..|+|||.+.+..++.++|+||+|+
T Consensus       132 ~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGv  211 (676)
T 3qa8_A          132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT  211 (676)
T ss_dssp             HHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHH
T ss_pred             HHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHH
Confidence             9999999999999999999999644344569999999998877666556677899999999999889999999999999


Q ss_pred             HHHHHHhCCCCCCCC
Q 030527          155 ILFELLNGYPPFSVG  169 (175)
Q Consensus       155 ~~~~~~~g~~pf~~~  169 (175)
                      +++++++|..||...
T Consensus       212 iLyeLltG~~Pf~~~  226 (676)
T 3qa8_A          212 LAFECITGFRPFLPN  226 (676)
T ss_dssp             HHHHHHSSCSSCCSS
T ss_pred             HHHHHHHCCCCCCcc
Confidence            999999999999653

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2e-33  Score=209.67  Aligned_cols=155  Identities=34%  Similarity=0.717  Sum_probs=113.6

Q ss_pred             HHHHHhhCCCCCeeeEeeEEee----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           16 ELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        16 e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ....++.++||||+++++++..    .+..++||||+.|++|.+++.+.+  .+++..+..++.|+  ||++||++|++|
T Consensus        72 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH  151 (336)
T 3fhr_A           72 VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAH  151 (336)
T ss_dssp             HHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            3345667799999999999876    456899999999999999998764  69999999999999  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      +||+|+||++...+..+.++|+|||++....... .....+++.|+|||.+.+..++.++|+||+|++++++++|..||.
T Consensus       152 ~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  230 (336)
T 3fhr_A          152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY  230 (336)
T ss_dssp             SCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CCCCHHHEEEEecCCCceEEEeccccceeccccc-cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            9999999999644446679999999998765432 334567899999999988889999999999999999999999997


Q ss_pred             CCCc
Q 030527          168 VGEE  171 (175)
Q Consensus       168 ~~~~  171 (175)
                      ....
T Consensus       231 ~~~~  234 (336)
T 3fhr_A          231 SNTG  234 (336)
T ss_dssp             ----
T ss_pred             Cccc
Confidence            6543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.3e-33  Score=207.52  Aligned_cols=159  Identities=28%  Similarity=0.479  Sum_probs=136.7

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC--eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ....+.+.+|++++++++||||+++++++...+  ..++|+|++++++|.+++.+. ..+++..+..++.|+  ||++||
T Consensus        83 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH  162 (326)
T 2w1i_A           83 EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG  162 (326)
T ss_dssp             SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            345667899999999999999999999886544  679999999999999999876 469999999999998  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~  157 (175)
                      +.|++|+||+|+||++   +.++.++|+|||++........    .....++..|+|||.+.+..++.++|+||||++++
T Consensus       163 ~~~ivH~dikp~NIli---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  239 (326)
T 2w1i_A          163 TKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY  239 (326)
T ss_dssp             HTTEECSCCCGGGEEE---EETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred             hCCEeccCCCcceEEE---cCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHH
Confidence            9999999999999999   4667899999999987754432    22334566799999998888999999999999999


Q ss_pred             HHHhCCCCCCC
Q 030527          158 ELLNGYPPFSV  168 (175)
Q Consensus       158 ~~~~g~~pf~~  168 (175)
                      ++++|..||..
T Consensus       240 el~tg~~~~~~  250 (326)
T 2w1i_A          240 ELFTYIEKSKS  250 (326)
T ss_dssp             HHHHTTCGGGS
T ss_pred             HHHhcCCCCCC
Confidence            99999998864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.5e-33  Score=212.85  Aligned_cols=157  Identities=15%  Similarity=0.187  Sum_probs=117.7

Q ss_pred             hhhhhHHHHHHHHhhC--CCCCeeeEe-------eEEeeC-----------------CeEEEEEeccCCCChHHHHHhcC
Q 030527            8 HLKSCLDCELNFLSSV--NHPNIIRLF-------DAFQAE-----------------NCIFLVVEFCAGGNLSSYIRLHG   61 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~   61 (175)
                      .....+.+|+++++.+  +||||++++       +++...                 ...++||||+. ++|.+++...+
T Consensus       104 ~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~  182 (371)
T 3q60_A          104 SELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD  182 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc
Confidence            3455677886555555  699988755       444332                 34799999997 79999998643


Q ss_pred             -CCCHHHH------HHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCc
Q 030527           62 -RVPEQTA------RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY  132 (175)
Q Consensus        62 -~l~~~~~------~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  132 (175)
                       .++....      ..++.|+  ||+|||++|++|+||||+||++   +.++.++|+|||++......  .....+++.|
T Consensus       183 ~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y  257 (371)
T 3q60_A          183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVTY  257 (371)
T ss_dssp             HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGGG
T ss_pred             cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcCC
Confidence             3444444      5666888  9999999999999999999999   57788999999999876433  2244567999


Q ss_pred             cCcccccc--cCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030527          133 MAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       133 ~~pe~~~~--~~~~~~~Di~slg~~~~~~~~g~~pf~~~~  170 (175)
                      +|||.+.+  ..++.++|+||+|+++|+|++|+.||.+..
T Consensus       258 ~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             CCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             cChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            99999987  679999999999999999999999998764

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.1e-33  Score=207.96  Aligned_cols=161  Identities=26%  Similarity=0.476  Sum_probs=138.4

Q ss_pred             hhhhhHHHHHHHHhhCCCCC------eeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--HH
Q 030527            8 HLKSCLDCELNFLSSVNHPN------IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GL   77 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--~l   77 (175)
                      .....+.+|++++++++|++      ++.+.+++...+..++|||++ ++++.+++....  .+++..+..++.|+  ||
T Consensus        58 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L  136 (355)
T 2eu9_A           58 KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL  136 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            45667888999999997665      899999999999999999999 678888777653  69999999999999  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeec----------------CCCceEEEeeecceeeccCCCccccccCCCCccCccccccc
Q 030527           78 EILNSHHIIHRDLKPENILLSGL----------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ  141 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~----------------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  141 (175)
                      ++||+.|++|+||||+||++...                +..+.++|+|||++......  .....+++.|+|||.+.+.
T Consensus       137 ~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~  214 (355)
T 2eu9_A          137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILEL  214 (355)
T ss_dssp             HHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTC
T ss_pred             HHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecC
Confidence            99999999999999999999422                24567999999999875433  2345688999999999988


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          142 RYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       142 ~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      .++.++|+||+|+++++|++|..||...+.
T Consensus       215 ~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          215 GWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999999999987654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.8e-33  Score=210.10  Aligned_cols=155  Identities=32%  Similarity=0.549  Sum_probs=131.3

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeE------EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      .....+.+|+++++.++||||+++++++...+..      ++|||++. ++|.+++.  ..+++..+..++.|+  ||++
T Consensus        83 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~  159 (371)
T 4exu_A           83 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKY  159 (371)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHH
Confidence            3456788999999999999999999999877654      99999995 68887764  358999999999998  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~  158 (175)
                      ||+.|++|+||+|+||++   +.++.++|+|||++......  .....+++.|+|||.+.+ ..++.++|+||+|+++++
T Consensus       160 LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (371)
T 4exu_A          160 IHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAE  234 (371)
T ss_dssp             HHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHH
T ss_pred             HHHCCCcCCCcCHHHeEE---CCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHH
Confidence            999999999999999999   57788999999999766433  234567899999999876 678999999999999999


Q ss_pred             HHhCCCCCCCCC
Q 030527          159 LLNGYPPFSVGE  170 (175)
Q Consensus       159 ~~~g~~pf~~~~  170 (175)
                      |++|+.||.+.+
T Consensus       235 l~~g~~pf~~~~  246 (371)
T 4exu_A          235 MLTGKTLFKGKD  246 (371)
T ss_dssp             HHHSSCSCCCSS
T ss_pred             HHhCCCCCCCCC
Confidence            999999998765

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.2e-33  Score=208.89  Aligned_cols=163  Identities=29%  Similarity=0.427  Sum_probs=131.9

Q ss_pred             CccccchhhhhhHHHHHHHHh--hCCCCCeeeEeeEEe-----eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHH
Q 030527            1 MLKKLNKHLKSCLDCELNFLS--SVNHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ   73 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~--~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~   73 (175)
                      ++|.++......+..|.++..  .++||||+++++.+.     .....++||||+++++|.+++... ..++..+..++.
T Consensus        40 avK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~  118 (336)
T 3g2f_A           40 AVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAH  118 (336)
T ss_dssp             EEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHH
T ss_pred             EEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHH
Confidence            367776666677776666655  479999999997543     233678999999999999999754 458889999999


Q ss_pred             HH--HHHHHHHc---------CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---------ccccccCCCCcc
Q 030527           74 QL--GLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYM  133 (175)
Q Consensus        74 ~i--~l~~lh~~---------~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---------~~~~~~~~~~~~  133 (175)
                      |+  ||+|||+.         |++|+||||+||++   +.++.++|+|||++.......         ......++..|+
T Consensus       119 qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~  195 (336)
T 3g2f_A          119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYM  195 (336)
T ss_dssp             HHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGC
T ss_pred             HHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEEeeccceeecccccccCccccccccccCCCcccee
Confidence            98  99999999         99999999999999   577889999999998764322         122345889999


Q ss_pred             Ccccccc-------cCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527          134 APEVLQF-------QRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus       134 ~pe~~~~-------~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      |||.+.+       ..++.++|+||||+++|+|++|..||.
T Consensus       196 aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          196 APEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             CHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             CchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            9999876       456788999999999999999966653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-32  Score=205.28  Aligned_cols=158  Identities=28%  Similarity=0.517  Sum_probs=134.3

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      .....+.+|++++++++||||+++++++...     +..++|+|++. ++|.+++.. +.+++..+..++.|+  ||++|
T Consensus        51 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~L  128 (353)
T 2b9h_A           51 LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVL  128 (353)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHH
Confidence            3456778999999999999999999987654     67899999995 699998875 579999999999998  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-----------cccccCCCCccCcccccc-cCCCcchh
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----------AEKVCGSPLYMAPEVLQF-QRYDEKVD  148 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-----------~~~~~~~~~~~~pe~~~~-~~~~~~~D  148 (175)
                      |+.|++|+||+|+||++   +.++.++|+|||++........           .....++..|+|||.+.+ ..++.++|
T Consensus       129 H~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  205 (353)
T 2b9h_A          129 HGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMD  205 (353)
T ss_dssp             HHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHH
T ss_pred             HHCCeecCCCCHHHeEE---cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhh
Confidence            99999999999999999   5778899999999987643321           112457888999998754 67899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCC
Q 030527          149 MWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       149 i~slg~~~~~~~~g~~pf~~~~  170 (175)
                      +||+|+++++|++|..||.+.+
T Consensus       206 i~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          206 VWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSS
T ss_pred             HHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999998765

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.5e-32  Score=200.64  Aligned_cols=158  Identities=32%  Similarity=0.580  Sum_probs=133.0

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEE--eeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ....+.+|++++++++||||+++++++  .+.+..++||||+.++ +.+++...  ..+++..+..++.|+  ||++||+
T Consensus        49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~  127 (305)
T 2wtk_C           49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS  127 (305)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence            456789999999999999999999998  4556889999999765 77777653  569999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC---CccccccCCCCccCcccccccC--CCcchhHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILF  157 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slg~~~~  157 (175)
                      +|++|+||+|+||++   +.++.++|+|||.+......   .......++..|+|||...+..  ++.++|+||+|++++
T Consensus       128 ~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~  204 (305)
T 2wtk_C          128 QGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLY  204 (305)
T ss_dssp             TTEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHH
T ss_pred             CCeeecCCCcccEEE---cCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHH
Confidence            999999999999999   57788999999999876432   2223456789999999987644  377999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 030527          158 ELLNGYPPFSVGE  170 (175)
Q Consensus       158 ~~~~g~~pf~~~~  170 (175)
                      ++++|..||.+.+
T Consensus       205 ~l~~g~~p~~~~~  217 (305)
T 2wtk_C          205 NITTGLYPFEGDN  217 (305)
T ss_dssp             HHHHSSCSCCCSS
T ss_pred             HHHhCCCCCCCch
Confidence            9999999998754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.2e-33  Score=222.00  Aligned_cols=161  Identities=28%  Similarity=0.536  Sum_probs=136.5

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ...+..+.+|+.++++++||||+++++++.+ +..++||||+.+++|.++++..+ .+++..+..++.|+  ||+|||+.
T Consensus       432 ~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  510 (656)
T 2j0j_A          432 DSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK  510 (656)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3445778999999999999999999999854 56899999999999999998654 69999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      |++|+||+|+||+++   .++.++|+|||++........  .....++..|+|||.+.+..++.++|+||+|+++++|++
T Consensus       511 givHrDikp~NILl~---~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt  587 (656)
T 2j0j_A          511 RFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM  587 (656)
T ss_dssp             TCCCSCCSGGGEEEE---ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CccccccchHhEEEe---CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence            999999999999994   677899999999987644332  223445678999999988889999999999999999997


Q ss_pred             -CCCCCCCCCc
Q 030527          162 -GYPPFSVGEE  171 (175)
Q Consensus       162 -g~~pf~~~~~  171 (175)
                       |..||.+.+.
T Consensus       588 ~g~~Pf~~~~~  598 (656)
T 2j0j_A          588 HGVKPFQGVKN  598 (656)
T ss_dssp             TSCCTTTTCCH
T ss_pred             cCCCCCCCCCH
Confidence             9999987654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3e-32  Score=202.28  Aligned_cols=157  Identities=31%  Similarity=0.537  Sum_probs=115.6

Q ss_pred             hhhhHHHHHH-HHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHH--HHHHH
Q 030527            9 LKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         9 ~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ...++..|.. +++.++||||+++++++...+..++||||+.+ +|.+++..     ...+++..+..++.|+  |+++|
T Consensus        63 ~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l  141 (327)
T 3aln_A           63 EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL  141 (327)
T ss_dssp             HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHH
Confidence            3344555555 67778999999999999999999999999965 88887763     4678999999999998  99999


Q ss_pred             HHc-CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccc----cccCCCcchhHHHHHHH
Q 030527           81 NSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVDMWSVGAI  155 (175)
Q Consensus        81 h~~-~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~----~~~~~~~~~Di~slg~~  155 (175)
                      |+. |++|+||+|+||++   +.++.++|+|||++.............++..|+|||.+    .+..++.++|+||||++
T Consensus       142 H~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~i  218 (327)
T 3aln_A          142 KENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT  218 (327)
T ss_dssp             HHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHH
T ss_pred             hccCCEeECCCCHHHEEE---cCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHH
Confidence            998 99999999999999   47788999999999877655444455788999999998    45668999999999999


Q ss_pred             HHHHHhCCCCCCCC
Q 030527          156 LFELLNGYPPFSVG  169 (175)
Q Consensus       156 ~~~~~~g~~pf~~~  169 (175)
                      +++|++|..||.+.
T Consensus       219 l~~l~~g~~pf~~~  232 (327)
T 3aln_A          219 LYELATGRFPYPKW  232 (327)
T ss_dssp             HHHHHHSCCCSSCC
T ss_pred             HHHHHHCCCCCCCc
Confidence            99999999999764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.4e-33  Score=205.24  Aligned_cols=156  Identities=29%  Similarity=0.528  Sum_probs=137.6

Q ss_pred             hhHHHHHHHHhhCC--CCCeeeEeeEEeeCCeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           11 SCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        11 ~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ..+.+|+.++++++  ||||+++++++...+..++++|++.+ ++|.+++.+.+.+++..+..++.|+  ||++||+.|+
T Consensus        91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i  170 (320)
T 3a99_A           91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV  170 (320)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            56778999999995  59999999999999999999999975 8999999988899999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +|+||+|+||+++  ..++.++|+|||++....... .....++..|+|||.+.+..+ +.++|+||||++++++++|+.
T Consensus       171 vH~Dlkp~NIll~--~~~~~~kL~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~  247 (320)
T 3a99_A          171 LHRDIKDENILID--LNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI  247 (320)
T ss_dssp             ECCCCSGGGEEEE--TTTTEEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred             EeCCCCHHHEEEe--CCCCCEEEeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCC
Confidence            9999999999994  356789999999998775443 234567899999999876665 678999999999999999999


Q ss_pred             CCCCC
Q 030527          165 PFSVG  169 (175)
Q Consensus       165 pf~~~  169 (175)
                      ||...
T Consensus       248 pf~~~  252 (320)
T 3a99_A          248 PFEHD  252 (320)
T ss_dssp             SCCSH
T ss_pred             CCCCh
Confidence            99753

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4e-32  Score=200.48  Aligned_cols=158  Identities=28%  Similarity=0.559  Sum_probs=133.0

Q ss_pred             hhhhhhHHHHHHHHhhCC--CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ......+.+|++++++++  ||||+++++++...+..+++||+ .+++|.+++.+...+++..+..++.|+  ||++||+
T Consensus        67 ~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  145 (313)
T 3cek_A           67 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ  145 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            445678899999999996  59999999999999999999995 588999999988899999999999998  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccc-----------cCCCcchh
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-----------QRYDEKVD  148 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~-----------~~~~~~~D  148 (175)
                      .|++|+||+|+||++.    ++.++|+|||++........   .....++..|+|||.+.+           ..++.++|
T Consensus       146 ~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  221 (313)
T 3cek_A          146 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD  221 (313)
T ss_dssp             TTCCCCCCCGGGEEEE----TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHH
T ss_pred             CCceecCCCcccEEEE----CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHH
Confidence            9999999999999994    36899999999987644322   234567899999999865           46788999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCC
Q 030527          149 MWSVGAILFELLNGYPPFSVG  169 (175)
Q Consensus       149 i~slg~~~~~~~~g~~pf~~~  169 (175)
                      +||||++++++++|..||...
T Consensus       222 i~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          222 VWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             HHHHHHHHHHHHHSSCTTTTC
T ss_pred             HHHHHHHHHHHHhCCCchhhH
Confidence            999999999999999999764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.4e-33  Score=208.50  Aligned_cols=160  Identities=22%  Similarity=0.361  Sum_probs=134.1

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      .....+.+|+.++++++||||+++++++...+..++++||+.+++|.+++.+.+ .+++..+..++.|+  ||++||+.|
T Consensus        71 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~  150 (319)
T 2y4i_B           71 DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG  150 (319)
T ss_dssp             CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345667889999999999999999999999999999999999999999998754 69999999999998  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCC------CccccccCCCCccCcccccc---------cCCCcchhH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG------NYAEKVCGSPLYMAPEVLQF---------QRYDEKVDM  149 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~---------~~~~~~~Di  149 (175)
                      ++|+||+|+||+++    ++.++|+|||++......      .......++..|+|||.+.+         ..++.++|+
T Consensus       151 i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di  226 (319)
T 2y4i_B          151 ILHKDLKSKNVFYD----NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV  226 (319)
T ss_dssp             CCCCCCCSTTEEEC------CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHH
T ss_pred             ccccCCChhhEEEe----CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhH
Confidence            99999999999993    467999999987654321      12223457788999999864         347889999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCc
Q 030527          150 WSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       150 ~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ||||++++++++|..||...+.
T Consensus       227 ~slG~il~el~~g~~p~~~~~~  248 (319)
T 2y4i_B          227 FALGTIWYELHAREWPFKTQPA  248 (319)
T ss_dssp             HHHHHHHHHHHHSSCSSSSCCH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999986543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.98  E-value=2.3e-32  Score=205.93  Aligned_cols=159  Identities=30%  Similarity=0.514  Sum_probs=134.4

Q ss_pred             hhhhHHHHHHHHhhCC-----------CCCeeeEeeEEeeCC----eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHH
Q 030527            9 LKSCLDCELNFLSSVN-----------HPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKF   71 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~   71 (175)
                      ....+.+|++++++++           ||||+++++++...+    ..++++|++ +++|.+++.+.  ..+++..+..+
T Consensus        58 ~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i  136 (373)
T 1q8y_A           58 YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI  136 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHH
T ss_pred             chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHH
Confidence            4567888999999886           899999999988654    789999999 89999999874  45999999999


Q ss_pred             HHHH--HHHHHHHc-CCeecCCCCCcEEEeec---CCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCc
Q 030527           72 LQQL--GLEILNSH-HIIHRDLKPENILLSGL---DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDE  145 (175)
Q Consensus        72 ~~~i--~l~~lh~~-~~~h~di~~~ni~~~~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~  145 (175)
                      +.|+  ||++||++ |++|+||||+||++...   +....++|+|||++......  .....+++.|+|||.+.+..++.
T Consensus       137 ~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~  214 (373)
T 1q8y_A          137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGC  214 (373)
T ss_dssp             HHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCT
T ss_pred             HHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCc
Confidence            9999  99999998 99999999999999532   23457999999999876443  23446789999999999888999


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCC
Q 030527          146 KVDMWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       146 ~~Di~slg~~~~~~~~g~~pf~~~~  170 (175)
                      ++|+||||+++|+|++|..||...+
T Consensus       215 ~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          215 GADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCC----
T ss_pred             hHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999999999999999998654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.98  E-value=1.2e-32  Score=206.59  Aligned_cols=155  Identities=32%  Similarity=0.548  Sum_probs=130.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCe------EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      .....+.+|+.++++++||||+++++++...+.      .++|||++. ++|.+++.  ..+++..+..++.|+  ||++
T Consensus        65 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~  141 (353)
T 3coi_A           65 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKY  141 (353)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence            445678899999999999999999999987653      499999995 58887764  358999999999999  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~  158 (175)
                      ||+.|++|+||+|+||++   +.++.++|+|||++......  .....++..|+|||.+.+ ..++.++|+||+|+++++
T Consensus       142 LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~e  216 (353)
T 3coi_A          142 IHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAE  216 (353)
T ss_dssp             HHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHH
T ss_pred             HHHCCcccCCCCHHHEeE---CCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHH
Confidence            999999999999999999   57788999999998765433  234567899999999876 678999999999999999


Q ss_pred             HHhCCCCCCCCC
Q 030527          159 LLNGYPPFSVGE  170 (175)
Q Consensus       159 ~~~g~~pf~~~~  170 (175)
                      |++|..||.+.+
T Consensus       217 l~~g~~pf~~~~  228 (353)
T 3coi_A          217 MLTGKTLFKGKD  228 (353)
T ss_dssp             HHHSSCSSBSSC
T ss_pred             HHhCCCCCCCCC
Confidence            999999998765

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.98  E-value=1.1e-32  Score=203.43  Aligned_cols=156  Identities=30%  Similarity=0.514  Sum_probs=132.3

Q ss_pred             hhhHHHHHHHHhhC----CCCCeeeEeeEEeeCCeEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527           10 KSCLDCELNFLSSV----NHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        10 ~~~~~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ...+..|+++++++    +||||+++++++...+..++|+|+ +.+++|.+++.+.+.+++..+..++.|+  +|++||+
T Consensus        78 ~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~  157 (312)
T 2iwi_A           78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS  157 (312)
T ss_dssp             -CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            44566799999998    899999999999999999999999 7789999999988889999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHh
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLN  161 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~  161 (175)
                      .|++|+||+|+||+++  ..++.++|+|||++....... .....++..|+|||.+.+..+ +.++|+||+|++++++++
T Consensus       158 ~~i~H~dlkp~Nil~~--~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  234 (312)
T 2iwi_A          158 RGVVHRDIKDENILID--LRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC  234 (312)
T ss_dssp             HTEECCCCSGGGEEEE--TTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred             CCeeecCCChhhEEEe--CCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHH
Confidence            9999999999999994  367789999999998775543 334567899999999876665 458999999999999999


Q ss_pred             CCCCCCC
Q 030527          162 GYPPFSV  168 (175)
Q Consensus       162 g~~pf~~  168 (175)
                      |+.||..
T Consensus       235 g~~pf~~  241 (312)
T 2iwi_A          235 GDIPFER  241 (312)
T ss_dssp             SSCSCCS
T ss_pred             CCCCCCC
Confidence            9999975

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=9e-34  Score=224.23  Aligned_cols=149  Identities=19%  Similarity=0.211  Sum_probs=114.1

Q ss_pred             hhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      +...++|.+|+++|+++ .|+||+++++++++++..|+||||++|++|.+++.+.+++++..   ++.|+  ||+|+|++
T Consensus       282 ~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~~---I~~QIl~AL~ylH~~  358 (569)
T 4azs_A          282 QRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDREK---ILGSLLRSLAALEKQ  358 (569)
T ss_dssp             HHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHHH---HHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHHH---HHHHHHHHHHHHHHC
Confidence            34456799999999999 89999999999999999999999999999999999988888754   67888  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      ||+||||||+||++   +.++.+||+|||+++..... .......||+.|+|||.+.+ .+..++|+||+|++.+.+.++
T Consensus       359 GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          359 GFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             TCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred             CceeccCchHhEEE---CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccc
Confidence            99999999999999   57888999999999876543 33445678999999999875 456779999999987665444

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.98  E-value=1.2e-31  Score=196.51  Aligned_cols=152  Identities=33%  Similarity=0.621  Sum_probs=126.1

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEee-------------CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-------------ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL   72 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~   72 (175)
                      ....+.+.+|++++++++||||+++++++.+             .+..++|+||+.+++|.+++.+.. .+++..+..++
T Consensus        43 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~  122 (303)
T 1zy4_A           43 EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF  122 (303)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHH
Confidence            3445678899999999999999999998754             457899999999999999998654 58889999999


Q ss_pred             HHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC---------------CccccccCCCCccCc
Q 030527           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------NYAEKVCGSPLYMAP  135 (175)
Q Consensus        73 ~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~---------------~~~~~~~~~~~~~~p  135 (175)
                      .|+  |+++||+.|++|+||+|+||++   +.++.++|+|||++......               .......++..|+||
T Consensus       123 ~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  199 (303)
T 1zy4_A          123 RQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT  199 (303)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCCCSCTTC-------------------------CTTSCH
T ss_pred             HHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCc
Confidence            998  9999999999999999999999   57788999999998765422               112345578899999


Q ss_pred             cccccc-CCCcchhHHHHHHHHHHHHh
Q 030527          136 EVLQFQ-RYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus       136 e~~~~~-~~~~~~Di~slg~~~~~~~~  161 (175)
                      |.+.+. .++.++|+||+|++++++++
T Consensus       200 E~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          200 EVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             HHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             ccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            998765 68999999999999999998

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.98  E-value=1.3e-31  Score=197.85  Aligned_cols=156  Identities=33%  Similarity=0.539  Sum_probs=123.0

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHc-CC
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH-HI   85 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~-~~   85 (175)
                      .+.+.++..+++.++||||+++++++...+..++|||++ ++.+..+... .+.+++..+..++.|+  ||++||++ |+
T Consensus        68 ~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i  146 (318)
T 2dyl_A           68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV  146 (318)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence            344555666788889999999999999999999999999 6666666654 4679999999999998  99999995 99


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccc-----ccCCCcchhHHHHHHHHHHHH
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~~~~  160 (175)
                      +|+||+|+||++   +.++.++|+|||++.............++..|+|||.+.     ...++.++|+||+|+++++++
T Consensus       147 ~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~  223 (318)
T 2dyl_A          147 IHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA  223 (318)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHH
T ss_pred             EeCCCCHHHEEE---CCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHH
Confidence            999999999999   577889999999997765554445567899999999984     456888999999999999999


Q ss_pred             hCCCCCCCC
Q 030527          161 NGYPPFSVG  169 (175)
Q Consensus       161 ~g~~pf~~~  169 (175)
                      +|..||...
T Consensus       224 ~g~~pf~~~  232 (318)
T 2dyl_A          224 TGQFPYKNC  232 (318)
T ss_dssp             HSSCTTTTC
T ss_pred             hCCCCCCCC
Confidence            999999863

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.98  E-value=4.6e-32  Score=205.40  Aligned_cols=166  Identities=39%  Similarity=0.541  Sum_probs=139.6

Q ss_pred             ccccc--hhhhhhHHHHHHHHhhCC-CC-----CeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHH
Q 030527            2 LKKLN--KHLKSCLDCELNFLSSVN-HP-----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKF   71 (175)
Q Consensus         2 lk~~~--~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~   71 (175)
                      ||.++  ....+++..|+++++.++ |+     +++++.+++...+..++|||++. ++|.+++...  ..+++..+..+
T Consensus        84 iK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i  162 (382)
T 2vx3_A           84 IKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKF  162 (382)
T ss_dssp             EEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHH
T ss_pred             EEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHH
Confidence            45443  334567788999999884 55     49999999999999999999995 5999999865  46999999999


Q ss_pred             HHHH--HHHHHH--HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcch
Q 030527           72 LQQL--GLEILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV  147 (175)
Q Consensus        72 ~~~i--~l~~lh--~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~  147 (175)
                      +.|+  ||++||  +.|++|+||||+||++.. +..+.++|+|||++......  .....+++.|+|||.+.+..++.++
T Consensus       163 ~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~  239 (382)
T 2vx3_A          163 AQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAI  239 (382)
T ss_dssp             HHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHH
T ss_pred             HHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCceecccc--cccccCCccccChHHHcCCCCCcHH
Confidence            9998  999999  579999999999999941 23567999999999877443  3345678999999999988999999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          148 DMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       148 Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      |+||+|+++++|++|+.||.+.++
T Consensus       240 DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          240 DMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999987654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.98  E-value=3e-32  Score=219.77  Aligned_cols=153  Identities=27%  Similarity=0.450  Sum_probs=131.0

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCe-----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      ......+.+|++++++++||||+++++++...+.     .++||||+.|++|.+++.+  .+++..+..++.|+  +|+|
T Consensus       120 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~  197 (681)
T 2pzi_A          120 AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSY  197 (681)
T ss_dssp             HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHH
Confidence            3455678899999999999999999999987665     7999999999999998764  79999999999999  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      ||++|++|+||||+||+++   . +.++|+|||++......   ....+|+.|+|||.+.+. ++.++|+||||+++++|
T Consensus       198 lH~~giiHrDlkp~NIll~---~-~~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l  269 (681)
T 2pzi_A          198 LHSIGLVYNDLKPENIMLT---E-EQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAAL  269 (681)
T ss_dssp             HHHTTEECCCCSGGGEEEC---S-SCEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHH
T ss_pred             HHHCCCeecccChHHeEEe---C-CcEEEEecccchhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHH
Confidence            9999999999999999994   3 37999999999876543   345689999999998654 58899999999999999


Q ss_pred             HhCCCCCCCC
Q 030527          160 LNGYPPFSVG  169 (175)
Q Consensus       160 ~~g~~pf~~~  169 (175)
                      ++|..||.+.
T Consensus       270 ~~g~~~~~~~  279 (681)
T 2pzi_A          270 TLDLPTRNGR  279 (681)
T ss_dssp             HSCCCEETTE
T ss_pred             HhCCCCCccc
Confidence            9999998764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=1.9e-30  Score=190.51  Aligned_cols=146  Identities=34%  Similarity=0.667  Sum_probs=122.0

Q ss_pred             ccccchhhhhhHHHHHHHH-hhCCCCCeeeEeeEEee----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHH
Q 030527            2 LKKLNKHLKSCLDCELNFL-SSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQ   74 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~   74 (175)
                      +|.++.  ...+.+|++++ +.++||||+++++++..    .+..++||||+.+++|.+++.+..  .+++..+..++.|
T Consensus        48 iK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~q  125 (299)
T 3m2w_A           48 LKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS  125 (299)
T ss_dssp             EEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHH
T ss_pred             EEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHH
Confidence            444432  34667888888 55699999999999887    678899999999999999998764  6999999999999


Q ss_pred             H--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHH
Q 030527           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  152 (175)
Q Consensus        75 i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl  152 (175)
                      +  ||++||+.|++|+||+|+||++...+.++.++|+|||++....                     +..++.++|+||+
T Consensus       126 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~~~~~~~Diwsl  184 (299)
T 3m2w_A          126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------GEKYDKSCDMWSL  184 (299)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------TCGGGGHHHHHHH
T ss_pred             HHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------cccCCchhhHHHH
Confidence            9  9999999999999999999999533336789999999886542                     1346788999999


Q ss_pred             HHHHHHHHhCCCCCCCCC
Q 030527          153 GAILFELLNGYPPFSVGE  170 (175)
Q Consensus       153 g~~~~~~~~g~~pf~~~~  170 (175)
                      |+++++|++|..||.+..
T Consensus       185 G~il~el~tg~~pf~~~~  202 (299)
T 3m2w_A          185 GVIMYILLCGYPPFYSNH  202 (299)
T ss_dssp             HHHHHHHHHSSCSCCC--
T ss_pred             HHHHHHHHHCCCCCCCCc
Confidence            999999999999997654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=2.1e-32  Score=203.90  Aligned_cols=153  Identities=24%  Similarity=0.264  Sum_probs=124.5

Q ss_pred             hhhHHHHHHHHhhCC---------CCCeeeEeeEE-----------------ee-------------CCeEEEEEeccCC
Q 030527           10 KSCLDCELNFLSSVN---------HPNIIRLFDAF-----------------QA-------------ENCIFLVVEFCAG   50 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~---------h~~i~~~~~~~-----------------~~-------------~~~~~lv~e~~~~   50 (175)
                      .+.+.+|++++++++         ||||+++.+.+                 ..             .+..++||||+.+
T Consensus        67 ~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~  146 (336)
T 2vuw_A           67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG  146 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECC
T ss_pred             HHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCC
Confidence            367889999999885         77777766653                 22             6789999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH-HcCCeecCCCCCcEEEeecC-----------------CCceEEEee
Q 030527           51 GNLSSYIRLHGRVPEQTARKFLQQL--GLEILN-SHHIIHRDLKPENILLSGLD-----------------DDVMLKIAD  110 (175)
Q Consensus        51 ~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh-~~~~~h~di~~~ni~~~~~~-----------------~~~~~~l~d  110 (175)
                      +++.+.+.+ ..+++..+..++.|+  ||+||| +.|++||||||+||++...+                 ....++|+|
T Consensus       147 g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~D  225 (336)
T 2vuw_A          147 GIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID  225 (336)
T ss_dssp             CEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECC
T ss_pred             CccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEee
Confidence            876666643 578999999999999  999999 99999999999999996322                 113899999


Q ss_pred             ecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHH-HHHHHhCCCCCCC
Q 030527          111 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI-LFELLNGYPPFSV  168 (175)
Q Consensus       111 f~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~-~~~~~~g~~pf~~  168 (175)
                      ||+++.....    ...||+.|+|||.+.+.. +.++|+||++++ .+++++|..||.+
T Consensus       226 FG~a~~~~~~----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          226 YTLSRLERDG----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             CTTCBEEETT----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             ccccEecCCC----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence            9999877543    346899999999998666 889999998777 6678889999853

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=3.5e-30  Score=188.26  Aligned_cols=134  Identities=19%  Similarity=0.200  Sum_probs=115.7

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+.+|++++++++||||+++++++.+.+..++||||+.|++|.++++++  ....++..++.|+  +|+|||++|+
T Consensus        73 ~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~gi  150 (286)
T 3uqc_A           73 DVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGV  150 (286)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCC
Confidence            34477899999999999999999999999999999999999999999999643  3556788899998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +|+||||+||+++   .++.++|++++                   |++       +++.++|+||||+++|+|++|+.|
T Consensus       151 vH~Dikp~NIll~---~~g~~kl~~~~-------------------~~~-------~~~~~~Di~slG~il~elltg~~P  201 (286)
T 3uqc_A          151 ALSIDHPSRVRVS---IDGDVVLAYPA-------------------TMP-------DANPQDDIRGIGASLYALLVNRWP  201 (286)
T ss_dssp             CCCCCSGGGEEEE---TTSCEEECSCC-------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEEC
T ss_pred             ccCCCCcccEEEc---CCCCEEEEecc-------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCC
Confidence            9999999999994   66778877433                   222       368999999999999999999999


Q ss_pred             CCCCCcc
Q 030527          166 FSVGEEH  172 (175)
Q Consensus       166 f~~~~~~  172 (175)
                      |.+.+..
T Consensus       202 f~~~~~~  208 (286)
T 3uqc_A          202 LPEAGVR  208 (286)
T ss_dssp             SCCCSBC
T ss_pred             CCcCCcc
Confidence            9887654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=1.4e-29  Score=193.63  Aligned_cols=156  Identities=15%  Similarity=0.147  Sum_probs=119.1

Q ss_pred             hhhHHHHHHHHhhCCC-CCe---------------------eeEeeEEee-----CCeEEEEEeccCCCChHHHHHhc--
Q 030527           10 KSCLDCELNFLSSVNH-PNI---------------------IRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH--   60 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h-~~i---------------------~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--   60 (175)
                      .+.+.+|+.+++.++| ++.                     ..+..++..     ....+++++.+ +++|.++++..  
T Consensus       122 ~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~  200 (413)
T 3dzo_A          122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS  200 (413)
T ss_dssp             CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhc
Confidence            5678899999999976 221                     111111111     12357777766 78999988521  


Q ss_pred             -----CCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCcc
Q 030527           61 -----GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM  133 (175)
Q Consensus        61 -----~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  133 (175)
                           ..+++..+..++.|+  ||+|||++|++||||||+||++   +.++.++|+|||++......  .....+ +.|+
T Consensus       201 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~  274 (413)
T 3dzo_A          201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFA  274 (413)
T ss_dssp             HTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTC
T ss_pred             ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-Ccee
Confidence                 247778888898998  9999999999999999999999   57778999999998776443  334456 8999


Q ss_pred             Ccccc----------cccCCCcchhHHHHHHHHHHHHhCCCCCCCCCcc
Q 030527          134 APEVL----------QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH  172 (175)
Q Consensus       134 ~pe~~----------~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~~  172 (175)
                      |||.+          .+..++.++|+||||+++|+|++|+.||...+..
T Consensus       275 aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~  323 (413)
T 3dzo_A          275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL  323 (413)
T ss_dssp             CHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGG
T ss_pred             CchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchh
Confidence            99998          5556888999999999999999999999876544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=1.2e-25  Score=177.06  Aligned_cols=145  Identities=18%  Similarity=0.181  Sum_probs=120.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ++++.+|++++++++||||+++..++...+..++||||++|++|.+++.+        +..++.|+  +|+|||++|++|
T Consensus       383 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiH  454 (540)
T 3en9_A          383 KSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIH  454 (540)
T ss_dssp             HHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCcc
Confidence            45689999999999999999666666677777999999999999999875        45788887  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--------cccccCCCCccCcccccc--cCCCcchhHHHHHHHHH
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILF  157 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slg~~~~  157 (175)
                      +||||+||+++   .  .++|+|||+++.......        .....+|+.|+|||.+..  ..|+...|.|+..+-..
T Consensus       455 rDiKp~NILl~---~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l  529 (540)
T 3en9_A          455 NDLTTSNFIFD---K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELM  529 (540)
T ss_dssp             TTCCTTSEEES---S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHH
T ss_pred             CCCCHHHEEEC---C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHH
Confidence            99999999994   3  899999999988755422        124568999999999976  56788889999888877


Q ss_pred             HHHhCCCCCC
Q 030527          158 ELLNGYPPFS  167 (175)
Q Consensus       158 ~~~~g~~pf~  167 (175)
                      +-..+..+|.
T Consensus       530 ~~v~~r~rY~  539 (540)
T 3en9_A          530 KDVERRARYV  539 (540)
T ss_dssp             HHHHTCSCCC
T ss_pred             HHHHhccccC
Confidence            7777766653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.74  E-value=6.2e-19  Score=128.43  Aligned_cols=94  Identities=18%  Similarity=0.267  Sum_probs=75.6

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      .+..+.+|++++++++  | +++.+++.. +..++||||++|++|.+ +.    .  .....++.|+  ++++||+.|++
T Consensus       147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----~--~~~~~i~~qi~~~l~~lH~~gii  215 (282)
T 1zar_A          147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR----V--ENPDEVLDMILEEVAKFYHRGIV  215 (282)
T ss_dssp             HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC----C--SCHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc----h--hhHHHHHHHHHHHHHHHHHCCCE
Confidence            4567889999999998  4 556655544 45699999999999988 32    1  2234677887  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      |+||||+||++   + ++.++|+|||++...
T Consensus       216 HrDlkp~NILl---~-~~~vkl~DFG~a~~~  242 (282)
T 1zar_A          216 HGDLSQYNVLV---S-EEGIWIIDFPQSVEV  242 (282)
T ss_dssp             CSCCSTTSEEE---E-TTEEEECCCTTCEET
T ss_pred             eCCCCHHHEEE---E-CCcEEEEECCCCeEC
Confidence            99999999999   4 778999999988643

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.55  E-value=3.3e-15  Score=107.40  Aligned_cols=97  Identities=20%  Similarity=0.258  Sum_probs=73.6

Q ss_pred             hhHHHHHHHHhhCCCCCee--eEeeEEeeCCeEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 030527           11 SCLDCELNFLSSVNHPNII--RLFDAFQAENCIFLVVEFCAG-G----NLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~--~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      ..+..|+++++++.|+++.  .++++    +..++||||+.+ +    +|.++...   .++..+..++.|+  ++++||
T Consensus       115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH  187 (258)
T 1zth_A          115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLY  187 (258)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHH
Confidence            3678899999999888653  33332    346899999942 2    67665432   2344567788888  999999


Q ss_pred             -HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccC
Q 030527           82 -SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  119 (175)
Q Consensus        82 -~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~  119 (175)
                       +.|++|+||+|.||++.   .  .++|+|||++.....
T Consensus       188 ~~~givHrDlkp~NILl~---~--~~~liDFG~a~~~~~  221 (258)
T 1zth_A          188 QEAELVHADLSEYNIMYI---D--KVYFIDMGQAVTLRH  221 (258)
T ss_dssp             HTSCEECSSCSTTSEEES---S--SEEECCCTTCEETTS
T ss_pred             HHCCEEeCCCCHHHEEEc---C--cEEEEECcccccCCC
Confidence             99999999999999994   3  799999999976633

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.21  E-value=4.6e-11  Score=85.61  Aligned_cols=107  Identities=18%  Similarity=0.193  Sum_probs=79.5

Q ss_pred             ccccch---hhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--
Q 030527            2 LKKLNK---HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--   75 (175)
Q Consensus         2 lk~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--   75 (175)
                      ||....   .....+.+|+++++.+ ++..+++++++....+..++|||+++|.++.+.+.   .  ......+..++  
T Consensus        42 lK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~---~--~~~~~~~~~~l~~  116 (263)
T 3tm0_A           42 LKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE---D--EQSPEKIIELYAE  116 (263)
T ss_dssp             EEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC---T--TTCHHHHHHHHHH
T ss_pred             EEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC---C--cccHHHHHHHHHH
Confidence            454443   3345789999999998 46778899999999999999999999999887521   1  11122444555  


Q ss_pred             HHHHHHH-----------------------------------------------------------cCCeecCCCCCcEE
Q 030527           76 GLEILNS-----------------------------------------------------------HHIIHRDLKPENIL   96 (175)
Q Consensus        76 ~l~~lh~-----------------------------------------------------------~~~~h~di~~~ni~   96 (175)
                      +++.||+                                                           ..++|||+++.||+
T Consensus       117 ~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil  196 (263)
T 3tm0_A          117 CIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIF  196 (263)
T ss_dssp             HHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEE
T ss_pred             HHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEE
Confidence            7888888                                                           44889999999999


Q ss_pred             EeecCCCceEEEeeecceee
Q 030527           97 LSGLDDDVMLKIADFGLSCT  116 (175)
Q Consensus        97 ~~~~~~~~~~~l~df~~~~~  116 (175)
                      +.   .+..+.++||+.+..
T Consensus       197 ~~---~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          197 VK---DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EE---TTEEEEECCCTTCEE
T ss_pred             EE---CCcEEEEEEchhccc
Confidence            94   445567999997644

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.17  E-value=2.7e-11  Score=91.35  Aligned_cols=98  Identities=18%  Similarity=0.187  Sum_probs=67.4

Q ss_pred             HHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCC
Q 030527           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLK   91 (175)
Q Consensus        14 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~   91 (175)
                      ..|.+.+.++.+.++.....+....  .++||||+.|.+|.++..    .+  ....+..|+  ++.++|+.|++|||||
T Consensus       161 ~kE~~nL~rL~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~----~~--~~~~l~~qll~~l~~lH~~gIVHrDLK  232 (397)
T 4gyi_A          161 IKEFAFMKALYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSS----VP--DPASLYADLIALILRLAKHGLIHGDFN  232 (397)
T ss_dssp             HHHHHHHHHHHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCC----CS--CHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             HHHHHHHHHHHhcCCCCCeeeeccC--ceEEEEecCCccHhhhcc----cH--HHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence            4577888888666654333222222  379999999888865422    22  234566777  9999999999999999


Q ss_pred             CCcEEEeecCC-------CceEEEeeecceeeccC
Q 030527           92 PENILLSGLDD-------DVMLKIADFGLSCTLYP  119 (175)
Q Consensus        92 ~~ni~~~~~~~-------~~~~~l~df~~~~~~~~  119 (175)
                      |.||++.....       ...+.++||+-+.....
T Consensus       233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             TTSEEEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             HHHEEEeCCCCcccccccccceEEEEeCCcccCCC
Confidence            99999963211       11488999997766543

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.02  E-value=7.5e-10  Score=78.85  Aligned_cols=105  Identities=15%  Similarity=0.124  Sum_probs=71.0

Q ss_pred             ccccchhhhhhHHHHHHHHhhCCCCC--eeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HH
Q 030527            2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GL   77 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l   77 (175)
                      ||.........+..|.++++.+.+.+  +++++++....+..++|||+++|.++.  ..   ..+..   .+..++  .+
T Consensus        49 lK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~~~~---~~~~~l~~~l  120 (264)
T 1nd4_A           49 VKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HLAPA---EKVSIMADAM  120 (264)
T ss_dssp             EEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CCCHH---HHHHHHHHHH
T ss_pred             EEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cCCHh---HHHHHHHHHH
Confidence            44444334467889999999995445  456888888888899999999998884  11   11111   222222  44


Q ss_pred             HHHHHc----------------------------------------------------------CCeecCCCCCcEEEee
Q 030527           78 EILNSH----------------------------------------------------------HIIHRDLKPENILLSG   99 (175)
Q Consensus        78 ~~lh~~----------------------------------------------------------~~~h~di~~~ni~~~~   99 (175)
                      +.||+.                                                          +++|+|++|.||++. 
T Consensus       121 ~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~-  199 (264)
T 1nd4_A          121 RRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE-  199 (264)
T ss_dssp             HHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE-
T ss_pred             HHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE-
Confidence            455543                                                          289999999999994 


Q ss_pred             cCCCceEEEeeecceeec
Q 030527          100 LDDDVMLKIADFGLSCTL  117 (175)
Q Consensus       100 ~~~~~~~~l~df~~~~~~  117 (175)
                        .+..+.++||+.+...
T Consensus       200 --~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          200 --NGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             --TTEEEEECCCTTCEEE
T ss_pred             --CCcEEEEEcchhcccC
Confidence              4455679999987543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.90  E-value=4e-09  Score=78.89  Aligned_cols=104  Identities=14%  Similarity=0.314  Sum_probs=77.0

Q ss_pred             hhhHHHHHHHHhhCCC--CCeeeEeeEEeeC---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHH
Q 030527           10 KSCLDCELNFLSSVNH--PNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ...+.+|.++++.+..  ..+++++.++.+.   +..++|||+++|..+.+.  ....++......+..++  .|+.||+
T Consensus        80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A           80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence            4578889999999964  4577888887766   457899999998877541  12346677777777777  7888886


Q ss_pred             ----------------------------------------------------------cCCeecCCCCCcEEEeecCCC-
Q 030527           83 ----------------------------------------------------------HHIIHRDLKPENILLSGLDDD-  103 (175)
Q Consensus        83 ----------------------------------------------------------~~~~h~di~~~ni~~~~~~~~-  103 (175)
                                                                                ..++|||+++.||++.  ..+ 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~--~~~~  235 (359)
T 3dxp_A          158 VDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFH--PTEP  235 (359)
T ss_dssp             SCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEEC--SSSS
T ss_pred             CCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEe--CCCC
Confidence                                                                      3589999999999994  222 


Q ss_pred             ceEEEeeecceeec
Q 030527          104 VMLKIADFGLSCTL  117 (175)
Q Consensus       104 ~~~~l~df~~~~~~  117 (175)
                      ..+.++||+.+...
T Consensus       236 ~v~~viDwe~a~~g  249 (359)
T 3dxp_A          236 RVLAVLDWELSTLG  249 (359)
T ss_dssp             CEEEECCCTTCEEE
T ss_pred             cEEEEECccccccC
Confidence            33689999988654

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.84  E-value=4.4e-09  Score=76.97  Aligned_cols=154  Identities=22%  Similarity=0.273  Sum_probs=92.5

Q ss_pred             hhhhHHHHHHHHhhC-CCCC--eeeEeeEEeeCC---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527            9 LKSCLDCELNFLSSV-NHPN--IIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l-~h~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ....+..|.++++.+ .+..  ++.++......+   ..++||++++|.++.+...  ..++..+...+..++  .++.|
T Consensus        53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~L  130 (304)
T 3sg8_A           53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSEL  130 (304)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHH
Confidence            456788999999888 4433  334444433332   3478999999988875332  235555555666665  55555


Q ss_pred             HH----------------------------------------------------------cCCeecCCCCCcEEEeecCC
Q 030527           81 NS----------------------------------------------------------HHIIHRDLKPENILLSGLDD  102 (175)
Q Consensus        81 h~----------------------------------------------------------~~~~h~di~~~ni~~~~~~~  102 (175)
                      |+                                                          ..++|+|+++.|+++.  +.
T Consensus       131 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~--~~  208 (304)
T 3sg8_A          131 HSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFD--TE  208 (304)
T ss_dssp             HHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEE--TT
T ss_pred             HcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEe--CC
Confidence            54                                                          1369999999999995  22


Q ss_pred             -CceEEEeeecceeeccCCCccccccCCCCccCcccc----cccC-CC---------cchhHHHHHHHHHHHHhCCCCC
Q 030527          103 -DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQR-YD---------EKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus       103 -~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~----~~~~-~~---------~~~Di~slg~~~~~~~~g~~pf  166 (175)
                       +..+.++||+.+....+............-..|+..    ...+ ..         -..+.|+++.+++.+.+|..+|
T Consensus       209 ~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          209 KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             456789999987654322110000000000122221    1110 01         1158999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.49  E-value=1.2e-06  Score=62.63  Aligned_cols=56  Identities=11%  Similarity=0.065  Sum_probs=43.5

Q ss_pred             ccccchhhhhhHHHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHH
Q 030527            2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI   57 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   57 (175)
                      ||.-.......+..|.+.++.+. +--+++++.++.+.+..++||++++|.++.+..
T Consensus        55 lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~  111 (272)
T 4gkh_A           55 LKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVL  111 (272)
T ss_dssp             EEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHH
T ss_pred             EEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccc
Confidence            55555556677889999999883 334678888889999999999999998776643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.34  E-value=5.2e-06  Score=60.75  Aligned_cols=47  Identities=17%  Similarity=0.077  Sum_probs=35.2

Q ss_pred             hhhhHHHHHHHHhhCCCC---CeeeEeeEEe-eCCeEEEEEeccCCCChHH
Q 030527            9 LKSCLDCELNFLSSVNHP---NIIRLFDAFQ-AENCIFLVVEFCAGGNLSS   55 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~   55 (175)
                      ....+..|.++++.+.+.   .+++++.+.. ..+..+++|++++|..+.+
T Consensus        52 ~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~  102 (306)
T 3tdw_A           52 GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE  102 (306)
T ss_dssp             HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence            456789999999999642   3556666664 4566789999999987765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.72  E-value=2e-05  Score=58.61  Aligned_cols=43  Identities=14%  Similarity=0.139  Sum_probs=31.5

Q ss_pred             hhHHHHHHHHhhCC-C--CCeeeEeeEEeeC---CeEEEEEeccCCCCh
Q 030527           11 SCLDCELNFLSSVN-H--PNIIRLFDAFQAE---NCIFLVVEFCAGGNL   53 (175)
Q Consensus        11 ~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L   53 (175)
                      ..+..|.++++.+. +  -.+++++.+..+.   +..++|||+++|..+
T Consensus        72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A           72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred             hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCCh
Confidence            56788999999883 3  2466777776654   456899999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.40  E-value=0.00083  Score=49.27  Aligned_cols=32  Identities=19%  Similarity=0.267  Sum_probs=26.6

Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .+++|||+++.|+++   +.++.+.++||+.+...
T Consensus       222 ~~l~HgD~~~~Nil~---~~~~~~~lIDfe~a~~g  253 (346)
T 2q83_A          222 PNLCHQDYGTGNTLL---GENEQIWVIDLDTVSFD  253 (346)
T ss_dssp             CCEECSSCSTTSEEE---CGGGCEEECCCTTCEEC
T ss_pred             CceecCCCCcccEEE---eCCCcEEEEehhhcccC
Confidence            579999999999999   45567999999977543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.00  E-value=0.002  Score=47.31  Aligned_cols=36  Identities=19%  Similarity=0.197  Sum_probs=26.5

Q ss_pred             cCCeecCCCCCcEEEeecCC-CceEEEeeecceeecc
Q 030527           83 HHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLY  118 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~-~~~~~l~df~~~~~~~  118 (175)
                      ..++|||+++.|+++..... ...+.++||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            36899999999999942100 2568999999876553

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.98  E-value=0.0017  Score=48.87  Aligned_cols=31  Identities=26%  Similarity=0.296  Sum_probs=24.6

Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      ..++|||+++.|+++.   . +.+.++||..+...
T Consensus       227 ~~L~HGDl~~~Nil~~---~-~~~~lID~e~a~~G  257 (397)
T 2olc_A          227 ETLIHGDLHTGSIFAS---E-HETKVIDPEFAFYG  257 (397)
T ss_dssp             CEEECSCCSGGGEEEC---S-SCEEECCCTTCEEE
T ss_pred             CceeeCCCCcCcEEEe---C-CCeEEEeCcccccC
Confidence            4689999999999993   2 24889999877654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.26  E-value=0.005  Score=44.55  Aligned_cols=29  Identities=28%  Similarity=0.134  Sum_probs=23.6

Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      ++|+|+.+.|++.    .++.+.++||..+...
T Consensus       175 l~HgDl~~~Nil~----~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          175 ACHCDPLCENFLD----TGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EECSCCCGGGEEE----CSSCEEECCCTTCEEE
T ss_pred             eeccCCCcCCEEE----CCCCEEEEecccccCC
Confidence            7999999999995    3445799999877654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.25  E-value=0.12  Score=35.88  Aligned_cols=94  Identities=21%  Similarity=0.195  Sum_probs=52.3

Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHc----CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcccc
Q 030527           51 GNLSSYIRLH-GRVPEQTARKFLQQLGLEILNSH----HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK  125 (175)
Q Consensus        51 ~~L~~~l~~~-~~l~~~~~~~~~~~i~l~~lh~~----~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~  125 (175)
                      -+|.+.++.. .+++++++++++.|- ...|++.    .-...=+.|..+++   ..++.+.+.+ .       ..    
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc-~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~-------~s----   96 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQC-CGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-A-------AD----   96 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHH-HHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHH-HHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-c-------cc----
Confidence            3788988865 589999999999995 2233332    11122333466666   3555554332 0       00    


Q ss_pred             ccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527          126 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus       126 ~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      ......+.|||... ...+.+.=|||||.++|..+-
T Consensus        97 ~~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           97 DAGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             cccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence            01133466777653 344567789999999997655

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=94.99  E-value=0.054  Score=39.59  Aligned_cols=52  Identities=15%  Similarity=0.183  Sum_probs=40.6

Q ss_pred             ccccchhhhhhHHHHHHHHhhCC---CCCeeeEeeEEeeCCeEEEEEeccCCCCh
Q 030527            2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNL   53 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   53 (175)
                      ||.-.......+..|.+.++.|.   ...+++++.+....+..++|||+++|..+
T Consensus        64 lK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           64 VKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            55555555677899999999883   35677888888888889999999988764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.96  E-value=0.037  Score=40.17  Aligned_cols=32  Identities=28%  Similarity=0.525  Sum_probs=24.9

Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .+++|+|+++.|+++.   .+..+.++||+.+...
T Consensus       187 ~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~~g  218 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFL---GDELSGLIDFYFACND  218 (322)
T ss_dssp             EEEECSCCCGGGEEEE---TTEEEEECCCTTCEEE
T ss_pred             cccCCCCCCccCEEEe---CCceEEEecchhccCc
Confidence            3689999999999994   4444579999877543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=92.88  E-value=0.051  Score=41.25  Aligned_cols=32  Identities=22%  Similarity=0.379  Sum_probs=25.8

Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      ...++|||+++.||++.   .++ +.++||+.+...
T Consensus       231 ~~~liHGDl~~~Nil~~---~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVT---QDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEEC---SSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEe---CCC-CEEEeCcccccC
Confidence            45689999999999993   333 999999877654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.12  E-value=0.18  Score=37.40  Aligned_cols=30  Identities=30%  Similarity=0.424  Sum_probs=23.4

Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .++|+|+++.||++.   . +.+.++||..+...
T Consensus       213 ~l~HgDl~~~Nil~~---~-~~~~lID~e~a~~g  242 (369)
T 3c5i_A          213 VFCHNDLQENNIINT---N-KCLRLIDFEYSGFN  242 (369)
T ss_dssp             EEECSCCCGGGEEEC---C--CEEECCCTTCEEE
T ss_pred             EEEeCCCCcccEEec---C-CcEEEEEecCCCCC
Confidence            489999999999983   3 34899999877543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=88.82  E-value=0.19  Score=36.96  Aligned_cols=31  Identities=19%  Similarity=0.367  Sum_probs=25.6

Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .++|+|+.+.|+++   +.++.+.++||+.+...
T Consensus       207 ~~~HgD~~~~N~l~---~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          207 VLCHSDIHAGNVLV---GNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             EEECSCCCGGGEEE---CGGGCEEECCCSSCEEE
T ss_pred             eeEeCCCCcCCEEE---eCCCeEEEEECCCCeeC
Confidence            58999999999999   44567899999877554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=88.80  E-value=0.17  Score=36.72  Aligned_cols=29  Identities=24%  Similarity=0.164  Sum_probs=23.7

Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .++|||+++.||++.    + .+.++||+.+...
T Consensus       196 ~l~HgD~~~~Nil~~----~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR----D-GPMFVDLDDARNG  224 (328)
T ss_dssp             EECCSSCSGGGEEES----S-SEEECCCTTCCEE
T ss_pred             eeeeCCCCcccEeEc----C-CCEEEECCCCCcC
Confidence            478999999999993    3 6899999876543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=86.67  E-value=0.34  Score=37.40  Aligned_cols=35  Identities=23%  Similarity=0.302  Sum_probs=24.1

Q ss_pred             HHHHHHHhhCCCCCe-eeEeeEEeeCCeEEEEEeccCCCC
Q 030527           14 DCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGN   52 (175)
Q Consensus        14 ~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~   52 (175)
                      ..|.++++.|...++ +++++.+.  +.  +|++|++|..
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~  187 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYA  187 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEE
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCcc
Confidence            679999999965555 46666552  22  5999998743

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=85.53  E-value=0.25  Score=37.71  Aligned_cols=38  Identities=16%  Similarity=0.253  Sum_probs=24.5

Q ss_pred             hhHHHHHHHHhhCCCCCe-eeEeeEEeeCCeEEEEEeccCCCC
Q 030527           11 SCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGN   52 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~   52 (175)
                      ..+..|.++++.+...++ +++++.+.  +.  +|++|++|.+
T Consensus       120 ~~li~E~~~l~~L~~~g~~P~l~~~~~--~g--~v~e~l~G~~  158 (429)
T 1nw1_A          120 SHLVAESVIFTLLSERHLGPKLYGIFS--GG--RLEEYIPSRP  158 (429)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEET--TE--EEECCCCEEE
T ss_pred             HHHHHHHHHHHHHHhCCCCCcEEEEeC--CC--EEEEEeCCcc
Confidence            455579999998843334 56665543  22  7899997633

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=84.28  E-value=0.41  Score=35.95  Aligned_cols=34  Identities=29%  Similarity=0.367  Sum_probs=25.2

Q ss_pred             CCeecCCCCCcEEEeec-CCCceEEEeeecceeec
Q 030527           84 HIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTL  117 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~-~~~~~~~l~df~~~~~~  117 (175)
                      .++|+|+.+.|+++... +..+.+.++||..+...
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence            48899999999999522 11357899999988654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.97  E-value=8.2  Score=26.58  Aligned_cols=82  Identities=15%  Similarity=0.060  Sum_probs=54.9

Q ss_pred             CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHcCCeecCCCCCcEEEeecCC
Q 030527           24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDD  102 (175)
Q Consensus        24 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i-~l~~lh~~~~~h~di~~~ni~~~~~~~  102 (175)
                      .||++  ....-.+.+.+.+.++..++..=...+   ..++....++.+..+ .+..-|...-+|.-+.|+|+++   +.
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~~~r~tf~l~P~NL~f---~~  119 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHSARRLIFIVCPENLMF---NR  119 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCCSSSEECCCCGGGEEE---CT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhhhCceeEEEeCceEEE---eC
Confidence            67777  334446677777777654332222223   356788888888877 4444244667899999999999   67


Q ss_pred             CceEEEeeecc
Q 030527          103 DVMLKIADFGL  113 (175)
Q Consensus       103 ~~~~~l~df~~  113 (175)
                      +..+++.-.|.
T Consensus       120 ~~~p~i~hRGi  130 (219)
T 4ano_A          120 ALEPFFLHVGV  130 (219)
T ss_dssp             TCCEEESCCEE
T ss_pred             CCcEEEEEcCC
Confidence            88888876664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=83.12  E-value=0.64  Score=35.02  Aligned_cols=33  Identities=30%  Similarity=0.337  Sum_probs=25.9

Q ss_pred             CeecCCCCCcEEEee---cCCCceEEEeeecceeec
Q 030527           85 IIHRDLKPENILLSG---LDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        85 ~~h~di~~~ni~~~~---~~~~~~~~l~df~~~~~~  117 (175)
                      ++|+|+.+.||++..   .+....+.++||..|..-
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            679999999999952   134567999999988654

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.24  E-value=12  Score=25.71  Aligned_cols=82  Identities=13%  Similarity=0.206  Sum_probs=53.7

Q ss_pred             CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH-HHHHHHHcCCeecCCCCCcEEEeecCC
Q 030527           24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDD  102 (175)
Q Consensus        24 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i-~l~~lh~~~~~h~di~~~ni~~~~~~~  102 (175)
                      .+|+.++. ..-...+.+.+.++.-  .+..+|-. -..++....++++..+ .+. -|...-+|--+.|+|+++   +.
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~~-ik~~~~~eKlr~l~ni~~l~-~~~~~r~tf~L~P~NL~f---~~  114 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFDN-IKSFTKNEKLRYLLNIKNLE-EVNRTRYTFVLAPDELFF---TR  114 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGGG-GGGSCHHHHHHHHHHGGGGG-GGGGSSEECCCSGGGEEE---CT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcC--cccCCHHH-HHhcCHHHHHHHHHHHHHHH-HHhcCceEEEEecceEEE---cC
Confidence            68888866 4555666666666643  33333322 2346788888888887 444 333446789999999999   67


Q ss_pred             CceEEEeeecc
Q 030527          103 DVMLKIADFGL  113 (175)
Q Consensus       103 ~~~~~l~df~~  113 (175)
                      +..+++.-.|.
T Consensus       115 ~~~p~i~~RGi  125 (215)
T 4ann_A          115 DGLPIAKTRGL  125 (215)
T ss_dssp             TSCEEESCCEE
T ss_pred             CCCEEEEEccC
Confidence            77777765553

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	175
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-51
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-51
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-49
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-48
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-47
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-46
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-45
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-41
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-41
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-40
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-40
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-38
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-38
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-38
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-37
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-37
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-37
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-37
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-36
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-36
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-36
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-35
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-34
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-33
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-33
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-33
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-32
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-31
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-31
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-27
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-13

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 5e-52
 Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 7/176 (3%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +  ++   +++ +  EL  L   N P I+  + AF ++  I + +E   GG+L   ++  
Sbjct: 39  IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 98

Query: 61  GRVPEQTARKFLQQL--GLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           GR+PEQ   K    +  GL  L   H I+HRD+KP NIL   ++    +K+ DFG+S  L
Sbjct: 99  GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL---VNSRGEIKLCDFGVSGQL 155

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
              + A    G+  YM+PE LQ   Y  + D+WS+G  L E+  G  P    +  +
Sbjct: 156 -IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-51
 Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 12/174 (6%)

Query: 2   LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK L K       ++  L  E+   S + HPNI+RL+  F     ++L++E+   G +  
Sbjct: 36  LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 95

Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
            ++   +  EQ    ++ +L   L   +S  +IHRD+KPEN+LL        LKIADFG 
Sbjct: 96  ELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGW 152

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
           S    P +    +CG+  Y+ PE+++ + +DEKVD+WS+G + +E L G PPF 
Sbjct: 153 SVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 205

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 1e-51
 Identities = 64/180 (35%), Positives = 102/180 (56%), Gaps = 6/180 (3%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K + K      +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I
Sbjct: 39  IKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 98

Query: 58  RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
              G   E+ A + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS 
Sbjct: 99  VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158

Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
              PG+     CG+P Y+APEVL  + Y + VD WS+G I + LL GYPPF    + +  
Sbjct: 159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  165 bits (419), Expect = 3e-51
 Identities = 53/178 (29%), Positives = 96/178 (53%), Gaps = 4/178 (2%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
            +   ++  K  +  E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   
Sbjct: 58  FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 117

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           H ++ E  A ++++Q+  GL  ++ ++ +H DLKPENI+ +       LK+ DFGL+  L
Sbjct: 118 HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-TKRSNELKLIDFGLTAHL 176

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
            P    +   G+  + APEV + +      DMWSVG + + LL+G  PF    + + +
Sbjct: 177 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 5e-50
 Identities = 57/173 (32%), Positives = 98/173 (56%), Gaps = 12/173 (6%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIR 58
           +KL K  +     E   L  + HPNI+R +D++++    + CI LV E    G L +Y++
Sbjct: 45  RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 104

Query: 59  LHGRVPEQTARKFLQQL--GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLS 114
               +  +  R + +Q+  GL+ L++    IIHRDLK +NI ++       +KI D GL+
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            TL   ++A+ V G+P +MAPE+ + ++YDE VD+++ G  + E+     P+S
Sbjct: 163 -TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYS 213

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  161 bits (409), Expect = 8e-50
 Identities = 51/180 (28%), Positives = 95/180 (52%), Gaps = 7/180 (3%)

Query: 2   LKKLNKHL---KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
            K +N      K  +  E++ ++ ++HP +I L DAF+ +  + L++EF +GG L   I 
Sbjct: 59  AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 118

Query: 59  LHG-RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
               ++ E     +++Q   GL+ ++ H I+H D+KPENI+         +KI DFGL+ 
Sbjct: 119 AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLAT 177

Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
            L P    +    +  + APE++  +      DMW++G + + LL+G  PF+  ++ + +
Sbjct: 178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 237

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 1e-49
 Identities = 58/185 (31%), Positives = 97/185 (52%), Gaps = 14/185 (7%)

Query: 2   LKKLNKHL------KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L K           +  E + +S ++HP  ++L+  FQ +  ++  + +   G L  
Sbjct: 38  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97

Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           YIR  G   E   R +  ++   LE L+   IIHRDLKPENIL   L++D+ ++I DFG 
Sbjct: 98  YIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGT 154

Query: 114 SCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 170
           +  L P +    A    G+  Y++PE+L  +   +  D+W++G I+++L+ G PPF  G 
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214

Query: 171 EHQFM 175
           E+   
Sbjct: 215 EYLIF 219

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 3e-49
 Identities = 61/186 (32%), Positives = 97/186 (52%), Gaps = 15/186 (8%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
            K ++   +  L+    E++ L+S +HPNI++L DAF  EN +++++EFCAGG + + + 
Sbjct: 42  AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML 101

Query: 58  RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
            L   + E   +   +Q    L  L+ + IIHRDLK  NIL      D  +K+ADFG+S 
Sbjct: 102 ELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL---FTLDGDIKLADFGVSA 158

Query: 116 TLY-PGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
                    +   G+P +MAPEV+       + YD K D+WS+G  L E+    PP    
Sbjct: 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218

Query: 170 EEHQFM 175
              + +
Sbjct: 219 NPMRVL 224

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 5e-48
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 13/175 (7%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LH 60
           +             E+  L    H NI+     +     + +V ++C G +L  ++  + 
Sbjct: 40  VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIE 98

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
            +          +Q   G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+    
Sbjct: 99  TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKS 155

Query: 119 PGNYAEK---VCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 167
             + + +   + GS L+MAPEV++ Q    Y  + D+++ G +L+EL+ G  P+S
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (392), Expect = 1e-47
 Identities = 56/185 (30%), Positives = 86/185 (46%), Gaps = 17/185 (9%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +KK++   K   +       E+ FL  + HPN I+    +  E+  +LV+E+C G     
Sbjct: 45  IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 104

Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
                  + E            GL  L+SH++IHRD+K  NIL   L +  ++K+ DFG 
Sbjct: 105 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL---LSEPGLVKLGDFGS 161

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSVGE 170
           +  + P N      G+P +MAPEV+      +YD KVD+WS+G    EL    PP     
Sbjct: 162 ASIMAPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

Query: 171 EHQFM 175
               +
Sbjct: 219 AMSAL 223

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 5e-47
 Identities = 49/170 (28%), Positives = 90/170 (52%), Gaps = 7/170 (4%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            +    +  K  +  E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +   
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-E 110

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 117
             + E       ++    LE L+S+ +IHRD+K +NILL     D  +K+ DFG    + 
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT 167

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
              +    + G+P +MAPEV+  + Y  KVD+WS+G +  E++ G PP+ 
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 5e-47
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 6/179 (3%)

Query: 2   LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
            K +         +  E++ L+   H NI+ L ++F++   + ++ EF +G ++   I  
Sbjct: 35  AKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT 94

Query: 60  HG-RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
               + E+    ++ Q+   L+ L+SH+I H D++PENI+         +KI +FG +  
Sbjct: 95  SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQ 153

Query: 117 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           L PG+    +  +P Y APEV Q        DMWS+G +++ LL+G  PF      Q +
Sbjct: 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 2e-46
 Identities = 58/181 (32%), Positives = 93/181 (51%), Gaps = 9/181 (4%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +  K        +  E+     +NH N+++ +   +  N  +L +E+C+GG L   I   
Sbjct: 38  VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD 97

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
             +PE  A++F  QL  G+  L+   I HRD+KPEN+L   LD+   LKI+DFGL+    
Sbjct: 98  IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFR 154

Query: 119 PGNYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSVGEEHQF 174
             N      K+CG+  Y+APE+L+ + +  E VD+WS G +L  +L G  P+    +   
Sbjct: 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214

Query: 175 M 175
            
Sbjct: 215 E 215

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 4e-46
 Identities = 59/188 (31%), Positives = 98/188 (52%), Gaps = 17/188 (9%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI-- 57
              + +  K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I  
Sbjct: 39  YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 98

Query: 58  --RLHGRVPEQTARKFLQQL--GLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 108
             +    + E+   + + QL   L+         H ++HRDLKP N+ L   D    +K+
Sbjct: 99  GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKL 155

Query: 109 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            DFGL+  L     +A+   G+P YM+PE +    Y+EK D+WS+G +L+EL    PPF+
Sbjct: 156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215

Query: 168 VGEEHQFM 175
              + +  
Sbjct: 216 AFSQKELA 223

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (373), Expect = 3e-45
 Identities = 68/182 (37%), Positives = 103/182 (56%), Gaps = 12/182 (6%)

Query: 3   KKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
            +  + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+    
Sbjct: 46  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV 105

Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
            + E+  RK ++ L   +  L+  +I+HRDLKPENIL   LDDD+ +K+ DFG SC L P
Sbjct: 106 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDP 162

Query: 120 GNYAEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           G    +VCG+P Y+APE+++         Y ++VDMWS G I++ LL G PPF   ++  
Sbjct: 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222

Query: 174 FM 175
            +
Sbjct: 223 ML 224

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 3e-44
 Identities = 61/173 (35%), Positives = 97/173 (56%), Gaps = 9/173 (5%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL    +   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 42  LKMLQDCPKARREVEL-HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 100

Query: 58  RLHG--RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +   ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 101 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +      N     C +P Y+APEVL  ++YD+  DMWS+G I++ LL GYPPF
Sbjct: 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-42
 Identities = 61/184 (33%), Positives = 96/184 (52%), Gaps = 13/184 (7%)

Query: 2   LKKLNKHLKSCLDCELNFL-------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K L K +    D     +        +  HP +  +F  FQ +  +F V+E+  GG+L 
Sbjct: 32  IKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM 91

Query: 55  SYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
            +I+   +     A  +  ++  GL+ L+S  I++RDLK +NILL   D D  +KIADFG
Sbjct: 92  YHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFG 148

Query: 113 LSCTLYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
           +      G+      CG+P Y+APE+L  Q+Y+  VD WS G +L+E+L G  PF   +E
Sbjct: 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208

Query: 172 HQFM 175
            +  
Sbjct: 209 EELF 212

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 8e-42
 Identities = 55/154 (35%), Positives = 93/154 (60%), Gaps = 3/154 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL+Q+
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             G+  L+S  I H DLKPENI+L   +     +KI DFGL+  +  GN  + + G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 133 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           +APE++ ++    + DMWS+G I + LL+G  PF
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  137 bits (347), Expect = 2e-41
 Identities = 46/179 (25%), Positives = 84/179 (46%), Gaps = 13/179 (7%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGG 51
           +K L   L            E    +++NHP I+ ++D  +AE       ++V+E+  G 
Sbjct: 37  VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 96

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDD-DVMLKI 108
            L   +   G +  + A + +      L   + + IIHRD+KP NI++S  +   VM   
Sbjct: 97  TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
               ++ +         V G+  Y++PE  +    D + D++S+G +L+E+L G PPF+
Sbjct: 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-41
 Identities = 43/181 (23%), Positives = 85/181 (46%), Gaps = 12/181 (6%)

Query: 2   LKKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRL 59
           +K +           E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R 
Sbjct: 35  VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 94

Query: 60  HGR--VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
            GR  +      KF   +   +E L  ++ +HRDL   N+L+    +D + K++DFGL+ 
Sbjct: 95  RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 151

Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSVGEEHQF 174
                   +       + APE L+ +++  K D+WS G +L+E+   G  P+        
Sbjct: 152 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209

Query: 175 M 175
           +
Sbjct: 210 V 210

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  138 bits (348), Expect = 5e-41
 Identities = 67/182 (36%), Positives = 100/182 (54%), Gaps = 13/182 (7%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L K +   L        E   LS V HP IIR++  FQ    IF+++++  GG L S
Sbjct: 34  MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93

Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
            +R   R P   A+ +  ++   LE L+S  II+RDLKPENILL   D +  +KI DFG 
Sbjct: 94  LLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGF 150

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           +  +    Y   +CG+P Y+APEV+  + Y++ +D WS G +++E+L GY PF      +
Sbjct: 151 AKYVPDVTY--TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208

Query: 174 FM 175
             
Sbjct: 209 TY 210

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-40
 Identities = 44/179 (24%), Positives = 78/179 (43%), Gaps = 10/179 (5%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IR 58
           +K + +   S  D   E   +  ++HP +++L+     +  I LV EF   G LS Y   
Sbjct: 34  IKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT 93

Query: 59  LHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
             G    +T       +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  
Sbjct: 94  QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRF 150

Query: 117 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           +    Y           + +PEV  F RY  K D+WS G +++E+ +          + 
Sbjct: 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 9e-40
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 11/172 (6%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +  +  LK  L  E N +  +++P I+R+    +AE+   LV+E    G L+ Y++ +  
Sbjct: 45  EANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH 103

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           V ++   + + Q+  G++ L   + +HRDL   N+LL         KI+DFGLS  L   
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRAD 160

Query: 121 NYAEK----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 167
               K          + APE + + ++  K D+WS G +++E  + G  P+ 
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  135 bits (341), Expect = 1e-39
 Identities = 52/154 (33%), Positives = 87/154 (56%), Gaps = 7/154 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
            L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++
Sbjct: 57  MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 116

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YM
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYM 172

Query: 134 APEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 166
           APEVLQ    YD   D +S+G +LF+LL G+ PF
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 206

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-39
 Identities = 43/174 (24%), Positives = 84/174 (48%), Gaps = 11/174 (6%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K + +   S  +   E   + +++H  +++L+     +  IF++ E+ A G L +Y+R 
Sbjct: 33  IKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 92

Query: 60  -HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
              R   Q   +  + +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  
Sbjct: 93  MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRY 149

Query: 117 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 167
           +    Y           +  PEVL + ++  K D+W+ G +++E+   G  P+ 
Sbjct: 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 1e-38
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 9/162 (5%)

Query: 16  ELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFL 72
           E+  L  V+     +IRL D F+  +   L++E      +L  +I   G + E+ AR F 
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q+   +   ++  ++HRD+K ENIL+    +   LK+ DFG    L          G+ 
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGA-LLKDTVYTDFDGTR 173

Query: 131 LYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFSVGEE 171
           +Y  PE +++ RY      +WS+G +L++++ G  PF   EE
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-38
 Identities = 43/183 (23%), Positives = 82/183 (44%), Gaps = 13/183 (7%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K L +   S      E N +  + H  ++RL+     +  I+++ E+   G+L  +++ 
Sbjct: 42  VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKT 100

Query: 60  HGRVP--EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
              +            Q+  G+  +   + IHRDL+  NIL+    D +  KIADFGL+ 
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLAR 157

Query: 116 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSVGEEH 172
            +    Y  +        + APE + +  +  K D+WS G +L E++ +G  P+      
Sbjct: 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217

Query: 173 QFM 175
           + +
Sbjct: 218 EVI 220

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 2e-38
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 12/183 (6%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           + +   K     +  E   +  +++P I+RL    QAE  + LV+E   GG L  ++   
Sbjct: 44  LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGK 102

Query: 61  -GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
              +P     + L Q+  G++ L   + +HRDL   N+LL    +    KI+DFGLS  L
Sbjct: 103 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKAL 159

Query: 118 YPGNYAEK----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEH 172
              +              + APE + F+++  + D+WS G  ++E L+ G  P+   +  
Sbjct: 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219

Query: 173 QFM 175
           + M
Sbjct: 220 EVM 222

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  130 bits (327), Expect = 4e-38
 Identities = 41/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +     +  +     E + +   +HPN+I L         + ++ EF   G+L S++R +
Sbjct: 62  LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 121

Query: 61  -GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
            G+         L+ +  G++ L   + +HRDL   NIL   ++ +++ K++DFGLS  L
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFL 178

Query: 118 YPGNYAEKV------CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGE 170
                               + APE +Q++++    D+WS G +++E+++ G  P+    
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238

Query: 171 EHQFM 175
               +
Sbjct: 239 NQDVI 243

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 5e-38
 Identities = 57/183 (31%), Positives = 91/183 (49%), Gaps = 12/183 (6%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L K +    D       E   L +  HP +  L  AFQ  + +  V+E+  GG L  
Sbjct: 35  MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF 94

Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           ++       E+ AR +  ++   LE L+S  +++RD+K EN++L   D D  +KI DFGL
Sbjct: 95  HLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGL 151

Query: 114 SCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 172
                  G   +  CG+P Y+APEVL+   Y   VD W +G +++E++ G  PF   +  
Sbjct: 152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

Query: 173 QFM 175
           +  
Sbjct: 212 RLF 214

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-37
 Identities = 61/186 (32%), Positives = 89/186 (47%), Gaps = 15/186 (8%)

Query: 2   LKKLNKHLKSCLD--------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL 53
           +KK+    +S            E+  L  ++HPNII L DAF  ++ I LV +F      
Sbjct: 28  IKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLE 87

Query: 54  SSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
                    +     + ++     GLE L+ H I+HRDLKP N+L   LD++ +LK+ADF
Sbjct: 88  VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADF 144

Query: 112 GLSCTLYPGNYAEK-VCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
           GL+ +    N A      +  Y APE+L   + Y   VDMW+VG IL ELL   P     
Sbjct: 145 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204

Query: 170 EEHQFM 175
            +   +
Sbjct: 205 SDLDQL 210

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-37
 Identities = 54/186 (29%), Positives = 84/186 (45%), Gaps = 15/186 (8%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
           +KK+ +  K   + EL  +  ++H NI+RL   F      + E  + LV+++        
Sbjct: 50  IKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108

Query: 56  ---YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
              Y R    +P    + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ D
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCD 166

Query: 111 FGLSCTLYPGNYAEKVCGSPLYMAP-EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
           FG +  L  G        S  Y AP  +     Y   +D+WS G +L ELL G P F   
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

Query: 170 EEHQFM 175
                +
Sbjct: 227 SGVDQL 232

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  129 bits (324), Expect = 2e-37
 Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 11/178 (6%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIR 58
           +K L    K  +  E+  L ++   PNII L D  +        LV E     +     +
Sbjct: 65  VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124

Query: 59  LHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
               + +   R ++ ++   L+  +S  I+HRD+KP N+++    +   L++ D+GL+  
Sbjct: 125 ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEF 179

Query: 117 LYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            +PG        S  +  PE+ + +Q YD  +DMWS+G +L  ++    PF  G ++ 
Sbjct: 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 5e-37
 Identities = 50/192 (26%), Positives = 78/192 (40%), Gaps = 22/192 (11%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           M +  +K        EL  L  + +HPNII L  A +    ++L +E+   GNL  ++R 
Sbjct: 45  MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 104

Query: 60  H----------------GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD 101
                              +  Q    F   +  G++ L+    IHRDL   NIL+    
Sbjct: 105 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---G 161

Query: 102 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 161
           ++ + KIADFGLS                 +MA E L +  Y    D+WS G +L+E+++
Sbjct: 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221

Query: 162 GYPPFSVGEEHQ 173
                  G    
Sbjct: 222 LGGTPYCGMTCA 233

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 7e-37
 Identities = 41/200 (20%), Positives = 75/200 (37%), Gaps = 29/200 (14%)

Query: 2   LKKLNKHLKSCL--DCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSS 55
           +K  +   +     + E+     + H NI+    A   +N     ++LV ++   G+L  
Sbjct: 31  VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 90

Query: 56  YIRLHGRVPEQTARKFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVML 106
           Y+  +    E   +  L             +       I HRDLK +NIL+     +   
Sbjct: 91  YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTC 147

Query: 107 KIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAI 155
            IAD GL+                  G+  YMAPEVL            ++ D++++G +
Sbjct: 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207

Query: 156 LFELLNGYPPFSVGEEHQFM 175
            +E+        + E++Q  
Sbjct: 208 FWEIARRCSIGGIHEDYQLP 227

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 1e-36
 Identities = 41/180 (22%), Positives = 78/180 (43%), Gaps = 12/180 (6%)

Query: 2   LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K L     S      E   +  + H  +++L+     E  I++V E+ + G+L  +++ 
Sbjct: 46  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKG 104

Query: 60  HGRVP--EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
                           Q+  G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+ 
Sbjct: 105 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 161

Query: 116 TLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            +    Y   +       + APE   + R+  K D+WS G +L EL         G  ++
Sbjct: 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-36
 Identities = 51/188 (27%), Positives = 79/188 (42%), Gaps = 18/188 (9%)

Query: 2   LKKLNKHLKS------CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L   + S          E+N + S++H N+IRL+        + +V E    G+L  
Sbjct: 41  VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLD 99

Query: 56  YIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
            +R H G     T  ++  Q+  G+  L S   IHRDL   N+LL       ++KI DFG
Sbjct: 100 RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFG 156

Query: 113 LSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 167
           L   L   +      E       + APE L+ + +    D W  G  L+E+   G  P+ 
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216

Query: 168 VGEEHQFM 175
                Q +
Sbjct: 217 GLNGSQIL 224

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 5e-36
 Identities = 55/168 (32%), Positives = 79/168 (47%), Gaps = 11/168 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTAR 69
            L  L +  HPN++RLFD         E  + LV E       +   ++    VP +T +
Sbjct: 60  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119

Query: 70  KFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             + Q   GL+ L+SH ++HRDLKP+NIL+        +K+ADFGL+           V 
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVV 176

Query: 128 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
            +  Y APEVL    Y   VD+WSVG I  E+    P F    +   +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 5e-36
 Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 33/197 (16%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           + +K +   +  L  EL  ++ + +H NI+ L  A      I+L+ E+C  G+L +Y+R 
Sbjct: 75  LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS 134

Query: 60  H-----------------------GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPEN 94
                                     +  +    F  Q+  G+E L     +HRDL   N
Sbjct: 135 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194

Query: 95  ILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWS 151
           +L   +    ++KI DFGL+  +   +             +MAPE L    Y  K D+WS
Sbjct: 195 VL---VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 251

Query: 152 VGAILFELLN-GYPPFS 167
            G +L+E+ + G  P+ 
Sbjct: 252 YGILLWEIFSLGVNPYP 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 6e-36
 Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 9/166 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   ++SV++P++ RL           +      G  L         +  Q    +  Q+
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 130
             G+  L    ++HRDL   N+L+        +KI DFGL+  L        AE      
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEHQFM 175
            +MA E +  + Y  + D+WS G  ++EL+  G  P+      +  
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (311), Expect = 7e-36
 Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 11/180 (6%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K L +      +   E   +  + HPN+++L      E   +++ EF   GNL  Y+R 
Sbjct: 47  VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 106

Query: 60  HGR--VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
             R  V          Q+   +E L   + IHRDL   N L   + ++ ++K+ADFGLS 
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL---VGENHLVKVADFGLSR 163

Query: 116 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
            +    Y           + APE L + ++  K D+W+ G +L+E+         G +  
Sbjct: 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 1e-35
 Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 10/166 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E   +   +HP+I++L      EN +++++E C  G L S++      +   +   +  Q
Sbjct: 58  EALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSP 130
           L   L  L S   +HRD+   N+L+     +  +K+ DFGLS  +    Y  A K     
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173

Query: 131 LYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSVGEEHQFM 175
            +MAPE + F+R+    D+W  G  ++E+L +G  PF   + +  +
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 3e-35
 Identities = 42/182 (23%), Positives = 76/182 (41%), Gaps = 19/182 (10%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------AENCIFLVVEFCAGGNL 53
           ++   +        E+  L  + H N++ L +  +         +  I+LV +FC     
Sbjct: 45  MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 104

Query: 54  SSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
                +  +      ++ +Q L  GL  ++ + I+HRD+K  N+L+     D +LK+ADF
Sbjct: 105 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADF 161

Query: 112 GLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPP 165
           GL+           N       +  Y  PE+L  +R Y   +D+W  G I+ E+    P 
Sbjct: 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

Query: 166 FS 167
             
Sbjct: 222 MQ 223

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  121 bits (305), Expect = 6e-35
 Identities = 56/178 (31%), Positives = 89/178 (50%), Gaps = 7/178 (3%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E              G
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG 95

Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 118
            +   TA+ FL QL  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+     
Sbjct: 96  GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFGI 152

Query: 119 PGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
           P         +  Y AP+VL   ++Y   +D+WSVG I  E++NG P F    E   +
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 6e-35
 Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 16/185 (8%)

Query: 2   LKKLNKHLK----SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSY 56
           +K LN+       S    E   +   +HPN++ L     ++E    +V+ +   G+L ++
Sbjct: 60  VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119

Query: 57  IRLHGRVPEQTARKFL---QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           IR     P              G++ L S   +HRDL   N +L   D+   +K+ADFGL
Sbjct: 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGL 176

Query: 114 SCTLYPGNYAEK-----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 168
           +  +Y   +              +MA E LQ Q++  K D+WS G +L+EL+    P   
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236

Query: 169 GEEHQ 173
                
Sbjct: 237 DVNTF 241

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 9e-35
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 8/179 (4%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLH 60
           L    + + S    E++ L  +NHPNI++L D    EN ++LV EF              
Sbjct: 37  LDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL 96

Query: 61  GRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
             +P    + +L Q   GL   +SH ++HRDLKP+N+L+   + +  +K+ADFGL+    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFG 153

Query: 119 -PGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
            P         +  Y APE+L   +Y    VD+WS+G I  E++     F    E   +
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (303), Expect = 4e-34
 Identities = 58/182 (31%), Positives = 103/182 (56%), Gaps = 13/182 (7%)

Query: 2   LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L+K     L        E   L +VN P +++L  +F+  + +++V+E+ AGG + S
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130

Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           ++R  GR  E  AR +  Q+    E L+S  +I+RDLKPEN+L+   D    +++ DFG 
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGF 187

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           +  +    +   +CG+P  +APE++  + Y++ VD W++G +++E+  GYPPF   +  Q
Sbjct: 188 AKRVKGRTW--TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

Query: 174 FM 175
             
Sbjct: 246 IY 247

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  119 bits (298), Expect = 8e-34
 Identities = 44/205 (21%), Positives = 87/205 (42%), Gaps = 36/205 (17%)

Query: 2   LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K L +   + +      E   ++  ++PNI++L         + L+ E+ A G+L+ ++
Sbjct: 48  VKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 107

Query: 58  RLHGR------------------------VPEQTARKFLQQL--GLEILNSHHIIHRDLK 91
           R                            +         +Q+  G+  L+    +HRDL 
Sbjct: 108 RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167

Query: 92  PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVD 148
             N L   + +++++KIADFGLS  +Y  +Y +          +M PE + + RY  + D
Sbjct: 168 TRNCL---VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 224

Query: 149 MWSVGAILFELLNGYPPFSVGEEHQ 173
           +W+ G +L+E+ +       G  H+
Sbjct: 225 VWAYGVVLWEIFSYGLQPYYGMAHE 249

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 3e-33
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 15/186 (8%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY- 56
           +K L        +     E   +   +H NIIRL         + ++ E+   G L  + 
Sbjct: 41  IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 100

Query: 57  IRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
               G          L+ +  G++ L + + +HRDL   NIL+   + +++ K++DFGLS
Sbjct: 101 REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLS 157

Query: 115 CTLYPGNYAEKV----CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSVG 169
             L     A            + APE + ++++    D+WS G +++E++  G  P+   
Sbjct: 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217

Query: 170 EEHQFM 175
             H+ M
Sbjct: 218 SNHEVM 223

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  117 bits (293), Expect = 4e-33
 Identities = 34/186 (18%), Positives = 63/186 (33%), Gaps = 12/186 (6%)

Query: 2   LKKLNKHLKSC-LDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRL 59
           +K      K   L  E      +     I       AE +   +V+E         +   
Sbjct: 37  IKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC 96

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
             +   +T      Q+   +E ++S + IHRD+KP+N L+       ++ I DFGL+   
Sbjct: 97  SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156

Query: 118 YPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 169
                         + + G+  Y +           + D+ S+G +L     G  P+   
Sbjct: 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216

Query: 170 EEHQFM 175
           +     
Sbjct: 217 KAATKR 222

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 6e-33
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 15/162 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+  L    H NII + D  +A          +V    G +L   ++    +       F
Sbjct: 56  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYF 114

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEK 125
           L Q+  GL+ ++S +++HRDLKP N+L   L+    LKI DFGL+    P +    +  +
Sbjct: 115 LYQILRGLKYIHSANVLHRDLKPSNLL---LNTTCDLKICDFGLARVADPDHDHTGFLTE 171

Query: 126 VCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 166
              +  Y APE++   + Y + +D+WSVG IL E+L+  P F
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 1e-32
 Identities = 40/191 (20%), Positives = 79/191 (41%), Gaps = 22/191 (11%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K +N+      +     E + +   N  +++RL           +++E    G+L SY+
Sbjct: 55  IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 114

Query: 58  RLHGRV----------PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVM 105
           R                     +   ++  G+  LN++  +HRDL   N +   + +D  
Sbjct: 115 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFT 171

Query: 106 LKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 162
           +KI DFG++  +Y  +Y     K      +M+PE L+   +    D+WS G +L+E+   
Sbjct: 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231

Query: 163 YPPFSVGEEHQ 173
                 G  ++
Sbjct: 232 AEQPYQGLSNE 242

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 3e-32
 Identities = 54/167 (32%), Positives = 88/167 (52%), Gaps = 10/167 (5%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E   L  +   P ++ L  AFQ E  + L++++  GG L +++    R  E   + ++ +
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YPGNYAEKVCGSP 130
           +   LE L+   II+RD+K ENIL   LD +  + + DFGLS          A   CG+ 
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 131 LYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
            YMAP++++     +D+ VD WS+G +++ELL G  PF+V  E    
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 241

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  114 bits (286), Expect = 4e-32
 Identities = 27/179 (15%), Positives = 64/179 (35%), Gaps = 14/179 (7%)

Query: 2   LKKLNKHLKS-CLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K   +   +  L  E      +     I  ++   Q      LV++             
Sbjct: 35  IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC 94

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSC 115
             +   +T     +Q+   ++ ++   +++RD+KP+N L+      +  M+ + DFG+  
Sbjct: 95  GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154

Query: 116 TLYPG--------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
                           + + G+  YM+      +    + D+ ++G +    L G  P+
Sbjct: 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 213

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 2e-31
 Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 7/176 (3%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L   ++ + S    E+  L  + H NI+RL D   ++  + LV EFC       +   +G
Sbjct: 37  LDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG 96

Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 118
            +  +  + FL QL  GL   +S +++HRDLKP+N+L   ++ +  LK+A+FGL+     
Sbjct: 97  DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLARAFGI 153

Query: 119 PGNYAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 173
           P         +  Y  P+VL   + Y   +DMWS G I  EL N   P   G +  
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 3e-31
 Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 30/193 (15%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           +K L         S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y
Sbjct: 50  VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109

Query: 57  IRLHG----------------RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS 98
           ++                   ++  +       Q+  G+E L S   IHRDL   N+L  
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL-- 167

Query: 99  GLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 155
            + +D ++KIADFGL+  ++  +Y +K         +MAPE L  + Y  + D+WS G +
Sbjct: 168 -VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226

Query: 156 LFELLN-GYPPFS 167
           L+E+   G  P+ 
Sbjct: 227 LWEIFTLGGSPYP 239

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 4e-31
 Identities = 48/182 (26%), Positives = 72/182 (39%), Gaps = 27/182 (14%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------------- 58
           EL  LS + NH NI+ L  A        ++ E+C  G+L +++R                
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 59  --LHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                 +  +    F  Q+  G+  L S + IHRDL   NIL   L    + KI DFGL+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLA 192

Query: 115 CTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 171
             +   +             +MAPE +    Y  + D+WS G  L+EL +       G  
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 172 HQ 173
             
Sbjct: 253 VD 254

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 1e-30
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 21/186 (11%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +         +LV+ F   
Sbjct: 48  IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-- 105

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
           G     +  H ++ E   +  + Q+  GL  +++  IIHRDLKP N+ +   ++D  LKI
Sbjct: 106 GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKI 162

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 167
            DFGL+      +       +  Y APEV L + RY + VD+WSVG I+ E++ G   F 
Sbjct: 163 LDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220

Query: 168 VGEEHQ 173
             +   
Sbjct: 221 GSDHLD 226

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 6e-29
 Identities = 56/178 (31%), Positives = 82/178 (46%), Gaps = 19/178 (10%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  ++         EL  +  VNH NII L + F  +        ++LV+E    
Sbjct: 47  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 106

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
                   +   +  +     L Q+  G++ L+S  IIHRDLKP NI    +  D  LKI
Sbjct: 107 NLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI---VVKSDCTLKI 160

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 166
            DFGL+ T            +  Y APEV+    Y E VD+WSVG I+ E++     F
Sbjct: 161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 1e-27
 Identities = 56/178 (31%), Positives = 92/178 (51%), Gaps = 19/178 (10%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F       E     +V    G 
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 107

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+ +   ++D  LKI 
Sbjct: 108 DLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKIL 163

Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 166
           DFGL+   +  +       +  Y APE+ L +  Y++ VD+WSVG I+ ELL G   F
Sbjct: 164 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 6e-27
 Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 30/197 (15%)

Query: 2   LKKLNKH-----LKSCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSS 55
           +K L +       ++ +      +   +H N++ L  A  +    + ++VEFC  GNLS+
Sbjct: 48  VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 107

Query: 56  YIRLHGR----------------VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILL 97
           Y+R                    +  +    +  Q+  G+E L S   IHRDL   NILL
Sbjct: 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167

Query: 98  SGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGA 154
               +  ++KI DFGL+  +Y      +         +MAPE +  + Y  + D+WS G 
Sbjct: 168 ---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224

Query: 155 ILFELLNGYPPFSVGEE 171
           +L+E+ +       G +
Sbjct: 225 LLWEIFSLGASPYPGVK 241

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 93.2 bits (230), Expect = 1e-23
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 13/180 (7%)

Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGN---LSSYIRLHG 61
           K L+   D +     S+   +I++L D F     N + +V+ F   G           H 
Sbjct: 61  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 120

Query: 62  RVPEQTARKFLQQL--GLEILNSHH-IIHRDLKPENILLSGLD---DDVMLKIADFGLSC 115
            +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D   + + +KIAD G +C
Sbjct: 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 175
                        +  Y +PEVL    +    D+WS   ++FEL+ G   F   E H + 
Sbjct: 181 WYDEHYT--NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 61.7 bits (149), Expect = 6e-13
 Identities = 20/147 (13%), Positives = 46/147 (31%), Gaps = 29/147 (19%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--G 76
            L  +    + +++          +++E               RV  +   + L  +   
Sbjct: 67  ALQKLQGLAVPKVYAWEG----NAVLMELIDAKE-------LYRVRVENPDEVLDMILEE 115

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE 136
           +       I+H DL   N+L+     +  + I DF  S  +    + E        +  +
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVGEEGWRE-------ILERD 164

Query: 137 VLQF-----QRYDEKVDMWSVGAILFE 158
           V        + Y  + D+ S    + +
Sbjct: 165 VRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	175
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.71
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.88
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.87
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.7
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.51
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.3
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.61

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-45  Score=263.03  Aligned_cols=161  Identities=34%  Similarity=0.641  Sum_probs=146.9

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .....+.+|++++++++||||+++++++.+++..++||||++|++|.+++.+.+.+++..+..++.|+  ||+|||++|+
T Consensus        48 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~i  127 (263)
T d2j4za1          48 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV  127 (263)
T ss_dssp             TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567889999999999999999999999999999999999999999999988999999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +||||||+||++   +.++.++|+|||++....... .....||+.|+|||.+.+..++.++|+||+||++|+|++|+.|
T Consensus       128 vHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~P  203 (263)
T d2j4za1         128 IHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP  203 (263)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             eeeeecccccee---cCCCCEeecccceeeecCCCc-ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCC
Confidence            999999999999   577889999999997765443 3456789999999999999999999999999999999999999


Q ss_pred             CCCCCcc
Q 030527          166 FSVGEEH  172 (175)
Q Consensus       166 f~~~~~~  172 (175)
                      |.+.+..
T Consensus       204 f~~~~~~  210 (263)
T d2j4za1         204 FEANTYQ  210 (263)
T ss_dssp             TCCSSHH
T ss_pred             CCCCCHH
Confidence            9876543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-45  Score=269.45  Aligned_cols=163  Identities=38%  Similarity=0.713  Sum_probs=133.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|++++++++||||+++++++.+++..++||||++|++|.+++.+.+.+++..+..++.|+  ||+|||++|++
T Consensus        50 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii  129 (307)
T d1a06a_          50 KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV  129 (307)
T ss_dssp             -----CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceee
Confidence            3456788999999999999999999999999999999999999999999988899999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      ||||||+||++...+.++.++|+|||++.............||+.|+|||.+.+..++.++|+||+||++|+|++|+.||
T Consensus       130 HrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf  209 (307)
T d1a06a_         130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF  209 (307)
T ss_dssp             CSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             eEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCC
Confidence            99999999999655567889999999998776666556677999999999999999999999999999999999999999


Q ss_pred             CCCCc
Q 030527          167 SVGEE  171 (175)
Q Consensus       167 ~~~~~  171 (175)
                      .+.+.
T Consensus       210 ~~~~~  214 (307)
T d1a06a_         210 YDEND  214 (307)
T ss_dssp             CCSSH
T ss_pred             CCCCH
Confidence            87653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=263.11  Aligned_cols=161  Identities=34%  Similarity=0.676  Sum_probs=144.1

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ....+.+|++++++++||||+++++++.+++..++||||++|++|.+++...+.+++..+..++.|+  ||+|||+.|++
T Consensus        51 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii  130 (288)
T d1uu3a_          51 KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGII  130 (288)
T ss_dssp             CHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEE
Confidence            3457899999999999999999999999999999999999999999999989999999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      ||||||+||++   +.++.++|+|||+++......   ......||+.|+|||.+.+..++.++|+||+||++|+|++|+
T Consensus       131 HrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~  207 (288)
T d1uu3a_         131 HRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL  207 (288)
T ss_dssp             CSCCSGGGEEE---CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             cCcCCcccccc---CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCC
Confidence            99999999999   577889999999998775432   233456899999999999999999999999999999999999


Q ss_pred             CCCCCCCcc
Q 030527          164 PPFSVGEEH  172 (175)
Q Consensus       164 ~pf~~~~~~  172 (175)
                      .||.+.+..
T Consensus       208 ~Pf~~~~~~  216 (288)
T d1uu3a_         208 PPFRAGNEY  216 (288)
T ss_dssp             CSSCCSSHH
T ss_pred             CCCCCcCHH
Confidence            999876543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-44  Score=259.10  Aligned_cols=160  Identities=31%  Similarity=0.603  Sum_probs=144.7

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+++.+ +.+++.++..++.|+  ||+|||++|+
T Consensus        59 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~i  137 (293)
T d1yhwa1          59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV  137 (293)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3456789999999999999999999999999999999999999999998775 579999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +||||||+||++   +.++.++|+|||++....... ......||+.|+|||.+.+..++.++|+||+||++|+|++|+.
T Consensus       138 iHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~  214 (293)
T d1yhwa1         138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP  214 (293)
T ss_dssp             ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cccCCcHHHeEE---CCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence            999999999999   567889999999998875443 3455678999999999999899999999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.++
T Consensus       215 Pf~~~~~  221 (293)
T d1yhwa1         215 PYLNENP  221 (293)
T ss_dssp             TTTTSCH
T ss_pred             CCCCCCH
Confidence            9987553

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=260.57  Aligned_cols=160  Identities=36%  Similarity=0.658  Sum_probs=142.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ..+.+.+|++++++++||||+++++++.+++..++||||+.|++|.+++.+.+.+++..+..++.|+  ||+|||++|++
T Consensus        46 ~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~Ii  125 (271)
T d1nvra_          46 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT  125 (271)
T ss_dssp             ---CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCc
Confidence            3567899999999999999999999999999999999999999999999888889999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHhC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~g  162 (175)
                      ||||||+||++   +.++.++|+|||+|+......   ......||+.|+|||.+.+.++ +.++|+||+|+++|+|++|
T Consensus       126 HrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G  202 (271)
T d1nvra_         126 HRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  202 (271)
T ss_dssp             CSCCCGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             cCcccHHHEEE---CCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence            99999999999   567789999999998764332   2345678999999999987775 6789999999999999999


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      +.||...++
T Consensus       203 ~~pf~~~~~  211 (271)
T d1nvra_         203 ELPWDQPSD  211 (271)
T ss_dssp             SCSCSSSST
T ss_pred             CCCCCCCCh
Confidence            999976544

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=265.73  Aligned_cols=162  Identities=33%  Similarity=0.569  Sum_probs=145.5

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ++..+.++.+|++++++++||||+++++++.+.+..++||||+.|++|.+++.+.+.+++..+..++.|+  ||+|||++
T Consensus        44 ~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~  123 (322)
T d1s9ja_          44 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK  123 (322)
T ss_dssp             CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            3455678899999999999999999999999999999999999999999999988999999999999998  99999975


Q ss_pred             -CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhC
Q 030527           84 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        84 -~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g  162 (175)
                       |++||||||+||++   +.++.++|+|||+|....+.. .....||+.|+|||.+.+..++.++|+||+||++|+|++|
T Consensus       124 ~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G  199 (322)
T d1s9ja_         124 HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG  199 (322)
T ss_dssp             HCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHHT-C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred             CCEEccccCHHHeeE---CCCCCEEEeeCCCccccCCCc-cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHC
Confidence             99999999999999   577889999999998764332 3356789999999999999999999999999999999999


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      +.||.+.+.
T Consensus       200 ~~Pf~~~~~  208 (322)
T d1s9ja_         200 RYPIPPPDA  208 (322)
T ss_dssp             SCCSSCCCT
T ss_pred             CCCCCCCCH
Confidence            999987654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-44  Score=263.47  Aligned_cols=161  Identities=33%  Similarity=0.565  Sum_probs=147.9

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...++.+|+.++++++||||+++++++.+.+.+++||||++|++|.+++.+.+.+++..+..++.|+  ||+|||++|++
T Consensus        48 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~ii  127 (337)
T d1o6la_          48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV  127 (337)
T ss_dssp             CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCcc
Confidence            3466788999999999999999999999999999999999999999999999999999999999998  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccC-CCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      ||||||+||++   +.++.++|+|||+++.... ........||+.|+|||.+.+..++.++|+||+||++|+|++|+.|
T Consensus       128 HRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~p  204 (337)
T d1o6la_         128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  204 (337)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccCHHHeEe---cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCC
Confidence            99999999999   6778999999999987644 3344566789999999999999999999999999999999999999


Q ss_pred             CCCCCcc
Q 030527          166 FSVGEEH  172 (175)
Q Consensus       166 f~~~~~~  172 (175)
                      |.+.+..
T Consensus       205 f~~~~~~  211 (337)
T d1o6la_         205 FYNQDHE  211 (337)
T ss_dssp             SCCSSHH
T ss_pred             CCCcCHH
Confidence            9887654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-43  Score=251.88  Aligned_cols=161  Identities=33%  Similarity=0.642  Sum_probs=141.3

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEee----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      .....+.+.+|++++++++||||+++++++.+    .+..++||||+++++|.+++.+.+.+++..+..++.|+  ||+|
T Consensus        48 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~y  127 (270)
T d1t4ha_          48 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  127 (270)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHH
Confidence            44556788999999999999999999999865    45689999999999999999988999999999999999  9999


Q ss_pred             HHHcC--CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHH
Q 030527           80 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        80 lh~~~--~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~  157 (175)
                      ||+++  ++||||||+||++.  +.++.++|+|||+++..... ......||+.|+|||.+.+ .++.++||||+||++|
T Consensus       128 LH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvily  203 (270)
T d1t4ha_         128 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML  203 (270)
T ss_dssp             HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred             HHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHH
Confidence            99998  99999999999994  34678999999999754333 3445678999999998864 6999999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 030527          158 ELLNGYPPFSVGE  170 (175)
Q Consensus       158 ~~~~g~~pf~~~~  170 (175)
                      +|++|+.||.+..
T Consensus       204 el~~g~~Pf~~~~  216 (270)
T d1t4ha_         204 EMATSEYPYSECQ  216 (270)
T ss_dssp             HHHHSSCTTTTCS
T ss_pred             HHHHCCCCCCCcc
Confidence            9999999997654

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-44  Score=258.94  Aligned_cols=165  Identities=35%  Similarity=0.576  Sum_probs=144.5

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      +....+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+++.+. +.+++..+..++.|+  ||+|||+
T Consensus        49 ~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~  128 (288)
T d2jfla1          49 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD  128 (288)
T ss_dssp             SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3455678899999999999999999999999999999999999999999997654 579999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCccccc-----ccCCCcchhHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~  156 (175)
                      +|++||||||+||++   +.++.++|+|||++...... .......||+.|+|||.+.     +..++.++||||+||++
T Consensus       129 ~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvil  205 (288)
T d2jfla1         129 NKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL  205 (288)
T ss_dssp             TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHH
T ss_pred             CCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHH
Confidence            999999999999999   57788999999999766433 2233567899999999984     45678999999999999


Q ss_pred             HHHHhCCCCCCCCCccC
Q 030527          157 FELLNGYPPFSVGEEHQ  173 (175)
Q Consensus       157 ~~~~~g~~pf~~~~~~~  173 (175)
                      |+|++|+.||.+.++.+
T Consensus       206 yemltg~~Pf~~~~~~~  222 (288)
T d2jfla1         206 IEMAEIEPPHHELNPMR  222 (288)
T ss_dssp             HHHHHSSCTTTTSCGGG
T ss_pred             HHHhhCCCCCCCCCHHH
Confidence            99999999998765543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-43  Score=264.02  Aligned_cols=165  Identities=32%  Similarity=0.586  Sum_probs=148.8

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ......+.+|++++++++||||+++++++.+.+..++||||++|++|.+++.+ .+.+++..+..++.|+  ||+|||++
T Consensus        64 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~  143 (350)
T d1koaa2          64 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN  143 (350)
T ss_dssp             HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence            34566788999999999999999999999999999999999999999999854 4679999999999999  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCC
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~  163 (175)
                      |++||||||+||++.. +.++.++|+|||++.............||+.|+|||.+.+..++.++|+||+||++|+|++|.
T Consensus       144 ~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~  222 (350)
T d1koaa2         144 NYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL  222 (350)
T ss_dssp             TEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSS
T ss_pred             CCeeeeechhHeeecc-CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCC
Confidence            9999999999999941 235679999999999887776666788999999999999999999999999999999999999


Q ss_pred             CCCCCCCcc
Q 030527          164 PPFSVGEEH  172 (175)
Q Consensus       164 ~pf~~~~~~  172 (175)
                      .||.+.+..
T Consensus       223 ~Pf~~~~~~  231 (350)
T d1koaa2         223 SPFGGENDD  231 (350)
T ss_dssp             CSSCCSSHH
T ss_pred             CCCCCCCHH
Confidence            999876543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.3e-43  Score=258.60  Aligned_cols=158  Identities=39%  Similarity=0.710  Sum_probs=145.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      .+.+.+|+.++++++||||+++++++.+.+..++||||+.|+++.+++.....+++..+..++.|+  |++|||++|++|
T Consensus        48 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiH  127 (316)
T d1fota_          48 VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIY  127 (316)
T ss_dssp             HHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEc
Confidence            457889999999999999999999999999999999999999999999998999999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      |||||+||++   +.++.++|+|||++......  .....||+.|+|||.+.+..++.++|+||+||++|+|++|+.||.
T Consensus       128 rDiKp~NILl---~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~  202 (316)
T d1fota_         128 RDLKPENILL---DKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY  202 (316)
T ss_dssp             CCCCGGGEEE---CTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             cccCchheeE---cCCCCEEEecCccceEeccc--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCC
Confidence            9999999999   67889999999999887544  335678999999999998899999999999999999999999998


Q ss_pred             CCCcc
Q 030527          168 VGEEH  172 (175)
Q Consensus       168 ~~~~~  172 (175)
                      +.+..
T Consensus       203 ~~~~~  207 (316)
T d1fota_         203 DSNTM  207 (316)
T ss_dssp             CSSHH
T ss_pred             CcCHH
Confidence            76543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.5e-43  Score=262.51  Aligned_cols=164  Identities=30%  Similarity=0.579  Sum_probs=148.5

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ..+..+.+|++++++++||||+++++++.+++..++||||+.|++|.+++.+.+ ++++.++..++.|+  ||+|||++|
T Consensus        68 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~  147 (352)
T d1koba_          68 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS  147 (352)
T ss_dssp             HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            445678899999999999999999999999999999999999999999876554 69999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      ++||||||+||++.. ...+.++|+|||++.............+++.|+|||.+.+..++.++||||+||++|+|++|..
T Consensus       148 iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~  226 (352)
T d1koba_         148 IVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS  226 (352)
T ss_dssp             EECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred             eeecccccccccccc-cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCC
Confidence            999999999999941 2457899999999999877776777889999999999999999999999999999999999999


Q ss_pred             CCCCCCcc
Q 030527          165 PFSVGEEH  172 (175)
Q Consensus       165 pf~~~~~~  172 (175)
                      ||.+.+..
T Consensus       227 Pf~~~~~~  234 (352)
T d1koba_         227 PFAGEDDL  234 (352)
T ss_dssp             SSCCSSHH
T ss_pred             CCCCCCHH
Confidence            99876543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-43  Score=254.00  Aligned_cols=163  Identities=34%  Similarity=0.654  Sum_probs=147.9

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++++++++||||+++++++.+.+..++||||++|++|.+++.+.+.+++..+..++.|+  ||+|||+.|++|
T Consensus        57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivH  136 (293)
T d1jksa_          57 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH  136 (293)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceee
Confidence            567899999999999999999999999999999999999999999999988899999999999998  999999999999


Q ss_pred             cCCCCCcEEEeecC-CCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |||||+||++...+ ....++++|||++.............+++.|+|||.+.+..++.++|+||+||++|+|++|+.||
T Consensus       137 rDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf  216 (293)
T d1jksa_         137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF  216 (293)
T ss_dssp             CCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCC
Confidence            99999999995322 12369999999998887666666677899999999999888999999999999999999999999


Q ss_pred             CCCCcc
Q 030527          167 SVGEEH  172 (175)
Q Consensus       167 ~~~~~~  172 (175)
                      .+.+..
T Consensus       217 ~~~~~~  222 (293)
T d1jksa_         217 LGDTKQ  222 (293)
T ss_dssp             CCSSHH
T ss_pred             CCCCHH
Confidence            876543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-43  Score=252.00  Aligned_cols=164  Identities=35%  Similarity=0.696  Sum_probs=133.0

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHH--HH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GL   77 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i--~l   77 (175)
                      ++...+.+.+|++++++++||||+++++++.+  ++..++||||++|++|.+++.+    ...+++..+..++.|+  ||
T Consensus        43 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al  122 (269)
T d2java1          43 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL  122 (269)
T ss_dssp             CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHH
Confidence            44556778999999999999999999999865  4568999999999999999864    3579999999999999  99


Q ss_pred             HHHHHcC-----CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHH
Q 030527           78 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWS  151 (175)
Q Consensus        78 ~~lh~~~-----~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~s  151 (175)
                      +|||++|     ++||||||+||++   +.++.++|+|||++....... ......||+.|+|||.+.+..++.++||||
T Consensus       123 ~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwS  199 (269)
T d2java1         123 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWS  199 (269)
T ss_dssp             HHHHHHCC---------CCGGGEEE---CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHH
T ss_pred             HHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHh
Confidence            9999987     9999999999999   577889999999998765443 334567899999999999889999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCcc
Q 030527          152 VGAILFELLNGYPPFSVGEEH  172 (175)
Q Consensus       152 lg~~~~~~~~g~~pf~~~~~~  172 (175)
                      +|+++|+|++|+.||.+.+..
T Consensus       200 lGvilyel~tg~~Pf~~~~~~  220 (269)
T d2java1         200 LGCLLYELCALMPPFTAFSQK  220 (269)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHH
T ss_pred             hCHHHHHHhhCCCCCCCCCHH
Confidence            999999999999999876543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-42  Score=257.73  Aligned_cols=157  Identities=34%  Similarity=0.654  Sum_probs=145.1

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ...+.+|++++++++||||+++++++.+.+..++|+|++.|++|.+++.+.+.+++..+..++.|+  ||+|||++|++|
T Consensus        85 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiH  164 (350)
T d1rdqe_          85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY  164 (350)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            456789999999999999999999999999999999999999999999988999999999999999  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS  167 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf~  167 (175)
                      |||||+||++   +.++.++|+|||+++.....  .....||+.|+|||.+.+..++.++|+|||||++|+|++|+.||.
T Consensus       165 RDIKP~NILl---~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  239 (350)
T d1rdqe_         165 RDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF  239 (350)
T ss_dssp             CCCSGGGEEE---CTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CcCCHHHccc---CCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC
Confidence            9999999999   57789999999999887544  335568999999999999999999999999999999999999998


Q ss_pred             CCCc
Q 030527          168 VGEE  171 (175)
Q Consensus       168 ~~~~  171 (175)
                      +.+.
T Consensus       240 ~~~~  243 (350)
T d1rdqe_         240 ADQP  243 (350)
T ss_dssp             CSSH
T ss_pred             CcCH
Confidence            7654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-42  Score=252.38  Aligned_cols=158  Identities=33%  Similarity=0.559  Sum_probs=141.6

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ...+.+.+|++++++++||||+++++++.+++..++||||+.++++..++...+++++..+..++.|+  ||+|||++|+
T Consensus        57 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~i  136 (309)
T d1u5ra_          57 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM  136 (309)
T ss_dssp             HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            34457889999999999999999999999999999999999999998888878899999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc---cCCCcchhHHHHHHHHHHHHhC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slg~~~~~~~~g  162 (175)
                      +||||||+||++   +.++.++|+|||++......   ....||+.|+|||.+.+   ..++.++||||+||++|+|++|
T Consensus       137 iHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g  210 (309)
T d1u5ra_         137 IHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER  210 (309)
T ss_dssp             BCCCCSGGGEEE---ETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             eccCCCcceEEE---CCCCCEEEeecccccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHC
Confidence            999999999999   47788999999999876433   34578999999999864   3588999999999999999999


Q ss_pred             CCCCCCCCc
Q 030527          163 YPPFSVGEE  171 (175)
Q Consensus       163 ~~pf~~~~~  171 (175)
                      ..||.+.+.
T Consensus       211 ~~Pf~~~~~  219 (309)
T d1u5ra_         211 KPPLFNMNA  219 (309)
T ss_dssp             SCTTTTSCH
T ss_pred             CCCCCCCCH
Confidence            999987543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-42  Score=253.61  Aligned_cols=164  Identities=25%  Similarity=0.491  Sum_probs=135.8

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      .+...++|.+|++++++++||||+++++++...+..++||||+++++|.+++.+. +.+++.++..++.|+  ||+|||+
T Consensus        67 ~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  146 (299)
T d1jpaa_          67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD  146 (299)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            3455678999999999999999999999999999999999999999999988875 579999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCcc------ccccCCCCccCcccccccCCCcchhHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~------~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~  156 (175)
                      +|++||||||+||++   +.++.++|+|||+++........      ....+++.|+|||.+.+..++.++||||||+++
T Consensus       147 ~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl  223 (299)
T d1jpaa_         147 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM  223 (299)
T ss_dssp             TTCCCSCCCGGGEEE---CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred             CCCccCccccceEEE---CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHH
Confidence            999999999999999   67889999999999876543221      123467889999999988999999999999999


Q ss_pred             HHHHh-CCCCCCCCCcc
Q 030527          157 FELLN-GYPPFSVGEEH  172 (175)
Q Consensus       157 ~~~~~-g~~pf~~~~~~  172 (175)
                      |||+| |+.||.+.++.
T Consensus       224 ~el~t~g~~Pf~~~~~~  240 (299)
T d1jpaa_         224 WEVMSYGERPYWDMTNQ  240 (299)
T ss_dssp             HHHHTTSCCTTTTCCHH
T ss_pred             HHHHhCCCCCCCCCCHH
Confidence            99998 89999876543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-42  Score=255.65  Aligned_cols=168  Identities=35%  Similarity=0.659  Sum_probs=146.2

Q ss_pred             ccccchhhhhhHHHHHHHHhh-CCCCCeeeEeeEEee----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHH
Q 030527            2 LKKLNKHLKSCLDCELNFLSS-VNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQ   74 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~   74 (175)
                      +|.++.  ...+.+|+.++.+ .+||||+++++++.+    ++.+++||||++|++|.+++.+.+  .+++.++..++.|
T Consensus        42 iK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~q  119 (335)
T d2ozaa1          42 LKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS  119 (335)
T ss_dssp             EEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHH
T ss_pred             EEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHH
Confidence            555543  3456789988665 489999999999875    467899999999999999998653  6999999999999


Q ss_pred             H--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHH
Q 030527           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  152 (175)
Q Consensus        75 i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl  152 (175)
                      +  ||+|||++|++||||||+||++...+..+.++|+|||+++............||+.|+|||.+.+..++.++|+||+
T Consensus       120 i~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSl  199 (335)
T d2ozaa1         120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL  199 (335)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHH
T ss_pred             HHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhh
Confidence            9  99999999999999999999996444567799999999998877766677889999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCc
Q 030527          153 GAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       153 g~~~~~~~~g~~pf~~~~~  171 (175)
                      ||++|+|++|+.||.+.+.
T Consensus       200 Gvily~lltg~~Pf~~~~~  218 (335)
T d2ozaa1         200 GVIMYILLCGYPPFYSNHG  218 (335)
T ss_dssp             HHHHHHHTTSSCSCEETTC
T ss_pred             chhHHHHhhCCCCCCCCCH
Confidence            9999999999999976543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-41  Score=245.20  Aligned_cols=161  Identities=42%  Similarity=0.803  Sum_probs=146.1

Q ss_pred             hhhhHHHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .+.++.+|+.++++++ ||||+++++++.+++..++||||++|++|.++++..+.+++.++..++.|+  ||+|||++|+
T Consensus        52 ~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~i  131 (277)
T d1phka_          52 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNI  131 (277)
T ss_dssp             HHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC
Confidence            3456888999999996 999999999999999999999999999999999988999999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc------cCCCcchhHHHHHHHHHHH
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~Di~slg~~~~~~  159 (175)
                      +||||||+||++   +.++.++|+|||++.............||..|+|||.+.+      ..++.++|+||+|+++|+|
T Consensus       132 vHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyem  208 (277)
T d1phka_         132 VHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL  208 (277)
T ss_dssp             ECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred             cccccccceEEE---cCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhh
Confidence            999999999999   6788899999999998876655556778999999999853      3468899999999999999


Q ss_pred             HhCCCCCCCCCcc
Q 030527          160 LNGYPPFSVGEEH  172 (175)
Q Consensus       160 ~~g~~pf~~~~~~  172 (175)
                      ++|+.||.+.++.
T Consensus       209 l~g~~Pf~~~~~~  221 (277)
T d1phka_         209 LAGSPPFWHRKQM  221 (277)
T ss_dssp             HHSSCSSCCSSHH
T ss_pred             ccCCCCCCCCCHH
Confidence            9999999887643

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-42  Score=249.03  Aligned_cols=162  Identities=28%  Similarity=0.519  Sum_probs=141.6

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      +..+++|.+|++++++++||||+++++++..+ ..++||||+++++|.+++.+...+++..+..++.|+  ||+|||+.|
T Consensus        49 ~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~  127 (277)
T d1xbba_          49 PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN  127 (277)
T ss_dssp             CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC
Confidence            34466899999999999999999999998654 578999999999999999988899999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      ++||||||+||++   +.++.++++|||+++.......    .....+|+.|+|||.+.+..++.++||||||+++|||+
T Consensus       128 iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell  204 (277)
T d1xbba_         128 FVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF  204 (277)
T ss_dssp             EECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             cccCCCcchhhcc---cccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence            9999999999999   4678899999999987654422    22356788999999999888999999999999999999


Q ss_pred             h-CCCCCCCCCcc
Q 030527          161 N-GYPPFSVGEEH  172 (175)
Q Consensus       161 ~-g~~pf~~~~~~  172 (175)
                      + |+.||.+.+..
T Consensus       205 t~g~~Pf~~~~~~  217 (277)
T d1xbba_         205 SYGQKPYRGMKGS  217 (277)
T ss_dssp             TTTCCSSTTCCHH
T ss_pred             hCCCCCCCCCCHH
Confidence            8 89999876543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-42  Score=252.13  Aligned_cols=163  Identities=29%  Similarity=0.544  Sum_probs=147.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|++++++++||||+++++++.+++.+++||||+.|++|.+++.+.+ .+++.++..++.|+  ||+|||++|+
T Consensus        44 ~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~i  123 (321)
T d1tkia_          44 DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI  123 (321)
T ss_dssp             HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Confidence            34567899999999999999999999999999999999999999999998665 79999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      +||||||+||++.. +....++++|||++.............+++.|+|||...+..++.++|+||+||++|+|++|..|
T Consensus       124 iHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~P  202 (321)
T d1tkia_         124 GHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP  202 (321)
T ss_dssp             ECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCT
T ss_pred             CcccccccceeecC-CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCC
Confidence            99999999999941 23457999999999888776666677889999999999988999999999999999999999999


Q ss_pred             CCCCCcc
Q 030527          166 FSVGEEH  172 (175)
Q Consensus       166 f~~~~~~  172 (175)
                      |.+.+..
T Consensus       203 f~~~~~~  209 (321)
T d1tkia_         203 FLAETNQ  209 (321)
T ss_dssp             TCCSSHH
T ss_pred             CCCCCHH
Confidence            9887643

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=245.93  Aligned_cols=162  Identities=30%  Similarity=0.517  Sum_probs=136.5

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ++...+.|.+|++++++++||||+++++++.+ +..++||||+++++|.+++... ..+++..+..++.|+  ||+|||+
T Consensus        44 ~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~  122 (276)
T d1uwha_          44 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA  122 (276)
T ss_dssp             CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            45556789999999999999999999998754 5579999999999999999765 569999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccc---cCCCcchhHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAIL  156 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slg~~~  156 (175)
                      +|++||||||+||++   +.++.++|+|||+++......   ......||+.|+|||.+.+   ..++.++||||+|+++
T Consensus       123 ~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l  199 (276)
T d1uwha_         123 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL  199 (276)
T ss_dssp             TTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHH
T ss_pred             CCEeccccCHHHEEE---cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHH
Confidence            999999999999999   577889999999997664332   2334568999999999864   3478999999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030527          157 FELLNGYPPFSVGEE  171 (175)
Q Consensus       157 ~~~~~g~~pf~~~~~  171 (175)
                      |+|+||+.||.+.++
T Consensus       200 ~el~tg~~Pf~~~~~  214 (276)
T d1uwha_         200 YELMTGQLPYSNINN  214 (276)
T ss_dssp             HHHHHSSCTTTTCCC
T ss_pred             HHHHHCCCCCCCCCh
Confidence            999999999987554

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-41  Score=250.00  Aligned_cols=159  Identities=38%  Similarity=0.676  Sum_probs=142.3

Q ss_pred             hhHHHHHHHHh-hCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           11 SCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        11 ~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      ..+..|..++. .++||||+++++++.+++..++||||++|++|.+++...+.+++.++..++.|+  ||+|||++|++|
T Consensus        47 ~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiH  126 (320)
T d1xjda_          47 ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVY  126 (320)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            34556666655 689999999999999999999999999999999999988999999999999999  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHhCCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF  166 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~g~~pf  166 (175)
                      |||||+||++   +..+.++|+|||++....... ......||+.|+|||.+.+..++.++|+||+||++|+|++|+.||
T Consensus       127 rDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF  203 (320)
T d1xjda_         127 RDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF  203 (320)
T ss_dssp             CCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCcccceee---cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCC
Confidence            9999999999   678889999999998765433 334467899999999999999999999999999999999999999


Q ss_pred             CCCCcc
Q 030527          167 SVGEEH  172 (175)
Q Consensus       167 ~~~~~~  172 (175)
                      .+.+..
T Consensus       204 ~~~~~~  209 (320)
T d1xjda_         204 HGQDEE  209 (320)
T ss_dssp             CCSSHH
T ss_pred             CCCCHH
Confidence            876654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=244.62  Aligned_cols=167  Identities=27%  Similarity=0.534  Sum_probs=135.4

Q ss_pred             ccccc--hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--H
Q 030527            2 LKKLN--KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G   76 (175)
Q Consensus         2 lk~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~   76 (175)
                      ||.++  .....+|.+|++++++++||||+++++++...+..++||||+++++|.+++... ..+++..+..++.|+  |
T Consensus        34 vK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~g  113 (263)
T d1sm2a_          34 IKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG  113 (263)
T ss_dssp             EEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHH
T ss_pred             EEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHH
Confidence            45443  334567999999999999999999999999999999999999999999998755 568999999999999  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHH
Q 030527           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  154 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~  154 (175)
                      |+|||+.+++||||||+||++   +.++.++|+|||+++.......  .....++..|+|||.+.+..++.++||||+|+
T Consensus       114 l~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gv  190 (263)
T d1sm2a_         114 MAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV  190 (263)
T ss_dssp             HHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHH
T ss_pred             HHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHH
Confidence            999999999999999999999   6788999999999987654432  23456789999999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCc
Q 030527          155 ILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       155 ~~~~~~~-g~~pf~~~~~  171 (175)
                      ++||++| |.+||...+.
T Consensus       191 il~el~t~~~~~~~~~~~  208 (263)
T d1sm2a_         191 LMWEVFSEGKIPYENRSN  208 (263)
T ss_dssp             HHHHHHTTSCCTTCSCCH
T ss_pred             HHHHHHHCCCCCCCCCCH
Confidence            9999999 5777765543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-41  Score=246.20  Aligned_cols=163  Identities=29%  Similarity=0.526  Sum_probs=141.9

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      ++...++|.+|++++++++||||+++++++..+ ..++||||+++++|.+++... ..+++..+..++.|+  ||+|||+
T Consensus        49 ~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~  127 (285)
T d1u59a_          49 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE  127 (285)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            345567899999999999999999999998654 578999999999999998654 579999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      +|++||||||+||++   +.++.++|+|||+++.......    .....+++.|+|||.+.+..++.++||||+|+++||
T Consensus       128 ~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E  204 (285)
T d1u59a_         128 KNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE  204 (285)
T ss_dssp             TTEECCCCSGGGEEE---EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred             CCeecCcCchhheee---ccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHH
Confidence            999999999999999   4677899999999987754432    223457888999999998899999999999999999


Q ss_pred             HHh-CCCCCCCCCcc
Q 030527          159 LLN-GYPPFSVGEEH  172 (175)
Q Consensus       159 ~~~-g~~pf~~~~~~  172 (175)
                      |+| |+.||.+.+..
T Consensus       205 ~lt~G~~Pf~~~~~~  219 (285)
T d1u59a_         205 ALSYGQKPYKKMKGP  219 (285)
T ss_dssp             HHTTSCCTTTTCCTH
T ss_pred             HHhCCCCCCCCCCHH
Confidence            998 89999876543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.6e-40  Score=248.41  Aligned_cols=152  Identities=34%  Similarity=0.619  Sum_probs=137.6

Q ss_pred             HHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCC
Q 030527           16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPE   93 (175)
Q Consensus        16 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~   93 (175)
                      |+++++.++||||+++++++.+.+..++||||++|++|.+++.+...+++..+..++.|+  ||+|||++|++||||||+
T Consensus        57 ~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~  136 (364)
T d1omwa3          57 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA  136 (364)
T ss_dssp             HHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccc
Confidence            466777889999999999999999999999999999999999988999999999999998  999999999999999999


Q ss_pred             cEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527           94 NILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus        94 ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ||++   +..+.++|+|||++....... .....||+.|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+.
T Consensus       137 NILl---~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~  211 (364)
T d1omwa3         137 NILL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT  211 (364)
T ss_dssp             GEEE---CSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred             eeEE---cCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence            9999   677889999999998775543 345678999999999864 5689999999999999999999999987654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.5e-41  Score=244.63  Aligned_cols=162  Identities=27%  Similarity=0.523  Sum_probs=136.9

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      +....++.+|++++++++||||+++++++...+    ..++||||+.|++|.+++.+.+.+++.++..++.|+  ||+||
T Consensus        48 ~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~l  127 (277)
T d1o6ya_          48 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS  127 (277)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence            444567899999999999999999999987643    479999999999999999988999999999999999  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC----ccccccCCCCccCcccccccCCCcchhHHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~  156 (175)
                      |++|++||||||+||++   +.++..+++|||.+.......    ......||+.|+|||.+.+..++.++|+||+|+++
T Consensus       128 H~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  204 (277)
T d1o6ya_         128 HQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL  204 (277)
T ss_dssp             HHTTEECCCCSGGGEEE---ETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             HhCCccCccccCccccc---CccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHH
Confidence            99999999999999999   477789999999886553332    23345689999999999988999999999999999


Q ss_pred             HHHHhCCCCCCCCCc
Q 030527          157 FELLNGYPPFSVGEE  171 (175)
Q Consensus       157 ~~~~~g~~pf~~~~~  171 (175)
                      |+|++|+.||.+.++
T Consensus       205 yelltG~~Pf~~~~~  219 (277)
T d1o6ya_         205 YEVLTGEPPFTGDSP  219 (277)
T ss_dssp             HHHHHSSCSCCCSSH
T ss_pred             HHHHhCCCCCCCcCH
Confidence            999999999987654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.6e-41  Score=244.22  Aligned_cols=165  Identities=27%  Similarity=0.432  Sum_probs=141.8

Q ss_pred             ccccc--hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--
Q 030527            2 LKKLN--KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--   75 (175)
Q Consensus         2 lk~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--   75 (175)
                      +|.++  ....++|.+|++++++++||||+++++++.+.+..++||||+++++|.+++.+.  ..+++..+..++.|+  
T Consensus        47 vK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~  126 (287)
T d1opja_          47 VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS  126 (287)
T ss_dssp             EEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHH
T ss_pred             EEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHH
Confidence            45543  334567899999999999999999999999999999999999999999999765  468999999999999  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      ||+|||++|++||||||+||++   +.++.++|+|||+++.......  .....++..|+|||.+.+..++.++||||+|
T Consensus       127 gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~G  203 (287)
T d1opja_         127 AMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG  203 (287)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHH
T ss_pred             HHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHH
Confidence            9999999999999999999999   6778999999999987654432  2234467889999999999999999999999


Q ss_pred             HHHHHHHhCCCCC-CCC
Q 030527          154 AILFELLNGYPPF-SVG  169 (175)
Q Consensus       154 ~~~~~~~~g~~pf-~~~  169 (175)
                      +++|+|++|..|| .+.
T Consensus       204 v~l~ell~~~~p~~~~~  220 (287)
T d1opja_         204 VLLWEIATYGMSPYPGI  220 (287)
T ss_dssp             HHHHHHHTTSCCSSTTC
T ss_pred             HHHHHHHhCCCCCCCcc
Confidence            9999999965554 443

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-41  Score=247.67  Aligned_cols=163  Identities=29%  Similarity=0.512  Sum_probs=140.9

Q ss_pred             chhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-----------------------
Q 030527            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------------------   61 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------   61 (175)
                      +......+.+|+++++++ +||||+++++++.+.+..++||||+++++|.+++.+..                       
T Consensus        80 ~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (325)
T d1rjba_          80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN  159 (325)
T ss_dssp             ----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred             CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccC
Confidence            344556788999999998 89999999999999999999999999999999997542                       


Q ss_pred             CCCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcc
Q 030527           62 RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPE  136 (175)
Q Consensus        62 ~l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe  136 (175)
                      .+++..+..++.|+  ||+|||++|++||||||+||++   +.++.++|+|||+|+.......   .....+|+.|+|||
T Consensus       160 ~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE  236 (325)
T d1rjba_         160 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE  236 (325)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChH
Confidence            48899999999999  9999999999999999999999   5778999999999977654432   23455688999999


Q ss_pred             cccccCCCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          137 VLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       137 ~~~~~~~~~~~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      .+.+..++.++||||+|+++|+|++ |..||.+.+.
T Consensus       237 ~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         237 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             HHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999999998 8999987654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-41  Score=244.59  Aligned_cols=159  Identities=36%  Similarity=0.508  Sum_probs=140.7

Q ss_pred             hhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCee
Q 030527           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (175)
Q Consensus        10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h   87 (175)
                      .+.+.+|++++++++||||+++++++..++..++||||+.++++..+......+++..+..++.|+  ||+|||++|++|
T Consensus        44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiH  123 (299)
T d1ua2a_          44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH  123 (299)
T ss_dssp             CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceec
Confidence            456889999999999999999999999999999999999887777776666789999999999999  999999999999


Q ss_pred             cCCCCCcEEEeecCCCceEEEeeecceeeccCCC-ccccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCCCC
Q 030527           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP  165 (175)
Q Consensus        88 ~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~~p  165 (175)
                      |||||+||++   +..+.++|+|||++....... ......+|+.|+|||.+... .++.++|+||+||++|+|++|+.|
T Consensus       124 rDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p  200 (299)
T d1ua2a_         124 RDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF  200 (299)
T ss_dssp             CCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCcceEEe---cCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCC
Confidence            9999999999   678899999999998765443 33456689999999988644 579999999999999999999999


Q ss_pred             CCCCCc
Q 030527          166 FSVGEE  171 (175)
Q Consensus       166 f~~~~~  171 (175)
                      |.+.++
T Consensus       201 f~~~~~  206 (299)
T d1ua2a_         201 LPGDSD  206 (299)
T ss_dssp             SCCSSH
T ss_pred             CCCCCH
Confidence            987654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-40  Score=236.14  Aligned_cols=168  Identities=25%  Similarity=0.498  Sum_probs=146.2

Q ss_pred             cccc--chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--H
Q 030527            2 LKKL--NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G   76 (175)
Q Consensus         2 lk~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~   76 (175)
                      ||.+  +....+.|.+|+.++++++||||+++++++.+++..++||||+.++++.+++... ..+++..+..++.|+  |
T Consensus        33 vK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~g  112 (258)
T d1k2pa_          33 IKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA  112 (258)
T ss_dssp             EEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHH
T ss_pred             EEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHH
Confidence            4544  3345678999999999999999999999999999999999999999999997654 578999999999999  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHH
Q 030527           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA  154 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~  154 (175)
                      |+|||+.|++|+||+|+||++   +.++.++|+|||+++.......  .....++..|+|||.+.+..++.++||||||+
T Consensus       113 l~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~  189 (258)
T d1k2pa_         113 MEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV  189 (258)
T ss_dssp             HHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             HHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccch
Confidence            999999999999999999999   5778899999999976654432  22355788899999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCcc
Q 030527          155 ILFELLN-GYPPFSVGEEH  172 (175)
Q Consensus       155 ~~~~~~~-g~~pf~~~~~~  172 (175)
                      ++|||+| |+.||.+.+..
T Consensus       190 ~l~el~t~g~~Pf~~~~~~  208 (258)
T d1k2pa_         190 LMWEIYSLGKMPYERFTNS  208 (258)
T ss_dssp             HHHHHHTTSCCTTTTSCHH
T ss_pred             hhHhHHhcCCCCCCCCCHH
Confidence            9999998 89999876544

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-40  Score=239.62  Aligned_cols=165  Identities=25%  Similarity=0.495  Sum_probs=139.5

Q ss_pred             ccccc--hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH--
Q 030527            2 LKKLN--KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--   75 (175)
Q Consensus         2 lk~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i--   75 (175)
                      ||.++  ....+.|.+|++++++++||||+++++++.+ +..++||||+++++|.+++...  .++++..+..++.|+  
T Consensus        42 vK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~  120 (272)
T d1qpca_          42 VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE  120 (272)
T ss_dssp             EEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHH
T ss_pred             EEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHH
Confidence            45553  2345679999999999999999999998765 4578999999999999977543  369999999999999  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      ||+|||+.|++||||||+||++   +.++.++|+|||+++.......  .....+++.|+|||.+.+..++.++||||+|
T Consensus       121 gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~G  197 (272)
T d1qpca_         121 GMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG  197 (272)
T ss_dssp             HHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHH
T ss_pred             HHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhH
Confidence            9999999999999999999999   6788999999999987755432  2345678899999999888899999999999


Q ss_pred             HHHHHHHhC-CCCCCCCC
Q 030527          154 AILFELLNG-YPPFSVGE  170 (175)
Q Consensus       154 ~~~~~~~~g-~~pf~~~~  170 (175)
                      +++|+|+|| .+||...+
T Consensus       198 vvl~ellt~~~~~~~~~~  215 (272)
T d1qpca_         198 ILLTEIVTHGRIPYPGMT  215 (272)
T ss_dssp             HHHHHHHTTTCCSSTTCC
T ss_pred             HHHHHHHhCCCCCCCCCC
Confidence            999999995 55555543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=235.45  Aligned_cols=164  Identities=27%  Similarity=0.530  Sum_probs=132.4

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~   82 (175)
                      .+..+..+.+|++++++++||||+++++++. ++..++||||++++++.+++.+. +.+++..+..++.|+  ||+|||+
T Consensus        48 ~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~  126 (273)
T d1mp8a_          48 SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES  126 (273)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc
Confidence            3455677899999999999999999999986 46689999999999999987654 579999999999999  9999999


Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHH
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL  160 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~  160 (175)
                      .|++||||||+||++   +..+.++|+|||+++.......  .....+++.|+|||.+.+..++.++||||+|+++|+|+
T Consensus       127 ~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~l  203 (273)
T d1mp8a_         127 KRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL  203 (273)
T ss_dssp             TTCCCSCCSGGGEEE---EETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred             cCeeccccchhheee---cCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHH
Confidence            999999999999999   4677899999999987654322  23455788999999999899999999999999999999


Q ss_pred             h-CCCCCCCCCccC
Q 030527          161 N-GYPPFSVGEEHQ  173 (175)
Q Consensus       161 ~-g~~pf~~~~~~~  173 (175)
                      + |.+||.+.+..+
T Consensus       204 t~g~~P~~~~~~~~  217 (273)
T d1mp8a_         204 MHGVKPFQGVKNND  217 (273)
T ss_dssp             TTSCCTTTTCCGGG
T ss_pred             hcCCCCCCCCCHHH
Confidence            8 899998876544

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-39  Score=232.51  Aligned_cols=161  Identities=24%  Similarity=0.442  Sum_probs=133.5

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      +....+|.+|++++++++||||+++++++.+.+..++|+|++.++++.+++... ..+++.++..++.|+  |++|||+.
T Consensus        50 ~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~  129 (283)
T d1mqba_          50 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM  129 (283)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc
Confidence            344567899999999999999999999999999999999999999999988765 579999999999999  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      +++||||||+||++   +.++.++|+|||+++.......    .....+|..|+|||.+.+..++.++||||||+++|||
T Consensus       130 ~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el  206 (283)
T d1mqba_         130 NYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV  206 (283)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred             ccccCccccceEEE---CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHH
Confidence            99999999999999   6788999999999987644321    2234578899999999999999999999999999999


Q ss_pred             HhC-CCCCCCCC
Q 030527          160 LNG-YPPFSVGE  170 (175)
Q Consensus       160 ~~g-~~pf~~~~  170 (175)
                      +++ .+||...+
T Consensus       207 ~t~~~~~~~~~~  218 (283)
T d1mqba_         207 MTYGERPYWELS  218 (283)
T ss_dssp             HTTSCCTTTTCC
T ss_pred             HhCCCCccccCC
Confidence            996 54554433

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=233.77  Aligned_cols=167  Identities=26%  Similarity=0.503  Sum_probs=135.1

Q ss_pred             cccc-chhhhhhHHHHHHHHhhCCCCCeeeEeeEEee-CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHH--
Q 030527            2 LKKL-NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--   75 (175)
Q Consensus         2 lk~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i--   75 (175)
                      ||.+ ++...+.+.+|++++++++||||+++++++.+ ++..++||||+++++|.+++.+..  .+++..+..++.|+  
T Consensus        35 vK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~  114 (262)
T d1byga_          35 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE  114 (262)
T ss_dssp             EEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHh
Confidence            4555 33446779999999999999999999998854 566899999999999999997553  58999999999999  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  155 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~  155 (175)
                      |++|||+.+++|+||+|+||++   +.++.++++|||++......  .....++..|+|||.+.+..++.++||||||++
T Consensus       115 al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~i  189 (262)
T d1byga_         115 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL  189 (262)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             hccccccCceeccccchHhhee---cCCCCEeecccccceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHH
Confidence            9999999999999999999999   67888999999999876443  334557889999999998899999999999999


Q ss_pred             HHHHHh-CCCCCCCCCccC
Q 030527          156 LFELLN-GYPPFSVGEEHQ  173 (175)
Q Consensus       156 ~~~~~~-g~~pf~~~~~~~  173 (175)
                      +|||+| |..||...+..+
T Consensus       190 l~el~t~~~~p~~~~~~~~  208 (262)
T d1byga_         190 LWEIYSFGRVPYPRIPLKD  208 (262)
T ss_dssp             HHHHHTTSCCSCTTSCGGG
T ss_pred             HHHHHHCCCCCCCCCCHHH
Confidence            999998 799998765543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-39  Score=234.26  Aligned_cols=158  Identities=34%  Similarity=0.589  Sum_probs=137.2

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ...++.+|++++++++||||+++++++.+.+..++||||+.+ ++.+++..  ...+++..+..++.|+  ||+|||++|
T Consensus        44 ~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~  122 (298)
T d1gz8a_          44 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR  122 (298)
T ss_dssp             CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC
Confidence            356788999999999999999999999999999999999954 55555543  3569999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCC-CccccccCCCCccCcccccccC-CCcchhHHHHHHHHHHHHhC
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG  162 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~g  162 (175)
                      ++||||||+||++   +.++.++|+|||.+...... .......+++.|+|||.+.... .+.++|+||+|+++|+|++|
T Consensus       123 IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G  199 (298)
T d1gz8a_         123 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR  199 (298)
T ss_dssp             CCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             EEccccCchheee---cccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhC
Confidence            9999999999999   57778999999999777543 3344567899999999887665 58899999999999999999


Q ss_pred             CCCCCCCC
Q 030527          163 YPPFSVGE  170 (175)
Q Consensus       163 ~~pf~~~~  170 (175)
                      +.||.+.+
T Consensus       200 ~~Pf~~~~  207 (298)
T d1gz8a_         200 RALFPGDS  207 (298)
T ss_dssp             SCSCCCSS
T ss_pred             CCCCCCCC
Confidence            99998754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-39  Score=235.12  Aligned_cols=162  Identities=27%  Similarity=0.431  Sum_probs=138.5

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHcC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~~   84 (175)
                      ...++|.+|++++++++||||+++++++.+.+ .+++++++.+++|.+++... ..+++..+..++.|+  ||+|||++|
T Consensus        53 ~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~  131 (317)
T d1xkka_          53 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR  131 (317)
T ss_dssp             CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence            44668999999999999999999999998765 56778888899999988765 579999999999999  999999999


Q ss_pred             CeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHHHHHHHHHHh
Q 030527           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        85 ~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~  161 (175)
                      ++||||||+||++   +.++.++|+|||+++.......   .....+|..|+|||.+.+..++.++||||||+++|+|+|
T Consensus       132 iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t  208 (317)
T d1xkka_         132 LVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT  208 (317)
T ss_dssp             CCCSCCCGGGEEE---EETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             cccCcchhhccee---CCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHH
Confidence            9999999999999   4677899999999987654332   223457899999999999999999999999999999998


Q ss_pred             -CCCCCCCCCccC
Q 030527          162 -GYPPFSVGEEHQ  173 (175)
Q Consensus       162 -g~~pf~~~~~~~  173 (175)
                       |..||.+.+..+
T Consensus       209 ~g~~p~~~~~~~~  221 (317)
T d1xkka_         209 FGSKPYDGIPASE  221 (317)
T ss_dssp             TSCCTTTTSCGGG
T ss_pred             CCCCCCCCCCHHH
Confidence             899998766543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-39  Score=232.59  Aligned_cols=156  Identities=29%  Similarity=0.528  Sum_probs=137.2

Q ss_pred             hhHHHHHHHHhhCC--CCCeeeEeeEEeeCCeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527           11 SCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus        11 ~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      .++.+|+.++++++  ||||+++++++.+.+..++|||++.+ +++.+++.+...+++..+..++.|+  ||+|||++|+
T Consensus        52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~i  131 (273)
T d1xwsa_          52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV  131 (273)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            45678999999986  89999999999999999999999975 6888899888899999999999999  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCC-CcchhHHHHHHHHHHHHhCCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~g~~  164 (175)
                      +||||||+||+++  ...+.++|+|||++....... .....||+.|+|||.+.+..+ +.++|+||+||++|+|++|+.
T Consensus       132 iHrDiKp~NIll~--~~~~~vkl~DFG~a~~~~~~~-~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~  208 (273)
T d1xwsa_         132 LHRDIKDENILID--LNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI  208 (273)
T ss_dssp             ECSCCSGGGEEEE--TTTTEEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccccCcccceEEe--cCCCeEEECccccceeccccc-ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCC
Confidence            9999999999994  345789999999997664433 345678999999999986665 677999999999999999999


Q ss_pred             CCCCC
Q 030527          165 PFSVG  169 (175)
Q Consensus       165 pf~~~  169 (175)
                      ||.+.
T Consensus       209 Pf~~~  213 (273)
T d1xwsa_         209 PFEHD  213 (273)
T ss_dssp             SCCSH
T ss_pred             CCCCc
Confidence            99763

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-39  Score=235.59  Aligned_cols=162  Identities=30%  Similarity=0.484  Sum_probs=139.6

Q ss_pred             hhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHH
Q 030527            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTAR   69 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~   69 (175)
                      ....+.+.+|+++++++ +||||+++++++.+.+..++||||+++++|.+++.+.                ..+++..+.
T Consensus        51 ~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  130 (309)
T d1fvra_          51 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL  130 (309)
T ss_dssp             ----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHH
Confidence            34566899999999999 7999999999999999999999999999999998644                468999999


Q ss_pred             HHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcch
Q 030527           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV  147 (175)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~  147 (175)
                      .++.|+  |++|+|+.|++||||||+||++   +.++.++|+|||+++............++..|+|||.+.+..++.++
T Consensus       131 ~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~s  207 (309)
T d1fvra_         131 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS  207 (309)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHH
T ss_pred             HHHHHHHHHHHhhhcCCccccccccceEEE---cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccc
Confidence            999999  9999999999999999999999   67788999999999876555555566789999999999989999999


Q ss_pred             hHHHHHHHHHHHHhC-CCCCCCCCc
Q 030527          148 DMWSVGAILFELLNG-YPPFSVGEE  171 (175)
Q Consensus       148 Di~slg~~~~~~~~g-~~pf~~~~~  171 (175)
                      |+||||+++|+|++| ..||.+.+.
T Consensus       208 DvwSfGvil~ell~~~~~p~~~~~~  232 (309)
T d1fvra_         208 DVWSYGVLLWEIVSLGGTPYCGMTC  232 (309)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             eeehhHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999996 567876554

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-39  Score=231.88  Aligned_cols=165  Identities=23%  Similarity=0.417  Sum_probs=133.6

Q ss_pred             ccccchh--hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHH--
Q 030527            2 LKKLNKH--LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL--   75 (175)
Q Consensus         2 lk~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i--   75 (175)
                      +|.++..  ....|.+|+.++++++||||+++++++.+ +..++||||+.+++|..++..  ...+++.++..++.|+  
T Consensus        46 iK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~  124 (285)
T d1fmka3          46 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS  124 (285)
T ss_dssp             EEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHH
T ss_pred             EEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHH
Confidence            4555332  34679999999999999999999999865 457899999999999988864  3569999999999999  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC--ccccccCCCCccCcccccccCCCcchhHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG  153 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg  153 (175)
                      ||++||+.|++||||||+||++   +.++.++|+|||+++......  ......++..|+|||.+.+..++.++||||+|
T Consensus       125 gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~G  201 (285)
T d1fmka3         125 GMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG  201 (285)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred             HHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcch
Confidence            9999999999999999999999   577889999999997664432  22345678999999999999999999999999


Q ss_pred             HHHHHHHhC-CCCCCCCC
Q 030527          154 AILFELLNG-YPPFSVGE  170 (175)
Q Consensus       154 ~~~~~~~~g-~~pf~~~~  170 (175)
                      +++|+|++| .+||.+..
T Consensus       202 iil~el~t~~~p~~~~~~  219 (285)
T d1fmka3         202 ILLTELTTKGRVPYPGMV  219 (285)
T ss_dssp             HHHHHHHTTTCCSSTTCC
T ss_pred             HHHHHHHhCCCCCCCCCC
Confidence            999999996 55555443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-39  Score=230.72  Aligned_cols=162  Identities=29%  Similarity=0.449  Sum_probs=137.8

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ++..++|.+|++++++++||||+++++++.+. ..++|+||+.++++.+++... +.+++..+..++.|+  ||+|||++
T Consensus        52 ~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~  130 (273)
T d1u46a_          52 PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK  130 (273)
T ss_dssp             CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC
Confidence            34456889999999999999999999999764 578999999999999887654 579999999999999  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc----cccccCCCCccCcccccccCCCcchhHHHHHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL  159 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~  159 (175)
                      |++||||||+||+++   .++.++|+|||+++.......    .....++..|+|||.+.+..++.++|+||||+++|||
T Consensus       131 ~iiHrDikp~NIll~---~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~em  207 (273)
T d1u46a_         131 RFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM  207 (273)
T ss_dssp             TEECSCCCGGGEEEE---ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred             CEeeeeecHHHhccc---cccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHH
Confidence            999999999999994   567899999999988754432    2234467789999999998999999999999999999


Q ss_pred             Hh-CCCCCCCCCcc
Q 030527          160 LN-GYPPFSVGEEH  172 (175)
Q Consensus       160 ~~-g~~pf~~~~~~  172 (175)
                      +| |..||.+.+..
T Consensus       208 lt~G~~Pf~~~~~~  221 (273)
T d1u46a_         208 FTYGQEPWIGLNGS  221 (273)
T ss_dssp             HTTSCCTTTTCCHH
T ss_pred             HhCCCCCCCCcCHH
Confidence            98 89999876543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-38  Score=232.89  Aligned_cols=160  Identities=35%  Similarity=0.545  Sum_probs=136.8

Q ss_pred             hhhhHHHHHHHHhhC---CCCCeeeEeeEEee-----CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HH
Q 030527            9 LKSCLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GL   77 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l   77 (175)
                      ....+.+|+.+++.+   +||||+++++++..     ....++++|++.++++....... ..+++..+..++.|+  ||
T Consensus        50 ~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL  129 (305)
T d1blxa_          50 MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL  129 (305)
T ss_dssp             CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHH
Confidence            344667788877766   79999999999853     35789999999776665444433 569999999999998  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF  157 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~  157 (175)
                      +|||++|++||||||+||++   +..+.++++|||++.............||+.|+|||.+.+.+++.++|+||+||++|
T Consensus       130 ~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~  206 (305)
T d1blxa_         130 DFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA  206 (305)
T ss_dssp             HHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred             HHHHhCCEEecCCCccEEEE---cCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHH
Confidence            99999999999999999999   577889999999988776666666788999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCc
Q 030527          158 ELLNGYPPFSVGEE  171 (175)
Q Consensus       158 ~~~~g~~pf~~~~~  171 (175)
                      +|++|+.||.+.++
T Consensus       207 ell~g~~pf~~~~~  220 (305)
T d1blxa_         207 EMFRRKPLFRGSSD  220 (305)
T ss_dssp             HHHHSSCSCCCSSH
T ss_pred             HHHHCCCCCCCCCH
Confidence            99999999987654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-38  Score=230.60  Aligned_cols=163  Identities=25%  Similarity=0.501  Sum_probs=140.3

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC------------------------C
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------R   62 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------~   62 (175)
                      +....+|.+|++++++++||||+++++++...+..++++|++.+++|.+++....                        .
T Consensus        57 ~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  136 (301)
T d1lufa_          57 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP  136 (301)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred             hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCC
Confidence            3446679999999999999999999999999999999999999999999986432                        3


Q ss_pred             CCHHHHHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCccc
Q 030527           63 VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEV  137 (175)
Q Consensus        63 l~~~~~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~  137 (175)
                      ++...+..++.|+  |++|||+.+++||||||+||++   +.++.++|+|||+++......   ......+++.|+|||.
T Consensus       137 l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~  213 (301)
T d1lufa_         137 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  213 (301)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHH
Confidence            7889999999998  9999999999999999999999   678889999999997654332   2234567788999999


Q ss_pred             ccccCCCcchhHHHHHHHHHHHHhCC-CCCCCCCcc
Q 030527          138 LQFQRYDEKVDMWSVGAILFELLNGY-PPFSVGEEH  172 (175)
Q Consensus       138 ~~~~~~~~~~Di~slg~~~~~~~~g~-~pf~~~~~~  172 (175)
                      +.+..++.++||||||+++|+|++|. .||.+.++.
T Consensus       214 ~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         214 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             HccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            99999999999999999999999985 678776544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-37  Score=227.20  Aligned_cols=162  Identities=31%  Similarity=0.532  Sum_probs=142.1

Q ss_pred             hhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHH
Q 030527            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~   69 (175)
                      ......+.+|...+.++ +||||+++++++.+++..++||||+.+++|.+++....                .+++.++.
T Consensus        59 ~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~  138 (299)
T d1fgka_          59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV  138 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHH
Confidence            34456778899988888 89999999999999999999999999999999997542                48999999


Q ss_pred             HHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCC
Q 030527           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD  144 (175)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~  144 (175)
                      .++.|+  ||+|||+.+++||||||+||++   +.++.++|+|||++........   .....+++.|+|||.+.+..++
T Consensus       139 ~~~~qi~~al~ylH~~~ivHrDiKp~NiLl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~  215 (299)
T d1fgka_         139 SCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT  215 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHhhhCCEEeeeecccceee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC
Confidence            999999  9999999999999999999999   6788899999999987755432   2345678889999999999999


Q ss_pred             cchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          145 EKVDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       145 ~~~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      .++|+||||+++|+|++ |..||.+.+.
T Consensus       216 ~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         216 HQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             chhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            99999999999999998 7999986654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.6e-38  Score=226.61  Aligned_cols=160  Identities=33%  Similarity=0.521  Sum_probs=137.4

Q ss_pred             hhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCe
Q 030527            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~   86 (175)
                      ...++.+|+.++++++||||+++++++...+..+++++++.++.+..+.+..+.+++..+..++.|+  ||+|||+.|++
T Consensus        43 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~Iv  122 (286)
T d1ob3a_          43 IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL  122 (286)
T ss_dssp             CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEE
Confidence            3568899999999999999999999999999999999999777777776667889999999999999  99999999999


Q ss_pred             ecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCccccccc-CCCcchhHHHHHHHHHHHHhCCC
Q 030527           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP  164 (175)
Q Consensus        87 h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~g~~  164 (175)
                      ||||||+||++   +.++.++++|||.+........ .....+++.|+|||.+.+. .++.++|+||+|+++++|++|+.
T Consensus       123 HrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~  199 (286)
T d1ob3a_         123 HRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP  199 (286)
T ss_dssp             CSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ecCCCCceeeE---cCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCC
Confidence            99999999999   5778899999999987755432 3345678899999998755 46899999999999999999999


Q ss_pred             CCCCCCc
Q 030527          165 PFSVGEE  171 (175)
Q Consensus       165 pf~~~~~  171 (175)
                      ||.+.++
T Consensus       200 pf~~~~~  206 (286)
T d1ob3a_         200 LFPGVSE  206 (286)
T ss_dssp             SCCCSSH
T ss_pred             CCCCCCH
Confidence            9987643

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-38  Score=233.49  Aligned_cols=167  Identities=32%  Similarity=0.497  Sum_probs=136.7

Q ss_pred             ccccchhhhhhHHHHHHHHhhCCCCCeeeEeeEEee------CCeEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHH
Q 030527            2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKFL   72 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~---l~~~~~l~~~~~~~~~   72 (175)
                      ||.+..+ .....+|++++++++||||+++++++..      ..+.++||||++++.+..+   ......+++.++..++
T Consensus        50 iK~i~~~-~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~  128 (350)
T d1q5ka_          50 IKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM  128 (350)
T ss_dssp             EEEEECC-SSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHH
T ss_pred             EEEECcc-chHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHH
Confidence            5555433 3344679999999999999999999854      3357999999966533332   2334579999999999


Q ss_pred             HHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccc-cCCCcchhH
Q 030527           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDM  149 (175)
Q Consensus        73 ~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di  149 (175)
                      .|+  ||+|||++|++||||||+||+++  ..+..++|+|||++.............++..|+|||.+.+ ..++.++|+
T Consensus       129 ~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DI  206 (350)
T d1q5ka_         129 YQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV  206 (350)
T ss_dssp             HHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHH
T ss_pred             HHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceee
Confidence            999  99999999999999999999994  2345799999999988877666667788999999998765 468999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCc
Q 030527          150 WSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       150 ~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ||+||++|+|++|+.||...+.
T Consensus       207 wSlG~il~el~~g~~pf~~~~~  228 (350)
T d1q5ka_         207 WSAGCVLAELLLGQPIFPGDSG  228 (350)
T ss_dssp             HHHHHHHHHHHHTSCSSCCSSH
T ss_pred             cccceEEEehhhCCCCCCCCCH
Confidence            9999999999999999987653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-37  Score=228.67  Aligned_cols=162  Identities=33%  Similarity=0.585  Sum_probs=142.4

Q ss_pred             hhhhHHHHHHHHhhCCC-CCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            9 LKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         9 ~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....+.+|++++++++| |||+++.+++.+....++++||+.+++|.+++...+.+++..+..++.|+  |++|+|++|+
T Consensus        71 ~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~i  150 (322)
T d1vzoa_          71 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI  150 (322)
T ss_dssp             SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCE
Confidence            35677889999999966 89999999999999999999999999999999999999999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCC--ccccccCCCCccCccccccc--CCCcchhHHHHHHHHHHHHh
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLN  161 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slg~~~~~~~~  161 (175)
                      +|+||||+||++   +.++.++|+|||++.......  ......+++.|++||.+.+.  .++.++||||+||++|+|++
T Consensus       151 vHrDiKp~Nill---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt  227 (322)
T d1vzoa_         151 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT  227 (322)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred             EeccCCccceee---cCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh
Confidence            999999999999   577889999999998764432  23456789999999998654  46889999999999999999


Q ss_pred             CCCCCCCCCccC
Q 030527          162 GYPPFSVGEEHQ  173 (175)
Q Consensus       162 g~~pf~~~~~~~  173 (175)
                      |+.||.+.+..+
T Consensus       228 G~~PF~~~~~~~  239 (322)
T d1vzoa_         228 GASPFTVDGEKN  239 (322)
T ss_dssp             SSCTTSCTTSCC
T ss_pred             CCCCCCCCCHHH
Confidence            999998765543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.3e-37  Score=222.07  Aligned_cols=169  Identities=18%  Similarity=0.267  Sum_probs=143.2

Q ss_pred             ccccc-hhhhhhHHHHHHHHhhCCC-CCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHH--H
Q 030527            2 LKKLN-KHLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--G   76 (175)
Q Consensus         2 lk~~~-~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i--~   76 (175)
                      +|.++ ......+.+|++.++.++| ++++.+.+++...+..++|||++ +++|.+++...+ .++..++..++.|+  +
T Consensus        35 vK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~  113 (293)
T d1csna_          35 IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLAR  113 (293)
T ss_dssp             EEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHH
T ss_pred             EEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHH
Confidence            45442 2345678899999999954 89999999999999999999998 789999988764 69999999999998  9


Q ss_pred             HHHHHHcCCeecCCCCCcEEEeecC--CCceEEEeeecceeeccCCC--------ccccccCCCCccCcccccccCCCcc
Q 030527           77 LEILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEK  146 (175)
Q Consensus        77 l~~lh~~~~~h~di~~~ni~~~~~~--~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~  146 (175)
                      |++||++|++||||||+||+++...  ..+.++|+|||+++......        ......||+.|+|||.+.+..++.+
T Consensus       114 l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~  193 (293)
T d1csna_         114 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR  193 (293)
T ss_dssp             HHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH
T ss_pred             HHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChH
Confidence            9999999999999999999995322  35679999999998764331        1234568999999999999999999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          147 VDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       147 ~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      +|+||+|+++|+|++|+.||.+.+.
T Consensus       194 ~DiwSlG~~l~elltg~~Pf~~~~~  218 (293)
T d1csna_         194 DDLEALGHVFMYFLRGSLPWQGLKA  218 (293)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred             HHHHHhhHHHHHHHhCCCcCCCccc
Confidence            9999999999999999999986544

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.8e-37  Score=227.34  Aligned_cols=166  Identities=27%  Similarity=0.466  Sum_probs=144.3

Q ss_pred             CccccchhhhhhHHHHHHHHhhC-CCCCeeeEeeEEee--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--
Q 030527            1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--   75 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--   75 (175)
                      ++|.++....+++.+|+++++++ .||||+++++++..  .+..++||||+.+++|.++   .+.+++..+..++.|+  
T Consensus        64 AiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~  140 (328)
T d3bqca1          64 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILK  140 (328)
T ss_dssp             EEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHH
T ss_pred             EEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHH
Confidence            46777777778899999999999 49999999999874  4578999999999998776   3579999999999999  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccccc-CCCcchhHHHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGA  154 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~  154 (175)
                      ||+|||++|++|+||||+||+++  ..+..++|+|||++.............+|+.|+|||.+.+. .++.++|+||+|+
T Consensus       141 aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  218 (328)
T d3bqca1         141 ALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC  218 (328)
T ss_dssp             HHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred             HHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhh
Confidence            99999999999999999999995  34557999999999887766666667789999999998765 4799999999999


Q ss_pred             HHHHHHhCCCCCCCCCc
Q 030527          155 ILFELLNGYPPFSVGEE  171 (175)
Q Consensus       155 ~~~~~~~g~~pf~~~~~  171 (175)
                      +++++++|..||....+
T Consensus       219 ~l~e~~~g~~pf~~~~~  235 (328)
T d3bqca1         219 MLASMIFRKEPFFHGHD  235 (328)
T ss_dssp             HHHHHHHTCSSSSCCSS
T ss_pred             hhHHhccCCCCCCCCch
Confidence            99999999999976543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-37  Score=224.05  Aligned_cols=161  Identities=29%  Similarity=0.460  Sum_probs=139.0

Q ss_pred             chhhhhhHHHHHHHHhhCCCCCeeeEeeEEee-CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHH
Q 030527            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILN   81 (175)
Q Consensus         6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i--~l~~lh   81 (175)
                      +.....+|.+|++++++++||||+++++++.. ++..++||||+.+++|.+++... ..++...+..++.|+  |+.|+|
T Consensus        68 ~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH  147 (311)
T d1r0pa_          68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA  147 (311)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc
Confidence            45556789999999999999999999999765 56899999999999999998855 457888899999999  999999


Q ss_pred             HcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-----cccccCCCCccCcccccccCCCcchhHHHHHHHH
Q 030527           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL  156 (175)
Q Consensus        82 ~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~  156 (175)
                      +.+++||||||+||++   +.++.++|+|||+++.......     .....++..|+|||.+.+..++.++||||||+++
T Consensus       148 ~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl  224 (311)
T d1r0pa_         148 SKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL  224 (311)
T ss_dssp             HTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             ccCcccCCccHHhEeE---CCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHH
Confidence            9999999999999999   6778899999999987654322     2234578889999999988999999999999999


Q ss_pred             HHHHhCCCCCCCC
Q 030527          157 FELLNGYPPFSVG  169 (175)
Q Consensus       157 ~~~~~g~~pf~~~  169 (175)
                      ||+++|..||...
T Consensus       225 ~El~t~~~p~~~~  237 (311)
T d1r0pa_         225 WELMTRGAPPYPD  237 (311)
T ss_dssp             HHHHTTSCCSCC-
T ss_pred             HHHHHCCCCCCCC
Confidence            9999987777543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-37  Score=224.55  Aligned_cols=161  Identities=32%  Similarity=0.518  Sum_probs=130.2

Q ss_pred             hhhhhHHHHHHHHhhC-CCCCeeeEeeEEee-CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHH
Q 030527            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTAR   69 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~   69 (175)
                      ...+.+.+|..++.++ +|+||+.+.+++.. ++..++||||+++++|.+++...                ..+++..+.
T Consensus        58 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  137 (299)
T d1ywna1          58 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI  137 (299)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHH
T ss_pred             HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHH
Confidence            3455677788877777 78999999998765 45689999999999999999753                238899999


Q ss_pred             HHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC---ccccccCCCCccCcccccccCCC
Q 030527           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD  144 (175)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~  144 (175)
                      .++.|+  ||+|||++|++||||||+||++   +.++.+||+|||+++......   ......||+.|+|||.+.+..++
T Consensus       138 ~~~~qi~~gl~ylH~~~ivHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~  214 (299)
T d1ywna1         138 CYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  214 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHhCCCcCCcCCccceeE---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC
Confidence            999998  9999999999999999999999   678899999999997654432   23345688999999999999999


Q ss_pred             cchhHHHHHHHHHHHHhC-CCCCCCCCc
Q 030527          145 EKVDMWSVGAILFELLNG-YPPFSVGEE  171 (175)
Q Consensus       145 ~~~Di~slg~~~~~~~~g-~~pf~~~~~  171 (175)
                      .++||||+|+++|+|+++ ..||.+.+.
T Consensus       215 ~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         215 IQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999986 678876543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-36  Score=221.50  Aligned_cols=163  Identities=20%  Similarity=0.243  Sum_probs=136.2

Q ss_pred             hhhhhHHHHHHHHhhCCCCC-eeeEeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHHc
Q 030527            8 HLKSCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH   83 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i--~l~~lh~~   83 (175)
                      ....++..|++++++++|++ |+.+.+++.+.+..++|||++ ++++.+.+.. ...+++..+..++.|+  ||+|||++
T Consensus        44 ~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  122 (299)
T d1ckia_          44 TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK  122 (299)
T ss_dssp             TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC
Confidence            34567889999999997665 556666778888999999999 6677766654 4579999999999998  99999999


Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc--------cccccCCCCccCcccccccCCCcchhHHHHHHH
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI  155 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~  155 (175)
                      |++||||||+||++...+.+..++++|||+++.......        .....||+.|+|||.+.+..++.++|+|||||+
T Consensus       123 ~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~  202 (299)
T d1ckia_         123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV  202 (299)
T ss_dssp             TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHH
T ss_pred             CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHH
Confidence            999999999999986444566799999999987754321        234568999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCc
Q 030527          156 LFELLNGYPPFSVGEE  171 (175)
Q Consensus       156 ~~~~~~g~~pf~~~~~  171 (175)
                      +++|++|+.||.....
T Consensus       203 l~el~tg~~P~~~~~~  218 (299)
T d1ckia_         203 LMYFNLGSLPWQGLKA  218 (299)
T ss_dssp             HHHHHHSSCTTCCCC-
T ss_pred             HHHHHhCCCcccccch
Confidence            9999999999977544

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-37  Score=222.90  Aligned_cols=166  Identities=26%  Similarity=0.359  Sum_probs=135.0

Q ss_pred             CccccchhhhhhHHHHHH--HHhhCCCCCeeeEeeEEeeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHH
Q 030527            1 MLKKLNKHLKSCLDCELN--FLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (175)
Q Consensus         1 ~lk~~~~~~~~~~~~e~~--~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~   74 (175)
                      +||.++.+..+.+..|.+  .+.+++||||+++++++.+.+    ..++||||+.+++|.+++++. +++......+..+
T Consensus        30 AvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~  108 (303)
T d1vjya_          30 AVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALS  108 (303)
T ss_dssp             EEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHH
T ss_pred             EEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHH
Confidence            367776666666655555  445779999999999987643    689999999999999999864 6889999999999


Q ss_pred             H--HHHHHHH--------cCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-----ccccccCCCCccCccccc
Q 030527           75 L--GLEILNS--------HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQ  139 (175)
Q Consensus        75 i--~l~~lh~--------~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~  139 (175)
                      +  +++++|+        +|++||||||+||++   +.++.++|+|||++.......     ......||+.|+|||.+.
T Consensus       109 ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  185 (303)
T d1vjya_         109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD  185 (303)
T ss_dssp             HHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHT
T ss_pred             HHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhcc
Confidence            8  9999996        599999999999999   678899999999998775432     223466899999999986


Q ss_pred             cc------CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030527          140 FQ------RYDEKVDMWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       140 ~~------~~~~~~Di~slg~~~~~~~~g~~pf~~~~  170 (175)
                      +.      .++.++||||||+++|+|+||..||....
T Consensus       186 ~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~  222 (303)
T d1vjya_         186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  222 (303)
T ss_dssp             TCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred             ccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence            43      25778999999999999999998885443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-36  Score=225.70  Aligned_cols=165  Identities=32%  Similarity=0.555  Sum_probs=136.6

Q ss_pred             ccccc----hhhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC-----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHH
Q 030527            2 LKKLN----KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL   72 (175)
Q Consensus         2 lk~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~   72 (175)
                      ||.++    .....++.+|++++++++||||+++++++....     ..+++ +++.|++|.++++. ..+++..+..++
T Consensus        38 vK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~  115 (345)
T d1pmea_          38 IKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFL  115 (345)
T ss_dssp             EEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHH
T ss_pred             EEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHH
Confidence            55553    334557789999999999999999999986543     34555 55669999999974 579999999999


Q ss_pred             HHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC----ccccccCCCCccCcccccc-cCCCc
Q 030527           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF-QRYDE  145 (175)
Q Consensus        73 ~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~-~~~~~  145 (175)
                      .|+  ||+|||++|++||||||+||++   +.++.++|+|||++.......    ......+++.|+|||.+.. ..++.
T Consensus       116 ~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~  192 (345)
T d1pmea_         116 YQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK  192 (345)
T ss_dssp             HHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCST
T ss_pred             HHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCc
Confidence            999  9999999999999999999999   577889999999997664432    2334568889999999854 45789


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCCc
Q 030527          146 KVDMWSVGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       146 ~~Di~slg~~~~~~~~g~~pf~~~~~  171 (175)
                      ++|+||+|+++++|++|+.||.+.+.
T Consensus       193 ~~DiwSlG~il~eml~g~~pf~~~~~  218 (345)
T d1pmea_         193 SIDIWSVGCILAEMLSNRPIFPGKHY  218 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             hhhhhccCceehHHhhCCCCCCCCCH
Confidence            99999999999999999999987653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-36  Score=221.63  Aligned_cols=162  Identities=31%  Similarity=0.478  Sum_probs=141.1

Q ss_pred             hhhhhhHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcC------------------CCCHHH
Q 030527            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQT   67 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~   67 (175)
                      ......+.+|+.+++++ +||||+++++++.+.+..+++|||+++++|.+++.+..                  .+++..
T Consensus        67 ~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~  146 (311)
T d1t46a_          67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED  146 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHH
T ss_pred             HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHH
Confidence            34556788999999999 79999999999999999999999999999999987543                  488999


Q ss_pred             HHHHHHHH--HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccC
Q 030527           68 ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQR  142 (175)
Q Consensus        68 ~~~~~~~i--~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~  142 (175)
                      +..++.|+  |++|||++|++||||||+||++   +..+.++++|||.++.......   .....+++.|+|||.+.+..
T Consensus       147 ~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  223 (311)
T d1t46a_         147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV  223 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecccccccccc---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC
Confidence            99999999  9999999999999999999999   5778899999999987754322   23456788999999999889


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 030527          143 YDEKVDMWSVGAILFELLN-GYPPFSVGEE  171 (175)
Q Consensus       143 ~~~~~Di~slg~~~~~~~~-g~~pf~~~~~  171 (175)
                      ++.++||||||+++|+|+| |.+||.+...
T Consensus       224 ~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         224 YTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             CCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999998 6777766544

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-36  Score=221.66  Aligned_cols=161  Identities=25%  Similarity=0.459  Sum_probs=134.7

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEee--------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GL   77 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l   77 (175)
                      ....++.+|++++++++|||++++++++..        .+..+++||++.++.+..+......+++..+..++.|+  |+
T Consensus        51 ~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l  130 (318)
T d3blha1          51 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL  130 (318)
T ss_dssp             SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHH
Confidence            345568899999999999999999998754        34679999999776666555555789999999999998  99


Q ss_pred             HHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCC-----ccccccCCCCccCccccccc-CCCcchhHHH
Q 030527           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWS  151 (175)
Q Consensus        78 ~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~s  151 (175)
                      +|||+.|++||||||+||++   +.++.++++|||++.......     ......+|+.|+|||.+.+. .++.++|+||
T Consensus       131 ~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwS  207 (318)
T d3blha1         131 YYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG  207 (318)
T ss_dssp             HHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred             HHhccCCEEecCcCchheee---cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHccc
Confidence            99999999999999999999   578889999999997665332     22345689999999998755 6899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCc
Q 030527          152 VGAILFELLNGYPPFSVGEE  171 (175)
Q Consensus       152 lg~~~~~~~~g~~pf~~~~~  171 (175)
                      +|+++++|++|+.||.+.++
T Consensus       208 lGvil~el~~g~~pf~~~~~  227 (318)
T d3blha1         208 AGCIMAEMWTRSPIMQGNTE  227 (318)
T ss_dssp             HHHHHHHHHHSSCSCCCSSH
T ss_pred             CCceeeeHhhCCCCCCCCCH
Confidence            99999999999999987553

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-36  Score=223.69  Aligned_cols=157  Identities=34%  Similarity=0.587  Sum_probs=136.8

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~   79 (175)
                      ...+++.+|++++++++||||+++++++...+      .+++||||+ +.+|..+.+ .+.+++..+..++.|+  ||+|
T Consensus        59 ~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~  136 (346)
T d1cm8a_          59 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRY  136 (346)
T ss_dssp             HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHH
Confidence            44567889999999999999999999997654      569999999 667777665 5689999999999998  9999


Q ss_pred             HHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCccccccc-CCCcchhHHHHHHHHHH
Q 030527           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE  158 (175)
Q Consensus        80 lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~  158 (175)
                      ||++|++||||||+||++   +.++.++++|||.+......  .....+++.|+|||.+.+. .++.++|+||+||++++
T Consensus       137 LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~e  211 (346)
T d1cm8a_         137 IHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE  211 (346)
T ss_dssp             HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHH
T ss_pred             HHhCCCcccccCcchhhc---ccccccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHH
Confidence            999999999999999999   67888999999999877544  3345689999999998764 56899999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030527          159 LLNGYPPFSVGEE  171 (175)
Q Consensus       159 ~~~g~~pf~~~~~  171 (175)
                      |++|..||.+.+.
T Consensus       212 ll~g~~pf~~~~~  224 (346)
T d1cm8a_         212 MITGKTLFKGSDH  224 (346)
T ss_dssp             HHHSSCSSCCSSH
T ss_pred             HHHCcCCCCCCCh
Confidence            9999999987654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-36  Score=219.68  Aligned_cols=161  Identities=24%  Similarity=0.441  Sum_probs=139.6

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHH--
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQL--   75 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~i--   75 (175)
                      .....|.+|++++++++||||+++++++...+..++||||+.+++|.+++...          ..++...+..++.++  
T Consensus        65 ~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~  144 (308)
T d1p4oa_          65 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD  144 (308)
T ss_dssp             HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHH
Confidence            33456889999999999999999999999999999999999999999988533          236888999999998  


Q ss_pred             HHHHHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc---cccccCCCCccCcccccccCCCcchhHHHH
Q 030527           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV  152 (175)
Q Consensus        76 ~l~~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl  152 (175)
                      ||+|||+++++||||||+||++   +.+..++|+|||+++.......   .....+++.|+|||.+.+..++.++|+||+
T Consensus       145 gl~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~  221 (308)
T d1p4oa_         145 GMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF  221 (308)
T ss_dssp             HHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHhhCCeeeceEcCCceee---cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccH
Confidence            9999999999999999999999   6888999999999986644322   233457899999999999999999999999


Q ss_pred             HHHHHHHHhC-CCCCCCCCc
Q 030527          153 GAILFELLNG-YPPFSVGEE  171 (175)
Q Consensus       153 g~~~~~~~~g-~~pf~~~~~  171 (175)
                      |+++|+|++| ..||.+.+.
T Consensus       222 G~il~El~t~~~~p~~~~~~  241 (308)
T d1p4oa_         222 GVVLWEIATLAEQPYQGLSN  241 (308)
T ss_dssp             HHHHHHHHHTSCCTTTTSCH
T ss_pred             HHHHHHHHhCCCCCCCCCCH
Confidence            9999999998 578876554

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-36  Score=222.00  Aligned_cols=159  Identities=35%  Similarity=0.497  Sum_probs=127.9

Q ss_pred             hhhhhhHHHHHHHHhhCCCCCeeeEeeEEee------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHH
Q 030527            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE   78 (175)
Q Consensus         7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~   78 (175)
                      .....++.+|+.++++++||||+++++++..      .+..|+||||+.+ ++.+.+  ...+++..+..++.|+  ||+
T Consensus        57 ~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~  133 (355)
T d2b1pa1          57 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIK  133 (355)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHH
Confidence            4445678899999999999999999999853      4688999999965 444444  3568999999999998  999


Q ss_pred             HHHHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccCCCcchhHHHHHHHHHH
Q 030527           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE  158 (175)
Q Consensus        79 ~lh~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~  158 (175)
                      |||++|++|+||||+||++   +.++.++++|||.+.............+|+.|+|||.+.+..+++++|+||+||++++
T Consensus       134 ~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~e  210 (355)
T d2b1pa1         134 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE  210 (355)
T ss_dssp             HHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             HhhhcccccccCCcccccc---ccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHH
Confidence            9999999999999999999   5778899999999888776666666778999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCc
Q 030527          159 LLNGYPPFSVGEE  171 (175)
Q Consensus       159 ~~~g~~pf~~~~~  171 (175)
                      |++|+.||.+.++
T Consensus       211 ll~g~~pF~~~~~  223 (355)
T d2b1pa1         211 MVRHKILFPGRDY  223 (355)
T ss_dssp             HHHSSCSSCCSSH
T ss_pred             HhhCCCCCCCCCH
Confidence            9999999987653

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-35  Score=211.30  Aligned_cols=158  Identities=32%  Similarity=0.520  Sum_probs=139.5

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCC
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~   85 (175)
                      ....++.+|+.+++.++||||+++.+++.+....+++++++.++++..++...+.+++..+..++.|+  ||+|||++|+
T Consensus        43 ~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~I  122 (292)
T d1unla_          43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV  122 (292)
T ss_dssp             THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCE
Confidence            44678899999999999999999999999999999999999999999988888899999999999998  9999999999


Q ss_pred             eecCCCCCcEEEeecCCCceEEEeeecceeeccCCCc-cccccCCCCccCcccccccC-CCcchhHHHHHHHHHHHHhCC
Q 030527           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGY  163 (175)
Q Consensus        86 ~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~g~  163 (175)
                      +|+||||+||++   +.++.++++|||.+........ .....++..|.|||.+.+.. ++.++|+||+||++++|++|.
T Consensus       123 vHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~  199 (292)
T d1unla_         123 LHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG  199 (292)
T ss_dssp             ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred             eeecccCccccc---ccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCC
Confidence            999999999999   5677899999999988765432 33445567789999887655 689999999999999999999


Q ss_pred             CCCCC
Q 030527          164 PPFSV  168 (175)
Q Consensus       164 ~pf~~  168 (175)
                      .||-.
T Consensus       200 ~p~~~  204 (292)
T d1unla_         200 RPLFP  204 (292)
T ss_dssp             CCSCC
T ss_pred             CCCCC
Confidence            88643

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-35  Score=217.50  Aligned_cols=158  Identities=32%  Similarity=0.523  Sum_probs=129.9

Q ss_pred             hhhhhHHHHHHHHhhCCCCCeeeEeeEEeeC-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 030527            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (175)
Q Consensus         8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~l   80 (175)
                      ....++.+|++++++++|||++++++++...     ...+++++++.|++|.+++. .+++++..+..++.|+  ||+||
T Consensus        59 ~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~L  137 (348)
T d2gfsa1          59 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYI  137 (348)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHH
Confidence            3445788999999999999999999998532     33455666777999999986 4579999999999999  99999


Q ss_pred             HHcCCeecCCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCcccccccC-CCcchhHHHHHHHHHHH
Q 030527           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFEL  159 (175)
Q Consensus        81 h~~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~  159 (175)
                      |++|++||||||+||++   +.++.++++|||.+......  .....+++.|+|||...+.. ++.++|+||+|+++|+|
T Consensus       138 H~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~l  212 (348)
T d2gfsa1         138 HSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL  212 (348)
T ss_dssp             HHTTCCCCCCCGGGEEE---CTTCCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHH
T ss_pred             HhCCCcccccCCccccc---cccccccccccchhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHH
Confidence            99999999999999999   67788999999998765332  33456778899999876654 68899999999999999


Q ss_pred             HhCCCCCCCCCc
Q 030527          160 LNGYPPFSVGEE  171 (175)
Q Consensus       160 ~~g~~pf~~~~~  171 (175)
                      ++|+.||.+.+.
T Consensus       213 l~g~~pF~~~~~  224 (348)
T d2gfsa1         213 LTGRTLFPGTDH  224 (348)
T ss_dssp             HHSSCSCCCSSH
T ss_pred             HhCCCCCCCCCH
Confidence            999999987653

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.95  E-value=1.8e-28  Score=182.67  Aligned_cols=167  Identities=30%  Similarity=0.482  Sum_probs=126.2

Q ss_pred             ccccch--hhhhhHHHHHHHHhhCC-----------CCCeeeEeeEEee--CCeEEEEEeccCCCChH-HHHH--hcCCC
Q 030527            2 LKKLNK--HLKSCLDCELNFLSSVN-----------HPNIIRLFDAFQA--ENCIFLVVEFCAGGNLS-SYIR--LHGRV   63 (175)
Q Consensus         2 lk~~~~--~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~-~~l~--~~~~l   63 (175)
                      ||.++.  ...+.+.+|+++++.++           |+||+++++++..  ....++++.++...... ....  ....+
T Consensus        43 vKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  122 (362)
T d1q8ya_          43 MKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI  122 (362)
T ss_dssp             EEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCC
T ss_pred             EEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCC
Confidence            555533  34567788999998875           5789999988754  34556666655444333 2222  22468


Q ss_pred             CHHHHHHHHHHH--HHHHHHH-cCCeecCCCCCcEEEeecCC---CceEEEeeecceeeccCCCccccccCCCCccCccc
Q 030527           64 PEQTARKFLQQL--GLEILNS-HHIIHRDLKPENILLSGLDD---DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV  137 (175)
Q Consensus        64 ~~~~~~~~~~~i--~l~~lh~-~~~~h~di~~~ni~~~~~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~pe~  137 (175)
                      ++..+..++.|+  |+++||+ .|++||||||+||++...+.   ...++++|||.+......  .....+++.|+|||.
T Consensus       123 ~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~  200 (362)
T d1q8ya_         123 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEV  200 (362)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc--cccccccccccChhh
Confidence            999999999998  9999998 89999999999999952221   235899999998766433  345668999999999


Q ss_pred             ccccCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 030527          138 LQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE  170 (175)
Q Consensus       138 ~~~~~~~~~~Di~slg~~~~~~~~g~~pf~~~~  170 (175)
                      +....++.++|+||+|+++++|++|+.||...+
T Consensus       201 ~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         201 LLGAPWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             HHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             ccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence            998899999999999999999999999997654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.71  E-value=5.3e-18  Score=115.13  Aligned_cols=123  Identities=17%  Similarity=0.193  Sum_probs=87.7

Q ss_pred             hhHHHHHHHHhhCCCCCeeeEeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHHcCCeec
Q 030527           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (175)
Q Consensus        11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (175)
                      .....|.+.+.++.|.+++..+++.  .  .+++||++.+..+.+       ++...+..++.|+  ++++||++|++|+
T Consensus        59 ~~~~~e~~~l~~l~~~~v~~~~~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHr  127 (191)
T d1zara2          59 RSARNEFRALQKLQGLAVPKVYAWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHG  127 (191)
T ss_dssp             HHHHHHHHHHHHTTTSSSCCEEEEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHHHccCCCcceEEEec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEc
Confidence            3445688999999999999887653  2  368999998765543       3445556778887  9999999999999


Q ss_pred             CCCCCcEEEeecCCCceEEEeeecceeeccCCCccccccCCCCccCc--c---cccccCCCcchhHHHHHHH
Q 030527           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP--E---VLQFQRYDEKVDMWSVGAI  155 (175)
Q Consensus        89 di~~~ni~~~~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~p--e---~~~~~~~~~~~Di~slg~~  155 (175)
                      ||||+||+++   . ..++|+|||.+.....+....       |...  +   ....+.++.++|+||+.--
T Consensus       128 DiKP~NILv~---~-~~~~liDFG~a~~~~~~~~~~-------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         128 DLSQYNVLVS---E-EGIWIIDFPQSVEVGEEGWRE-------ILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCSTTSEEEE---T-TEEEECCCTTCEETTSTTHHH-------HHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             cCChhheeee---C-CCEEEEECCCcccCCCCCcHH-------HHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            9999999994   3 348899999987764332211       1111  0   0113567888999996543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.88  E-value=3.5e-05  Score=52.98  Aligned_cols=45  Identities=9%  Similarity=0.033  Sum_probs=34.8

Q ss_pred             hhHHHHHHHHhhCC-CCCeeeEeeEEeeCCeEEEEEeccCCCChHH
Q 030527           11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSS   55 (175)
Q Consensus        11 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   55 (175)
                      ..+..|..+++.+. +--+++++.+....+..++||++++|..+.+
T Consensus        54 ~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~   99 (263)
T d1j7la_          54 YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE   99 (263)
T ss_dssp             TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred             hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccc
Confidence            35678999988873 3336788888888899999999998876643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.87  E-value=3.4e-05  Score=52.79  Aligned_cols=52  Identities=17%  Similarity=0.103  Sum_probs=38.8

Q ss_pred             ccccchhhhhhHHHHHHHHhhCCCCC--eeeEeeEEeeCCeEEEEEeccCCCCh
Q 030527            2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNL   53 (175)
Q Consensus         2 lk~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L   53 (175)
                      ||.........+..|.+.++.+...+  +++++.+..+.+..++||++++|.++
T Consensus        40 lK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          40 VKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             EEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            45555555667889999998884333  55677777888889999999988654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.70  E-value=0.0026  Score=46.25  Aligned_cols=30  Identities=27%  Similarity=0.301  Sum_probs=24.3

Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .++|||+++.||++.   . +.++++|+..+..-
T Consensus       224 ~LiHGDl~~gNIlv~---~-~~~~vID~E~a~~G  253 (392)
T d2pula1         224 TLIHGDLHTGSIFAS---E-HETKVIDPEFAFYG  253 (392)
T ss_dssp             EEECSCCCGGGEEEC---S-SCEEECCCTTCEEE
T ss_pred             ceeccCCcCCceeEc---C-CceEEechhhcccC
Confidence            489999999999993   3 34899999877554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.51  E-value=0.014  Score=41.02  Aligned_cols=28  Identities=25%  Similarity=0.264  Sum_probs=21.9

Q ss_pred             CCeecCCCCCcEEEeecCCCceEEEeeecceee
Q 030527           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (175)
Q Consensus        84 ~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~  116 (175)
                      +++|+|+.+.|+++   +.+  ..++||+-+..
T Consensus       193 ~liHgDlh~~NvL~---~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILW---RDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEE---SSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEE---eCC--ceEEechhccc
Confidence            58999999999999   332  35789987754

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.30  E-value=0.0027  Score=44.49  Aligned_cols=32  Identities=28%  Similarity=0.505  Sum_probs=25.9

Q ss_pred             cCCeecCCCCCcEEEeecCCCceEEEeeecceeec
Q 030527           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (175)
Q Consensus        83 ~~~~h~di~~~ni~~~~~~~~~~~~l~df~~~~~~  117 (175)
                      .|++|+|+.++|+++   +.+....++||+.+...
T Consensus       183 ~giIHgDl~~dNvl~---~~~~v~gvIDF~~~~~~  214 (316)
T d2ppqa1         183 AGVIHADLFQDNVFF---LGDELSGLIDFYFACND  214 (316)
T ss_dssp             EEEECSCCCGGGEEE---ETTEEEEECCCTTCEEE
T ss_pred             cccccCCcchhhhhc---ccccceeEecccccccc
Confidence            368999999999999   45555689999988544

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.61  E-value=0.015  Score=41.98  Aligned_cols=38  Identities=16%  Similarity=0.141  Sum_probs=25.7

Q ss_pred             hHHHHHHHHhhC-CCCCeeeEeeEEeeCCeEEEEEeccCCCCh
Q 030527           12 CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNL   53 (175)
Q Consensus        12 ~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   53 (175)
                      ...+|.++++.+ ++.-.+++++++.+    .+|++|+.|..+
T Consensus        90 dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          90 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            456799999988 44444577766543    478999987443